<SEC-DOCUMENT>0001140361-25-036535.txt : 20250929
<SEC-HEADER>0001140361-25-036535.hdr.sgml : 20250929
<ACCEPTANCE-DATETIME>20250929170616
ACCESSION NUMBER:		0001140361-25-036535
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		22
CONFORMED PERIOD OF REPORT:	20250925
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
ITEM INFORMATION:		Unregistered Sales of Equity Securities
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250929
DATE AS OF CHANGE:		20250929

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Momentus Inc.
		CENTRAL INDEX KEY:			0001781162
		STANDARD INDUSTRIAL CLASSIFICATION:	GUIDED MISSILES & SPACE VEHICLES & PARTS [3760]
		ORGANIZATION NAME:           	04 Manufacturing
		EIN:				841905538
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39128
		FILM NUMBER:		251357145

	BUSINESS ADDRESS:	
		STREET 1:		3901 N. FIRST STREET
		CITY:			SAN JOSE
		STATE:			CA
		ZIP:			95134
		BUSINESS PHONE:		6505647820

	MAIL ADDRESS:	
		STREET 1:		3901 N. FIRST STREET
		CITY:			SAN JOSE
		STATE:			CA
		ZIP:			95134

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Stable Road Acquisition Corp.
		DATE OF NAME CHANGE:	20190628
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>ny20047547x33_8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:srt="http://fasb.org/srt/2025" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:country="http://xbrl.sec.gov/country/2025" xmlns:currency="http://xbrl.sec.gov/currency/2025" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2024-01-31" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:naics="http://xbrl.sec.gov/naics/2025" xmlns:sic="http://xbrl.sec.gov/sic/2025" xmlns:stpr="http://xbrl.sec.gov/stpr/2025" xmlns:exch="http://xbrl.sec.gov/exch/2025" xmlns:cef="http://xbrl.sec.gov/cef/2025" xmlns:cyd="http://xbrl.sec.gov/cyd/2025" xmlns:mnts="http://momentus.space/20250925" xmlns="http://www.w3.org/1999/xhtml">
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc.
         Document created using Broadridge PROfile 25.9.1.5330
         Copyright 1995 - 2025 Broadridge -->
    <meta http-equiv="Content-Type" content="text/html"/>
</head>

<body style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000; background-color: #ffffff;">
<div id="DSPFiXBRLHidden" style="display: none;"><ix:header><ix:hidden><ix:nonNumeric name="dei:AmendmentFlag" id="Fact_d376102dd3134298b4c407817bcf65b4" contextRef="c20250925to20250925" format="ixt:fixed-false">false</ix:nonNumeric><ix:nonNumeric name="dei:DocumentPeriodEndDate" id="Fact_9d8820e0ecc746fa907da689fe54af74" contextRef="c20250925to20250925">2025-09-25</ix:nonNumeric><ix:nonNumeric name="dei:EntityCentralIndexKey" id="Fact_80246123b6b24e4397fed63868e3124f" contextRef="c20250925to20250925">0001781162</ix:nonNumeric><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" id="Fact_aab4d6bb89ca45f899afc974b9579a02" contextRef="c20250925to20250925">DE</ix:nonNumeric><ix:nonNumeric name="dei:EntityAddressAddressLine1" id="Fact_6496073cfd4041d5bd499182983d50b3" contextRef="c20250925to20250925">3901 N. FIRST STREET</ix:nonNumeric><ix:nonNumeric name="dei:EntityAddressCityOrTown" id="Fact_845c5cacaafe477c95196d8369966472" contextRef="c20250925to20250925">SAN JOSE</ix:nonNumeric><ix:nonNumeric name="dei:EntityAddressStateOrProvince" id="Fact_4ec4fd48e404438caa2040897c56b6a5" contextRef="c20250925to20250925">CA</ix:nonNumeric><ix:nonNumeric name="dei:SecurityExchangeName" id="Fact_8105e2dc74d844c4a41ffc7b8629e8e8" contextRef="c20250925to20250925_StatementClassOfStockAxis_WarrantsMember">NASDAQ</ix:nonNumeric><ix:nonNumeric name="dei:SecurityExchangeName" id="Fact_93a7c9e06f3c471a81965345f0121279" contextRef="c20250925to20250925_StatementClassOfStockAxis_CommonStockMember">NASDAQ</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:href="mnts-20250925.xsd" xlink:type="simple"/></ix:references><ix:resources><xbrli:context id="c20250925to20250925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001781162</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2025-09-25</xbrli:startDate><xbrli:endDate>2025-09-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20250925to20250925_StatementClassOfStockAxis_WarrantsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001781162</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mnts:WarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-09-25</xbrli:startDate><xbrli:endDate>2025-09-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20250925to20250925_StatementClassOfStockAxis_CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001781162</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-09-25</xbrli:startDate><xbrli:endDate>2025-09-25</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div>
<div style="line-height: initial;">
  <hr style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"/>
  <div>
    <div style="text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 14pt; font-weight: bold;">UNITED STATES</div>

    <div style="text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 14pt; font-weight: bold;">SECURITIES AND EXCHANGE COMMISSION</div>

    <div style="text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 12pt; font-weight: bold;">Washington, D.C. 20549</div>

    <div><br/>
    </div>

    <div style="text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 18pt; font-weight: bold;">FORM <ix:nonNumeric name="dei:DocumentType" id="Fact_6b32b7868bab4f8b93583c369c4519f8" contextRef="c20250925to20250925">8-K</ix:nonNumeric></div>

    <div><br/>
    </div>

    <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">CURRENT REPORT</div>

    <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934</div>

    <div><br/>
    </div>

    <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><span style="-sec-ix-hidden:Fact_9d8820e0ecc746fa907da689fe54af74">September 25, 2025</span><br/>
    </div>

    <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Date of Report (date of earliest event reported)</div>

    <div><br/>
    </div>

    <div style="text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 18pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityRegistrantName" id="Fact_f1a420de4d7a4121b7c8d36078535415" contextRef="c20250925to20250925">Momentus Inc.</ix:nonNumeric><br/>
    </div>

    <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">(Exact name of registrant as specified in its charter)</div>

    <div><br/>
    </div>

    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 36.97%; vertical-align: top;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;"><span style="-sec-ix-hidden:Fact_aab4d6bb89ca45f899afc974b9579a02">Delaware</span><br/>
            </div>
          </td>

    <td style="width: 26.06%; vertical-align: bottom;" colspan="2">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityFileNumber" id="Fact_18a30d82eeea4101897ba9ed27addf02" contextRef="c20250925to20250925">001-39128</ix:nonNumeric><br/>
            </div>
          </td>

    <td style="width: 36.97%; vertical-align: top;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" id="Fact_017d915069464821b92cd5e981bb0d37" contextRef="c20250925to20250925">84-1905538</ix:nonNumeric><br/>
            </div>
          </td>

  </tr>

  <tr>

    <td style="width: 36.97%; vertical-align: top;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(State or other jurisdiction of </div>
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">incorporation or organization)</div>
          </td>

    <td style="width: 26.06%; vertical-align: top;" colspan="2">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(Commission File Number)</div>
          </td>

    <td style="width: 36.97%; vertical-align: top;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(I.R.S. Employer Identification No.)</div>
          </td>

  </tr>

  <tr>

    <td style="width: 36.97%; vertical-align: bottom;">&#160;</td>

    <td style="width: 13.03%; vertical-align: bottom;">&#160;</td>

    <td style="width: 13.03%; vertical-align: bottom;">&#160;</td>

    <td style="width: 36.97%; vertical-align: bottom;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 36.97%; vertical-align: top;">
            <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;"><span style="-sec-ix-hidden:Fact_6496073cfd4041d5bd499182983d50b3">3901 N. First Street</span><br/>
            </div>
            <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;"><span style="-sec-ix-hidden:Fact_845c5cacaafe477c95196d8369966472">San Jose</span>, <span style="-sec-ix-hidden:Fact_4ec4fd48e404438caa2040897c56b6a5">California</span></div>
          </td>

    <td style="width: 13.03%; vertical-align: bottom;">&#160;</td>

    <td style="width: 13.03%; vertical-align: bottom;">&#160;</td>

    <td style="width: 36.97%; vertical-align: middle;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressPostalZipCode" id="Fact_ddd74282c87e48de9bedabc6caef3fc8" contextRef="c20250925to20250925">95134</ix:nonNumeric><br/>
            </div>
          </td>

  </tr>

  <tr>

    <td style="width: 36.97%; vertical-align: top;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(Address of Principal Executive Offices)</div>
          </td>

    <td style="width: 13.03%; vertical-align: bottom;">&#160;</td>

    <td style="width: 13.03%; vertical-align: bottom;">&#160;</td>

    <td style="width: 36.97%; vertical-align: top;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(Zip Code)</div>
          </td>

  </tr>


</table>
    <div><br/>
    </div>

    <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">(<ix:nonNumeric name="dei:CityAreaCode" id="Fact_0c5fef8c3dea426989e255633f038a56" contextRef="c20250925to20250925">650</ix:nonNumeric>) <ix:nonNumeric name="dei:LocalPhoneNumber" id="Fact_50b80b7d7e5d4e6cb3ea58a6d0cd8f28" contextRef="c20250925to20250925">564-7820</ix:nonNumeric></div>

    <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Registrant&#8217;s telephone number, including area code</div>

    <div><br/>
    </div>

    <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the
      following provisions (see General Instruction A.2. below):</div>

    <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"> <br/>
    </div>

    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 5.29%; vertical-align: top;">
            <div style="text-align: left; color: #000000; font-family: 'Segoe UI Symbol', sans-serif; font-size: 10pt;"><ix:nonNumeric name="dei:WrittenCommunications" id="Fact_604ce8e12db74624bb0242b7a2773e5d" contextRef="c20250925to20250925" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric><br/>
            </div>
          </td>

    <td style="width: 94.71%; vertical-align: top;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</div>
          </td>

  </tr>

  <tr>

    <td style="width: 5.29%; vertical-align: top;">
            <div style="text-align: left; color: #000000; font-family: 'Segoe UI Symbol', sans-serif; font-size: 10pt;"><ix:nonNumeric name="dei:SolicitingMaterial" id="Fact_56b59e6ddfa24089a3ec3bb170c4be38" contextRef="c20250925to20250925" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric><br/>
            </div>
          </td>

    <td style="width: 94.71%; vertical-align: top;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</div>
          </td>

  </tr>

  <tr>

    <td style="width: 5.29%; vertical-align: top;">
            <div style="text-align: left; color: #000000; font-family: 'Segoe UI Symbol', sans-serif; font-size: 10pt;"><ix:nonNumeric name="dei:PreCommencementTenderOffer" id="Fact_a00618ee0b1c4fa1809980c84eaba185" contextRef="c20250925to20250925" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric><br/>
            </div>
          </td>

    <td style="width: 94.71%; vertical-align: top;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d&#8209;2(b))</div>
          </td>

  </tr>

  <tr>

    <td style="width: 5.29%; vertical-align: top;">
            <div style="text-align: left; color: #000000; font-family: 'Segoe UI Symbol', sans-serif; font-size: 10pt;"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" id="Fact_946835efbdfd4ed8b069b69a810d9ae6" contextRef="c20250925to20250925" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric><br/>
            </div>
          </td>

    <td style="width: 94.71%; vertical-align: top;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e&#8209;4(c))</div>
          </td>

  </tr>


</table>
    <div><br/>
    </div>

    <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Securities registered pursuant to section 12(g) of the Act:</div>

    <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"> <br/>
    </div>

    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 36.38%; vertical-align: bottom; border-left: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Title of each class</div>
          </td>

    <td style="width: 23.56%; vertical-align: bottom; border-left: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Trading Symbol(s)</div>
          </td>

    <td style="width: 40.06%; vertical-align: bottom; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Name of each exchange on which registered</div>
          </td>

  </tr>

  <tr>

    <td style="width: 36.38%; vertical-align: middle; border-left: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><ix:nonNumeric name="dei:Security12bTitle" id="Fact_9c45aeb00c2b4a45994b60ce787fa83a" contextRef="c20250925to20250925_StatementClassOfStockAxis_CommonStockMember">Class A common stock</ix:nonNumeric><br/>
            </div>
          </td>

    <td style="width: 23.56%; vertical-align: middle; border-left: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><ix:nonNumeric name="dei:TradingSymbol" id="Fact_45374d598ab9482393c16ac72616af5f" contextRef="c20250925to20250925_StatementClassOfStockAxis_CommonStockMember">MNTS</ix:nonNumeric><br/>
            </div>
          </td>

    <td style="width: 40.06%; vertical-align: middle; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><span style="-sec-ix-hidden:Fact_93a7c9e06f3c471a81965345f0121279">The Nasdaq Stock Market LLC</span><br/>
            </div>
          </td>

  </tr>

  <tr>

    <td style="width: 36.38%; vertical-align: middle; border-left: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><ix:nonNumeric name="dei:Security12bTitle" id="Fact_c2101116c0dc4c43b0676f8cef2319db" contextRef="c20250925to20250925_StatementClassOfStockAxis_WarrantsMember">Warrants</ix:nonNumeric><br/>
            </div>
          </td>

    <td style="width: 23.56%; vertical-align: middle; border-left: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><ix:nonNumeric name="dei:TradingSymbol" id="Fact_0f30fbaf1b08412d830aef8275ce1b29" contextRef="c20250925to20250925_StatementClassOfStockAxis_WarrantsMember">MNTSW</ix:nonNumeric><br/>
            </div>
          </td>

    <td style="width: 40.06%; vertical-align: middle; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><span style="-sec-ix-hidden:Fact_8105e2dc74d844c4a41ffc7b8629e8e8">The Nasdaq Stock Market LLC</span><br/>
            </div>
          </td>

  </tr>


</table>
    <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"> <br/>
    </div>

    <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167; 230.405 of this chapter)
      or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167; 240.12b&#8209;2 of this chapter).</div>

    <div><br/>
    </div>

    <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Emerging growth company <ix:nonNumeric name="dei:EntityEmergingGrowthCompany" id="Fact_f416ae9d20354992b2ba12b372888696" contextRef="c20250925to20250925" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></div>

    <div><br/>
    </div>

    <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or
      revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. <span style="font-size: 10pt; font-family: 'Segoe UI Symbol', sans-serif;">&#9744;</span></div>

    <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Segoe UI Symbol', sans-serif;"> <br/>
      </span></div>

    <div>
      <hr style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"/></div>

    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"/></div>

    </div>

    <div style="text-align: left;">
<div><span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; color: #000000;"> </span></div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%; border-spacing: 0;">


  <tr>

    <td style="width: 10%;"><span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; color: #000000;">Item 1.01</span> <br/>
            </td>

    <td style="width: 90%;"><span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; color: #000000;">Entry into a Material Definitive Agreement</span></td>

  </tr>


</table>
    </div>

    <div style="text-align: left;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <br/>
    </div>

    <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Private Placement Offering</div>

    <div><br/>
    </div>

    <div style="text-align: justify; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">On September 25, 2025, Momentus Inc. (the &#8220;Company&#8221;) entered into a securities purchase agreement (the &#8220;Purchase Agreement&#8221;) with Yield
      Point NY, LLC (the &#8220;Investor&#8221;), pursuant to which the Company agreed to sell (the &#8220;Offering&#8221;) (i) a Junior Secured Convertible Note having an aggregate principal amount of $1,630,435, maturing twelve months after the issue date, with original issue
      discount of 8%, convertible into shares of Class A common stock of the Company, par value $0.00001 per share (&#8220;Common Stock&#8221;) at a conversion price of $1.116 per share, and if not converted then amortized over the final six months concluding on the
      maturity date, and (ii) warrants to purchase up to 1,460,964 shares of Common Stock at an exercise price of $1.40 per share (the &#8220;Investor Warrants&#8221;). The Company received approximately $1,500,000 in gross proceeds from the Offering.</div>

    <div><br/>
    </div>

    <div style="text-align: justify; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic;">Securities Purchase Agreement</div>

    <div><br/>
    </div>

    <div style="text-align: justify; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">The Purchase Agreement contains representations and warranties of the Company and the Investor which are typical for transactions of this
      type. In addition, the Purchase Agreement contains customary covenants on the Company&#8217;s part that are typical for transactions of this type, as well as the following additional covenants: (i) for as long as the Notes remain outstanding, the Company
      agreed not to effect or enter into an Equity Line of Credit or agreement to effect any issuance by the Company or any of its subsidiaries involving a variable rate transaction, other than an &#8220;at the market&#8221; offering of Common Stock; and (ii) the
      Company agreed to hold a stockholder meeting within 60 days of the date of the Agreement at which the Company will solicit the stockholders&#8217; affirmative vote for approval of the issuance in excess of 19.9% of shares outstanding as of the date of the
      Purchase Agreement in accordance with the applicable law and rules and regulations of The Nasdaq Stock Market LLC (&#8220;Nasdaq&#8221;).</div>

    <div><br/>
    </div>

    <div style="text-align: justify; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">The Purchase Agreement obligates the Company to indemnify the Investor and various related parties for certain losses including those
      resulting from (i) any misrepresentation or breach of any representation or warranty made by the Company, (ii) any breach of any obligation of the Company, and (iii) certain claims by third parties.</div>

    <div><br/>
    </div>

    <div style="text-align: justify; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic;">Convertible Note and Warrants</div>

    <div><br/>
    </div>

    <div style="text-align: justify; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">The Convertible Note is a junior secured obligation of the Company and is secured by certain personal property of the Company, pursuant to
      a Security Agreement (as defined below). Unless earlier converted, the Convertible Note will mature in September 2026. The Convertible Note bears interest at a rate of 8% per annum, subject to increase in the event of default to the lesser of 18% per
      annum or the maximum rate permitted under applicable law. The Convertible Note, including interest accrued thereon, is convertible at any time, in whole or in part, at the option of the holder into shares of Common Stock at a conversion price of
      $1.116 per share, subject to adjustment as set forth therein. The Convertible Note has a beneficial ownership limitation such that the Investor will not have the right to convert any portion of the Convertible Note if the Investor (together with its
      affiliates or any other persons acting together as a group with the Investor) would beneficially own in excess of 4.99% of the number of shares of Common Stock outstanding immediately after giving effect to the issuance of Common Stock issuable upon
      conversion of the Convertible Note, or, upon 61 days&#8217; prior written notice to the Company, 9.99% of the number of shares of Common Stock outstanding immediately after giving effect to the issuance of Common Stock issuable upon conversion of the
      Convertible Note. Commencing on the six-month anniversary of the date of the issuance of the Note, and on the same date every month thereafter, the Company shall make six equal amortization payments, with each payment being equal to one-sixth of the
      initial principal amount, plus all accrued but unpaid interest.</div>

    <div><br/>
    </div>

    <div style="text-align: justify; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">The Convertible Note also contains certain negative covenants, including prohibitions on the incurrence of indebtedness, liens, amendments
      to the Company&#8217;s organizational documents, dividends, redemption, related party transactions and entry into any equity line of credit agreement or variable rate transactions other than an &#8220;at the market&#8221; offering of Common Stock. The Convertible
      Notes also contain standard and customary events of default including, but not limited to, failure to make payments when due, failure to observe or perform covenants or agreements contained in the Convertible Note, existence of a default or event of
      default under any of the Transaction Documents (as defined in the Convertible Note), the bankruptcy or insolvency of the Company or any of its subsidiaries and unsatisfied judgments against the Company.</div>

    <div><br/>
    </div>

    <div style="text-align: justify; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">The Investor Warrants entitle the holder to purchase up to 1,460,964 shares of Common Stock. The Investor Warrants are exercisable
      immediately and have a term of five years. The Investor Warrants each have an exercise price of $1.40 per share, subject to adjustment as set forth therein.</div>

    <div><br/>
    </div>

    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"/></div>

    </div>

    <div style="text-align: justify; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic;">AIR Warrants</div>

    <div><br/>
    </div>

    <div style="text-align: justify; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Pursuant to the Purchase Agreement the Company also sold to the investor warrants to purchase up to $4,000,000 in principal amount of
      additional Convertible Notes and Investor Warrants (the &#8220;AIR Warrants&#8221;). The AIR Warrants are exercisable immediately and have a term of five years.&#160; The Company may require the holder of the AIR Warrants to exercise AIR Warrants with respect to no
      more than two times the average daily trading volume of the Common Stock for the five prior trading days at any time when such average daily trading price for the Common Stock for the five prior trading days is at least 125% of the original
      conversion price of the Convertible Note.</div>

    <div><br/>
    </div>

    <div style="text-align: justify; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic;">Registration Rights Agreement</div>

    <div><br/>
    </div>

    <div style="text-align: justify; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">In connection with the Purchase Agreement, the Company and the Investor entered into a Registration Rights Agreement (the &#8220;Registration
      Rights Agreement&#8221;), pursuant to which the Company has agreed to register the resale of the shares of Common Stock issuable upon conversion and exercise of the Convertible Note, Investor Warrants and the AIR Warrants on a registration statement on
      Form S-3 (the &#8220;Registration Statement&#8221;) to be filed with the United States Securities and Exchange Commission (the &#8220;SEC&#8221;) within 30 days after the date of Registration Rights Agreement and to cause the Registration Statement to be declared effective
      under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;) no later than 45 calendar days after the initial filing deadline, in the event the registration statement is not subject to a full review by the SEC, or 90 calendar days after the
      initial filing deadline, in the event the registration statement is subject to a full review by the SEC, and in any event by the fifth business day after the date the Company is notified by the SEC that the registration statement will not be reviewed
      or will not be subject to further review. If certain of the Company&#8217;s obligations under the Registration Rights Agreement are not met, the Company is required to pay partial liquidated damages to the Investor.</div>

    <div><br/>
    </div>

    <div style="text-align: justify; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic;">Security Agreement</div>

    <div><br/>
    </div>

    <div style="text-align: justify; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">The Company also entered into a Security Agreement (the &#8220;Security Agreement&#8221;) with the Investor, as collateral agent (the &#8220;Collateral
      Agent&#8221;), the Investor and such holders of the Convertible Notes as may be issued in the future (together with the Investor, the &#8220;Secured Parties&#8221;). Pursuant to the Security Agreement, the Secured Parties were granted a security interest in certain of
      the Company&#8217;s personal property to secure the payment and performance of all of the Company&#8217;s obligations under the Convertible Note, Investor Warrants, Purchase Agreement, Registration Rights Agreement, and Security Agreement (together, the
      &#8220;Transaction Documents&#8221;).</div>

    <div><br/>
    </div>

    <div style="text-align: justify; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">The foregoing descriptions of the Purchase Agreement, Registration Rights Agreement, Security Agreement, Convertible Note, Investor
      Warrants, and AIR Warrants are incomplete and are subject to, and qualified in their entirety by reference to the full text of thereof, copies of each of which are attached hereto as Exhibits 10.1, 10.2, 10.3, 4.1, 4.2, and 4.3, respectively, each of
      which is incorporated herein in its entirely by reference.</div>

    <div><br/>
    </div>

    <div style="text-align: justify; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Equity Line of Credit</div>

    <div><br/>
    </div>

    <div style="text-align: justify; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic;">Equity Purchase Agreement</div>

    <div><br/>
    </div>

    <div style="text-align: justify; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">On September 25, 2025 (the &#8220;Execution Date&#8221;), the Company, entered into an equity purchase agreement (&#8220;Equity Purchase Agreement&#8221;) with the
      Investor. Under the Equity Purchase Agreement, the Company has the right, but not the obligation, to direct the Investor to purchase up to $50,000,000 (the &#8220;Maximum Commitment Amount&#8221;) in shares of Common Stock of the Company upon satisfaction of
      certain terms and conditions contained in the Equity Purchase Agreement, including, without limitation, an effective registration statement filed with the SEC registering the resale of the shares of Put Stock (defined below) and the shares of
      Commitment Stock (defined below) and additional shares to be sold to the Investor from time to time under the Equity Purchase Agreement. The term of the Equity Purchase Agreement began on the Execution Date and ends on the earlier of (i) the date on
      which the Investor shall have purchased shares of Common Stock issued, or that the Company shall be entitled to issue, per any applicable Put Notice in accordance with the terms and conditions of the Equity Purchase Agreement (the &#8220;Put Stock&#8221;) equal
      to the Maximum Commitment Amount, (ii) the date that is thirty-six (36) months from the date the registration statement is declared effective, (iii) written notice of termination by the Company to the Investor (which shall not occur at any time that
      the Investor holds any of the shares of Put Stock, or within 30 days of the sale to the Investor of Put Stock), or (iv) written notice of termination by the Investor to the Company (the &#8220;Commitment Period&#8221;).</div>

    <div><br/>
    </div>

    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"/></div>

    </div>

    <div style="text-align: justify; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">During the Commitment Period, the Company may direct the Investor to purchase shares of Put Stock by delivering a notice (a &#8220;Put Notice&#8221;)
      to the Investor. The Company shall, in its sole discretion, select the number of shares of Put Stock requested by the Company in each Put Notice. However, such amount may not exceed the Maximum Put Amount (as defined in the Equity Purchase
      Agreement). The purchase price to be paid by the Investor for the shares of Put Stock will be $1.24 per share.</div>

    <div><br/>
    </div>

    <div style="text-align: justify; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">In consideration for the Investor&#8217;s execution and delivery of, and performance under the Equity Purchase Agreement, on the Execution Date,
      the Company in its discretion shall either (i) pay to the Investor in cash $750,000 (&#8220;Commitment Cash&#8221;) or (ii) issue pre-funded warrants to purchase common stock (the &#8220;Pre-Funded Warrant&#8221;) to the Investor in a form acceptable to the Investor in its
      sole discretion and having an exercise price per share of $0.00001 (the &#8220;Commitment Stock&#8221;) having a value of $750,000 based on closing price of the Common Stock based on the shares price that is calculated the 5-day volume weighted average price of
      the Common Stock beginning on the date that the Initial Registration Statement (defined below) is declared effective (the &#8220;Commitment Stock Price&#8221;). All of the shares of Commitment Stock were fully earned as of the Execution Date, and the issuance of
      the shares of Commitment Stock is not contingent upon any other event or condition, including, without limitation, the effectiveness of the Initial Registration Statement or the Company&#8217;s submission of a Put Notice to the Investor and irrespective of
      any termination of the Equity Purchase Agreement.</div>

    <div><br/>
    </div>

    <div style="text-align: justify; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Under the Equity Purchase Agreement, the Company is obligated to file with the SEC, on or before October 25, 2025, a registration statement
      on Form S-3 (the &#8220;Initial Registration Statement&#8221;) covering only the resale of the shares of Put Stock and Commitment Stock and to use its best efforts to have the Initial Registration declared effective no later than November 24, 2025.</div>

    <div><br/>
    </div>

    <div style="text-align: justify; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">The Equity Purchase Agreement contains customary representations, warranties, agreements, and conditions to completing future sale
      transactions, indemnification rights and obligations of the parties. Among other things, the Investor represented to the Company, that it is an &#8220;accredited investor&#8221; (as such term is defined in Rule 501(a) of Regulation D under the Securities Act).</div>

    <div><br/>
    </div>

    <div style="text-align: justify; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic;">Pre-Funded Warrant</div>

    <div><br/>
    </div>

    <div style="text-align: justify; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">The Pre-Funded Warrant certifies that, for value received, the Investor is entitled to be issued up to $750,000 of shares of Common Stock
      based upon the Commitment Stock Price&#160; and has an initial exercise price of $0.00001 per share. The pre-funded warrants may not be exercised if the aggregate number of shares of the Common Stock beneficially owned by the holder would exceed 4.99%
      immediately after exercise thereof, which ownership cap may be increased by the holder up to 9.99% upon 61 days&#8217; prior notice.</div>

    <div><br/>
    </div>

    <div style="text-align: justify; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic;">EPA Registration Rights Agreement</div>

    <div><br/>
    </div>

    <div style="text-align: justify; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">On the Effective Date, in connection with the Equity Purchase Agreement, the Company entered into a registration rights agreement with the
      Investor (the &#8220;EPA Registration Rights Agreement&#8221;), pursuant to which the Company shall, by October 25, 2025, file with the SEC the Initial Registration Statement covering the maximum number of (i) shares of Commitment Stock, (ii) shares of Put
      Stock, which have been, or which may, from time to time be issued, including without limitation all of the shares of Common Stock which have been issued or will be issued to the Investor under the Equity Purchase Agreement (without regard to any
      limitation or restriction on purchases), and (iii) any and all shares of capital stock issued or issuable with respect to the Put Stock, Commitment Stock, and the Equity Purchase Agreement as a result of any stock split, combination, stock dividend,
      recapitalization, exchange, or similar event, or otherwise, without regard to any limitation on purchases under the Equity Purchase Agreement (the &#8220;Registrable Securities&#8221;), as shall be permitted to be included thereon in accordance with applicable
      SEC rules, regulations, and interpretations so as to permit the resale of the Registrable Securities by the Investor, including, but not limited to, under Rule 415 at then-prevailing market prices (and not fixed prices). The Initial Registration
      Statement shall register only Registrable Securities. The Company shall use its commercial best efforts to have the Initial Registration Statement and any amendment thereto declared effective by the SEC at the earliest possible date, but in no event
      later than November 24, 2025.</div>

    <div><br/>
    </div>

    <div style="text-align: justify; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">The foregoing summary of the terms and conditions of each of the Equity Purchase Agreement, EPA Registration Rights Agreement and
      Pre-Funded Warrant is subject to, and qualified in its entirety by reference to the full text of such agreement, copies of which are filed as Exhibits 10.4, 10.5, and 4.4, respectively, to this Current Report on Form 8-K and is incorporated herein by
      reference.</div>

    <div><br/>
    </div>

    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"/></div>

    </div>

    <div style="text-align: left;">
<div><span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; color: #000000;"> </span></div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%; border-spacing: 0;">


  <tr>

    <td style="width: 10%;"><span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; color: #000000;">Item 2.03</span></td>

    <td style="width: 90%;"><span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; color: #000000;">Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet</span></td>

  </tr>

  <tr>

    <td rowspan="1" style="width: 10%;">&#160;</td>

    <td rowspan="1" style="width: 90%;"><span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; color: #000000;">Arrangement of a Registrant</span></td>

  </tr>


</table>
    </div>

    <div style="text-align: left;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; color: #000000;"><br/>
      </span></div>

    <div style="text-align: left; margin-left: 63pt;"><span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; color: #000000;">&#160;</span></div>

    <div><br/>
    </div>

    <div style="text-align: justify; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">The disclosure contained in Item 1.01 of this Current Report is incorporated by reference in this Item 2.03.</div>

    <div><br/>
    </div>

    <div style="text-align: left;">
<div><span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; color: #000000;"> </span></div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%; border-spacing: 0;">


  <tr>

    <td style="width: 10%;"><span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; color: #000000;">Item 3.02</span> <br/>
            </td>

    <td style="width: 90%;">
              <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; color: #000000;">Unregistered Sales of Equity Securities</span></div>
            </td>

  </tr>


</table>
    </div>

    <div style="text-align: left;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <br/>
    </div>

    <div style="text-align: justify; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">The information contained above in Item 1.01 of this Current Report on Form 8-K related to the Convertible Note, the Investor Warrants, the
      AIR Warrants and the shares of Common Stock issuable thereunder (collectively, the &#8220;Securities&#8221;) is hereby incorporated by reference into this Item 3.02. The Securities were sold without registration under the Securities Act in reliance on the
      exemptions provided by Section 4(a)(2) of the Securities Act as a transaction not involving a public offering and Rule 506(b) of Regulation D promulgated under the Securities Act as sales to accredited Investor and in reliance on similar exemptions
      under applicable state laws. The Securities may not be offered or sold in the absence of an effective registration statement or exemption from the registration requirements under the Securities Act.</div>

    <div><br/>
    </div>

    <div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%; border-spacing: 0;">


  <tr>

    <td style="width: 10%;"><span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; color: #000000;">Item 9.01</span></td>

    <td style="width: 90%;">
              <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; color: #000000;">Fi</span> <span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; color: #000000;">nancial Statements and Exhibits</span></div>
            </td>

  </tr>


</table>
    </div>

    <div style="text-align: left;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <br/>
    </div>

    <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">(d)</span>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">Exhibits</span></div>

    <div><br/>
    </div>

    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 10%; vertical-align: bottom;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Exhibit </div>
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Number</div>
          </td>

    <td style="width: 2%; vertical-align: bottom;">&#160;</td>

    <td style="width: 88%; vertical-align: bottom;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Exhibit Description</div>
          </td>

  </tr>

  <tr>

    <td style="width: 10%; vertical-align: top;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><a href="ny20047547x33_ex4-1.htm">4.1</a></div>
          </td>

    <td style="width: 2%; vertical-align: top;">&#160;</td>

    <td style="width: 88%; vertical-align: top;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Junior Secured Convertible Note Due September 25, 2026, dated September 25, 2025, between Momentus Inc. and Yield Point NY, LLC.</div>
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"> <br/>
            </div>
          </td>

  </tr>

  <tr>

    <td style="width: 10%; vertical-align: top;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><a href="ny20047547x33_ex4-2.htm">4.2</a></div>
          </td>

    <td style="width: 2%; vertical-align: top;">&#160;</td>

    <td style="width: 88%; vertical-align: top;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Common Stock Purchase Warrant, dated September 25, 2025, between Momentus Inc. and Yield Point NY, LLC.</div>
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"> <br/>
            </div>
          </td>

  </tr>

  <tr>

    <td style="width: 10%; vertical-align: top;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><a href="ny20047547x33_ex4-3.htm">4.3</a></div>
          </td>

    <td style="width: 2%; vertical-align: top;">&#160;</td>

    <td style="width: 88%; vertical-align: top;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">AIR Warrant, dated September 25, 2025, between Momentus Inc. and Yield Point NY, LLC.</div>
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"> <br/>
            </div>
          </td>

  </tr>

  <tr>

    <td style="width: 10%; vertical-align: top;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><a href="ny20047547x33_ex4-4.htm">4.4</a></div>
          </td>

    <td style="width: 2%; vertical-align: top;">&#160;</td>

    <td style="width: 88%; vertical-align: top;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Pre-Funded Common Stock Purchase Warrant, dated September 25, 2025, between Momentus Inc. and Yield Point NY, LLC.</div>
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"> <br/>
            </div>
          </td>

  </tr>

  <tr>

    <td style="width: 10%; vertical-align: top;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><a href="ny20047547x33_ex10-1.htm">10.1</a></div>
          </td>

    <td style="width: 2%; vertical-align: top;">&#160;</td>

    <td style="width: 88%; vertical-align: top;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Securities Purchase Agreement, dated September 25, 2025, between Momentus Inc. and Yield Point NY, LLC</div>
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"> <br/>
            </div>
          </td>

  </tr>

  <tr>

    <td style="width: 10%; vertical-align: top;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><a href="ny20047547x33_ex10-2.htm">10.2</a></div>
          </td>

    <td style="width: 2%; vertical-align: top;">&#160;</td>

    <td style="width: 88%; vertical-align: top;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Registration Rights Agreement, dated September 25, 2025, between Momentus Inc. and Yield Point NY, LLC</div>
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"> <br/>
            </div>
          </td>

  </tr>

  <tr>

    <td style="width: 10%; vertical-align: top;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><a href="ny20047547x33_ex10-3.htm">10.3</a></div>
          </td>

    <td style="width: 2%; vertical-align: top;">&#160;</td>

    <td style="width: 88%; vertical-align: top;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Security Agreement, dated September 25, 2025, between Momentus Inc. and Yield Point NY, LLC</div>
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"> <br/>
            </div>
          </td>

  </tr>

  <tr>

    <td style="width: 10%; vertical-align: top;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><a href="ny20047547x33_ex10-4.htm">10.4</a></div>
          </td>

    <td style="width: 2%; vertical-align: top;">&#160;</td>

    <td style="width: 88%; vertical-align: top;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Equity Purchase Agreement, dated September 25, 2025, between Momentus Inc. and Yield Point NY, LLC</div>
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"> <br/>
            </div>
          </td>

  </tr>

  <tr>

    <td style="width: 10%; vertical-align: top;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><a href="ny20047547x33_ex10-5.htm">10.5</a></div>
          </td>

    <td style="width: 2%; vertical-align: top;">&#160;</td>

    <td style="width: 88%; vertical-align: top;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">EPA Registration Rights Agreement, dated September 25, 2025, between Momentus Inc. and Yield Point NY, LLC</div>
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"> <br/>
            </div>
          </td>

  </tr>

  <tr>

    <td style="width: 10%; vertical-align: bottom;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">104</div>
          </td>

    <td style="width: 2%; vertical-align: bottom;">&#160;</td>

    <td style="width: 88%; vertical-align: bottom;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Cover Page Interactive Data File (embedded within the Inline XBRL document)</div>
          </td>

  </tr>


</table>
    <div><br/>
    </div>

    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"/></div>

    </div>

    <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">SIGNATURE</div>

    <div><br/>
    </div>

    <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf
      by the undersigned hereunto duly authorized.</div>

    <div><br/>
    </div>

    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 10.31%; vertical-align: bottom;">&#160;</td>

    <td style="width: 15.02%; vertical-align: bottom;">&#160;</td>

    <td style="width: 19.97%; vertical-align: bottom;">
            <div style="text-align: right; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">By:</div>
          </td>

    <td style="width: 3.98%; vertical-align: bottom;">&#160;</td>

    <td style="width: 50.65%; vertical-align: bottom; border-bottom: 2px solid black;">
            <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">/s/ Lon Ensler</div>
          </td>

  </tr>

  <tr>

    <td style="width: 10.31%; vertical-align: bottom;" rowspan="1">&#160;</td>

    <td style="width: 15.02%; vertical-align: bottom;" rowspan="1">&#160;</td>

    <td style="width: 19.97%; vertical-align: bottom;" rowspan="1">&#160;</td>

    <td style="width: 3.98%; vertical-align: bottom;" rowspan="1">&#160;</td>

    <td style="width: 50.65%; vertical-align: bottom;" rowspan="1">&#160;</td>

  </tr>

  <tr>

    <td style="width: 10.31%; vertical-align: bottom;">&#160;</td>

    <td style="width: 15.02%; vertical-align: bottom;">&#160;</td>

    <td style="width: 19.97%; vertical-align: bottom;">
            <div style="text-align: right; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Name:</div>
          </td>

    <td style="width: 3.98%; vertical-align: bottom;">&#160;</td>

    <td style="width: 50.65%; vertical-align: bottom;">
            <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Lon Ensler</div>
          </td>

  </tr>

  <tr>

    <td style="width: 10.31%; vertical-align: bottom;" rowspan="1">&#160;</td>

    <td style="width: 15.02%; vertical-align: bottom;" rowspan="1">&#160;</td>

    <td style="width: 19.97%; vertical-align: bottom;" rowspan="1">&#160;</td>

    <td style="width: 3.98%; vertical-align: bottom;" rowspan="1">&#160;</td>

    <td style="width: 50.65%; vertical-align: bottom;" rowspan="1">&#160;</td>

  </tr>

  <tr>

    <td style="width: 10.31%; vertical-align: bottom;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Dated:</div>
          </td>

    <td style="width: 15.02%; vertical-align: bottom;">
            <div style="text-align: right; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">September 29, 2025</div>
          </td>

    <td style="width: 19.97%; vertical-align: bottom;">
            <div style="text-align: right; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Title:</div>
          </td>

    <td style="width: 3.98%; vertical-align: bottom;">&#160;</td>

    <td style="width: 50.65%; vertical-align: bottom;">
            <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Chief Financial Officer</div>
          </td>

  </tr>


</table>
    <div><br/>
    </div>

    <div>
      <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;"/></div>

  </div>

</div>
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.1
<SEQUENCE>2
<FILENAME>ny20047547x33_ex4-1.htm
<DESCRIPTION>EXHIBIT 4.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc.
         Document created using Broadridge PROfile 25.9.1.5330
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body style="font-family: Arial; font-size: 9pt; text-align: left; color: #000000;" bgcolor="#ffffff">
  <font style="font-size: 10pt; font-family: 'Times New Roman';"> </font>
  <div>
    <div>
      <hr style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;" noshade="noshade" align="center">
      <div style="text-align: right;"><font style="font-weight: bold; font-size: 10pt; font-family: 'Times New Roman';">Exhibit 4.1</font><font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
        </font> </div>
      <div><font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
        </font> </div>
      <div>
        <div style="text-align: justify; font-weight: bold; font-size: 10pt; font-family: 'Times New Roman';">NEITHER THIS SECURITY NOR THE SECURITIES INTO WHICH THIS SECURITY IS CONVERTIBLE HAS BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION
          OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &#8220;SECURITIES ACT&#8221;), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE
          REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. THIS
          SECURITY AND THE SECURITIES ISSUABLE UPON CONVERSION OF THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT WITH A REGISTERED BROKER&#8209;DEALER OR OTHER LOAN WITH A FINANCIAL INSTITUTION THAT IS AN ACCREDITED INVESTOR AS
          DEFINED IN RULE 501(a) UNDER THE SECURITIES ACT OR OTHER LOAN SECURED BY SUCH SECURITIES.</div>
        <div style="text-align: right;"> <font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
          </font> </div>
        <div style="text-align: right; font-size: 10pt; font-family: 'Times New Roman';">Original Issue Date: <a name="z_Hlk201845907"></a><font style="font-weight: bold;">September 25, 2025</font></div>
        <div><font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
          </font> </div>
        <div style="text-align: justify; font-weight: bold; font-size: 10pt; font-family: 'Times New Roman';">Principal Amount: $1,630,434.78 [8%OID]</div>
        <div><font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
          </font> </div>
        <div style="text-align: justify; font-weight: bold; font-size: 10pt; font-family: 'Times New Roman';">Purchase Price: $1,500,000</div>
        <div><font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
          </font> </div>
        <div style="text-align: center; font-weight: bold; font-size: 10pt; font-family: 'Times New Roman';">JUNIOR SECURED CONVERTIBLE NOTE</div>
        <div style="text-align: center; font-weight: bold; font-size: 10pt; font-family: 'Times New Roman';">DUE SEPTEMBER 25, 2026</div>
        <div style="text-align: justify;"> <font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
          </font> </div>
        <div style="text-align: justify; text-indent: 36pt; font-size: 10pt; font-family: 'Times New Roman';">THIS CONVERTIBLE NOTE is one of a series of duly authorized and validly issued Notes of <font style="font-weight: bold;">Momentus Inc.</font>, a
          Delaware corporation, (the &#8220;<u>Company</u>&#8221; or &#8220;<u>Borrower</u>&#8221;), having its principal place of business at 3901 N. First Street, San Jose, CA, 95134<font style="color: rgb(0, 0, 0);">, email: </font>[***]<font style="color: rgb(0, 0, 0);">, </font>due
          <font style="font-weight: bold;">September 25, 2026 </font>(this note, the &#8220;<u>Note</u>&#8221; and, collectively with the other notes of such series, the &#8220;<u>Notes</u>&#8221;).</div>
        <div style="text-align: justify;"> <font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
          </font> </div>
        <div style="text-align: justify; text-indent: 36pt; font-size: 10pt; font-family: 'Times New Roman';">FOR VALUE RECEIVED, Borrower promises to pay to Yield Point NY LLC, or its registered assigns (the &#8220;<u>Holder</u>&#8221;), with the addresses indicated
          on the signature pages to the Purchase Agreement, or shall have paid pursuant to the terms hereunder, the principal sum of <font style="font-weight: bold;">One Million Six Hundred Thirty Thousand Four Hundred Thirty Four and 78/100 Dollars
            ($1,630,434.78)</font> on <font style="font-weight: bold;">September 25, 2026</font> (the &#8220;<u>Maturity Date</u>&#8221;) or such earlier date as this Note is required or permitted to be repaid as provided hereunder, and to pay interest, if any, to
          the Holder on the aggregate unconverted and then outstanding principal amount of this Note in accordance with the provisions hereof.</div>
        <div><font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
          </font> </div>
        <div style="text-align: justify; text-indent: 36pt; font-size: 10pt; font-family: 'Times New Roman';">The Holder of this Note has been granted a junior security interest in assets of Borrower.</div>
        <div><font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
          </font> </div>
        <div style="text-align: justify; text-indent: 36pt; font-size: 10pt; font-family: 'Times New Roman';">This Note is subject to the following additional provisions:</div>
        <div><font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
          </font> </div>
        <div style="text-align: justify; text-indent: 36pt; font-size: 10pt; font-family: 'Times New Roman';"><u>Section 1</u>.&#160; &#160; &#160; &#160;&#160; <u>Definitions</u>. For the purposes hereof, in addition to the terms defined elsewhere in this Note, (a) capitalized
          terms not otherwise defined herein shall have the meanings set forth in the Purchase Agreement and (b) the following terms shall have the following meanings:</div>
        <div style="text-align: justify;"> <font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
          </font> </div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-size: 10pt; font-family: 'Times New Roman';">&#8220;<u>Alternate Consideration</u>&#8221; shall have the meaning set forth in Section 5(d).</div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"> <font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
          </font> </div>
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" noshade="noshade"></div>
        </div>
        <!--PROfilePageNumberReset%Num%2%%%-->
        <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-size: 10pt; font-family: 'Times New Roman';">&#8220;<u>Bankruptcy Event</u>&#8221; means any of the following events: (a) Borrower or any Subsidiary thereof commences a case or other
          proceeding under any bankruptcy, reorganization, arrangement, adjustment of debt, relief of debtors, dissolution, insolvency or liquidation or similar law of any jurisdiction relating to Borrower or any Subsidiary thereof, (b) there is commenced
          against Borrower or any Subsidiary thereof any such case or proceeding that is not dismissed within 60 days after commencement, (c) Borrower or any Subsidiary thereof is adjudicated insolvent or bankrupt or any order of relief or other order
          approving any such case or proceeding is entered, (d) Borrower or any Subsidiary thereof suffers any appointment of any custodian or the like for it or any substantial part of its property that is not discharged or stayed within 60 calendar days
          after such appointment, (e) Borrower or any Subsidiary thereof makes a general assignment for the benefit of creditors, (f) Borrower or any Subsidiary thereof calls a meeting of its creditors with a view to arranging a composition, adjustment or
          restructuring of its debts or (g) Borrower or any Subsidiary thereof, by any act or failure to act, expressly indicates its consent to, approval of or acquiescence in any of the foregoing or takes any corporate or other action for the purpose of
          effecting any of the foregoing.</div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"> <font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
          </font> </div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-size: 10pt; font-family: 'Times New Roman';">&#8220;<u>Beneficial Ownership Limitation</u>&#8221; shall have the meaning set forth in Section 4(d).</div>
        <div style="text-align: justify;"> <font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
          </font> </div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-size: 10pt; font-family: 'Times New Roman';">&#8220;<u>Buy-In</u>&#8221; shall have the meaning set forth in Section 4(c)(v).</div>
        <div><font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
          </font> </div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-size: 10pt; font-family: 'Times New Roman';">&#8220;<u>Change of Control Transaction</u>&#8221; means, other than by means of conversion or exercise of the Notes and the Securities
          issued together with the Notes, the occurrence after the date hereof of any of (a) an acquisition after the date hereof by an individual or legal entity or &#8220;group&#8221; (as described in Rule 13d-5(b)(1) promulgated under the Exchange Act) of effective
          control (whether through legal or beneficial ownership of capital stock of Borrower, by contract or otherwise) of in excess of 50% of the voting securities of Borrower, (b) Borrower merges into or consolidates with any other Person, or any Person
          merges into or consolidates with Borrower and, after giving effect to such transaction, the stockholders of Borrower immediately prior to such transaction own less than 50% of the aggregate voting power of Borrower or the successor entity of such
          transaction, (c) Borrower sells or transfers all or substantially all of its assets to another Person and the stockholders of Borrower immediately prior to such transaction own less than 50% of the aggregate voting power of the acquiring entity
          immediately after the transaction, (d) a replacement at one time or during the time any principal or interest remains outstanding under this Note, of more than one-half of the members of the Board of Directors which is not approved by a majority
          of those individuals who are members of the Board of Directors on the Original Issue Date (or by those individuals who are serving as members of the Board of Directors on any date whose nomination to the Board of Directors was approved by a
          majority of the members of the Board of Directors who are members on the date hereof), or (e) the execution by Borrower of an agreement to which Borrower is a party or by which it is bound, providing for any of the events set forth in clauses (a)
          through (d) above.</div>
        <div><font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
          </font> </div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-size: 10pt; font-family: 'Times New Roman';">&#8220;<u>Closing Price</u>&#8221; means on any particular date (a) the last reported closing bid price per share of Common Stock on such
          date on the Trading Market (as reported by Bloomberg L.P. at 4:15 p.m. (New York City time)), or (b) if there is no such price on such date, then the closing bid price on the Trading Market on the date nearest preceding such date (as reported by
          Bloomberg L.P. at 4:15 p.m. (New York City time)), or (c)&#160; if the Common Stock is not then listed or quoted on a Trading Market and if prices for the Common Stock are then reported on the OTC Bulletin Board, OTCQX, OTCQB or in the &#8220;pink sheets&#8221;
          published by OTC Pink Open Market maintained by the OTC Markets Group, Inc. (or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported, or (d) if the
          shares of Common Stock are not then publicly traded the fair market value of a share of Common Stock as determined by an independent appraiser selected in good faith by the Holder and reasonably acceptable to Borrower, the fees and expenses of
          which shall be paid by Borrower.</div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"> <font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
          </font> </div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-size: 10pt; font-family: 'Times New Roman';">&#8220;<u>Conversion</u>&#8221; shall have the meaning ascribed to such term in Section 4.</div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"> <font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
          </font> </div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-size: 10pt; font-family: 'Times New Roman';">&#8220;<u>Conversion Date</u>&#8221; shall have the meaning set forth in Section 4(a).</div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"> <font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
          </font> </div>
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div class="BRPFPageNumberArea" style="text-align: center; font-size: 10pt; font-family: 'Times New Roman';"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">2</font></div>
          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" noshade="noshade"></div>
        </div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-size: 10pt; font-family: 'Times New Roman';">&#8220;<u>Conversion Price</u>&#8221; shall have the meaning set forth in Section 4(b).</div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"> <font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
          </font> </div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-size: 10pt; font-family: 'Times New Roman';">&#8220;<u>Conversion Shares</u>&#8221; means, collectively, the shares of Common Stock issuable upon conversion of this Note in accordance
          with the terms hereof.</div>
        <div><font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
          </font> </div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-size: 10pt; font-family: 'Times New Roman';">&#8220;<u>Event of Default</u>&#8221; shall have the meaning set forth in Section 8(a).</div>
        <div><font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
          </font> </div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-size: 10pt; font-family: 'Times New Roman';">&#8220;<u>Floor Price</u>&#8221; means $0.22, subject to adjustment for share splits, share dividends, share combinations,
          recapitalizations or other similar events.</div>
        <div><font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
          </font> </div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-size: 10pt; font-family: 'Times New Roman';">&#8220;<u>Fundamental Transaction</u>&#8221; shall have the meaning set forth in Section 5(c).</div>
        <div><font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
          </font> </div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-size: 10pt; font-family: 'Times New Roman';">&#8220;<u>Interest Payment Date</u>&#8221; shall have the meaning set forth in Section 2(1).</div>
        <div><font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
          </font> </div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-size: 10pt; font-family: 'Times New Roman';">&#8220;<u>Mandatory Default Amount</u>&#8221; means the sum of (a) the greater of (i) the outstanding principal amount of this Note divided
          by the Conversion Price on the date the Mandatory Default Amount is either (A) demanded (if demand or notice is required to create an Event of Default) or otherwise due or (B) paid in full, whichever has a lower Conversion Price, multiplied by
          the VWAP on the date the Mandatory Default Amount is either (x) demanded (if demand or notice is required to create an Event of Default) or otherwise due or (y) paid in full, whichever has a higher VWAP, or (ii) 120% of the outstanding principal
          amount of this Note and (b) all other amounts, costs, expenses and liquidated damages due in respect of this Note.</div>
        <div><font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
          </font> </div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-size: 10pt; font-family: 'Times New Roman';">&#8220;<u>Note Register</u>&#8221; shall have the meaning set forth in Section 2(c).</div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"> <font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
          </font> </div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-size: 10pt; font-family: 'Times New Roman';">&#8220;<u>Notice of Conversion</u>&#8221; shall have the meaning set forth in Section 4(a).</div>
        <div><font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
          </font> </div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-size: 10pt; font-family: 'Times New Roman';">&#8220;<u>Original Issue Date</u>&#8221; means the date of the first issuance of the Notes, regardless of any transfers of any Note and
          regardless of the number of instruments which may be issued to evidence such Notes.</div>
        <div><font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
          </font> </div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-size: 10pt; font-family: 'Times New Roman';">&#8220;<u>Other Holders</u>&#8221; means holders of Other Notes.</div>
        <div><font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
          </font> </div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-size: 10pt; font-family: 'Times New Roman';">&#8220;<u>Other Notes</u>&#8221; means Notes nearly identical to this Note issued to other Holders pursuant to the Purchase Agreement.</div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"> <font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
          </font> </div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-size: 10pt; font-family: 'Times New Roman';">&#8220;<u>Purchase Agreement</u>&#8221; means the Securities Purchase Agreement, dated as of September 25, 2025 among Borrower and the
          original Holders, as amended, modified or supplemented from time to time in accordance with its terms.</div>
        <div><font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
          </font> </div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-size: 10pt; font-family: 'Times New Roman';">&#8220;<u>Securities Act</u>&#8221; means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</div>
        <div><font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
          </font> </div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-size: 10pt; font-family: 'Times New Roman';">&#8220;<u>Standard Settlement Period</u>&#8221; means the standard settlement period, expressed in a number of Trading Days, on the
          Borrower&#8217;s primary Trading Market with respect to the Common Stock as in effect on the date of delivery of a book entry statement representing Underlying Shares, as applicable, issued with a restrictive legend.</div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"> <font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
          </font> </div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-size: 10pt; font-family: 'Times New Roman';">&#8220;<u>Share Delivery Date</u>&#8221; shall have the meaning set forth in Section 4(c)(ii).</div>
        <div><font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
          </font> </div>
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div class="BRPFPageNumberArea" style="text-align: center; font-size: 10pt; font-family: 'Times New Roman';"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">3</font></div>
          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" noshade="noshade"></div>
        </div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-size: 10pt; font-family: 'Times New Roman';">&#160;&#8220;<u>Successor Entity</u>&#8221; shall have the meaning set forth in Section 5(d).</div>
        <div><font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
          </font> </div>
        <div style="text-align: justify; text-indent: 36pt; font-size: 10pt; font-family: 'Times New Roman';"><u>Section 2</u>.&#160; &#160; &#160; &#160; &#160;&#160; &#160; <u>Interest and General Provisions</u>.</div>
        <div><font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
          </font> </div>
        <div style="text-align: justify; text-indent: 72pt; font-size: 10pt; font-family: 'Times New Roman';">a)&#160;&#160; &#160; &#160;&#160; &#160;&#160; <a name="z_Ref489017969"></a><u>Interest</u>.&#160; Interest shall accrue on this Note at the annual rate of eight percent (8%) per
          annum.</div>
        <div><font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
          </font> </div>
        <div style="text-align: justify; text-indent: 72pt; font-size: 10pt; font-family: 'Times New Roman';">b)&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160; <u>Payment Grace Period</u>.&#160; The Borrower shall have a five (5) Business Day grace period to pay any monetary amounts due under this
          Note.</div>
        <div><font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
          </font> </div>
        <div style="text-align: justify; text-indent: 72pt; font-size: 10pt; font-family: 'Times New Roman';">c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Conversion Privileges</u>.&#160; The Conversion Rights set forth in Section 4 shall remain in full force and effect immediately from the
          date hereof and until the Note is paid in full regardless of the occurrence of an Event of Default.&#160; This Note shall be payable in full on the Maturity Date, unless previously converted into Common Stock in accordance with Section 4 hereof.</div>
        <div><font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
          </font> </div>
        <div style="text-align: justify; text-indent: 72pt; font-size: 10pt; font-family: 'Times New Roman';">d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Application of Payments</u>.&#160; Interest on this Note shall be calculated on the basis of a 360-day year and the actual number of
          days elapsed.&#160; Payments made in connection with this Note shall be applied first to amounts due hereunder other than principal and interest, thereafter to interest and finally to principal.</div>
        <div><font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
          </font> </div>
        <div style="text-align: justify; text-indent: 72pt; font-size: 10pt; font-family: 'Times New Roman';">e)&#160;&#160;&#160;&#160;&#160; &#160;&#160; <u>Pari Passu</u>.&#160;&#160; Except as otherwise set forth herein, all payments made on this Note and the Other Notes and all actions taken by
          the Borrower with respect to this Note and the Other Notes, shall be made and taken <font style="font-style: italic;">pari passu</font> with respect to this Note and the Other Notes.&#160; Notwithstanding anything to the contrary contained herein or
          in the Transaction Documents, it shall not be considered non-pari passu for a Holder or Other Holder to elect to receive interest paid in Common Stock or for the Borrower to actually pay interest in Common Stock to such electing Holder or other
          Holder.</div>
        <div style="text-align: justify;"> <font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
          </font> </div>
        <div style="text-align: justify; text-indent: 72pt; font-size: 10pt; font-family: 'Times New Roman';">f)&#160;&#160;&#160;&#160;&#160; &#160; &#160; <u>Manner and Place of Payment</u>.&#160;&#160; Principal and interest on this Note and other payments in connection with this Note shall be
          payable at the Holder&#8217;s offices as designated above in lawful money of the United States of America in immediately available funds without set-off, deduction or counterclaim.&#160; Upon assignment of the interest of Holder in this Note, Borrower shall
          instead make its payment pursuant to the assignee&#8217;s instructions upon receipt of written notice thereof.&#160; Except as set forth herein, this Note may not be prepaid or mandatorily converted without the consent of the Holder.</div>
        <div><font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
          </font> </div>
        <div style="text-align: justify; text-indent: 72pt; font-size: 10pt; font-family: 'Times New Roman';">g)&#160;&#160;&#160;&#160;&#160; &#160; &#160; <u>Amortization Payments</u>.&#160; Commencing upon 180 days after the Original Issue Date and every 30 days thereafter (each such date an
          &#8220;Amortization Payment Date&#8221;), the Borrower will make equal monthly redemptions equal to 1/6<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup> of the initial Principal Amount together with any accrued interest
          (each an &#8220;<u>Amortization Payment</u>&#8221;).&#160; Each Amortization Payment shall be paid in cash.</div>
        <div><font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
          </font> </div>
        <div style="text-align: justify; text-indent: 36pt; font-size: 10pt; font-family: 'Times New Roman';"><u>Section 3.</u>&#160; &#160; &#160; &#160;&#160; &#160; &#160; <u>Registration of Transfers and Exchanges</u>.</div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"> <font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
          </font> </div>
        <div style="text-align: justify; text-indent: 72pt; font-size: 10pt; font-family: 'Times New Roman';">a)&#160; &#160; &#160;&#160;&#160; <u>Different Denominations</u>. This Note is exchangeable for an equal aggregate principal amount of Notes of different authorized
          denominations, as requested by the Holder surrendering the same. No service charge will be payable for such registration of transfer or exchange.</div>
        <div style="text-align: justify; text-indent: 72pt;"> <font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
          </font> </div>
        <div style="text-align: justify; text-indent: 72pt; font-size: 10pt; font-family: 'Times New Roman';">b)&#160; &#160; &#160; &#160; <u>Investment Representations</u>. This Note has been issued subject to certain investment representations of the original Holder set
          forth in the Purchase Agreement and may be transferred or exchanged only in compliance with the Purchase Agreement and applicable federal and state securities laws and regulations.</div>
        <div style="text-align: justify; text-indent: 72pt;"> <font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
          </font> </div>
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div class="BRPFPageNumberArea" style="text-align: center; font-size: 10pt; font-family: 'Times New Roman';"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">4</font></div>
          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" noshade="noshade"></div>
        </div>
        <div style="text-align: justify; text-indent: 72pt; font-size: 10pt; font-family: 'Times New Roman';">c)&#160; &#160;&#160; &#160; &#160; <u>Reliance on Note Register</u>. Prior to due presentment for transfer to Borrower of this Note, Borrower and any agent of Borrower
          may treat the Person in whose name this Note is duly registered on the Note Register as the owner hereof for the purpose of receiving payment as herein provided and for all other purposes, whether or not this Note is overdue, and neither Borrower
          nor any such agent shall be affected by notice to the contrary.</div>
        <div style="text-align: justify;"> <font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
          </font> </div>
        <div style="text-align: justify; text-indent: 36pt; font-size: 10pt; font-family: 'Times New Roman';"><u>Section 4.</u>&#160; &#160; &#160; &#160;&#160; &#160;&#160; <u>Conversion</u>.</div>
        <div style="text-align: justify; text-indent: 31.5pt; margin-left: 36pt;"> <font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
          </font> </div>
        <div style="text-align: justify; text-indent: 72pt; font-size: 10pt; font-family: 'Times New Roman';">a)&#160; &#160; &#160; &#160; &#160; <u>Voluntary Conversion</u>.&#160;&#160; At any time after the Original Issue Date until the principal and interest due under this Note have
          been paid in full, this Note including interest accrued hereon shall be convertible, in whole or in part, into shares of Common Stock at the option of the Holder, at any time and from time to time (subject to the conversion limitations set forth
          in Section 4(d) hereof). The Holder shall effect conversions by delivering to Borrower a Notice of Conversion, the form of which is attached hereto as <u>Annex A</u> (each, a &#8220;<u>Notice of Conversion</u>&#8221;), specifying therein the principal
          amount of this Note and accrued interest, if any, to be converted and the date on which such conversion shall be effected (such date, the &#8220;<u>Conversion Date</u>&#8221;). If no Conversion Date is specified in a Notice of Conversion, the Conversion Date
          shall be the date that such Notice of Conversion is deemed delivered hereunder. To effect conversions hereunder, the Holder shall not be required to physically surrender this Note to Borrower unless the entire principal amount of this Note has
          been so converted. Conversions hereunder shall have the effect of lowering the outstanding principal amount of this Note in an amount equal to the applicable conversion. The Holder and Borrower shall maintain records showing the principal
          amount(s) converted and the date of such conversion(s). Borrower may deliver an objection to any Notice of Conversion within one (1) Business Day of delivery of such Notice of Conversion. In the event of any dispute or discrepancy, the records of
          the Holder shall be controlling and determinative in the absence of manifest error. <font style="font-weight: bold;">The Holder, and any assignee by acceptance of this Note, acknowledges and agrees that, by reason of the provisions of this
            paragraph, following conversion of a portion of this Note, the unpaid and unconverted principal amount of this Note may be less than the amount stated on the face hereof.</font></div>
        <div><font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
          </font> </div>
        <div style="text-align: justify; text-indent: 72pt; font-size: 10pt; font-family: 'Times New Roman';">b)&#160; &#160; &#160; &#160; &#160; <u>Conversion Price</u>.&#160; The conversion price for the principal and interest, if any, in connection with voluntary conversions by
          the Holder shall be $1.116 per share of Common Stock, subject to adjustment as provided herein (the &#8220;<u>Conversion Price</u>&#8221;).</div>
        <div style="text-align: justify;"> <font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
          </font> </div>
        <div style="text-align: justify; text-indent: -18pt; margin-left: 90pt; font-size: 10pt; font-family: 'Times New Roman';">c)&#160; &#160; &#160; &#160;&#160; &#160; <u>Mechanics of Conversion</u>.</div>
        <div style="text-align: justify; text-indent: 31.5pt;"> <font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
          </font> </div>
        <div style="text-align: justify; margin-left: 72pt; text-indent: 36pt; font-size: 10pt; font-family: 'Times New Roman';">i.&#160; &#160; &#160; &#160; &#160; <u>Conversion Shares Issuable Upon Conversion of Principal Amount</u>. The number of Conversion Shares issuable
          upon a conversion hereunder shall be determined by the quotient obtained by dividing (x) the outstanding principal amount of this Note to be converted plus interest, if any, elected by the Holder to be converted by (y) the Conversion Price.</div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;"> <font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
          </font> </div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt; font-size: 10pt; font-family: 'Times New Roman';">ii.&#160; &#160; &#160; &#160; &#160;&#160; <u>Delivery of Book Entry Statements Upon Conversion</u>. Not later than the earlier of (i) two (2) Trading Days
          and (ii) the number of Trading Days comprising the Standard Settlement Period after each Conversion Date (the &#8220;<u>Share Delivery Date</u>&#8221;), Borrower shall deliver, or cause to be delivered, to the Holder a book entry statement representing the
          Conversion Shares which, on or after the earlier of (i) the six month anniversary of the Original Issue Date or (ii) the Effective Date, shall be free of restrictive legends and trading restrictions (other than those which may then be required by
          the Purchase Agreement or any restrictions contained herein) representing the number of Conversion Shares being acquired upon the conversion of this Note.&#160; Borrower shall use its best efforts to deliver book entry statements reflecting the number
          of Conversion Shares required to be delivered by Borrower under this Section 4(c) electronically through the Depository Trust Company or another established clearing corporation performing similar functions.</div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;"> <font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
          </font> </div>
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div class="BRPFPageNumberArea" style="text-align: center; font-size: 10pt; font-family: 'Times New Roman';"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">5</font></div>
          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" noshade="noshade"></div>
        </div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt; font-size: 10pt; font-family: 'Times New Roman';">iii.&#160; &#160; &#160; &#160; &#160; <u>Failure to Deliver Book Entry Statements</u>. If, in the case of any Notice of Conversion, such book entry
          statements are not delivered to or as directed by the applicable Holder by the Share Delivery Date, the Holder shall be entitled to elect by written notice to Borrower at any time on or before its receipt of such book entry statements, to rescind
          such Conversion, in which event Borrower shall promptly return to the Holder any original Note delivered to Borrower and the Holder shall promptly return to Borrower the shares of Common Stock issued to such Holder pursuant to the rescinded
          Conversion Notice.</div>
        <div><font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
          </font> </div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt; font-size: 10pt; font-family: 'Times New Roman';">iv.&#160; &#160;&#160; &#160;&#160; <u>Obligation Absolute; Partial Liquidated Damages</u>. Borrower&#8217;s obligations to issue and deliver the Conversion
          Shares upon conversion of this Note in accordance with the terms hereof are absolute and unconditional, irrespective of any action or inaction by the Holder to enforce the same, any waiver or consent with respect to any provision hereof, the
          recovery of any judgment against any Person or any action to enforce the same, or any setoff, counterclaim, recoupment, limitation or termination, or any breach or alleged breach by the Holder or any other Person of any obligation to Borrower or
          any violation or alleged violation of law by the Holder or any other Person, and irrespective of any other circumstance which might otherwise limit such obligation of Borrower to the Holder in connection with the issuance of such Conversion
          Shares; <u>provided</u>, <u>however</u>, that such delivery shall not operate as a waiver by Borrower of any such action Borrower may have against the Holder&#160;; provided, further, that Borrower shall be under no obligation to deliver any shares
          that would exceed the Beneficial Ownership Limitation, or exceed the Nasdaq 19.99% Cap prior to the Shareholder Approval, in each case as determined in good faith by Borrower. In the event the Holder of this Note shall elect to convert any or all
          of the outstanding principal amount hereof, Borrower may not refuse conversion based on any claim that the Holder or anyone associated or affiliated with the Holder has been engaged in any violation of law, agreement or for any other reason,
          unless an injunction from a court, on notice to Holder, restraining and or enjoining conversion of all or part of this Note shall have been sought and obtained, and Borrower posts a surety bond for the benefit of the Holder in the amount of 150%
          of the outstanding principal amount of this Note, which is subject to the injunction, which bond shall remain in effect until the completion of arbitration/litigation of the underlying dispute and the proceeds of which shall be payable to the
          Holder to the extent it obtains judgment. In the absence of such injunction, Borrower shall issue Conversion Shares or, if applicable, cash, upon a properly noticed conversion. If Borrower fails for any reason to deliver to the Holder such book
          entry statements evidencing the shares of Common Stock pursuant to Section 4(c)(ii) by the Share Delivery Date, Borrower shall pay to the Holder, in cash, as liquidated damages and not as a penalty, for each $1,000 of principal amount being
          converted, $10 per Trading Day (increasing to $20 per Trading Day on the fifth (5<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup>) Trading Day after such liquidated damages being to accrue) for each Trading Day
          after such Share Delivery Date until such book entry statements evidencing the shares of Common Stock are delivered or Holder rescinds such conversion. Nothing herein shall limit a Holder&#8217;s right to pursue actual damages or declare an Event of
          Default pursuant to Section 8 hereof for Borrower&#8217;s failure to deliver Conversion Shares within the period specified herein and the Holder shall have the right to pursue all remedies available to it hereunder, at law or in equity including,
          without limitation, a decree of specific performance and/or injunctive relief. The exercise of any such rights shall not prohibit the Holder from seeking to enforce damages pursuant to any other Section hereof or under applicable law.</div>
        <div><font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
          </font> </div>
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div class="BRPFPageNumberArea" style="text-align: center; font-size: 10pt; font-family: 'Times New Roman';"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">6</font></div>
          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" noshade="noshade"></div>
        </div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt; font-size: 10pt; font-family: 'Times New Roman';">v.&#160; &#160; &#160;&#160; &#160;&#160; <u>Compensation for Buy-In on Failure to Timely Deliver Book Entry Statements Upon Conversion</u>. In addition to
          any other rights available to the Holder, if Borrower fails for any reason to deliver to the Holder such book entry statements evidencing the shares of Common Stock by the Share Delivery Date pursuant to Section 4(c)(ii), and if after such Share
          Delivery Date the Holder is required by its brokerage firm to purchase (in an open market transaction or otherwise), or the Holder or Holder&#8217;s brokerage firm otherwise purchases, shares of Common Stock to deliver in satisfaction of a sale by the
          Holder of the Conversion Shares which the Holder was entitled to receive upon the conversion relating to such Share Delivery Date (a &#8220;<u>Buy-In</u>&#8221;), then Borrower shall (A) pay in cash to the Holder (in addition to any other remedies available
          to or elected by the Holder) the amount, if any, by which (x) the Holder&#8217;s total purchase price (including any brokerage commissions) for the Common Stock so purchased exceeds (y) the product of (1) the aggregate number of shares of Common Stock
          that the Holder was entitled to receive from the conversion at issue multiplied by (2) the actual sale price at which the sell order giving rise to such purchase obligation was executed (including any brokerage commissions) and (B) at the option
          of the Holder, either reissue (if surrendered) this Note in a principal amount equal to the principal amount of the attempted conversion (in which case such conversion shall be deemed rescinded) or deliver to the Holder the number of shares of
          Common Stock that would have been issued if Borrower had timely complied with its delivery requirements under Section 4(c)(ii). For example, if the Holder purchases Common Stock having a total purchase price of $11,000 to cover a Buy-In with
          respect to an attempted conversion of this Note with respect to which the actual sale price of the Conversion Shares (including any brokerage commissions) giving rise to such purchase obligation was a total of $10,000 under clause (A) of the
          immediately preceding sentence, Borrower shall be required to pay the Holder $1,000. The Holder shall provide Borrower written notice indicating the amounts payable to the Holder in respect of the Buy-In and, upon request of Borrower, evidence of
          the amount of such loss. Nothing herein shall limit a Holder&#8217;s right to pursue any other remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific performance and/or injunctive relief with respect
          to Borrower&#8217;s failure to timely deliver book entry statements representing shares of Common Stock upon conversion of this Note as required pursuant to the terms hereof.</div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;"> <font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
          </font> </div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt; font-size: 10pt; font-family: 'Times New Roman';">vi.&#160; &#160; &#160;&#160;&#160; <u>Reservation of Shares Issuable Upon Conversion</u>. Borrower covenants that it will at all times reserve and
          keep available out of its authorized and unissued shares of Common Stock for the sole purpose of issuance upon conversion of this Note as herein provided, free from preemptive rights or any other actual contingent purchase rights of Persons other
          than the Holder (and the other holders of the Notes), not less than 150% of the aggregate number of shares of the Common Stock as shall (subject to the terms and conditions set forth in the Purchase Agreement) be issuable (taking into account the
          adjustments and restrictions of Section 5) upon the conversion of the then outstanding principal amount of this Note and interest which has accrued and would accrue on such principal amount assuming such principal amount was not converted through
          the Maturity Date.&#160; Borrower covenants that all shares of Common Stock that shall be so issuable shall, upon issue, be duly authorized, validly issued, fully paid and nonassessable.</div>
        <div><font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
          </font> </div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt; font-size: 10pt; font-family: 'Times New Roman';">vii.&#160; &#160; &#160; &#160;&#160; <u>Fractional Shares</u>. No fractional shares or scrip representing fractional shares shall be issued upon the
          conversion of this Note. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such conversion, Borrower shall at its election, either pay a cash adjustment in respect of such final fraction in an amount
          equal to such fraction multiplied by the Conversion Price or round up to the next whole share.</div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;"> <font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
          </font> </div>
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div class="BRPFPageNumberArea" style="text-align: center; font-size: 10pt; font-family: 'Times New Roman';"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">7</font></div>
          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" noshade="noshade"></div>
        </div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt; font-size: 10pt; font-family: 'Times New Roman';">viii.&#160; &#160;&#160;&#160; <u>Transfer Taxes and Expenses</u>. The issuance of book entry statements for shares of the Common Stock on
          conversion of this Note shall be made without charge to the Holder hereof for any documentary stamp or similar taxes that may be payable in respect of the issue or delivery of such book entry statements evidencing the shares of Common Stock,
          provided that, Borrower shall not be required to pay any tax that may be payable in respect of any transfer involved in the issuance and delivery of any such shares of Common Stock evidenced by such book entry statements upon conversion in a name
          other than that of the Holder of this Note so converted and Borrower shall not be required to issue or deliver such book entry statements evidencing the shares of Common Stock unless or until the Person or Persons requesting the issuance thereof
          shall have paid to Borrower the amount of such tax or shall have established to the satisfaction of Borrower that such tax has been paid. Borrower shall pay all Transfer Agent fees required for same-day processing of any Notice of Conversion.</div>
        <div><font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
          </font> </div>
        <div style="text-align: justify; text-indent: 72pt; font-size: 10pt; font-family: 'Times New Roman';">d)&#160; &#160; &#160; &#160; &#160; <u>Holder&#8217;s Conversion Limitations</u>. Borrower shall not effect any conversion of this Note, and a Holder shall not have the right
          to convert any portion of this Note, to the extent that after giving effect to the conversion set forth on the applicable Notice of Conversion, the Holder (together with the Holder&#8217;s Affiliates, and any Persons acting as a group together with the
          Holder or any of the Holder&#8217;s Affiliates) would beneficially own in excess of the Beneficial Ownership Limitation (as defined below).&#160; For purposes of the foregoing sentence, the number of shares of Common Stock beneficially owned by the Holder
          and its Affiliates shall include the number of shares of Common Stock issuable upon conversion of this Note with respect to which such determination is being made, but shall exclude the number of shares of Common Stock which are issuable upon (i)
          conversion of the remaining, unconverted principal amount of this Note beneficially owned by the Holder or any of its Affiliates and (ii) exercise or conversion of the unexercised or unconverted portion of any other securities of Borrower subject
          to a limitation on conversion or exercise analogous to the limitation contained herein (including, without limitation, any other Notes or the Warrants) beneficially owned by the Holder or any of its Affiliates.&#160; Except as set forth in the
          preceding sentence, for purposes of this Section 4(d), beneficial ownership shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder. To the extent that the limitation contained
          in this Section 4(d) applies, the determination of whether this Note is convertible (in relation to other securities owned by the Holder together with any Affiliates) and of which principal amount of this Note is convertible shall be in the sole
          discretion of the Holder, and the submission of a Notice of Conversion shall be deemed to be the Holder&#8217;s determination of whether this Note may be converted (in relation to other securities owned by the Holder together with any Affiliates) and
          which principal amount of this Note is convertible, in each case subject to the Beneficial Ownership Limitation. To ensure compliance with this restriction, the Holder will be deemed to represent to Borrower each time it delivers a Notice of
          Conversion that such Notice of Conversion has not violated the restrictions set forth in this paragraph and Borrower shall have no obligation to verify or confirm the accuracy of such determination. In addition, a determination as to any group
          status as contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder. For purposes of this Section 4(d), in determining the number of outstanding shares of
          Common Stock, the Holder may rely on the number of outstanding shares of Common Stock as stated in the most recent of the following: (i) Borrower&#8217;s most recent periodic or annual report filed with the Commission, as the case may be, (ii) a more
          recent public announcement by Borrower, or (iii) a more recent written notice by Borrower or Borrower&#8217;s transfer agent setting forth the number of shares of Common Stock outstanding.&#160; Upon the written or oral request of a Holder, Borrower shall
          within two Trading Days confirm orally and in writing to the Holder the number of shares of Common Stock then outstanding.&#160; In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion or
          exercise of securities of Borrower, including this Note, by the Holder or its Affiliates since the date as of which such number of outstanding shares of Common Stock was reported.&#160; The &#8220;<u>Beneficial Ownership Limitation</u>&#8221; shall be 4.99% of
          the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable upon conversion of this Note held by the Holder. The Holder may increase the Beneficial Ownership Limitation
          at any time and the Holder, upon not less than 61 days&#8217; prior notice to Borrower, and may increase the Beneficial Ownership Limitation provided that the Beneficial Ownership Limitation in no event exceeds 9.99% of the number of shares of the
          Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock upon conversion of this Note held by the Holder and the Beneficial Ownership Limitation provisions of this Section 4(d) shall continue to apply.
          Any such increase will not be effective until the 61<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">st</sup> day after such notice is delivered to Borrower. The Beneficial Ownership Limitation provisions of this
          paragraph shall be construed and implemented in a manner otherwise than in strict conformity with the terms of this Section 4(d) to correct this paragraph (or any portion hereof) which may be defective or inconsistent with the intended Beneficial
          Ownership Limitation contained herein or to make changes or supplements necessary or desirable to properly give effect to such limitation. The limitations contained in this paragraph shall apply to a successor holder of this Note.</div>
        <div><font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
          </font> </div>
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div class="BRPFPageNumberArea" style="text-align: center; font-size: 10pt; font-family: 'Times New Roman';"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">8</font></div>
          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" noshade="noshade"></div>
        </div>
        <div style="text-align: justify; text-indent: 72pt; font-size: 10pt; font-family: 'Times New Roman';">(e) [Reserved]</div>
        <div><font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
          </font> </div>
        <div style="text-align: justify; text-indent: 72pt; font-size: 10pt; font-family: 'Times New Roman';">(f) Issuance Restrictions. Notwithstanding anything to the contrary contained in this Note or the other Transaction Documents, Borrower and Holder
          agree that the total cumulative number of shares of Common Stock that may be issued hereunder and under the other Transaction Documents may not exceed the requirements of Nasdaq Listing Rule 5635(d) (&#8220;Nasdaq 19.99% Cap&#8221;), except that such
          limitation will not apply following Shareholder Approval, as defined in the Purchase Agreement. If Borrower has not obtained Shareholder Approval for the issuance of shares of Common Stock issuable upon the conversion of this Note in excess of
          the Nasdaq 19.99% Cap in accordance with the requirements of Nasdaq Listing Rule 5635(d), and such Shareholder Approval is required pursuant to the rules of the principal Trading Market, then Borrower may not issue any shares of Common Stock in
          excess of the amount permitted under the rules of the principal Trading Market.</div>
        <div><font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
          </font> </div>
        <div style="text-align: justify; margin-left: 36pt; font-size: 10pt; font-family: 'Times New Roman';"><u>Section 5</u>.<font style="font-style: italic;">&#160; &#160; &#160; &#160;&#160; &#160;&#160; </font><u>Certain Adjustments</u>.</div>
        <div style="text-align: justify; text-indent: 31.5pt; margin-left: 36pt;"> <font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
          </font> </div>
        <div style="text-align: justify; text-indent: 72pt; font-size: 10pt; font-family: 'Times New Roman';">a)&#160; &#160; &#160; &#160; &#160; <u>Stock Dividends and Stock Splits</u>. If Borrower, at any time while this Note is outstanding: (i) declares and pays a stock
          dividend or otherwise declares and makes a distribution or distributions payable in shares of Common Stock, pro rata to the record holders of Common Stock or any Common Stock Equivalents (which, for avoidance of doubt, shall not include any
          shares of Common Stock issued by Borrower upon conversion of the Notes or any Common Stock Equivalents previously existing as of the date of this Note), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii)
          combines (including by way of a reverse stock split) outstanding shares of Common Stock into a smaller number of shares or (iv) issues, in the event of a reclassification of shares of the Common Stock, any shares of capital stock of Borrower,
          then the Conversion Price shall be multiplied by a fraction of which the numerator shall be the number of shares of Common Stock (excluding any treasury shares of Borrower) outstanding immediately before such event, and of which the denominator
          shall be the number of shares of Common Stock outstanding immediately after such event. Any adjustment made pursuant to this Section shall become effective immediately after the record date for the determination of stockholders entitled to
          receive such dividend or distribution and shall become effective immediately after the effective date in the case of a subdivision, combination or re-classification.</div>
        <div><font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
          </font> </div>
        <div style="text-align: justify; text-indent: 72pt; font-size: 10pt; font-family: 'Times New Roman';">b)&#160;&#160;&#160;&#160; &#160;&#160; <u>Subsequent Rights Offerings</u>. During the period the Note remains outstanding and not fully repaid or converted, <font style="color: rgb(0, 0, 0);">in addition to any adjustments pursuant to Section 5(a) above, if at any time Borrower grants, issues or sells any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro
            rata to the record holders of any class of shares of the Company&#8217;s Common Stock (the &#8220;<u>Purchase Rights</u>&#8221;), then the Holder will be entitled to acquire, upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which
            the Holder could have acquired if the Holder had held the number of shares of Common Stock acquirable upon complete conversion of this Note (without regard to any limitations on exercise hereof, including without limitation, the Beneficial
            Ownership Limitation) immediately before the date on which a record is taken for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are to be
            determined for the grant, issue or sale of such Purchase Rights (provided, however, to the extent that the Holder&#8217;s right to participate in any such Purchase Right would result in the Holder exceeding the Beneficial Ownership Limitation, then
            the Holder shall not be entitled to participate in such Purchase Right to such extent (or beneficial ownership of such shares of Common Stock as a result of such Purchase Right to such extent) and such Purchase Right to such extent shall be
            held in abeyance for the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).</font></div>
        <div style="text-align: justify; text-indent: 72pt;"> <font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
          </font> </div>
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div class="BRPFPageNumberArea" style="text-align: center; font-size: 10pt; font-family: 'Times New Roman';"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">9</font></div>
          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" noshade="noshade"></div>
        </div>
        <div style="text-align: justify; text-indent: 72pt; font-size: 10pt; font-family: 'Times New Roman';">c)&#160;&#160;&#160;&#160;&#160;&#160; &#160; <u>Pro Rata Distributions</u>. During such time as this Note is outstanding, if Borrower shall declare or make any dividend whether or
          not permitted, or makes any other distribution of its assets (or rights to acquire its assets), pro rata to the record holders of all outstanding shares of Common Stock, by way of return of capital or otherwise (including, without limitation, any
          distribution of cash, stock or other securities, property or options by way of a dividend, spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (a &#8220;<u>Distribution</u>&#8221;), at any time after the
          issuance of this Note, then, in each such case, the Holder shall be entitled to participate in such Distribution to the same extent that the Holder would have participated therein if the Holder had held the number of shares of Common Stock
          acquirable upon complete exercise of this Note (without regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date of which a record is taken for such Distribution,
          or, if no such record is taken, the date as of which the record holders of shares of Common Stock are to be determined for the participation in such Distribution (<u>provided</u>, <u>however</u>, to the extent that the Holder&#8217;s right to
          participate in any such Distribution would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such extent (or in the beneficial ownership of any shares
          of Common Stock as a result of such Distribution to such extent) and the portion of such Distribution shall be held in abeyance for the benefit of the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding
          the Beneficial Ownership Limitation).</div>
        <div><font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
          </font> </div>
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div class="BRPFPageNumberArea" style="text-align: center; font-size: 10pt; font-family: 'Times New Roman';"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">10</font></div>
          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" noshade="noshade"></div>
        </div>
        <div style="text-align: justify; text-indent: 72pt; font-size: 10pt; font-family: 'Times New Roman';">d)&#160; &#160; &#160;&#160; &#160; <u>Fundamental Transaction</u>. If, at any time while this Note is outstanding, (i) Borrower, directly or indirectly, in one or more
          related transactions effects any merger or consolidation of Borrower with or into another Person&#160;for which (A) Borrower is not the surviving entity, and (B) after giving effect to such transaction, the stockholders of Borrower immediately prior
          to such transaction own less than 50.1% of the aggregate voting power of the surviving successor entity of such transaction, (ii) Borrower, directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other
          disposition of all or substantially all of its assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange offer (whether by Borrower or another Person) is completed pursuant to which
          holders of Common Stock are permitted to sell, tender or exchange their shares for other securities, cash or property and has been accepted by the holders of 50% or more of the outstanding Common Stock, (iv) Borrower, directly or indirectly, in
          one or more related transactions effects any reclassification, reorganization or recapitalization of the Common Stock or any compulsory share exchange pursuant to which the Common Stock is effectively converted into or exchanged for other
          securities, cash or property, (v) Borrower, directly or indirectly, in one or more related transactions consummates a stock or share purchase agreement or other business combination (including, without limitation, a reorganization,
          recapitalization, spin-off or scheme of arrangement) with another Person whereby such other Person acquires more than 50% of the outstanding shares of Common Stock (not including any shares of Common Stock held by the other Person or other
          Persons making or party to, or associated or affiliated with the other Persons making or party to, such stock or share purchase agreement or other business combination) (each a &#8220;<u>Fundamental Transaction</u>&#8221;), then, upon any subsequent
          conversion of this Note, the Holder shall have the right to receive, for each Conversion Share that would have been issuable upon such conversion immediately prior to the occurrence of such Fundamental Transaction (without regard to any
          limitation in Section 4(d) on the conversion of this Note), the number of shares of Common Stock of the successor or acquiring corporation or of Borrower, if it is the surviving corporation, and any additional consideration (the &#8220;<u>Alternate
            Consideration</u>&#8221;) receivable as a result of such Fundamental Transaction by a holder of the number of shares of Common Stock for which this Note is convertible immediately prior to such Fundamental Transaction (without regard to any
          limitation in Section 4(d) on the conversion of this Note). For purposes of any such conversion, the determination of the Conversion Price shall be appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate
          Consideration issuable in respect of one (1) share of Common Stock in such Fundamental Transaction, and Borrower shall apportion the Conversion Price among the Alternate Consideration in a reasonable manner reflecting the relative value of any
          different components of the Alternate Consideration. If holders of Common Stock are given any choice as to the securities, cash or property to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the
          Alternate Consideration it receives upon any conversion of this Note following such Fundamental Transaction. Borrower shall cause any successor entity in a Fundamental Transaction in which Borrower is not the survivor (the &#8220;<u>Successor Entity</u>&#8221;)

          to assume in writing all of the obligations of Borrower under this Note and the other Transaction Documents (as defined in the Purchase Agreement) in accordance with the provisions of this Section 5(d) pursuant to written agreements in form and
          substance reasonably satisfactory to the Holder and approved by the Holder (without unreasonable delay) prior to such Fundamental Transaction and shall, at the option of the holder of this Note, deliver to the Holder in exchange for this Note a
          security of the Successor Entity evidenced by a written instrument substantially similar in form and substance to this Note which is convertible for a corresponding number of shares of capital stock of such Successor Entity (or its parent entity)
          equivalent to the shares of Common Stock acquirable and receivable upon conversion of this Note (without regard to any limitations on the conversion of this Note) prior to such Fundamental Transaction, and with a conversion price which applies
          the conversion price hereunder to such shares of capital stock (but taking into account the relative value of the shares of Common Stock pursuant to such Fundamental Transaction and the value of such shares of capital stock, such number of shares
          of capital stock and such conversion price being for the purpose of protecting the economic value of this Note immediately prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory in form and substance to
          the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall succeed to, and be substituted for (so that from and after the date of such Fundamental Transaction, the provisions of this Note and the other
          Transaction Documents referring to the &#8220;Company&#8221; or &#8220;Borrower&#8221; shall refer instead to the Successor Entity), and may exercise every right and power of Borrower and shall assume all of the obligations of Borrower under this Note and the other
          Transaction Documents with the same effect as if such Successor Entity had been named as Borrower herein.&#160; Fundamental Transaction shall not include the transactions described on Schedule 3.1(i) of the Purchase Agreement under the heading
          &#8220;Fundamental Transaction Exclusions.&#8221;</div>
        <div><font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
          </font> </div>
        <div style="text-align: justify; text-indent: 72pt; font-size: 10pt; font-family: 'Times New Roman';">e)&#160;&#160;&#160; &#160; &#160;&#160; <u>Adjustment Upon Issuance of Shares of Common Stock</u>.&#160; If and whenever on or after the date hereof, the Company issues or sells,
          or in accordance with this Section 5 (e) is deemed to have issued or sold, any shares of Common Stock (including the issuance or sale of shares of Common Stock owned or held by or for the account of the Company, but excluding any Exempt Issuance
          issued or sold or deemed to have been issued or sold) for a consideration per share (the &#8220;<u>New Issuance Price</u>&#8221;) less than a price equal to the Conversion Price in effect immediately prior to such issue or sale or deemed issuance or sale
          (such Conversion Price then in effect is referred to as the &#8220;<u>Applicable Price</u>&#8221;) (the foregoing a &#8220;<u>Dilutive Issuance</u>&#8221;), then immediately after such Dilutive Issuance, the Conversion Price then in effect shall be reduced to the New
          Issuance Price.&#160; For all purposes of the foregoing (including, without limitation, determining the adjusted Conversion Price and consideration per share under this Section 5(e)), the following shall be applicable:</div>
        <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div class="BRPFPageNumberArea" style="text-align: center; font-size: 10pt; font-family: 'Times New Roman';"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">11</font></div>
          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" noshade="noshade"></div>
        </div>
        <div style="text-align: justify; text-indent: 72pt; margin-left: 36pt; font-size: 10pt; font-family: 'Times New Roman';">i.&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; <u>Issuance of Options</u>.&#160; If the Company in any manner grants or sells any options (other than options that
          qualify as Exempt Issuances) and the lowest price per share for which one share of Common Stock is issuable upon the exercise of any such option or upon conversion, exercise or exchange of any Common Stock Equivalents issuable upon exercise of
          any such option is less than the Applicable Price, then such share of Common Stock shall be deemed to be outstanding and to have been issued and sold by the Company at the time of the granting or sale of such option for such price per share.&#160; For
          purposes of this Section 5(e)(i), the &#8220;lowest price per share for which one share of Common Stock is issuable upon the exercise of any such options or upon conversion, exercise or exchange of any Common Stock Equivalents issuable upon exercise of
          any such option&#8221; shall be equal to (1) the lower of (x) the sum of the lowest amounts of consideration (if any) received or receivable by the Company with respect to any one share of Common Stock upon the granting or sale of such option, upon
          exercise of such option and upon conversion, exercise or exchange of any Common Stock Equivalent issuable upon exercise of such option and (y) the lowest exercise price set forth in such option for which one share of Common Stock is issuable upon
          the exercise of any such options or upon conversion, exercise or exchange of any Common Stock Equivalents issuable upon exercise of any such option minus (2) the sum of all amounts paid or payable to the holder of such option (or any other
          Person) upon the granting or sale of such option, upon exercise of such option and upon conversion, exercise or exchange of any Common Stock Equivalent issuable upon exercise of such option plus the value of any other consideration received or
          receivable by, or benefit conferred on, the holder of such option (or any other Person).&#160; Except as contemplated below, no further adjustment of the Conversion Price shall be made upon the actual issuance of such shares of Common Stock or of such
          Common Stock Equivalents upon the exercise of such options or upon the actual issuance of such shares of Common Stock upon conversion, exercise or exchange of such Common Stock Equivalents.</div>
        <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
        <div style="text-align: justify; text-indent: 72pt; margin-left: 36pt; font-size: 10pt; font-family: 'Times New Roman';">ii.&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Issuance of Common Stock Equivalents</u>.&#160; If the Company in any manner issues or sells any Common Stock
          Equivalents (other than Common Stock Equivalents that qualify as Exempt Issuances) and the lowest price per share for which one share of Common Stock is issuable upon the conversion, exercise or exchange thereof is less than the Applicable Price,
          then such share of Common Stock shall be deemed to be outstanding and to have been issued and sold by the Company at the time of the issuance or sale of such Common Stock Equivalents for such price per share.&#160; For the purposes of this Section
          5(e)(ii), the &#8220;lowest price per share for which one share of Common Stock is issuable upon the conversion, exercise or exchange thereof&#8221; shall be equal to (1) the lower of (x) the sum of the lowest amounts of consideration (if any) received or
          receivable by the Company with respect to one share of Common Stock upon the issuance or sale of the Common Stock Equivalent and upon conversion, exercise or exchange of such Common Stock Equivalent and (y) the lowest conversion price set forth
          in such Common Stock Equivalent for which one share of Common Stock is issuable upon conversion, exercise or exchange thereof minus (2) the sum of all amounts paid or payable to the holder of such Common Stock Equivalent (or any other Person)
          upon the issuance or sale of such Common Stock Equivalent plus the value of any other consideration received or receivable by, or benefit conferred on, the holder of such Common Stock Equivalent (or any other Person).&#160; Except as contemplated
          below, no further adjustment of the Conversion Price shall be made upon the actual issuance of such shares of Common Stock upon conversion, exercise or exchange of such Common Stock Equivalents, and if any such issue or sale of such Common Stock
          Equivalents is made upon exercise of any Options for which adjustment of this Note has been or is to be made pursuant to other provisions of this Section 5(e), except as contemplated below, no further adjustment of the Conversion Price shall be
          made by reason of such issue or sale.</div>
        <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
        <div style="text-align: justify; text-indent: 72pt; margin-left: 36pt; font-size: 10pt; font-family: 'Times New Roman';">iii.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Change in Option Price or Rate of Conversion</u>.&#160; If the purchase or exercise price provided for in any
          options, the additional consideration, if any, payable upon the issue, conversion, exercise or exchange of any Common Stock Equivalents, or the rate at which any Common Stock Equivalents are convertible into or exercisable or exchangeable for
          shares of Common Stock increases or decreases at any time, the Conversion Price in effect at the time of such increase or decrease shall be adjusted to the Conversion Price which would have been in effect at such time had such options or Common
          Stock Equivalents provided for such increased or decreased purchase price, additional consideration or increased or decreased conversion rate, as the case may be, at the time initially granted, issued or sold.&#160; For purposes of this Section
          5(e)(iii), if the terms of any option or Common Stock Equivalent that was outstanding as of the date of issuance of this Note are increased or decreased in the manner described in the immediately preceding sentence, then such option or Common
          Stock Equivalent and the shares of Common Stock deemed issuable upon exercise, conversion or exchange thereof shall be deemed to have been issued as of the date of such increase or decrease.&#160; No adjustment pursuant to this Section 5(e)(iii) shall
          be made if such adjustment would result in an increase of the Conversion Price then in effect.</div>
        <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div class="BRPFPageNumberArea" style="text-align: center; font-size: 10pt; font-family: 'Times New Roman';"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">12</font></div>
          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" noshade="noshade"></div>
        </div>
        <div style="text-align: justify; text-indent: 72pt; margin-left: 36pt; font-size: 10pt; font-family: 'Times New Roman';">iv.&#160;&#160;&#160;&#160;&#160;&#160; <u>Calculation of Consideration Received</u>.&#160; If any option and/or Common Stock Equivalent and/or Adjustment Right
          is issued in connection with the issuance or sale or deemed issuance or sale of any other securities of the Company (as determined by the Holder, the &#8220;<u>Primary Security</u>&#8221;, and such option and/or Common Stock Equivalent and/or Adjustment
          Right, the &#8220;<u>Secondary Securities</u>&#8221;), together comprising one integrated transaction, the consideration per share of Common Stock with respect to such Primary Security shall be deemed to be equal to the difference of (x) the lowest price per
          share for which one share of Common Stock was issued in such integrated transaction (or was deemed to be issued pursuant to Section 5(e)(i) or 5(e)(ii) above, as applicable) solely with respect to such Primary Security, minus (y) with respect to
          such Secondary Securities, the sum of (I) the Black Scholes Consideration Value of each such option, if any, (II) the fair market value (as determined by the Holder) or the Black Scholes Consideration Value, as applicable, of such Adjustment
          Right, if any, and (III) the fair market value (as determined by the Holder) of such Common Stock Equivalent, if any, in each case, as determined on a per share basis in accordance with this Section 5(e)(iv).&#160; If any shares of Common Stock,
          options or Common Stock Equivalents are issued or sold or deemed to have been issued or sold for cash, the consideration received therefor (for the purpose of determining the consideration paid for such Common Stock, option or Common Stock
          Equivalent, but not for the purpose of the calculation of the Black Scholes Consideration Value) will be deemed to be the net amount of consideration received by the Company therefor.&#160; If any shares of Common Stock, options or Common Stock
          Equivalents are issued or sold for a consideration other than cash (for the purpose of determining the consideration paid for such Common Stock, option or Common Stock Equivalent, but not for the purpose of the calculation of the Black Scholes
          Consideration Value), the amount of such consideration received by the Company will be the fair value of such consideration, except where such consideration consists of publicly traded securities, in which case the amount of consideration
          received by the Company for such securities will be the arithmetic average of the VWAPs of such security for each of the five (5) Trading Days immediately preceding the date of receipt.&#160; If any shares of Common Stock, Options or Common Stock
          Equivalents are issued to the owners of the non-surviving entity in connection with any merger in which the Company is the surviving entity (for the purpose of determining the consideration paid for such Common Stock, option or Common Stock
          Equivalent, but not for the purpose of the calculation of the Black Scholes Consideration Value), the amount of consideration therefor will be deemed to be the fair value of such portion of the net assets and business of the non-surviving entity
          as is attributable to such shares of Common Stock, options or Common Stock Equivalents, as the case may be.&#160; The fair value of any consideration other than cash or publicly traded securities (for the purpose of determining the consideration paid
          for such Common Stock, option or Common Stock Equivalent, but not for the purpose of the calculation of the Black Scholes Consideration Value) will be determined jointly by the Company and the Holder.&#160; If such parties are unable to reach
          agreement within ten (10) days after the occurrence of an event requiring valuation (the &#8220;<u>Valuation Event</u>&#8221;), the fair value of such consideration will be determined within five (5) Trading Days after the tenth (10th) day following such
          Valuation Event by an independent, reputable appraiser jointly selected by the Company and the Holder.&#160; The determination of such appraiser shall be final and binding upon all parties absent manifest error and the fees and expenses of such
          appraiser shall be borne by the Company.</div>
        <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
        <div style="text-align: justify; text-indent: 72pt; font-size: 10pt; font-family: 'Times New Roman';">f)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Calculations</u>. All calculations under this Section 5 shall be made to the nearest cent or the nearest 1/100th of a share, as
          the case may be. For purposes of this Section 5, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall be the sum of the number of shares of Common Stock (excluding any treasury shares of Borrower)
          issued and outstanding.</div>
        <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div class="BRPFPageNumberArea" style="text-align: center; font-size: 10pt; font-family: 'Times New Roman';"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">13</font></div>
          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" noshade="noshade"></div>
        </div>
        <div style="text-align: justify; margin-left: 72pt; font-size: 10pt; font-family: 'Times New Roman';">g)&#160; &#160; &#160; &#160; &#160;&#160; <u>Notice to the Holder</u>.</div>
        <div style="text-align: justify;"> <font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
          </font> </div>
        <div style="text-align: justify; text-indent: 108pt; font-size: 10pt; font-family: 'Times New Roman';">i.&#160; &#160;&#160; &#160;&#160; &#160; <u>Adjustment to Conversion Price</u>. Whenever the Conversion Price is adjusted pursuant to any provision of this Section 5,
          Borrower shall promptly deliver to each Holder a notice setting forth the Conversion Price after such adjustment and setting forth a brief statement of the facts requiring such adjustment.</div>
        <div style="text-align: justify; text-indent: 108pt;"> <font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
          </font> </div>
        <div style="text-align: justify; text-indent: 108pt; font-size: 10pt; font-family: 'Times New Roman';">ii.&#160; &#160; &#160; &#160;&#160; <u>Notice to Allow Conversion by Holder</u>. If (A) Borrower shall declare a dividend (or any other distribution in whatever form)
          on the Common Stock, (B) Borrower shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) Borrower shall authorize the granting to all holders of the Common Stock of rights or warrants to subscribe for or
          purchase any shares of capital stock of any class or of any rights, (D) the approval of any stockholders of Borrower shall be required in connection with any reclassification of the Common Stock, any consolidation or merger to which Borrower is a
          party, any sale or transfer of all or substantially all of the assets of Borrower, or any compulsory share exchange whereby the Common Stock is converted into other securities, cash or property or (E) <font style="color: rgb(0, 0, 0);">Borrower
            shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs of Borrower, then, in each case, Borrower shall cause to be filed at each office or agency maintained for the purpose of conversion of this Note,
            and shall cause to be delivered to the Holder at its last address as it shall appear upon the Note Register, at least twenty (20) calendar days prior to the applicable record or effective date hereinafter specified, a notice stating </font>(x)
          the date on which a record is to be taken for the purpose of such dividend, distribution, redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common Stock of record to be entitled to such
          dividend, distributions, redemption, rights or warrants are to be determined or (y) the date on which such reclassification, consolidation, merger, sale, transfer or share exchange is expected to become effective or close, and the date as of
          which it is expected that holders of the Common Stock of record shall be entitled to exchange their shares of the Common Stock for securities, cash or other property deliverable upon such reclassification, consolidation, merger, sale, transfer or
          share exchange, provided that the failure to deliver such notice or any defect therein or in the delivery thereof shall not affect the validity of the corporate action required to be specified in such notice. To the extent that any notice
          provided hereunder constitutes, or contains, material, non-public information regarding Borrower or any of the Subsidiaries, Borrower shall simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K. The Holder
          shall remain entitled to convert this Note during the 20-day period commencing on the date of such notice through the effective date of the event triggering such notice except as may otherwise be expressly set forth herein.</div>
        <div><font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
          </font> </div>
        <div style="text-align: justify; text-indent: 36pt; font-size: 10pt; font-family: 'Times New Roman';">Section 6.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Prepayment and Redemption</u>.&#160; This Note may be prepaid, in whole or in part, or redeemed at any time without the consent
          of the Holder,&#160;subject to the Borrower paying the Holder a prepayment fee equal to ten percent (10%) of the amount of the obligations prepaid. This Note may not be mandatorily converted without the consent of the Holder.</div>
        <div><font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
          </font> </div>
        <div style="text-align: justify; text-indent: 36pt; font-size: 10pt; font-family: 'Times New Roman';"><u>Section 7</u>.&#160;&#160;&#160;&#160;&#160; &#160;&#160; &#160;&#160; <u>Negative Covenants</u>. As long as at least 25% of the aggregate principal of the Notes issued to the Holder and
          each Other Holder on the Original Issue Date of this Note remains outstanding, unless the holders of more than 50% in principal amount of the then outstanding Notes shall have otherwise given prior written consent, Borrower shall not, and shall
          not permit any of the Subsidiaries to, directly or indirectly:</div>
        <div style="text-align: justify; text-indent: 36pt;"> <font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
          </font> </div>
        <div style="text-align: justify; text-indent: 72pt;"><font style="color: rgb(0, 0, 0); font-size: 10pt; font-family: 'Times New Roman';">a)</font><font style="font-size: 10pt; font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);">other than Permitted Indebtedness, enter into, create, incur, assume, guarantee or suffer to exist any indebtedness for borrowed money of any kind, including, but not limited to, a guarantee, on or with respect to any of its property or
              assets now owned or hereafter acquired or any interest therein or any income or profits therefrom;</font></font></div>
        <div style="text-align: justify; text-indent: 72pt;"> <font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
          </font> </div>
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div class="BRPFPageNumberArea" style="text-align: center; font-size: 10pt; font-family: 'Times New Roman';"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">14</font></div>
          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" noshade="noshade"></div>
        </div>
        <div style="text-align: justify; text-indent: 72pt;"><font style="color: rgb(0, 0, 0); font-size: 10pt; font-family: 'Times New Roman';">b)</font><font style="font-size: 10pt; font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160; &#160; &#160; <font style="color: rgb(0, 0, 0);">other than Permitted Liens, enter into, create, incur, assume or suffer to exist any Liens of any kind, on or with respect to any of its property or assets now owned or hereafter acquired or any interest therein or any income or
              profits therefrom;</font></font></div>
        <div style="text-align: justify; text-indent: 72pt;"> <font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
          </font> </div>
        <div style="text-align: justify; text-indent: 72pt; font-size: 10pt; font-family: 'Times New Roman';">c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);">amend its charter documents, including, without limitation, its certificate of incorporation and
            bylaws, in any manner that materially and adversely affects any rights of the Holder, except </font>in case of the need to comply with the rules of the Principal Trading Market, as determined in Borrower&#8217;s sole discretion it may amend is
          charter documents to complete a reverse stock split<font style="color: rgb(0, 0, 0);">;</font></div>
        <div style="text-align: justify; text-indent: 72pt;"> <font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
          </font> </div>
        <div style="text-align: justify; text-indent: 72pt; font-size: 10pt; font-family: 'Times New Roman';">d)&#160;&#160;&#160;&#160;&#160; &#160;&#160; repay, repurchase or offer to repay, repurchase or otherwise acquire more than a <u>de</u>&#160;<u>minimis</u> number of shares of its
          Common Stock or Common Stock Equivalents other than as to the Conversion Shares as permitted or required under the Transaction Documents;</div>
        <div><font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
          </font> </div>
        <div style="text-align: justify; text-indent: 72pt; font-size: 10pt; font-family: 'Times New Roman';">e)&#160;&#160;&#160;&#160;&#160; &#160; other than in the ordinary course of business, and except with regards for Permitted Indebtedness, redeem, defease, repurchase, repay or
          make any payments in respect of, by the payment of cash or cash equivalents (in whole or in part, whether by way of open market purchases, tender offers, private transactions or otherwise), all or any portion of any Indebtedness (other than the
          Notes if on a pro-rata basis), whether by way of payment in respect of principal of (or premium, if any) or interest on, such Indebtedness, the foregoing restriction shall also apply to Permitted Indebtedness from and after the occurrence of an
          Event of Default<font style="color: rgb(0, 0, 0);">;</font></div>
        <div style="text-align: justify; text-indent: 72pt;"> <font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
          </font> </div>
        <div style="text-align: justify; text-indent: 72pt; font-size: 10pt; font-family: 'Times New Roman';">f)&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160; declare or make any cash dividend or other distribution of its assets or rights to acquire its assets to all holders of shares of
          Common Stock as a class, by way of return of capital or otherwise including, without limitation, any distribution of cash, stock or other securities, property or options by way of a dividend, spin off, reclassification, liquidation, distribution,
          preferential payments in connection with any securities or debt issuances, corporate rearrangement, scheme of arrangement or other similar transaction<font style="color: rgb(0, 0, 0);">;</font></div>
        <div><font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
          </font> </div>
        <div><font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
          </font> </div>
        <div style="text-align: justify; text-indent: 72pt; font-size: 10pt; font-family: 'Times New Roman';">g)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; enter into any transaction with any Affiliate of Borrower which would be required to be disclosed in any public filing with the
          Commission, unless such transaction is made on an arm&#8217;s-length basis and expressly approved by a majority of the disinterested directors of Borrower (even if less than a quorum otherwise required for board approval); or</div>
        <div><font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
          </font> </div>
        <div style="text-align: justify; text-indent: 72pt; font-size: 10pt; font-family: 'Times New Roman';">h)&#160;&#160;&#160;&#160;&#160; &#160; &#160; enter into any agreement with respect to any of the foregoing<font style="color: rgb(0, 0, 0);">.</font></div>
        <div style="text-align: justify; text-indent: 72pt;"> <font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
          </font> </div>
        <div style="text-align: justify; text-indent: 72pt; font-size: 10pt; font-family: 'Times New Roman';"><u>Section 8</u>.&#160; &#160;&#160; &#160; &#160; &#160;&#160; <u>Events of Default</u>.</div>
        <div style="text-align: justify; text-indent: 72pt;"> <font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
          </font> </div>
        <div style="text-align: justify; text-indent: 72pt; font-size: 10pt; font-family: 'Times New Roman';">a)&#160; &#160; &#160; &#160;&#160; &#8220;<u>Event of Default</u>&#8221; means, wherever used herein, any of the following events (whatever the reason for such event and whether such
          event shall be voluntary or involuntary or effected by operation of law or pursuant to any judgment, decree or order of any court, or any order, rule or regulation of any administrative or governmental body):</div>
        <div><font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
          </font> </div>
        <div style="text-align: justify; text-indent: 108pt; font-size: 10pt; font-family: 'Times New Roman';">i.&#160; &#160; &#160;&#160;&#160; &#160; any default in the payment of (A) the principal or interest amount of this Note or (B) liquidated damages and other amounts owing to
          a Holder on any Note, as and when the same shall become due and payable (whether on a Conversion Date or the Maturity Date or by acceleration or otherwise) which default, solely in the case of a default under clause (B) above, is not cured within
          5 Trading Days after Borrower has become aware of such default;</div>
        <div style="text-align: justify; text-indent: 108pt;"> <font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
          </font> </div>
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div class="BRPFPageNumberArea" style="text-align: center; font-size: 10pt; font-family: 'Times New Roman';"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">15</font></div>
          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" noshade="noshade"></div>
        </div>
        <div style="text-align: justify; text-indent: 108pt;"><font style="color: rgb(0, 0, 0); font-size: 10pt; font-family: 'Times New Roman';">ii.&#160; &#160; &#160; &#160; &#160; </font><font style="font-size: 10pt; font-family: 'Times New Roman';">Borrower fails to observe
            or perform any other material covenant or material agreement contained in the Notes (other than a breach by Borrower of its obligations to deliver shares of Common Stock to the Holder upon conversion, which breach is addressed in clause (ix)
            below) which failure is not cured, if possible to cure, within the earlier to <font style="color: rgb(0, 0, 0);">occur of (A) 5 Trading Days after written notice of such failure sent by the Holder or by any Other Holder to Borrower and (B) 10
              Trading Days after Borrower has become aware of such failure;</font></font></div>
        <div style="text-align: justify; text-indent: 108pt;"> <font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
          </font> </div>
        <div style="text-align: justify; text-indent: 108pt;"><font style="color: rgb(0, 0, 0); font-size: 10pt; font-family: 'Times New Roman';">iii.&#160;&#160; &#160; &#160;&#160; </font><font style="font-size: 10pt; font-family: 'Times New Roman';">a material default or
            material event of default (subject to any grace or cure period provided in the applicable agreement, document or instrument) shall occur under any of the Transaction Documents;</font></div>
        <div style="text-align: justify; text-indent: 108pt;"> <font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
          </font> </div>
        <div style="text-align: justify; text-indent: 108pt; font-size: 10pt; font-family: 'Times New Roman';">iv.&#160;&#160;&#160;&#160; &#160; <font style="color: rgb(0, 0, 0);">any material representation or warranty made in this Note, any other Transaction Documents, any
            written statement pursuant hereto or thereto or any other report, financial statement or certificate made or delivered to the Holder or any Other Holder shall be untrue or incorrect in any material respect as of the date when made or deemed
            made;</font></div>
        <div style="text-align: justify; text-indent: 108pt;"> <font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
          </font> </div>
        <div style="text-align: justify; text-indent: 108pt; font-size: 10pt; font-family: 'Times New Roman';">v.&#160; &#160; &#160; &#160; &#160;&#160; Borrower or any Subsidiary shall be subject to a Bankruptcy Event;</div>
        <div style="text-align: justify; text-indent: 108pt;"> <font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
          </font> </div>
        <div style="text-align: justify; text-indent: 108pt; font-size: 10pt; font-family: 'Times New Roman';">vi.&#160; &#160; &#160; &#160;&#160; Borrower or any Subsidiary shall default on any of its obligations under any mortgage, credit agreement or other facility, indenture
          agreement, factoring agreement or other instrument under which there may be issued, or by which there may be secured or evidenced, any indebtedness for borrowed money or money due under any long term leasing or factoring arrangement that (a)
          involve obligations greater than $1,500,000 in the aggregate, whether such indebtedness now exists or shall hereafter be created, and (b) results in such indebtedness becoming or being declared due and payable prior to the date on which it would
          otherwise become due and payable;</div>
        <div style="text-align: justify; text-indent: 108pt;"> <font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
          </font> </div>
        <div style="text-align: justify; text-indent: 108pt; font-size: 10pt; font-family: 'Times New Roman';">vii.&#160; &#160; &#160;&#160; Borrower shall be a party to any Change of Control Transaction or Fundamental Transaction or shall agree to sell or dispose of all or
          in excess of 50% of its assets in one transaction or a series of related transactions (whether or not such sale would constitute a Change of Control Transaction);</div>
        <div style="text-align: justify; text-indent: 108pt;"> <font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
          </font> </div>
        <div style="text-align: justify; text-indent: 108pt; font-size: 10pt; font-family: 'Times New Roman';">viii.&#160; &#160;&#160; &#160; Borrower does not meet the current public information requirements under Rule 144;</div>
        <div style="text-indent: 108pt;"> <font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
          </font> </div>
        <div style="text-align: justify; text-indent: 108pt; font-size: 10pt; font-family: 'Times New Roman';">ix.&#160; &#160;&#160;&#160; &#160; Borrower shall fail for any reason to deliver book-entry statements to a Holder prior to the fifth (5<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup>) Trading Day after a Conversion Date pursuant to Section 4(c) or Borrower shall provide at any time notice to the Holder, including by way of public announcement, of Borrower&#8217;s intention
          to not honor requests for conversions of any Notes in accordance with the terms hereof, except as allowed pursuant to the Transaction Documents;</div>
        <div style="text-align: justify; text-indent: 108pt;"> <font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
          </font> </div>
        <div style="text-align: justify; text-indent: 108pt; font-size: 10pt; font-family: 'Times New Roman';">x.&#160; &#160;&#160; &#160; &#160;&#160; any monetary judgment, writ or similar final process shall be entered or filed against Borrower, any subsidiary or any of their
          respective property or other assets for more than $500,000, and such judgment, writ or similar final process shall remain unvacated, unbonded or unstayed for a period of 90 calendar days;</div>
        <div><font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
          </font> </div>
        <div style="text-align: justify; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">xi.&#160;&#160;&#160;&#160;&#160; &#160; &#160; any dissolution, liquidation or winding up by Borrower or a material Subsidiary of a substantial portion of their
            business; <br>
          </font> </div>
        <div><font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
          </font> </div>
        <div style="text-align: justify; text-indent: 108pt; font-size: 10pt; font-family: 'Times New Roman';">xii.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; cessation of operations by Borrower or a material Subsidiary;</div>
        <div><font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
          </font> </div>
        <div style="text-align: justify; text-indent: 108pt; font-size: 10pt; font-family: 'Times New Roman';">xiii.&#160; &#160; &#160; the failure by Borrower or any material Subsidiary to maintain any material intellectual property rights, personal, real property,
          equipment, leases or other assets which are necessary to conduct its business (whether now or in the future) and such breach is not cured with twenty (20) days after written notice to the Borrower from the Holder;</div>
        <div><font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
          </font> </div>
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div class="BRPFPageNumberArea" style="text-align: center; font-size: 10pt; font-family: 'Times New Roman';"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">16</font></div>
          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" noshade="noshade"></div>
        </div>
        <div style="text-align: justify; text-indent: 108pt; font-size: 10pt; font-family: 'Times New Roman';">xiv.&#160;&#160;&#160;&#160;&#160;&#160;&#160; an event resulting in the Common Stock no longer being listed or quoted on a Trading Market, or the expiration of all cure periods
          and opportunities to appeal any non-compliance with the conditions for continued quotation on the Trading Market following notification that the Borrower is not in compliance with the conditions for such continued quotation;</div>
        <div><font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
          </font> </div>
        <div style="text-align: justify; text-indent: 108pt; font-size: 10pt; font-family: 'Times New Roman';">xv.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; a Commission or judicial stop trade order or suspension from the Borrower&#8217;s Principal Trading Market;</div>
        <div><font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
          </font> </div>
        <div style="text-align: justify; text-indent: 108pt; font-size: 10pt; font-family: 'Times New Roman';">xvi. &#160; &#160;&#160;&#160; the restatement after the date hereof of any financial statements filed by the Borrower with the Commission for any date or period
          from two years prior to the Original Issue Date and until this Note is no longer outstanding, if the result of such restatement would, by comparison to the unrestated financial statements, have constituted a Material Adverse Effect.&#160; For the
          avoidance of doubt, any restatement related to new accounting pronouncements shall not constitute a default under this Section;</div>
        <div><font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
          </font> </div>
        <div style="text-align: justify; text-indent: 108pt; font-size: 10pt; font-family: 'Times New Roman';">xviii.&#160;&#160;&#160; the Borrower effectuates a reverse split of its Common Stock without two (2) days prior written notice to the Holder;</div>
        <div><font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
          </font> </div>
        <div style="text-align: justify; text-indent: 108pt; font-size: 10pt; font-family: 'Times New Roman';">xix.&#160;&#160;&#160;&#160;&#160; a failure by Borrower to provide any notice required by any of the Transaction Documents, and the failure to provide such notice has a
          materially adverse effect on the Holder;</div>
        <div><font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
          </font> </div>
        <div style="text-align: justify; text-indent: 108pt; font-size: 10pt; font-family: 'Times New Roman';">xx.&#160;&#160;&#160; &#160; &#160; any material provision of any Transaction Document shall at any time for any reason (other than pursuant to the express terms thereof)
          cease to be valid and binding on or enforceable against the Borrower, or the validity or enforceability thereof shall be contested by Borrower; or</div>
        <div><font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
          </font> </div>
        <div style="text-align: justify; text-indent: 108pt;"><font style="color: rgb(0, 0, 0); font-size: 10pt; font-family: 'Times New Roman';">xxiii.</font><font style="font-size: 10pt; font-family: 'Times New Roman';">&#160; &#160; a proceeding shall be
            commenced by Borrower or any governmental authority having jurisdiction over Borrower or Holder, seeking to establish the invalidity or unenforceability thereof, or Borrower shall deny in writing that it has any liability or obligation
            purported to be created under any Transaction Document.</font></div>
        <div><font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
          </font> </div>
        <div style="text-align: justify; text-indent: 72pt; font-size: 10pt; font-family: 'Times New Roman';">b)&#160; &#160; &#160; &#160; &#160; <u>Remedies Upon Event of Default, Fundamental Transaction and Change of Control Transaction</u>.&#160; If, after the expiration of any
          grace period(s) set forth herein, any Event of Default or a Fundamental Transaction or a Change of Control Transaction occurs, the outstanding principal amount of this Note, liquidated damages and other amounts owing in respect thereof through
          the date of acceleration, shall become, at the Holder&#8217;s election, immediately due and payable in cash at the Mandatory Default Amount. Commencing on the Maturity Date and also five (5) days after the occurrence of any Event of Default, interest
          on this Note shall accrue at an interest rate equal to the lesser of 18% per annum or the maximum rate permitted under applicable law. Upon the payment in full of the Mandatory Default Amount, the Holder shall promptly surrender this Note to or
          as directed by Borrower. In connection with such acceleration described herein, the Holder need not provide, and Borrower hereby waives, any presentment, demand, protest or other notice of any kind, and the Holder may immediately enforce any and
          all of its rights and remedies hereunder and all other remedies available to it under applicable law. Such acceleration may be rescinded and annulled by Holder at any time prior to payment hereunder and the Holder shall have all rights as a
          holder of the Note until such time, if any, as the Holder receives full payment pursuant to this Section 8(b). No such rescission or annulment shall affect any subsequent Event of Default or impair any right consequent thereon.</div>
        <div><font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
          </font> </div>
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div class="BRPFPageNumberArea" style="text-align: center; font-size: 10pt; font-family: 'Times New Roman';"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">17</font></div>
          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" noshade="noshade"></div>
        </div>
        <div style="text-align: justify; text-indent: 36pt; font-size: 10pt; font-family: 'Times New Roman';"><u>Section 9</u>.&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160;&#160; <u>Security Interest/Waiver of Automatic Stay</u>. This Note is secured by a security interest granted to the Holder
          pursuant to a Security Agreement, as delivered by Borrower to Holder.&#160; The Borrower acknowledges and agrees that should a proceeding under any bankruptcy or insolvency law be commenced by or against the Borrower or a Subsidiary, or if any of the
          Collateral (as defined in the Security Agreement) should become the subject of any bankruptcy or insolvency proceeding, then the Holder should be entitled to, among other relief to which the Holder may be entitled under the Transaction Documents
          and any other agreement to which the Borrower or a Subsidiary and Holder are parties (collectively, &#8220;<u>Loan Documents</u>&#8221;) and/or applicable law, an order from the court granting immediate relief from the automatic stay pursuant to 11 U.S.C.
          Section 362 to permit the Holder to exercise all of its rights and remedies pursuant to the Loan Documents and/or applicable law.&#160; TO THE EXTENT PERMITTED BY APPLICABLE LAW, THE BORROWER EXPRESSLY WAIVES THE BENEFIT OF THE AUTOMATIC STAY IMPOSED
          BY 11 U.S.C. SECTION 362.&#160; FURTHERMORE, THE BORROWER EXPRESSLY ACKNOWLEDGES AND AGREES THAT NEITHER 11 U.S.C. SECTION 362 NOR ANY OTHER SECTION OF THE BANKRUPTCY CODE OR OTHER STATUTE OR RULE (INCLUDING, WITHOUT LIMITATION, 11 U.S.C. SECTION 105)
          SHALL STAY, INTERDICT, CONDITION, REDUCE OR INHIBIT IN ANY WAY THE ABILITY OF THE HOLDER TO ENFORCE ANY OF ITS RIGHTS AND REMEDIES UNDER THE LOAN DOCUMENTS AND/OR APPLICABLE LAW.&#160; The Borrower hereby consents to any motion for relief from stay
          that may be filed by the Holder in any bankruptcy or insolvency proceeding initiated by or against the Borrower and, further, agrees not to file any opposition to any motion for relief from stay filed by the Holder.&#160; The Borrower represents,
          acknowledges and agrees that this provision is a specific and material aspect of the Loan Documents, and that the Holder would not agree to the terms of the loan Documents if this waiver were not a part of this Note.&#160; The Borrower further
          represents, acknowledges and agrees that is waiver is knowingly, intelligently and voluntarily made, that neither the Holder nor any person acting on behalf of the Holder has made any representations to induce this waiver, that the Borrower has
          been represented (or has had the opportunity to by represented) in the signing of this Note and the Loan Documents and in the making of this waiver by independent legal counsel selected by the Borrower and that the Borrower has discussed this
          waiver with counsel.</div>
        <div><font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
          </font> </div>
        <div style="text-align: justify; text-indent: 36pt; font-size: 10pt; font-family: 'Times New Roman';"><u>Section 10</u>.&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160; <u>Miscellaneous</u>.</div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"> <font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
          </font> </div>
        <div style="text-align: justify; text-indent: 72pt; font-size: 10pt; font-family: 'Times New Roman';">a)&#160; &#160; &#160; &#160;&#160; &#160; <u>Notices</u>. <font style="color: rgb(0, 0, 0);">All notices, demands, requests, consents, approvals, and other communications
            required or permitted hereunder shall be in writing and, unless otherwise specified herein, shall be (i) personally served, (ii) deposited in the mail, registered or certified, return receipt requested, postage prepaid, (iii) delivered by
            reputable air courier service with charges prepaid, or (iv) transmitted by hand delivery, telegram, or electronic mail (&#8220;e-mail&#8221;), addressed as set forth below or to such other address as such party shall have specified most recently by written
            notice.&#160; Any notice or other communication required or permitted to be given hereunder shall be deemed effective (a) upon hand delivery at the address designated below (if delivered on a Business Day during normal business hours where such
            notice is to be received), or the first Business Day following such delivery (if delivered other than on a Business Day during normal business hours where such notice is to be received), or (b) upon receipt, when sent by electronic mail
            (provided confirmation of transmission is electronically generated and kept on file by the sending party), or (c) on the second (2</font><sup style="color: #000000; vertical-align: text-top; line-height: 1; font-size: smaller;">nd</sup><font style="color: rgb(0, 0, 0);">) Business Day following the date of mailing by express courier service, fully prepaid, addressed to such address, or upon actual receipt of such mailing, whichever shall first occur. The addresses for such
            communications shall be: (i) if to Borrower, to: </font><a name="z_Hlk507748635"></a><a name="z_Hlk68707556"></a><font style="color: rgb(0, 0, 0);">Momentus Inc., </font><a name="z_Hlk85453853"></a><font style="color: rgb(0, 0, 0);">3901 N.
            First Street, San Jose, CA, 95134, Attn: John Rood, email: [***],&#160; </font>with a copy by e-mail only to (which shall not constitute notice): <font style="color: rgb(0, 0, 0);">Bradley Arant Boult Cummings LLP</font>, <font style="color: rgb(0, 0, 0);">1221 Broadway, Suite 2400, Nashville, TN 37203</font>, Attn: <font style="color: rgb(0, 0, 0);">Stephen Hinton</font>, Esq., email: <font style="color: rgb(0, 0, 0);">[***]</font>, and (ii) if to the Holder, to: the address
          indicated on the front page of this Note, with an additional copy by e-mail only to (which shall not constitute notice): Grushko &amp; Mittman, P.C., 1800 Rockaway Avenue, Suite 206, Hewlett, New York 11557, Attn: Eliezer Drew, Esq., email:
          [***].</div>
        <div style="text-align: justify; text-indent: 72pt;"> <font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
          </font> </div>
        <div style="text-align: justify; text-indent: 72pt; font-size: 10pt; font-family: 'Times New Roman';">b)&#160; &#160; &#160; &#160; &#160; <u>Absolute Obligation</u>. Except as expressly provided herein, no provision of this Note shall alter or impair the obligation of
          Borrower, which is absolute and unconditional, to pay the principal of, liquidated damages and accrued interest, as applicable, on this Note at the time, place, and rate, and in the coin or currency, herein prescribed. This Note is a direct debt
          obligation of Borrower. This Note ranks <u>pari</u>&#160;<u>passu </u>with all other Notes now or hereafter issued under the terms set forth herein.</div>
        <div style="text-align: justify; text-indent: 72pt;"> <font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
          </font> </div>
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div class="BRPFPageNumberArea" style="text-align: center; font-size: 10pt; font-family: 'Times New Roman';"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">18</font></div>
          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" noshade="noshade"></div>
        </div>
        <div style="text-align: justify; text-indent: 72pt; font-size: 10pt; font-family: 'Times New Roman';">c)&#160; &#160; &#160; &#160; &#160; <u>Lost or Mutilated Note</u>. If this Note shall be mutilated, lost, stolen or destroyed, Borrower shall execute and deliver, in
          exchange and substitution for and upon cancellation of a mutilated Note, or in lieu of or in substitution for a lost, stolen or destroyed Note, a new Note for the principal amount of this Note so mutilated, lost, stolen or destroyed, but only
          upon receipt of evidence of such loss, theft or destruction of such Note, and of the ownership hereof, reasonably satisfactory to Borrower.</div>
        <div><font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
          </font> </div>
        <div style="text-align: justify; text-indent: 72pt; font-size: 10pt; font-family: 'Times New Roman';">d)&#160; &#160; &#160;&#160; &#160;&#160; <u>Governing Law</u>.&#160;&#160; All questions concerning the construction, validity, enforcement and interpretation of this Note shall be
          governed by and construed and enforced in accordance with the internal laws of the State of Delaware, without regard to the principles of conflict of laws thereof.&#160; Each party agrees that all legal proceedings concerning the interpretation,
          enforcement and defense of the transactions contemplated by any of the Transaction Documents (whether brought against a party hereto or its respective Affiliates, directors, officers, shareholders, employees or agents) shall be commenced in the
          state and federal courts sitting in the state of Delaware (the &#8220;<u>Delaware Courts</u>&#8221;). Each party hereto hereby irrevocably submits to the exclusive jurisdiction of the Delaware Courts for the adjudication of any dispute hereunder or in
          connection herewith or with any transaction contemplated hereby or discussed herein (including with respect to the enforcement of any of the Transaction Documents), and hereby irrevocably waives, and agrees not to assert in any suit, action or
          proceeding, any claim that it is not personally subject to the jurisdiction of such Delaware Courts, or such Delaware Courts are improper or inconvenient venue for such proceeding. Each party hereby waives personal service of process and consents
          to process being served in any such suit, action or proceeding by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under this Note
          and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any other manner permitted by applicable law. Each
          party hereto hereby irrevocably waives, to the fullest extent permitted by applicable law, any and all right to trial by jury in any legal proceeding arising out of or relating to this Note or the transactions contemplated hereby. If any party
          shall commence an action or proceeding to enforce any provisions of this Note, then the prevailing party in such action or proceeding shall be reimbursed by the other party for its attorneys fees and other costs and expenses incurred in the
          investigation, preparation and prosecution of such action or proceeding.&#160; <font style="font-weight: bold;">This Note shall be deemed an unconditional obligation of Borrower for the payment of money and, without limitation to any other remedies
            of Holder, may be enforced against Borrower by summary proceedings in the jurisdiction where enforcement is sought.&#160; For purposes of such rule or statute, any other document or agreement to which Holder and Borrower are parties or which
            Borrower delivered to Holder, which may be convenient or necessary to determine Holder&#8217;s rights hereunder or Borrower&#8217;s obligations to Holder are deemed a part of this Note, whether or not such other document or agreement was delivered together
            herewith or was executed apart from this Note.</font></div>
        <div style="text-align: justify; text-indent: 72pt;"> <font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
          </font> </div>
        <div style="text-align: justify; text-indent: 72pt; font-size: 10pt; font-family: 'Times New Roman';">e)&#160; &#160; &#160;&#160; &#160; <u>Waiver</u>. Any waiver by Borrower or the Holder of a breach of any provision of this Note shall not operate as or be construed to
          be a waiver of any other breach of such provision or of any breach of any other provision of this Note. The failure of Borrower or the Holder to insist upon strict adherence to any term of this Note on one or more occasions shall not be
          considered a waiver or deprive that party of the right thereafter to insist upon strict adherence to that term or any other term of this Note on any other occasion. Any waiver by Borrower or the Holder must be in writing.</div>
        <div style="text-align: justify; text-indent: 72pt;"> <font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
          </font> </div>
        <div style="text-align: justify; text-indent: 72pt; font-size: 10pt; font-family: 'Times New Roman';">f)&#160; &#160; &#160; &#160;&#160;&#160; <u>Severability</u>. If any provision of this Note is invalid, illegal or unenforceable, the balance of this Note shall remain in
          effect, and if any provision is inapplicable to any Person or circumstance, it shall nevertheless remain applicable to all other Persons and circumstances.</div>
        <div style="text-indent: 72pt;"> <font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
          </font> </div>
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div class="BRPFPageNumberArea" style="text-align: center; font-size: 10pt; font-family: 'Times New Roman';"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">19</font></div>
          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" noshade="noshade"></div>
        </div>
        <div style="text-align: justify; text-indent: 72pt; font-size: 10pt; font-family: 'Times New Roman';">g)&#160; &#160; &#160; &#160;&#160; <u>Usury</u>. If it shall be found that any interest or other amount deemed interest due hereunder violates the applicable law
          governing usury, the applicable rate of interest due hereunder shall automatically be lowered to equal the maximum rate of interest permitted under applicable law. Borrower covenants (to the extent that it may lawfully do so) that it shall not at
          any time insist upon, plead, or in any manner whatsoever claim or take the benefit or advantage of, any stay, extension or usury law or other law which would prohibit or forgive Borrower from paying all or any portion of the principal of or
          interest on this Note as contemplated herein, wherever enacted, now or at any time hereafter in force, or which may affect the covenants or the performance of this Note, and Borrower (to the extent it may lawfully do so) hereby expressly waives
          all benefits or advantage of any such law, and covenants that it will not, by resort to any such law, hinder, delay or impede the execution of any power herein granted to the Holder, but will suffer and permit the execution of every such as
          though no such law has been enacted.</div>
        <div><font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
          </font> </div>
        <div style="text-align: justify; text-indent: 72pt; font-size: 10pt; font-family: 'Times New Roman';">h)&#160; &#160; &#160; &#160; &#160; <u>Equitable Adjustment</u>.&#160; Trading volume amounts, price/volume amounts, the amount of Warrants, the amount of shares of Common
          Stock identified in this Agreement, Conversion Price, Exercise Price, Underlying Shares and similar figures in the Transaction Documents shall be equitably adjusted (but without duplication) to offset the effect of stock splits, similar events
          and as otherwise described in the Securities Purchase Agreement, Note and Warrants.</div>
        <div><font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
          </font> </div>
        <div style="text-align: justify; text-indent: 72pt; font-size: 10pt; font-family: 'Times New Roman';">i)&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; <u>Next Business Day</u>. Whenever any payment or other obligation hereunder shall be due on a day other than a Business Day, such
          payment shall be made on the next succeeding Business Day.</div>
        <div style="text-align: justify; text-indent: 72pt;"> <font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
          </font> </div>
        <div style="text-align: justify; text-indent: 72pt; font-size: 10pt; font-family: 'Times New Roman';">j)&#160; &#160; &#160;&#160; &#160;&#160;&#160; <u>Headings</u>. The headings contained herein are for convenience only, do not constitute a part of this Note and shall not be
          deemed to limit or affect any of the provisions hereof.</div>
        <div style="text-indent: 72pt;"> <font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
          </font> </div>
        <div style="text-align: justify; text-indent: 72pt; font-size: 10pt; font-family: 'Times New Roman';">k)&#160; &#160;&#160; &#160; &#160; <u>Amendment</u>. Unless otherwise provided for hereunder, this Note may not be modified or amended or the provisions hereof waived
          without the written consent of Borrower <font style="color: rgb(0, 0, 0);">and the Holder</font>.</div>
        <div style="text-align: justify; text-indent: 72pt;"> <font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
          </font> </div>
        <div style="text-align: justify; text-indent: 72pt; font-size: 10pt; font-family: 'Times New Roman';">l)&#160; &#160;&#160; &#160; &#160; &#160; <u>Electronic Signature</u>.&#160; In the event that the Borrower&#8217;s signature is delivered by facsimile transmission, PDF, electronic
          signature or other similar electronic means, such signature shall create a valid and binding obligation of the Borrower with the same force and effect as if such signature page were an original thereof.</div>
        <div><font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
          </font> </div>
        <div style="text-align: center; font-size: 10pt; font-family: 'Times New Roman';">*********************</div>
        <div style="text-align: center; font-style: italic; font-size: 10pt; font-family: 'Times New Roman';">(Signature Pages Follow)</div>
        <div style="text-align: center; font-style: italic;"> <font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
          </font> </div>
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div class="BRPFPageNumberArea" style="text-align: center; font-size: 10pt; font-family: 'Times New Roman';"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">20</font></div>
          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" noshade="noshade"></div>
        </div>
        <div style="text-indent: 36pt;"><font style="font-weight: bold; font-size: 10pt; font-family: 'Times New Roman';">IN WITNESS WHEREOF</font><font style="font-size: 10pt; font-family: 'Times New Roman';">, Borrower has caused this Note to be signed
            in its name by an authorized officer as of the 25<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup> day of September, 2025.</font></div>
        <div><font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
          </font> </div>
        <div>
          <table style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;" id="z05cd4dd7be724816bf2bebf87c173f4a" border="0" cellpadding="0" cellspacing="0">

              <tr>
                <td style="width: 40%;"><br>
                </td>
                <td rowspan="1" colspan="3"><font style="font-weight: bold;">MOMENTUS INC.</font><br>
                </td>
              </tr>
              <tr>
                <td rowspan="1" style="width: 40%;">&#160;</td>
                <td rowspan="1" colspan="3">&#160;</td>
              </tr>
              <tr>
                <td style="width: 40%; padding-bottom: 2px;"><br>
                </td>
                <td style="width: 3%; padding-bottom: 2px;">By:</td>
                <td style="width: 17%; border-bottom: 2px solid rgb(0, 0, 0);">/s/ John C. Rood</td>
                <td style="width: 40%; padding-bottom: 2px;"><br>
                </td>
              </tr>

          </table>
          <table id="zb5029a8f289d4904a52208dff73cd933" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;" border="0" cellpadding="0" cellspacing="0">

              <tr>
                <td style="width: 40%;"><br>
                </td>
                <td style="width: 3%;"><br>
                </td>
                <td style="width: 4%;">Name:</td>
                <td style="width: 53%;"> John C. Rood</td>
              </tr>
              <tr>
                <td style="width: 40%;" rowspan="1">&#160;</td>
                <td style="width: 3%;" rowspan="1"><br>
                </td>
                <td style="width: 4%;" rowspan="1">Title:</td>
                <td style="width: 53%;" rowspan="1">Chief Executive Officer</td>
              </tr>
              <tr>
                <td style="width: 40%;" rowspan="1"><br>
                </td>
                <td style="width: 3%;" rowspan="1"><br>
                </td>
                <td style="width: 4%;" rowspan="1"><br>
                </td>
                <td style="width: 53%;" rowspan="1"><br>
                </td>
              </tr>
              <tr>
                <td style="width: 40%;" rowspan="1">
                  <div style="text-align: left; color: rgb(0, 0, 0);"><a name="z_DV_M100"></a>WITNESS:</div>
                </td>
                <td style="width: 3%;" rowspan="1"><br>
                </td>
                <td style="width: 4%;" rowspan="1"><br>
                </td>
                <td style="width: 53%;" rowspan="1"><br>
                </td>
              </tr>
              <tr>
                <td style="width: 40%;" rowspan="1"><br>
                </td>
                <td style="width: 3%;" rowspan="1"><br>
                </td>
                <td style="width: 4%;" rowspan="1"><br>
                </td>
                <td style="width: 53%;" rowspan="1"><br>
                </td>
              </tr>
              <tr>
                <td style="width: 40%; border-bottom: 2px solid rgb(0, 0, 0);" rowspan="1"><br>
                </td>
                <td style="width: 3%;" rowspan="1">&#160;</td>
                <td style="width: 4%;" rowspan="1">&#160;</td>
                <td style="width: 53%;" rowspan="1">&#160;</td>
              </tr>

          </table>
        </div>
        <div style="text-indent: 216pt; color: rgb(0, 0, 0);"><font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
          </font> </div>
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div class="BRPFPageNumberArea" style="text-align: center; font-size: 10pt; font-family: 'Times New Roman';"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">21</font></div>
          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" noshade="noshade"></div>
        </div>
        <div style="text-align: center; font-weight: bold; font-size: 10pt; font-family: 'Times New Roman';">ANNEX A</div>
        <div style="text-align: center;"><font style="font-weight: bold; font-size: 10pt; font-family: 'Times New Roman';"> </font><font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
          </font> </div>
        <div style="text-align: center; font-weight: bold; font-size: 10pt; font-family: 'Times New Roman';">NOTICE OF CONVERSION</div>
        <div style="text-align: justify;"> <font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
          </font> </div>
        <div style="text-align: justify; text-indent: 36pt; font-size: 10pt; font-family: 'Times New Roman';">The undersigned hereby elects to convert principal under the Convertible Note due September 25, 2026 of Momentus Inc., a Delaware corporation (the
          &#8220;<u>Company</u>&#8221;), into shares of common stock (the &#8220;<u>Common Stock</u>&#8221;), of Borrower according to the conditions hereof, as of the date written below. If shares of Common Stock are to be issued in the name of a person other than the
          undersigned, the undersigned will pay all transfer taxes payable with respect thereto and is delivering herewith such certificates and opinions as reasonably requested by Borrower in accordance therewith. No fee will be charged to the holder for
          any conversion, except for such transfer taxes, if any.</div>
        <div style="text-align: justify;"> <font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
          </font> </div>
        <div style="text-align: justify; text-indent: 36pt; font-size: 10pt; font-family: 'Times New Roman';">By the delivery of this Notice of Conversion the undersigned represents and warrants to Borrower that its ownership of the Common Stock does not
          exceed the amounts specified under Section 4 of this Note, as determined in accordance with Section 13(d) of the Exchange Act.</div>
        <div style="text-align: justify;"> <font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
          </font> </div>
        <div style="text-align: justify; text-indent: 36pt; font-size: 10pt; font-family: 'Times New Roman';">The undersigned agrees to comply with the prospectus delivery requirements under the applicable securities laws in connection with any transfer of
          the aforesaid shares of Common Stock.</div>
        <div style="text-align: justify;"> <font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
          </font> </div>
        <div style="font-size: 10pt; font-family: 'Times New Roman';">Conversion calculations:</div>
        <table id="z0e17f728067248ed90ecfff5b438bebb" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" border="0" cellpadding="0" cellspacing="0">

            <tr>
              <td style="width: 34.99%; vertical-align: top;">&#160;</td>
              <td style="width: 65.01%; vertical-align: top;">
                <div style="text-align: justify;">Date to Effect Conversion: ____________________________</div>
              </td>
            </tr>
            <tr>
              <td style="width: 34.99%; vertical-align: top;">&#160;</td>
              <td style="width: 65.01%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 34.99%; vertical-align: top;">&#160;</td>
              <td style="width: 65.01%; vertical-align: top;">
                <div>Principal Amount of Note to be Converted: $__________________</div>
              </td>
            </tr>
            <tr>
              <td style="width: 34.99%; vertical-align: top;">&#160;</td>
              <td style="width: 65.01%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 34.99%; vertical-align: top;">&#160;</td>
              <td style="width: 65.01%; vertical-align: top;">
                <div>Accrued Interest to be Converted, if any: $______________</div>
              </td>
            </tr>
            <tr>
              <td style="width: 34.99%; vertical-align: top;">&#160;</td>
              <td style="width: 65.01%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 34.99%; vertical-align: top;">&#160;</td>
              <td style="width: 65.01%; vertical-align: top;">
                <div>Conversion Price: $_________________</div>
              </td>
            </tr>
            <tr>
              <td style="width: 34.99%; vertical-align: top;">&#160;</td>
              <td style="width: 65.01%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 34.99%; vertical-align: top;">&#160;</td>
              <td style="width: 65.01%; vertical-align: top;">
                <div>Number of shares of Common Stock to be issued: ______________</div>
              </td>
            </tr>
            <tr>
              <td style="width: 34.99%; vertical-align: top;">&#160;</td>
              <td style="width: 65.01%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 34.99%; vertical-align: top;">&#160;</td>
              <td style="width: 65.01%; vertical-align: top;">
                <div style="text-align: justify;">Signature: _________________________________________</div>
              </td>
            </tr>
            <tr>
              <td style="width: 34.99%; vertical-align: top;">&#160;</td>
              <td style="width: 65.01%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 34.99%; vertical-align: top;">&#160;</td>
              <td style="width: 65.01%; vertical-align: top;">
                <div style="text-align: justify;">Name: ____________________________________________</div>
              </td>
            </tr>
            <tr>
              <td style="width: 34.99%; vertical-align: top;">&#160;</td>
              <td style="width: 65.01%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 34.99%; vertical-align: top;">&#160;</td>
              <td style="width: 65.01%; vertical-align: top;">
                <div style="text-align: justify;">Address for Delivery of Common Stock Certificates: __________</div>
              </td>
            </tr>
            <tr>
              <td style="width: 34.99%; vertical-align: top;">&#160;</td>
              <td style="width: 65.01%; vertical-align: top;">
                <div style="text-align: justify;">_____________________________________________________</div>
              </td>
            </tr>
            <tr>
              <td style="width: 34.99%; vertical-align: top;">&#160;</td>
              <td style="width: 65.01%; vertical-align: top;">
                <div style="text-align: justify;">_____________________________________________________</div>
              </td>
            </tr>
            <tr>
              <td style="width: 34.99%; vertical-align: top;">&#160;</td>
              <td style="width: 65.01%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 34.99%; vertical-align: top;">&#160;</td>
              <td style="width: 65.01%; vertical-align: top;">
                <div><u>Or</u></div>
              </td>
            </tr>
            <tr>
              <td style="width: 34.99%; vertical-align: top;">&#160;</td>
              <td style="width: 65.01%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 34.99%; vertical-align: top;">&#160;</td>
              <td style="width: 65.01%; vertical-align: top;">
                <div>DWAC Instructions: _________________________________</div>
              </td>
            </tr>
            <tr>
              <td style="width: 34.99%; vertical-align: top;">&#160;</td>
              <td style="width: 65.01%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 34.99%; vertical-align: top;">&#160;</td>
              <td style="width: 65.01%; vertical-align: top;">
                <div>Broker No:_____________</div>
              </td>
            </tr>
            <tr>
              <td style="width: 34.99%; vertical-align: top;">&#160;</td>
              <td style="width: 65.01%; vertical-align: top;">
                <div>Account No: _______________</div>
              </td>
            </tr>

        </table>
        <div> <font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
          </font> </div>
        <div> <font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
          </font> </div>
      </div>
      <div style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal; font-family: 'Times New Roman';">22</font> </div>
      <div>
        <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;" noshade="noshade" align="center"></div>
    </div>
  </div>
  <font style="font-size: 10pt; font-family: 'Times New Roman';"> </font>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.2
<SEQUENCE>3
<FILENAME>ny20047547x33_ex4-2.htm
<DESCRIPTION>EXHIBIT 4.2
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc.
         Document created using Broadridge PROfile 25.9.1.5330
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body style="font-family: Arial; font-size: 9pt; text-align: left; color: #000000;" bgcolor="#ffffff">
  <font style="font-family: 'Times New Roman'; font-size: 10pt;"> </font><!--PROfilePageNumberReset%Num%1%%%-->
  <div>
    <hr style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;" noshade="noshade" align="center">
    <div style="text-align: right;"><font style="font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;">Exhibit 4.2</font><font style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
      </font> </div>
    <div><font style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
      </font> </div>
    <div>
      <div style="text-align: justify; font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;">NEITHER THIS SECURITY NOR THE SECURITIES INTO WHICH THIS SECURITY IS EXERCISABLE HAS BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR
        THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &#8220;SECURITIES ACT&#8221;), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION
        STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE
        SECURITIES ISSUABLE UPON EXERCISE OF THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT WITH A REGISTERED BROKER-DEALER OR OTHER LOAN WITH A FINANCIAL INSTITUTION THAT IS AN ACCREDITED INVESTOR AS DEFINED IN RULE 501(a)
        UNDER THE SECURITIES ACT OR OTHER LOAN SECURED BY SUCH SECURITIES.</div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <div style="text-align: center; font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;">COMMON STOCK PURCHASE WARRANT</div>
      <div><font style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
        </font> </div>
      <div style="text-align: center; font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;">&#160;MOMENTUS INC.</div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <div>
        <table id="zfe878cac489c45d7860b29c821e249ae" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;" border="0" cellpadding="0" cellspacing="0">

            <tr>
              <td style="width: 50%;">Warrant Shares: <font style="font-weight: bold;">1,460,964</font></td>
              <td style="width: 50%; text-align: center;">Initial Exercise Date: <font style="font-weight: bold;">September 25, 2025</font></td>
            </tr>

        </table>
      </div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman'; font-size: 10pt;">THIS COMMON STOCK PURCHASE WARRANT (the &#8220;<u>Warrant</u>&#8221;) certifies that, for value received, Yield Point NY LLC or its assigns (the &#8220;<u>Holder</u>&#8221;)

        is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the &#8220;<u>Initial Exercise Date</u>&#8221;) and on or prior to 5:00 p.m. (New York City time) on the
        five (5) year anniversary of the Initial Exercise Date (the &#8220;<u>Termination Date</u>&#8221;) but not thereafter, to subscribe for and purchase from Momentus Inc., a Delaware corporation (the &#8220;<u>Company</u>&#8221;), up to 1,460,964 shares (as subject to
        adjustment hereunder, the &#8220;<u>Warrant Shares</u>&#8221;) of Common Stock.&#160; The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).</div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><u>Section 1</u>.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Definitions</u>.&#160; Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that
        certain Securities Purchase Agreement (the &#8220;<u>Purchase Agreement</u>&#8221;), dated September 25, 2025, among the Company and the purchasers signatory thereto.</div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><u>Section 2</u>.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Exercise</u>.</div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">1</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" noshade="noshade"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman'; font-size: 10pt;">a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Exercise of Warrant</u>.&#160; Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time
        or times on or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed facsimile copy or PDF copy submitted by e-mail (or e-mail attachment) of the Notice of Exercise in the form annexed
        hereto (the &#8220;<u>Notice of Exercise</u>&#8221;).&#160; Within the earlier of (i) two (2) Trading Days and (ii) the number of Trading Days comprising the Standard Settlement Period (as defined in Section 2(d)(i) herein) following the date of exercise as
        aforesaid, the Holder shall deliver the aggregate Exercise Price for the shares specified in the applicable Notice of Exercise by wire transfer or cashier&#8217;s check drawn on a United States bank unless the cashless exercise procedure specified in
        Section 2(c) below is specified in the applicable Notice of Exercise.<font style="font-weight: bold;">&#160; </font>No ink-original Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of
        any Notice of Exercise be required.&#160; Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company until the Holder has purchased all of the Warrant Shares available hereunder
        and the Warrant has been exercised in full, in which case, the Holder shall surrender this Warrant to the Company for cancellation within three (3) Trading Days of the date on which the final Notice of Exercise is delivered to the Company. Partial
        exercises of this Warrant resulting in purchases of a portion of the total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding number of Warrant Shares purchasable hereunder in an amount equal to the
        applicable number of Warrant Shares purchased.&#160; The Holder and the Company shall maintain records showing the number of Warrant Shares purchased and the date of such purchases. The Company shall deliver any objection to any Notice of Exercise
        within one (1) Business Day of receipt of such notice.&#160; Notwithstanding the foregoing, with respect to any Notice(s) of Exercise delivered on or prior to 4:00 p.m. (New York City time) on the Trading Date prior to the Initial Exercise Date, which
        may be delivered at any time after the time of execution of the Purchase Agreement, the Company agrees to deliver the Warrant Shares subject to such notice(s) by 4:00 p.m. (New York City time) on the Initial Exercise Date and the Initial Exercise
        Date shall be the Warrant Share Delivery Date for purposes hereunder, provided that payment of the aggregate Exercise Price (other than in the case of a cashless exercise) is received by such Warrant Share Delivery Date.&#160; <font style="font-weight: bold;">The Holder and any assignee, by acceptance of this Warrant, acknowledge and agree that, by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant Shares hereunder, the number of Warrant Shares
          available for purchase hereunder at any given time may be less than the amount stated on the face hereof.</font></div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman'; font-size: 10pt;">b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Exercise Price</u>.&#160; The exercise price per share of Common Stock under this Warrant shall be <font style="font-weight: bold;">$1.40</font>,
        subject to adjustment hereunder (the &#8220;<u>Exercise Price</u>&#8221;).</div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman'; font-size: 10pt;">c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Cashless Exercise</u>.&#160; After the Effectiveness Deadline (as defined in the Registration Rights Agreement) if at the time of exercise
        hereof there is no effective registration statement registering, or the prospectus contained therein is not available for the resale of the Warrant Shares by the Holder, then this Warrant may also be exercised, in whole or in part, at such time by
        means of a &#8220;cashless exercise&#8221; in which the Holder shall be entitled to receive a number of Warrant Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:</div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: -27pt; margin-left: 99pt; font-family: 'Times New Roman'; font-size: 10pt;">(A) = as applicable: (i) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise if such
        Notice of Exercise is (1) both executed and delivered pursuant to Section 2(a) hereof on a day that is not a Trading Day or (2) both executed and delivered pursuant to Section 2(a) hereof on a Trading Day prior to the opening of &#8220;regular trading
        hours&#8221; (as defined in Rule 600(b)(68) of Regulation NMS promulgated under the federal securities laws) on such Trading Day, (ii) at the option of the Holder, either (y) the VWAP on the Trading Day immediately preceding the date of the applicable
        Notice of Exercise or (z) the Bid Price of the Common Stock on the principal Trading Market as reported by Bloomberg L.P. (&#8220;<u>Bloomberg</u>&#8221;) as of the time of the Holder&#8217;s execution of the applicable Notice of Exercise if such Notice of Exercise
        is executed during &#8220;regular trading hours&#8221; on a Trading Day and is delivered within two (2) hours thereafter (including until two (2) hours after the close of &#8220;regular trading hours&#8221; on a Trading Day) pursuant to Section 2(a) hereof or (iii) the
        VWAP on the date of the applicable Notice of Exercise if the date of such Notice of Exercise is a Trading Day and such Notice of Exercise is both executed and delivered pursuant to Section 2(a) hereof after the close of &#8220;regular trading hours&#8221; on
        such Trading Day;</div>
      <div><font style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
        </font> </div>
      <div style="text-align: justify; text-indent: -36pt; margin-left: 108pt; font-family: 'Times New Roman'; font-size: 10pt;">(B) = the Exercise Price of this Warrant, as adjusted hereunder; and</div>
      <div><font style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
        </font> </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">2</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" noshade="noshade"></div>
      </div>
      <div>
        <table class="DSPFListTable" id="zb8453a7d884d454f9ed44f50c2ed4a92" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%;" cellpadding="0" cellspacing="0">

            <tr style="vertical-align: top;">
              <td style="width: 72pt;">&#160;</td>
              <td style="text-align: right; vertical-align: top;">
                <div style="text-align: justify;">(X)</div>
              </td>
              <td style="text-align: left; vertical-align: top; width: auto;">
                <div style="text-align: justify; text-indent: -9pt; margin-left: 9pt;">= the number of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such exercise were by means of a cash
                  exercise rather than a cashless exercise.</div>
              </td>
            </tr>

        </table>
      </div>
      <div><font style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
        </font> </div>
      <div style="text-align: justify; text-indent: 72pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">If Warrant Shares are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section
        3(a)(9) of the Securities Act, the Warrant Shares shall take on the characteristics of the Warrants being exercised, and the holding period of the Warrant Shares being issued may be tacked on to the holding period of this Warrant.&#160; The Company
        agrees not to take any position contrary to this Section 2(c).</div>
      <div><font style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
        </font> </div>
      <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Bid Price</u>&#8221; means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then
        listed or quoted on a Trading Market, the bid price of the Common Stock for the time in question (or the nearest preceding date) on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading
        Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b)&#160; if OTCQB or OTCQX is not a Trading Market, the volume weighted average price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as
        applicable, (c) if the Common Stock is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on The Pink Open Market (or a similar organization or agency succeeding to its functions of
        reporting prices), the most recent bid price per share of the Common Stock so reported, or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good faith by the Purchasers
        of a majority in interest of the Securities then outstanding and reasonably acceptable to the Company, the fees and expenses of which shall be paid by the Company.</div>
      <div><font style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
        </font> </div>
      <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>VWAP</u>&#8221; means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed
        or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date) on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a
        Trading Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b)&#160; if OTCQB or OTCQX is not a Trading Market, the volume weighted average price of the Common Stock for such date (or the nearest preceding date) on OTCQB or
        OTCQX as applicable, (c) if the Common Stock is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported in The Pink Open Market (or a similar organization or agency succeeding to its functions of
        reporting prices), the most recent bid price per share of the Common Stock so reported, or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good faith by the Purchasers
        of a majority in interest of the Securities then outstanding and reasonably acceptable to the Company, the fees and expenses of which shall be paid by the Company.</div>
      <div><font style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
        </font> </div>
      <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman'; font-size: 10pt;">Notwithstanding anything herein to the contrary, on the Termination Date, unless the Holder notifies the Company otherwise, if there is no effective
        Registration Statement registering, or no current prospectus available for, the resale of the Warrant Shares by the Holder and the Exercise Price is greater than the VWAP on the Trading Day immediately preceding the date on which the Warrant would
        otherwise expire, then this Warrant shall be automatically exercised via cashless exercise pursuant to this Section 2(c), and if the exercise of the Warrant pursuant to this sentence would be prevented by the application of the Beneficial Ownership
        Limitation, then such exercise pursuant to this sentence shall be delayed until the soonest date or dates when such Warrant Shares may be permissibly delivered without exceeding the Beneficial Ownership Limitation notwithstanding the prior
        occurrence of the Termination Date.</div>
      <div><font style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
        </font> </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">3</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" noshade="noshade"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">d)&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160; <u>Mechanics of Exercise</u>.</div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman'; font-size: 10pt;">i.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Delivery of Warrant Shares Upon Exercise</u>.&#160; The Company shall cause the Warrant Shares purchased hereunder to be transmitted by
        the Transfer Agent to the Holder by crediting the account of the Holder&#8217;s or its designee&#8217;s balance account with The Depository Trust Company through its Deposit or Withdrawal at Custodian system (&#8220;<u>DWAC</u>&#8221;) if the Company is then a participant
        in such system and either (A) there is an effective registration statement permitting the issuance of the Warrant Shares to or resale of the Warrant Shares by the Holder or (B) the Warrant Shares are eligible for resale by the Holder without volume
        or manner-of-sale limitations pursuant to Rule 144 (assuming cashless exercise of the Warrants), and otherwise by physical delivery of a certificate, registered in the Company&#8217;s share register in the name of the Holder or its designee, for the
        number of Warrant Shares to which the Holder is entitled pursuant to such exercise to the address specified by the Holder in the Notice of Exercise by the date that is the earliest of (i) two (2) Trading Days after the delivery to the Company of
        the Notice of Exercise, (ii) one (1) Trading Day after delivery of the aggregate Exercise Price to the Company and (iii) the number of Trading Days comprising the Standard Settlement Period after the delivery to the Company of the Notice of
        Exercise (such date, the &#8220;<u>Warrant Share Delivery Date</u>&#8221;).&#160;&#160; Upon delivery of the Notice of Exercise, the Holder shall be deemed for all corporate purposes to have become the holder of record of the Warrant Shares with respect to which this
        Warrant has been exercised, irrespective of the date of delivery of the Warrant Shares, provided&#160; that payment of the aggregate Exercise Price (other than in the case of a cashless exercise) is received within the earlier of (i) two (2) Trading
        Days and (ii) the number of Trading Days comprising the Standard Settlement Period following delivery of the Notice of Exercise.&#160; If the Company fails for any reason to deliver to the Holder the Warrant Shares subject to a Notice of Exercise by the
        Warrant Share Delivery Date, the Company shall pay to the Holder, in cash, as liquidated damages and not as a penalty, for each $1,000 of Warrant Shares subject to such exercise (based on the VWAP of the Common Stock on the date of the applicable
        Notice of Exercise), $10 per Trading Day (increasing to $20 per Trading Day on the fifth Trading Day after such liquidated damages begin to accrue) for each Trading Day after such Warrant Share Delivery Date until such Warrant Shares are delivered
        or Holder rescinds such exercise. The Company agrees to maintain a transfer agent that is a participant in the FAST program so long as this Warrant remains outstanding and exercisable. As used herein, &#8220;<u>Standard Settlement Period</u>&#8221; means the
        standard settlement period, expressed in a number of Trading Days, on the Company&#8217;s primary Trading Market with respect to the Common Stock as in effect on the date of delivery of the Notice of Exercise.</div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman'; font-size: 10pt;">ii.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Delivery of New Warrants Upon Exercise</u>.&#160; If this Warrant shall have been exercised in part, the Company shall, at the request of
        a Holder and upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant evidencing the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant,
        which new Warrant shall in all other respects be identical with this Warrant.</div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman'; font-size: 10pt;">iii.&#160;&#160;&#160;&#160;&#160;&#160; <u>Rescission Rights</u>.&#160; If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to
        Section 2(d)(i) by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise.</div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">4</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" noshade="noshade"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman'; font-size: 10pt;">iv.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Compensation for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</u>.&#160; In addition to any other rights available to
        the Holder, if the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions of Section 2(d)(i) above pursuant to an exercise on or before the Warrant Share Delivery Date, and if after
        such date the Holder is required by its broker to purchase (in an open market transaction or otherwise) or the Holder&#8217;s brokerage firm otherwise purchases, shares of Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant
        Shares which the Holder anticipated receiving upon such exercise (a &#8220;<u>Buy-In</u>&#8221;), then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x) the Holder&#8217;s total purchase price (including brokerage commissions, if any)
        for the shares of Common Stock so purchased exceeds (y) the amount obtained by multiplying (1) the number of Warrant Shares that the Company was required to deliver to the Holder in connection with the exercise at issue times (2) the price at which
        the sell order giving rise to such purchase obligation was executed, and (B) at the option of the Holder, either reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such exercise was not honored (in which case
        such exercise shall be deemed rescinded) or deliver to the Holder the number of shares of Common Stock that would have been issued had the Company timely complied with its exercise and delivery obligations hereunder.&#160; For example, if the Holder
        purchases Common Stock having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted exercise of shares of Common Stock with an aggregate sale price giving rise to such purchase obligation of $10,000, under clause (A) of
        the immediately preceding sentence the Company shall be required to pay the Holder $1,000. The Holder shall provide the Company written notice indicating the amounts payable to the Holder in respect of the Buy-In and, upon request of the Company,
        evidence of the amount of such loss.&#160; Nothing herein shall limit a Holder&#8217;s right to pursue any other remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific performance and/or injunctive relief
        with respect to the Company&#8217;s failure to timely deliver shares of Common Stock upon exercise of the Warrant as required pursuant to the terms hereof.</div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman'; font-size: 10pt;">v.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>No Fractional Shares or Scrip</u>.&#160; No fractional shares or scrip representing fractional shares shall be issued upon the exercise of
        this Warrant.&#160; As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company shall, at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such
        fraction multiplied by the Exercise Price or round up to the next whole share.</div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman'; font-size: 10pt;">vi.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Charges, Taxes and Expenses</u>.&#160; Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer
        tax or other incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company, and such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be
        directed by the Holder; <u>provided</u>, <u>however</u>, that, in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when surrendered for exercise shall be accompanied by the Assignment Form
        attached hereto duly executed by the Holder and the Company may require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto.&#160; The Company shall pay all Transfer Agent fees required for
        same-day processing of any Notice of Exercise and all fees to the Depository Trust Company (or another established clearing corporation performing similar functions) required for same-day electronic delivery of the Warrant Shares.</div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman'; font-size: 10pt;">vii.&#160; &#160;&#160;&#160;&#160;&#160; <u>Closing of Books</u>.&#160; The Company will not close its stockholder books or records in any manner which prevents the timely exercise
        of this Warrant, pursuant to the terms hereof.</div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">5</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" noshade="noshade"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Holder&#8217;s Exercise Limitations</u>.&#160; The Company shall not effect any exercise of this Warrant, and a Holder shall not have the right
        to exercise any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance after exercise as set forth on the applicable Notice of Exercise, the Holder (together with the Holder&#8217;s
        Affiliates, and any other Persons acting as a group together with the Holder or any of the Holder&#8217;s Affiliates (such Persons, &#8220;<u>Attribution Parties</u>&#8221;)), would beneficially own in excess of the Beneficial Ownership Limitation (as defined
        below).&#160; For purposes of the foregoing sentence, the number of shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties shall include the number of shares of Common Stock issuable upon exercise of this
        Warrant with respect to which such determination is being made, but shall exclude the number of shares of Common Stock which would be issuable upon (i) exercise of the remaining, nonexercised portion of this Warrant beneficially owned by the Holder
        or any of its Affiliates or Attribution Parties and (ii) exercise or conversion of the unexercised or nonconverted portion of any other securities of the Company (including, without limitation, any other&#160; Common Stock Equivalents) subject to a
        limitation on conversion or exercise analogous to the limitation contained herein beneficially owned by the Holder or any of its Affiliates or Attribution Parties.&#160; Except as set forth in the preceding sentence, for purposes of this Section 2(e),
        beneficial ownership shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder, it being acknowledged by the Holder that the Company is not representing to the Holder that such
        calculation is in compliance with Section 13(d) of the Exchange Act and the Holder is solely responsible for any schedules required to be filed in accordance therewith.&#160;&#160; To the extent that the limitation contained in this Section 2(e) applies, the
        determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable shall be in the sole discretion of
        the Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder&#8217;s determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution
        Parties) and of which portion of this Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation, and the Company shall have no obligation to verify or confirm the accuracy of such determination.&#160;&#160; In addition, a
        determination as to any group status as contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder.&#160; For purposes of this Section 2(e), in determining the number
        of outstanding shares of Common Stock, a Holder may rely on the number of outstanding shares of Common Stock as reflected in (A) the Company&#8217;s most recent periodic or annual report filed with the Commission, as the case may be, (B) a more recent
        public announcement by the Company or (C) a more recent written notice by the Company or the Transfer Agent setting forth the number of shares of Common Stock outstanding.&#160; Upon the written or oral request of a Holder, the Company shall within one
        Trading Day confirm orally and in writing to the Holder the number of shares of Common Stock then outstanding.&#160; In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise of
        securities of the Company, including this Warrant, by the Holder or its Affiliates or Attribution Parties since the date as of which such number of outstanding shares of Common Stock was reported.&#160; The &#8220;<u>Beneficial Ownership Limitation</u>&#8221; shall
        be 4.99% of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable upon exercise of this Warrant.&#160; The Holder, upon notice to the Company, may increase or decrease the
        Beneficial Ownership Limitation provisions of this Section 2(e), provided that the Beneficial Ownership Limitation in no event exceeds 9.99% of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of
        shares of Common Stock upon exercise of this Warrant held by the Holder and the provisions of this Section 2(e) shall continue to apply.&#160; Any increase in the Beneficial Ownership Limitation will not be effective until the 61<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">st</sup> day after such notice is delivered to the Company.&#160; The provisions of this paragraph shall be construed and implemented in a manner otherwise than in strict conformity
        with the terms of this Section 2(e) to correct this paragraph (or any portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership Limitation herein contained or to make changes or supplements necessary or desirable
        to properly give effect to such limitation. The limitations contained in this paragraph shall apply to a successor holder of this Warrant.</div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman'; font-size: 10pt;">f)&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Issuance Restrictions</u>.&#160; Notwithstanding anything to the contrary contained in this Warrant or the other Transaction Documents, the
        Company and Holder agree that the total cumulative number of shares of Common Stock that may be issued to Holder and its Affiliates hereunder and under the other Transaction Documents may not exceed the requirements of Nasdaq Listing Rule 5635(d)
        (&#8220;<u>Nasdaq 19.99% Cap</u>&#8221;), except that such limitation will not apply following Shareholder Approval, as defined in the Purchase Agreement. If the Company has not obtained Shareholder Approval&#160; for the issuance of shares of Common Stock issuable
        upon the exercise of this Warrant in excess of the Nasdaq 19.99% Cap in accordance with the requirements of Nasdaq Listing Rule 5635(d), and such Shareholder Approval is required pursuant to the rules of the principal Trading Market, then the
        Company may not issue any Warrant Shares in excess of the amount permitted under the rules of the principal Trading Market. For avoidance of doubt, unless and until any required Shareholder Approval is obtained and effective, warrants issued to any
        registered broker-dealer as a fee in connection with the Securities issued pursuant to the Purchase Agreement shall provide that such warrants shall be unexercisable unless and until such Shareholder Approval is obtained and effective.</div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">6</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" noshade="noshade"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><u>Section 3</u>.&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160;&#160; <u>Certain Adjustments</u>.</div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman'; font-size: 10pt;">a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Stock Dividends and Splits</u>. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise
        makes a distribution or distributions on shares of its Common Stock, pro rata to all record holders of the Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this
        Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by
        reclassification of shares of the Common Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which the numerator shall be the number of shares of Common Stock (excluding
        treasury shares, if any) outstanding immediately before such event and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the number of shares issuable upon exercise of this Warrant
        shall be proportionately adjusted such that the aggregate Exercise Price for all shares of Common Stock issuable pursuant to this Warrant shall remain unchanged.&#160; Any adjustment made pursuant to this Section 3(a) shall become effective immediately
        after the record date for the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the effective date in the case of a subdivision, combination or re&#8209;classification.</div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman'; font-size: 10pt;">b)&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; <u>Subsequent Rights Offerings</u>.&#160; <font style="color: rgb(0, 0, 0);">In addition to any adjustments pursuant to Section 3(a) above,
          if at any time the Company grants, issues or sells any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the record holders of any class of shares of Common Stock (the &#8220;<u>Purchase Rights</u>&#8221;),
          then the Holder will be entitled to acquire, upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had held the number of shares of Common Stock acquirable upon
          complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date on which a record is taken for the grant, issuance or sale of
          such Purchase Rights, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights (<u>provided</u>, <u>however</u>, that, to the
          extent that the Holder&#8217;s right to participate in any such Purchase Right would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Purchase Right to such extent (or
          beneficial ownership of such shares of Common Stock as a result of such Purchase Right to such extent) and such Purchase Right to such extent shall be held in abeyance for the Holder until such time, if ever, as its right thereto would not result
          in the Holder exceeding the Beneficial Ownership Limitation).</font></div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman'; font-size: 10pt;"><font style="color: rgb(0, 0, 0);">c)&#160;&#160;&#160;&#160;&#160;&#160; &#160; <u>Pro Rata Distributions</u>.&#160; During such time as this Warrant is outstanding, if the Company shall
          declare or make any dividend or other distribution of its assets (or rights to acquire its assets), pro rata to the record holders of shares of Common Stock, by way of return of capital or otherwise (including, without limitation, any
          distribution of cash, stock or other securities, property or options by way of a dividend, spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (a &#8220;<u>Distribution</u>&#8221;), at any time after the
          issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution to the same extent that the Holder would have participated therein if the Holder had held the number of shares of Common Stock
          acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date of which a record is taken for such
          Distribution, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are to be determined for the participation in such Distribution (<u>provided</u>, <u>however</u>, that, to the extent that the
          Holder&#8217;s right to participate in any such Distribution would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such extent (or in the beneficial
          ownership of any shares of Common Stock as a result of such Distribution to such extent) and the portion of such Distribution shall be held in abeyance for the benefit of the Holder until such time, if ever, as its right thereto would not result
          in the Holder exceeding the Beneficial Ownership Limitation).</font></div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">7</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" noshade="noshade"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman'; font-size: 10pt;">d)&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160; [Reserved]</div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman'; font-size: 10pt;">e)&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; <u>Fundamental Transaction</u>. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or
        more related transactions effects any merger or consolidation of the Company with or into another Person for which (a) the Company is not the surviving entity, and (b) after giving effect to such transaction, the stockholders of the Company
        immediately prior to such transaction own less than 50.1% of the aggregate voting power of the surviving successor entity of such transaction, (ii) the Company (or all of its Subsidiaries, taken as a whole), directly or indirectly, effects any
        sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially all of its assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange offer (whether
        by the Company or another Person) is completed pursuant to which holders of Common Stock are permitted to sell, tender or exchange their shares for other securities, cash or property and has been accepted by the holders of 50.1% or more of the
        aggregate voting power of the Company, (iv) the Company, directly or indirectly, in one or more related transactions effects any reclassification, reorganization or recapitalization of the Common Stock or any compulsory share exchange pursuant to
        which the Common Stock is effectively converted into or exchanged for other securities, cash or property, or (v) the Company<a name="OLE_LINK5"></a><a name="OLE_LINK6"></a>, directly or indirectly, in one or more related transactions consummates a
        stock or share purchase agreement or other business combination (including, without limitation, a reorganization, recapitalization, spin-off, merger or scheme of arrangement) with another Person or group of Persons whereby such other Person or
        group acquires more than 50.1% of the outstanding voting power of the Company (not including any shares of Common Stock held by the other Person or other Persons making or party to, or associated or affiliated with the other Persons making or party
        to, such stock or share purchase agreement or other business combination) (each a &#8220;<u>Fundamental Transaction</u>&#8221;), then, upon any subsequent exercise of this Warrant, the Holder shall have the right to receive, for each Warrant Share that would
        have been issuable upon such exercise immediately prior to the occurrence of such Fundamental Transaction, at the option of the Holder (without regard to any limitation in Section 2(e) on the exercise of this Warrant), the number of shares of
        Common Stock of the successor or acquiring corporation or of the Company, if it is the surviving corporation, and any additional consideration (the &#8220;<u>Alternate Consideration</u>&#8221;) receivable as a result of such Fundamental Transaction by a holder
        of the number of shares of Common Stock for which this Warrant is exercisable immediately prior to such Fundamental Transaction (without regard to any limitation in Section 2(e) on the exercise of this Warrant).&#160; For purposes of any such exercise,
        the determination of the Exercise Price shall be appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration issuable in respect of one share of Common Stock in such Fundamental Transaction, and
        the Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable manner reflecting the relative value of any different components of the Alternate Consideration.&#160; If holders of Common Stock are given any choice as to
        the securities, cash or property to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate Consideration it receives upon any exercise of this Warrant following such Fundamental Transaction<font style="color: rgb(0, 0, 0);">.&#160; </font>Notwithstanding anything to the contrary, in the event of a Fundamental Transaction, the Company or any Successor Entity (as defined below) shall, at the Holder&#8217;s option, exercisable at any time
        concurrently with, or within 30 days after, the consummation of the Fundamental Transaction (or, if later, the date of the public announcement of the applicable Fundamental Transaction), <font style="color: rgb(0, 0, 0);">purchase this Warrant
          from the Holder by paying to the Holder</font> an amount of cash equal to the Black Scholes Value (as defined below) of the remaining unexercised portion of this Warrant on the date of the consummation of such Fundamental Transaction; <u>provided</u>,<font style="font-style: italic;">&#160;</font><u>however</u>, that, if the Fundamental Transaction is not within the Company&#8217;s control, including not approved by the Company&#8217;s Board of Directors, Holder shall only be entitled to receive from the Company or
        any Successor Entity the same type or form of consideration (and in the same proportion), at the Black Scholes Value of the unexercised portion of this Warrant, that is being offered and paid to the holders of Common Stock of the Company in
        connection with the Fundamental Transaction, whether that consideration be in the form of cash, stock or any combination thereof, or whether the holders of Common Stock are given the choice to receive from among alternative forms of consideration
        in connection with the Fundamental Transaction; <u>provided</u>, <u>further</u>, that if holders of Common Stock of the Company are not offered or paid any consideration in such Fundamental Transaction, such holders of Common Stock will be deemed
        to have received common stock of the Successor Entity (which Entity may be the Company following such Fundamental Transaction) in such Fundamental Transaction.&#160; &#8220;<u>Black Scholes Value</u>&#8221; means the value of this Warrant based on the Black-Scholes
        Option Pricing Model obtained from the &#8220;OV&#8221; function on Bloomberg determined as of the day of consummation of the applicable Fundamental Transaction for pricing purposes and reflecting (A) a risk-free interest rate corresponding to the U.S.
        Treasury rate for a period equal to the time between the date of the public announcement of the applicable Fundamental Transaction and the Termination Date, (B) an expected volatility equal to the greater of 100% and the 100 day volatility obtained
        from the HVT function on Bloomberg (determined utilizing a 365 day annualization factor) as of the Trading Day immediately following the public announcement of the applicable Fundamental Transaction, <a name="z_Hlk55295831"></a>(C) the underlying
        price per share used in such calculation shall be the greater of (i) the sum of the price per share being offered in cash, if any, plus the value of any non-cash consideration, if any, being offered in such Fundamental Transaction and (ii) the
        highest VWAP during the period beginning on the Trading Day immediately preceding the announcement of the applicable Fundamental Transaction (or the consummation of the applicable Fundamental Transaction, if earlier) and ending on the Trading Day <a name="OLE_LINK13"></a><a name="OLE_LINK14"></a>of the Holder&#8217;s request pursuant to this Section 3(e) and (D) a remaining option time equal to the time between the date of the public announcement of the applicable Fundamental Transaction and the
        Termination Date<font style="color: rgb(0, 0, 0);">&#160;</font>and (E) a zero cost of borrow.<font style="color: rgb(0, 0, 0);"> The payment of the Black Scholes Value will be made by wire transfer of immediately available funds (or such other
          consideration) within the later of (i) five Business Days of the Holder&#8217;s election and (ii) the date of consummation of the Fundamental Transaction.&#160; </font>The Company shall cause any successor entity in a Fundamental Transaction in which the
        Company is not the survivor (the &#8220;<u>Successor Entity</u>&#8221;) to assume in writing all of the obligations of the Company under this Warrant and the other Transaction Documents in accordance with the provisions of this Section 3(e) pursuant to written
        agreements in form and substance reasonably satisfactory to the Holder and approved by the Holder (without unreasonable delay) prior to such Fundamental Transaction and shall, at the option of the Holder, deliver to the Holder in exchange for this
        Warrant a security of the Successor Entity evidenced by a written instrument substantially similar in form and substance to this Warrant which is exercisable for a corresponding number of shares of capital stock of such Successor Entity (or its
        parent entity) equivalent to the shares of Common Stock acquirable and receivable upon exercise of this Warrant (without regard to any limitations on the exercise of this Warrant) prior to such Fundamental Transaction, and with an exercise price
        which applies the exercise price hereunder to such shares of capital stock (but taking into account the relative value of the shares of Common Stock pursuant to such Fundamental Transaction and the value of such shares of capital stock, such number
        of shares of capital stock and such exercise price being for the purpose of protecting the economic value of this Warrant immediately prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory in form and
        substance to the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall succeed to, and be substituted for (so that from and after the date of such Fundamental Transaction, the provisions of this Warrant and the
        other Transaction Documents referring to the &#8220;Company&#8221; shall refer instead to the Successor Entity), and may exercise every right and power of the Company and shall assume all of the obligations of the Company under this Warrant and the other
        Transaction Documents with the same effect as if such Successor Entity had been named as the Company herein.&#160; Fundamental Transaction shall not include the transactions described on Schedule 3.1(i) of the Purchase Agreement under the heading
        &#8220;Fundamental Transaction Exclusions.&#8221;</div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">8</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" noshade="noshade"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman'; font-size: 10pt;">f)&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160; <u>Calculations</u>. All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the
        case may be. For purposes of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall be the sum of the number of shares of Common Stock (excluding treasury shares, if any) issued and
        outstanding.</div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">g)&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; <u>Notice to Holder</u>.</div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 108pt; font-family: 'Times New Roman'; font-size: 10pt;">i.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Adjustment to Exercise Price</u>. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company
        shall promptly deliver to the Holder by facsimile or email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment to the number of Warrant Shares and setting forth a brief statement of the facts requiring such
        adjustment.</div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 108pt; font-family: 'Times New Roman'; font-size: 10pt;">ii.&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Notice to Allow Exercise by Holder</u>. If (A) the Company shall declare a dividend (or any other distribution in whatever form)
        payable pro rata to the holders of the Company&#8217;s&#160; Common Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, payable pro rata to the record holders of the Company&#8217;s Common Stock, (C) the
        Company shall authorize the granting to all record holders of the Common Stock rights or warrants to subscribe for or purchase any shares of capital stock of any class or of any rights, (D) the approval of the holders of a majority of the
        outstanding voting securities of the Company shall be required in connection with (i) any reclassification of the Common Stock, (ii) any consolidation or merger to which the Company (or any of its Subsidiaries) is a party, (iii) any sale or
        transfer of all or substantially all of its assets, or (iv) any compulsory share exchange whereby the Common Stock is converted into other securities, cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution,
        liquidation or winding up of the affairs of the Company, then, in each case, the Company shall cause to be delivered by facsimile or email to the Holder at its last facsimile number or email address as it shall appear upon the Warrant Register of
        the Company, at least 10 calendar days prior to the applicable record or effective date hereinafter specified, an initial notice (the &#8220;<u>Initial Notice</u>&#8221;) of the potential triggering of the Company&#8217;s obligation to notify the Holder of the
        occurrence of certain corporate actions pursuant to the terms of this Warrant, which Initial Notice shall ask Holder if it agrees to receive material, non-public information, and upon written confirmation of Holder that Holder agrees to receive
        such material, non-public information, the Company will deliver an additional notice to Holder (the &#8220;Corporate Action Notice&#8221;) stating (x) the date on which a record is to be taken for the purpose of such dividend, distribution, redemption, rights
        or warrants, or if a record is not to be taken, the date as of which the holders of the Common Stock of record to be entitled to such dividend, distributions, redemption, rights or warrants are to be determined or (y) the date on which such
        reclassification, consolidation, merger, sale, transfer or share exchange is expected to become effective or close, and the date as of which it is expected that holders of the Common Stock of record shall be entitled to exchange their shares of the
        Common Stock for securities, cash or other property deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange; provided that the failure to deliver such Initial Notice or Corporate Action Notice, or any defect
        therein or in the delivery thereof shall not affect the validity of the corporate action required to be specified in such notice.&#160; The Holder shall respond in writing to an Initial Notice regarding the Holder&#8217;s election whether to accept material
        non-public information within two (2) Business Days of the delivery of the Initial Notice by the Company.&#160; If the Company does not receive such written response from the Holder within such two (2) Business Day period, the Holder shall be deemed to
        have notified the Company that it does not elect to receive any material, non-public information.&#160; In the event the Holder either does not elect to receive material non-public information, or is deemed to elect not to receive material, non-public
        information, the Holder shall remain entitled to exercise this Warrant during the period commencing on the date of such notice to the effective date of the event triggering such notice&#160; except as may otherwise be expressly set forth herein or
        pursuant to applicable law.&#160; The Company shall file with the Commission a Current Report on Form 8-K publicly disclosing the contents of the Corporate Action Notice as soon as reasonably practicable after such time as the Company&#8217;s Board of
        Directors determines in good faith that (i) such disclosure would not, and will not, cause a Material Adverse Effect, and (ii) the terms of any binding agreements or applicable laws permit the disclosure of the contents of such Corporate Action
        Notice, in each case, such filing shall occur no later than as required to be disclosed pursuant to the Exchange Act</div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">9</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" noshade="noshade"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman'; font-size: 10pt;">h)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Voluntary Adjustment By Company</u>. The Company may at any time during the term of this Warrant reduce the then current Exercise
        Price to any amount and for any period of time deemed appropriate by the Board of Directors of the Company; provided, however, that the Company agrees not to adjust the Exercise Price in any way that would violate the listing rules of the Nasdaq
        Stock Market.</div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><u>Section 4</u>.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Transfer of Warrant</u>.</div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman'; font-size: 10pt;">a)&#160;&#160;&#160;&#160; &#160; &#160;&#160; <u>Transferability</u>.&#160; Subject to compliance with any applicable securities laws and the conditions set forth in Section 4(d) hereof
        and to the provisions of Section 4.1 of the Purchase Agreement, this Warrant and all rights hereunder (including, without limitation, any registration rights) are transferable, in whole or in part, upon surrender of this Warrant at the principal
        office of the Company or its designated agent, together with a written assignment of this Warrant substantially in the form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient to pay any transfer taxes payable
        upon the making of such transfer.&#160; Upon such surrender and, if required, such payment, the Company shall execute and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable, and in the denomination or denominations
        specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not so assigned, and this Warrant shall promptly be cancelled.&#160; Notwithstanding anything herein to the contrary, the
        Holder shall not be required to physically surrender this Warrant to the Company unless the Holder has assigned this Warrant in full, in which case, the Holder shall surrender this Warrant to the Company within three (3) Trading Days of the date on
        which the Holder delivers an assignment form to the Company assigning this Warrant in full.&#160; The Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for the purchase of Warrant Shares without having a new Warrant
        issued.</div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman'; font-size: 10pt;">b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>New Warrants</u>. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the
        Company, together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the Holder or its agent or attorney.&#160; Subject to compliance with Section 4(a), as to any transfer which may be involved
        in such division or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in accordance with such notice. All Warrants issued on transfers or exchanges shall
        be dated the Initial Exercise Date and shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.</div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman'; font-size: 10pt;">c)&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Warrant Register</u>. The Company shall register this Warrant, upon records to be maintained by the Company and its transfer agent for
        that purpose (the &#8220;<u>Warrant Register</u>&#8221;), in the name of the record Holder hereof from time to time.&#160; The Company may deem and treat the registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or
        any distribution to the Holder, and for all other purposes, absent actual notice to the contrary.</div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman'; font-size: 10pt;">d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Transfer Restrictions</u>. If, at the <a name="z_DV_C75"></a>time of the surrender of this Warrant in connection with any transfer
        of this Warrant, the transfer of this Warrant shall not be either (i) registered pursuant to an effective registration<a name="z_DV_C76"></a> statement under the Securities Act and <a name="z_DV_C78"></a>under applicable state securities or blue
        sky laws or (ii) eligible for resale without volume or manner-of-sale restrictions or current public information requirements pursuant to Rule 144, the Company may require, as a condition of allowing such transfer, that the Holder or transferee of
        this Warrant, as the case may be, comply with the provisions of Section 5.7 of the Purchase Agreement.</div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">10</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" noshade="noshade"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman'; font-size: 10pt;">e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Representation by the Holder</u>.&#160; The Holder, by the acceptance hereof, represents and warrants that it is acquiring this Warrant
        and, upon any exercise hereof, will acquire the Warrant Shares issuable upon such exercise, for its own account and not with a view to or for distributing or reselling such Warrant Shares or any part thereof in violation of the Securities Act or
        any applicable state securities law, except pursuant to sales registered or exempted under the Securities Act.</div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><u>Section 5</u>.&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160;&#160; <u>Miscellaneous</u>.</div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman'; font-size: 10pt;">a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>No Rights as Stockholder Until Exercise; No Settlement in Cash</u>.&#160; This Warrant does not entitle the Holder to any voting rights,
        dividends or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly set forth in Section 3.&#160; Without limiting any rights of a Holder to receive Warrant Shares on a &#8220;cashless
        exercise&#8221; pursuant to Section 2(c) or to receive cash payments pursuant to Section 2(d)(i) and Section 2(d)(iv) herein, in no event shall the Company be required to net cash settle an exercise of this Warrant.</div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman'; font-size: 10pt;">b)&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Loss, Theft, Destruction or Mutilation of Warrant</u>. The Company covenants that upon receipt by the Company of evidence reasonably
        satisfactory to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares, and in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in
        the case of the Warrant, shall not include the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the Company will make and deliver a new Warrant or stock certificate of like tenor and
        dated as of such cancellation, in lieu of such Warrant or stock certificate.</div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman'; font-size: 10pt;">c)&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; <u>Saturdays, Sundays, Holidays, etc</u>.&#160; If the last or appointed day for the taking of any action or the expiration of any right
        required or granted herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business Day.</div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman'; font-size: 10pt;">d)&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160; <u>Authorized Shares</u>.</div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman'; font-size: 10pt;">The Company covenants that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Stock a sufficient
        number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant.&#160; The Company further covenants that its issuance of this Warrant shall constitute full authority to its officers who are
        charged with the duty of issuing the necessary Warrant Shares upon the exercise of the purchase rights under this Warrant.&#160; The Company will take all such action as may be necessary to assure that such Warrant Shares may be issued as provided
        herein without violation of any applicable law or regulation, or of any requirements of the Trading Market upon which the Common Stock may be listed.&#160; The Company covenants that all Warrant Shares which may be issued upon the exercise of the
        purchase rights represented by this Warrant will, upon exercise of the purchase rights represented by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly issued, fully paid and nonassessable and free
        from all taxes, liens and charges created by the Company in respect of the issue thereof (other than taxes in respect of any transfer occurring contemporaneously with such issue).</div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">11</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" noshade="noshade"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman'; font-size: 10pt;">Except and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending its
        certificate of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms
        of this Warrant, but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary or appropriate to protect the rights of Holder as set forth in this Warrant against
        impairment.&#160; Without limiting the generality of the foregoing, the Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise immediately prior to such increase in par value, (ii) take all
        such action as may be necessary or appropriate in order that the Company may validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially reasonable efforts to obtain all such
        authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof, as may be, necessary to enable the Company to perform its obligations under this Warrant.</div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman'; font-size: 10pt;">Before taking any action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the
        Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from any public regulatory body or bodies having jurisdiction thereof.</div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman'; font-size: 10pt;">e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Jurisdiction</u>. All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be
        determined in accordance with the provisions of the Purchase Agreement.</div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman'; font-size: 10pt;">f)&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Restrictions</u>.&#160; The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and
        the Holder does not utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.</div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman'; font-size: 10pt;">g)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Nonwaiver and Expenses</u>.&#160; No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall
        operate as a waiver of such right or otherwise prejudice the Holder&#8217;s rights, powers or remedies.&#160; Without limiting any other provision of this Warrant or the Purchase Agreement, if the Company willfully and knowingly fails to comply with any
        provision of this Warrant, which results in any material damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and expenses including, but not limited to, reasonable attorneys&#8217; fees,
        including those of appellate proceedings, incurred by the Holder in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman'; font-size: 10pt;">h)&#160;&#160;&#160; &#160; &#160;&#160; <u>Notices</u>.&#160; Any notice, request or other document required or permitted to be given or delivered to the Holder by the Company shall
        be delivered in accordance with the notice provisions of the Purchase Agreement.</div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman'; font-size: 10pt;">i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Limitation of Liability</u>.&#160; No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to
        purchase Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase price of any Common Stock or as a stockholder of the Company, whether such liability is
        asserted by the Company or by creditors of the Company.</div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman'; font-size: 10pt;">j)&#160;&#160;&#160;&#160;&#160; &#160; &#160;&#160; <u>Remedies</u>.&#160; The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will
        be entitled to specific performance of its rights under this Warrant.&#160; The Company agrees that monetary damages would not be adequate compensation for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees
        to waive and not to assert the defense in any action for specific performance that a remedy at law would be adequate.</div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman'; font-size: 10pt;">k)&#160;&#160;&#160;&#160;&#160; &#160;&#160; <u>Successors and Assigns</u>.&#160; Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby
        shall inure to the benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of Holder.&#160; The provisions of this Warrant are intended to be for the benefit of any Holder from time to
        time of this Warrant and shall be enforceable by the Holder or holder of Warrant Shares.</div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">12</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" noshade="noshade"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman'; font-size: 10pt;">l)&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160; <u>Amendment</u>.&#160; This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company <font style="color: rgb(0, 0, 0);">and the Holder</font>.</div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman'; font-size: 10pt;">m)&#160;&#160;&#160;&#160; &#160; &#160; <u>Severability</u>.&#160; Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid
        under applicable law, but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of such
        provisions or the remaining provisions of this Warrant.</div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman'; font-size: 10pt;">n)&#160;&#160; &#160; &#160;&#160;&#160;&#160;&#160; <u>Headings</u>.&#160; The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be
        deemed a part of this Warrant.</div>
      <div><font style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
        </font> </div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">********************</div>
      <div><font style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
        </font> </div>
      <div style="text-align: center; font-style: italic; font-family: 'Times New Roman'; font-size: 10pt;">(Signature Page Follows)</div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">13</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" noshade="noshade"></div>
      </div>
      <div><font style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
        </font> </div>
      <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman'; font-size: 10pt;">IN WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above
        indicated.</div>
      <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </div>
      <div style="font-family: 'Times New Roman',Times,serif; font-size: 10pt;">
        <table style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" border="0" cellpadding="0" cellspacing="0">

            <tr>
              <td style="width: 50%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;" colspan="1">&#160;</td>
              <td style="vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;" colspan="3">
                <div style="font-weight: bold;">MOMENTUS INC.</div>
              </td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;" colspan="1" rowspan="1">&#160;</td>
              <td style="vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;" rowspan="1" colspan="3">&#160;</td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; padding-bottom: 2px;" colspan="1" rowspan="1">&#160;</td>
              <td style="width: 4%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; padding-bottom: 2px;" rowspan="1">By:</td>
              <td style="width: 16%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; border-bottom: 2px solid rgb(0, 0, 0);" rowspan="1" nowrap="nowrap">/s/ John C. Rood</td>
              <td style="width: 30%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; padding-bottom: 2px;" rowspan="1">&#160;</td>
            </tr>

        </table>
      </div>
      <div>
        <table id="z049058301e1f4a89b50c0a30a9e2b34d" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;" border="0" cellpadding="0" cellspacing="0">

            <tr>
              <td rowspan="1" style="width: 50%;"><br>
              </td>
              <td rowspan="1" style="width: 4%;">Name:</td>
              <td rowspan="1" style="width: 46%;">John C. Rood</td>
            </tr>
            <tr>
              <td rowspan="1" style="width: 50%;"><br>
              </td>
              <td rowspan="1" style="width: 4%;">Title: <br>
              </td>
              <td rowspan="1" style="width: 46%;">Chief Executive Officer</td>
            </tr>

        </table>
      </div>
      <div style="text-align: justify; text-indent: 180pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
        </font> </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">14</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" noshade="noshade"></div>
      </div>
      <div style="text-align: center; font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;">NOTICE OF EXERCISE</div>
      <div><font style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
        </font> </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">TO:&#160;&#160;&#160;&#160;&#160;&#160;&#160; MOMENTUS INC.</div>
      <div><font style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
        </font> </div>
      <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman'; font-size: 10pt;">(1) The undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only if
        exercised in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.</div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman'; font-size: 10pt;">(2) Payment shall take the form of (check applicable box):</div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; margin-left: 135pt; font-family: 'Times New Roman'; font-size: 10pt;">[&#160; ] in lawful money of the United States; or</div>
      <div style="margin-left: 27pt; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; margin-left: 135pt; font-family: 'Times New Roman'; font-size: 10pt;">[ ] if permitted the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection 2(c), to
        exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure set forth in subsection 2(c).</div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman'; font-size: 10pt;">(3) Please issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:</div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <div>
        <table id="z8f9a49acd77f442e8291fd1483c73431" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;" border="0" cellpadding="0" cellspacing="0">

            <tr>
              <td style="width: 23%; padding-bottom: 2px;"><br>
              </td>
              <td style="width: 30%; border-bottom: 2px solid rgb(0, 0, 0);"><br>
              </td>
              <td style="width: 47%; padding-bottom: 2px;"><br>
              </td>
            </tr>

        </table>
      </div>
      <div><font style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
        </font> </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">The Warrant Shares shall be delivered to the following DWAC Account Number:</div>
      <div><font style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
        </font> </div>
      <div style="text-align: justify; text-indent: 108pt;">
        <table id="zf60fac1601bc41198698ee51aeb37d3a" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;" border="0" cellpadding="0" cellspacing="0">

            <tr>
              <td style="width: 23%; padding-bottom: 2px;"><br>
              </td>
              <td style="width: 30%; border-bottom: 2px solid rgb(0, 0, 0);"><br>
              </td>
              <td style="width: 47%; padding-bottom: 2px;"><br>
              </td>
            </tr>

        </table>
      </div>
      <div><font style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
        </font> </div>
      <div style="text-align: justify; text-indent: 108pt;">
        <table id="z58da6dcebcfa432fbd3f3b6d6320a391" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;" border="0" cellpadding="0" cellspacing="0">

            <tr>
              <td style="width: 23%; padding-bottom: 2px;"><br>
              </td>
              <td style="width: 30%; border-bottom: 2px solid rgb(0, 0, 0);"><br>
              </td>
              <td style="width: 47%; padding-bottom: 2px;"><br>
              </td>
            </tr>

        </table>
      </div>
      <div><font style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
        </font> </div>
      <div style="text-align: justify; text-indent: 108pt;">
        <table id="z577dba455288474f87440b1215cb42a9" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;" border="0" cellpadding="0" cellspacing="0">

            <tr>
              <td style="width: 23%; padding-bottom: 2px;"><br>
              </td>
              <td style="width: 30%; border-bottom: 2px solid rgb(0, 0, 0);"><br>
              </td>
              <td style="width: 47%; padding-bottom: 2px;"><br>
              </td>
            </tr>

        </table>
      </div>
      <div><font style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
        </font> </div>
      <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman'; font-size: 10pt;">(4) <u>Accredited Investor</u>.&#160; The undersigned is an &#8220;accredited investor&#8221; as defined in Regulation D promulgated under the Securities Act of
        1933, as amended.</div>
      <div><font style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
        </font> </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">[SIGNATURE OF HOLDER]</div>
      <div><font style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
        </font> </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">Name of Investing Entity: ________________________________________________________________________</div>
      <div style="text-align: justify;"><font style="font-style: italic; font-family: 'Times New Roman'; font-size: 10pt;">Signature of Authorized Signatory of Investing Entity</font><font style="font-family: 'Times New Roman'; font-size: 10pt;">:
          _________________________________________________</font></div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">Name of Authorized Signatory: ___________________________________________________________________</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">Title of Authorized Signatory: ____________________________________________________________________</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">Date: ________________________________________________________________________________________</div>
      <div><font style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
        </font> </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" noshade="noshade"></div>
      </div>
      <div style="text-align: right; font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;">EXHIBIT B</div>
      <div><font style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
        </font> </div>
      <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><a name="z_DV_M89"></a>ASSIGNMENT FORM</div>
      <div style="text-indent: 10.5pt; color: rgb(0, 0, 0); font-style: italic; font-family: 'Times New Roman'; font-size: 10pt;"><a name="z_DV_M162"></a>&#160;(To assign the foregoing Warrant, execute this form and supply required information.&#160; Do not use this
        form to purchase shares.)</div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <div style="text-indent: 10.5pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><a name="z_DV_M163"></a>FOR VALUE RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby assigned to</div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <div>
        <table id="z68036d5df23e424481d08ae75072769f" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;" border="0" cellpadding="0" cellspacing="0">

            <tr>
              <td style="width: 45%; padding-bottom: 2px;">
                <div style="text-align: justify; color: rgb(0, 0, 0);">Name:</div>
              </td>
              <td style="width: 45%; border-bottom: 2px solid rgb(0, 0, 0);"><br>
              </td>
              <td style="width: 10%; padding-bottom: 2px;"><br>
              </td>
            </tr>
            <tr>
              <td rowspan="1" style="width: 45%;"><br>
              </td>
              <td rowspan="1" style="width: 45%;">
                <div style="text-align: justify; color: rgb(0, 0, 0);">(Please Print)</div>
              </td>
              <td rowspan="1" style="width: 10%;"><br>
              </td>
            </tr>
            <tr>
              <td rowspan="1" style="width: 45%; padding-bottom: 2px;">
                <div style="text-align: justify; color: rgb(0, 0, 0);">Address:</div>
              </td>
              <td rowspan="1" style="width: 45%; border-bottom: 2px solid rgb(0, 0, 0);"><br>
              </td>
              <td rowspan="1" style="width: 10%; padding-bottom: 2px;"><br>
              </td>
            </tr>
            <tr>
              <td rowspan="1" style="width: 45%;"><br>
              </td>
              <td rowspan="1" style="width: 45%;">
                <div style="text-align: justify;">(Please Print)</div>
              </td>
              <td rowspan="1" style="width: 10%;"><br>
              </td>
            </tr>
            <tr>
              <td rowspan="1" style="width: 45%;"><br>
              </td>
              <td rowspan="1" style="width: 45%;"><br>
              </td>
              <td rowspan="1" style="width: 10%;"><br>
              </td>
            </tr>

        </table>
        <table id="z932d454627e74d4e8cfc43f7ca0335e8" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;" border="0" cellpadding="0" cellspacing="0">

            <tr>
              <td rowspan="1" style="width: 45%; padding-bottom: 2px;">
                <div style="text-align: justify;"><a name="z_DV_C128"></a>Phone Number:</div>
              </td>
              <td rowspan="1" style="width: 42%; border-bottom: 2px solid rgb(0, 0, 0);"><br>
              </td>
              <td rowspan="1" style="width: 13%; padding-bottom: 2px;"><br>
              </td>
            </tr>
            <tr>
              <td rowspan="1" style="width: 45%;"><br>
              </td>
              <td rowspan="1" style="width: 42%;"><br>
              </td>
              <td rowspan="1" style="width: 13%;"><br>
              </td>
            </tr>
            <tr>
              <td rowspan="1" style="width: 45%; padding-bottom: 2px;">
                <div style="text-align: justify;"><a name="z_DV_C129"></a>Email Address:</div>
              </td>
              <td rowspan="1" style="width: 42%; border-bottom: 2px solid rgb(0, 0, 0);"><br>
              </td>
              <td rowspan="1" style="width: 13%; padding-bottom: 2px;"><br>
              </td>
            </tr>
            <tr>
              <td rowspan="1" style="width: 45%; padding-bottom: 2px;">&#160;</td>
              <td rowspan="1" style="width: 42%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
              <td rowspan="1" style="width: 13%; padding-bottom: 2px;">&#160;</td>
            </tr>

        </table>
      </div>
      <table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z21253b4008f948b8ab06f501a9b44dd4" cellpadding="0" cellspacing="0">

          <tr>
            <td style="width: 50%; vertical-align: top;">
              <div style="text-align: justify; color: rgb(0, 0, 0);">Dated: _______________ __, ______</div>
            </td>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td rowspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
            <td rowspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
          </tr>

      </table>
      <table id="za28766d6f676484d991c2b1e7749272b" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" border="0" cellpadding="0" cellspacing="0">

          <tr>
            <td style="width: 14%; vertical-align: top; padding-bottom: 2px;">
              <div style="text-align: justify;"><font style="color: rgb(0, 0, 0);">Holder&#8217;s Signature:</font></div>
            </td>
            <td style="width: 31%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);"><br>
            </td>
            <td style="width: 55%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
          </tr>
          <tr>
            <td colspan="2" rowspan="1" style="vertical-align: top;">&#160;</td>
            <td rowspan="1" style="width: 55%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 14%; vertical-align: top; padding-bottom: 2px;">
              <div style="text-align: justify;"><font style="color: rgb(0, 0, 0);">Holder&#8217;s Address:</font><br>
              </div>
            </td>
            <td style="width: 31%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);"><br>
            </td>
            <td style="width: 55%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
          </tr>

      </table>
      <div><font style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
        </font> </div>
      <div><font style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
        </font> </div>
    </div>
    <div>
      <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;" noshade="noshade" align="center"></div>
  </div>
  <font style="font-family: 'Times New Roman'; font-size: 10pt;"> </font>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.3
<SEQUENCE>4
<FILENAME>ny20047547x33_ex4-3.htm
<DESCRIPTION>EXHIBIT 4.3
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc.
         Document created using Broadridge PROfile 25.9.1.5330
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body style="font-family: Arial; font-size: 9pt; text-align: left; color: #000000;" bgcolor="#ffffff">
  <!--PROfilePageNumberReset%Num%1%%%-->
  <hr style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;" noshade="noshade" align="center">
  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: right; font-weight: bold;">Exhibit 4.3<br>
  </div>
  <div style="font-family: 'Times New Roman'; font-size: 10pt;"> <br>
  </div>
  <div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">NEITHER THIS SECURITY NOR THE SECURITIES INTO WHICH THIS SECURITY IS EXERCISABLE HAS BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR
      THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &#8220;SECURITIES ACT&#8221;), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION
      STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE
      SECURITIES ISSUABLE UPON EXERCISE OF THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT WITH A REGISTERED BROKER-DEALER OR OTHER LOAN WITH A FINANCIAL INSTITUTION THAT IS AN ACCREDITED INVESTOR AS DEFINED IN RULE 501(a) UNDER
      THE SECURITIES ACT OR OTHER LOAN SECURED BY SUCH SECURITIES.</div>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">AIR WARRANT</div>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">MOMENTUS INC.</div>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
    </div>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;">Initial Exercise Date: <font style="font-weight: bold;">September 25, 2025</font></div>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">THIS AIR WARRANT (the &#8220;<u>Warrant</u>&#8221;) certifies that, for value received, Yield Point NY LLC or its assigns (the &#8220;<u>Holder</u>&#8221;) is entitled, upon
      the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the &#8220;<u>Initial Exercise Date</u>&#8221;) and on or prior to 5:00 p.m. (New York City time) on the five (5) year
      anniversary of the Initial Exercise Date (the &#8220;<u>Termination Date</u>&#8221;) but not thereafter, to subscribe for and purchase from Momentus Inc., a Delaware corporation (the &#8220;<u>Company</u>&#8221;), up to $4,000,000 Subscription Amount of Notes and Warrants.</div>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt;"><u>Section 1</u>.</font><font class="TRGRRTFtoHTMLTab" style="font-size: 10pt; font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-family: 'Times New Roman'; font-size: 10pt;"><u>Definitions</u>.&#160; Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain Securities Purchase Agreement (the &#8220;<u>Purchase Agreement</u>&#8221;),
        dated September 25, 2025, among the Company and the purchasers signatory thereto.</font></div>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt;"><u>Section 2</u>.</font><font class="TRGRRTFtoHTMLTab" style="font-size: 10pt; font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-family: 'Times New Roman'; font-size: 10pt;"><u>Exercise</u>.</font></div>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
    </div>
    <div style="text-align: justify; text-indent: 72pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt;">a)</font><font class="TRGRRTFtoHTMLTab" style="font-size: 10pt; font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-family: 'Times New Roman'; font-size: 10pt;"><u>Exercise of Warrant</u>.&#160; Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time or times on or after the Initial Exercise Date and on or
        before the Termination Date by delivery to the Company of a duly executed facsimile copy or PDF copy submitted by e-mail (or e-mail attachment) of the Notice of Exercise in the form annexed hereto (the &#8220;<u>Notice of Exercise</u>&#8221;).&#160; Within five (5)
        Trading Days following the date of exercise as aforesaid, the Holder and Company shall arrange for a Closing pursuant to Section 2.4 of the Purchase Agreement.&#160; No ink-original Notice of Exercise shall be required, nor shall any medallion guarantee
        (or other type of guarantee or notarization) of any Notice of Exercise be required.&#160; Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company until the Holder has
        purchased all of the Notes and Warrants.&#160; The Holder and the Company shall maintain records showing the number of Notes and Warrants purchased and the date of such purchases.&#160; The Company shall deliver any objection to any Notice of Exercise within
        one (1) Business Day of receipt of such notice.&#160; <font style="font-weight: bold;">The Holder and any assignee, by acceptance of this Warrant, acknowledge and agree that, by reason of the provisions of this paragraph, following the purchase of a
          portion of the Notes and Warrants hereunder, the number of Notes and Warrants available for purchase hereunder at any given time may be less than the amount stated on the face hereof.</font></font></div>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 9pt; margin-bottom: 9pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">1</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" noshade="noshade"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt;">b)</font><font class="TRGRRTFtoHTMLTab" style="font-size: 10pt; font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-family: 'Times New Roman'; font-size: 10pt;"><u>Issuance Restrictions</u>.&#160; Notwithstanding anything to the contrary contained in this Warrant or the other Transaction Documents, the Company and Holder agree that the total cumulative
        number of shares of Common Stock that may be issued to Holder and its Affiliates hereunder and under the other Transaction Documents may not exceed the requirements of Nasdaq Listing Rule 5635(d) (&#8220;<u>Nasdaq 19.99% Cap</u>&#8221;), except that such
        limitation will not apply following Shareholder Approval, as defined in the Purchase Agreement. If the Company has not obtained Shareholder Approval&#160;&#160; for the issuance of shares of Common Stock issuable upon the exercise of this Warrant in excess
        of the Nasdaq 19.99% Cap in accordance with the requirements of Nasdaq Listing Rule 5635(d), and such Shareholder Approval is required pursuant to the rules of the principal Trading Market, then the Company may not issue any Notes and Warrants in
        excess of the amount permitted under the rules of the principal Trading Market. For avoidance of doubt, unless and until any required Shareholder Approval is obtained and effective, warrants issued to any registered broker-dealer as a fee in
        connection with the Securities issued pursuant to the Purchase Agreement shall provide that such warrants shall be unexercisable unless and until such Shareholder Approval is obtained and effective.</font></div>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt;">c)</font><font class="TRGRRTFtoHTMLTab" style="font-size: 10pt; font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-family: 'Times New Roman'; font-size: 10pt;"><u>Call</u>.&#160; Subject to the Exercise Criteria and Trading Conditions listed below, the Company may require the Holder to exercise all or a portion of this Warrant, by sending written notice
        (the &#8220;<u>Call Notice</u>&#8221;) to the Holder.&#160; Within 10 Trading Days after receipt of a Call Notice (the &#8220;<u>Call Due Date</u>&#8221;), the Holder may submit an Exercise Notice for the Subscription Amount set forth in the Call Notice.&#160; Provided the Trading
        Conditions have been met Any portion of the Subscription Amount set forth in the Call Notice for which an Exercise Notice is not submitted by the Holder by the Call Due Date, may be canceled by the Company.&#160; As used herein &#8220;Exercise Criteria&#8221; shall
        mean: (i)&#160;the average daily trading price for the Common Stock on the Trading Market for the five (5) consecutive Trading Days prior to the date the Call Notice is delivered is greater than a 125% of the original Conversion Price of the Notes, and
        (ii) Subscription Amount in the Call Notice shall not exceed two times the average daily trading volume in dollars for the five (5) consecutive Trading Days prior to the date the Call Notice is delivered.&#160;&#160; As used herein Trading Conditions shall
        mean: (i) the Underlying Shares issuable as a result of the Call Notice are authorized and reserved for issuance upon conversion or exercise of the Note and Warrant to be issued (the &#8220;<u>Put Underlying Shares</u>&#8221;); (ii) the Put Underlying Shares
        are registered for resale by Holder in an effective registration statement filed with the Commission; and (iii) the Common Shares are still traded on a Trading Market;</font></div>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt;">d)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 10pt; font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-family: 'Times New Roman'; font-size: 10pt;"><u>Cancellation</u>.&#160; This Warrant may be terminated at the election of the Company at such time as all outstanding Notes and Senior Secured Debt have been satisfied in full.</font></div>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt;"><u>Section 3</u>.</font><font class="TRGRRTFtoHTMLTab" style="font-size: 10pt; font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-family: 'Times New Roman'; font-size: 10pt;"><u>Secured Status of the Notes</u>. If permitted by the holders of the Senior Secured Debt, the Notes issued upon exercise of this Warrant shall be secured pari passu with the Senior Secured
        Debt.</font></div>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt;"><u>Section 4</u>.</font><font class="TRGRRTFtoHTMLTab" style="font-size: 10pt; font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-family: 'Times New Roman'; font-size: 10pt;"><u>Transfer of Warrant</u>.</font></div>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
    </div>
    <div style="text-align: justify; text-indent: 72pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt;">a)</font><font class="TRGRRTFtoHTMLTab" style="font-size: 10pt; font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-family: 'Times New Roman'; font-size: 10pt;"><u>Transferability</u>.&#160; Subject to compliance with any applicable securities laws and the conditions set forth in Section 4(d) hereof and to the provisions of Section 4.1 of the Purchase
        Agreement, this Warrant and all rights hereunder (including, without limitation, any registration rights) are transferable, in whole or in part, upon surrender of this Warrant at the principal office of the Company or its designated agent, together
        with a written assignment of this Warrant substantially in the form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient to pay any transfer taxes payable upon the making of such transfer.&#160; Upon such surrender
        and, if required, such payment, the Company shall execute and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable, and in the denomination or denominations specified in such instrument of assignment, and shall
        issue to the assignor a new Warrant evidencing the portion of this Warrant not so assigned, and this Warrant shall promptly be cancelled.&#160; <font style="color: rgb(0, 0, 255);"><font style="color: rgb(0, 0, 0);">Notwithstanding anything herein to
            the contrary, the Holder shall not be required to physically surrender this Warrant to the Company unless the Holder has assigned this Warrant in full, in which case, the Holder shall surrender this Warrant to the Company within three (3)
            Trading Days of the date on which the Holder delivers an assignment form to the Company assigning this Warrant in full.&#160;</font> </font>The Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for the purchase
        of Notes and Warrants without having a new Warrant issued.</font></div>
    <div style="text-align: justify; text-indent: 72pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </font></div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 9pt; margin-bottom: 9pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">2</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" noshade="noshade"></div>
    </div>
    <div style="text-align: justify; text-indent: 72pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt;">b)</font><font class="TRGRRTFtoHTMLTab" style="font-size: 10pt; font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-family: 'Times New Roman'; font-size: 10pt;"><u>New Warrants</u>. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the Company, together with a written notice specifying the
        names and denominations in which new Warrants are to be issued, signed by the Holder or its agent or attorney.&#160; Subject to compliance with Section 4(a), as to any transfer which may be involved in such division or combination, the Company shall
        execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the Initial Exercise Date and shall be
        identical with this Warrant except as to the aggregate Subscription Amount exercisable pursuant thereto.</font></div>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
    </div>
    <div style="text-align: justify; text-indent: 72pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt;">c)</font><font class="TRGRRTFtoHTMLTab" style="font-size: 10pt; font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-family: 'Times New Roman'; font-size: 10pt;"><u>Warrant Register</u>. The Company shall register this Warrant, upon records to be maintained by the Company and its transfer agent for that purpose (the &#8220;<u>Warrant Register</u>&#8221;), in the
        name of the record Holder hereof from time to time.&#160; The Company may deem and treat the registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other
        purposes, absent actual notice to the contrary.</font></div>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
    </div>
    <div style="text-align: justify; text-indent: 72pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt;">d)</font><font class="TRGRRTFtoHTMLTab" style="font-size: 10pt; font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-family: 'Times New Roman'; font-size: 10pt;"><u>Transfer Restrictions</u>. <font style="color: rgb(0, 0, 0);">If, at the time of the surrender of this Warrant in connection with any transfer of this Warrant, the transfer of this
          Warrant shall not be either (i) registered pursuant to an effective registration statement under the Securities Act and under applicable state securities or blue sky laws or (ii) eligible for resale without volume or manner-of-sale restrictions
          or current public information requirements pursuant to Rule 144, the Company may require, as a condition of allowing such transfer, that the Holder or transferee of this Warrant, as the case may be, comply with the provisions of Section 5.7 of
          the Purchase Agreement.</font></font></div>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
    </div>
    <div style="text-align: justify; text-indent: 72pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt;">e)</font><font class="TRGRRTFtoHTMLTab" style="font-size: 10pt; font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-family: 'Times New Roman'; font-size: 10pt;"><u>Representation by the Holder</u>.&#160; The Holder, by the acceptance hereof, represents and warrants that it is acquiring this Warrant and, upon any exercise hereof, will acquire the Notes and
        Warrants issuable upon such exercise, for its own account and not with a view to or for distributing or reselling such Notes and Warrants or any part thereof in violation of the Securities Act or any applicable state securities law, except pursuant
        to sales registered or exempted under the Securities Act.</font></div>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt;"><u>Section 5</u>.</font><font class="TRGRRTFtoHTMLTab" style="font-size: 10pt; font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-family: 'Times New Roman'; font-size: 10pt;"><u>Miscellaneous</u>.</font></div>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
    </div>
    <div style="text-align: justify; text-indent: 72pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt;">a)</font><font class="TRGRRTFtoHTMLTab" style="font-size: 10pt; font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-family: 'Times New Roman'; font-size: 10pt;"><u>No Rights as Stockholder Until Exercise; No Settlement in Cash</u>.&#160; This Warrant does not entitle the Holder to any voting rights, dividends or other rights as a stockholder of the
        Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly set forth in Section 3.</font></div>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
    </div>
    <div style="text-align: justify; text-indent: 72pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt;">b)</font><font class="TRGRRTFtoHTMLTab" style="font-size: 10pt; font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-family: 'Times New Roman'; font-size: 10pt;"><u>Loss, Theft, Destruction or Mutilation of Warrant</u>. The Company covenants that upon receipt by the Company of evidence reasonably satisfactory to it of the loss, theft, destruction or
        mutilation of this Warrant or any stock certificate relating to the Notes and Warrants, and in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant, shall not include the
        posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the Company will make and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such
        Warrant or stock certificate.</font></div>
    <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 9pt; margin-bottom: 9pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">3</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" noshade="noshade"></div>
    </div>
    <div style="text-align: justify; text-indent: 72pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt;">c)</font><font class="TRGRRTFtoHTMLTab" style="font-size: 10pt; font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-family: 'Times New Roman'; font-size: 10pt;"><u>Saturdays, Sundays, Holidays, etc</u>.&#160; If the last or appointed day for the taking of any action or the expiration of any right required or granted herein shall not be a Business Day,
        then such action may be taken or such right may be exercised on the next succeeding Business Day.</font></div>
    <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
    </div>
    <div style="text-align: justify; text-indent: 72pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt;">d)</font><font class="TRGRRTFtoHTMLTab" style="font-size: 10pt; font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-family: 'Times New Roman'; font-size: 10pt;"><u>Authorized Shares</u>.</font></div>
    <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
    </div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 72pt;">The Company covenants that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Stock a sufficient
      number of shares to provide for the issuance of the Underlying Shares upon the exercise of any purchase rights under this Warrant.&#160; The Company further covenants that its issuance of this Warrant shall constitute full authority to its officers who
      are charged with the duty of issuing the necessary Notes, Warrants, and Underlying Shares upon the exercise of the purchase rights under this Warrant.&#160; The Company will take all such action as may be necessary to assure that such Notes, Warrants, and
      Underlying Shares may be issued as provided herein without violation of any applicable law or regulation, or of any requirements of the Trading Market upon which the Common Stock may be listed.&#160; The Company covenants that all Notes, Warrants, and
      Underlying Shares which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise of the purchase rights represented by this Warrant and payment for such Notes, Warrants, and Underlying Shares in
      accordance herewith, be duly authorized, validly issued, fully paid and nonassessable and free from all taxes, liens and charges created by the Company in respect of the issue thereof (other than taxes in respect of any transfer occurring
      contemporaneously with such issue).</div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 72pt;"> <br>
    </div>
    <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman'; font-size: 10pt;">Except and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending its
      certificate of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of
      this Warrant, but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary or appropriate to protect the rights of Holder as set forth in this Warrant against impairment.</div>
    <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
    </div>
    <div style="text-align: justify; text-indent: 72pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt;">e)</font><font class="TRGRRTFtoHTMLTab" style="font-size: 10pt; font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-family: 'Times New Roman'; font-size: 10pt;"><u>Jurisdiction</u>. All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be determined in accordance with the provisions of the Purchase
        Agreement.</font></div>
    <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
    </div>
    <div style="text-align: justify; text-indent: 72pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt;">f)</font><font class="TRGRRTFtoHTMLTab" style="font-size: 10pt; font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-family: 'Times New Roman'; font-size: 10pt;"><u>Restrictions</u>.&#160; The Holder acknowledges that the Underlying Shares acquired upon the exercise of this Warrant, if not registered, and the Holder does not utilize cashless exercise, will
        have restrictions upon resale imposed by state and federal securities laws.</font></div>
    <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
    </div>
    <div style="text-align: justify; text-indent: 72pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt;">g)</font><font class="TRGRRTFtoHTMLTab" style="font-size: 10pt; font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-family: 'Times New Roman'; font-size: 10pt;"><u>Nonwaiver and Expenses</u>.&#160; No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall operate as a waiver of such right or otherwise
        prejudice the Holder&#8217;s rights, powers or remedies.&#160; Without limiting any other provision of this Warrant or the Purchase Agreement, if the Company willfully and knowingly fails to comply with any provision of this Warrant, which results in any
        material damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and expenses including, but not limited to, reasonable attorneys&#8217; fees, including those of appellate proceedings, incurred by
        the Holder in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</font></div>
    <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
    </div>
    <div style="text-align: justify; text-indent: 72pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt;">h)</font><font class="TRGRRTFtoHTMLTab" style="font-size: 10pt; font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-family: 'Times New Roman'; font-size: 10pt;"><u>Notices</u>.&#160; Any notice, request or other document required or permitted to be given or delivered to the Holder by the Company shall be delivered in accordance with the notice provisions
        of the Purchase Agreement.</font></div>
    <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 9pt; margin-bottom: 9pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">4</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" noshade="noshade"></div>
    </div>
    <div style="text-align: justify; text-indent: 72pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt;">i)</font><font class="TRGRRTFtoHTMLTab" style="font-size: 10pt; font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-family: 'Times New Roman'; font-size: 10pt;"><u>Limitation of Liability</u>.&#160; Except for Section 2(c), no provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase Notes, Warrants, and
        Underlying Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase price of any Common Stock or as a stockholder of the Company, whether such liability is asserted
        by the Company or by creditors of the Company.</font></div>
    <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
    </div>
    <div style="text-align: justify; text-indent: 72pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt;">j)</font><font class="TRGRRTFtoHTMLTab" style="font-size: 10pt; font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-family: 'Times New Roman'; font-size: 10pt;"><u>Remedies</u>.&#160; The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled to specific performance of its rights under
        this Warrant.&#160; The Company agrees that monetary damages would not be adequate compensation for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert the defense in any action
        for specific performance that a remedy at law would be adequate.</font></div>
    <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
    </div>
    <div style="text-align: justify; text-indent: 72pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt;">k)</font><font class="TRGRRTFtoHTMLTab" style="font-size: 10pt; font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-family: 'Times New Roman'; font-size: 10pt;"><u>Successors and Assigns</u>.&#160; Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure to the benefit of and be binding upon the
        successors and permitted assigns of the Company and the successors and permitted assigns of Holder.&#160; The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall be enforceable by the
        Holder or holder of Notes, Warrants, and Underlying Shares.</font></div>
    <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
    </div>
    <div style="text-align: justify; text-indent: 72pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt;">l)</font><font class="TRGRRTFtoHTMLTab" style="font-size: 10pt; font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; </font><font style="font-family: 'Times New Roman'; font-size: 10pt;"><u>Amendment</u>.&#160; This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company <font style="color: rgb(0, 0, 0);">and the Holder</font>.</font></div>
    <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
    </div>
    <div style="text-align: justify; text-indent: 72pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt;">m)</font><font class="TRGRRTFtoHTMLTab" style="font-size: 10pt; font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-family: 'Times New Roman'; font-size: 10pt;"><u>Severability</u>.&#160; Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable law, but if any provision of this
        Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Warrant.</font></div>
    <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
    </div>
    <div style="text-align: justify; text-indent: 72pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt;">n)</font><font class="TRGRRTFtoHTMLTab" style="font-size: 10pt; font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; </font><font style="font-family: 'Times New Roman'; font-size: 10pt;"><u>Headings</u>.&#160; The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of this Warrant.</font></div>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">********************</div>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">(Signature Page Follows)</div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;"> <br>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 9pt; margin-bottom: 9pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">5</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" noshade="noshade"></div>
    </div>
    <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman'; font-size: 10pt;">IN WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above indicated.</div>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
    </div>
    <table id="z43fe0057747f4ed0a0f15896e09682a8" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 50%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;" colspan="1">&#160;</td>
          <td style="vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;" colspan="3">
            <div style="font-weight: bold;">MOMENTUS INC.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;" colspan="1" rowspan="1">&#160;</td>
          <td style="vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;" rowspan="1" colspan="3">&#160;</td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; padding-bottom: 2px;" colspan="1" rowspan="1">&#160;</td>
          <td style="width: 3%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; padding-bottom: 2px;" rowspan="1">By:</td>
          <td style="width: 17%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; border-bottom: 2px solid rgb(0, 0, 0);" rowspan="1" nowrap="nowrap">/s/ John C. Rood</td>
          <td style="width: 30%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; padding-bottom: 2px;" rowspan="1">&#160;</td>
        </tr>

    </table>
    <table style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 50%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;" colspan="1" rowspan="1">&#160;</td>
          <td style="width: 3%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;" rowspan="1"><br>
          </td>
          <td style="width: 47%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;" rowspan="1">
            <div>Name: John C. Rood</div>
          </td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;" colspan="1" rowspan="1">&#160;</td>
          <td style="width: 3%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;" rowspan="1">&#160;</td>
          <td style="width: 47%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;" rowspan="1">Title:&#160;&#160; Chief Executive Officer</td>
        </tr>

    </table>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 9pt; margin-bottom: 9pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">6</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" noshade="noshade"></div>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">NOTICE OF EXERCISE</div>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
    </div>
    <div style="text-align: justify;"><font style="font-family: 'Times New Roman'; font-size: 10pt;">TO:</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 10pt; font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-family: 'Times New Roman'; font-size: 10pt;">MOMENTUS INC.</font></div>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
    </div>
    <div style="text-align: justify; text-indent: 72pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt;">(1)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 10pt; font-family: 'Times New Roman';">&#160; </font><font style="font-family: 'Times New Roman'; font-size: 10pt;">The undersigned hereby elects to purchase $________ in subscription amount of Notes and Warrants.</font></div>
    <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
    </div>
    <div style="text-align: justify; text-indent: 72pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt;">(2)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 10pt; font-family: 'Times New Roman';">&#160; </font><font style="font-family: 'Times New Roman'; font-size: 10pt;">The principal amount of the Note shall be $__________________.</font></div>
    <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
    </div>
    <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman'; font-size: 10pt;">(3)&#160; <u>Accredited Investor</u>.&#160; The undersigned is an &#8220;accredited investor&#8221; as defined in Regulation D promulgated under the Securities Act of
      1933, as amended.</div>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
    </div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">[SIGNATURE OF HOLDER]</div>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
    </div>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;">
      <table style="font-family: Arial; font-size: 9pt; color: #000000; width: 100%;" id="z8116a518ba2547e1a09065c4cc62d2d4" border="0" cellpadding="0" cellspacing="0">

          <tr>
            <td style="width: 13%; font-family: 'Times New Roman'; font-size: 10pt; padding-bottom: 2px;">Name of Investing Entity: </td>
            <td style="width: 87%; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
              <div>&#160;</div>
            </td>
          </tr>

      </table>
      <table style="font-family: Arial; font-size: 9pt; color: #000000; width: 100%;" border="0" cellpadding="0" cellspacing="0">

          <tr>
            <td style="width: 26%; padding-bottom: 2px;"><font style="font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">Signature of Authorized Signatory of Investing Entity</font><font style="font-family: 'Times New Roman'; font-size: 10pt;">:</font></td>
            <td style="width: 74%; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
              <div>&#160;</div>
            </td>
          </tr>

      </table>
      <table style="font-family: Arial; font-size: 9pt; color: #000000; width: 100%;" border="0" cellpadding="0" cellspacing="0">

          <tr>
            <td style="width: 15%; font-family: 'Times New Roman'; font-size: 10pt; padding-bottom: 2px;">Name of Authorized Signatory:</td>
            <td style="width: 85%; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
              <div>&#160;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 15%; font-family: 'Times New Roman'; font-size: 10pt; padding-bottom: 2px;">Title of Authorized Signatory:</td>
            <td style="width: 85%; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
              <div>&#160;</div>
            </td>
          </tr>

      </table>
      <table style="font-family: Arial; font-size: 9pt; color: #000000; width: 100%;" border="0" cellpadding="0" cellspacing="0">

          <tr>
            <td style="width: 4%; font-family: 'Times New Roman'; font-size: 10pt; padding-bottom: 2px;" rowspan="1">Date: </td>
            <td style="width: 96%; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;" rowspan="1">&#160;</td>
          </tr>

      </table>
    </div>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 9pt; margin-bottom: 9pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" noshade="noshade"></div>
    </div>
    <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">EXHIBIT B</div>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
    </div>
    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">ASSIGNMENT FORM</div>
    <div style="text-indent: 10.5pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">&#160;(To assign the foregoing Warrant, execute this form and supply required information.&#160; Do not use this form to purchase shares.)</div>
    <div style="text-indent: 10.5pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;"> <br>
    </div>
    <div style="text-indent: 10.5pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">FOR VALUE RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby assigned to</div>
    <div style="text-indent: 10.5pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <br>
    </div>
    <div style="text-indent: 10.5pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
      <table style="font-family: Arial; font-size: 9pt; color: #000000; width: 100%;" id="z2e20886702be41749646b12bc9717b8d" border="0" cellpadding="0" cellspacing="0">

          <tr>
            <td style="padding-bottom: 2px; font-family: 'Times New Roman'; font-size: 10pt;" colspan="3">
              <div style="text-align: justify; color: rgb(0, 0, 0);">Name:</div>
            </td>
            <td style="border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;" colspan="2">
              <div>&#160;</div>
            </td>
          </tr>
          <tr>
            <td style="font-family: 'Times New Roman'; font-size: 10pt;" colspan="3">
              <div>&#160;</div>
            </td>
            <td style="font-family: 'Times New Roman'; font-size: 10pt;" colspan="2">
              <div style="text-align: justify; color: rgb(0, 0, 0);">(Please Print)</div>
            </td>
          </tr>
          <tr>
            <td style="font-family: 'Times New Roman'; font-size: 10pt;" colspan="3">
              <div>&#160;</div>
            </td>
            <td style="font-family: 'Times New Roman'; font-size: 10pt;" colspan="2">
              <div>&#160;</div>
            </td>
          </tr>
          <tr>
            <td style="padding-bottom: 2px; font-family: 'Times New Roman'; font-size: 10pt;" colspan="3">
              <div style="text-align: justify; color: rgb(0, 0, 0);">Address:</div>
            </td>
            <td style="border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;" colspan="2">
              <div>&#160;</div>
            </td>
          </tr>
          <tr>
            <td style="font-family: 'Times New Roman'; font-size: 10pt;" colspan="3">
              <div>&#160;</div>
            </td>
            <td style="font-family: 'Times New Roman'; font-size: 10pt;" colspan="2">
              <div style="text-align: justify; color: rgb(0, 0, 0);">(Please Print)</div>
            </td>
          </tr>
          <tr>
            <td style="font-family: 'Times New Roman'; font-size: 10pt;" colspan="3">
              <div>&#160;</div>
            </td>
            <td style="font-family: 'Times New Roman'; font-size: 10pt;" colspan="2">
              <div>&#160;</div>
            </td>
          </tr>
          <tr>
            <td style="padding-bottom: 2px; font-family: 'Times New Roman'; font-size: 10pt;" colspan="3">
              <div style="text-align: justify; color: rgb(0, 0, 0);">Phone Number:</div>
            </td>
            <td style="width: 38%; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
              <div>&#160;</div>
            </td>
            <td style="width: 9.41%; padding-bottom: 2px; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>
          </tr>
          <tr>
            <td style="font-family: 'Times New Roman'; font-size: 10pt;" colspan="3">
              <div>&#160;</div>
            </td>
            <td style="font-family: 'Times New Roman'; font-size: 10pt;" colspan="2">
              <div>&#160;</div>
            </td>
          </tr>
          <tr>
            <td style="padding-bottom: 2px; font-family: 'Times New Roman'; font-size: 10pt;" colspan="3">
              <div style="text-align: justify; color: rgb(0, 0, 0);">Email Address:</div>
            </td>
            <td style="width: 38%; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
              <div>&#160;</div>
            </td>
            <td style="width: 9.41%; padding-bottom: 2px; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>
          </tr>
          <tr>
            <td style="font-family: 'Times New Roman'; font-size: 10pt;" colspan="3">
              <div>&#160;</div>
            </td>
            <td style="font-family: 'Times New Roman'; font-size: 10pt;" colspan="2">
              <div>&#160;</div>
            </td>
          </tr>
          <tr>
            <td style="font-family: 'Times New Roman'; font-size: 10pt;" colspan="3">Dated: _______________ __, ______</td>
            <td style="font-family: 'Times New Roman'; font-size: 10pt;" colspan="2">
              <div>&#160;</div>
            </td>
          </tr>
          <tr>
            <td style="font-family: 'Times New Roman'; font-size: 10pt;" colspan="3">
              <div>&#160;</div>
            </td>
            <td style="font-family: 'Times New Roman'; font-size: 10pt;" colspan="2">
              <div>&#160;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 10%; padding-bottom: 2px;" nowrap="nowrap">
              <div style="text-align: justify;"><font style="font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0);">Holder&#8217;s Signature:</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 10pt; font-family: 'Times New Roman';"><br>
                </font></div>
            </td>
            <td style="width: 38%; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><br>
            </td>
            <td style="width: 4.76%; font-family: 'Times New Roman'; font-size: 10pt; padding-bottom: 2px;">&#160;</td>
            <td style="padding-bottom: 2px; font-family: 'Times New Roman'; font-size: 10pt;" colspan="2">
              <div>&#160;</div>
            </td>
          </tr>
          <tr>
            <td style="font-family: 'Times New Roman'; font-size: 10pt;" colspan="3"><br>
            </td>
            <td style="font-family: 'Times New Roman'; font-size: 10pt;" colspan="2">
              <div>&#160;</div>
            </td>
          </tr>
          <tr>
            <td style="padding-bottom: 2px; width: 10%;">
              <div style="text-align: justify;"><font style="font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0);">Holder&#8217;s Address:</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 10pt; font-family: 'Times New Roman';"><br>
                </font></div>
            </td>
            <td style="border-bottom: 2px solid rgb(0, 0, 0); width: 38%; font-family: 'Times New Roman'; font-size: 10pt;"><br>
            </td>
            <td style="width: 4.76%; font-family: 'Times New Roman'; font-size: 10pt; padding-bottom: 2px;">&#160;</td>
            <td style="padding-bottom: 2px; font-family: 'Times New Roman'; font-size: 10pt;" colspan="2">
              <div>&#160;</div>
            </td>
          </tr>

      </table>
    </div>
    <div> <font style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
      </font></div>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
    </div>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;">
      <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;" noshade="noshade" align="center"></div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.4
<SEQUENCE>5
<FILENAME>ny20047547x33_ex4-4.htm
<DESCRIPTION>EXHIBIT 4.4
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc.
         Document created using Broadridge PROfile 25.9.1.5330
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body style="font-family: Arial; font-size: 9pt; text-align: left; color: #000000;" bgcolor="#ffffff">
  <font style="font-family: 'Times New Roman'; font-size: 10pt;"> </font>
  <div>
    <hr style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;" noshade="noshade" align="center">
    <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: right; font-weight: bold;">Exhibit 4.4<br>
    </div>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
    </div>
    <div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES
        COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &#8220;SECURITIES ACT&#8221;), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER
        THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS.&#160; THIS SECURITY AND THE SECURITIES
        ISSUABLE UPON EXERCISE OF THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.</div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
      </div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">PRE-FUNDED&#160;COMMON STOCK PURCHASE WARRANT</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">MOMENTUS, INC.</div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
      </div>
      <table id="z9210918a7cf342829565ae8cfc247228" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" border="0" cellpadding="0" cellspacing="0">

          <tr>
            <td style="width: 50%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-indent: -12pt; margin-left: 12pt;">Warrant Shares: 750,000</div>
            </td>
            <td style="width: 50%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt;" nowrap="nowrap">
              <div style="text-align: right;">Initial Exercise Date: September 25, 2025</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">THIS&#160;PRE-FUNDED&#160;WARRANT TO PURCHASE SHARES OF COMMON STOCK (the &#8220;<u>Warrant</u>&#8221;) certifies that, for value received, Yield Point NY LLC or its
        assigns (the &#8220;<u>Holder</u>&#8221;) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the &#8220;<u>Initial Exercise Date</u>&#8221;) and until this Warrant is
        exercised in full (the &#8220;<u>Termination Date</u>&#8221;), but not thereafter, to subscribe for and purchase from&#160;Momentus, Inc., a Delaware corporation (the &#8220;<u>Company</u>&#8221;), up to 750,000 shares of common stock, par value $0.00001 per share (the &#8220;<u>Common
          Stock</u>&#8221;) (as subject to adjustment hereunder, the &#8220;<u>Warrant Shares</u>&#8221;).&#160; The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section&#160;2(b).</div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">This Warrant was issued pursuant to the terms and conditions of that Equity Purchase Agreement, dated September 25, 2025 (each
        a &#8220;<u>Purchase Agreement</u>&#8221;), by and among the Company and the purchasers signatory thereto.</div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">This Warrant will be initially exercisable for 675,000 Warrant Shares.&#160; If the Purchase Agreement is terminated on or before January 25, 2026,
        75,000 of the Warrant Shares will be cancelled and this Warrant will only be exercisable for 675,000 Warrant Shares.&#160; If the Purchase Agreement is in effect on January 26, 2026, all 750,000 Warrant Shares will be exercisable.</div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif; font-size: 10pt;"><font style="font-family: 'Times New Roman';"><u>Section 1</u>.&#160; <u>Definitions</u>.&#160; Capitalized terms used and not otherwise defined
          herein shall have the meanings set forth in the Purchase Agreement.</font></div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif; font-size: 10pt;"><font style="font-family: 'Times New Roman';"><u>Section 2</u>.&#160; <u>Exercise</u>.</font></div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
      </div>
      <div style="text-indent: 72pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt;">(a)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 10pt; font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-family: 'Times New Roman'; font-size: 10pt;"><u>Exercise of Warrant</u>.&#160; Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time or times on or after the Initial Exercise Date and on
          or before the Termination Date by delivery to the Company of a duly executed PDF copy submitted by&#160;e-mail&#160;(or&#160;e-mail&#160;attachment) of the Notice of Exercise in the form annexed hereto as&#160;<u>Exhibit A</u>&#160;(the &#8220;<u>Notice of Exercise</u>&#8221;).&#160; Within
          the earlier of (i) one (1) Trading Day and (ii) the number of Trading Day(s) comprising the Standard Settlement Period (as defined in Section&#160;2(d)(i) herein) following the date of exercise as aforesaid, the Holder shall deliver the aggregate
          Exercise Price for the number of Warrant Shares specified in the applicable Notice of Exercise by wire transfer or cashier&#8217;s check drawn on a United States bank unless the cashless exercise procedure specified in Section&#160;2(c) below is specified
          in the applicable Notice of Exercise.&#160; No&#160;ink-original&#160;Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise be required.&#160; Notwithstanding anything herein to
          the contrary, the Holder shall not be required to physically surrender this Warrant to the Company until the Holder has purchased all of the Warrant Shares purchasable hereunder and the Warrant has been exercised in full, at which time the Holder
          shall surrender this Warrant to the Company for cancellation within three (3)&#160;Trading Days of the date on which the Warrant Shares issuable in connection with the final Notice of Exercise are delivered by the Company.&#160; Partial exercises of this
          Warrant resulting in purchases of a portion of the total number of Warrant Shares purchasable hereunder shall have the effect of lowering the outstanding number of Warrant Shares purchasable hereunder by the number of Warrant Shares equal to the
          applicable number of Warrant Shares purchased in connection with such partial exercise.&#160; The Holder and the Company shall maintain records showing the number of Warrant Shares purchased and the date of such purchases.&#160; The Company shall deliver
          any objection to any Notice of Exercise within one (1)&#160;Trading Day of receipt of such notice.&#160; Notwithstanding the foregoing, with respect to any Notice(s) of Exercise delivered on or prior to 9:00 a.m. (New York City time) on the Initial
          Exercise Date, which may be delivered at any time after the time of execution of the Purchase Agreement, the Company agrees to deliver, or cause to be delivered, the Warrant Shares subject to such notice(s) by 4:00 p.m. (New York City time) on
          the Initial Exercise Date, and the Initial Exercise Date shall be the Warrant Share Delivery Date for purposes hereunder, provided that payment of the aggregate Exercise Price (other than in the case of a cashless exercise) is received by such
          Warrant Share Delivery Date.&#160; The Holder and the Company shall maintain records showing the number of Warrant Shares purchased and the date of such purchases.&#160; The Company shall deliver any objection to any Notice of Exercise within one
          (1)&#160;Business Day of receipt of such notice.&#160; The Holder and any assignee, by acceptance of this Warrant, acknowledge and agree that, by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant Shares
          hereunder, the number of Warrant Shares available for purchase hereunder at any given time will be less than the amount stated on the face hereof.</font></div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
      </div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
      </div>
      <!--PROfilePageNumberReset%Num%2%%%-->
      <div style="text-indent: 72pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt;">(b)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 10pt; font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-family: 'Times New Roman'; font-size: 10pt;"><u>Exercise Price</u>.&#160; The consideration for the receipt of this Warrant, except for a nominal exercise price of $0.00001 per Warrant Share, was&#160;paid to the Company in connection with the
          entry in the Purchase Agreement and, consequently, no additional consideration (other than the nominal exercise price of $0.00001 per Warrant Share) shall be required to be paid by the Holder to the Company to effect any exercise of this
          Warrant.&#160; The Holder shall not be entitled to the return or refund of all, or any portion, of such&#160;pre-paid&#160;aggregate exercise price under any circumstance or for any reason whatsoever, including in the event this Warrant shall not have been
          exercised prior to the Termination Date.&#160; The remaining unpaid exercise price per Warrant Share under this Warrant shall be $0.00001, subject to adjustment hereunder (the &#8220;<u>Exercise Price</u>&#8221;).</font></div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
      </div>
      <div style="text-indent: 72pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt;">(c)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 10pt; font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-family: 'Times New Roman'; font-size: 10pt;"><u>Cashless Exercise</u>.&#160; This Warrant may also be exercised, in whole or in part, at any time while this Warrant is outstanding by means of a &#8220;cashless exercise&#8221; in which the Holder shall
          be entitled to receive a number of Warrant Shares equal to the quotient obtained by dividing&#160;(A-B)&#160;(X)&#160;by (A), where:</font></div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">(A) = as applicable: (i)&#160;the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise if such Notice of Exercise
        is (1)&#160;both executed and delivered pursuant to Section&#160;2(a) hereof on a day that is not a Trading Day or (2)&#160;both executed and delivered pursuant to Section&#160;2(a) hereof on a Trading Day prior to the opening of &#8220;regular trading hours&#8221; (as defined in
        Rule 600(b) of Regulation NMS promulgated under the federal securities laws) on such Trading Day, (ii)&#160;at the option of the Holder, either (y)&#160;the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise or
        (z)&#160;the Bid Price of the Common Stock on the principal Trading Market as reported by Bloomberg L.P. (&#8220;<u>Bloomberg</u>&#8221;) as of the time of the Holder&#8217;s execution of the applicable Notice of Exercise if such Notice of Exercise is executed during
        &#8220;regular trading hours&#8221; on a Trading Day and is delivered within two (2)&#160;hours thereafter (including until two (2)&#160;hours after the close of &#8220;regular trading hours&#8221; on a Trading Day) pursuant to Section&#160;2(a) hereof or (iii)&#160;the VWAP on the date of
        the applicable Notice of Exercise if the date of such Notice of Exercise is a Trading Day and such Notice of Exercise is both executed and delivered pursuant to Section&#160;2(a) hereof after the close of &#8220;regular trading hours&#8221; on such Trading Day;</div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">(B) = the Exercise Price, as adjusted hereunder; and</div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">(X) = the number of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such
        exercise were by means of a cash exercise rather than a cashless exercise.</div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">If Warrant Shares are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section&#160;3(a)(9) of the
        Securities Act, the Warrant Shares shall take on the characteristics of the Warrants being exercised, and the holding period of the Warrant Shares being issued may be tacked on to the holding period of this Warrant.&#160; The Company agrees not to take
        any position contrary to this Section&#160;2(c).</div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
      </div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">2</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
      </div>
      <!--PROfilePageNumberReset%Num%2%%%-->
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Bid Price</u>&#8221; means, for any date, the price determined by the first of the following clauses that applies: (a)&#160;if the Common Stock is then
        listed or quoted on a Trading Market, the bid price of the Common Stock for the time in question (or the nearest preceding date) on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading
        Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the VWAP of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c)&#160;if the Common
        Stock is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on The Pink Open Market (or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid
        price per share of Common Stock so reported, or (d)&#160;in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good faith by the Purchasers of a majority in interest of the Securities
        then outstanding and reasonably acceptable to the Company, the fees and expenses of which shall be paid by the Company.</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>VWAP</u>&#8221; means, for any date, the price determined by the first of the following clauses that applies: (a)&#160;if the Common Stock is then listed
        or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date) on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a
        Trading Day from 9:30 a.m. (New York City time) to 4:02&#160;p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX
        as applicable, (c)&#160;if the Common Stock is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on The Pink Open Market (or a similar organization or agency succeeding to its functions of
        reporting prices), the most recent bid price per share of Common Stock so reported, or (d)&#160;in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good faith by the Purchasers of a
        majority in interest of the Securities then outstanding and reasonably acceptable to the Company, the fees and expenses of which shall be paid by the Company.</div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Notwithstanding anything herein to the contrary, on the Termination Date, this Warrant shall be automatically exercised via cashless exercise
        pursuant to this Section&#160;2(c).</div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt;">(d)</font><font class="TRGRRTFtoHTMLTab" style="font-size: 10pt; font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-family: 'Times New Roman'; font-size: 10pt;"><u>Mechanics of Exercise</u>.</font></div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
      </div>
      <div style="text-indent: 117pt;">
        <div>
          <div>
            <div>
              <div style="text-align: justify; text-indent: 108pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt;">i.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Delivery of Warrant Shares Upon Exercise</u>.&#160; The Company shall cause the Warrant Shares purchased hereunder
                  to be transmitted to the Holder by crediting the account of the Holder&#8217;s or its designee&#8217;s balance account with The Depository Trust Company through its Deposit or Withdrawal at Custodian system (&#8220;<u>DWAC</u>&#8221;) if the Company is then a
                  participant in such system and either (A)&#160;there is an effective registration statement permitting the issuance of the Warrant Shares to, or resale of, the Warrant Shares by Holder or (B)&#160;the Warrant Shares are eligible for resale by the
                  Holder without volume or&#160;manner-of-sale&#160;limitations pursuant to Rule 144 (assuming cashless exercise of the Warrants), and otherwise by physical delivery of a certificate (if such shares are certificated), registered in the Company&#8217;s
                  share register in the name of the Holder or its designee, for the number of Warrant Shares to which the Holder is entitled pursuant to such exercise to the address specified by the Holder in the Notice of Exercise by the date that is the
                  earlier of (i) one (1) Trading Day after the delivery to the Company of the Notice of Exercise and (ii) the number of Trading Day(s) comprising the Standard Settlement Period after the delivery to the Company of the Notice of Exercise
                  (such date, the &#8220;<u>Warrant Share Delivery Date</u>&#8221;), in each case subject to delivery of the aggregate Exercise Price to the Company (if applicable).&#160; Upon delivery of the Notice of Exercise, the Holder shall be deemed for all corporate
                  purposes to have become the holder of record of the Warrant Shares with respect to which this Warrant has been exercised, irrespective of the date of delivery of the Warrant Shares, provided that payment of the aggregate Exercise Price
                  (other than in the case of a cashless exercise) is received by the Warrant Share Delivery Date.&#160; The Company agrees to maintain a transfer agent that is a participant in the FAST program so long as this Warrant remains outstanding and
                  exercisable.&#160; As used herein, &#8220;<u>Standard Settlement Period</u>&#8221; means the standard settlement period, expressed in a number of Trading Days, on the Company&#8217;s primary Trading Market with respect to the Common Stock as in effect on the
                  date of delivery of the Notice of Exercise.&#160; If the Company fails to deliver to the Holder the Warrant Shares subject to a Notice of Exercise by the Warrant Share Delivery Date, the Company shall pay to the Holder, in cash, as liquidated
                  damages and not as a penalty, for each $1,000 of Warrant Shares subject to such exercise (based on the VWAP of the Common Stock on the date of the applicable Notice of Exercise), $10 per Trading Day (increasing to $20 per Trading Day on
                  the fifth Trading Day after such liquidated damages begin to accrue) for each Trading Day after such Warrant Share Delivery Date until such Warrant Shares are delivered or Holder rescinds such exercise.</font></div>
            </div>
          </div>
        </div>
      </div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
      </div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">2</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
      </div>
      <div style="text-align: justify; text-indent: 108pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt;">ii.</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 10pt; font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-family: 'Times New Roman'; font-size: 10pt;"><u>Delivery of New Warrants Upon Exercise</u>.&#160; If this Warrant shall have been exercised in part, the Company shall, at the request of a Holder and upon surrender of this Warrant
          certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant evidencing the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in all other
          respects be identical with this Warrant.</font></div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 108pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt;">iii.</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 10pt; font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-family: 'Times New Roman'; font-size: 10pt;"><u>Rescission Rights</u>.&#160; Except in connection with an exercise on the Initial Exercise Date, if the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares
          pursuant to Section&#160;2(d)(i) by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise.</font></div>
      <div style="text-align: justify; text-indent: 108pt; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 108pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt;">iv.</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 10pt; font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-family: 'Times New Roman'; font-size: 10pt;"><u>Compensation for&#160;Buy-In&#160;on Failure to Timely Deliver Warrant Shares Upon Exercise</u>.&#160; In addition to any other rights available to the Holder, if the Company fails to cause the
          Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions of Section&#160;2(d)(i) above pursuant to an exercise on or before the Warrant Share Delivery Date, and if after such date the Holder is required by its
          broker to purchase (in an open market transaction or otherwise) or the Holder&#8217;s brokerage firm otherwise purchases, shares of Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated
          receiving upon such exercise (a &#8220;<u>Buy-In</u>&#8221;), then the Company shall (A)&#160;pay in cash to the Holder the amount, if any, by which (x)&#160;the Holder&#8217;s total purchase price (including brokerage commissions, if any) for the shares of Common Stock so
          purchased exceeds (y)&#160;the amount obtained by multiplying (1)&#160;the number of Warrant Shares that the Company was required to deliver to the Holder in connection with the exercise at issue times (2)&#160;the price at which the sell order giving rise to
          such purchase obligation was executed, and (B)&#160;at the option of the Holder, either reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such exercise was not honored (in which case such exercise shall be deemed
          rescinded) or deliver to the Holder the number of shares of Common Stock that would have been issued had the Company timely complied with its exercise and delivery obligations hereunder.&#160; For example, if the Holder purchases shares of Common
          Stock having a total purchase price of $11,000 to cover a&#160;Buy-In&#160;with respect to an attempted exercise of Warrants with an aggregate sale price giving rise to such purchase obligation of $10,000, under clause (A)&#160;of the immediately preceding
          sentence the Company shall be required to pay the Holder $1,000.&#160; The Holder shall provide the Company written notice indicating the amounts payable to the Holder in respect of the&#160;Buy-In&#160;and, upon request of the Company, evidence satisfactory to
          the Company with respect to the amount of such loss.&#160; Nothing herein shall limit a Holder&#8217;s right to pursue any other remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific performance and/or
          injunctive relief with respect to the Company&#8217;s failure to timely deliver Warrant Shares upon exercise of the Warrant as required pursuant to the terms hereof.</font></div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 108pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt;">v.</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 10pt; font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-family: 'Times New Roman'; font-size: 10pt;"><u>No Fractional Shares or Scrip</u>.&#160; No fractional Warrant Shares or scrip representing fractional Warrant Shares shall be issued upon the exercise of this Warrant.&#160; As to any fraction of
          a Warrant Share which the Holder would otherwise be entitled to purchase upon such exercise, the Company shall, at its election and in lieu of the issuance of such fractional Warrant Share, either (i)&#160;pay cash in an amount equal to such fraction
          multiplied by the Exercise Price or (ii)&#160;round up to the next whole Warrant Share.</font></div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 108pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt;">vi.</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 10pt; font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-family: 'Times New Roman'; font-size: 10pt;"><u>Charges, Taxes and Expenses</u>.&#160; The issuance and delivery of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax or other incidental expense in
          respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company, and such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; provided,
          however, that, in the event that Warrant Shares are to be issued in a name other than the name of the Holder, the Notice of Exercise shall be accompanied by the Assignment Form, attached hereto as&#160;<u>Exhibit B</u>, duly executed by the Holder and
          the Company may require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto and this Warrant shall be surrendered to the Company and, if any portion of this Warrant remains unexercised,
          a new Warrant in the form hereof shall be delivered to the assignee.&#160; The Company shall pay all Transfer Agent fees required for&#160;same-day&#160;processing of any Notice of Exercise and all fees to the Depository Trust Company (or another established
          clearing corporation performing similar functions) required for&#160;same-day&#160;electronic delivery of the Warrant Shares.</font></div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 108pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt;">vii.</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 10pt; font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-family: 'Times New Roman'; font-size: 10pt;"><u>Closing of Books</u>.&#160; The Company will not close its stockholder books or records in any manner which prevents the timely exercise of this Warrant, pursuant to the terms hereof.</font></div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">3</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt;">(e)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 10pt; font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-family: 'Times New Roman'; font-size: 10pt;"><u>Holder&#8217;s Exercise Limitations</u>.&#160; The Company shall not effect any exercise of this Warrant, and a Holder shall not have the right to exercise any portion of this Warrant, pursuant to
          Section&#160;2 or otherwise, to the extent that after giving effect to such issuance after exercise as set forth on the applicable Notice of Exercise, the Holder (together with the Holder&#8217;s Affiliates, and any other Persons acting as a group together
          with the Holder or any of the Holder&#8217;s Affiliates (such Persons, &#8220;<u>Attribution Parties</u>&#8221;)), would beneficially own in excess of the Beneficial Ownership Limitation (as defined below).&#160; For purposes of the foregoing sentence, the number of
          shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties shall include the number of shares of Common Stock issuable upon exercise of this Warrant with respect to which such determination is being made,
          but shall exclude the number of shares of Common Stock which would be issuable upon (i)&#160;exercise of the remaining, nonexercised portion of this Warrant beneficially owned by the Holder or any of its Affiliates or Attribution Parties and
          (ii)&#160;exercise or conversion of the unexercised or nonconverted portion of any other securities of the Company (including, without limitation, any other Common Stock Equivalents) subject to a limitation on conversion or exercise analogous to the
          limitation contained herein beneficially owned by the Holder or any of its Affiliates or Attribution Parties.&#160; Except as set forth in the preceding sentence, for purposes of this Section&#160;2(e), beneficial ownership shall be calculated in
          accordance with Section&#160;13(d) of the Exchange Act and the rules and regulations promulgated thereunder, it being acknowledged by the Holder that the Company is not representing to the Holder that such calculation is in compliance with
          Section&#160;13(d) of the Exchange Act and the Holder is solely responsible for any schedules required to be filed in accordance therewith.&#160; To the extent that the limitation contained in this Section&#160;2(e) applies, the determination of whether this
          Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable, shall be in the sole discretion of the Holder, and the
          submission of a Notice of Exercise shall be deemed to be the Holder&#8217;s determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which
          portion of this Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation, and the Company shall have no obligation to verify or confirm the accuracy of such determination.&#160; In addition, a determination as to any group
          status as contemplated above shall be determined in accordance with Section&#160;13(d) of the Exchange Act and the rules and regulations promulgated thereunder.&#160; For purposes of this Section&#160;2(e), in determining the number of outstanding shares of
          Common Stock, a Holder may rely on the number of outstanding shares of Common Stock as reflected in (A)&#160;the Company&#8217;s most recent periodic or annual report filed with the Commission, as the case may be, (B)&#160;a more recent public announcement by
          the Company or (C)&#160;a more recent written notice by the Company or the Transfer Agent setting forth the number of shares of Common Stock outstanding.&#160; Upon the written or oral request of a Holder, the Company shall within one (1)&#160;Trading Day
          confirm orally and in writing to the Holder the number of shares of Common Stock then outstanding.&#160; In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise of securities
          of the Company, including this Warrant, by the Holder or its Affiliates or Attribution Parties since the date as of which such number of outstanding shares of Common Stock was reported.&#160; The &#8220;<u>Beneficial Ownership Limitation</u>&#8221; shall be 4.99%<font style="font-style: italic;">&#160;</font>of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable upon exercise of this Warrant.&#160; The Holder, upon notice to the
          Company, may increase or decrease the Beneficial Ownership Limitation provisions of this Section&#160;2(e), provided that the Beneficial Ownership Limitation in no event exceeds 9.99% of the number of shares of the Common Stock outstanding immediately
          after giving effect to the issuance of shares of Common Stock upon exercise of this Warrant held by the Holder and the provisions of this Section&#160;2(e) shall continue to apply.&#160; Any increase in the Beneficial Ownership Limitation will not be
          effective until the 61<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">st</sup>&#160;day after such notice is delivered to the Company.&#160; The provisions of this paragraph shall be construed and implemented in a manner
          otherwise than in strict conformity with the terms of this Section&#160;2(e) to correct this paragraph (or any portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership Limitation herein contained or to make changes
          or supplements necessary or desirable to properly give effect to such limitation.&#160; The limitations contained in this paragraph shall apply to a successor holder of this Warrant.</font></div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif; font-size: 10pt;"><font style="font-family: 'Times New Roman';"><u>Section 3</u>.&#160; <u>Certain Adjustments</u>.</font></div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
      </div>
      <div style="text-indent: 72pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt;">(a)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 10pt; font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-family: 'Times New Roman'; font-size: 10pt;"><u>Stock Dividends and Splits</u>.&#160; If the Company, at any time while this Warrant is outstanding: (i)&#160;pays a stock dividend or otherwise makes a distribution or distributions on shares of
          Common Stock or any other equity or equity equivalent securities payable in shares of Common Stock (which, for avoidance of doubt, shall not include any Warrant Shares issued by the Company upon exercise of this Warrant), (ii) subdivides
          outstanding shares of Common Stock into a larger number of shares, (iii)&#160;combines (including by way of reverse stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv)&#160;issues by reclassification of shares of Common
          Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which the numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding
          immediately before such event and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the number of shares issuable upon exercise of this Warrant shall be proportionately adjusted
          such that the aggregate Exercise Price of this Warrant remains unchanged.&#160; Any adjustment made pursuant to this Section&#160;3(a) shall become effective immediately after the record date for the determination of stockholders entitled to receive such
          dividend or distribution and shall become effective immediately after the effective date in the case of a subdivision, combination or&#160;re-classification.</font></div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
      </div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">4</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
      </div>
      <div style="text-indent: 72pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt;">(b)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 10pt; font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-family: 'Times New Roman'; font-size: 10pt;"><u>Subsequent Rights Offerings</u>.&#160; In addition to (but without duplication of) any adjustments pursuant to Section&#160;3(a) above, if at any time the Company grants, issues or sells any
          Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to all of the record holders of any class of shares of Common Stock (the &#8220;<u>Purchase Rights</u>&#8221;), then the Holder will be entitled to acquire,
          upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to
          any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date on which a record is taken for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken,
          the date as of which the record holders of shares of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights (provided, however, that, to the extent that the Holder&#8217;s right to participate in any such Purchase Right
          would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Purchase Right to such extent (or beneficial ownership of such shares of Common Stock as a result of such
          Purchase Right to such extent) and such Purchase Right to such extent shall be held in abeyance for the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).</font></div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
      </div>
      <div style="text-indent: 72pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt;">(c)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 10pt; font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-family: 'Times New Roman'; font-size: 10pt;"><u>Pro Rata Distributions</u>.&#160; During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or other distribution of its assets (or rights to acquire
          its assets) to all holders of shares of its Common Stock, by way of return of capital or otherwise (including, without limitation, any distribution of cash, stock or other securities, property or options by way of a dividend, spin off,
          reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) other than a dividend or other distribution of the type described in Section&#160;3(a) above (a &#8220;Distribution&#8221;), at any time after the issuance of this
          Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution to the same extent that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable upon
          complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date of which a record is taken for such Distribution, or, if no
          such record is taken, the date as of which the record holders of shares of Common Stock are to be determined for the participation in such Distribution (provided, however, that, to the extent that the Holder&#8217;s right to participate in any such
          Distribution would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such extent (or in the beneficial ownership of any shares of Common Stock as a
          result of such Distribution to such extent) and the portion of such Distribution shall be held in abeyance for the benefit of the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial
          Ownership Limitation).</font></div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
      </div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">5</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
      </div>
      <div style="text-indent: 72pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt;">(d)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 10pt; font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-family: 'Times New Roman'; font-size: 10pt;"><u>Fundamental Transaction</u>.&#160; If, at any time while this Warrant is outstanding, (i)&#160;the Company, directly or indirectly, in one or more related transactions effects any merger or
          consolidation of the Company with or into another Person (other than a transaction solely to change the domicile of the Company), (ii) the Company, directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or
          other disposition of all or substantially all of its assets in one or a series of related transactions, (iii)&#160;any, direct or indirect, purchase offer, tender offer or exchange offer (whether by the Company or another Person) is completed pursuant
          to which holders of Common Stock are permitted to sell, tender or exchange their shares for other securities, cash or property and has been accepted by the holders of 50% or more of the outstanding Common Stock, (iv)&#160;the Company, directly or
          indirectly, in one or more related transactions effects any reclassification, reorganization or recapitalization of the Common Stock or any compulsory share exchange pursuant to which the Common Stock is effectively converted into or exchanged
          for other securities, cash or property, or (v)&#160;the Company, directly or indirectly, in one or more related transactions consummates a stock or share purchase agreement or other business combination (including, without limitation, a
          reorganization, recapitalization,&#160;spin-off,&#160;merger or scheme of arrangement) with another Person or group of Persons whereby such other Person or group acquires more than 50% of the outstanding shares of Common Stock (not including any shares of
          Common Stock held by the other Person or other Persons making or party to, or associated or affiliated with the other Persons making or party to, such stock or share purchase agreement or other business combination) (each a &#8220;<u>Fundamental
            Transaction</u>&#8221;), then, upon any subsequent exercise of this Warrant, the Holder shall have the right to receive, for each Warrant Share that would have been issuable upon such exercise immediately prior to the occurrence of such Fundamental
          Transaction, at the option of the Holder (without regard to any limitation in Section&#160;2(e) on the exercise of this Warrant), the number of shares of Common Stock of the successor or acquiring corporation or of the Company, if it is the surviving
          corporation, and any additional consideration (the &#8220;<u>Alternate Consideration</u>&#8221;) receivable as a result of such Fundamental Transaction by a holder of the number of shares of Common Stock for which this Warrant is exercisable immediately
          prior to such Fundamental Transaction (without regard to any limitation in Section&#160;2(e) on the exercise of this Warrant).&#160; For purposes of any such exercise, the determination of the Exercise Price shall be appropriately adjusted to apply to such
          Alternate Consideration based on the amount of Alternate Consideration issuable in respect of one share of Common Stock in such Fundamental Transaction, and the Company shall apportion the Exercise Price among the Alternate Consideration in a
          reasonable manner reflecting the relative value of any different components of the Alternate Consideration.&#160; If holders of Common Stock are given any choice as to the securities, cash or property to be received in a Fundamental Transaction, then
          the Holder shall be given the same choice as to the Alternate Consideration it receives upon any exercise of this Warrant following such Fundamental Transaction.&#160; The Company shall cause any successor entity in a Fundamental Transaction in which
          the Company is not the survivor (the &#8220;<u>Successor Entity</u>&#8221;) to assume in writing all of the obligations of the Company under this Warrant in accordance with the provisions of this Section&#160;3(d) pursuant to written agreements in form and
          substance reasonably satisfactory to the Holder and approved by the Holder (without unreasonable delay) prior to such Fundamental Transaction and shall, at the option of the Holder, deliver to the Holder in exchange for this Warrant a security of
          the Successor Entity evidenced by a written instrument substantially similar in form and substance to this Warrant which is exercisable for a corresponding number of shares of capital stock of such Successor Entity (or its parent entity)
          equivalent to the shares of Common Stock acquirable and receivable upon exercise of this Warrant (without regard to any limitations on the exercise of this Warrant) prior to such Fundamental Transaction, and with an exercise price which applies
          the exercise price hereunder to such shares of capital stock (but taking into account the relative value of the shares of Common Stock pursuant to such Fundamental Transaction and the value of such shares of capital stock, such number of shares
          of capital stock and such exercise price being for the purpose of protecting the economic value of this Warrant immediately prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory in form and substance to
          the Holder.&#160; Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall succeed to, and be substituted for (so that from and after the date of such Fundamental Transaction, the provisions of this Warrant referring to the
          &#8220;Company&#8221; shall refer instead to the Successor Entity), and may exercise every right and power of the Company and shall assume all of the obligations of the Company under this Warrant with the same effect as if such Successor Entity had been
          named as the Company herein.</font></div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
      </div>
      <div style="text-indent: 72pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt;">(e)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 10pt; font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-family: 'Times New Roman'; font-size: 10pt;"><u>Calculations</u>.&#160; All calculations under this Section&#160;3 shall be made to the nearest cent or the nearest 1/100th of a share of Common Stock, as the case may be.&#160; For purposes of this
          Section&#160;3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall be the sum of the number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.</font></div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
      </div>
      <div style="text-indent: 72pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt;">(f)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 10pt; font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-family: 'Times New Roman'; font-size: 10pt;"><u>Notice to Holder</u>.</font></div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 108pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt;">i.</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 10pt; font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-family: 'Times New Roman'; font-size: 10pt;"><u>Adjustment to Exercise Price</u>.&#160; Whenever the Exercise Price is adjusted pursuant to any provision of this Section&#160;3, the Company shall promptly deliver to the Holder by email a notice
          setting forth the Exercise Price after such adjustment and any resulting adjustment to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.</font></div>
      <div style="text-align: justify; text-indent: 108pt; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">6</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
      </div>
      <div style="text-align: justify; text-indent: 108pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt;">ii.</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 10pt; font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-family: 'Times New Roman'; font-size: 10pt;"><u>Notice to Allow Exercise by Holder</u>.&#160; If (A)&#160;the Company shall declare a dividend (or any other distribution in whatever form) on the Common Stock, (B)&#160;the Company shall declare a
          special nonrecurring cash dividend on or a redemption of the Common Stock, (C)&#160;the Company shall authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of capital stock of any class or
          of any rights, (D)&#160;the approval of any stockholders of the Company shall be required in connection with any reclassification of the Common Stock, any consolidation or merger to which the Company is a party (other than a transaction solely to
          change the domicile of the Company), any sale or transfer of all or substantially all of the assets of the Company, or any compulsory share exchange whereby the Common Stock is converted into other securities, cash or property, or (E)&#160;the Company
          shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs of the Company, then, in each case, the Company shall cause to be delivered by email to the Holder at its last email address as it shall appear
          upon the Warrant Register of the Company, at least 20 calendar days prior to the applicable record or effective date hereinafter specified, a notice stating (x)&#160;the date on which a record is to be taken for the purpose of such dividend,
          distribution, redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common Stock of record to be entitled to such dividend, distributions, redemption, rights or warrants are to be determined or
          (y)&#160;the date on which such reclassification, consolidation, merger, sale, transfer or share exchange is expected to become effective or close, and the date as of which it is expected that holders of the Common Stock of record shall be entitled to
          exchange their shares of the Common Stock for securities, cash or other property deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange; provided that the failure to deliver such notice or any defect
          therein or in the delivery thereof shall not affect the validity of the corporate action required to be specified in such notice.&#160; To the extent that any notice provided in this Warrant constitutes, or contains, material,&#160;non-public&#160;information
          regarding the Company or any of the Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a Current Report on Form&#160;8-K.&#160; The Holder shall remain entitled to exercise this Warrant during the period
          commencing on the date of such notice to the effective date of the event triggering such notice except as may otherwise be expressly set forth&#160;herein.</font></div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
      </div>
      <div style="text-indent: 72pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt;">(g)</font><font class="TRGRRTFtoHTMLTab" style="font-size: 10pt; font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-family: 'Times New Roman'; font-size: 10pt;"><u>Delayed Delivery</u>.&#160; Notwithstanding anything herein to the contrary, on the Termination Date, if the conditions of a cashless exercise are otherwise met, this Warrant shall be automatically exercised via cashless
          exercise pursuant to this Section&#160;2(c), and if the exercise of the Warrant pursuant to this sentence would be prevented by the application of the Beneficial Ownership Limitation, then such exercise shall be delayed until the soonest date or dates
          when such Warrant Shares may be permissibly be delivered without exceeding the Beneficial Ownership Limitation notwithstanding the prior occurrence of the Termination Date.</font></div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
      </div>
      <div style="text-indent: 72pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt;">(h)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 10pt; font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-family: 'Times New Roman'; font-size: 10pt;">The total number of Warrant Shares exercisable hereunder shall be adjusted as follows.&#160; The product of (a) initial Warrant Shares and (b) highest of (x) the closing price of the Common
          Stock on the Issuance Date, (y) the average of the three lowest VWAPs over the five Trading Days following the Effective Date, or (y) the average of the three lowest VWAPs over the five Trading Days following the date the Company obtains
          shareholder approval to issue all the Common Stock issuable under the Purchase Agreement (the &#8220;Reference VWAP Price&#8221;) shall be referred to as the &#8220;Commitment Share Value.&#8221; If the Commitment Share Value is in excess of $750,000, the number of
          Warrant Shares shall be reduced by an amount equal to the Cancellable Commitment Share Amount.&#160; For purposes of this Agreement, the &#8220;Cancellable Commitment Share Amount&#8221; means the Commitment Share Value minus $750,000, divided by the Reference
          VWAP Price.&#160; If the Reference Commitment Share Value is below $750,000, the number of Warrant Shares shall increase by an amount equal to the Increase Commitment Share Amount.&#160; For purposes of this Agreement, the &#8220;Increase Commitment Share
          Amount&#8221; means the $750,000 minus Reference Commitment Share Value, multiplied by the Reference VWAP Price.</font></div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif; font-size: 10pt;"><font style="font-family: 'Times New Roman';"><u>Section 4.</u>&#160; <u>Transfer of Warrant</u>.</font></div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
      </div>
      <div style="text-indent: 72pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt;">(a)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 10pt; font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-family: 'Times New Roman'; font-size: 10pt;"><u>Transferability</u>.&#160; Subject to the Holder&#8217;s appropriate compliance with the restrictive legend on this Warrant and to the provisions set forth in the Purchase Agreement, this Warrant
          and all rights hereunder (including, without limitation, any registration rights) are transferable, in whole or in part, upon surrender of this Warrant at the principal office of the Company or its designated agent, together with a written
          assignment of this Warrant substantially in the form attached hereto as&#160;<u>Exhibit B</u>&#160;duly executed by the Holder or its agent or attorney and funds sufficient to pay any transfer taxes payable upon the making of such transfer.&#160; Upon such
          surrender and, if required, such payment, the Company shall execute and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable, and in the denomination or denominations specified in such instrument of
          assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not so assigned, and this Warrant shall promptly be cancelled.&#160; Notwithstanding anything herein to the contrary, the Holder shall not be required to
          physically surrender this Warrant to the Company unless the Holder has assigned this Warrant in full, in which case, the Holder shall surrender this Warrant to the Company within three (3) Trading Days of the date on which the Holder delivers an
          assignment form to the Company assigning this Warrant or the remaining unexercised portion of this Warrant in full.&#160; The Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for the purchase of Warrant Shares
          without having a new Warrant issued.</font></div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
      </div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">7</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
      </div>
      <div style="text-indent: 72pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt;">(b)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 10pt; font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-family: 'Times New Roman'; font-size: 10pt;"><u>New Warrants</u>.&#160; Subject to compliance with applicable securities laws, this Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of
          the Company, together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the Holder or its agent or attorney.&#160; Subject to compliance with Section&#160;4(a), as to any transfer which may be
          involved in such division or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in accordance with such notice.&#160; All Warrants issued on transfers or
          exchanges shall be dated the initial issuance date of this Warrant and shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.</font></div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
      </div>
      <div style="text-indent: 72pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt;">(c)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 10pt; font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-family: 'Times New Roman'; font-size: 10pt;"><u>Warrant Register</u>.&#160; The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the &#8220;<u>Warrant Register</u>&#8221;), in the name of the record
          Holder hereof from time to time.&#160; The Company may deem and treat the registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other purposes, absent
          actual notice to the contrary.</font></div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
      </div>
      <div style="text-indent: 72pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt;">(d)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 10pt; font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-family: 'Times New Roman'; font-size: 10pt;"><u>Transfer Restrictions</u>.&#160; If, at the time of the surrender of this Warrant in connection with any transfer of this Warrant, the transfer of this Warrant shall not be either
          (i)&#160;registered pursuant to an effective registration statement under the Securities Act and under applicable state securities or blue sky laws or (ii)&#160;eligible for resale without volume or&#160;manner-of-sale&#160;restrictions or current public information
          requirements pursuant to Rule 144, the Company may require, as a condition of allowing such transfer, that the Holder or transferee of this Warrant, as the case may be, comply with the provisions of Section&#160;4.1 of the Purchase Agreement.</font></div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
      </div>
      <div style="text-indent: 72pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt;">(e)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 10pt; font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-family: 'Times New Roman'; font-size: 10pt;"><u>Representation by Holder</u>.&#160; The Holder, by the acceptance hereof, represents and warrants that it is acquiring this Warrant and, upon any exercise hereof, will acquire the Warrant
          Shares issuable upon such exercise, for its own account and not with a view to or for distributing or reselling such Warrant Shares or any part thereof in violation of the Securities Act or any applicable state securities law, except pursuant to
          sales registered or exempted under the Securities Act.</font></div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif; font-size: 10pt;"><font style="font-family: 'Times New Roman';"><u>Section 5.&#160; Miscellaneous</u>.</font></div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
      </div>
      <div style="text-indent: 72pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt;">(a)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 10pt; font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-family: 'Times New Roman'; font-size: 10pt;"><u>No Rights as Stockholder Until Exercise; No Settlement in Cash</u>.&#160; This Warrant does not entitle the Holder to any voting rights, dividends or other rights as a stockholder of the
          Company prior to the exercise hereof as set forth in Section&#160;2(d)(i), except as expressly set forth in Section&#160;3.&#160; Without limiting any rights of a Holder to receive Warrant Shares on a &#8220;cashless exercise&#8221; pursuant to Section&#160;2(c) or to receive
          cash payments pursuant to Section&#160;2(d)(iv) herein, in no event shall the Company be required to net cash settle an exercise of this Warrant.&#160; For the avoidance of doubt, except as expressly set forth in this Warrant, in no event does this
          agreement result in the Company having an obligation to issue cash or other assets to the Holder.</font></div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
      </div>
      <div style="text-indent: 72pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt;">(b)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 10pt; font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-family: 'Times New Roman'; font-size: 10pt;"><u>Loss, Theft, Destruction or Mutilation of Warrant</u>.&#160; The Company covenants that upon receipt by the Company of evidence reasonably satisfactory to it of the loss, theft, destruction
          or mutilation of this Warrant or any stock certificate relating to the Warrant Shares, and in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant, shall not include the
          posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the Company will make and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such
          Warrant or stock certificate.</font></div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
      </div>
      <div style="text-indent: 72pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt;">(c)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 10pt; font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-family: 'Times New Roman'; font-size: 10pt;"><u>Saturdays, Sundays, Holidays, etc</u>.&#160; If the last or appointed day for the taking of any action or the expiration of any right required or granted herein shall not be a Trading Day,
          then such action may be taken or such right may be exercised on the next succeeding Trading Day.</font></div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
      </div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">8</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
      </div>
      <div style="text-indent: 72pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt;">(d)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 10pt; font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-family: 'Times New Roman'; font-size: 10pt;"><u>Authorized Shares</u>.&#160; The Company covenants that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued shares of Common Stock a sufficient
          number of shares to provide for the issuance of the Warrant Shares underlying this Warrant.&#160; The Company further covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with the duty of issuing
          the necessary Warrant Shares upon the exercise of the purchase rights under this Warrant.&#160; The Company will take all such reasonable action as may be necessary to assure that such Warrant Shares may be issued and delivered as provided herein
          without violation of any applicable law or regulation, or of any requirements of the Trading Market upon which the Common Stock may be listed.&#160; The Company covenants that all Warrant Shares underlying this Warrant, which may be issued upon the
          exercise of the purchase rights represented by this Warrant will, upon exercise of the purchase rights represented by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly issued, fully paid and
          nonassessable and free from all taxes, liens and charges created by the Company in respect of the issue thereof (other than taxes in respect of any transfer occurring contemporaneously with such issue).</font></div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Except and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending its
        certificate of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms
        of this Warrant, but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary or appropriate to protect the rights of Holder as set forth in this Warrant against
        impairment.&#160; Without limiting the generality of the foregoing, the Company will (i)&#160;not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise immediately prior to such increase in par value, (ii)&#160;take all
        such action as may be necessary or appropriate in order that the Company may validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii)&#160;use commercially reasonable efforts to obtain all such
        authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof, as may be, necessary to enable the Company to perform its obligations under this Warrant.</div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Before taking any action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the
        Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from any public regulatory body or bodies having jurisdiction thereof.</div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
      </div>
      <div style="text-indent: 72pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt;">(e)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 10pt; font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-family: 'Times New Roman'; font-size: 10pt;"><u>Jurisdiction</u>.&#160; All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be determined in accordance with the provisions of the
          Purchase Agreement.</font></div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
      </div>
      <div style="text-indent: 72pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt;">(f)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 10pt; font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-family: 'Times New Roman'; font-size: 10pt;"><u>Restrictions</u>.&#160; The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and if the Holder does not utilize cashless exercise,
          will have restrictions upon resale imposed by state and federal securities laws.</font></div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
      </div>
      <div style="text-indent: 72pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt;">(g)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 10pt; font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-family: 'Times New Roman'; font-size: 10pt;"><u>Nonwaiver and Expenses</u>.&#160; No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall operate as a waiver of such right or otherwise
          prejudice the Holder&#8217;s rights, powers or remedies.&#160; Without limiting any other provision of this Warrant or the Purchase Agreement, if the Company willfully and knowingly fails to comply with any provision of this Warrant, which results in any
          material damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and expenses including, but not limited to, reasonable and documented attorneys&#8217; fees, including those of appellate
          proceedings, incurred by the Holder in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</font></div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
      </div>
      <div style="text-indent: 72pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt;">(h)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 10pt; font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-family: 'Times New Roman'; font-size: 10pt;"><u>Notices</u>.&#160; Any notice, request or other document required or permitted to be given or delivered to the Holder by the Company shall be delivered in accordance with the notice
          provisions of the Purchase&#160;Agreement.</font></div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
      </div>
      <div style="text-indent: 72pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt;">(i)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 10pt; font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-family: 'Times New Roman'; font-size: 10pt;"><u>Limitation of Liability</u>.&#160; No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase Warrant Shares, and no enumeration herein
          of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase price of any share of Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company or by creditors of
          the Company.</font></div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
      </div>
      <div style="text-indent: 72pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt;">(j)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 10pt; font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-family: 'Times New Roman'; font-size: 10pt;"><u>Remedies</u>.&#160; The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled to specific performance of its rights
          under this Warrant.&#160; The Company agrees that monetary damages would not be adequate compensation for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert the defense in any
          action for specific performance that a remedy at law would be adequate.</font></div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
      </div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">9</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
      </div>
      <div style="text-indent: 72pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt;">(k)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 10pt; font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-family: 'Times New Roman'; font-size: 10pt;"><u>Successors and Assigns</u>.&#160; Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure to the benefit of and be binding upon the
          successors and permitted assigns of the Company and the successors and permitted assigns of Holder.&#160; The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall be enforceable by the
          Holder.</font></div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
      </div>
      <div style="text-indent: 72pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt;">(l)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 10pt; font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-family: 'Times New Roman'; font-size: 10pt;"><u>Amendment</u>.&#160; This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company and the Holder.</font></div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
      </div>
      <div style="text-indent: 72pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt;">(m)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 10pt; font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-family: 'Times New Roman'; font-size: 10pt;"><u>Severability</u>.&#160; Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable law, but if any provision of this
          Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this
          Warrant.</font></div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
      </div>
      <div style="text-indent: 72pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt;">(n)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 10pt; font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-family: 'Times New Roman'; font-size: 10pt;"><u>Headings</u>.&#160; The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of this Warrant.</font></div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
      </div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">********************</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">(Signature Page Follows)</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 9pt; margin-bottom: 9pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">10</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" noshade="noshade"></div>
      </div>
      <div style="text-indent: 24.5pt; font-family: 'Times New Roman'; font-size: 10pt;">IN WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above indicated.</div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table id="z5802072f2d03417883baf302f52ec163" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" border="0" cellpadding="0" cellspacing="0">

          <tr>
            <td style="vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;" colspan="3">
              <div style="text-indent: -12pt; margin-left: 12pt; font-weight: bold;">MOMENTUS, INC.</div>
            </td>
            <td style="vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; width: 66%;" colspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="width: 3%; vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>
            <td style="vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt;" colspan="2">&#160;</td>
            <td style="vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt; width: 66%;" colspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="width: 3%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt; padding-bottom: 2px;">
              <div>By:</div>
            </td>
            <td style="width: 1%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt; padding-bottom: 2px;">
              <div>&#160;</div>
            </td>
            <td style="width: 30%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt; border-bottom: 2px solid rgb(0, 0, 0);">
              <div>&#160;/s/ John C. Rood</div>
            </td>
            <td style="width: 66%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt; padding-bottom: 2px;" colspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="width: 3%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>
            <td style="width: 1%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>&#160;</div>
            </td>
            <td style="width: 30%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>Name: John C. Rood</div>
            </td>
            <td style="width: 66%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt;" colspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="width: 3%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>
            <td style="width: 1%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>&#160;</div>
            </td>
            <td style="width: 30%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>Title:&#160;&#160; Chief Executive Officer</div>
            </td>
            <td style="width: 66%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt;" colspan="1">&#160;</td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 9pt; margin-bottom: 9pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">11</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" noshade="noshade"></div>
      </div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">EXHIBIT A</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">NOTICE OF EXERCISE</div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
      </div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">TO:&#160;<font style="font-weight: bold;">MOMENTUS, INC.</font></div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 24.5pt; font-family: 'Times New Roman'; font-size: 10pt;">(1) The undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only if
        exercised in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.</div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 24.5pt; font-family: 'Times New Roman'; font-size: 10pt;">(2) Payment shall take the form of (check applicable box):</div>
      <div style="text-align: justify; text-indent: 79.55pt; font-family: 'Times New Roman', serif; font-size: 10pt;">&#9744;<font style="font-family: 'Times New Roman';">&#8195;in lawful money of the United States; or</font></div>
      <div style="text-align: justify; text-indent: 79.55pt; font-family: 'Times New Roman', serif; font-size: 10pt;">&#9744;<font style="font-family: 'Times New Roman';">&#8195;if permitted the cancellation of such number of Warrant Shares as is necessary, in
          accordance with the formula set forth in subsection 2(c), to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure set forth in subsection 2(c).</font></div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 24.5pt; font-family: 'Times New Roman'; font-size: 10pt;">(3) Please issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">If applicable, the Warrant Shares shall be delivered to the following DWAC Account Number:</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table id="z8370a2d53eeb45188b070948e5f50f54" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" border="0" cellpadding="0" cellspacing="0">

          <tr>
            <td style="width: 33%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>
            <td style="width: 34%; vertical-align: top; border-bottom: 1px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: justify;">&#160;</div>
            </td>
            <td style="width: 33%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 33%; vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>
            <td style="width: 34%; vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>
            <td style="width: 33%; vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 33%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>
            <td style="width: 34%; vertical-align: top; border-bottom: 1px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: justify;">&#160;</div>
            </td>
            <td style="width: 33%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 33%; vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>
            <td style="width: 34%; vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>
            <td style="width: 33%; vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 33%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>
            <td style="width: 34%; vertical-align: top; border-bottom: 1px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: justify;">&#160;</div>
            </td>
            <td style="width: 33%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 24.5pt; font-family: 'Times New Roman'; font-size: 10pt;">(4)&#160;<u>Accredited Investor</u>.&#160; The undersigned is an &#8220;accredited investor&#8221; as defined in Regulation D promulgated under the Securities Act of
        1933, as amended (the &#8220;Securities Act&#8221;); or (ii)&#160;a &#8220;qualified institutional buyer&#8221; as defined in Rule 144A(a) under the Securities Act.</div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table id="za96c2249fd02470abf3b2777652e2077" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" border="0" cellpadding="0" cellspacing="0">

          <tr>
            <td style="width: 100%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; border-top: 2px solid rgb(0, 0, 0);">
              <div style="text-indent: -12pt; margin-left: 12pt;">SIGNATURE OF HOLDER</div>
            </td>
          </tr>
          <tr>
            <td style="width: 100%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>&#160;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 100%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; border-top: 2px solid rgb(0, 0, 0);">
              <div style="text-indent: -12pt; margin-left: 12pt;">Name of Investing Entity</div>
            </td>
          </tr>
          <tr>
            <td style="width: 100%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>&#160;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 100%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; border-top: 2px solid rgb(0, 0, 0);">
              <div style="text-indent: -12pt; margin-left: 12pt; font-style: italic;">Signature of Authorized Signatory of Investing Entity</div>
            </td>
          </tr>
          <tr>
            <td style="width: 100%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>&#160;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 100%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; border-top: 2px solid rgb(0, 0, 0);">
              <div style="text-indent: -12pt; margin-left: 12pt;">Name of Authorized Signatory</div>
            </td>
          </tr>
          <tr>
            <td style="width: 100%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>&#160;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 100%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; border-top: 2px solid rgb(0, 0, 0);">
              <div style="text-indent: -12pt; margin-left: 12pt;">Title of Authorized Signature</div>
            </td>
          </tr>
          <tr>
            <td style="width: 100%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>&#160;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 100%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; border-top: 2px solid rgb(0, 0, 0);">
              <div style="text-indent: -12pt; margin-left: 12pt;">Date</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 9pt; margin-bottom: 9pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">12</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" noshade="noshade"></div>
      </div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">EXHIBIT B</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">ASSIGNMENT FORM</div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">(<font style="font-style: italic;">To assign the foregoing Warrant, execute this form and supply required information.&#160; Do not use this form to purchase&#160;shares.</font>)</div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">FOR VALUE RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby assigned to</div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table id="z3a912a8f2c4042b59ea6c4f23ece4aad" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" border="0" cellpadding="0" cellspacing="0">

          <tr>
            <td style="width: 12%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; padding-bottom: 2px;">
              <div>Name:</div>
            </td>
            <td style="width: 88%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; border-bottom: 2px solid rgb(0, 0, 0);">
              <div>
                <div>&#160;</div>
              </div>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>
            <td style="width: 88%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>(Please Print)</div>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>
            <td style="width: 88%; vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; padding-bottom: 2px;">
              <div>Address:</div>
            </td>
            <td style="width: 88%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; border-bottom: 2px solid rgb(0, 0, 0);"><br>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; padding-bottom: 2px;">&#160;</td>
            <td style="width: 88%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div>
                <div>&#160;</div>
              </div>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; padding-bottom: 2px;">&#160;</td>
            <td style="width: 88%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; border-bottom: 2px solid rgb(0, 0, 0);">
              <div>
                <div>&#160;</div>
              </div>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>
            <td style="width: 88%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>(Please Print)</div>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>
            <td style="width: 88%; vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; padding-bottom: 2px;">
              <div>Phone Number</div>
            </td>
            <td style="width: 88%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; border-bottom: 2px solid rgb(0, 0, 0);"><br>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>
            <td style="width: 88%; vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; padding-bottom: 2px;">
              <div>Email Address:</div>
            </td>
            <td style="width: 88%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; border-bottom: 2px solid rgb(0, 0, 0);"><br>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>
            <td style="width: 88%; vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; padding-bottom: 2px;">
              <div>Dated:</div>
            </td>
            <td style="width: 88%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; border-bottom: 2px solid rgb(0, 0, 0);"><br>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>
            <td style="width: 88%; vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; padding-bottom: 2px;">
              <div>Holder&#8217;s Signature</div>
            </td>
            <td style="width: 88%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; border-bottom: 2px solid rgb(0, 0, 0);"><br>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>
            <td style="width: 88%; vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; padding-bottom: 2px;">
              <div>Holder&#8217;s Address</div>
            </td>
            <td style="width: 88%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; border-bottom: 2px solid rgb(0, 0, 0);"><br>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"> </div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">
        <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;" noshade="noshade" align="center"></div>
    </div>
  </div>
  <font style="font-family: 'Times New Roman'; font-size: 10pt;"> </font>
  <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">13</font></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>6
<FILENAME>ny20047547x33_ex10-1.htm
<DESCRIPTION>EXHIBIT 10.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc.
         Document created using Broadridge PROfile 25.9.1.5330
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">




  <div>
    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
    <div>
      <div style="text-align: right; font-weight: bold;"> Exhibit 10.1<br>
      </div>
      <div style="text-align: center; font-weight: bold;"> <br>
      </div>
      <div style="text-align: center; font-weight: bold;">SECURITIES PURCHASE AGREEMENT</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">This Securities Purchase Agreement (this &#8220;<u>Agreement</u>&#8221;) is dated as of September 25, 2025, between Momentus Inc., a Delaware corporation (the &#8220;<u>Company</u>&#8221;), and each purchaser identified
        on the signature pages hereto (each, including its successors and assigns, a &#8220;<u>Purchaser</u>&#8221; and collectively, the &#8220;<u>Purchasers</u>&#8221;).</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">WHEREAS, the Company and Purchasers desire to enter into this Agreement, pursuant to which the Purchasers are to be granted the right to acquire securities of the Company as set forth herein and</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">WHEREAS, <a name="z_Hlk189746083"></a>subject to the terms and conditions set forth in this Agreement and pursuant to Section&#160;4(a)(2) of the Securities Act of 1933, as amended, and/or Rule 506
        promulgated thereunder, the Company desires to issue and sell to each Purchaser, and each Purchaser, severally and not jointly, desires to purchase from the Company, securities of the Company as more fully described in this Agreement (the&#160;&#8220;<u>Offering</u>&#8221;).</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">NOW, THEREFORE, IN CONSIDERATION of the mutual covenants contained in this Agreement, and for other good and valuable consideration, the receipt and adequacy of which are hereby acknowledged, the
        Company and each Purchaser agree as follows:</div>
      <div>&#160;</div>
      <div style="text-align: center; font-weight: bold;">ARTICLE I.</div>
      <div>&#160;</div>
      <div style="text-align: center; font-weight: bold;">DEFINITIONS</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #000000;">1.1</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Definitions</u>.&#160; In addition to the terms defined elsewhere in this Agreement: (a) capitalized terms that are not otherwise defined herein have
        the meanings given to such terms in the Securities (as defined herein), and (b) the following terms have the meanings set forth in this Section 1.1:</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">&#8220;<u>Accredited Investor</u>&#8221; shall have the meaning ascribed to such term in Section 3.2(c).</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">&#8220;<u>Acquiring Person</u>&#8221; shall have the meaning ascribed to such term in Section 4.7.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">&#8220;<u>Action</u>&#8221; shall have the meaning ascribed to such term in Section 3.1(j).</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">&#8220;<u>Affiliate</u>&#8221; means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control with a Person, as such terms are used in
        and construed under Rule 405 under the Securities Act.<a name="z_Toc430524857"></a><a name="z_Toc449254725"></a></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">&#8220;<u>AIR Warrant</u>&#8221; means the AIR warrant in the form of Exhibit C hereto.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">&#8220;<u>Applicable Law</u>&#8221; shall mean any law, rule or regulation of any governmental authority or jurisdiction applicable to any party to this Agreement, as the case may be.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">&#8220;<u>Board of Directors</u>&#8221; means the board of directors of the Company.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">&#160;&#8220;<u>Business Day</u>&#8221; means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized or required by law to remain closed; <u>provided</u>,
        <u>however</u>, for clarification, commercial banks shall not be deemed to be authorized or required by law to remain closed due to &#8220;stay at home&#8221;, &#8220;shelter-in-place&#8221;, &#8220;non-essential employee&#8221;&#160; or any other similar orders or restrictions or the
        closure of any physical branch locations at the direction of any governmental authority so long as the electronic funds transfer systems (including for wire transfers) of commercial banks in The City of New York are generally are open for use by
        customers on such day.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <!--PROfilePageNumberReset%Num%2%%%-->
      <div style="text-align: justify; text-indent: 72pt;">&#8220;<u>Buy-In</u>&#8221; shall have the meaning ascribed to such term in Section 4.1(h).</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">&#8220;<u>Closing</u>&#8221; <font style="color: #000000;">means the delivery and sale of the Securities and payment of the aggregate Subscription Amount</font>&#160;<font style="color: #000000;">pursuant to
          Section 2.1.</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">&#8220;<u>Closing Date</u>&#8221; <font style="color: #000000;">means the Business Day on which all of the Transaction Documents have been executed and delivered by the applicable parties thereto, and all
          conditions precedent to (i) the Purchasers&#8217; obligation to pay the Subscription Amount at the Closing, and (ii) the Company&#8217;s obligations to deliver the Securities to be issued and sold at the Closing, in each case, have been satisfied or waived,
          but in no event later than the fifth Business Day following the date hereof.</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">&#8220;<u>Commission</u>&#8221; means the United States Securities and Exchange Commission.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">&#8220;<u>Common Stock</u>&#8221; means the Class A Common Stock of the Company, par value $0.00001 per share, and any other class of securities into which such securities may hereafter be reclassified
        or&#160;changed.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">&#8220;<u>Common Stock Equivalents</u>&#8221; means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire at any time Common Stock, including, without limitation,
        any debt, preferred stock, right, option, warrant or other instrument that is at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">&#8220;<u>Company Counsel</u>&#8221; means, Bradley Arant Boult Cummings LLP, Attn: Stephen Hinton, Esq., email: [***].</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">&#8220;<u>Conversion Price</u>&#8221; shall have the meaning ascribed to such term in the Notes.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">&#8220;<u>Disclosure Schedules</u>&#8221; means the Disclosure Schedules of the Company delivered concurrently herewith.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">&#8220;<u>Disqualification Event</u>&#8221; shall have the meaning ascribed to such term in Section 3.1(nn).</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">&#160;&#8220;<u>Effective Date</u>&#8221; means the latest of the date that (a) a Registration Statement has been declared effective by the Commission with respect to that number of shares equal to the Required
        Minimum of Underlying Shares (as defined herein) and has been continuously effective for not less than six (6) months, or, if earlier, the date that all of the Underlying Shares are eligible to be sold pursuant to Rule 144, and (b) Company counsel
        has delivered to the Transfer Agent and Purchasers at the Company&#8217;s expense a standing written unqualified opinion that resales may then be made by such holders of all of the Underlying Shares pursuant to an effective Registration Statement, which
        opinion shall be in form and substance reasonably acceptable to Purchaser.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">&#8220;<u>Equity Line of Credit</u>&#8221; shall have the meaning ascribed to such term in Section 4.13.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">&#8220;<u>Exchange Act</u>&#8221; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">2</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt;">&#8220;<u>Exempt Issuance</u>&#8221; means the issuance of (a) shares of Common Stock<font style="color: #000000;">, restricted stock units or </font>options<font style="color: #000000;">, including the
          shares of Common Stock underlying the restricted stock units or options,</font> to employees, <font style="color: #000000;">officers,</font> consultants <font style="color: #000000;">or directors </font>of the Company pursuant to <font style="color: #000000;">any stock or option plan or arrangement duly adopted for such purpose and disclosed in the SEC Reports</font> filed not later than ten (10) days before the Closing Date<font style="color: #000000;">,</font> (b)<font style="color: #000000;"> securities upon the exercise or exchange of or conversion of any Securities issued hereunder </font>(subject to adjustment for forward and reverse stock splits and the like that occur after the date hereof) <font style="color: #000000;">and/or other</font> securities exercisable or exchangeable for or convertible into shares of Common Stock issued and outstanding on the date of this Agreement,&#160;provided that such securities and any term thereof have not
        been amended since the date of this Agreement in a way that causes such securities to fall within the definition of a Variable Rate Transaction (for the avoidance of doubt, such securities outstanding as of the date hereof that fall within the
        definition of a Variable Rate Transaction as of the date hereof shall remain an Exempt Issuance notwithstanding any amendment or exchange of such security for a security with similar terms after the date hereof)<font style="color: #000000;">, and
          (c) securities issued pursuant to mergers, acquisitions or strategic transactions, including license and co-development agreements with third parties, approved by a majority of the disinterested directors of the Company, provided that such
          securities are issued as &#8220;restricted securities&#8221; (as defined in Rule 144) and carry no registration rights that require or permit the filing of any registration statement in connection therewith until one (1) year after the effective date of the
          Initial Registration Statement except for (A) a Registration Statement on behalf of the Holders, (B) a registration statement on Form S-8 in connection with any employee benefit plan, (C) one hundred twenty (120) days following the Effectiveness
          Date of the Initial Registration Statement, a registration statement relating to the resale of Common Stock or Common Stock Equivalents, provided that such Common Stock or Common Stock Equivalents (on an as converted to Common Stock basis) do not
          represent more than 10% of the shares of Common Stock then outstanding ,and (d) shares of Common Stock in an &#8220;at the market offering&#8221;</font>.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">&#8220;<u>Exercise Price</u>&#8221; shall have the meaning ascribed to such term in the Warrants.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">&#8220;<u>FCPA</u>&#8221; means the Foreign Corrupt Practices Act of 1977, as amended.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">&#8220;<u>FDA</u>&#8221; shall have the meaning ascribed to such term in Section&#160;3.1(mm).</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">&#8220;<u>Form 8-K</u>&#8221; shall have the meaning ascribed to such term in Section 4.6.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">&#8220;<u>GAAP</u>&#8221; shall have the meaning ascribed to such term in Section 3.1(h).</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">&#8220;<u>G&amp;M</u>&#8221; shall mean Grushko &amp; Mittman, P.C., legal counsel to the Purchasers with offices located at 1800 Rockaway Avenue, Suite 206, Hewlett, NY 11557, Attn: Eliezer Drew, Esq., email:
        [***].</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">&#8220;<u>Indebtedness</u>&#8221; shall have the meaning ascribed to such term in Section 3.1(y).</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">&#8220;<u>Intellectual Property Rights</u>&#8221; shall have the meaning ascribed to such term in Section&#160;3.1(o).</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">&#8220;<u>Investor Questionnaire</u>&#8221; means the form of Accredited Investor Questionnaire annexed hereto as <u>Exhibit F</u>.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">&#8220;<u>Issuer Covered Person</u>&#8221; shall have the meaning ascribed to such term in Section 3.1(oo).</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">&#8220;<u>Legal Opinion</u>&#8221; shall have the meaning ascribed to such term in Section 2.2(a).</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">&#8220;<u>Legend Removal Date</u>&#8221; shall have the meaning ascribed to such term in Section 4.1(d).</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">&#8220;<u>Liens</u>&#8221; means a lien, charge, pledge, security interest, encumbrance, right of first refusal, pre-emptive right or other restriction.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">3</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt;">&#8220;<u>Listing Default</u>&#8221; shall have the meaning ascribed to such term in Section 4.11(b).</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">&#8220;<u>Majority in Interest</u>&#8221; shall have the meaning ascribed to such term in Section 5.5.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">&#8220;<u>Material Adverse Effect</u>&#8221; shall have the meaning assigned to such term in Section 3.1(b).</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">&#8220;<u>Material Permits</u>&#8221; shall have the meaning ascribed to such term in Section 3.1(m).</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">&#8220;<u>Maximum Rate</u>&#8221; shall have the meaning ascribed to such term in Section 5.17.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; color: #000000;">&#8220;<u>Money Laundering Laws</u>&#8221; shall have the meaning ascribed to such term in Section 3.1(ff).</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">&#8220;<u>Notes</u>&#8221; means the junior secured convertible notes issuable pursuant to this Agreement and the AIR Warrant, in the form of <u>Exhibit A</u> hereto.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">&#8220;<u>OFAC</u>&#8221; shall have the meaning ascribed to such term in Section 3.1(hh).</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">&#8220;<u>Offering</u>&#8221; shall have the meaning attributed to such term in the recitals.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">&#8220;<u>Participation Maximum</u>&#8221; shall have the meaning ascribed to such term in Section 4.17(a).</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">&#8220;<u>Permitted Indebtedness</u>&#8221; means (a) all liabilities of the Company that were already incurred as of the date of this Agreement, (b) unsecured Indebtedness junior to the Notes, (b) all
        guaranties, endorsements and other contingent obligations in respect of indebtedness of others, whether or not the same are or should be reflected in the Company&#8217;s consolidated balance sheet (or the notes thereto) not affecting more than $1,500,000
        in the aggregate, except guaranties by endorsement of negotiable instruments for deposit or collection or similar transactions in the ordinary course of business; and (c) the present value of any lease payments not in excess of $1,500,000 due under
        leases required to be capitalized in accordance with GAAP.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">&#8220;<u>Permitted Lien</u>&#8221; means the individual and collective reference to the following: (a) the Liens currently existing on the date hereof, as disclosed in the disclosure schedules or in the SEC
        Documents, (b) Liens for taxes, assessments and other governmental charges or levies not yet due or Liens for taxes, assessments and other governmental charges or levies being contested in good faith and by appropriate proceedings for which
        adequate reserves (in the good faith judgment of the management of the Company) have been established in accordance with GAAP, (c) Liens imposed by law which were incurred in the ordinary course of the Company&#8217;s business, such as carriers&#8217;,
        warehousemen&#8217;s and mechanics&#8217; Liens, statutory landlords&#8217; Liens, and other similar Liens arising in the ordinary course of the Company&#8217;s business, and which (x) do not individually or in the aggregate materially detract from the value of such
        property or assets or materially impair the use thereof in the operation of the business of the Company and its Subsidiaries or (y) are being contested in good faith by appropriate proceedings, which proceedings have the effect of preventing for so
        long as any amount in excess of $1,500,000 remains on the Note the forfeiture or sale of the property or asset subject to such Liens, (d) Liens incurred in connection with Permitted Indebtedness that are contractually subordinate to the Notes, and
        (g) liens securing the Senior Secured Debt.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">&#8220;<u>Person</u>&#8221; means an individual, corporation or Company, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company, joint stock company,
        government (or an agency or subdivision thereof) or other entity of any kind.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">&#8220;<u>Pre-Notice</u>&#8221; shall have the meaning ascribed to such term in Section 4.17(b).</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">4</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt;">&#8220;<u>Proceeding</u>&#8221; means an action, claim, suit, investigation or proceeding (including, without limitation, an informal investigation or partial proceeding, such as a deposition), whether
        commenced or threatened.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">&#8220;<u>Pro-Rata Portion</u>&#8221; shall have the meaning ascribed to such term in Section 4.17(e).</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><a name="z_Hlk189235267"></a>&#8220;<u>Public Information Failure</u>&#8221; shall have the meaning ascribed to such term in Section&#160;4.3(b).</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">&#8220;<u>Public Information Failure Payments</u>&#8221; shall have the meaning ascribed to such term in Section 4.3(b).</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">&#8220;<u>Purchaser Party</u>&#8221; shall have the meaning ascribed to such term in Section 4.10.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">&#8220;<u>Registration Rights Agreement</u>&#8221; means the Registration Rights Agreement, dated on or about the date hereof, among the Company and the Purchasers, in the form of <u>Exhibit G</u> attached
        hereto.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">&#8220;<u>Registration Statement</u>&#8221; means a registration statement meeting the requirements set forth in the Registration Rights Agreement and covering the resale of the Underlying Shares by each
        Purchaser as provided for in the Registration Rights Agreement.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">&#8220;<u>Required Approvals</u>&#8221; shall have the meaning ascribed to such term in Section 3.1(e).</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">&#8220;<u>Required Minimum</u>&#8221; means, as of any date, 80% of the maximum aggregate number of shares of Common Stock then issued or potentially issuable in the future pursuant to the Transaction
        Documents, including any Underlying Shares issuable upon exercise in full of all Warrants or conversion in full of all Notes, ignoring any conversion or exercise limits set forth therein.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">&#8220;<u>Rule 144</u>&#8221; means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted from time to time, or any similar rule or regulation
        hereafter adopted by the Commission having substantially the same purpose and effect as such Rule.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">&#8220;<u>SEC</u>&#8221; means the U.S.&#160; Securities and Exchange Commission.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">&#8220;<u>SEC Reports</u>&#8221; shall have the meaning ascribed to such term in Section 3.1(h).</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">&#8220;<u>Securities</u>&#8221; means the Notes, the Warrants, and the Underlying Shares.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">&#8220;<u>Securities Act</u>&#8221; means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">&#8220;<u>Security Agreement</u>&#8221; means the Security Agreement to be entered into in connection with the sale of the Securities, a copy of which is annexed hereto as <u>Exhibit D</u>.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">&#8220;<u>Senior Secured Debt</u>&#8221; shall mean Indebtedness under those certain Amended and Restated Secured Convertible Promissory Notes dated September 8, 2025, issued by the Company in favor of Space
        Infrastructures Ventures, LLC.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">&#8220;<u>Shareholder Approval</u>&#8221; means such approval, if required, by the applicable rules and regulations of the Nasdaq Stock Market (or any successor entity) from the shareholders of the Company
        with respect to the transactions contemplated by the Transaction Documents, including the issuance of all of the Underlying Shares; and as further described in this Agreement.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">5</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt;">&#8220;<u>Short Sales</u>&#8221; means &#8220;short sales&#8221; as defined in Rule 200 of Regulation SHO under the Exchange Act and all types of direct and indirect stock pledges, forward sale contracts, options, puts,
        calls, swaps and similar arrangements (including on a total return basis) whether such transactions are made through U.S. or non-U.S. broker dealers or foreign regulated brokers, but shall not include locating or borrowing shares of Common Stock.&#160;</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">&#8220;<u>Standard Settlement Period</u>&#8221; shall have the meaning ascribed to such term in Section&#160;4.1(d).</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">&#8220;<u>Subscription Amount</u>&#8221; <font style="color: #000000;">means, as to each Purchaser, the aggregate amoun</font><a name="z_DV_M77"></a><font style="color: #000000;">t to be paid for the Notes
          and Warrants purchased hereunder at each Closing as specified below such Purchaser&#8217;s name on the signature page of this Agreement and next to the heading &#8220;Subscription Amount,&#8221; in United States dollars and in immediately available funds.</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">&#8220;<u>Subsequent Closing Date</u>&#8221; shall have the meaning ascribed to such term in Section 2.4(a).</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">&#8220;<u>Subsidiary</u>&#8221; means <font style="color: #000000;">with respect to any entity at any date, any direct or indirect Person, limited or general partnership, limited liability company, trust,
          estate, association, joint venture or other business entity&#160;of which (A) more than 30% of (i)&#160;the outstanding capital stock having (in the absence of contingencies) ordinary voting power to elect a majority of the board of directors or other
          managing body of such entity, (ii)&#160;in the case of a partnership or limited liability company, the interest in the capital or profits of such partnership or limited liability company or (iii)&#160;in the case of a trust, estate, association, joint
          venture or other entity, the beneficial interest in such trust, estate, association or other entity business is, at the time of determination, owned or controlled directly or indirectly through one or more intermediaries, by such entity, or (B)
          is under the actual control of the Company.</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">&#8220;<u>Termination Date</u>&#8221; shall mean October 1, 2025.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">&#8220;<u>Trading Day</u>&#8221; means a day on which the principal Trading Market is open for trading for three or more hours.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">&#8220;<u>Trading Market</u>&#8221; means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date in question: the NYSE American, the Nasdaq Capital
        Market, the Nasdaq Global Market, the Nasdaq Global Select Market, and the New York Stock Exchange (or any successors to any of the foregoing).&#160; As of the date of this Agreement and the Initial Closing Date, the Nasdaq Capital Market is the Trading
        Market.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">&#8220;<u>Transaction Documents</u>&#8221; means this Agreement, the Security Agreement, the Notes, the Warrants, AIR Warrant, the Registration Rights Agreement, the Security Agreement, and Legal Opinion, all
        exhibits and schedules thereto and hereto and any other documents or agreements executed by any party hereto in connection with the transactions contemplated hereunder.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">&#8220;<u>Transfer Agent</u>&#8221; means Continental Stock Transfer and Trust Company, 1 State Street, Floor 30, New York, New York 10004, and any successor transfer agent of the Company.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">&#8220;<u>Underlying Shares</u>&#8221; means the shares of Common Stock issued and issuable upon conversion of the Notes and upon exercise of the Warrants and issued and issuable in lieu of the cash payment of
        interest on the Notes in accordance with the terms of the Notes and any other shares of Common Stock issued or issuable to a Purchaser in connection with or pursuant to the Securities or Transaction&#160;Documents.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">6</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt;">&#8220;<u>Unlegended Shares</u>&#8221; shall have the meaning ascribed to such term in Section 4.1(d).</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">&#8220;<u>Variable Priced Equity Linked Instruments</u>&#8221; shall have the meaning ascribed to such term in Section 4.13.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">&#8220;<u>Variable Rate Transaction</u>&#8221; <font style="color: #000000;">shall have the meaning ascribed to such term in Section 4.13.</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">&#160;&#160;&#8220;<u>VWAP</u>&#8221; means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or quoted on a Trading Market, the daily volume
        weighted average price of the Common Stock for such date (or the nearest preceding date) on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30 a.m. (New York City
        time) to 4:02 p.m. (New York City time)), (b)&#160; if the Common Stock is not then listed or quoted for trading on a Trading Market but is then reported on the OTCQB, OTCQX, OTC Bulletin Board, OTC Pink Open Market maintained by the OTC Markets Group,
        Inc. (or a similar organization or agency succeeding to its functions of reporting prices), the volume weighted average price of the Common Stock on the first such facility (or a similar organization or agency succeeding to its functions of
        reporting prices), or (d)&#160;in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good faith by a Majority in Interest and reasonably acceptable to the Company, the fees and
        expenses of which shall be paid by the Company.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">&#8220;<u>Warrants</u>&#8221; means the Common Stock purchase warrants delivered to the Purchasers at each Closing in accordance with Section 2.2(a) hereof and the AIR Warrant in the form of <u>Exhibit&#160;B</u>
        attached hereto.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">&#8220;<u>Warrant Shares</u>&#8221; means the shares of Common Stock issuable upon exercise of the&#160;Warrants.</div>
      <div>&#160;</div>
      <div style="text-align: center; font-weight: bold;">ARTICLE II.</div>
      <div style="text-align: center; font-weight: bold;">PURCHASE AND SALE</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #000000;">2.1</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u></u><u>Closing</u>.&#160; On the Closing Date, upon the terms and subject to the conditions set forth herein, substantially concurrent with the
        execution and delivery of this Agreement by the parties hereto, the Company agrees to sell, and the Purchasers, severally and not jointly, agree to purchase <font style="color: #000000;">up to</font>, an aggregate of <font style="color: #000000;">$1,630,434.78</font>
        Subscription Amount of Notes as determined pursuant to Section 2.2(a).&#160; The Securities are being issued and sold pursuant to an exemption from Section&#160;5 of the Securities Act contained in Section&#160;4(a)(2) <font style="color: #000000;">thereof
          and/or </font>Regulation D thereunder.&#160; Each Purchaser shall deliver to the Company via wire transfer immediately available funds equal to its <font style="color: #000000;">Subscription Amount</font> and the Company shall deliver to each
        Purchaser its respective Note and other items set forth in Section 2.2 of this Agreement at the Closing on the Closing Date.&#160; Upon satisfaction of the covenants and conditions set forth in Sections 2.2 and 2.3, the Closing shall <font style="color: #000000;">take place remotely by electronic transfer</font> on <font style="color: #000000;">the</font> Closing Date.&#160; If the Closing is not held on or before the Termination Date, the Company shall cause (i) all subscription
        documents executed by the Purchasers to be returned to the Purchasers, and (ii) the Subscription Amount to be returned, without interest or deduction, to the Purchasers.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">7</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; font-weight: bold;">IN THE EVENT THERE IS MORE THAN ONE PURCHASER, NO MINIMUM AMOUNT OF NOTES MUST BE SOLD IN ORDER FOR THE COMPANY TO ACCEPT ANY SUBSCRIPTIONS, AND ALL NET PROCEEDS OF THE OFFERING
        WILL BE IMMEDIATELY AVAILABLE FOR COMPANY PURPOSES UPON CLOSING.&#160; NOTHING IN THIS PARAGRAPH SHALL BE DEEMED OR OTHERWISE INTERPRETED TO REQUIRE THE COMPANY TO ACCEPT SUBSCRIPTIONS FOR LESS THAN THE AGGREGATE SUBSCRIPTION AMOUNT.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #000000;">2.2</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Deliveries</u>.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;On or prior to the Closing Date, the Company shall deliver or cause to be delivered to each Purchaser the following:</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 108pt;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;this Agreement duly executed by the Company;</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 108pt;">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; a legal opinion of Company Counsel, substantially in the form of <u>Exhibit&#160;E</u> attached hereto;</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 108pt;">(iii)&#160;&#160;&#160;&#160;&#160;&#160; a Note equal to 108% of such Purchaser&#8217;s Subscription Amount as set forth on the signature page hereto registered in the name of such Purchaser (the &#8220;<u>Initial Notes</u>&#8221;);</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 108pt;">(iv)&#160;&#160;&#160;&#160;&#160; Common Stock Purchase Warrants registered in the name of such Purchaser, each representing the right to purchase up to a number of shares of Common Stock equal to such Purchaser&#8217;s Note
        principal amount divided by the Conversion Price in effect on the Initial Closing Date, having an initial per share Exercise Price equal to $1.40, subject to adjustment as provided herein and&#160;therein;</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 108pt;">(v)&#160;&#160;&#160;&#160;&#160;&#160; An AIR Warrant to purchase such Purchaser&#8217;s pro rata portion of $4,000,000 of Subscription Amount of additional Notes and Warrants;</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 108pt;">(vi)&#160;&#160;&#160;&#160;&#160;&#160; the Security Agreement and documents referred to therein duly executed by the Company and Subsidiaries;</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 108pt;">(vii)&#160;&#160;&#160;&#160;&#160; the Registration Rights Agreement duly executed by the Company;</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 108pt;">(viii)&#160;&#160;&#160; a certificate executed on behalf of the Company by its Principal Executive Officer or Chief Executive Officer (each as defined in the Exchange Act), dated as of the Initial Closing Date,
        in which such officer shall certify that the conditions set forth in <u>Section 2.3(b)</u> have been fulfilled;&#160;and</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 108pt;">(ix)&#160;&#160;&#160;&#160;&#160;&#160;&#160; a certificate executed on behalf of the Company by its Secretary containing (i) copies of the text of the resolutions by which the corporate action on the part of the Company necessary
        to approve this Agreement and the other Transaction Documents and the transactions and actions contemplated hereby and thereby, which shall be accompanied by a certificate of the corporate secretary or assistant corporate secretary of Company dated
        as of the Initial Closing Date certifying to the Purchasers that such resolutions were duly adopted and have not been amended or rescinded, (ii) an incumbency certificate dated as of the Initial Closing Date executed on behalf of Company by its
        corporate secretary or one of its assistant corporate secretaries certifying the office of each officer of Company executing this Agreement, or any other agreement, certificate or other instrument executed pursuant hereto, and (iii) copies of (A)
        the Company&#8217;s Seconded Amended and Restated Certificate of Incorporation and bylaws in effect on the Initial Closing Date, and (B) the certificate evidencing the good standing of Company as of a day within five (5) Business Days prior to the
        Initial Closing Date<font style="color: #231F20;">.</font></div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">8</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;On or prior to the Initial Closing Date, each Purchaser shall deliver or cause to be delivered to the Company the following:</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 108pt;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;this Agreement<font style="color: #000000;">, </font>duly executed by such Purchaser;</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 108pt;">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; such Purchaser&#8217;s Subscription Amount by wire transfer to the Company;</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 108pt;">(iii)&#160;&#160;&#160;&#160;&#160;&#160;&#160; the Registration Rights Agreement duly executed by each Purchaser;</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 108pt;">(iv)&#160;&#160;&#160;&#160;&#160;&#160;&#160; Accredited Investor Questionnaire duly executed by each Purchaser;</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 108pt;">(v)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; the Security Agreement duly executed by each Purchaser and the Collateral Agent; and</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 108pt;">(vi)&#160;&#160;&#160;&#160;&#160;&#160;&#160; a certificate executed on behalf of each Purchaser by its Principal Executive Officer or Chief Executive Officer (each as defined in the Exchange Act), dated as of the Initial Closing
        Date, in which such officer shall certify that the conditions set forth in Section 2.3(a) have been fulfilled by such Purchaser.</div>
      <div>&#160;</div>
      <div style="text-align: justify; margin-left: 36pt;"><font style="color: rgb(0, 0, 0);">2.3</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Initial Closing Conditions</u>.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The obligations of the Company hereunder to effect the Initial Closing are subject to the following conditions being met:</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 108pt;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160; the accuracy in all material respects <font style="color: #000000;">(determined without regard to any materiality, Material Adverse Effect or other similar qualifiers therein)</font>
        on the date of this Agreement and the Initial Closing Date of the representations and warranties of the Purchasers contained herein (unless as of a specific date therein in which case they shall be accurate as of such date);</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 108pt;">(ii)&#160;&#160;&#160;&#160;&#160;&#160; all obligations, covenants and agreements of each Purchaser under this Agreement required to be performed or obtained at or prior to the Initial Closing Date shall have been performed
        and obtained;</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 108pt;">(iii)&#160;&#160;&#160;&#160;&#160;&#160; the delivery by each Purchaser of the items set forth in Section 2.2(b) of this Agreement; and</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160; The respective obligations of a Purchaser hereunder to effect the Initial Closing, unless waived by such Purchaser, are subject to the following conditions being met:</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 108pt;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160; the accuracy in all material respects <font style="color: #000000;">(determined without regard to any materiality, Material Adverse Effect or other similar qualifiers therein)</font>
        on the date of this Agreement and Closing Date of the representations and warranties of the Company contained herein (unless as of a specific date therein in which case they shall be accurate as of such date);</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 108pt;">(ii)&#160;&#160;&#160;&#160; &#160;&#160; the Required Approval in Section 3.1(e)(iii), and all obligations, covenants and agreements of the Company and other parties and required signatories to and under the Transaction
        Documents (except for Purchasers) required to be performed or obtained at or prior to the Closing Date shall have been materially performed and obtained;</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">9</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 108pt;">(iii)&#160;&#160;&#160;&#160;&#160;&#160; the delivery by the Company of the items set forth in Section 2.2(a) of this Agreement; and</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 108pt;">(iv)&#160;&#160;&#160;&#160;&#160;&#160; there shall have been no Material Adverse Effect with respect to the Company since the date hereof.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #000000;">2.4</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="color: #000000;"><u>AIR Warrant Closing</u>.</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #000000;">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="color: #000000;">On or prior to the closing of any AIR Warrant exercise (the date of each such closing, a &#8220;<u>Subsequent Closing Date</u>&#8221;),

          the Company shall deliver or cause to be delivered to the Purchasers the&#160;following:</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; margin-left: 36pt;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;a legal opinion of Company Counsel, substantially in the form of <u>Exhibit&#160;E</u> attached hereto;</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; margin-left: 36pt;">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; a Note in the amount set forth in the AIR Warrant exercise notice;</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; margin-left: 36pt;">(iii)&#160;&#160;&#160;&#160;&#160;&#160;&#160; a Warrant for the number of shares set forth in the AIR Warrant exercise&#160;notice;</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; margin-left: 36pt;"><font style="color: #000000;">(iv)</font>&#160;&#160;&#160;&#160;&#160;&#160; a certificate executed on behalf of the Company by its Principal Executive Officer or Chief Executive Officer (each as defined in
        the Exchange Act), dated as of the <font style="color: #000000;">Subsequent</font> Closing Date, in which such officer shall certify that the conditions set forth in <u>Section&#160;2.3(b)</u> have been fulfilled as of the closing of the AIR Warrant;
        and</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; margin-left: 36pt;"><font style="color: #000000;">(v)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; a certificate executed on behalf of the Company by its Secretary containing (i) copies of the text of the resolutions by which
        the corporate action on the part of the Company necessary to approve this Agreement and the other Transaction Documents and the transactions and actions contemplated hereby and thereby, which shall be accompanied by a certificate of the corporate
        secretary or assistant corporate secretary of Company dated as of the Closing Date certifying to the Purchasers that such resolutions were duly adopted and have not been amended or rescinded, (ii) an incumbency certificate dated as of the Closing
        Date executed on behalf of Company by its corporate secretary or one of its assistant corporate secretaries certifying the office of each officer of Company executing this Agreement, or any other agreement, certificate or other instrument executed
        pursuant hereto, and (iii) copies of (A) the Company&#8217;s Certificate of Incorporation and bylaws in effect on the Subsequent Closing Date, and (B) the certificate evidencing the good standing of Company as of a day within five (5) Business Days prior
        to the Subsequent Closing Date<font style="color: #000000;">.</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="color: #000000;">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160; <font style="color: #000000;">On or prior to the closing of any AIR Warrant exercise, each Purchaser shall deliver or cause to be delivered to the
          Company, the following:</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;"><font style="color: #000000;">(i)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; such Purchaser&#8217;s Subscription Amount in the amount set forth in the AIR Warrant exercise notice by wire transfer to the Company.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #000000;">2.6</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="color: #000000;"><u>Force Majeure</u>.&#160; Any Purchaser or the Company may, upon prior notice to the other, not effect the Closing if, </font>from

        the date hereof to the Closing Date, (i) trading in the Common Stock has been suspended by the Commission or the Company&#8217;s principal Trading Market, and (ii) trading in securities generally as reported by Bloomberg L.P. has been suspended or
        materially limited, (iii) a banking moratorium has been declared either by the United States or New York State authorities, or (iv) there has occurred any material outbreak or escalation of hostilities, pandemic or other national or international
        calamity of such magnitude in its effect on, or any material adverse change in, any financial market which, in each case, in the reasonable judgment of such Purchaser or the Company, makes it impracticable or inadvisable to purchase the Securities
        at the Closing.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">10</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: center; font-weight: bold;">ARTICLE III.</div>
      <div style="text-align: center; font-weight: bold;">REPRESENTATIONS AND WARRANTIES</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #000000;">3.1</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="color: #000000;"><u>Representations and Warranties of the Company</u>.&#160; </font>Except as set forth in this Section 3.1 or the
        Disclosure Schedules, which Disclosure Schedules shall be deemed a part hereof and shall qualify any representation made herein to the extent of the disclosure contained in the Disclosure Schedules, the Company hereby makes the following
        representations and warranties to each Purchaser as of the date hereof and as of each Closing Date (unless as of a specific date therein):</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Subsidiaries</u>.&#160; All of the direct and indirect Subsidiaries of the Company and the Company&#8217;s ownership interests therein are set forth on <u>Schedule 3.1(a)</u>.&#160; The Company
        owns, directly or indirectly, all of the capital stock or other equity interests and rights to receive equity of each Subsidiary free and clear of any Liens, other than Permitted Liens, and all of the issued and outstanding shares of capital stock
        of each Subsidiary are validly issued and are fully paid, non-assessable and free of pre-emptive and similar rights to subscribe for or purchase securities.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u></u><u>Organization and Qualification</u>.&#160; The Company and each Subsidiary is an entity duly incorporated or otherwise organized, validly existing and in good standing under the
        laws of the jurisdiction of its incorporation or organization, with the requisite power and authority to own and use its properties and assets and to carry on its business as currently conducted.&#160; Neither the Company nor any Subsidiary is in
        violation nor default of any of the provisions of its respective certificate or articles of incorporation, bylaws or other organizational or charter documents.&#160; Each of the Company and each Subsidiary&#160; is duly qualified to conduct business and is
        in good standing as a foreign Person or other entity in each jurisdiction in which the nature of the business conducted or property owned by it makes such qualification necessary, except where the failure to be so qualified or in good standing, as
        the case may be, would not reasonably be expected to result in: (i) a material adverse effect on the legality, validity or enforceability of any Transaction Document, (ii) a material adverse effect on the results of operations, assets, business, or
        financial condition of the Company and each Subsidiary, taken as a whole, or (iii) a material adverse effect on the Company&#8217;s ability to perform in any material respect on a timely basis its obligations under any Transaction Document (any of (i),
        (ii) or (iii), a &#8220;<u>Material Adverse Effect</u>&#8221;) and, no Proceeding has been instituted in any such jurisdiction revoking, limiting or curtailing or seeking to revoke, limit or curtail such power and authority or qualification.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">(c)&#160;&#160;&#160;&#160;&#160;&#160; <u>Authorization; Enforcement</u>.&#160; The Company has the requisite corporate power and authority to enter into and to consummate the transactions contemplated by this Agreement and each
        of the other Transaction Documents and otherwise to carry out its obligations hereunder and thereunder.&#160; Except as set forth in the Disclosure Schedules, the execution and delivery of this Agreement and each of the other Transaction Documents by
        the Company and the consummation by it of the transactions contemplated hereby and thereby have been duly authorized by unanimous approval of the Board of Directors and all other necessary action on the part of the Company and no further action is
        required by the Company, the Board of Directors or the Company&#8217;s stockholders in connection herewith or therewith other than in connection with the Required Approvals.&#160; This Agreement and each other Transaction Document to which it is a party has
        been (or upon delivery will have been) duly executed by the Company and, when delivered in accordance with the terms hereof and thereof, will constitute the valid and binding obligation of the Company enforceable against the Company in accordance
        with its terms, except: (i) as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application affecting enforcement of creditors&#8217; rights generally, (ii) as limited by
        laws relating to the availability of specific performance, injunctive relief or other equitable remedies and (iii) insofar as indemnification and contribution provisions may be limited by Applicable Law.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">11</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt;">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>No Conflicts</u>.&#160; Except as set forth in the Disclosure Schedules, the execution, delivery and performance by the Company and all Persons other than the Purchasers and Collateral
        Agent (as defined in the Security Agreement) of this Agreement and the other Transaction Documents, the issuance and sale of the Securities and the consummation by it of the transactions contemplated hereby and thereby to which it is a party do not
        and will not: (i) conflict with or violate any provision of the Company&#8217;s or any Subsidiary&#8217;s or such other Person&#8217;s certificate or articles of incorporation, bylaws or other organizational or charter documents, (ii) conflict with, or constitute a
        default (or an event that with notice or lapse of time or both would become a default) under, result in the creation of any Lien upon any of the properties or assets of the Company or any Subsidiary, or give to others any rights of termination,
        amendment, <font style="color: #000000;">anti&#8209;dilution or similar adjustments </font>acceleration, adjustment, exchange, reset, exercise or cancellation (with or without notice, lapse of time or both) of, any material agreement, credit facility,
        debt, equity or other instrument (evidencing Company or Subsidiary equity, debt or otherwise) or other understanding to which the Company or any Subsidiary is a party or by which any property or asset of the Company or any Subsidiary is bound or
        affected, or (iii) subject to the Required Approvals, conflict with or result in a violation of any law, rule, regulation, order, judgment, injunction, decree or other restriction of any court, governmental authority or Trading Market to which the
        Company or a Subsidiary is subject (including federal and state securities laws and regulations), or by which any property or asset of the Company or a Subsidiary is bound or affected; except in the case of each of clause (ii) and (iii), such as
        would not reasonably be expected to result in a Material Adverse Effect.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Filings, Consents and Approvals</u>.&#160; Except as set forth in <u>the Disclosure Schedules</u>, the Company is not required to obtain any consent, waiver, authorization or order of,
        give any notice to, or make any filing or registration with, any court or other federal, state, local or other governmental authority or other Person in connection with the execution, delivery and performance by the Company of the Transaction
        Documents, other than: (i) the filings required pursuant to Section 4.6 of this Agreement, (ii)&#160;the filing with the Commission pursuant to the Registration Rights Agreement, (iii) the notice and/or application(s) to each applicable Trading Market
        for the issuance and sale of the Securities and the listing of the Underlying Shares for trading thereon in the time and manner required thereby, (iv) the filing of Form D with the Commission and such filings as are required to be made under
        applicable state securities laws and (v) Shareholder Approval (collectively, the &#8220;<u>Required Approvals</u>&#8221;).</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">(f)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u></u><u>Issuance of the Securities</u>.&#160; The Securities are duly authorized and, when issued and paid for in accordance with the applicable Transaction Documents, will be duly and
        validly issued, fully paid and nonassessable, free and clear of all Liens imposed by the Company.&#160; As of the Closing Date, the Company will have reserved from its capital stock such number of Common Stock for issuance of the Underlying Shares at
        least equal to the Required Minimum on the date hereof.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">12</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt;">(g)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Capitalization</u>.&#160; The authorized capital stock of the Company as of the date hereof is as set forth in the SEC Documents.&#160; Except as set forth in the SEC Documents or on Schedule
        3.1(g), the Company has not issued any capital stock since its most recently filed periodic report under the Exchange Act, other than pursuant to the exercise of employee stock options under the Company&#8217;s stock option plans, the issuance of shares
        of Common Stock to employees pursuant to the Company&#8217;s employee stock purchase plans and pursuant to the conversion and/or exercise of Common Stock Equivalents outstanding as of the date of the most recently filed periodic report under the Exchange
        Act.&#160; No Person has any right of first refusal, preemptive right, right of participation, or any similar right to participate in the transactions contemplated by the Transaction Documents.&#160; Except as set forth in the SEC Documents or on
        Schedule&#160;3.1(g), and except as a result of the purchase and sale of the Securities, issuances of stock under the Company&#8217;s equity incentive plans and the issuance of shares of Common Stock to employees pursuant to the Company&#8217;s employee stock
        purchase plans, as of the date hereof there are no outstanding options, warrants, scrip rights to subscribe to, calls or commitments of any character whatsoever relating to, or securities, rights or obligations convertible into or exercisable or
        exchangeable for, or giving any Person any right to subscribe for or acquire any shares of Common Stock, or contracts, commitments, understandings or arrangements by which the Company or any Subsidiary is or may become bound to issue additional
        shares of Common Stock or Common Stock Equivalents.&#160; Except as set forth on Schedule&#160;3.1(g), as of the date hereof, the issuance and sale of the Securities will not obligate the Company to issue shares of Common Stock or other securities to any
        Person (other than the Investor) and will not result in a right of any holder of Company securities to adjust the exercise, conversion, exchange or reset price under any of such securities.&#160; Except as set forth on Schedule 3.1(g), as of the date
        hereof there are no material agreements of the Company with its stockholders or, to the knowledge of the Company, between or among any of the Company&#8217;s stockholders, that (a) govern or restrict the voting of any equity securities of the Company,
        (b) provide for rights to participate in future issuances of equity securities of the Company, or (c) provide a stockholder with information or governance rights not available to stockholders generally.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">(h)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Reporting Company; Financial Statements</u>.&#160; Except as set forth on Schedule 3.1(h), the Company has filed all reports, schedules, forms, statements and other documents required to
        be filed by the Company under the Securities Act and the Exchange Act, including pursuant to Section 13(a) or 15(d) thereof, for the two years preceding the date hereof (or such shorter period as the Company was required by law or regulation to
        file such material) (the foregoing materials, including the exhibits thereto and documents incorporated by reference therein, being collectively referred to herein as the &#8220;<u>SEC Reports</u>&#8221;) on a timely basis or has received a valid extension of
        such time of filing and has filed any such SEC Reports prior to the expiration of any such extension.&#160; As of their respective dates, the SEC Reports complied in all material respects with the requirements of the Securities Act and the Exchange Act,
        as applicable, and none of the SEC Reports, when filed, contained any untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary in order to make the statements therein, in the light of the
        circumstances under which they were made, not misleading.&#160; The Company has been an issuer subject to Rule 144(i) under the Securities Act. The financial statements of the Company included in the SEC Reports comply in all material respects with
        applicable accounting requirements and the rules and regulations of the Commission with respect thereto as in effect at the time of filing.&#160; Such financial statements have been prepared in accordance with United States generally accepted accounting
        principles applied in all material respects on a consistent basis during the periods involved (&#8220;<u>GAAP</u>&#8221;), except as may be otherwise specified in such financial statements or the notes thereto and except that unaudited financial statements may
        not contain all footnotes required by GAAP, and fairly present in all material respects the financial position of the Company and its consolidated Subsidiaries as of and for the dates thereof and the results of operations and cash flows for the
        periods then ended, subject, in the case of unaudited statements, to normal, year-end audit adjustments.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">13</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Material Changes; Undisclosed Events, Liabilities or Developments</u>.&#160; <a name="z_Hlk209195860"></a>Except as set forth in the Disclosure Schedules, since the date of the latest
        audited financial statements included within the SEC Reports, except as disclosed in a subsequent SEC Report, (i) there has been no event, occurrence or development that has had or that would reasonably be expected to result in a Material Adverse
        Effect, (ii) the Company has not incurred any liabilities (contingent or otherwise) other than (A) trade payables and accrued expenses incurred in the ordinary course of business consistent with past practice and (B)&#160;liabilities not required to be
        reflected in the Company&#8217;s financial statements pursuant to GAAP or disclosed in filings made with the Commission, (iii) the Company has not altered its method of accounting, <font style="color: #000000;">(iv)&#160;the Company has not declared or made
          any dividend or distribution of cash or other property to its stockholders or purchased, redeemed or made any agreements to purchase or redeem any shares of its capital stock and (v)&#160;</font>the Company has not issued any equity securities to any
        officer, director or Affiliate, except pursuant to <font style="color: #000000;">existing Company stock option plans.</font>&#160; The Company does not have pending before the Commission any request for confidential treatment of information.&#160; Except as
        disclosed in the Disclosure Schedules or for the issuance of the Securities contemplated by this Agreement, no event, liability, fact, circumstance, occurrence or development has occurred or exists or is reasonably expected to occur or exist with
        respect to the Company or its Subsidiaries or their respective businesses, prospects, properties, operations, assets or financial condition, that would be required to be disclosed by the Company under applicable securities laws at the time this
        representation is made or deemed made that has not been publicly disclosed at least five Business Days prior to the date that this representation is made.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">(j)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Litigation</u>.&#160; Except as disclosed in <u>Schedule 3.1(j)</u>, there is no action, suit, inquiry, notice of violation, proceeding or investigation pending or, to the knowledge of
        the Company, threatened against or affecting the Company, any Subsidiary or any of their respective properties before or by any court, arbitrator, governmental or administrative agency or regulatory authority (federal, state, county, local or
        foreign) <font style="color: #000000;">that would</font> reasonably be expected to <font style="color: #000000;">have</font> a Material Adverse Effect<font style="color: #000000;"> (collectively, an &#8220;<u>Action</u>&#8221;).</font>&#160; Neither the Company
        nor any Subsidiary, nor any director or officer thereof, is or has been in the past three years the subject of any Action involving a claim of violation of or liability under federal or state securities laws or a claim of breach of fiduciary duty.&#160;
        In the past three years there has not been, and to the knowledge of the Company, there is not pending or contemplated, any investigation by the Commission or regulatory agency or Trading Market involving the Company or any current or former
        director or officer of the Company.&#160; The Commission has not issued any stop order or other order suspending the effectiveness of any registration statement filed by the Company or any Subsidiary under the Exchange Act or the Securities&#160;Act<font style="color: #000000;">.</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">(k)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Labor Relations</u>.&#160; No labor dispute exists or, to the knowledge of the Company, is imminent with respect to any of the employees of the Company or any Subsidiary, which <font style="color: #000000;">would</font> reasonably be expected to result in a Material Adverse Effect.&#160; None of the Company&#8217;s or its Subsidiaries&#8217; employees is a member of a union that relates to such employee&#8217;s relationship with the Company or such
        Subsidiary, and neither the Company nor any of its Subsidiaries is a party to a collective bargaining agreement, and the Company and its Subsidiaries believe that their relationships with their employees are good.&#160; To the knowledge of the Company,
        no executive officer of the Company or any Subsidiary is or, in light of existing facts known to the Company, is now expected to be, in material violation of any material term of any employment contract, confidentiality, disclosure or proprietary
        information agreement or non-competition agreement, or any other contract or agreement or any restrictive covenant in favor of any third party, and the continued employment of each such executive officer does not subject the Company or any of its
        Subsidiaries to any material liability with respect to any of the foregoing matters.&#160; The Company and its Subsidiaries are in compliance with all U.S. federal, state, local and foreign laws and regulations relating to employment and employment
        practices, terms and conditions of employment and wages and hours, except where the failure to be in compliance <font style="color: #000000;">would</font> not, individually or in the aggregate, reasonably be expected to have a Material Adverse
        Effect.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">(l)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Compliance</u>.&#160; Except as set forth in the Disclosure Schedules, to the Company&#8217;s knowledge, neither the Company nor any Subsidiary, (i) is in default under or in violation of (and
        no event has occurred that has not been waived that, with notice or lapse of time or both, would result in a default by the Company or any Subsidiary under), nor has the Company or any Subsidiary received notice of a claim that it is in default
        under or that it is in violation of, any indenture, loan or credit agreement or any other agreement or instrument to which it is a party or by which it or any of its properties is bound (whether or not such default or violation has been waived),
        (ii) is in violation of any judgment, decree or order of any court, arbitrator or other governmental authority or (iii) is or has been in violation of any statute, rule, ordinance or regulation of any governmental authority, including without
        limitation all foreign, federal, state and local laws relating to taxes, environmental protection, occupational health and safety, product quality and safety and employment and labor matters, except in each case as <font style="color: #000000;">would</font>
        not reasonably be expected to result in a Material Adverse Effect.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">14</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt;">(m)&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Regulatory Permits</u>.&#160; The Company and each Subsidiary possesses all certificates, authorizations and permits issued by the appropriate federal, state, local or foreign regulatory
        authorities necessary to conduct their respective businesses as described in the SEC Reports or as actually conducted, except where the failure to possess such permits would not reasonably be expected to result in a Material Adverse Effect (&#8220;<u>Material

          Permits</u>&#8221;), and neither the Company nor any Subsidiary has received any notice of proceedings relating to the revocation or modification of any Material Permit.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">(n)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u></u><u>Title to Assets</u>.&#160; The Company and the Subsidiaries have good and marketable title in fee simple to all real property, if any, owned by them and good and marketable title
        in all personal property owned by them that is material to the business of the Company and the Subsidiaries, in each case free and clear of all Liens, except for Permitted Liens and (i) Liens as do not materially affect the value of such property
        and do not materially interfere with the use made and proposed to be made of such property by the Company and the Subsidiaries and (ii) Liens for the payment of federal, state or other taxes, for which appropriate reserves have been made in
        accordance with GAAP and, the payment of which is neither delinquent nor subject to penalties.&#160; Any real property and facilities held under lease by the Company and the Subsidiaries are held by them under valid, subsisting and enforceable leases
        with which the Company and the Subsidiaries are in compliance.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">(o)&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u></u><u>Intellectual Property</u>.&#160; The Company and the Subsidiaries have, or have rights to use, all patents, patent applications, trademarks, trademark applications, service marks,
        trade names, trade secrets, inventions, copyrights, licenses and other intellectual property rights and similar rights necessary or required for use in connection with their respective businesses as described in the SEC Reports and which the
        failure to so have <font style="color: #000000;">would reasonably be expected to</font> have a Material Adverse Effect (collectively, the &#8220;<u>Intellectual Property Rights</u>&#8221;).&#160; None of, and neither the Company nor any Subsidiary has received a
        notice (written or otherwise) that any of, the Intellectual Property Rights has expired, terminated or been abandoned, or is expected to expire or terminate or be abandoned, within two (2) years from the date of this Agreement<font style="color: #000000;">, except where such expiration, termination or abandonment would not reasonably be expected to, individually or in the aggregate, have a Material Adverse Effect</font>.&#160; Neither the Company nor any Subsidiary has received, since the
        date of the latest audited financial statements included within the SEC Reports, a written notice of a claim or otherwise has any knowledge that the Intellectual Property Rights violate or infringe upon the rights of any Person, except as <font style="color: #000000;">would</font> not reasonably be expected to have a Material Adverse Effect.&#160; To the knowledge of the Company, all such Intellectual Property Rights are enforceable and there is no existing infringement by another Person of
        any of the Intellectual Property Rights.&#160; The Company and its Subsidiaries have taken reasonable security measures to protect the secrecy, confidentiality and value of all of their intellectual properties, except where failure to do so would not,
        individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">(p)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Insurance</u>.&#160; The Company and each Subsidiary are insured by insurers of recognized financial responsibility against such losses and risks and in such amounts as are prudent and
        customary in the businesses in which the Company and each Subsidiary are engaged. Neither the Company nor any Subsidiary has any reason to believe that it will not be able to renew its existing insurance coverage as and when such coverage expires
        or to obtain similar coverage from similar insurers as may be necessary to continue its business without a significant increase in cost.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">15</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt;">(q)&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;<u></u><u>Transactions With Affiliates and Employees</u>.&#160; None of the officers or directors of the Company or any Subsidiary and, to the knowledge of the Company, none of the employees
        of the Company or any Subsidiary is presently a party to any transaction with the Company or any Subsidiary (other than for services as employees, officers and directors), including any contract, agreement or other arrangement providing for the
        furnishing of services to or by, providing for rental of real or personal property to or from, providing for the borrowing of money from or lending of money to or otherwise requiring payments to or from any officer, director or such employee or, to
        the knowledge of the Company, any entity in which any officer, director, or any such employee has a substantial interest or is an officer, director, trustee, stockholder, member or partner, in each case in excess of $50,000 other than for: (i)
        payment of salary or consulting fees for services rendered, (ii) reimbursement for expenses incurred on behalf of the Company or any Subsidiary, and (iii) other employee benefits, including stock option agreements under <font style="color: rgb(0, 0, 0);">any stock option plan of the Company</font>.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">(r)&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Certain Fees</u>.&#160; Except as set forth on <u>Schedule 3.1(r)</u>, no brokerage, finder&#8217;s fees, commissions or due diligence fees are or will be payable by the Company or any
        Subsidiary to any broker, financial advisor or consultant, finder, placement agent, investment banker, bank or other Person with respect to the transactions contemplated by the Transaction Documents.&#160; The Purchasers shall have no obligation with
        respect to any such fees or with respect to any claims made by or on behalf of other Persons for fees of a type contemplated in this Section 3.1(r) that may be due in connection with the transactions contemplated by the Transaction Documents.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">(s)&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160; <u>Investment Company</u>. The Company is not, and is not an Affiliate of, and immediately after receipt of payment for the Securities, will not be or be an Affiliate of, an
        &#8220;investment company&#8221; within the meaning of the Investment Company Act of 1940, as amended.&#160; The Company shall conduct its business in a manner so that it will not become an &#8220;investment company&#8221; subject to registration under the Investment Company
        Act of 1940, as amended.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><a name="z_Toc430524909"></a><a name="z_Toc449254780"></a>(t)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Registration Rights</u>.&#160; <a name="z_Hlk209196350"></a>Except as set forth in the Disclosure Schedules, no Person has any
        right to cause the Company or any Subsidiary to effect the registration under the Securities Act of any securities of the Company or any Subsidiary, except for the Purchasers.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">(u)&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;<u></u><u>Sarbanes-Oxley; Internal Accounting Controls</u>.&#160; The Company and the Subsidiaries are in compliance with any and all material applicable requirements of the Sarbanes-Oxley
        Act of 2002 that are effective as of the date hereof, and any and all material applicable rules and regulations promulgated by the Commission thereunder that are effective as of the date hereof and as of each Closing Date.&#160; <font style="color: rgb(0, 0, 0);">The Company and the Subsidiaries maintain a system of internal accounting controls sufficient to provide reasonable assurance that: (i) transactions are executed in accordance with management&#8217;s general or specific authorizations,
          (ii) transactions are recorded as necessary to permit preparation of financial statements in conformity with applicable securities laws and GAAP and to maintain asset accountability, (iii) access to assets is permitted only in accordance with
          management&#8217;s general or specific authorization, and (iv) the recorded accountability for assets is compared with the existing assets at reasonable intervals and appropriate action is taken with respect to any differences. The Company and the
          Subsidiaries have established disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the Company and the Subsidiaries and designed such disclosure controls and procedures to ensure that information
          required to be disclosed by the Company in the reports it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the Commission&#8217;s rules and forms.&#160; The Company&#8217;s certifying
          officers have evaluated the effectiveness of the disclosure controls and procedures of the Company and the Subsidiaries as of the end of the period covered by the most recently filed periodic report under the Exchange Act (such date, the &#8220;<u>Evaluation

            Date</u>&#8221;).&#160; The Company presented in its most recently filed periodic report under the Exchange Act the conclusions of the certifying officers about the effectiveness of the disclosure controls and procedures based on their evaluations as of
          the Evaluation Date.&#160; Since the Evaluation Date, there have been no changes in the internal control over financial reporting (as such term is defined in the Exchange Act) of the Company and its Subsidiaries that have materially affected, or is
          reasonably likely to materially affect, the internal control over financial reporting of the Company and its Subsidiaries</font>.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">16</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt;">(v)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="color: rgb(0, 0, 0);">[Reserved]</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">(w)&#160;&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);"><u>Reporting Company/Shell Company</u>.&#160; The Company has no reason to believe that it will not in the year following the Closing Date continue to be in
          compliance with all listing and reporting requirements applicable to the Company as of the Closing Date.&#160; As of the Closing Date, the Company is not a &#8220;shell company&#8221; (as defined in Rule 405 of the Securities Act).</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">(x)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Registration</u>.&#160; The Common Stock is registered pursuant to Section&#160;12(b) or 12(g) of the Exchange Act, and the Company has taken no action designed to, or which to its knowledge
        is likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act.&#160; Except as disclosed in the SEC Reports, there is no suit, action, proceeding or investigation pending or, to the knowledge of the&#160;Company,
        threatened against the&#160;Company&#160;by&#160;Nasdaq&#160;or the&#160;SEC, respectively, to prohibit or terminate the listing of the&#160;Common Stock&#160;on the Nasdaq Capital Market or to deregister the&#160;Common Stock&#160;under the&#160;Exchange Act.&#160; Except as disclosed in the SEC
        Reports, the Company has not, in the 12 months preceding the date hereof, received notice from any Trading Market on which the Common Stock is or has been listed or quoted to the effect that the Company is not in compliance with the listing or
        maintenance requirements of such Trading Market.&#160; The shares of Common Stock are currently eligible for electronic transfer through The Depository Trust Company or another established clearing corporation and the Company is current in payment of
        the fees to The Depository Trust Company (or such other established clearing corporation) in connection with such electronic transfer.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">(y)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u></u><u>Application of Takeover Protections</u>.&#160; Except as set forth in the Disclosure Schedules, the Company and the Board of Directors have taken all action in order to render
        inapplicable any control share acquisition, business combination, poison pill (including any distribution under a rights agreement) or other similar anti-takeover provision under the Company&#8217;s certificate of incorporation (or similar charter
        documents) or the laws of the State of Delaware that are or could become applicable to the Purchasers as a result of the Purchasers and the Company fulfilling their obligations or exercising their rights under the Transaction Documents, including
        without limitation as a result of the Company&#8217;s issuance of the Securities and the Purchasers&#8217; ownership of the Securities.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">(z)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="color: rgb(0, 0, 0);">[Reserved]</font></div>
      <div style="text-indent: 72pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">(aa)&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Disclosure</u>.&#160; Except with respect to the material terms and conditions of the transactions contemplated by the Transaction Documents, the Company confirms that neither it nor any
        other Person acting on its behalf has provided any of the Purchasers or their agents or counsel with any information that it believes constitutes or might constitute material, non-public information.&#160; The Company understands and confirms that the
        Purchasers will rely on the foregoing representation in effecting transactions in securities of the Company.&#160; All of the disclosure furnished by or on behalf of the Company to the Purchasers regarding the Company and its Subsidiaries, their
        respective businesses and the transactions contemplated hereby, including the Disclosure Schedules to this Agreement, is true and correct and does not contain any untrue statement of a material fact or omit to state any material fact necessary in
        order to make the statements made therein, in light of the circumstances under which they were made, not misleading.&#160;&#160; The press releases disseminated by the Company during the twelve months preceding the date of this Agreement do not contain any
        untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they were made and when made, not misleading.&#160; The
        Company acknowledges and agrees that no Purchaser makes or has made any representations or warranties with respect to the transactions contemplated hereby other than those specifically set forth in Section 3.2 hereof.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">17</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt;">(bb)&#160;&#160;&#160;&#160;&#160; <u>No Integrated Offering</u>. Assuming the accuracy of the Purchasers&#8217; representations and warranties set forth in Section 3.2, neither the Company, nor any of its Affiliates, nor any
        Person acting on its or their behalf has, directly or indirectly, made any offers or sales of any security or solicited any offers to buy any security, under circumstances that would cause the Offering of the Securities to be integrated with prior
        offerings by the Company for purposes of (i) the Securities Act which would require the registration of any such securities under the Securities Act or (ii) except as set forth on Schedule 3.1(bb), any applicable shareholder approval provisions of
        any Trading Market on which any of the securities of the Company are listed or designated.</div>
      <div style="text-indent: 72pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">(cc)&#160;&#160;&#160;&#160;&#160;&#160; <u>Tax Status</u>. Except for matters that would not, individually or in the aggregate, have or reasonably be expected to result in a Material Adverse Effect, the Company and its
        Subsidiaries each (i) has made or filed all required United States federal, state and local income and all foreign income and franchise tax returns, reports and declarations required by any jurisdiction to which it is subject, (ii) has paid all
        taxes and other governmental assessments and charges that are material in amount, shown or determined to be due on such returns, reports and declarations and (iii) has set aside on its books provision reasonably adequate for the payment of all
        material taxes for periods subsequent to the periods to which such returns, reports or declarations apply.&#160; There are no unpaid taxes in any material amount claimed to be due by the taxing authority of any jurisdiction, and the officers of the
        Company or of any Subsidiary know of no basis for any such claim.</div>
      <div style="text-indent: 72pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">(dd)&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Foreign Corrupt Practices</u>.&#160; Neither the Company nor any Subsidiary, nor to the knowledge of the Company or any Subsidiary, any agent or other person acting on behalf of the
        Company or any Subsidiary, has: (i) directly or indirectly, used any funds for unlawful contributions, gifts, entertainment or other unlawful expenses related to foreign or domestic political activity, (ii) made any unlawful payment to foreign or
        domestic government officials or employees or to any foreign or domestic political parties or campaigns from corporate funds, (iii) failed to disclose fully any contribution made by the Company or any Subsidiary (or made by any person acting on its
        behalf of which the Company is aware) which is&#160; in violation of law or (iv) violated in any material respect any provision of FCPA.</div>
      <div style="text-indent: 72pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">(ee)&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);"><u>Accountants</u></font><u> and Lawyers</u><font style="color: rgb(0, 0, 0);">.&#160; The Company&#8217;s independent registered public accounting firm is </font>disclosed

        in the SEC Reports<font style="color: rgb(0, 0, 0);">.&#160; To the knowledge and belief of the Company, such accounting firm is a registered public accounting firm as required by the Exchange Act</font>.</div>
      <div style="text-indent: 72pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">(ff)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Acknowledgment Regarding Purchasers&#8217; Purchase of Securities</u>.&#160; The Company acknowledges and agrees that each of the Purchasers is acting solely in the capacity of an arm&#8217;s
        length purchaser with respect to the Transaction Documents and the transactions contemplated thereby.&#160; The Company further acknowledges that no Purchaser is acting as a financial advisor or fiduciary of the Company (or in any similar capacity) with
        respect to the Transaction Documents and the transactions contemplated thereby and any advice given by any Purchaser or any of their respective representatives or agents in connection with the Transaction Documents and the transactions contemplated
        thereby is merely incidental to the Purchasers&#8217; purchase of the Securities.&#160; The Company further represents to each Purchaser that the Company&#8217;s decision to enter into this Agreement and the other Transaction Documents has been based solely on the
        independent evaluation of the transactions contemplated hereby by the Company and its&#160;representatives.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">18</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt;">(gg)&#160;&#160;&#160;&#160;&#160;&#160; <u>Regulation M Compliance</u>.&#160; The Company has not, and to its knowledge no one acting on its behalf has, (i) taken, directly or indirectly, any action designed to cause or to result
        in the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of any of the Securities, (ii) sold, bid for, purchased, or paid any compensation for soliciting purchases of, any of the Securities,
        or (iii) paid or agreed to pay to any Person any compensation for soliciting another to purchase any other securities of the Company, except, in the case of clauses (ii) and (iii) the Persons included in Section 3.1(r) of the Disclosure Schedules
        in connection with the placement of the Securities.</div>
      <div style="text-indent: 72pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">(hh)&#160;&#160;&#160;&#160;&#160;&#160; <u>Money Laundering</u>.&#160; The operations of the Company and its Subsidiaries are and have been conducted at all times in compliance with applicable financial record-keeping and
        reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as amended, applicable money laundering statutes and applicable rules and regulations thereunder (collectively, the &#8220;<u>Money Laundering Laws</u>&#8221;), and no
        action, suit or proceeding by or before any court or governmental agency, authority or body or any arbitrator involving the Company or any Subsidiary with respect to the Money Laundering Laws is pending or, to the knowledge of the Company or any
        Subsidiary, threatened.</div>
      <div style="text-indent: 72pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Stock Option Plans</u>. Each stock option and similar security granted by the Company pursuant to any Stock Option Plan was granted (i) in accordance with the terms of the
        applicable equity incentive plan and (ii) with an exercise price at least equal to the fair market value of the Common Stock on the date such stock option would be considered granted under GAAP and applicable law. No stock option granted under any
        Stock Option Plan has been backdated.&#160; The Company has not knowingly granted, and there is no and has been no Company policy or practice to knowingly grant, stock options prior to, or otherwise knowingly coordinate the grant of stock options with,
        the release or other public announcement of material information regarding the Company or its Subsidiaries or their financial results or prospects.</div>
      <div style="text-indent: 72pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">(jj)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u></u><u>Office of Foreign Assets Control</u>.&#160; Neither the Company nor any Subsidiary nor, to the Company&#8217;s knowledge, any director, officer, agent, employee or affiliate of the
        Company is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (&#8220;<u>OFAC</u>&#8221;).</div>
      <div style="text-indent: 72pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">(kk)&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u></u><u>Private Placement</u>. Assuming the accuracy of the Purchasers&#8217; representations and warranties set forth in Section 3.2, no registration under the Securities Act is required
        for the offer and sale of the Securities by the Company to the Purchasers as contemplated hereby. The issuance and sale of the Securities hereunder does not contravene the rules and regulations of any Trading Market upon which the Company&#8217;s
        securities are traded or listed.</div>
      <div style="text-indent: 72pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">(ll)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>No General Solicitation</u>.&#160; Neither the Company nor any person acting on behalf of the Company has offered or sold any of the Securities by any form of general solicitation or
        general advertising.&#160; The Company has offered the Securities for sale only to the Purchasers.</div>
      <div style="text-indent: 72pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">(mm)&#160;&#160;&#160;&#160; <u>No Disqualification Events</u>.&#160; With respect to the Securities to be offered and sold hereunder in reliance on Rule 506 under the Securities Act, none of the Company, any of its
        predecessors, any affiliated issuer, any director, executive officer, other officer of the Company participating in the offering hereunder, any beneficial owner of 20% or more of the Company&#8217;s outstanding voting equity securities, calculated on the
        basis of voting power, nor any promoter (as that term is defined in Rule 405 under the Securities Act) connected with the Company in any capacity at the time of sale (each, an &#8220;<u>Issuer Covered Person</u>&#8221; and, together, &#8220;<u>Issuer Covered Persons</u>&#8221;)

        is subject to any of the &#8220;Bad Actor&#8221; disqualifications described in Rule 506(d)(1)(i) to (viii) under the Securities Act (a &#8220;<u>Disqualification Event</u>&#8221;), except for a Disqualification Event covered by Rule 506(d)(2) or (d)(3). The Company has
        exercised reasonable care to determine whether any Issuer Covered Person is subject to a Disqualification Event. The Company has complied, to the extent applicable, with its disclosure obligations under Rule&#160;506(e), and has furnished to <font style="color: rgb(0, 0, 0);">each Purchaser a copy of any disclosures provided thereunder</font>.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">19</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt;">(nn)&#160;&#160;&#160;&#160;&#160;&#160; <u>Regulatory Matters</u>.&#160; The Company and its Subsidiaries have complied in all material respects with all statutes and regulations related to the research, manufacture and sale of
        its products to the extent applicable to the Company&#8217;s and its Subsidiaries&#8217; activities. Items manufactured or under investigation by the Company and its Subsidiaries comply in all material respects with all applicable manufacturing practices
        regulations and other requirements established by government regulators in the jurisdictions in which the Company or its Subsidiaries manufacture their products and Applicable Law.&#160; To the knowledge of the Company, the Company is not and its
        Subsidiaries are not the subject of any investigation by any authority with respect to the development, testing, manufacturing and distribution of their products, nor has any investigation, prosecution, or other enforcement action been threatened
        by any regulatory agency. Neither the Company nor any of its Subsidiaries has received from any regulatory agency any letter or other document asserting that the Company or any Subsidiary has violated any statute or regulation enforced by that
        agency with respect to the development, testing, manufacturing and distribution of their products. To the Company&#8217;s knowledge, research conducted by or for the Company and its Subsidiaries has complied in all material respects with Applicable Law.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">(oo)&#160;&#160;&#160;&#160;&#160; <u>Other Covered Persons</u>. Except for attorneys for legal services and accountants for accounting services and the Persons set forth on Section 3.1(r) of the Disclosure Schedules, the
        Company is not aware of any person that has been or will be paid (directly or indirectly) remuneration in connection with the sale of any Securities pursuant to this Agreement.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">(pp)&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Environmental Laws</u>.&#160;&#160; To its knowledge, the Company and its Subsidiaries (i)&#160;are in material compliance with all federal, state, local and foreign laws relating to pollution or
        protection of human health or the environment (including ambient air, surface water, groundwater, land surface or subsurface strata), including laws relating to emissions, discharges, releases or threatened releases of chemicals, pollutants,
        contaminants, or toxic or hazardous substances or wastes (collectively, &#8220;<u>Hazardous Materials</u>&#8221;) into the environment, or otherwise relating to the manufacture, processing, distribution, use, treatment, storage, disposal, transport or handling
        of Hazardous Materials, as well as all authorizations, codes, decrees, demands, or demand letters, injunctions, judgments, licenses, notices or notice letters, orders, permits, plans or regulations, issued, entered, promulgated or approved
        thereunder (&#8220;<u>Environmental Laws</u>&#8221;); (ii) have received all permits licenses or other approvals required of them under applicable Environmental Laws to conduct their respective businesses; and (iii) are in compliance with all terms and
        conditions of any such permit, license or approval where, in each clause (i), (ii) and (iii), the failure to so comply would be reasonably expected to have, individually or in the aggregate, a Material Adverse Effect.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">(qq)&#160;&#160;&#160;&#160;&#160;&#160; <u></u><u>Listing and Maintenance Requirements</u>.&#160; <font style="color: #000000;">The Common Stock is listed for trading on the Nasdaq Capital Market under the symbol MNTS</font>.&#160;
        The Common Stock is registered pursuant to Section 12(b) or 12(g) of the Exchange Act, and the Company has taken no action designed to, or which to its knowledge is likely to have the effect of, terminating the registration of the Common Stock
        under the Exchange Act nor has the Company received any notification that the Commission is contemplating terminating such registration.&#160; Except as set forth in the SEC Reports or in the Disclosure Schedules, the Company has not, in the 12 months
        preceding the date hereof, received notice from any Trading Market on which the Common Stock is or has been listed or quoted to the effect that the Company is not in compliance with the listing or maintenance requirements of such Trading Market.
        The Company is, and has no reason to believe that it will not in the foreseeable future continue to be, in compliance with all such listing and maintenance requirements, except as otherwise set forth in the SEC Reports or in the Disclosure
        Schedules. The Common Stock is currently eligible for electronic transfer through the Depository Trust Company or another established clearing corporation and the Company is current in payment of the fees to the Depository Trust Company (or such
        other established clearing corporation) in connection with such electronic transfer.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">20</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt;">(rr)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>[Reserved]</u></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">(ss)&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>No Disagreements with Accountants.</u>&#160; There are no material disagreements of any kind presently existing between the Company and the accountants presently employed by the Company.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">(tt)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Bank Holding Company Act</u>.&#160; Neither the Company nor any of its Subsidiaries or Affiliates is subject to the Bank Holding Company Act of 1956, as amended (the &#8220;<u>BHCA</u>&#8221;) and
        to regulation by the Board of Governors of the Federal Reserve System (the &#8220;<u>Federal Reserve</u>&#8221;).&#160; Neither the Company nor any of its Subsidiaries or Affiliates owns or controls, directly or indirectly, five percent (5%) or more of the
        outstanding shares of any class of voting securities or twenty-five percent or more of the total equity of a bank or any entity that is subject to the BHCA and to regulation by the Federal Reserve.&#160; Neither the Company nor any of its Subsidiaries
        or Affiliates exercises a controlling influence over the management or policies of a bank or any entity that is subject to the BHCA and to regulation by the Federal Reserve.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">(uu)&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Survival</u>.&#160; The foregoing representations and warranties shall survive the Closing.</div>
      <div>&#160;</div>
      <div style="text-align: justify;">Each Purchaser acknowledges and agrees that the representations contained in this Section 3.1 shall not modify, amend or affect the Company&#8217;s right to rely on such Purchaser&#8217;s representations and warranties contained
        in this Agreement or any representations and warranties contained in any other Transaction Document or any other document or instrument executed and/or delivered in connection with this Agreement or the consummation of the transactions contemplated
        hereby.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #000000;">3.2</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Representations and Warranties of the Purchasers</u>.&#160; &#160; Each Purchaser, for itself and for no other Purchaser, hereby represents and warrants
        as of the date hereof and as of the Closing Date to the Company as follows (unless as of a specific date therein, in which case they shall be accurate as of such&#160;date):</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Organization; Authority</u>.&#160; Such Purchaser is either an individual or an entity duly incorporated or formed, validly existing and in good standing under the laws of the
        jurisdiction of its incorporation or formation with full right, corporate, partnership, limited liability company or similar power and authority to enter into and to consummate the transactions contemplated by the Transaction Documents and
        otherwise to carry out its obligations hereunder and thereunder. The execution and delivery of the Transaction Documents and performance by such Purchaser of the transactions contemplated by the Transaction Documents have been duly authorized by
        all necessary corporate, partnership, limited liability company or similar action, as applicable, on the part of such Purchaser.&#160; Each Transaction Document to which it is a party has been duly executed by such Purchaser, and when delivered by such
        Purchaser in accordance with the terms hereof, will constitute the valid and legally binding obligation of such Purchaser, enforceable against it in accordance with its terms, except (i) as limited by general equitable principles and applicable
        bankruptcy, insolvency, reorganization, moratorium and other laws of general application affecting enforcement of creditors&#8217; rights generally, (ii) as limited by laws relating to the availability of specific performance, injunctive relief or other
        equitable remedies and (iii) insofar as indemnification and contribution provisions may be limited by applicable law.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">21</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u></u><u>Own Account</u>.&#160; Such Purchaser understands that the Securities are &#8220;restricted securities&#8221; and have not been registered under the Securities Act or any applicable state
        securities law and is acquiring the Securities as principal for its own account and not with a view to or for distributing or reselling such Securities or any part thereof in violation of the Securities Act or any applicable state securities law,
        has no present intention of distributing any of such Securities in violation of the Securities Act or any applicable state securities law and has no direct or indirect arrangement or understandings with any other persons to distribute or regarding
        the distribution of such Securities in violation of the Securities Act or any applicable state securities law (this representation and warranty not limiting such Purchaser&#8217;s right to sell the Securities pursuant to the Registration Statement or
        otherwise in compliance with applicable federal and state securities laws).&#160; Such Purchaser is acquiring the Securities hereunder in the ordinary course of its business.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Purchaser Status</u>.&#160; At the time such Purchaser was offered the Securities, it was, and as of the date hereof it is, and on each date on which it exercises any Warrants or
        converts any shares of Preferred Stock, it will be either: (i) an &#8220;accredited investor&#8221; as defined in Rule 501(a)(1), (a)(2), (a)(3), (a)(7), (a)(8), (a)(9), (a)(12), or (a)(13) under the Securities Act or (ii) a &#8220;qualified institutional buyer&#8221; as
        defined in Rule 144A(a) under the Securities Act.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Experience of Such Purchaser</u>.&#160; Such Purchaser, either alone or together with its representatives, has such knowledge, sophistication and experience in business and financial
        matters so as to be capable of evaluating the merits and risks of the prospective investment in the Securities, and has so evaluated the merits and risks of such investment.&#160; Such Purchaser is able to bear the economic risk of an investment in the
        Securities and, at the present time, is able to afford a complete loss of such investment.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>General Solicitation</u>.&#160; Such Purchaser is not, to such Purchaser&#8217;s knowledge, purchasing the Securities as a result of any advertisement, article, notice or other communication
        regarding the Securities published in any newspaper, magazine or similar media or broadcast over television or radio or presented at any seminar or, to the knowledge of such Purchaser, any other general solicitation or general&#160;advertisement.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 67.5pt; margin-left: 4.5pt;">(f)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Access to Information</u>. Such Purchaser acknowledges that it has had the opportunity to review the Transaction Documents (including all exhibits and
        schedules thereto) and the SEC Reports and has been afforded (i) the opportunity to ask such questions as it has deemed necessary of, and to receive answers from, representatives of the Company concerning the terms and conditions of the offering of
        the Securities and the merits and risks of investing in the Securities; (ii) access to information about the Company and its financial condition, results of operations, business, properties, management and prospects sufficient to enable it to
        evaluate its investment; and (iii) the opportunity to obtain such additional information that the Company possesses or can acquire without unreasonable effort or expense that is necessary to make an informed investment decision with respect to the
        investment.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; margin-left: 4.5pt;">(g)&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u></u><font style="color: #000000;"><u>Certain Transactions and Confidentiality</u>.&#160; Other than consummating the transactions contemplated hereunder, such
          Purchaser has not, nor has any Person acting on behalf of or pursuant to any understanding with such Purchaser, directly or indirectly executed any purchases or sales, including Short Sales,&#160;of the securities of the Company during the period
          commencing as of</font> the time that such Purchaser first received a term sheet signed on behalf of the Company setting forth the material terms, which terms included definitive pricing terms, of the transactions contemplated hereunder and
        ending immediately prior to the execution hereof<font style="color: #000000;">.&#160; </font>Notwithstanding the foregoing, in the case of a Purchaser that is a multi-managed investment vehicle whereby separate portfolio managers manage separate
        portions of such Purchaser&#8217;s assets and the portfolio managers have no direct knowledge of the investment decisions made by the portfolio managers managing other portions of such Purchaser&#8217;s assets, the representation set forth above shall only
        apply with respect to the portion of assets managed by the portfolio manager that made the investment decision to acquire the Securities covered by this Agreement.&#160; Notwithstanding the foregoing, for the avoidance of doubt, nothing contained herein
        shall constitute a representation or warranty, or preclude any actions, with respect to locating or borrowing shares in order to effect Short Sales or similar transactions in the future.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">22</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify;">The Company acknowledges and agrees that the representations contained in this Section 3.2 shall not modify, amend or affect such Purchaser&#8217;s right to rely on the Company&#8217;s representations and warranties contained in
        this Agreement or any representations and warranties contained in any other Transaction Document or any other document or instrument executed and/or delivered in connection with this Agreement or the consummation of the transactions contemplated
        hereby.</div>
      <div>&#160;</div>
      <div style="text-align: center; font-weight: bold;">ARTICLE IV.</div>
      <div style="text-align: center; font-weight: bold;">OTHER AGREEMENTS OF THE PARTIES</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">4.1&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; (a)&#160;&#160;&#160;&#160;&#160; &#160;&#160; <u>Transfer Restrictions</u>.&#160; The Securities may only be disposed of in compliance with state and federal securities laws.&#160; In connection with any transfer of Securities
        other than pursuant to an effective registration statement or Rule 144 or other available exemption, to the Company or to an Affiliate of a Purchaser or in connection with a pledge as contemplated in Section 4.1(c), the Company may require the
        transferor thereof to provide to the Company, at the Company&#8217;s expense, an opinion of counsel selected by the transferor and reasonably acceptable to the Company, the form and substance of which opinion shall be reasonably satisfactory to the
        Company, to the effect that such transfer does not require registration of such transferred Securities under the Securities Act.&#160; As a condition of such transfer, any such transferee shall agree in writing to be bound by the terms of this Agreement
        and the Registration Rights Agreement shall have the rights and obligations of a Purchaser under this Agreement and the other Transaction&#160;Documents.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Legend</u>.&#160; The Purchasers agree to the imprinting, so long as is required by this Section 4.1, of a legend on any of the Securities in the following form:</div>
      <div>&#160;</div>
      <div style="text-align: justify; margin-left: 36pt;"><a name="z_Hlk85451334"></a>[NEITHER] THIS SECURITY [NOR THE SECURITIES INTO WHICH THIS SECURITY IS [EXERCISABLE] [CONVERTIBLE]] HAS [NOT] BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE
        COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &#8220;SECURITIES ACT&#8221;), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE
        REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. THIS
        SECURITY [AND THE SECURITIES ISSUABLE UPON [EXERCISE] [CONVERSION] OF THIS SECURITY] MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT WITH A REGISTERED BROKER-DEALER OR OTHER LOAN WITH A FINANCIAL INSTITUTION THAT IS AN ACCREDITED
        INVESTOR AS DEFINED IN RULE 501(a) UNDER THE SECURITIES ACT OR OTHER LOAN SECURED BY SUCH SECURITIES.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Pledge</u>.&#160; The Company acknowledges and agrees that a Purchaser may from time to time pledge pursuant to a bona fide margin agreement with a registered broker-dealer or grant a
        security interest in some or all of the Securities to a financial institution that is an Accredited Investor and who agrees to be bound by the provisions of this Agreement and, if required under the terms of such arrangement, such Purchaser may
        transfer pledge or secure Securities to the pledgees or secured parties.&#160; Such a pledge or transfer would not be subject to approval of the Company and no legal opinion of legal counsel of the pledgee, secured party or pledgor shall be required in
        connection therewith.&#160; Further, no notice shall be required of such pledge.&#160; At the appropriate Purchaser&#8217;s expense, the Company will execute and deliver such reasonable documentation as a pledgee or secured party of Securities may reasonably
        request in connection with a pledge or transfer of the Securities, including, if the Securities are included for registration pursuant to the Registration Rights Agreement, the preparation and filing of any required prospectus supplement under Rule
        424(b)(3) under the Securities Act or other applicable provision of the Securities Act to appropriately amend the list of Selling Stockholders <font style="color: #000000;">thereunder.</font></div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">23</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt;">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Legend Removal</u>.&#160; Certificates evidencing the Underlying Shares shall not contain any legend (&#8220;<u>Unlegended Shares</u>&#8221;) (including the legend set forth in Section 4.1(b)
        hereof): (i) while a registration statement (including the Registration Statement) covering the resale of such security is effective under the Securities Act, (ii) following any sale of such Underlying Shares pursuant to Rule 144 (assuming with
        respect to Warrant Shares, cashless exercise of the Warrants), (iii) if such Underlying Shares are eligible for sale under Rule 144 without information requirements (assuming with respect to Warrant Shares, cashless exercise of the Warrants) or
        (iv) if such legend is not required under applicable requirements of the Securities Act (including judicial interpretations and pronouncements issued by the staff of the Commission). The Company shall cause its counsel, at the expense of the
        Company, to issue a legal opinion to the Transfer Agent or the Purchaser promptly after each date a registration statement is declared effective by the Commission, if required by the Transfer Agent to effect the removal of the legend hereunder, or
        if requested by a Purchaser, respectively. If all or any Notes are converted or any portion of a Warrant is exercised at a time when there is an effective registration statement to cover the resale of the Underlying Shares, or if the Underlying
        Shares may be sold under Rule 144 (assuming with respect to Warrant Shares, cashless exercise of the Warrants) without the requirement for the Company to be in compliance with the current public information required under Rule 144 as to such
        Underlying Shares and without volume or manner-of-sale restrictions or if such legend is not otherwise required under applicable requirements of the Securities Act (including judicial interpretations and pronouncements issued by the staff of the
        Commission) then such Underlying Shares shall be issued free of all legends.&#160; The Company agrees that following such time as such legend is no longer required under this Section 4.1(c), it will, no later than the earlier of (i) two (2) Trading Days
        and (ii) the number of Trading Days comprising the Standard Settlement Period (as defined below) following the delivery by a Purchaser to the Company or the Transfer Agent of a certificate representing Underlying Shares, as applicable, issued with
        a restrictive legend (such date, the &#8220;<u>Legend Removal Date</u>&#8221;), deliver or cause to be delivered to such Purchaser a certificate representing such shares that is free from all restrictive and other legends.&#160; The Company may not make any
        notation on its records or give instructions to the Transfer Agent that enlarge the restrictions on transfer set forth in this Section 4.&#160; Certificates for Underlying Shares subject to legend removal hereunder shall be transmitted by the Transfer
        Agent to the Purchaser by crediting the account of the Purchaser&#8217;s prime broker with the Depository Trust Company System as directed by such Purchaser.&#160; As used herein, &#8220;<u>Standard Settlement Period</u>&#8221; means the standard settlement period,
        expressed in a number of Trading Days, on the Company&#8217;s primary Trading Market with respect to the Common Stock as in effect on the date of delivery of a certificate representing Underlying Shares, as applicable, issued with a restrictive legend.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Legend Removal Default</u>.&#160; In addition to such Purchaser&#8217;s other available remedies, the Company shall pay to a Purchaser, in cash, as partial liquidated damages and not as a
        penalty, for each $1,000 of Underlying Shares (based on the highest of the actual purchase price or VWAP of the Common Stock on the date such Securities are submitted to the Transfer Agent) delivered for removal of the restrictive legend and
        subject to Section 4.1(d), $10 per Trading Day for each Trading Day after the Legend Removal Date (increasing to $20 per Trading Day after the fifth Trading Day) until such certificate is delivered without a legend.&#160; Nothing herein shall limit such
        Purchaser&#8217;s right to pursue actual damages for the Company&#8217;s failure to deliver certificates representing any Securities as required by the Transaction Documents, and such Purchaser shall have the right to pursue all remedies available to it at law
        or in equity including, without limitation, a decree of specific performance and/or injunctive relief.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">24</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="color: #000000;">(f)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="color: #000000;"><u>DWAC</u>.&#160; In lieu of delivering physical certificates representing the Unlegended Shares, upon request of a
          Purchaser, so long as the certificates therefor do not bear a legend and the Purchaser is not obligated to return such certificate for the placement of a legend thereon, the Company shall cause its transfer agent to electronically transmit the
          Unlegended Shares by crediting the account of Purchaser&#8217;s prime broker with the Depository Trust Company through its Deposit Withdrawal At Custodian system, provided that the Company&#8217;s Common Stock is DTC eligible and the Company&#8217;s transfer agent
          participates in the Deposit Withdrawal at Custodian system. Such delivery must be made on or before the Legend Removal Date.</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="color: #000000;">(g)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="color: #000000;"><u>Injunction</u>. In the event a Purchaser shall request delivery of Unlegended Shares as described in this Section
          4.1 and the Company is required to deliver such Unlegended Shares, the Company may not refuse to deliver Unlegended Shares based on any claim that such Purchaser or anyone associated or affiliated with such Purchaser has not complied with
          Purchaser&#8217;s obligations under the Transaction Documents, or for any other reason, unless, an injunction or temporary restraining order from a court, on notice, restraining and or enjoining delivery of such Unlegended Shares shall have been sought
          and obtained by the Company and the Company has posted a surety bond for the benefit of such Purchaser in the amount of the greater of (i) 120% of the amount of the aggregate purchase price of the Underlying Shares to be subject to the injunction
          or temporary restraining order, or (ii) the VWAP of the Common Stock on the Trading Day before the issue date of the injunction multiplied by the number of Unlegended Shares to be subject to the injunction, which bond shall remain in effect until
          the completion of arbitration/litigation of the dispute and the proceeds of which shall be payable to such Purchaser to the extent Purchaser obtains judgment in Purchaser&#8217;s favor.</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="color: #000000;">(h)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="color: #000000;"><u>Buy-In</u>.&#160; In addition to any other rights available to a Purchaser, if the Company fails to (a)&#160;issue and
          deliver (or cause to be delivered) to a Purchaser by the Legend Removal Date a certificate representing the Securities for which a Purchaser has requested the legend to be removed and was so delivered to the Company if such security was in
          certificated form, by such Purchaser that is free from all restrictive and other legends and (b)&#160;if after the Legend Removal Date such Purchaser purchases (in an open market transaction or otherwise) shares of Common Stock to deliver in
          satisfaction of a sale by such Purchaser of all or any portion of the number of shares of Common Stock, or a sale of a number of shares of Common Stock equal to all or any portion of the number of shares of Common Stock, that such Purchaser
          anticipated receiving from the Company without any restrictive legend, then an amount equal to the excess of such Purchaser&#8217;s total purchase price (including brokerage commissions and other&#160;out&#8209;of&#8209;pocket&#160;expenses, if any) for the shares of Common
          Stock so purchased (including brokerage commissions and other&#160;out-of-pocket&#160;expenses, if any) over the product of (A)&#160;such number of Underlying Shares that the Company was required to deliver to such Purchaser by the Legend Removal Date
          multiplied by (B)&#160;the lowest closing sale price of the Common Stock on any Trading Day during the period commencing on the date of the delivery by such Purchaser to the Company of the applicable Underlying Shares and ending on the date of such
          delivery and payment under this Section&#160;4.1.</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Plan of Distribution</u>.&#160; Each Purchaser, severally and not jointly with the other Purchasers, agrees with the Company that such Purchaser will sell any Securities pursuant to
        either the registration requirements of the Securities Act, including any applicable prospectus delivery requirements, or an exemption therefrom, and that if Securities are sold pursuant to the Registration Statement, they will be sold in
        compliance with the plan of distribution set forth therein, and acknowledges that the removal of the restrictive legend from certificates representing Securities as set forth in this Section 4.1 is predicated upon the Company&#8217;s reliance upon this
        understanding.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">25</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">4.2&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Acknowledgment of Dilution</u>.&#160; The Company acknowledges that the issuance of the Securities may result in dilution of the outstanding shares of Common Stock, which dilution may be
        substantial under certain market conditions.&#160; The Company further acknowledges that its obligations under the Transaction Documents, including, without limitation, its obligation to issue the Underlying Shares pursuant to the Transaction Documents,
        are unconditional and absolute and not subject to any right of set off, counterclaim, delay or reduction, regardless of the effect of any such dilution or any claim the Company may have against any Purchaser and regardless of the dilutive effect
        that such issuance may have on the ownership of the other stockholders of the Company.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">4.3&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Furnishing of Information; Public Information</u>.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160; As long as the Securities are outstanding, the Company covenants to file all current and periodic reports required to be filed in conjunction with all applicable laws.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; At any time commencing on the Closing Date and ending at such time that all of the Securities may be sold without the requirement for the Company to be in compliance with Rule 144(c)(2)
        and otherwise without restriction or limitation pursuant to Rule 144, if the Company shall fail for any reason to satisfy the current public information requirement under Rule 144(c) or subparagraph (a) above after taking into account any extended
        filing period (a &#8220;<u>Public Information Failure</u>&#8221;) then, in addition to such Purchaser&#8217;s other available remedies, the Company shall pay to such Purchaser, in cash, as partial liquidated damages and not as a penalty, by reason of any such delay
        in or reduction of its ability to sell the Securities, an amount in cash equal to two percent (2.0%) of the aggregate Note principal held by such Purchaser on the day of a Public Information Failure and on every thirtieth (30<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup>) day (pro
        -rated for periods totaling less than thirty days) thereafter until the earlier of (a) the date such Public Information Failure is cured and (b) such time that such public information is no longer required&#160; for the Purchasers to transfer the
        Underlying Shares pursuant to Rule 144.&#160; The payments to which a Purchaser shall be entitled pursuant to this Section 4.3(b) are referred to herein as &#8220;<u>Public Information Failure Payments</u>.&#8221;&#160; Public Information Failure<font style="font-weight: bold;">&#160;</font>Payments shall be paid on the earlier of (i) the last day of the calendar month during which such Public Information Failure<font style="font-weight: bold;">&#160;</font>Payments are incurred and (ii) the third (3<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">rd</sup>)
        Business Day after the event or failure giving rise to the Public Information Failure<font style="font-weight: bold;">&#160;</font>Payments is cured.&#160; In the event the Company fails to make Public Information Failure<font style="font-weight: bold;">&#160;</font>Payments

        in a timely manner, such Public Information Failure<font style="font-weight: bold;">&#160;</font>Payments shall bear interest at the rate of 1.5% per month (prorated for partial months) until paid in full. Nothing herein shall limit such Purchaser&#8217;s
        right to pursue actual damages for the Public Information Failure, and such Purchaser shall have the right to pursue all remedies available to it at law or in equity including, without limitation, a decree of specific performance and/or injunctive
        relief.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">4.4&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Integration</u>.&#160; The Company shall not sell, offer for sale or solicit offers to buy or otherwise negotiate in respect of any security (as defined in Section 2 of the Securities
        Act) that would be integrated with the offer or sale of the Securities in a manner that would require the registration under the Securities Act of the sale of the Securities or that would be integrated with the offer or sale of the Securities for
        purposes of the rules and regulations of any Trading Market such that it would require shareholder approval, other than the requirement for Shareholder Approval as contemplated herein, prior to the closing of such other transaction or to effectuate
        such other transaction unless shareholder approval is obtained before the earlier of the closing of such subsequent transaction or effectuation of such other transaction.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">4.5&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Conversion and Exercise Procedures</u>.&#160; Each of the form of Notice of Exercise included in the Warrants and the form of Notice of Conversion included in the Note set forth the
        totality of the procedures required of the Purchasers in order to exercise the Warrants or convert the Note.&#160; Without limiting the preceding sentences, no ink-original Notice of Exercise or Notice of Conversion shall be required, nor shall any
        medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise or Notice of Conversion form be required in order to exercise the Warrants or convert the Note.&#160; No additional legal opinion, other information or
        instructions shall be required of the Purchasers to exercise their Warrants or convert their Note.&#160; The Company shall honor exercises of the Warrants and conversions of the Note and shall deliver Underlying Shares in accordance with the terms,
        conditions and time periods set forth in the Transaction Documents.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">26</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">4.6&#160;&#160;&#160;&#160;&#160; &#160;&#160; <u>Securities Laws Disclosure; Publicity</u>.&#160; The Company shall, by 9:30 a.m. (New York City time) on the Trading Day of the Closing Date, issue a press release and file a form 8-K
        with the Commission. From and after the issuance of the <font style="color: #000000;">press release</font>, the Company represents to the Purchasers that it shall have publicly disclosed all material, non-public information delivered to any of the
        Purchasers by the Company or any <font style="color: #000000;">of its Subsidiaries</font>, or any of their respective officers, directors, employees<font style="color: #000000;">, Affiliates</font> or agents<font style="color: #000000;">.&#160; In
          addition, effective upon the issuance of such press release, the Company acknowledges and agrees that any and all confidentiality or similar obligations under any agreement, whether written or oral, between the Company, any of its Subsidiaries or
          any of their respective officers, directors, employees, Affiliates or agents, on the one hand, and any of </font>the Purchasers <font style="color: #000000;">or any of their Affiliates on the other hand, shall terminate and be no further force
          or effect.&#160; The Company understands and confirms that each Purchaser shall be relying on the foregoing covenant in effecting transactions in securities of the Company.&#160; The Company and each Purchaser </font>shall consult with each other in
        issuing any <font style="color: #000000;">other </font>press releases with respect to the transactions contemplated hereby, and neither the Company nor any Purchaser shall issue any<font style="color: #000000;"> such</font> press release nor
        otherwise make any such public statement without the prior consent of the Company, with respect to any press release of any Purchaser, or without the prior consent of <font style="color: #000000;">each Purchaser</font>, with respect to any press
        release of the Company, which consent shall not unreasonably be withheld or delayed, except if such disclosure is required by law, in which case the disclosing party shall promptly provide the other party with prior notice of such public statement
        or communication.&#160; Notwithstanding the foregoing, the Company shall not publicly disclose the name of any Purchaser, or include the name of any Purchaser in any filing with the Commission or any regulatory agency or Trading Market, without the
        prior written consent of such Purchaser, except: (a) as required by federal securities law in connection with the filing of final Transaction Documents with the Commission and any registration statement registering the Securities on behalf of each
        of the Purchasers, and (b) to the extent such disclosure is required by law or Trading Market regulations, in which case the Company shall provide the Purchasers with prior notice of such disclosure permitted under this clause (b<font style="color: #000000;">)&#160;and reasonably cooperate with such Purchaser regarding such&#160;disclosure</font>.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">4.7&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Shareholder Rights Plan</u>.&#160; No claim will be made or enforced by the Company or, with the consent of the Company, any other Person, that any Purchaser is an &#8220;Acquiring Person&#8221;
        under any control share acquisition, business combination, poison pill (including any distribution under a rights agreement) or similar anti-takeover plan or arrangement in effect or hereafter adopted by the Company, or that any Purchaser could be
        deemed to trigger the provisions of any such plan or arrangement, by virtue of receiving Securities under the Transaction Documents or under any other agreement between the Company and the&#160;Purchasers.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">27</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">4.8&#160;&#160;&#160;&#160;&#160; <u>Non-Public Information</u>.&#160; Except with respect to the material terms and conditions of the transactions contemplated by the Transaction Documents, which shall be disclosed pursuant
        to Section 4.6, the Company covenants and agrees that, after the date hereof, neither it, nor any other Person acting on its behalf will provide any Purchaser or its agents or counsel with any information that constitutes, or the Company reasonably
        believes constitutes, material non-public information, unless prior thereto such Purchaser shall have consented to the receipt of such information and agreed with the Company to keep such information confidential.&#160; The Company understands and
        confirms that each Purchaser shall be relying on the foregoing covenant in effecting transactions in securities of the Company.&#160; To the extent that the Company, any of its Subsidiaries, or any of their respective officers, directors, agents,
        employees or Affiliates delivers any material, non-public information to a Purchaser without such Purchaser&#8217;s consent to hold such information in a confidential manner, the Company hereby covenants and agrees that such Purchaser shall not have any
        duty of confidentiality to the Company, any of its Subsidiaries, or any of their respective officers, directors, agents, employees or Affiliates, or a duty to the Company, any of its Subsidiaries or any of their respective officers, directors,
        agents, employees or Affiliates not to trade on the basis of, such material, non-public information, provided that the Purchaser shall remain subject to applicable law. To the extent that any notice provided pursuant to any Transaction Document
        constitutes, or contains, material, non-public information regarding the Company or any Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K.&#160; The Company understands and
        confirms that each Purchaser shall be relying on the foregoing covenant in effecting transactions in securities of the Company.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">4.9&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Use of Proceeds</u>.&#160;&#160; Except as set forth on <u>Schedule 4.9</u> attached hereto, the Company shall use the net proceeds from the sale of the Securities hereunder for working
        capital purposes which may include repayment of debt outstanding as of the date of this Agreement and shall not use such proceeds: (a)&#160;for the satisfaction of any portion of the Company&#8217;s debt incurred on or after the date of this Agreement (other
        than payment of trade payables in the ordinary course of the Company&#8217;s business and prior practices), (b) for the redemption of any Common Stock or Common Stock Equivalents, or (c) in violation of FCPA or OFAC regulations.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">4.10&#160;&#160;&#160;&#160;&#160; <u>Indemnification of Purchasers</u>.&#160; <a name="OLE_LINK1"></a><a name="OLE_LINK2"></a>Subject to the provisions of this Section 4.10, the Company will indemnify and hold each Purchaser
        and its directors, officers, shareholders, members, partners, employees and agents (and any other Persons with a functionally equivalent role of a Person holding such titles notwithstanding a lack of such title or any other title), each Person who
        controls such Purchaser (within the meaning of Section 15 of the Securities Act and Section 20 of the Exchange Act), and the directors, officers, shareholders, agents, members, partners or employees (and any other Persons with a functionally
        equivalent role of a Person holding such titles notwithstanding a lack of such title or any other title) of such controlling persons (each, a &#8220;<u>Purchaser Party</u>&#8221;) harmless from any and all losses, liabilities, obligations, claims,
        contingencies, damages, costs and expenses, including all judgments, amounts paid in settlements, court costs and reasonable attorneys&#8217; fees and costs of investigation that any such Purchaser Party may suffer or incur as a result of or relating to
        (a) any breach of any of the representations, warranties, covenants or agreements made by the Company in this Agreement or in the other Transaction Documents or (b) any action instituted against the Purchaser Parties in any capacity, or any of them
        or their respective Affiliates, by any stockholder of the Company who is not an Affiliate of such Purchaser Party, with respect to any of the transactions contemplated by the Transaction Documents (unless such action is based upon a material breach
        of such Purchaser Party&#8217;s representations, warranties or covenants under the Transaction Documents or any agreements or understandings such Purchaser Party may have with any such stockholder or any violations by such Purchaser Party of state or
        federal securities laws or any conduct by such Purchaser Party which is finally judicially determined to constitute fraud, <font style="color: #000000;">gross negligence or willful misconduct).</font>&#160; If any action shall be brought against any
        Purchaser Party in respect of which indemnity may be sought pursuant to this Agreement, such Purchaser Party shall promptly notify the Company in writing, and the Company shall have the right to assume the defense thereof with counsel of its own
        choosing reasonably acceptable to the Purchaser Party.&#160; Any Purchaser Party shall have the right to employ separate counsel in any such action and participate in the defense thereof, but the fees and expenses of such counsel shall be at the expense
        of such Purchaser Party except to the extent that (i) the employment thereof has been specifically authorized by the Company in writing, (ii) the Company has failed after a reasonable period of time to assume such defense and to employ counsel or
        (iii) in such action there is, in the reasonable opinion of counsel, a material conflict on any material issue between the position of the Company and the position of such Purchaser Party, in which case the Company shall be responsible for the
        reasonable fees and expenses of no more than one such separate counsel.&#160; The Company will not be liable to any Purchaser Party under this Agreement (y) for any settlement by a Purchaser Party effected without the Company&#8217;s prior written consent,
        which shall not be unreasonably withheld or delayed; or (z) to the extent, but only to the extent that a loss, claim, damage or liability is attributable to any Purchaser Party&#8217;s breach of any of the representations, warranties, covenants or
        agreements made by such Purchaser Party in this Agreement or in the other Transaction Documents.<font style="color: #000000;">&#160; </font>The indemnification required by this Section 4.10 shall be made by periodic payments of the amount thereof
        during the course of the investigation or defense, as and when bills are received or are incurred. The indemnity agreements contained herein shall be in addition to any cause of action or similar right of any Purchaser Party against the Company or
        others and any liabilities the Company may be subject to pursuant to law.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">28</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">4.11&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Reservation and Listing of Securities/Shareholder Approval</u>.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 12pt;">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);">As of the date hereof, the Company has reserved for each Purchaser and the Company shall continue to reserve
          and keep available at all times, the &#8220;Required Minimum&#8221;, free of pre&#8209;emptive rights.&#160; </font>If, on any date, the number of authorized but unissued (and otherwise unreserved) shares of Common Stock is less than the Required Minimum on such date
        (an &#8220;<u>Authorized Share Failure</u>&#8221;), then the Board of Directors shall amend the Company&#8217;s certificate of incorporation to increase the number of authorized but unissued shares of Common Stock to at least the Required Minimum plus such other
        amount as may be required for the Company&#8217;s other purposes, and use its commercially reasonable efforts to reserve the Required Minimum on behalf of the Purchaser, as soon as possible and in any event not later than the 90<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup> day after
        such date.&#160; Without limiting the generality of the foregoing sentence, as soon as practicable after the date of the occurrence of an Authorized Share Failure, but in no event later than ninety (90) days after the occurrence of such Authorized Share
        Failure, the Company shall hold a meeting of its stockholders for the approval of an increase in the number of authorized shares of Common Stock.&#160; In connection with such meeting, the Company shall provide each stockholder with a proxy statement
        and shall solicit its stockholders' approval of such increase in authorized shares of Common Stock and to cause its board of directors to recommend to the stockholders that they approve such proposal.&#160; Notwithstanding the foregoing, if any such
        time of an Authorized Share Failure, the Company is able to obtain the written consent of a majority of the shares of its issued and outstanding Common Stock to approve the increase in the number of authorized shares of Common Stock without
        soliciting its stockholders, the Company may satisfy this obligation by obtaining such consent and submitting for filing with the SEC an Information Statement on Schedule 14C.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 12pt;">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; The Company shall prior to the Closing: (i) in the time and manner required by the principal Trading Market, prepare and file with such Trading
        Market an additional shares listing application covering a number of shares of Common Stock at least equal to the Required Minimum on the date of such application, (ii) take all steps necessary to cause such shares of Common Stock to be approved
        for listing or quotation on such Trading Market as soon as possible thereafter, (iii) provide to the Purchasers evidence of such listing or quotation and (iv) maintain the listing or quotation of such Common Stock on any date at least equal to the
        Required Minimum on such date on such Trading Market or another Trading Market.&#160; <font style="color: #000000;">The Company will take all action necessary to continue the listing or quotation and trading of its Common Stock on a Trading Market for
          so long as the Notes or Warrants are outstanding, and will comply in all respects with the Company&#8217;s reporting, filing and other obligations under the bylaws or rules of the Trading Market.&#160; </font>In the event the aforedescribed listing is not
        continuously maintained for so long as Notes or Warrants are outstanding (a &#8220;<u>Listing Default</u>&#8221;), then in addition to any other rights the Purchasers may have hereunder or under Applicable Law, on the first day of a Listing Default and on each
        monthly anniversary of each such Listing Default date (if the applicable Listing Default shall not have been cured by such date) until the applicable Listing Default is cured, the Company shall pay to each Purchaser an amount in cash, as partial
        liquidated damages and not as a penalty, equal to 2% of the aggregate outstanding Note principal and accrued interest, conversion price of Note Underlying Shares and purchase price of Warrant Shares held by such Purchaser or which may be acquired
        upon exercise of Warrants on the day of a Listing Default and on every thirtieth day (pro-rated for periods less than thirty days) thereafter until the date such Listing Default is cured.&#160; If the Company fails to pay any liquidated damages pursuant
        to this Section in a timely manner, the Company will pay interest thereon at a rate of 1<font style="color: #000000;">.5</font>% per month (pro-rated for partial months) to the&#160;Purchaser.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">29</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">4.12&#160;&#160;&#160;&#160;&#160;&#160; <u>Purchaser&#8217;s Exercise Limitations</u>.&#160; The Company shall not effect any exercise of the rights granted in this Agreement, and any Purchaser shall not have the right to exercise any
        portion of such rights granted in this Agreement to the extent that after giving effect to such exercise, <a name="z_Hlk99101464"></a>such Purchaser (together with such Purchaser&#8217;s Affiliates, and any other Persons acting as a group together with
        such Purchaser or any of such Purchaser&#8217;s Affiliates), would beneficially own in excess of the Beneficial Ownership Limitation (as defined in the Notes), applied in the manner set forth in the Notes.&#160; In such event the right by such Purchaser to
        benefit from such rights or receive shares in excess of the Beneficial Ownership Limitation shall be held in abeyance until such times as such excess shares shall not exceed the Beneficial Ownership Limitation.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">4.13&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Preservation of Corporate Existence</u>.&#160; The Company and each Subsidiary shall preserve and maintain its corporate existence, rights, privileges and franchises in the jurisdiction
        of its incorporation, and qualify and remain qualified, as a foreign Company in each jurisdiction in which such qualification is necessary in view of its business or operations and where the failure to qualify or remain qualified would reasonably
        be expected to have a Material Adverse Effect.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">4.14&#160;&#160;&#160;&#160;&#160;&#160; <u>Notice of Disqualification Events</u>. The Company will notify the Purchasers in writing, prior to the Closing Date, of (i) any Disqualification Event relating to any Issuer Covered
        Person and (ii) any event that would, with the passage of time, become a Disqualification Event relating to any Issuer Covered Person not otherwise disclosed herein or in the SEC Reports.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #000000;">4.15</font>&#160;&#160;&#160;&#160;&#160;&#160; <font style="color: #000000;"><u>Listing of Shares</u>.&#160; The Company hereby agrees to use reasonable best efforts to maintain the listing or
          quotation of the Common Stock on the Trading Market on which it is currently listed and concurrently with the Closing, to apply to list or quote all of the Company&#8217;s Underlying Shares on such Trading Market and to promptly secure the listing of
          all the Underlying Shares on such Trading Market.&#160; The Company further agrees, if the Company applies to have the Common Stock traded on any other Trading Market, it will then include in such application all of the Underlying Shares, and will
          take such other action as is necessary to cause all of the Underlying Shares to be listed or quoted on such other Trading Market as promptly as possible.&#160; The Company will then take all action reasonably necessary to continue the listing and
          trading of the Common Stock on a Trading Market and will comply in all material respects with the Company&#8217;s reporting, filing and other obligations under the rules of the Trading Market.&#160; For so long as the Company maintains a listing or
          quotation of the Common Stock, the Company agrees to use commercially reasonable efforts</font> to maintain the eligibility of the Common Stock for electronic transfer through the Depository Trust Company or another established clearing
        corporation, including, without limitation, by timely payment of fees to the Depository Trust Company or such other established clearing corporation in connection with such electronic transfer.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">30</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">4.16&#160;&#160;&#160;&#160; <font style="color: #000000;"><u>Shareholder Approval</u>. </font> Notwithstanding anything to the contrary contained in this Agreement or the other Transaction Documents, the Company
        and each Purchaser agree that the total cumulative number of shares of Common Stock that may be issued under the other Transaction Documents may not exceed the requirements of Nasdaq Listing Rule 5635(d) (&#8220;Nasdaq 19.99% Cap&#8221;), except that such
        limitation will not apply following Shareholder Approval. If the Company has not obtained Shareholder Approval, and such Shareholder Approval is required pursuant to the rules of the principal Trading Market, then the Company may not issue any
        shares of Common Stock under this Agreement or the other Transaction Documents in excess of the amount permitted under the rules of the principal Trading Market. The Company shall no later than 20 days after the date of this Agreement file the
        initial filings with the Commission to hold and no later than 60 days after the date of this Agreement hold a meeting of shareholders (which may also be at the annual meeting of shareholders) at which the Company shall seek to obtain shareholder
        approval to issue the number of shares of Common Stock issuable pursuant to this Agreement on a fully converted or exercised basis (ignoring for such purposes any conversion or exercise limitations therein) exceeds 19.9% of the issued and
        outstanding shares of Common Stock on the Closing Date for the purpose of obtaining Shareholder Approval, with the recommendation of the Company&#8217;s Board of Directors that such proposal be approved, and the Company shall solicit proxies from its
        shareholders in connection therewith in the same manner as all other management proposals in such proxy statement and all management-appointed proxyholders shall vote their proxies in favor of such proposal. The Company shall use its reasonable
        best efforts to obtain such Shareholder Approval. If the Company does not obtain Shareholder Approval at the first meeting, the Company shall call a meeting every three months thereafter to seek Shareholder Approval until the earlier of the date
        Shareholder Approval is obtained or Purchasers no longer hold any Notes or Warrants.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">4.17&#160;&#160;&#160;&#160;&#160; <u>Form D; Blue Sky Filings</u>.&#160; The Company agrees to timely file a Form D with respect to the Securities as required under Regulation D and to provide a copy thereof, promptly upon
        request of any Purchaser. The Company shall take such action as the Company shall reasonably determine is necessary in order to obtain an exemption for, or to qualify the Securities for, sale to the Purchasers at a Closing under Applicable Law,
        including &#8220;Blue Sky&#8221; laws of the states of the United States, and shall provide evidence of such actions promptly upon request of any Purchaser.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">4.18&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Subsequent Equity Sales</u>.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;[Reserved]</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Other than an Exempt Issuance, from the date hereof and for as long as the Notes remain outstanding, the Company shall be, without the prior consent of Purchasers holding a Majority in
        Interest, prohibited from effecting or entering into an Equity Line of Credit or an agreement to effect any issuance by the Company or any of its Subsidiaries of Common Stock or Common Stock Equivalents (or a combination of units thereof) involving
        a Variable Rate Transaction.&#160; &#8220;<u>Equity Line of Credit</u>&#8221; means any transaction involving a written agreement between the Company and an investor or underwriter whereby the Company has the right to &#8220;put&#8221; its securities to the investor or
        underwriter over an agreed period of time and at an agreed price or price formula.&#160; &#8220;<u>Variable Rate Transaction</u>&#8221; means, collectively, an Equity Line of Credit and a transaction in which the Company (i) issues or sells any debt or equity
        securities that are convertible into, exchangeable or exercisable for, or include the right to receive, additional shares of Common Stock either (A) at a conversion price, exercise price or exchange rate or other price that is based upon, and/or
        varies with, the trading prices of or quotations for the shares of Common Stock at any time after the initial issuance of such debt or equity securities or (B) with a conversion, exercise or exchange price that is subject to being reset at some
        future date after the initial issuance of such debt or equity security or upon the occurrence of specified or contingent events directly or indirectly related to the business of the Company or the market for the Common Stock or (ii) enters into, or
        effects a transaction under, any agreement, including, but not limited to, an equity line of credit, whereby the Company may issue securities at a future determined price.&#160; Any Purchaser shall be entitled to obtain injunctive relief against the
        Company to preclude any such issuance, which remedy shall be in addition to any right to collect damages.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">31</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">4.19&#160;&#160;&#160;&#160;&#160; <u>&#160;</u><u>Equal Treatment of Purchasers</u>.&#160; No consideration (including any modification of any Transaction Document) shall be offered or paid to any Person to amend or consent to a
        waiver or modification of any provision of any of this Agreement unless the same consideration is also offered on a ratable basis to all of the parties to this Agreement. For clarification purposes, this provision constitutes a separate right
        granted to each Purchaser by the Company and negotiated separately by each Purchaser, and is intended for the Company to treat the Purchasers as a class and shall not in any way be construed as the Purchasers acting in concert or as a group with
        respect to the purchase, disposition or voting of Securities or otherwise.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">4.20&#160;&#160;&#160;&#160;&#160; <u>Capital Changes</u>.&#160; <a name="z_Hlk208383771"></a>Except in case of the need to comply with the rules of the Principal Trading Market, as determined in the Company&#8217;s sole
        discretion, until the one (1) year anniversary of the Closing Date, the Company shall not undertake a reverse or forward stock split or reclassification of the Common Stock without ten (10) days prior written notice to the Purchasers.&#160; In no event
        will the Company at any time Securities are outstanding reduce the par value of the Common Stock to an amount less than the lower of (i) the Conversion Price, or (ii) lowest Warrant Exercise Price, then in effect.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">4.21&#160;&#160;&#160;&#160;&#160; <u>Certain Transactions and Confidentiality</u>. Each Purchaser, severally and not jointly with the other Purchasers, covenants that neither it, nor any Affiliate acting on such
        Purchaser&#8217;s behalf or pursuant to any understanding with such Purchaser will execute any purchases or sales, including Short Sales, of any of the Company&#8217;s securities during the period commencing with the execution of this Agreement and ending at
        such time that the transactions contemplated by this Agreement are publicly announced pursuant to a press release or Form 8-K as described in Section 4.6.&#160; The Company expressly acknowledges and agrees that (i) no Purchaser makes any
        representation, warranty or covenant hereby that it will not engage in effecting transactions in any securities of the Company after the time that the transactions contemplated by this Agreement are first publicly announced pursuant to a press
        release or Form 8-K as described in Section 4.6, (ii) no Purchaser shall be restricted or prohibited from effecting any transactions in any securities of the Company in accordance with Applicable Law from and after the time that the transactions
        contemplated by this Agreement are first publicly announced pursuant to a press release or Form 8-K, and (iii) no Purchaser shall have any duty of confidentiality to the Company or its Subsidiaries.&#160; Except as described in this Section 4.21, the
        Company acknowledges that no Purchaser owes any confidentiality obligation to the Company or any Subsidiary.&#160; Notwithstanding the foregoing, in the case of a Purchaser that is a multi-managed investment vehicle or maintains a &#8220;Chinese Wall&#8221; whereby
        separate portfolio managers, traders, consultants or advisors manage separate portions of such Purchaser&#8217;s assets and the portfolio managers, traders, consultants or advisors have no direct knowledge of the investment decisions made by the
        portfolio managers managing other portions of such Purchaser&#8217;s assets, the covenant set forth above shall only apply with respect to the portion of assets managed by the portfolio manager, trader, consultant or advisor that made the investment
        decision to purchase the Securities covered by this Agreement.<a name="z_Hlk189168853"></a></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">4.22&#160;&#160;&#160;&#160;&#160;&#160; <u>Maintenance of Property/Insurance</u>.&#160; The Company shall and shall cause each Subsidiary to keep all of its property, which is necessary or useful to the conduct of its business, in
        good working order and condition, ordinary wear and tear excepted and insured by insurers of recognized financial responsibility against such losses and risks and in such amounts as are prudent and customary for the businesses of the Company and
        Subsidiary.&#160; From and after the Closing Date and for so long as any Securities are held by a Purchaser, the Company will maintain directors and officers insurance coverage at least equal to the aggregate Subscription Amount.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">4.23&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u></u><u>Preservation of Corporate Existence</u>.&#160; The Company and each Subsidiary shall preserve and maintain its corporate existence, rights, privileges and franchises in the
        jurisdiction of its incorporation, and qualify and remain qualified, as a foreign entity in each jurisdiction in which such qualification is necessary in view of its business or operations and where the failure to qualify or remain qualified would
        reasonably be expected have a Material Adverse Effect.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">32</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">4.24&#160;&#160;&#160;&#160;&#160;&#160; <font style="color: #000000;"><u>DTC Program</u>.&#160; At all times that Notes or Warrants are outstanding, the Company shall employ as the transfer agent for its Common Stock and
          Underlying Shares a participant in the Depository Trust Company Automated Securities Transfer Program and cause the Common Stock and Underlying Shares to be transferable pursuant to such program.</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">4.25&#160;&#160;&#160;&#160;&#160;&#160;<u></u><u>Reimbursement.</u>&#160; If any Purchaser becomes involuntarily involved in any capacity in any Proceeding by or against any Person who is a stockholder of the Company (except (i) as
        a result of sales, pledges, margin sales and similar transactions by such Purchaser to or with any current stockholder, and (ii) to the extent such Person is affiliated to any Purchaser), solely as a result of such Purchaser&#8217;s acquisition of the
        Securities under this Agreement, the Company will reimburse such Purchaser for its reasonable legal and other expenses (including the cost of any investigation preparation and travel in connection therewith) incurred in connection therewith, as
        such expenses are incurred.&#160; The reimbursement obligations of the Company under this paragraph shall be in addition to any liability which the Company may otherwise have, shall extend upon the same terms and conditions to any Affiliates of the
        Purchasers who are actually named in such action, proceeding or investigation, and partners, directors, agents, employees and controlling persons (if any), as the case may be, of the Purchasers and any such Affiliate, and shall be binding upon and
        inure to the benefit of any successors, assigns, heirs and personal representatives of the Company, the Purchasers and any such Affiliate and any such Person.&#160; The Company also agrees that neither the Purchasers nor any such Affiliates, partners,
        directors, agents, employees or controlling persons shall have any liability to the Company or any Person asserting claims on behalf of or in right of the Company solely as a result of acquiring the Securities under this Agreement.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">4.26&#160;&#160;&#160;&#160;&#160; <u>Indebtedness</u>.&#160; For so long as any Note is outstanding, the Company will not incur any Indebtedness other than Permitted Indebtedness, without the consent of the Majority in
        Interest.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">4.27&#160;&#160;&#160;&#160;&#160;&#160; <u>Duration of Undertakings</u>.&#160; Unless otherwise stated in this Article IV, all of the Company&#8217;s undertakings, obligations and responsibilities set forth in Article IV of this
        Agreement shall remain in effect for so long as any Securities remain outstanding.</div>
      <div>&#160;</div>
      <div style="text-align: center; font-weight: bold;">ARTICLE V.</div>
      <div style="text-align: center; font-weight: bold;">MISCELLANEOUS</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">5.1&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Termination</u>.&#160; This Agreement may be terminated by any Purchaser, as to such Purchaser&#8217;s obligations hereunder only and without any effect whatsoever on the obligations between
        the Company and the other Purchasers, by written notice to the other parties, if the Closing has not been consummated on or before the Termination Date; <u>provided</u>, <u>however</u>, that such termination will not affect the right of any party
        to sue for any breach by any other party (or parties).</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">5.2&#160;&#160;&#160;&#160;&#160;&#160; <u>Fees and Expenses</u>.&#160; The Company has agreed to pay $35,000 to G&amp;M, at the Closing in connection with G&amp;M&#8217;s representation of Purchasers.&#160; Except as expressly set forth in
        the Transaction Documents and on <u>Schedule 3.1(r)</u>, each party shall pay the fees and expenses of its advisers, counsel, accountants and other experts, if any, and all other expenses incurred by such party incident to the negotiation,
        preparation, execution, delivery and performance of this Agreement.&#160; The Company shall reimburse Purchasers for the reasonable, actual out-of-pocket expenses incurred in connection with UCC, lien, judgment, tax and similar searches and filings
        conducted in connection with the Offering, such amount not to exceed $2,500. The Company shall pay all Transfer Agent fees (including, without limitation, any fees required for same-day processing of any instruction letter delivered by the Company
        and any conversion or exercise notice delivered by a Purchaser), stamp taxes and other taxes and duties levied in connection with the delivery of any Securities to the Purchasers.&#160; All of the Purchasers acknowledge that they have been advised to
        seek the advice of their own attorneys.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">33</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">5.3&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Entire Agreement</u>.&#160; The Transaction Documents, together with the exhibits and schedules thereto, contain the entire understanding of the parties with respect to the subject matter
        hereof and thereof and supersede all prior agreements and understandings, oral or written, with respect to such matters, which the parties acknowledge have been merged into such documents, exhibits and schedules.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">5.4&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Notices</u>.&#160; <font style="color: #000000;">All notices, demands, requests, consents, approvals, and other communications required or permitted hereunder shall be in writing and,
          unless otherwise specified herein, shall be (i)&#160;personally served, (ii) deposited in the mail, registered or certified, return receipt requested, postage prepaid, (iii) delivered by reputable air courier service with charges prepaid, or (iv)
          transmitted by hand delivery, or e-mail as a PDF, addressed as set forth below or to such other address as such party shall have specified most recently by written notice.&#160; Any notice or other communication required or permitted to be given
          hereunder shall be deemed effective (a) upon hand delivery or delivery by e-mail, at the address designated below (if delivered on a business day during normal business hours where such notice is to be received), or the first business day
          following such delivery (if delivered other than on a business day during normal business hours where such notice is to be received) (b) on the second business day following the date of mailing by express courier service, fully prepaid, addressed
          to such address, or upon actual receipt of such mailing, whichever shall first occur, or (c) on the fifth (5</font><sup style="color: #000000; vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup><font style="color: #000000;">) business day after deposited in the mail, fully prepaid,
          addressed to such address, or upon actual receipt of such mailing, whichever shall first occur. The addresses for such communications shall be: (i) if to the Company, to: </font><a name="z_Hlk507748635"></a><a name="z_Hlk68707556"></a>Momentus<font style="color: #000000;"> Inc., </font><a name="z_Hlk193817996"></a><a name="z_Hlk85453853"></a>3901 N. First Street, San Jose, CA, 95134, Attention: John Rood, E-mail: [***],<font style="color: #000000;">&#160;</font><a name="z_Hlk85451886"></a>with
        a copy by email only to (which shall not constitute notice): Jon Layman, email: [***], and to Stephen Hinton, email: [***], and (ii) if to the Purchasers, to: the addresses and e-mails indicated on the signature pages hereto, with an additional
        copy by e-mail only to (which shall not constitute notice): Grushko &amp; Mittman, P.C., 1800 Rockaway Avenue, Suite 206, Hewlett, NY 11557, Attn: Eliezer Drew, Esq., email: [***].</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">5.5&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u></u><u>Amendments; Waivers</u>.&#160; No provision of this Agreement may be waived, modified, supplemented or amended except in a written instrument signed, in the case of an amendment,
        by the Company and the Purchasers holding <font style="color: #000000;">at least </font>a majority in interest of the Securities then outstanding (<a name="z_Hlk189319075"></a>the &#8220;<u>Majority in Interest</u>&#8221;), or, in the case of a waiver, by
        the party against whom enforcement of any such waived provision is sought.&#160; Whenever the term &#8220;consent of the Purchasers&#8221; or a similar term is employed herein, it shall mean the consent of a Majority in Interest.&#160; No waiver of any default with
        respect to any provision, condition or requirement of this Agreement shall be deemed to be a continuing waiver in the future or a waiver of any subsequent default or a waiver of any other provision, condition or requirement hereof, nor shall any
        delay or omission of any party to exercise any right hereunder in any manner impair the exercise of any such right.&#160; Any proposed amendment or waiver that disproportionately, materially and adversely affects the rights and obligations of any
        Purchaser relative to the comparable rights and obligations of the other Purchasers shall require the prior written consent of such adversely affected Purchaser. Any amendment effected in accordance with this Section 5.5 shall be binding upon each
        Purchaser and holder of Securities and the Company.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">5.6&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Headings</u>.&#160; The headings herein are for convenience only, do not constitute a part of this Agreement and shall not be deemed to limit or affect any of the provisions hereof.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">5.7&#160;&#160;&#160;&#160;&#160;&#160; <u>Successors and Assigns</u>.&#160; This Agreement shall be binding upon and inure to the benefit of the parties and their successors and permitted assigns.&#160; The Company may not assign this
        Agreement or any rights or obligations hereunder without the prior written consent of each Purchaser (other than by merger).&#160; Following the Closing, any Purchaser may assign any or all of its rights under this Agreement to any Person to whom such
        Purchaser assigns or transfers any Securities, provided that such transferee agrees in writing to be bound, with respect to the transferred Securities, by the provisions of the Transaction Documents that apply to the &#8220;Purchasers.&#8221;</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">34</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">5.8&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>No Third-Party Beneficiaries</u>.&#160; This Agreement is intended for the benefit of the parties hereto and their respective successors and permitted assigns and is not for the benefit
        of, nor may any provision hereof be enforced by, any other Person, except as otherwise set forth in Section 4.10.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">5.9&#160;&#160;&#160;&#160;&#160;&#160; <u>Governing Law</u>.&#160; All questions concerning the construction, validity, enforcement and interpretation of the Transaction Documents shall be governed by and construed and enforced in
        accordance with the internal laws of the State of Delaware, without regard to the principles of conflicts of law thereof.&#160; <a name="z_Hlk172053256"></a>Each party agrees that all legal proceedings concerning the interpretations, enforcement and
        defense of the transactions contemplated by this Agreement and any other Transaction Documents (whether brought against a party hereto or its respective affiliates, directors, officers, shareholders, partners, members, employees or agents) shall be
        commenced exclusively in the state and federal courts sitting in the State of Delaware.&#160; Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in the State of Delaware for the adjudication of
        any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein (including with respect to the enforcement of any of the Transaction Documents), and hereby irrevocably waives, and agrees not to assert
        in any action, suit or proceeding, any claim that it is not personally subject to the jurisdiction of any such court, that such suit, action or proceeding is improper or is an inconvenient venue for such proceeding.&#160; Each party and each signatory
        hereto on behalf of the Company, hereby irrevocably waives personal service of process and consents to process being served in any such suit, action or proceeding by mailing a copy thereof via registered or certified mail or overnight delivery
        (with evidence of delivery) to such party at the address in effect for notices to it under this Agreement and agrees that such service shall constitute good and sufficient service of process and notice thereof.&#160; Nothing contained herein shall be
        deemed to limit in any way any right to serve process in any other manner permitted by law.&#160; If either party shall commence an action or proceeding to enforce any provisions of the Transaction Documents, then, in addition to the obligations of the
        Company under Section 4.10, the prevailing party in such action, suit or proceeding shall be reimbursed by the other party for its reasonable attorneys&#8217; fees and other costs and expenses incurred with the investigation, preparation and prosecution
        of such action or proceeding.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">5.10&#160;&#160;&#160;&#160;&#160;&#160; <u>Execution</u>.&#160; This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered one and the same agreement and shall become effective
        when counterparts have been signed by each party and delivered to each other party, it being understood that the parties need not sign the same counterpart.&#160; In the event that any signature is delivered by facsimile transmission or by e-mail
        delivery of a &#8220;.pdf&#8221; format data file, such signature shall create a valid and binding obligation of the party executing (or on whose behalf such signature is executed) with the same force and effect as if such facsimile or &#8220;.pdf&#8221; signature page
        were an original thereof.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">5.11&#160;&#160;&#160;&#160;&#160;&#160; <u>Severability</u>. If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to be invalid, illegal, void or unenforceable, the
        remainder of the terms, provisions, covenants and restrictions set forth herein shall remain in full force and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their commercially reasonable efforts
        to find and employ an alternative means to achieve the same or substantially the same result as that contemplated by such term, provision, covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that they
        would have executed the remaining terms, provisions, covenants and restrictions without including any of such that may be hereafter declared invalid, illegal, void or&#160;unenforceable.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">35</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">5.12&#160;&#160;&#160;&#160;&#160;&#160; <u>Rescission and Withdrawal Right</u>.&#160; <font style="color: #000000;">Notwithstanding anything</font> to the <font style="color: #000000;">contrary</font> contained in (and without
        limiting any similar provisions of) any of the other Transaction Documents, whenever any Purchaser exercises a right, election, demand or option under a Transaction Document and the Company does not timely perform its related obligations within the
        periods therein provided, then such Purchaser may, at any time prior to the Company&#8217;s performance of such obligations, rescind or withdraw, in its sole discretion from time to time upon written notice to the Company, any relevant notice, demand or
        election in whole or in part without prejudice to its future actions and rights; <u>provided</u>, <u>however</u>, that in the case of a rescission of a conversion of a Note or exercise of a Warrant, the applicable Purchaser shall be required to
        return any shares of Common Stock subject to any such rescinded conversion or exercise notice concurrently with the return to such Purchaser of the aggregate Exercise Price paid to the Company for such shares and the restoration of such Purchaser&#8217;s
        right to acquire such shares pursuant to such Purchaser&#8217;s Warrant (including, issuance of a replacement warrant certificate evidencing such restored right).</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">5.13&#160;&#160;&#160;&#160;&#160; <u>Replacement of Securities</u>.&#160; If any certificate or instrument evidencing any Securities is mutilated, lost, stolen or destroyed, the Company shall issue or cause to be issued in
        exchange and substitution for and upon cancellation thereof (in the case of mutilation), or in lieu of and substitution therefor, a new certificate or instrument, but only upon receipt of evidence reasonably satisfactory to the Company of such
        loss, theft or destruction.&#160; The applicant for a new certificate or instrument under such circumstances shall also pay any reasonable third-party costs (including customary indemnity) associated with the issuance of such replacement Securities.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">5.14&#160;&#160;&#160;&#160;&#160; <u>Remedies</u>.&#160; In addition to being entitled to exercise all rights provided herein or granted by law, including recovery of damages, each of the Purchasers and the Company will be
        entitled to specific performance under the Transaction Documents.&#160; The parties agree that monetary damages may not be adequate compensation for any loss incurred by reason of any breach of obligations contained in the Transaction Documents and
        hereby agree to waive and not to assert in any action for specific performance of any such obligation the defense that a remedy at law would be adequate.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">5.15&#160;&#160;&#160;&#160;&#160;&#160; <u>Payment Set Aside</u>. To the extent that the Company makes a payment or payments to any Purchaser pursuant to any Transaction Document or a Purchaser enforces or exercises its
        rights thereunder, and such payment or payments or the proceeds of such enforcement or exercise or any part thereof are subsequently invalidated, declared to be fraudulent or preferential, set aside, recovered from, disgorged by or are required to
        be refunded, repaid or otherwise restored to the Company, a trustee, receiver or any other Person under any law (including, without limitation, any bankruptcy law, state or federal law, common law or equitable cause of action), then to the extent
        of any such restoration the obligation or part thereof originally intended to be satisfied shall be revived and continued in full force and effect as if such payment had not been made or such enforcement or setoff had not occurred.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">5.16&#160;&#160;&#160;&#160;&#160;&#160; <u>Usury</u>.&#160; To the extent it may lawfully do so, the Company hereby agrees not to insist upon or plead or in any manner whatsoever claim, and will resist any and all efforts to be
        compelled to take the benefit or advantage of, usury laws wherever enacted, now or at any time hereafter in force, in connection with any claim, action or proceeding that may be brought by any Purchaser in order to enforce any right or remedy under
        any Transaction Document.&#160; Notwithstanding any provision to the contrary contained in any Transaction Document, it is expressly agreed and provided that the total liability of the Company under the Transaction Documents for payments in the nature
        of interest shall not exceed the maximum lawful rate authorized under Applicable Law (the &#8220;<u>Maximum Rate</u>&#8221;), and, without limiting the foregoing, in no event shall any rate of interest or default interest, or both of them, when aggregated with
        any other sums in the nature of interest that the Company may be obligated to pay under the Transaction Documents exceed such Maximum Rate.&#160; It is agreed that if the maximum contract rate of interest allowed by law and applicable to the Transaction
        Documents is increased or decreased by statute or any official governmental action subsequent to the date hereof, the new maximum contract rate of interest allowed by law will be the Maximum Rate applicable to the Transaction Documents from the
        Closing Date thereof forward, unless such application is precluded by Applicable Law.&#160; If under any circumstances whatsoever, interest in excess of the Maximum Rate is paid by the Company to any Purchaser with respect to indebtedness evidenced by
        the Transaction Documents, such excess shall be applied by such Purchaser to the unpaid principal balance of any such indebtedness or be refunded to the Company, the manner of handling such excess to be at such Purchaser&#8217;s election.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">36</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">5.17&#160;&#160;&#160;&#160;&#160; <u>Independent Nature of Purchasers&#8217; Obligations and Rights</u>.&#160; The obligations of each Purchaser under any Transaction Document are several and not joint with the obligations of any
        other Purchaser, and no Purchaser shall be responsible in any way for the performance or non-performance of the obligations of any other Purchaser under any Transaction Document.&#160; Nothing contained herein or in any other Transaction Document, and
        no action taken by any Purchaser pursuant hereto or thereto, shall be deemed to constitute the Purchasers as a partnership, an association, a joint venture or any other kind of entity, or create a presumption that the Purchasers are in any way
        acting in concert or as a group with respect to such obligations or the transactions contemplated by the Transaction Documents.&#160; Each Purchaser shall be entitled to independently protect and enforce its rights, including, without limitation, the
        rights arising out of this Agreement or out of the other Transaction Documents, and it shall not be necessary for any other Purchaser to be joined as an additional party in any proceeding for such purpose.&#160; Each Purchaser has been represented by
        its own separate legal counsel in its review and negotiation of the Transaction Documents.&#160; For reasons of administrative convenience only, each Purchaser and its respective counsel have chosen to communicate with the Company through G&amp;M.&#160; The
        Company has elected to provide all Purchasers with the same terms and Transaction Documents for the convenience of the Company and not because it was required or requested to do so by any of the Purchasers.&#160; It is expressly understood and agreed
        that each provision contained in this Agreement and in each other Transaction Document is between the Company and a Purchaser, solely, and not between the Company and the Purchasers collectively and not between and among the Purchasers.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">5.18&#160;&#160;&#160;&#160; <u>Liquidated Damages</u>.&#160; The Company&#8217;s obligations to pay any partial liquidated damages or other amounts owing under the Transaction Documents is a continuing obligation of the
        Company and shall not terminate until all unpaid partial liquidated damages and other amounts have been paid notwithstanding the fact that the instrument or security pursuant to which such partial liquidated damages or other amounts are due and
        payable shall have been canceled.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">5.19&#160;&#160;&#160;&#160;&#160;&#160; <u>Saturdays, Sundays, Holidays, etc</u>.&#160; If the last or appointed day for the taking of any action or the expiration of any right required or granted herein shall not be a Business
        Day or Trading Day, as the case may be, then such action may be taken or such right may be exercised on the next succeeding Business Day or Trading Day, as the case may be.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">5.20&#160;&#160;&#160;&#160; <u>Construction</u>. The parties agree that each of them and/or their respective counsel have reviewed and had an opportunity to revise the Transaction Documents and, therefore, the
        normal rule of construction to the effect that any ambiguities are to be resolved against the drafting party shall not be employed in the interpretation of the Transaction Documents or any amendments thereto. In addition, each and every reference
        to share prices and shares of Common Stock in any Transaction Document shall be subject to adjustment for reverse and forward stock splits, stock dividends, stock combinations and other similar transactions <font style="color: #000000;">relating
          to shares of</font> Common Stock that occur after the date of this Agreement.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">5.21&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>WAIVER OF JURY TRIAL</u>.&#160; IN ANY ACTION, SUIT, OR PROCEEDING IN ANY JURISDICTION BROUGHT BY ANY PARTY AGAINST ANY OTHER PARTY, THE PARTIES EACH
          KNOWINGLY AND INTENTIONALLY, TO THE GREATEST EXTENT PERMITTED BY APPLICABLE LAW, HEREBY ABSOLUTELY, UNCONDITIONALLY, IRREVOCABLY AND EXPRESSLY WAIVES FOREVER TRIAL BY JURY.</font></div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-weight: bold;"> <br>
        </font></div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">37</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <!--PROfilePageNumberReset%Num%38%%%-->
      <div style="text-align: justify; text-indent: 36pt;">5.22&#160;&#160;&#160;&#160;&#160; <u></u><u>Equitable Adjustment</u>.&#160; Trading volume amounts, price/volume amounts, the amount of Warrants, the amount of shares of Common Stock identified in this Agreement, Conversion
        Price, Exercise Price, Underlying Shares and similar figures in the Transaction Documents shall be equitably adjusted (but without duplication) to offset the effect of stock splits, similar events and as otherwise described in this Agreement, Note
        and Warrants.</div>
      <div>&#160;</div>
      <div style="text-align: center; font-style: italic;">(Signature Pages Follow)</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">38</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">IN WITNESS WHEREOF, the parties hereto have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first indicated above.</div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" border="0" id="zc241c96658b1486d8ed10356f094dc37" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="vertical-align: top;" colspan="2">
              <div style="font-weight: bold;">MOMENTUS INC.</div>
            </td>
            <td style="width: 53%; vertical-align: top;"><br>
            </td>
          </tr>
          <tr>
            <td style="vertical-align: top;" rowspan="1" colspan="2"><br>
            </td>
            <td style="width: 53%; vertical-align: top;" rowspan="1">&#160;</td>
          </tr>
          <tr>
            <td nowrap="nowrap" style="width: 12%; vertical-align: top; padding-bottom: 2px;" rowspan="1">
              <div>By: /s/ John C. Rood</div>
            </td>
            <td style="width: 35%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);" rowspan="1">&#160;</td>
            <td style="width: 53%; vertical-align: top; padding-bottom: 2px;" rowspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align: top;" rowspan="1" colspan="2">
              <div style="margin-left: 9pt;">Name:<font style="color: rgb(0, 0, 0);"> John C. Rood</font></div>
            </td>
            <td style="width: 53%; vertical-align: top;" rowspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align: top;" colspan="2">
              <div style="color: rgb(0, 0, 0); margin-left: 9pt;">Title:&#160; Chief Executive Officer</div>
            </td>
            <td style="width: 53%; vertical-align: top;">&#160;</td>
          </tr>

      </table>
      <div><br>
      </div>
      <div style="text-align: center;">[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK</div>
      <div style="text-align: center;">SIGNATURE <font style="color: #000000;">PAGES</font> FOR <font style="color: #000000;">PURCHASERS FOLLOW.]</font></div>
      <div style="text-align: center;"><font style="color: #000000;"> <br>
        </font></div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">39</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: center;">[PURCHASER SIGNATURE PAGE TO MOMENTUS, INC.</div>
      <div style="text-align: center;">SECURITIES PURCHASE AGREEMENT]</div>
      <div><br>
      </div>
      <div>IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first indicated above.</div>
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" id="z9d2d3b7a51194e5e87b4d923dac8cf48" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

          <tr>
            <td nowrap="nowrap" style="width: 10%; vertical-align: top; padding-bottom: 2px;">
              <div>Name of Purchaser: <br>
              </div>
            </td>
            <td style="width: 90%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

          <tr>
            <td style="vertical-align: top;" colspan="2">&#160;</td>
          </tr>
          <tr>
            <td nowrap="nowrap" style="width: 15%; vertical-align: top; padding-bottom: 2px;">
              <div><font style="font-style: italic;">Signature of Authorized Signatory of Purchaser</font>: <br>
              </div>
            </td>
            <td style="width: 85%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

          <tr>
            <td style="vertical-align: top;" colspan="2">&#160;</td>
          </tr>
          <tr>
            <td nowrap="nowrap" style="width: 10%; vertical-align: top; padding-bottom: 2px;">
              <div>Name of Authorized Signatory: <br>
              </div>
            </td>
            <td style="width: 90%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

          <tr>
            <td style="vertical-align: top;" colspan="2">&#160;</td>
          </tr>
          <tr>
            <td nowrap="nowrap" style="width: 10%; vertical-align: top; padding-bottom: 2px;">
              <div>Title of Authorized Signatory: <br>
              </div>
            </td>
            <td style="width: 90%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

          <tr>
            <td style="vertical-align: top;" colspan="2">&#160;</td>
          </tr>
          <tr>
            <td nowrap="nowrap" style="width: 10%; vertical-align: top; padding-bottom: 2px;">
              <div>Email Address of Authorized Signatory: <br>
              </div>
            </td>
            <td style="width: 90%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

          <tr>
            <td style="vertical-align: top;" colspan="2">&#160;</td>
          </tr>
          <tr>
            <td nowrap="nowrap" style="width: 10%; vertical-align: top; padding-bottom: 2px;">
              <div>Facsimile Number of Authorized Signatory:</div>
            </td>
            <td style="width: 90%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

          <tr>
            <td style="vertical-align: top;" colspan="2">&#160;</td>
          </tr>
          <tr>
            <td nowrap="nowrap" style="width: 10%; vertical-align: top; padding-bottom: 2px;">
              <div>State of Incorporation of Purchaser:<br>
              </div>
            </td>
            <td style="width: 90%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          </tr>

      </table>
      <div><br>
      </div>
      <div>Address for Notice to Purchaser:</div>
      <div><br>
      </div>
      <div>Address for Delivery of Securities to Purchaser (if not same as address for notice):</div>
      <div><br>
      </div>
      <div>
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;" id="ze2cee1b1d45a4206b44f9b93820b14cb">

            <tr>
              <td nowrap="nowrap" style="width: 10%; padding-bottom: 2px;">Subscription Amount: </td>
              <td style="width: 15%; border-bottom: 2px solid rgb(0, 0, 0);">
                <div>US$</div>
              </td>
              <td style="width: 75%; padding-bottom: 2px;">
                <div>&#160;</div>
              </td>
            </tr>

        </table>
      </div>
      <div> <br>
        <div>
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

              <tr>
                <td nowrap="nowrap" style="width: 10%; padding-bottom: 2px;">Note principal amount:</td>
                <td style="width: 15%; border-bottom: 2px solid rgb(0, 0, 0);"><br>
                </td>
                <td style="width: 75%; padding-bottom: 2px;"> (reflects an original issue discount of 8%)</td>
              </tr>

          </table>
        </div>
        <div><br>
        </div>
      </div>
      <div>
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

            <tr>
              <td nowrap="nowrap" style="width: 5%; padding-bottom: 2px;">Warrants:</td>
              <td style="width: 15%; border-bottom: 2px solid rgb(0, 0, 0);"><br>
              </td>
              <td style="width: 80%; padding-bottom: 2px;"><br>
              </td>
            </tr>

        </table>
      </div>
      <div><br>
      </div>
      <div>
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

            <tr>
              <td nowrap="nowrap" style="width: 10%; padding-bottom: 2px;">AIR WARRANT:</td>
              <td style="width: 15%; border-bottom: 2px solid rgb(0, 0, 0);">$</td>
              <td style="width: 75%; padding-bottom: 2px;"><br>
              </td>
            </tr>

        </table>
      </div>
      <br>
      <div>EIN Number, if applicable, will be provided under separate cover</div>
      <div><br>
      </div>
      <div style="text-align: center;">[SIGNATURE PAGES CONTINUE]</div>
      <div style="text-align: center;"> <br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">40</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: center; font-weight: bold;"><u>EXHIBIT F</u></div>
      <div><br>
      </div>
      <div style="text-align: center; font-weight: bold;">ACCREDITED INVESTOR QUESTIONNAIRE</div>
      <div style="text-align: center; font-weight: bold;">IN CONNECTION WITH INVESTMENT IN SECURED CONVERTIBLE NOTE</div>
      <div style="text-align: center; font-weight: bold;">MOMENTUS INC.,</div>
      <div style="text-align: center; font-weight: bold;">A DELAWARE CORPORATION</div>
      <div style="text-align: center; font-weight: bold;">PURSUANT TO SECURITIES PURCHASE AGREEMENT DATED SEPTEMBER 25, 2025</div>
      <div><br>
      </div>
      <div>TO&#160;:&#160;&#160;&#160;&#160;&#160;&#160; Momentus Inc.</div>
      <div style="margin-left: 36pt; color: #000000;">[*]</div>
      <div style="margin-left: 36pt; color: #000000;">[*]</div>
      <div style="margin-left: 36pt; color: #000000;">Email: [*]</div>
      <div>&#160;</div>
      <div><u>INSTRUCTIONS</u></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">PLEASE ANSWER ALL QUESTIONS. If the appropriate answer is &#8220;None&#8221; or &#8220;Not Applicable&#8221;, so state.&#160; Please print or type your answers to all questions. Attach additional sheets if necessary to
        complete your answers to any item.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">Your answers will be kept strictly confidential at all times. However, Momentus Inc. (the &#8220;Company&#8221;) may present this Questionnaire to such parties as it deems appropriate in order to assure itself
        that the offer and sale of securities of the Company will not result in a violation of the registration provisions of the Securities Act of 1933, as amended, or a violation of the securities laws of any state.</div>
      <div>&#160;</div>
      <div>1.&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160; Please provide the following information:</div>
      <div>&#160;</div>
      <div>
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;" id="zbdb60a976c14424288e8e569c52e956a">

            <tr>
              <td style="width: 5%; padding-bottom: 2px;">
                <div>Name: <br>
                </div>
              </td>
              <td style="width: 95%; border-bottom: 2px solid rgb(0, 0, 0);"><br>
              </td>
            </tr>

        </table>
      </div>
      <div><br>
      </div>
      <div>
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

            <tr>
              <td nowrap="nowrap" style="width: 5%; padding-bottom: 2px;" rowspan="1">Name of additional purchaser: </td>
              <td style="width: 95%; border-bottom: 2px solid rgb(0, 0, 0);" rowspan="1">&#160;</td>
            </tr>
            <tr>
              <td nowrap="nowrap" style="width: 5%; padding-bottom: 2px;" rowspan="1" colspan="2">
                <div style="text-align: left;">(Please complete information in Question 5)</div>
              </td>
            </tr>

        </table>
      </div>
      <div><br>
      </div>
      <div>
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;" id="zff26cd4616294aaf8cc245a3d327618f">

            <tr>
              <td style="width: 100%;">
                <div>
                  <div style="text-align: left;">Date of birth, or if other than an individual, year of organization or incorporation:</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 100%;"><br>
              </td>
            </tr>
            <tr>
              <td style="width: 100%; border-bottom: 2px solid rgb(0, 0, 0);"><br>
              </td>
            </tr>
            <tr>
              <td style="width: 100%;"><br>
              </td>
            </tr>
            <tr>
              <td style="width: 100%; border-bottom: 2px solid rgb(0, 0, 0);" rowspan="1"><br>
              </td>
            </tr>

        </table>
      </div>
      <div>
        <div><br>
        </div>
        <div>
          <div>2.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Residence address, or if other than an individual, principal office address:</div>
        </div>
        <br>
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;" id="z461750cd7fa140b189fe20d41f8513e3">

            <tr>
              <td style="width: 100%; border-bottom: 2px solid rgb(0, 0, 0);" rowspan="1"><br>
              </td>
            </tr>
            <tr>
              <td style="width: 100%;" rowspan="1">&#160;</td>
            </tr>
            <tr>
              <td style="width: 100%; border-bottom: 2px solid rgb(0, 0, 0);" rowspan="1">&#160;</td>
            </tr>
            <tr>
              <td style="width: 100%;" rowspan="1">&#160;</td>
            </tr>
            <tr>
              <td style="width: 100%; border-bottom: 2px solid rgb(0, 0, 0);" rowspan="1">&#160;</td>
            </tr>
            <tr>
              <td style="width: 100%;" rowspan="1">&#160;</td>
            </tr>

        </table>
        <div><br>
        </div>
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

            <tr>
              <td nowrap="nowrap" style="width: 10%; padding-bottom: 2px;">
                <div>
                  <div style="text-align: left;">Telephone number:<br>
                  </div>
                </div>
              </td>
              <td style="width: 90%; border-bottom: 2px solid rgb(0, 0, 0);"><br>
              </td>
            </tr>

        </table>
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

            <tr>
              <td colspan="2">
                <div>&#160;</div>
              </td>
            </tr>
            <tr>
              <td nowrap="nowrap" style="width: 10%; padding-bottom: 2px;">
                <div>Social Security Number:</div>
              </td>
              <td style="width: 90%; border-bottom: 2px solid rgb(0, 0, 0);"><br>
              </td>
            </tr>

        </table>
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

            <tr>
              <td rowspan="1" colspan="2">&#160;</td>
            </tr>
            <tr>
              <td nowrap="nowrap" style="width: 10%; padding-bottom: 2px;">
                <div>Taxpayer Identification Number:</div>
              </td>
              <td style="width: 90%; border-bottom: 2px solid rgb(0, 0, 0);"><br>
              </td>
            </tr>

        </table>
        &#160;&#160;&#160;&#160;&#160;&#160; <br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">41</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div>
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;" id="zb7d10661d3504117b0084336777c94ca">

            <tr>
              <td nowrap="nowrap" style="width: 10%; padding-bottom: 2px;">
                <div>3.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Business address:&#160;&#160; <br>
                </div>
              </td>
              <td style="width: 90%; border-bottom: 2px solid rgb(0, 0, 0);"><br>
              </td>
            </tr>
            <tr>
              <td style="width: 10%;">
                <div>&#160;</div>
              </td>
              <td style="width: 90%;">
                <div>&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 10%; border-bottom: 2px solid rgb(0, 0, 0);" rowspan="1" colspan="2"><br>
              </td>
            </tr>
            <tr>
              <td style="width: 10%;" rowspan="1" colspan="2">&#160;</td>
            </tr>
            <tr>
              <td style="width: 10%; border-bottom: 2px solid rgb(0, 0, 0);" rowspan="1" colspan="2"><br>
              </td>
            </tr>

        </table>
      </div>
      <div> <br>
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

            <tr>
              <td nowrap="nowrap" style="width: 10%; padding-bottom: 2px;">Business telephone number:&#160; <br>
              </td>
              <td style="width: 90%; border-bottom: 2px solid rgb(0, 0, 0);"><br>
              </td>
            </tr>

        </table>
      </div>
      <div><br>
      </div>
      <div>4.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; Send mail to:&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Residence ______&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Business _______</div>
      <div>&#160;</div>
      <div>5.&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; With respect to tenants in common, joint tenants and tenants by the entirety, complete only if information differs from that above:</div>
      <div><br>
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

            <tr>
              <td nowrap="nowrap" style="width: 10%; padding-bottom: 2px;">Residence address:&#160; <br>
              </td>
              <td nowrap="nowrap" style="width: 90%; border-bottom: 2px solid rgb(0, 0, 0);"><br>
              </td>
            </tr>
            <tr>
              <td nowrap="nowrap" style="width: 10%;" rowspan="1" colspan="2"><br>
              </td>
            </tr>
            <tr>
              <td nowrap="nowrap" style="width: 10%; border-bottom: 2px solid rgb(0, 0, 0);" rowspan="1" colspan="2">&#160;</td>
            </tr>
            <tr>
              <td nowrap="nowrap" style="width: 10%;" rowspan="1" colspan="2"><br>
              </td>
            </tr>
            <tr>
              <td nowrap="nowrap" style="width: 10%; border-bottom: 2px solid rgb(0, 0, 0);" rowspan="1" colspan="2">&#160;</td>
            </tr>

        </table>
      </div>
      <div> <br>
      </div>
      <div>
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;" id="z5dce5f1133b948848ea94255a553458f">

            <tr>
              <td nowrap="nowrap" style="width: 10%; padding-bottom: 2px;">
                <div>
                  <div style="text-align: left;">Telephone number:<br>
                  </div>
                </div>
              </td>
              <td style="width: 90%; border-bottom: 2px solid rgb(0, 0, 0);"><br>
              </td>
            </tr>

        </table>
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

            <tr>
              <td style="width: 10%;"><br>
              </td>
              <td style="width: 90%;"><br>
              </td>
            </tr>
            <tr>
              <td nowrap="nowrap" style="width: 10%; padding-bottom: 2px;">
                <div>Social Security Number:</div>
              </td>
              <td style="width: 90%; border-bottom: 2px solid rgb(0, 0, 0);"><br>
              </td>
            </tr>

        </table>
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

            <tr>
              <td style="width: 10%;"><br>
              </td>
              <td style="width: 90%;"><br>
              </td>
            </tr>
            <tr>
              <td nowrap="nowrap" style="width: 10%; padding-bottom: 2px;">
                <div>Taxpayer Identification Number:</div>
              </td>
              <td style="width: 90%; border-bottom: 2px solid rgb(0, 0, 0);"><br>
              </td>
            </tr>

        </table>
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

            <tr>
              <td style="width: 10%;">
                <div>&#160;</div>
              </td>
              <td style="width: 90%;"><br>
              </td>
            </tr>
            <tr>
              <td nowrap="nowrap" style="width: 10%; padding-bottom: 2px;">
                <div>Business address:&#160;&#160; <br>
                </div>
              </td>
              <td style="width: 90%; border-bottom: 2px solid rgb(0, 0, 0);"><br>
              </td>
            </tr>
            <tr>
              <td nowrap="nowrap" style="width: 10%; padding-bottom: 2px;" rowspan="1" colspan="2"><br>
              </td>
            </tr>
            <tr>
              <td nowrap="nowrap" style="width: 10%; border-bottom: 2px solid rgb(0, 0, 0);" rowspan="1" colspan="2"><br>
              </td>
            </tr>
            <tr>
              <td nowrap="nowrap" style="width: 10%; padding-bottom: 2px;" rowspan="1" colspan="2"><br>
              </td>
            </tr>
            <tr>
              <td nowrap="nowrap" style="width: 10%; border-bottom: 2px solid rgb(0, 0, 0);" rowspan="1" colspan="2"><br>
              </td>
            </tr>

        </table>
      </div>
      <div> <br>
      </div>
      <div>
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

            <tr>
              <td nowrap="nowrap" style="width: 10%; padding-bottom: 2px;">
                <div>Business telephone number:&#160; <br>
                </div>
              </td>
              <td style="width: 90%; border-bottom: 2px solid rgb(0, 0, 0);"><br>
              </td>
            </tr>

        </table>
      </div>
      <div><br>
      </div>
      <div>Send Mail to:&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Residence _______&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Business _______</div>
      <div>&#160;</div>
      <div style="text-align: justify;">6.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Please describe your present or most recent business or occupation and indicate such information as the nature of your employment, how long you have been employed there, the principal business of your
        employer, the principal activities under your management or supervision and the scope (e.g. dollar volume, industry rank, etc.) of such activities:</div>
      <div><br>
      </div>
      <div>
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

            <tr>
              <td style="width: 100%; border-bottom: 2px solid rgb(0, 0, 0);"><br>
              </td>
            </tr>
            <tr>
              <td style="width: 100.00%;">
                <div>&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 100%; border-bottom: 2px solid rgb(0, 0, 0);">
                <div>&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 100.00%;">
                <div>&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 100%; border-bottom: 2px solid rgb(0, 0, 0);">
                <div>&#160;</div>
              </td>
            </tr>

        </table>
      </div>
      <br>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">42</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      7.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Please state whether you (i) are associated with or affiliated with a member of the Financial Industry Regulatory Association, Inc. (&#8220;FINRA&#8221;), (ii) are an owner of stock or other securities of FINRA member (other than stock or other
      securities purchased on the open market), or (iii) have made a subordinated loan to any FINRA member:
      <div>&#160;</div>
      <div>
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;" id="z6a2647cbea5f4cf0b155127d7cd02d3e">

            <tr>
              <td style="width: 15%; padding-bottom: 2px;"><br>
              </td>
              <td style="width: 5%; border-bottom: 2px solid rgb(0, 0, 0);">
                <div>&#160;</div>
              </td>
              <td style="width: 10%; padding-bottom: 2px;" colspan="1">&#160;</td>
              <td style="width: 5%; border-bottom: 2px solid rgb(0, 0, 0);">
                <div>&#160;</div>
              </td>
              <td style="width: 65%; padding-bottom: 2px;">
                <div>&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 15%;"><br>
              </td>
              <td style="width: 5%;">
                <div>Yes</div>
              </td>
              <td style="width: 10%;" colspan="1">&#160;</td>
              <td style="width: 5%;">
                <div>No</div>
              </td>
              <td style="width: 65%;">
                <div>&#160;</div>
              </td>
            </tr>

        </table>
      </div>
      <div> <br>
      </div>
      <div style="text-align: justify; margin-left: 36pt;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;If you answered yes to any of (i) &#8211; (iii) above, please indicate the applicable answer and briefly describe the facts below:</div>
      <div>&#160;<br>
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;" id="z471c3b6412c94a81a9b109f743fd2754">

            <tr>
              <td style="width: 100%; border-bottom: 2px solid rgb(0, 0, 0);"><br>
              </td>
            </tr>
            <tr>
              <td style="width: 100.00%;">
                <div>&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 100%; border-bottom: 2px solid rgb(0, 0, 0);">
                <div>&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 100.00%;">
                <div>&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 100%; border-bottom: 2px solid rgb(0, 0, 0);">
                <div>&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 100.00%;">
                <div>&#160;</div>
              </td>
            </tr>

        </table>
      </div>
      <div style="text-align: justify;">8A.&#160;&#160;&#160;&#160;&#160;&#160; Applicable to Individuals ONLY.&#160; Please answer the following questions concerning your financial condition as an &#8220;accredited investor&#8221; (within the meaning of Rule 501 of Regulation D).&#160; If the purchaser is
        more than one individual, each individual must initial an answer where the question indicates a &#8220;yes&#8221; or &#8220;no&#8221; response and must answer any other question fully, indicating to which individual such answer applies.&#160; If the purchaser is purchasing
        jointly with his or her spouse, one answer may be indicated for the couple as a whole:</div>
      <div>&#160;</div>
      <div>8.1&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Does your net worth* (or joint net worth with your spouse or spousal equivalent) exceed $1,000,000?</div>
      <div> <br>
      </div>
      <div>
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

            <tr>
              <td style="width: 15%; padding-bottom: 2px;"><br>
              </td>
              <td style="width: 5%; border-bottom: 2px solid rgb(0, 0, 0);">
                <div>&#160;</div>
              </td>
              <td style="width: 10%; padding-bottom: 2px;" colspan="1">&#160;</td>
              <td style="width: 5%; border-bottom: 2px solid rgb(0, 0, 0);">
                <div>&#160;</div>
              </td>
              <td style="width: 65%; padding-bottom: 2px;">
                <div>&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 15%;"><br>
              </td>
              <td style="width: 5%;">
                <div>Yes</div>
              </td>
              <td style="width: 10%;" colspan="1">&#160;</td>
              <td style="width: 5%;">
                <div>No</div>
              </td>
              <td style="width: 65%;">
                <div>&#160;</div>
              </td>
            </tr>

        </table>
      </div>
      <div>&#160;</div>
      <div style="text-align: justify;">8.2&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Did you have an individual income** in excess of $200,000 or joint income together with your spouse or spousal equivalent in excess of $300,000 in each of the two most recent years and do you reasonably
        expect to reach the same income level in the current year?</div>
      <div style="text-align: justify;"> <br>
      </div>
      <div style="text-align: justify;">
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

            <tr>
              <td style="width: 15%; padding-bottom: 2px;"><br>
              </td>
              <td style="width: 5%; border-bottom: 2px solid rgb(0, 0, 0);">
                <div>&#160;</div>
              </td>
              <td style="width: 10%; padding-bottom: 2px;" colspan="1">&#160;</td>
              <td style="width: 5%; border-bottom: 2px solid rgb(0, 0, 0);">
                <div>&#160;</div>
              </td>
              <td style="width: 65%; padding-bottom: 2px;">
                <div>&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 15%;"><br>
              </td>
              <td style="width: 5%;">
                <div>Yes</div>
              </td>
              <td style="width: 10%;" colspan="1">&#160;</td>
              <td style="width: 5%;">
                <div>No</div>
              </td>
              <td style="width: 65%;">
                <div>&#160;</div>
              </td>
            </tr>

        </table>
      </div>
      <div>&#160;</div>
      <div>8.3&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Are you an executive officer of the Company?</div>
      <div>&#160;</div>
      <div>
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

            <tr>
              <td style="width: 15%; padding-bottom: 2px;"><br>
              </td>
              <td style="width: 5%; border-bottom: 2px solid rgb(0, 0, 0);">
                <div>&#160;</div>
              </td>
              <td style="width: 10%; padding-bottom: 2px;" colspan="1">&#160;</td>
              <td style="width: 5%; border-bottom: 2px solid rgb(0, 0, 0);">
                <div>&#160;</div>
              </td>
              <td style="width: 65%; padding-bottom: 2px;">
                <div>&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 15%;"><br>
              </td>
              <td style="width: 5%;">
                <div>Yes</div>
              </td>
              <td style="width: 10%;" colspan="1">&#160;</td>
              <td style="width: 5%;">
                <div>No</div>
              </td>
              <td style="width: 65%;">
                <div>&#160;</div>
              </td>
            </tr>

        </table>
      </div>
      <br>
      <div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%;" id="za3c6401e24b149a2866054132f6d8e3c" class="DSPFListTable">

            <tr style="vertical-align: top;">
              <td style="text-align: right; vertical-align: top; width: 9pt;">
                <div style="text-align: justify;">*</div>
              </td>
              <td style="text-align: left; vertical-align: top; width: auto;">
                <div style="text-align: justify;">For purposes hereof, net worth shall be deemed to include ALL of your assets, liquid or illiquid MINUS any liabilities.</div>
              </td>
            </tr>

        </table>
      </div>
      <div>&#160;</div>
      <div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%;" id="za4d6c3f31a1b4ed9b86b36f534b76a24" class="DSPFListTable">

            <tr style="vertical-align: top;">
              <td style="text-align: right; vertical-align: top; width: 9pt;">
                <div style="text-align: justify;">**</div>
              </td>
              <td style="text-align: left; vertical-align: top; width: auto;">
                <div style="text-align: justify;">For purposes hereof, the term &#8220;income&#8221; is not limited to &#8220;adjusted gross income&#8221; as that term is defined for federal income tax purposes, but rather includes certain items of income which are deducted in
                  computing &#8220;adjusted gross income&#8221;.&#160; For investors who are salaried employees, the gross salary of such investor, minus any significant expenses personally incurred by such investor in connection with earning the salary, plus any income
                  from any other source including unearned income, is a fair measure of &#8220;income&#8221; for purposes hereof.&#160; For investors who are self&#8209;employed, &#8220;income&#8221; is generally construed to mean total revenues received during the calendar year minus
                  significant expenses incurred in connection with earning such revenues.</div>
              </td>
            </tr>

        </table>
        <div> <br>
        </div>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">43</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div>8.B&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Applicable to Corporations, Partnerships, Trusts, Limited Liability Companies and other Entities&#160;ONLY:</div>
      <div>&#160;</div>
      <div style="text-align: justify;">The purchaser is an accredited investor because the purchaser falls within at least one of the following categories (Check all appropriate lines):</div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z2db850e524c34024a82b1da342bbb938" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 72pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top;">___</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>(i) a bank as defined in Section 3(a)(2) of the Act or any savings and loan association or other institution as defined in Section 3(a)(5)(A) of the Act whether acting in its individual or fiduciary capacity;</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z3a7ac81c4f9f45a19ecd0d7cf96b241a" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 72pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top;">___</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>(ii) a broker&#8209;dealer registered pursuant to Section 15 of the Securities Exchange Act of 1934, as amended;</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" id="zdeb1f4f9b3c64332819d12fdc5652bfe" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 72pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top;">___</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>(iii) an investment adviser registered pursuant to Section 203 of the Investment Advisers Act of 1940 or registered pursuant to the laws of a state;</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z77c83cc44ce74b1ab71b5969a5c90114" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 72pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top;">___</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>(iv) an investment adviser relying on the exemption from registering with the Commission under Section 203(l) or (m) of the Investment Advisers Act of 1940;</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z34d5fbf7a6c34dc3bc85a40e37c5110a" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 72pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top;">___</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>(v) an insurance company as defined in Section 2(13) of the Act;</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z5d984d34ef9f4ac68a202c122f207d53" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 72pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top;">___</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>(vi) an investment company registered under the Investment Company Act of 1940, as amended (the &#8220;Investment Act&#8221;) or a business development company as defined in Section 2(a)(48) of the Investment Act;</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" id="zeb873ccc62674b08b8083a68f994e0a5" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 72pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top;">___</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>(vii) a Small Business Investment Company licensed by the U.S. Small Business Administration under Section 301(c) or (d) of the Small Business Investment Act of 1958, as amended;</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z3095e398369344ec9f41b65ce1e63537" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 72pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top;">___</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>(viii) a Rural Business Investment Company as defined in Section 384A of the Consolidated Farm and Rural Development Act;</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z557f8f0962a941df81391b5c49f4c978" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 72pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top;">___</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>(ix) a plan established and maintained by a state, its political subdivisions, or any agency or instrumentality of a state or its political subdivisions, for the benefit of its employees, where such plan has total assets in excess of
                $5,000,000;</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z5b7283d6357941e4aa2dbbf4031f8243" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 72pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top;">___</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>(x) an employee benefit plan within the meaning of Title 1 of the Employee Retirement Income Security Act of 1974, as amended (the &#8220;Employee Act&#8221;), where the investment decision is made by a plan fiduciary, as defined in Section&#160;3(21) of
                the Employee Act, which is either a bank, savings and loan association, insurance company, or registered investment adviser, or an employee benefit plan that has total assets in excess of $5,000,000, or a self&#8209;directed plan the investment
                decisions of which are made solely by persons that are accredited&#160;investors;</div>
            </td>
          </tr>

      </table>
      <div> <br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">44</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" id="zaa9856112cbb4538b953642ea2e4cd7f" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 72pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top;">___</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>(xi) a private business development company, as defined in Section 202(a)(22) of the Investment Advisers Act of 1940, as amended;</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z133c55728a514eeb89b10b607d3458c4" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 72pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top;">___</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>(xii) an organization described in Section 501(c)(3) of the Internal Revenue Code, a corporation, a Massachusetts or similar business trust, or a partnership, or limited liability company, not formed for the specific purpose of acquiring
                the securities offered, with total assets in excess of $5,000,000;</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" id="ze9cc73de6d534eedbf6c7b157fce48f3" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 72pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top;">___</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>(xiii) a director, executive officer, or general partner of the issuer of the securities being offered or sold, or any director, executive officer, or general partner of a general partner of that issuer;</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z86d5773ae88a4acba2801561fecd0434" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 72pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top;">___</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>(xiv) a natural person whose individual net worth, or joint net worth with that person&#8217;s spouse or spousal equivalent exceeds $1,000,000;</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z577dc4d8fa2e479d8967410875deaff7" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 72pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top;">___</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>(xv) a natural person who had an individual income in excess of $200,000 in each of the two most recent years or joint income with that person&#8217;s spouse or spousal equivalent in excess of $300,000 in each of those years and has a
                reasonable expectation of reaching the same income level in the current year;</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z813ddd9c61554a2892f6093b7f531fb9" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 72pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top;">___</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>(xvi) a trust, with total assets in excess of $5,000,000, not formed for the specific purpose of acquiring the securities offered, whose purchase is directed by a &#8220;sophisticated&#8221; person, as described in Rule 506(b)(2)(ii) promulgated
                under the Act, who has such knowledge and experience in financial and business matters that he or she is capable of evaluating the merits and risks of the prospective&#160;investment;</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z665d3b85826045aebdb75fb54a651a7d" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 72pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top;">___</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>(xvii) a natural person holding in good standing one or more professional certifications or designations or credentials from an accredited educational institution that the Commission has designated as qualifying an individual for
                accredited investor status;</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z4d2da5208ccb414bbbe0a732961e63e9" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 72pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top;">___</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>(xviii) a natural person who is a &#8220;knowledgeable employee&#8221; as defined in Rule&#160;3c5(a)(4) under the Investment Company Act of 1940 (17 CFR 270.3c&#8209;5(a)(41)), of the issuer of the securities being offered or sold where the issuer would be an
                investment company, as defined in Section 3 of such act, but for the exclusion provided by either Section 3(c)(1) or Section 3(c)(7) of such Act;</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z874c7745a0d24374bb121e51e0421040" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 72pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top;">___</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>(xix) a &#8220;family office&#8221;, as defined in Rule 202(a)(11)(G)-1 under the Investment Advisers Act of 1940 (17CFR 275.202(a)(11)(G)-1) (the &#8220;Family Office Rule&#8221;), with assets under management in excess of $5,000,000, that is not formed for
                the specific purpose of acquiring the securities offered, and whose prospective investment is directed by a person who has such knowledge and experience in financial and business matters that such family office is capable of evaluating the
                merits and risks of the prospective investment;</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z3cccbacfc1004d0792b95cb286c89e4d" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 72pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top;">___</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>(xx) a &#8220;family client&#8221; as defined in the Family Office Rule, of a family office that satisfies the above requirements and whose investments are directed by that family&#160;office;</div>
            </td>
          </tr>

      </table>
      <div> <br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">45</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" id="z12de3f7910b34b1d8cbc1c0f9c97f699" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 72pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top;">___</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>(xxi) an individual that holds professional certification or designation or credentials in good standing from an accredited institution that the Securities and Exchange Commission has designated as sufficient to demonstrate his or her
                investment knowledge, which initially consists of Series 7, 65 or 82 exam, but may be expanded in the future to encompass other exams or certifications as sufficient by order if the designations satisfy specified criteria;</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z4d63c81b35e34507a86400af83a7da97" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 72pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top;">___</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>(xxii) an entity not otherwise specified in the accredited investor definition and not formed for the specific purpose of acquiring the securities offered that owns more than $5,000,000 in &#8220;investments&#8221; as defined in Rule 2a51-1(b);</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z1ef258eb3aa14a7a82c9ac2be9349756" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 72pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top;">___</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>(xxiii) an investment adviser registered under the Investment Advisers Act of 1940, as amended or a person exempt from registration as a private fund adviser or a venture capital adviser;</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z022ca5c337c7486a81e645662df00807" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 72pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top;">___</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>(xxiv) an entity in which all of the equity investors are persons or entities described above (&#8220;accredited investors&#8221;).&#160; ALL EQUITY OWNERS MUST COMPLETE &#8220;EXHIBIT A&#8221; ATTACHED HERETO.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="text-align: justify;">9.A&#160;&#160;&#160;&#160;&#160;&#160; Do you have sufficient knowledge and experience in financial and business matters so as to be capable of evaluating the merits and risks associated with investing in the Company?</div>
      <div>&#160;</div>
      <div>
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

            <tr>
              <td style="width: 15%; padding-bottom: 2px;"><br>
              </td>
              <td style="width: 5%; border-bottom: 2px solid rgb(0, 0, 0);">
                <div>&#160;</div>
              </td>
              <td style="width: 10%; padding-bottom: 2px;" colspan="1">&#160;</td>
              <td style="width: 5%; border-bottom: 2px solid rgb(0, 0, 0);">
                <div>&#160;</div>
              </td>
              <td style="width: 65%; padding-bottom: 2px;">
                <div>&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 15%;"><br>
              </td>
              <td style="width: 5%;">
                <div>Yes</div>
              </td>
              <td style="width: 10%;" colspan="1">&#160;</td>
              <td style="width: 5%;">
                <div>No</div>
              </td>
              <td style="width: 65%;">
                <div>&#160;</div>
              </td>
            </tr>

        </table>
      </div>
      <br>
      <div>ANSWER QUESTION 9B ONLY IF THE ANSWER TO QUESTION 9A WAS &#8220;NO.&#8221;</div>
      <div>&#160;</div>
      <div style="text-align: justify;">9.B&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;If the answer to Question 9A was &#8220;NO,&#8221; do you have a financial or investment adviser (a) that is acting in the capacity as a purchaser representative and (b) who has sufficient knowledge and experience
        in financial and business matters so as to be capable of evaluating the merits and risks associated with investing in the Company?</div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

          <tr>
            <td style="width: 15%; padding-bottom: 2px;"><br>
            </td>
            <td style="width: 5%; border-bottom: 2px solid rgb(0, 0, 0);">
              <div>&#160;</div>
            </td>
            <td style="width: 10%; padding-bottom: 2px;" colspan="1">&#160;</td>
            <td style="width: 5%; border-bottom: 2px solid rgb(0, 0, 0);">
              <div>&#160;</div>
            </td>
            <td style="width: 65%; padding-bottom: 2px;">
              <div>&#160;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 15%;"><br>
            </td>
            <td style="width: 5%;">
              <div>Yes</div>
            </td>
            <td style="width: 10%;" colspan="1">&#160;</td>
            <td style="width: 5%;">
              <div>No</div>
            </td>
            <td style="width: 65%;">
              <div>&#160;</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="text-align: justify;">If you have a financial or investment adviser(s), please identify each such person and indicate his or her business address and telephone number in the space below.&#160; (Each such person must complete, and you must
        review and acknowledge, a separate Purchaser Representative Questionnaire which will be supplied at your request).</div>
      <div>&#160;</div>
      <div style="text-align: justify;">10.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; You have the right, will be afforded an opportunity, and are encouraged to investigate the Company and review relevant factors and documents pertaining to the officers of the Company, and the Company and
        its business and to ask questions of a qualified representative of the Company regarding this investment and the properties, operations, and methods of doing business of the Company.</div>
      <div style="text-align: justify;"><br>
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

            <tr>
              <td style="width: 100%; border-bottom: 2px solid rgb(0, 0, 0);"><br>
              </td>
            </tr>
            <tr>
              <td style="width: 100%;">
                <div>&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 100%; border-bottom: 2px solid rgb(0, 0, 0);">
                <div>&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 100%;">
                <div>&#160;</div>
              </td>
            </tr>

        </table>
      </div>
      <div style="text-align: justify;"> <br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">46</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify;">Have you or has your purchaser representative, if any, conducted any such investigation, sought such documents or asked questions of a qualified representative of the Company regarding this investment and the
        properties, operations, and methods of doing business of the Company?</div>
      <div style="text-align: justify;"> <br>
      </div>
      <div style="text-align: justify;">
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

            <tr>
              <td style="width: 15%; padding-bottom: 2px;"><br>
              </td>
              <td style="width: 5%; border-bottom: 2px solid rgb(0, 0, 0);">
                <div>&#160;</div>
              </td>
              <td style="width: 10%; padding-bottom: 2px;" colspan="1">&#160;</td>
              <td style="width: 5%; border-bottom: 2px solid rgb(0, 0, 0);">
                <div>&#160;</div>
              </td>
              <td style="width: 65%; padding-bottom: 2px;">
                <div>&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 15%;"><br>
              </td>
              <td style="width: 5%;">
                <div>Yes</div>
              </td>
              <td style="width: 10%;" colspan="1">&#160;</td>
              <td style="width: 5%;">
                <div>No</div>
              </td>
              <td style="width: 65%;">
                <div>&#160;</div>
              </td>
            </tr>

        </table>
      </div>
      <div>&#160;</div>
      <div>
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;" id="z9ac5ac85363a4241ab1233d3b42fb8aa">

            <tr>
              <td style="width: 15%; padding-bottom: 2px;">If so, briefly describe:&#160; <br>
              </td>
              <td style="width: 85%; border-bottom: 2px solid rgb(0, 0, 0);"><br>
              </td>
            </tr>
            <tr>
              <td style="width: 15%;"><br>
              </td>
              <td style="width: 85%;">
                <div>&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="border-bottom: 2px solid rgb(0, 0, 0);" rowspan="1" colspan="2"><br>
              </td>
            </tr>

        </table>
      </div>
      <div> <br>
      </div>
      <div style="text-align: justify;">If so, have you completed your investigation and/or received satisfactory answers to your questions?</div>
      <div style="text-align: justify;"> <br>
      </div>
      <div style="text-align: justify;">
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

            <tr>
              <td style="width: 15%; padding-bottom: 2px;"><br>
              </td>
              <td style="width: 5%; border-bottom: 2px solid rgb(0, 0, 0);">
                <div>&#160;</div>
              </td>
              <td style="width: 10%; padding-bottom: 2px;" colspan="1">&#160;</td>
              <td style="width: 5%; border-bottom: 2px solid rgb(0, 0, 0);">
                <div>&#160;</div>
              </td>
              <td style="width: 65%; padding-bottom: 2px;">
                <div>&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 15%;"><br>
              </td>
              <td style="width: 5%;">
                <div>Yes</div>
              </td>
              <td style="width: 10%;" colspan="1">&#160;</td>
              <td style="width: 5%;">
                <div>No</div>
              </td>
              <td style="width: 65%;">
                <div>&#160;</div>
              </td>
            </tr>

        </table>
      </div>
      <div>&#160;</div>
      <div>11.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Do you understand the nature of an investment in the Company and the risks associated with such an investment?</div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

          <tr>
            <td style="width: 15%; padding-bottom: 2px;"><br>
            </td>
            <td style="width: 5%; border-bottom: 2px solid rgb(0, 0, 0);">
              <div>&#160;</div>
            </td>
            <td style="width: 10%; padding-bottom: 2px;" colspan="1">&#160;</td>
            <td style="width: 5%; border-bottom: 2px solid rgb(0, 0, 0);">
              <div>&#160;</div>
            </td>
            <td style="width: 65%; padding-bottom: 2px;">
              <div>&#160;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 15%;"><br>
            </td>
            <td style="width: 5%;">
              <div>Yes</div>
            </td>
            <td style="width: 10%;" colspan="1">&#160;</td>
            <td style="width: 5%;">
              <div>No</div>
            </td>
            <td style="width: 65%;">
              <div>&#160;</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="text-align: justify;">12.&#160;&#160;&#160;&#160;&#160;&#160; Do you understand that there is no guarantee of any financial return on this investment and that you will be exposed to the risk of losing your entire investment?</div>
      <div style="text-align: justify;"> <br>
      </div>
      <div style="text-align: justify;">
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

            <tr>
              <td style="width: 15%; padding-bottom: 2px;"><br>
              </td>
              <td style="width: 5%; border-bottom: 2px solid rgb(0, 0, 0);">
                <div>&#160;</div>
              </td>
              <td style="width: 10%; padding-bottom: 2px;" colspan="1">&#160;</td>
              <td style="width: 5%; border-bottom: 2px solid rgb(0, 0, 0);">
                <div>&#160;</div>
              </td>
              <td style="width: 65%; padding-bottom: 2px;">
                <div>&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 15%;"><br>
              </td>
              <td style="width: 5%;">
                <div>Yes</div>
              </td>
              <td style="width: 10%;" colspan="1">&#160;</td>
              <td style="width: 5%;">
                <div>No</div>
              </td>
              <td style="width: 65%;">
                <div>&#160;</div>
              </td>
            </tr>

        </table>
      </div>
      <div>&#160;</div>
      <div>13.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Do you understand that this investment is not liquid?</div>
      <div> <br>
      </div>
      <div>
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

            <tr>
              <td style="width: 15%; padding-bottom: 2px;"><br>
              </td>
              <td style="width: 5%; border-bottom: 2px solid rgb(0, 0, 0);">
                <div>&#160;</div>
              </td>
              <td style="width: 10%; padding-bottom: 2px;" colspan="1">&#160;</td>
              <td style="width: 5%; border-bottom: 2px solid rgb(0, 0, 0);">
                <div>&#160;</div>
              </td>
              <td style="width: 65%; padding-bottom: 2px;">
                <div>&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 15%;"><br>
              </td>
              <td style="width: 5%;">
                <div>Yes</div>
              </td>
              <td style="width: 10%;" colspan="1">&#160;</td>
              <td style="width: 5%;">
                <div>No</div>
              </td>
              <td style="width: 65%;">
                <div>&#160;</div>
              </td>
            </tr>

        </table>
      </div>
      <div>&#160;</div>
      <div style="text-align: justify;">14.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Do you have adequate means of providing for your current needs and personal contingencies in view of the fact that this is not a liquid investment?</div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

          <tr>
            <td style="width: 15%; padding-bottom: 2px;"><br>
            </td>
            <td style="width: 5%; border-bottom: 2px solid rgb(0, 0, 0);">
              <div>&#160;</div>
            </td>
            <td style="width: 10%; padding-bottom: 2px;" colspan="1">&#160;</td>
            <td style="width: 5%; border-bottom: 2px solid rgb(0, 0, 0);">
              <div>&#160;</div>
            </td>
            <td style="width: 65%; padding-bottom: 2px;">
              <div>&#160;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 15%;"><br>
            </td>
            <td style="width: 5%;">
              <div>Yes</div>
            </td>
            <td style="width: 10%;" colspan="1">&#160;</td>
            <td style="width: 5%;">
              <div>No</div>
            </td>
            <td style="width: 65%;">
              <div>&#160;</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="text-align: justify;">15.&#160;&#160;&#160;&#160;&#160;&#160;&#160; Are you aware of the Company&#8217;s business affairs and financial condition, and have you acquired all such information about the Company as you deem necessary and appropriate to enable you to reach an
        informed and knowledgeable decision to acquire the Interests?</div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

          <tr>
            <td style="width: 15%; padding-bottom: 2px;"><br>
            </td>
            <td style="width: 5%; border-bottom: 2px solid rgb(0, 0, 0);">
              <div>&#160;</div>
            </td>
            <td style="width: 10%; padding-bottom: 2px;" colspan="1">&#160;</td>
            <td style="width: 5%; border-bottom: 2px solid rgb(0, 0, 0);">
              <div>&#160;</div>
            </td>
            <td style="width: 65%; padding-bottom: 2px;">
              <div>&#160;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 15%;"><br>
            </td>
            <td style="width: 5%;">
              <div>Yes</div>
            </td>
            <td style="width: 10%;" colspan="1">&#160;</td>
            <td style="width: 5%;">
              <div>No</div>
            </td>
            <td style="width: 65%;">
              <div>&#160;</div>
            </td>
          </tr>

      </table>
      <div> <br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">47</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify;">16.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Do you have a &#8220;pre&#8209;existing relationship&#8221; with the Company or any of the officers of the Company?</div>
      <br>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

          <tr>
            <td style="width: 15%; padding-bottom: 2px;"><br>
            </td>
            <td style="width: 5%; border-bottom: 2px solid rgb(0, 0, 0);">
              <div>&#160;</div>
            </td>
            <td style="width: 10%; padding-bottom: 2px;" colspan="1">&#160;</td>
            <td style="width: 5%; border-bottom: 2px solid rgb(0, 0, 0);">
              <div>&#160;</div>
            </td>
            <td style="width: 65%; padding-bottom: 2px;">
              <div>&#160;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 15%;"><br>
            </td>
            <td style="width: 5%;">
              <div>Yes</div>
            </td>
            <td style="width: 10%;" colspan="1">&#160;</td>
            <td style="width: 5%;">
              <div>No</div>
            </td>
            <td style="width: 65%;">
              <div>&#160;</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="text-align: justify;">(For purposes hereof, &#8220;pre&#8209;existing relationship&#8221; means any relationship consisting of personal or business contacts of a nature and duration such as would enable a reasonably prudent investor to be aware of the
        character, business acumen, and general business and financial circumstances of the person with whom such relationship exists.)</div>
      <div>&#160;</div>
      <div style="text-align: justify;">If so, please name the individual or other person with whom you have a pre&#8209;existing relationship and describe the relationship:</div>
      <div>&#160;</div>
      <div>
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;" id="z66279ee96ddb4a43a2ad28dc8d735ebb">

            <tr>
              <td style="width: 85%; border-bottom: 2px solid rgb(0, 0, 0);"><br>
              </td>
              <td style="width: 15%; padding-bottom: 2px;"><br>
              </td>
            </tr>
            <tr>
              <td style="width: 85%;">
                <div>&#160;</div>
              </td>
              <td style="width: 15%;"><br>
              </td>
            </tr>
            <tr>
              <td style="width: 85%; border-bottom: 2px solid rgb(0, 0, 0);">
                <div>&#160;</div>
              </td>
              <td style="width: 15%; padding-bottom: 2px;"><br>
              </td>
            </tr>
            <tr>
              <td style="width: 85%;">
                <div>&#160;</div>
              </td>
              <td style="width: 15%;"><br>
              </td>
            </tr>

        </table>
      </div>
      <div>&#160;</div>
      <div style="text-align: justify;"><font style="font-weight: bold;">17.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;">Exceptions to the representations and warranties made in Section 3.2 of the Securities Purchase Agreement (if no exceptions, write
          &#8220;none&#8221; &#8211; if left blank, the response will be deemed to be &#8220;none&#8221;): ___________________________________________________</font></div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

          <tr>
            <td style="width: 85%; border-bottom: 2px solid rgb(0, 0, 0);"><br>
            </td>
            <td style="width: 15%; padding-bottom: 2px;"><br>
            </td>
          </tr>

      </table>
      <div> <br>
      </div>
      <div>
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;" id="z0e3e399f1c2e4113a7c62bec354ea7b1">

            <tr>
              <td style="width: 5%; padding-bottom: 2px;">Dated: </td>
              <td style="width: 15%; border-bottom: 2px solid rgb(0, 0, 0); text-align: right;">,<br>
              </td>
              <td style="width: 5%; padding-bottom: 2px;">
                <div>2025</div>
              </td>
              <td style="width: 75%; padding-bottom: 2px;" colspan="1"><br>
              </td>
            </tr>

        </table>
      </div>
      <div><br>
      </div>
      <div>If purchaser is one or more individuals (all individuals must sign):</div>
      <div> <br>
      </div>
      <div>
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;" id="z613c623d5c5b4c9da5c30cd22401d6aa">

            <tr>
              <td style="width: 100%; border-bottom: 2px solid rgb(0, 0, 0);"><br>
              </td>
            </tr>
            <tr>
              <td style="width: 100%;">
                <div>(Type or print name of prospective purchaser)</div>
              </td>
            </tr>
            <tr>
              <td style="width: 100%; border-bottom: 2px solid rgb(0, 0, 0);"><br>
              </td>
            </tr>
            <tr>
              <td style="width: 100%;">Signature of prospective purchaser</td>
            </tr>
            <tr>
              <td style="width: 100%; border-bottom: 2px solid rgb(0, 0, 0);"><br>
              </td>
            </tr>
            <tr>
              <td style="width: 100%;">
                <div>Social Security Number</div>
              </td>
            </tr>
            <tr>
              <td style="width: 100%; border-bottom: 2px solid rgb(0, 0, 0);" rowspan="1"><br>
              </td>
            </tr>
            <tr>
              <td style="width: 100%;" rowspan="1">(Type or print name of additional purchaser)</td>
            </tr>
            <tr>
              <td style="width: 100%; border-bottom: 2px solid rgb(0, 0, 0);" rowspan="1">&#160;</td>
            </tr>
            <tr>
              <td style="width: 100%;" rowspan="1">Signature of spouse, joint tenant, tenant in common or other signature, if required</td>
            </tr>
            <tr>
              <td style="width: 100%; border-bottom: 2px solid rgb(0, 0, 0);" rowspan="1">&#160;</td>
            </tr>
            <tr>
              <td style="width: 100%;" rowspan="1">Social Security Number</td>
            </tr>

        </table>
      </div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">48</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: center; font-weight: bold;">Annex A</div>
      <div>&#160;</div>
      <div style="text-align: center; font-weight: bold;">Definition of Accredited Investor</div>
      <div>&#160;</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">The securities will only be sold to investors who represent in writing in the Securities Purchase Agreement that they are accredited investors, as defined in Regulation D, Rule 501 under the Act
        which definition is set forth below:</div>
      <div>&#160;</div>
      <div style="text-align: justify;">1.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; A natural person whose net worth, or joint net worth with spouse or spousal equivalent, at the time of purchase exceeds $1 million (excluding home); or</div>
      <div>&#160;</div>
      <div style="text-align: justify;">2.&#160;&#160;&#160;&#160;&#160;&#160;&#160; A natural person whose individual gross income exceeded $200,000 or whose joint income with that person&#8217;s spouse or spousal equivalent exceeded $300,000 in each of the last two years, and who reasonably
        expects to exceed such income level in the current year; or</div>
      <div>&#160;</div>
      <div style="text-align: justify;">3.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; A trust with total assets in excess of $5 million, not formed for the specific purpose of acquiring the securities offered, whose purchase is directed by a sophisticated person as described in
        Section&#160;230.506(b)(2)(ii); or</div>
      <div>&#160;</div>
      <div style="text-align: justify;">4.&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160; A director or executive officer of the Company; or</div>
      <div>&#160;</div>
      <div>&#160;</div>
      <div style="text-align: justify;">5.&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160; The investor is an entity, all of the owners of which are accredited investors; or</div>
      <div>&#160;</div>
      <div>&#160;</div>
      <div style="text-align: justify;">6.&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; (a) a bank as defined in Section 3(a)(2) of the Act or any savings and loan association or other institution as defined in Section 3(a)(5)(A) of the Act whether acting in its individual or fiduciary
        capacity;</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">(b) any broker or dealer registered pursuant to Section 15 of the Securities Exchange Act of 1934, as amended;</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">(c) an investment adviser registered pursuant to Section 203 of the Investment Advisers Act of 1940 or registered pursuant to the laws of a state;</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">(d) any investment adviser relying on the exemption from registering with the Commission under Section 203(l) or (m) of the Investment Advisers Act of 1940 or registered pursuant to Section 203 of
        the Investment Advisers Act of 1940;</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">(e) an insurance company as defined in Section 2(13) of the Act;</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">(f) an investment company registered under the Investment Company Act of 1940, as amended (the &#8220;Investment Act&#8221;) or a business development company as defined in Section 2(a)(48) of the
        Investment&#160;Act;</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">(g) a Small Business Investment Company licensed by the U.S. Small Business Administration under Section 301(c) or (d) of the Small Business Investment Act of 1958, as amended;</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">(h) a Rural Business Investment Company as defined in Section 384A of the Consolidated Farm and Rural Development Act;</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">(i) an employee benefit plan established and maintained by a state, its political subdivisions, or any agency or instrumentality of a state or its political subdivisions, for the benefit of its
        employees, where such plan has total assets in excess of $5,000,000;</div>
      <div style="text-align: justify; text-indent: 36pt;"> <br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">49</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">(j) an employee benefit plan within the meaning of Title 1 of the Employee Retirement Income Security Act of 1974, as amended (the &#8220;Employee Act&#8221;), where the investment decision is made by a plan
        fiduciary, as defined in Section 3(21) of the Employee Act, which is either a bank, savings and loan association, insurance company, or registered investment adviser, or an employee benefit plan that has total assets in excess of $5,000,000, or a
        self&#8209;directed plan the investment decisions of which are made solely by persons that are accredited investors;</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">(k) a private business development company, as defined in Section 202(a)(22) of the Investment Advisers Act of 1940, as amended;</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">(l) an organization described in Section 501(c)(3) of the Internal Revenue Code, a corporation, a Massachusetts or similar business trust, or a partnership, or limited liability company, not formed
        for the specific purpose of acquiring the securities offered, with total assets in excess of $5,000,000;</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">(m) any natural person holding in good standing one or more professional certifications or designations or credentials from an accredited educational institution that the Commission has designated
        as qualifying an individual for accredited investor status, which in determining whether to designate a professional certification or designation or credential from an accredited educational institution for purposes of this paragraph, the
        Commission will consider, among others, the following attributes:</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">(i), the certification, designation, or credential arises out of an examination or series of examinations administered by a self-regulatory organization or other industry body or
        is issued by an accredited educational institution,</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">(ii) the examination or series of examinations is designed to reliably and validly demonstrate an individual&#8217;s comprehension and sophistication in the areas of securities
        and&#160;investing,</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">(iii) persons obtaining such certification, designation, or credential can reasonably be expected to have sufficient knowledge and experience in financial and business matters to
        evaluate the merits and risks of a prospective investment, and</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">(iv) an indication that an individual holds the certification or designation is either made publicly available by the relevant self-regulatory organization or other industry body
        or is otherwise independently verifiable;</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">(n) a natural person who is a &#8220;knowledgeable employee&#8221; as defined in Rule 3c5(a)(4) under the Investment Company Act of 1940 (17 CFR 270.3c-5(a)(41)), of the issuer of the securities being offered
        or sold where the issuer would be an investment company, as defined in Section 3 of such act, but for the exclusion provided by either Section 3(c)(1) or Section 3(c)(7) of such Act;</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">(o) any &#8220;family office&#8221;, as defined in Rule 202(a)(11)(G)-1 under the Investment Advisers Act of 1940 (17CFR 275.202(a)(11)(G)-1) (the &#8220;Family Office Rule&#8221;), with assets under management in excess
        of $5,000,000, that is not formed for the specific purpose of acquiring the securities offered, and whose prospective investment is directed by a person who has such knowledge and experience in financial and business matters that such family office
        is capable of evaluating the merits and risks of the prospective&#160;investment;</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">(p) any &#8220;family client&#8221; as defined in the Family Office Rule, of a family office that satisfies the above requirements and whose investments are directed by that family office;</div>
      <div style="text-align: justify; text-indent: 36pt;"> <br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">50</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">(q) an entity not otherwise specified in the accredited investor definition and not formed for the specific purpose of acquiring the securities offered that owns more than $5,000,000 in
        &#8220;investments&#8221; as defined in Rule 2a51-1(b); or</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">(r) an investment adviser registered under the Investment Advisers Act of 1940, as amended or a person exempt from registration as a private fund adviser or a venture capital adviser.</div>
      <div style="text-align: justify; text-indent: 36pt;"> <br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">51</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: center;">EXHIBIT &#8220;A&#8221; TO ACCREDITED INVESTOR QUESTIONNAIRE</div>
      <div>&#160;</div>
      <div style="text-align: justify;">ACCREDITED CORPORATIONS, PARTNERSHIPS, LIMITED LIABILITY COMPANIES, TRUSTS OR OTHER ENTITIES INITIALING QUESTION 8B(xi) MUST PROVIDE THE FOLLOWING INFORMATION.</div>
      <div>&#160;</div>
      <div style="text-align: justify;">I hereby certify that set forth below is a complete list of all equity owners in __________________ [NAME OF ENTITY], a ____________ [TYPE OF ENTITY] formed pursuant to the laws of the State of<u>&#160;</u>_________.&#160; I
        also certify that <u>EACH SUCH OWNER HAS INITIALED THE SPACE OPPOSITE HIS OR HER NAME</u> and that each such owner understands that by initialing that space he or she is representing that he or she is an accredited individual investor satisfying
        the test for accredited individual investors indicated under &#8220;Type of Accredited Investor.&#8221;</div>
      <div>&#160;</div>
      <div>
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;" id="z6cc40161c4764dbdb505824540e8f047">

            <tr>
              <td style="width: 50%; padding-bottom: 2px;" rowspan="1">&#160;</td>
              <td style="width: 50%; border-bottom: 2px solid rgb(0, 0, 0);" rowspan="1">&#160;</td>
            </tr>
            <tr>
              <td style="width: 50.00%;"><br>
              </td>
              <td style="width: 50%;">
                <div>
                  <div style="text-align: left;">signature of authorized corporate officer, general partner or trustee</div>
                </div>
              </td>
            </tr>

        </table>
      </div>
      <div><br>
      </div>
      <div style="text-indent: 36pt;"><u>Name of Equity Owner</u>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Type of Accredited Investor</u></div>
      <div>&#160;</div>
      <div>
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;" id="za15f66de884e4a0ca8ae6947f9aa86e7">

            <tr>
              <td style="width: 3%; padding-bottom: 2px;">1.<br>
              </td>
              <td style="width: 97%; border-bottom: 2px solid rgb(0, 0, 0);">
                <div>&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 3%; padding-bottom: 2px;">2.<br>
              </td>
              <td style="width: 97%; border-bottom: 2px solid rgb(0, 0, 0);">
                <div>&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 3%; padding-bottom: 2px;">3.<br>
              </td>
              <td style="width: 97%; border-bottom: 2px solid rgb(0, 0, 0);">
                <div>&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 3%; padding-bottom: 2px;">4.<br>
              </td>
              <td style="width: 97%; border-bottom: 2px solid rgb(0, 0, 0);">
                <div>&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 3%; padding-bottom: 2px;">5.<br>
              </td>
              <td style="width: 97%; border-bottom: 2px solid rgb(0, 0, 0);">
                <div>&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 3%; padding-bottom: 2px;">6.<br>
              </td>
              <td style="width: 97%; border-bottom: 2px solid rgb(0, 0, 0);">
                <div>&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 3%; padding-bottom: 2px;">7.<br>
              </td>
              <td style="width: 97%; border-bottom: 2px solid rgb(0, 0, 0);">
                <div>&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 3%; padding-bottom: 2px;">8.<br>
              </td>
              <td style="width: 97%; border-bottom: 2px solid rgb(0, 0, 0);">
                <div>&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 3%; padding-bottom: 2px;">9.<br>
              </td>
              <td style="width: 97%; border-bottom: 2px solid rgb(0, 0, 0);">
                <div>&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 3%; padding-bottom: 2px;">10.<br>
              </td>
              <td style="width: 97%; border-bottom: 2px solid rgb(0, 0, 0);">
                <div>&#160;</div>
              </td>
            </tr>

        </table>
      </div>
      <div><br>
      </div>
      <div><br>
      </div>
      <div style="text-align: center;"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">52</font></div>
      <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>7
<FILENAME>ny20047547x33_ex10-2.htm
<DESCRIPTION>EXHIBIT 10.2
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc.
         Document created using Broadridge PROfile 25.9.1.5330
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">



  <!--PROfilePageNumberReset%Num%1%%%-->
  <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
  <div>
    <div style="text-align: right; font-weight: bold;">Exhibit 10.2</div>
    <div><br>
    </div>
    <div style="text-align: center; font-weight: bold;">REGISTRATION RIGHTS AGREEMENT</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 72pt;"><font style="font-weight: bold;">REGISTRATION RIGHTS AGREEMENT</font> (this &#8220;<font style="font-weight: bold;">Agreement</font>&#8221;), dated as of September 25, 2025, by and among Momentus Inc., <font style="color: #000000;">a Delaware corporation</font>, with headquarters located at 3901 N. First Street, San Jose, CA, 95134<font style="color: #000000;">&#160;</font>(the &#8220;<font style="font-weight: bold;">Company</font>&#8221;), and the investors listed on
      the Schedule of Purchasers attached hereto (each, a &#8220;<font style="font-weight: bold;">Purchaser</font>&#8221; and collectively, the &#8220;<font style="font-weight: bold;">Purchasers</font>&#8221;).</div>
    <div>&#160;</div>
    <div style="text-indent: 72pt; font-weight: bold;">WHEREAS:</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 72pt;">A.&#160;&#160;&#160;&#160;&#160; &#160;&#160; In connection with the Securities Purchase Agreement by and among the parties hereto dated September 25, 2025 (the &#8220;<font style="font-weight: bold;">Securities Purchase Agreement</font>&#8221;),
      the Company has agreed, upon the terms and subject to the conditions of the Securities Purchase Agreement, to issue and sell to each Purchaser, (i) one or more Secured Convertible Notes (collectively, the &#8220;<font style="font-weight: bold;">Notes</font>&#8221;),

      which will be convertible into shares of the Company&#8217;s common stock, par value $0.001 per share (the &#8220;<font style="font-weight: bold;">Common Stock</font>&#8221;) (the shares of Common Stock issuable upon conversion of the Notes, collectively, the &#8220;<font style="font-weight: bold;">Common Shares</font>&#8221;) and (ii) warrants (the &#8220;<font style="font-weight: bold;">Warrants</font>&#8221;) which will be exercisable to purchase shares of Common Stock (as exercised, collectively, the &#8220;<font style="font-weight: bold;">Warrant Shares</font>&#8221;) in accordance with the terms of the Warrants.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 72pt;">B.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; In accordance with the terms of the Securities Purchase Agreement, the Company has agreed to provide certain registration rights under the Securities Act of 1933, as amended, and the rules
      and regulations thereunder, or any similar successor statute (collectively, the &#8220;<font style="font-weight: bold;">1933 Act</font>&#8221;), and applicable state securities laws.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 72pt;"><font style="font-weight: bold;">NOW, THEREFORE,</font> in consideration of the premises and the mutual covenants contained herein and other good and valuable consideration, the receipt and
      sufficiency of which are hereby acknowledged, the Company and each of the Purchasers hereby agree as follows:</div>
    <div>&#160;</div>
    <div style="text-indent: 72pt;">1.&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160; <u>Definitions</u>.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 72pt;">Capitalized terms used herein and not otherwise defined herein shall have the respective meanings set forth in the Securities Purchase Agreement. As used in this Agreement, the following terms shall
      have the following meanings:</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 108pt;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#8220;<font style="font-weight: bold;">Additional Effective Date</font>&#8221; means the date the Additional Registration Statement is declared effective by the SEC.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 108pt;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#8220;<font style="font-weight: bold;">Additional Effectiveness Deadline</font>&#8221; means the date which is the earlier of (x) (i) in the event that the Additional Registration Statement is not
      subject to a full review by the SEC, thirty (30) calendar days after the earlier of <font style="color: #000000;">the Additional Filing Date and the Additional Filing Deadline </font>or (ii) in the event that the Additional Registration Statement
      is subject to a full review by the SEC, fifty (50) calendar days after the earlier of <font style="color: #000000;">the Additional Filing Date and the Additional Filing Deadline </font>and (y) the fifth (5<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup>) Business Day after the date
      the Company is notified (orally or in writing, whichever is earlier) by the SEC that such Additional Registration Statement will not be reviewed or will not be subject to further review; provided, however, that if the Additional Effectiveness
      Deadline falls on a Saturday, Sunday or other day that the SEC is closed for business, the Additional Effectiveness Deadline shall be extended to the next Business Day on which the SEC is open for business.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 108pt;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8220;<font style="font-weight: bold;">Additional Filing Date</font>&#8221; means the date on which the Additional Registration Statement is filed with the SEC.</div>
    <div style="text-align: justify; text-indent: 108pt;"> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">1</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 108pt;">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#8220;<font style="font-weight: bold;">Additional Filing Deadline</font>&#8221; means if Cutback Shares are required to be included in any Additional Registration Statement, thirty (30) days after
      the date substantially all of the Registrable Securities registered under the immediately preceding Registration Statement are sold.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 108pt;">(e)&#160;&#160;&#160;&#160;&#160;&#160; &#8220;<font style="font-weight: bold;">Additional Registrable Securities</font>&#8221; means, (i) any Cutback Shares not previously included on a Registration Statement and (ii) any capital stock of
      the Company issued or issuable with respect to the Common Shares, the Warrants, the Warrant Shares, or the Cutback Shares, as applicable, as a result of any stock split, stock dividend, recapitalization, exchange or similar event or otherwise without
      regard to any limitations on exercise of the warrants.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 108pt;">(f)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8220;<font style="font-weight: bold;">Additional Registration Statement</font>&#8221; means a registration statement or registration statements of the Company filed under the 1933 Act covering
      the resale of any Additional Registrable Securities.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 108pt;">(g)&#160;&#160;&#160;&#160;&#160;&#160; &#8220;<font style="font-weight: bold;">Additional Required Registration Amount</font>&#8221; means (I) any Cutback Shares not previously included on a Registration Statement, all subject to
      adjustment as provided in Section 2(f) or (II) such other amount as may be permitted by the staff of the SEC pursuant to Rule 415, without regard to any limitations on exercise of the Warrants.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 108pt;">(h)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8220;<font style="font-weight: bold;">Business Day</font>&#8221; means any day other than Saturday, Sunday or any other day on which commercial banks in the City of New York are authorized or
      required by law to remain closed.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 108pt;">(i)&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; &#8220;<font style="font-weight: bold;">Closing Date</font>&#8221; shall have the meaning set forth in the Securities Purchase Agreement.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 108pt;">(j)&#160;&#160;&#160;&#160; &#160; &#160;&#160; &#8220;<font style="font-weight: bold;">Cutback Shares</font>&#8221; means any of the Initial Required Registration Amount or the Additional Required Registration Amount (without regard to clause
      (II) in the definition thereof) of Registrable Securities not included in all Registration Statements previously declared effective as contemplated hereunder as a result of a limitation on the maximum number of shares of Common Stock of the Company
      permitted to be registered by the staff of the SEC pursuant to Rule 415.&#160; For the purpose of determining the Cutback Shares, in order to determine any applicable Required Registration Amount, unless an Investor gives written notice to the Company to
      the contrary with respect to the allocation of its Cutback Shares, first the Warrant Shares shall be excluded on a pro rata basis among the Investors until all of the Warrant Shares have been excluded (sequentially starting with the Warrants having
      the highest Exercise Price and thereafter the next higher price, etc., calculated for each Purchaser based on such Purchaser&#8217;s pro&#8209;rata amount of Warrants included comprising Registrable Securities) and then the Common Shares shall be excluded on a
      pro rata basis among the Investors until all of the Common Shares have been excluded.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 108pt;">(k)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8220;<font style="font-weight: bold;">Effective Date</font>&#8221; means the Initial Effective Date and the Additional Effective Date, as applicable.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 108pt;">(l)&#160;&#160;&#160;&#160;&#160; &#160; &#160;&#160; &#8220;<font style="font-weight: bold;">Effectiveness Deadline</font>&#8221; means the Initial Effectiveness Deadline and the Additional Effectiveness Deadline, as applicable.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 108pt;">(m)&#160;&#160; &#160; &#160;&#160; &#8220;<font style="font-weight: bold;">Eligible Market</font>&#8221; means the Principal Market, The New York Stock Exchange, Inc., the NYSE American, The Nasdaq Capital Market, The Nasdaq Global
      Select Market, The Nasdaq Global Market, the OTC Bulletin Board, the OTCQB or the OTCQX (or any successor to any of the foregoing).</div>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">2</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 108pt;">(n)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8220;<font style="font-weight: bold;">Filing Deadline</font>&#8221; means the Initial Filing Deadline and the Additional Filing Deadline, as applicable.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 108pt;">(o)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#8220;<font style="font-weight: bold;">Initial Effective Date</font>&#8221; means the date that the Initial Registration Statement has been declared effective by the SEC.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 108pt;">(p)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8220;<font style="font-weight: bold;">Initial Effectiveness Deadline</font>&#8221; means the date which is the earlier of (x) (i) in the event that the Initial Registration Statement is not
      subject to a full review by the SEC, forty&#8209;five (45) calendar days after the Initial Filing Deadline, or (ii) in the event that the Initial Registration Statement is subject to a full review by the SEC, ninety (90) calendar days after the date of
      this Agreement, and (y) the fifth (5<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup>) Business Day after the date the Company is notified (orally or in writing, whichever is earlier) by the SEC that such Initial Registration Statement will not be reviewed or will not be subject to
      further review; provided, however, that if the Initial Effectiveness Deadline falls on a Saturday, Sunday or other day that the SEC is closed for business, the Initial Effectiveness Deadline shall be extended to the next Business Day<font style="color: #000000;">.</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 108pt;"><font style="color: #000000;">(q)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8220;<font style="font-weight: bold;">Initial Filing Date</font>&#8221; means the date on which the Initial Registration Statement is filed with the SEC.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 108pt;">(r)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8220;<font style="font-weight: bold;">Initial Filing Deadline</font>&#8221; means thirty (30) calendar days after the date of this Agreement.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 108pt;">(s)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#8220;<font style="font-weight: bold;">Initial Registrable Securities</font>&#8221; means (i) the number of Common Shares issued or issuable upon conversion of the Notes issued pursuant to the
      terms of the Securities Purchase Agreement, at the Conversion Prices set forth in the Notes as of the date of this Agreement, (ii) the Warrant Shares issued or issuable upon exercise of the Warrants, calculated at the Exercise Price set forth in the
      Warrants as of the date of this Agreement, and (iii) any capital stock of the Company issued or issuable with respect to the Common Shares, the Notes, the Warrant Shares or the Warrants as a result of any stock split, stock dividend,
      recapitalization, exchange or similar event, or otherwise without regard to any limitations on conversion of the Notes or exercise of the Warrants, each as calculated at the Exercise Price and the Conversion Price as of the date of this Agreement.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 108pt;">(t)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#8220;<font style="font-weight: bold;">Initial Registration Statement</font>&#8221; means a registration statement or registration statements of the Company filed under the 1933 Act covering the
      resale of the Initial Registrable Securities.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 108pt;">(u)&#160;&#160;&#160;&#160; &#160; &#160; &#8220;<font style="font-weight: bold;">Initial Required Registration Amount</font>&#8221; <font style="color: #000000;">means (I) the sum of (i) the number of Common Shares and (ii) the maximum
        number of Warrant Shares issued and issuable pursuant to the Warrants, without regard to any limitations on exercise of the Warrants</font> or (II) such other amount as may be permitted by the staff of the SEC pursuant to Rule 415.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 108pt;">(v)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#8220;<font style="font-weight: bold;">Investor</font>&#8221; means a Purchaser or any transferee or assignee thereof to whom a Purchaser assigns its rights under this Agreement and who agrees to
      become bound by the provisions of this Agreement in accordance with Section 9 and any transferee or assignee thereof to whom a transferee or assignee assigns its rights under this Agreement and who agrees to become bound by the provisions of this
      Agreement in accordance with Section 9.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 108pt;">(w)&#160;&#160;&#160;&#160; &#160;&#160; &#8220;<font style="font-weight: bold;">Person</font>&#8221; means an individual, a limited liability company, a partnership, a joint venture, a corporation, a trust, an unincorporated organization
      and a government or any department or agency thereof.</div>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">3</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 72pt; margin-left: 36pt;">(x)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="color: #000000;">&#8220;</font><font style="font-weight: bold;">Principal Market</font>&#8221; means The Nasdaq Stock Market.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 108pt;">(y)&#160;&#160;&#160;&#160; &#160; &#160; &#8220;<font style="font-weight: bold;">register</font>,&#8221; &#8220;<font style="font-weight: bold;">registered</font>,&#8221; and &#8220;<font style="font-weight: bold;">registration</font>&#8221; refer to a
      registration effected by preparing and filing one or more Registration Statements (as defined below) in compliance with the 1933 Act and pursuant to Rule 415, and the declaration or ordering of effectiveness of such Registration Statement(s) by the
      SEC.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 108pt;">(z)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8220;<font style="font-weight: bold;">Registrable Securities</font>&#8221; means the Initial Registrable Securities and the Additional Registrable Securities.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 108pt;">(aa)&#160;&#160;&#160;&#160; &#160;&#160; &#8220;<font style="font-weight: bold;">Registration Statement</font>&#8221; means the Initial Registration Statement and the Additional Registration Statement, as applicable.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 108pt;">(bb)&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#8220;<font style="font-weight: bold;">Required Holders</font>&#8221; means holders of at least a majority of the Registrable Securities.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 108pt;">(cc)&#160;&#160;&#160;&#160;&#160; &#8220;<font style="font-weight: bold;">Required Registration Amount</font>&#8221; means either the Initial Required Registration Amount or the Additional Required Registration Amount, as applicable.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 108pt;">(dd)&#160;&#160;&#160;&#160;&#160;&#160; &#8220;<font style="font-weight: bold;">Rule 415</font>&#8221; means Rule 415 promulgated under the 1933 Act or any successor rule providing for offering securities on a continuous or delayed basis.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;">(ee)&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#8220;<font style="font-weight: bold;">SEC</font>&#8221; means the United States Securities and Exchange Commission.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 108pt;">(ff)&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 12pt;"><font style="font-size: 10pt; color: #000000;">&#8220;</font><font style="font-size: 10pt; font-weight: bold; color: #000000;">Trading Day</font><font style="font-size: 10pt; color: #000000;">&#8221; means any day on which the Common Stock is traded on the Principal Market, or, if the Principal Market is not the principal trading market for the Common Stock, then on the principal securities exchange
          or securities market on which the Common Stock is then traded; provided that &#8220;Trading Day&#8221; shall not include any day on which the Common Stock is scheduled to trade on such exchange or market for 3 or more hours or any day that the Common Stock
          is suspended from trading during the final hour of trading</font><font style="color: #000000;">&#160;</font><font style="font-size: 10pt; color: #000000;">on such exchange or market (or if such exchange or market does not designate in advance the
          closing time of trading on such exchange or market, then during the hour ending at 4:00:00 p.m., New York time).</font></font></div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">2.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; <u>Registration</u>.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 108pt;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Initial Mandatory Registration</u>.&#160; Promptly following the Closing Date, the Company shall prepare, and, as soon as practicable but in no event later than the Initial Filing
      Deadline, file with the SEC the Initial Registration Statement on Form S-3 covering the resale of all of the Initial Registrable Securities.&#160; In the event that Form S-3 is unavailable for such a registration, the Company shall use Form S-1 or such
      other form as is available for such a registration on another appropriate form reasonably acceptable to the Required Holders, subject to the provisions of Section 2(e).&#160; The Initial Registration Statement prepared pursuant hereto shall register for
      resale at least the number of shares of Common Stock equal to the Initial Required Registration Amount determined as of the date the Initial Registration Statement is initially filed with the SEC, subject to adjustment as provided in Section 2(f).&#160;
      The Initial Registration Statement shall contain (except if otherwise directed by the Required Holders) the &#8220;<font style="font-weight: bold;">Plan of Distribution</font>&#8221; and &#8220;<font style="font-weight: bold;">Selling Shareholders</font>&#8221; sections in
      substantially the form attached hereto as <u>Exhibit B</u>, with such modifications as may be required by law.&#160; The Company shall use its commercially reasonable efforts to have the Initial Registration Statement declared effective by the SEC as
      soon as practicable, but in no event later than the Initial Effectiveness Deadline.&#160; By 9:30 a.m. New York time on the second (2<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">nd</sup>) Business Day following the Initial Effective Date, the Company shall file with the SEC in accordance with
      Rule 424 under the 1933 Act the final prospectus to be used in connection with sales pursuant to such Initial Registration Statement.&#160; The Company represents and warrants that Cutbacks will not apply with respect to at least 3,552,146 Initial
      Registrable Securities and that not fewer than 3,552,146 shares of Initial Registrable Securities must be included for registration in the Initial Registration Statement.</div>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">4</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 108pt;">(b)&#160;&#160;&#160;&#160; &#160;&#160; <u>Additional Mandatory Registrations</u>.&#160; The Company shall prepare, and, as soon as practicable but in no event later than the Additional Filing Deadline, file with the SEC an
      Additional Registration Statement on Form S-3 covering the resale of all of the Additional Registrable Securities not previously registered on an Additional Registration Statement hereunder.&#160; To the extent the staff of the SEC does not permit the
      Additional Required Registration Amount to be registered on an Additional Registration Statement, the Company shall file Additional Registration Statements successively trying to register on each such Additional Registration Statement the maximum
      number of remaining Additional Registrable Securities until the Additional Required Registration Amount has been registered with the SEC; provided that after two rejections by the SEC of Additional Registration Statements, the Company shall not be
      required to file Additional Registration Statements more frequently than once per sixty day period commencing subsequent to the second rejection.&#160; In the event that Form S-3 is unavailable for such a registration, the Company shall use Form S-1 or
      such other form as is available for such a registration on another appropriate form reasonably acceptable to the Required Holders, subject to the provisions of Section 2(e).&#160; Each Additional Registration Statement prepared pursuant hereto shall
      register for resale at least that number of shares of Common Stock equal to the Additional Required Registration Amount determined as of the date such Additional Registration Statement is initially filed with the SEC<font style="font-weight: bold; font-style: italic;">, </font>subject to adjustment as provided in Section 2(f).&#160; Each Additional Registration Statement shall contain (except if otherwise directed by the Required Holders) the &#8220;<font style="font-weight: bold;">Plan of
        Distribution</font>&#8221; and &#8220;<font style="font-weight: bold;">Selling Shareholders</font>&#8221; sections in substantially the form attached hereto as <u>Exhibit B</u>, with such modifications as may be required by law.&#160; The Company shall use its
      commercially reasonable efforts to have each Additional Registration Statement declared effective by the SEC as soon as practicable, but in no event later than the Additional Effectiveness Deadline.&#160; By 9:30 a.m. New York time on the second (2<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">nd</sup>)
      Business Day following the Additional Effective Date, the Company shall file with the SEC in accordance with Rule 424 under the 1933 Act the final prospectus to be used in connection with sales pursuant to such Additional Registration Statement.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 108pt;">(c)&#160;&#160;&#160;&#160; &#160;&#160; <u>Allocation of Registrable Securities</u>.&#160; The initial number of Registrable Securities included in any Registration Statement and any increase or decrease in the number of
      Registrable Securities included therein shall be allocated pro rata among the Investors based on the number of Registrable Securities held by each Investor at the time the Registration Statement covering such initial number of Registrable Securities
      or increase or decrease thereof is declared effective by the SEC.&#160; In the event that an Investor sells or otherwise transfers any of such Investor's Registrable Securities, each transferee shall be allocated a pro rata portion of the then remaining
      number of Registrable Securities included in such Registration Statement for such transferor.&#160; Any shares of Common Stock included in a Registration Statement and which remain allocated to any Person which ceases to hold any Registrable Securities
      covered by such Registration Statement shall be allocated to the remaining Investors, pro rata based on the number of Registrable Securities then held by such Investors which are covered by such Registration Statement.&#160; In no event shall the Company
      include any securities other than Registrable Securities on any Registration Statement without the prior written consent of the Required Holders.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 108pt;">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Legal Counsel</u>.&#160; Subject to Section 5 hereof, the Required Holders shall have the right to select one legal counsel at their sole cost to review and oversee any registration
      pursuant to this Section 2 (&#8220;<font style="font-weight: bold;">Legal Counsel</font>&#8221;), which shall be Grushko &amp; Mittman, P.C., or such other counsel as thereafter designated by the Required Holders.&#160; The Company and Legal Counsel shall reasonably
      cooperate with each other in performing the Company&#8217;s obligations under this Agreement.</div>
    <div style="text-align: justify; text-indent: 108pt;"> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">5</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 108pt;">(e)&#160;&#160;&#160;&#160;&#160;&#160; <u>Ineligibility for Form S-3</u>.&#160; In the event that Form S-3 is not available for the registration of the resale of Registrable Securities hereunder, the Company shall (i) register the
      resale of the Registrable Securities on Form S-1 or another appropriate form reasonably acceptable to the Required Holders and (ii) undertake to register the Registrable Securities on Form S-3 as soon as such form is available, provided that the
      Company shall maintain the effectiveness of the Registration Statement then in effect until such time as any such Registration Statement on Form S-3 filed by the Company covering the Registrable Securities has been declared effective by the SEC.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 108pt;">(f)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Sufficient Number of Shares Registered</u>.&#160; In the event the number of shares available under a Registration Statement filed pursuant to Section 2(a) or Section 2(b) is insufficient
      to cover at least eighty percent (80%) of the Required Registration Amount of Registrable Securities required to be covered by such Registration Statement or an Investor&#8217;s allocated portion of the Registrable Securities pursuant to Section 2(c), the
      Company shall amend the applicable Registration Statement, or file a new Registration Statement (on the short form available therefor, if applicable), or both, so as to cover at least the Required Registration Amount as of the Trading Day immediately
      preceding the date of the filing of such amendment or new Registration Statement, in each case, as soon as practicable, but in any event not later than fifteen (15) days after the necessity therefor arises.&#160; The Company shall use its commercially
      reasonable efforts to cause such amendment and/or new Registration Statement to become effective as soon as practicable following the filing thereof.&#160; For purposes of the foregoing provision, the number of shares available under a Registration
      Statement shall be deemed &#8220;insufficient to cover all of the Registrable Securities&#8221; if at any time the number of shares of Common Stock available for resale under the Registration Statement is less than the Required Registration Amount. The
      calculation set forth in the foregoing sentence shall be made without regard to any limitations on the exercise of the Warrants and such calculation shall assume the Warrants are then exercisable in full into shares of Common Stock at the then
      prevailing Exercise Price (as defined in the Warrants).</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 108pt;">(g)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u></u><u>Effect of Failure to File and Obtain and Maintain Effectiveness of Registration Statement</u>.&#160; If (i) the Initial Registration Statement when declared effective fails to
      register the Initial Required Registration Amount of Initial Registrable Securities (a &#8220;<font style="font-weight: bold;">Registration Failure</font>&#8221;), (ii) a Registration Statement covering all of the Registrable Securities required to be covered
      thereby and required to be filed by the Company pursuant to this Agreement is (A) not filed with the SEC on or before the applicable Filing Deadline (a &#8220;<font style="font-weight: bold;">Filing Failure</font>&#8221;) or (B) not declared effective by the SEC
      on or before the applicable Effectiveness Deadline, (an &#8220;<font style="font-weight: bold;">Effectiveness Failure</font>&#8221;)<font style="font-weight: bold;">&#160;</font>or (iii) on any day after the applicable Effective Date, sales of all of the Registrable
      Securities required to be included on such Registration Statement cannot be made (other than during an Allowable Grace Period (as defined in Section 3(r))) pursuant to such Registration Statement or otherwise (including, without limitation, because
      of the suspension of trading or any other limitation imposed by an Eligible Market, a failure to keep such Registration Statement effective, a failure to disclose such information as is necessary for sales to be made pursuant to such Registration
      Statement, a failure to register a sufficient number of shares of Common Stock or a failure to maintain the listing of the Common Stock) (a &#8220;<font style="font-weight: bold;">Maintenance Failure</font>&#8221; and collectively with a Registration Failure, a
      Filing Failure, and an Effectiveness Failure, the &#8220;<font style="font-weight: bold;">Failures</font>&#8221; and each a &#8220;<font style="font-weight: bold;">Failure</font>&#8221;), then, as partial relief for the damages to any holder by reason of a Failure (which
      remedy shall not be exclusive of any other remedies available at law or in equity, including, without limitation, specific performance or the additional obligation of the Company to register any Cutback Shares), the Company shall pay to each holder
      of Registrable Securities relating to such Registration Statement an amount in cash equal to one percent (1.0%) of the aggregate Subscription Amount (as defined in the Securities Purchase Agreement) of such Investor&#8217;s Registrable Securities whether
      or not included in such Registration Statement, on each of the following dates: (i) the day of a Registration Failure, (ii) the day of a Filing Failure; (iii) the day of an Effectiveness Failure; (iv) the initial day of a Maintenance Failure; (v) on
      the thirtieth day after the date of a Registration Failure and every thirtieth day thereafter (pro rated for periods totaling less than thirty days) until such Registration Failure is cured; (vi) on the thirtieth day after the date of a Filing
      Failure and every thirtieth day thereafter (pro rated for periods totaling less than thirty days) until such Filing Failure is cured; (vii) on the thirtieth day after the date of an Effectiveness Failure and every thirtieth day thereafter (pro rated
      for periods totaling less than thirty days) until such Effectiveness Failure is cured; and (viii) on the thirtieth day after the initial date of a Maintenance Failure and every thirtieth day thereafter (pro rated for periods totaling less than thirty
      days) until such Maintenance Failure is cured; provided however, in the event that there shall be more than one Failure occurring simultaneously, the 1.0% shall apply in the aggregate (e.g., during any single or multiple Failure, 1% shall be due,
      however 1% shall not be due &#8220;per Failure&#8221; if the Failures are simultaneous and for so long as such Failures are simultaneous).&#160; The payments to which a holder shall be entitled pursuant to this Section 2(g) are referred to herein as &#8220;<font style="font-weight: bold;">Registration Delay Payments</font>.&#8221;&#160; Registration Delay Payments shall be paid on the earlier of (I) the dates set forth above and (II) the third Business Day after the event or failure giving rise to the Registration
      Delay Payments is cured.&#160; In the event the Company fails to make Registration Delay Payments in a timely manner, such Registration Delay Payments shall bear interest at the rate of one percent (1%) per month (prorated for partial months) until paid
      in full.&#160; Notwithstanding anything to the contrary contained herein, Registration Delay Payments shall (i) not, in the aggregate, exceed twenty percent (20%) of the aggregate Purchase Price, (ii) cease to accrue when all of the Registrable Securities
      may be sold pursuant to Rule 144 without any restrictions or limitations and (iii) cease to accrue upon the termination of the Registration Period (as defined below).</div>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">6</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 108pt;">(h)&#160;&#160;&#160;&#160; &#160; &#160; <u>Limitation on Other Registration Statements</u>.&#160; The Company shall not file another registration statement under the 1933 Act prior to the earlier of (i) date that the Initial
      Registration Statement is declared effective by the SEC and (ii) the end of the Registration Period (as defined in Section 3(a); <u>provided that</u>, this Section 2(h) shall not prevent the Company from filing a registration statement on Form S-4
      beginning thirty (30) days after the initial filing of the Initial Registration Statement with the SEC or Form S-8, with the SEC at any time.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 72pt;">3.&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160; <u>Related Obligations</u>.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 72pt;">At such time as the Company is obligated to file a Registration Statement with the SEC pursuant to Section 2(a), 2(b), 2(e) or 2(f), the Company will use its commercially reasonable efforts to effect
      the registration of the Registrable Securities in accordance with the intended method of disposition thereof and, pursuant thereto, the Company shall have the following obligations:</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 108pt;">(a)&#160;&#160;&#160;&#160;&#160; The Company shall promptly prepare and file with the SEC a Registration Statement with respect to the Registrable Securities and use its commercially reasonable efforts to cause such
      Registration Statement relating to the Registrable Securities to become effective as soon as practicable after such filing (but in no event later than the Effectiveness Deadline).&#160; The Company shall keep each Registration Statement effective pursuant
      to Rule 415 at all times until the earliest of (i) the date that is two (2) years after each Effective Date, (ii) the date on which the Investors shall have sold all of the Registrable Securities required to be covered by such Registration Statement,
      or (iii) may be sold pursuant to Rule 144 without any information of volume restrictions (the &#8220;<font style="font-weight: bold;">Registration Period</font>&#8221;).&#160; The Company shall ensure that each Registration Statement (including any amendments or
      supplements thereto and prospectuses contained therein) shall not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein, or necessary to make the statements therein (in the case of
      prospectuses, in the light of the circumstances in which they were made) not misleading.&#160; The term &#8220;commercially reasonable efforts&#8221; shall mean, among other things, that the Company shall submit to the SEC, within two (2) Business Days after the
      later of the date that (i) the Company learns that no review of a particular Registration Statement will be made by the staff of the SEC or that the staff has no further comments on a particular Registration Statement, as the case may be, and (ii)
      the approval of Legal Counsel pursuant to Section 3(c) (which approval is immediately sought), a request for acceleration of effectiveness of such Registration Statement to a time and date not later than two (2) Business Days after the submission of
      such request.&#160; The Company shall respond in writing to comments made by the SEC in respect of a Registration Statement as soon as practicable, but in no event later than fifteen (15) days after the receipt of comments by or notice from the SEC that
      an amendment is required in order for a Registration Statement to be declared effective.</div>
    <div style="text-align: justify; text-indent: 108pt;"> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">7</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 108pt;">(b)&#160;&#160;&#160;&#160;&#160;&#160; The Company shall prepare and file with the SEC such amendments (including post-effective amendments) and supplements to a Registration Statement and the prospectus used in connection with
      such Registration Statement, which prospectus is to be filed pursuant to Rule 424 promulgated under the 1933 Act, as may be necessary to keep such Registration Statement effective at all times during the Registration Period, and, during such period,
      comply with the provisions of the 1933 Act with respect to the disposition of all Registrable Securities of the Company covered by such Registration Statement until such time as all of such Registrable Securities shall have been disposed of in
      accordance with the intended methods of disposition by the seller or sellers thereof as set forth in such Registration Statement.&#160; In the case of amendments and supplements to a Registration Statement which are required to be filed pursuant to this
      Agreement (including pursuant to this Section 3(b)) by reason of the Company filing a report on Form 10-K, Form 10-Q, Form 8-K or any analogous report under the Securities Exchange Act of 1934, as amended (the &#8220;<font style="font-weight: bold;">1934
        Act</font>&#8221;), the Company shall have incorporated such report by reference into such Registration Statement, if applicable, or shall file such amendments or supplements with the SEC on the same day on which the 1934 Act report is filed which
      created the requirement for the Company to amend or supplement such Registration Statement.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 108pt;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; The Company shall (A) permit Legal Counsel to review and comment upon (i) a Registration Statement at least three (3) Business Days prior to its filing with the SEC and (ii) all
      amendments and supplements to all Registration Statements (except for those filed by reason of the Company filing Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, and any similar or successor reports) within a
      reasonable number of days prior to their filing with the SEC, (B) permit each Investor to review and comment on the &#8220;Plan of Distribution&#8221; and &#8220;Selling Shareholders&#8221; sections of the Registration Statement and all amendments and supplements to the
      Registration Statement to the extent any changes are made to those sections, and (C) not file any Registration Statement or amendment or supplement thereto in a form to which Legal Counsel reasonably objects; provided however, that if the delay in
      filing the Registration Statement is due to Legal Counsel&#8217;s or an Investor&#8217;s unreasonable objections (and unreasonable refusal to allow the Company to file the Registration Statement) then in such event, no Registration Failure (or similar event that
      triggers a Registration Delay Payment) shall be deemed to have occurred with such delay arising from Legal Counsel&#8217;s unreasonable objections, or solely with respect to an Investor, arising from such Investor&#8217;s unreasonable objections.&#160; The Company
      shall not submit a request for acceleration of the effectiveness of a Registration Statement or any amendment or supplement thereto without the prior approval of Legal Counsel, which consent shall not be unreasonably withheld; provided however, that
      if the delay in filing the effectiveness of the Registration Statement is due to Legal Counsel&#8217;s unreasonable objections (and unreasonable refusal to allow the Registration Statement to become effective) then in such event, no Effectiveness Failure
      (or similar event that triggers a Registration Delay Payment) shall be deemed to have occurred. The Company shall furnish to Legal Counsel, without charge, copies of any correspondence from the SEC or the staff of the SEC to the Company or its
      representatives relating to any Registration Statement.&#160; The Company shall reasonably cooperate with Legal Counsel in performing the Company&#8217;s obligations pursuant to this Section 3.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 108pt;">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160; The Company shall furnish to each Investor whose Registrable Securities are included in any Registration Statement, without charge, (i) promptly after the same is prepared and filed with
      the SEC, at least one copy of such Registration Statement and any amendment(s) thereto, including financial statements and schedules, all documents incorporated therein by reference, if requested by an Investor, all exhibits and each preliminary
      prospectus, (ii) upon the effectiveness of any Registration Statement, ten (10) copies of the prospectus included in such Registration Statement and all amendments and supplements thereto (or such other number of copies as such Investor may
      reasonably request) and (iii) such other documents, including copies of any preliminary or final prospectus, as such Investor may reasonably request from time to time in order to facilitate the disposition of the Registrable Securities owned by such
      Investor.</div>
    <div style="text-align: justify; text-indent: 108pt;"> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">8</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 108pt;">(e)&#160;&#160;&#160;&#160; &#160; &#160; The Company shall use its commercially reasonable efforts to (i) register and qualify, unless an exemption from registration and qualification applies, the resale by Investors of the
      Registrable Securities covered by a Registration Statement under such other securities or &#8220;blue sky&#8221; laws of all applicable jurisdictions in the United States, (ii) prepare and file in those jurisdictions such amendments (including post-effective
      amendments) and supplements to such registrations and qualifications as may be necessary to maintain the effectiveness thereof during the Registration Period, (iii) take such other actions as may be necessary to maintain such registrations and
      qualifications in effect at all times during the Registration Period, and (iv) take all other actions reasonably necessary or advisable to qualify the Registrable Securities for sale in such jurisdictions; provided, however, that the Company shall
      not be required in connection therewith or as a condition thereto to (x) qualify to do business in any jurisdiction where it would not otherwise be required to qualify but for this Section 3(e), (y) subject itself to general taxation in any such
      jurisdiction, or (z) file a general consent to service of process in any such jurisdiction.&#160; The Company shall promptly notify Legal Counsel of the receipt by the Company of any notification with respect to the suspension of the registration or
      qualification of any of the Registrable Securities for sale under the securities or &#8220;blue sky&#8221; laws of any jurisdiction in the United States or its receipt of actual notice of the initiation or threatening of any proceeding for such purpose.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 108pt;">(f)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; The Company shall notify Investors in writing of the happening of any event, as promptly as practicable but not later than the first Business Day after becoming aware of such event, (i)
      as a result of which the prospectus included in a Registration Statement, as then in effect, includes an untrue statement of a material fact or omission to state a material fact required to be stated therein or necessary to make the statements
      therein, in the light of the circumstances under which they were made, not misleading (provided that in no event shall such notice contain any material, nonpublic information), or (ii) that results in the lack of effectiveness of any Registration
      Statement, and, subject to Section 3(r), promptly prepare a supplement or amendment to such Registration Statement to correct such untrue statement or omission, or lack of effectiveness of any Registration Statement.&#160; The Company shall also promptly
      notify Legal Counsel in writing (i) when a prospectus or any prospectus supplement or post&#8209;effective amendment has been filed, and when a Registration Statement or any post-effective amendment has become effective (notification of such effectiveness
      shall be delivered to Legal Counsel by facsimile or email on the same day of such effectiveness and by overnight mail), (ii) of any request by the SEC for amendments or supplements to a Registration Statement or related prospectus or related
      information, and (iii) of the Company&#8217;s reasonable determination that a post-effective amendment to a Registration Statement would be appropriate.&#160; By 9:30 a.m. New York City time on the second (2<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">nd</sup>) day following the date any
      post-effective amendment has become effective, the Company shall file with the SEC in accordance with Rule 424 under the 1933 Act the final prospectus to be used in connection with sales pursuant to such Registration Statement.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 108pt;">(g)&#160;&#160;&#160;&#160;&#160;&#160; The Company shall use its commercially reasonable efforts to prevent the issuance of any stop order or other suspension of effectiveness of a Registration Statement, or the suspension of
      the qualification of any of the Registrable Securities for sale in any jurisdiction and, if such an order or suspension is issued, to obtain the withdrawal of such order or suspension at the earliest possible moment and to notify Legal Counsel of the
      issuance of such order and the resolution thereof or its receipt of actual notice of the initiation or threat of any proceeding for such purpose.</div>
    <div style="text-align: justify; text-indent: 108pt;"> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">9</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 108pt;">(h)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; If any Investor is required by the SEC to be described in the Registration Statement as an underwriter or the Company and an Investor agree that it should be identified as an underwriter
      of Registrable Securities in the Registration Statement and the Registration Statement is so modified, the Company shall furnish to such Investor, on the date of the effectiveness of the Registration Statement and thereafter from time to time on such
      dates as an Investor may reasonably request (i) a letter, dated such date, from the Company&#8217;s independent certified public accountants in form and substance as is customarily given by independent certified public accountants to underwriters in an
      underwritten public offering, addressed to the Investors, and (ii) an opinion, dated as of such date, of counsel representing the Company for purposes of such Registration Statement, in form, scope and substance as is customarily given in an
      underwritten public offering, addressed to the Investors.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 108pt;">(i)&#160;&#160;&#160;&#160;&#160;&#160; &#160; If any Investor is required under applicable securities laws to be described in the Registration Statement as an underwriter or the Company and an Investor agrees that it could
      reasonably be deemed to be an underwriter of Registrable Securities, the Company shall make available for inspection by (i) such Investor, (ii) Legal Counsel and (iii) one firm of accountants or other agents retained by the Investors (collectively,
      the &#8220;<font style="font-weight: bold;">Inspectors</font>&#8221;), all pertinent financial and other records, and pertinent corporate documents and properties of the Company (collectively, the &#8220;<font style="font-weight: bold;">Records</font>&#8221;), as shall be
      reasonably deemed necessary by each Inspector, and cause the Company's officers, directors and employees to supply all information which any Inspector may reasonably request; provided, however, that each Inspector shall agree to hold in strict
      confidence and shall not make any disclosure (except to an Investor) or use of any Record or other information which the Company determines in good faith to be confidential, and of which determination the Inspectors are so notified, unless (a) the
      disclosure of such Records is necessary to avoid or correct a misstatement or omission in any Registration Statement or is otherwise required under the 1933 Act, (b) the release of such Records is ordered pursuant to a final, non-appealable subpoena
      or order from a court or government body of competent jurisdiction, or (c) the information in such Records has been made generally available to the public other than by disclosure in violation of this Agreement.&#160; Each Investor agrees that it shall,
      upon learning that disclosure of such Records is sought in or by a court or governmental body of competent jurisdiction or through other means, give prompt notice to the Company and allow the Company, at its expense, to undertake appropriate action
      to prevent disclosure of, or to obtain a protective order for, the Records deemed confidential.&#160; Nothing herein (or in any other confidentiality agreement between the Company and any Investor) shall be deemed to limit the Investors&#8217; ability to sell
      Registrable Securities in a manner which is otherwise consistent with applicable laws and regulations.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 108pt;">(j)&#160;&#160; &#160; &#160;&#160; The Company shall hold in confidence and not make any disclosure of information concerning an Investor provided to the Company unless (i) disclosure of such information is necessary to
      comply with federal or state securities laws, (ii) the disclosure of such information is necessary to avoid or correct a misstatement or omission in any Registration Statement, (iii) the release of such information is ordered pursuant to a subpoena
      or other final, non-appealable order from a court or governmental body of competent jurisdiction, or (iv) such information has been made generally available to the public other than by disclosure in violation of this Agreement or any other
      agreement.&#160; The Company agrees that it shall, upon learning that disclosure of such information concerning an Investor is sought in or by a court or governmental body of competent jurisdiction or through other means, give prompt written notice to
      such Investor and allow such Investor a reasonable period of time, at the Investor&#8217;s expense, to undertake appropriate action to prevent disclosure of, or to obtain a protective order for, such information.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 108pt;">(k)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; The Company shall use its commercially reasonable efforts either to (i) cause all of the Registrable Securities covered by a Registration Statement to be listed on each securities
      exchange on which securities of the same class or series issued by the Company are then listed, if any, if the listing of such Registrable Securities is then permitted under the rules of such exchange or (ii) secure the inclusion for quotation of all
      of the Registrable Securities on the Principal Market or (iii) if, despite the Company&#8217;s commercially reasonable efforts, the Company is unsuccessful in satisfying the preceding clauses (i) and (ii), to secure the inclusion for quotation on another
      Eligible Market for such Registrable Securities and, without limiting the generality of the foregoing, to use its commercially reasonable efforts to arrange for at least two market makers to register with the Financial Industry Regulatory Authority,
      Inc. (&#8220;<font style="font-weight: bold;">FINRA</font>&#8221;) as such with respect to such Registrable Securities.&#160; The Company shall pay all fees and expenses in connection with satisfying its obligation under this Section 3(k).</div>
    <div style="text-align: justify; text-indent: 108pt;"> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">10</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 108pt;">(l)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; The Company shall cooperate with the Investors who hold Registrable Securities being offered and, to the extent applicable, facilitate the timely preparation and delivery of certificates
      (not bearing any restrictive legend) representing the Registrable Securities to be offered pursuant to a Registration Statement and enable such certificates to be in such denominations or amounts, as the case may be, as the Investors may reasonably
      request and registered in such names as the Investors may request. Each Investor hereby agrees that it shall cooperate with the Company, its counsel, and its transfer agent in connection with any issuances of any Common Shares and Warrant Shares that
      have been registered and hereby represents, warrants and covenants to the Company that it will resell the registered shares only pursuant to the Registration Statement in which the registered shares are included, in a manner described under the
      caption &#8220;Plan of Distribution&#8221; in the Registration Statement, and in a manner in compliance with all applicable U.S. federal and state securities laws, rules and regulations, including, without limitation, any applicable prospectus delivery
      requirements of the 1933 Act.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 108pt;">(m)&#160;&#160;&#160;&#160;&#160; If reasonably requested by an Investor, the Company shall as soon as practicable (i) incorporate in a prospectus supplement or post-effective amendment such information as an Investor
      reasonably requests to be included therein relating to the sale and distribution of Registrable Securities, including, without limitation, information with respect to the number of Registrable Securities being offered or sold, the purchase price
      being paid therefor and any other terms of the offering of the Registrable Securities to be sold in such offering; (ii) make all required filings of such prospectus supplement or post-effective amendment after being notified of the matters to be
      incorporated in such prospectus supplement or post-effective amendment; and (iii) supplement or make amendments to any Registration Statement if reasonably requested by an Investor holding any Registrable Securities.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 108pt;">(n)&#160;&#160;&#160;&#160;&#160; &#160;&#160; The Company shall use its commercially reasonable efforts to cause the Registrable Securities covered by a Registration Statement to be registered with or approved by such other
      governmental agencies or authorities as may be necessary to consummate the disposition of such Registrable Securities.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 108pt;">(o)&#160;&#160;&#160; &#160; &#160; The Company shall make generally available to its security holders (which may be satisfied by making such information available on the SEC&#8217;s Electronic Data Gathering, Analysis, and
      Retrieval system) as soon as practical, but not later than ninety (90) days after the close of the period covered thereby, an earnings statement (in form complying with, and in the manner provided by, the provisions of Rule 158 under the 1933 Act)
      covering a twelve-month period beginning not later than the first day of the Company&#8217;s fiscal quarter next following the applicable Effective Date of a Registration Statement.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 108pt;">(p)&#160;&#160;&#160;&#160;&#160;&#160;&#160; The Company shall otherwise use its commercially reasonable efforts to comply in all material respects with all applicable rules and regulations of the SEC in connection with any
      registration hereunder.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 108pt;">(q)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Within two (2) Business Days after a Registration Statement which covers Registrable Securities is ordered effective by the SEC, the Company shall deliver, and shall cause legal counsel
      for the Company to deliver, to the transfer agent for such Registrable Securities (with copies to the Investors whose Registrable Securities are included in such Registration Statement) confirmation that such Registration Statement has been declared
      effective by the SEC in the form attached hereto as <u>Exhibit A</u>.</div>
    <div style="text-align: justify; text-indent: 108pt;"> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">11</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 108pt;">(r)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Notwithstanding anything to the contrary herein, at any time after the Effective Date, the Company may delay the disclosure of material, non-public information concerning the Company the
      disclosure of which at the time is not, in the good faith opinion of the Board of Directors of the Company and its counsel, in the best interest of the Company and, in the opinion of counsel to the Company, otherwise required (a &#8220;<font style="font-weight: bold;">Grace Period</font>&#8221;); provided, that the Company shall promptly (i) notify the Investors in writing of the existence of material, non-public information giving rise to a Grace Period (provided that in each notice the
      Company will not disclose the content of such material, non-public information to the Investors) and the date on which the Grace Period will begin, and (ii) notify the Investors in writing of the date on which the Grace Period ends; and, provided
      further, that no Grace Period shall exceed fifteen (15) consecutive Trading Days and during any three hundred sixty five (365) day period such Grace Periods shall not exceed an aggregate of thirty (30) Trading Days and the first day of any Grace
      Period must be at least five (5) Trading Days after the last day of any prior Grace Period (each, an &#8220;<font style="font-weight: bold;">Allowable Grace Period</font>&#8221;).&#160; For purposes of determining the length of a Grace Period above, the Grace Period
      shall begin on and include the date the Investors receive the notice referred to in clause (i) and shall end on and include the later of the date the Investors receive the notice referred to in clause (ii) and the date referred to in such notice.&#160;
      The provisions of Section 3(g) hereof shall not be applicable during the period of any Allowable Grace Period.&#160; Upon expiration of the Grace Period, the Company shall again be bound by the first sentence of Section 3(f) with respect to the
      information giving rise thereto unless such material, non-public information is no longer applicable.&#160; Notwithstanding anything to the contrary, the Company shall cause its transfer agent to deliver unlegended shares of Common Stock to a transferee
      of an Investor in accordance with the terms of the Securities Purchase Agreement in connection with any sale of Registrable Securities with respect to which an Investor has entered into a contract for sale, prior to the Investor&#8217;s receipt of the
      notice of a Grace Period and for which the Investor has not yet settled.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 108pt;">(s)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Except as required by applicable law, neither the Company nor any Subsidiary or affiliate thereof shall identify any Investor as an underwriter in any public disclosure or filing with
      the SEC, the Principal Market<font style="color: #000000;">&#160;</font>or any Eligible Market and any Purchaser being deemed an underwriter by the SEC shall not relieve the Company of any obligations it has under this Agreement or any other Transaction
      Document <font style="color: #000000;">(as defined in the Securities Purchase Agreement); <u>provided</u>, <u>however</u>, that the foregoing shall not prohibit the Company from including the disclosure found in the &#8220;Plan of Distribution&#8221; section
        attached hereto as <u>Exhibit B</u> in the Registration Statement</font>.&#160; If the Company is required by law to identify any Investor as an underwriter in any public disclosure or filing with the SEC, the Principal Market or any Eligible Market,
      prior to so identifying any such Investor, the Company shall promptly notify each such Investor of the legal requirement and give each such Investor a reasonable opportunity to persuade the applicable regulator that said disclosure is not required.
      If the applicable Investors are unable to eliminate the legal requirement to be identified as an underwriter, the applicable Investor shall have five (5) Business Days, or such shorter time as required by the applicable regulator or applicable law,
      to consent to such disclosure or to agree to withdraw as a selling shareholder under the Registration Statement. If an Investor agrees to withdraw as a selling shareholder under the Registration Statement, the Company shall not be responsible for any
      such Failures with respect to any such Investor.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 108pt;">(t)&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; Neither the Company nor any of its Subsidiaries has entered, as of the date hereof, nor shall the Company or any of its Subsidiaries, on or after the date of this Agreement, enter into
      any agreement with respect to its securities, that would have the effect of preventing the Company from performing its obligations hereunder.</div>
    <div style="text-align: justify; text-indent: 108pt;"> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">12</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 72pt;">4.&#160;&#160;&#160;&#160; &#160; &#160;&#160;&#160; <u>Obligations of the Investors</u>.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 108pt;">(a)&#160;&#160;&#160; &#160; &#160;&#160; At least ten (10) Business Days prior to the first anticipated Filing Date of a Registration Statement, the Company shall notify each Investor in writing of the information the Company
      requires from each such Investor if such Investor elects to have any of such Investor&#8217;s Registrable Securities included in such Registration Statement.&#160; It shall be a condition precedent to the obligations of the Company to complete any registration
      pursuant to this Agreement with respect to the Registrable Securities of a particular Investor that such Investor shall timely furnish to the Company such information regarding itself, the Registrable Securities held by it and the intended method of
      disposition of the Registrable Securities held by it as shall be reasonably required by the Company to effect and maintain the effectiveness of the registration of such Registrable Securities and shall timely execute such documents in connection with
      such registration as the Company may reasonably request.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 108pt;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160; Each Investor, by such Investor&#8217;s acceptance of the Registrable Securities, agrees to cooperate with the Company as reasonably requested by the Company in connection with the preparation
      and filing of any Registration Statement hereunder, unless such Investor has notified the Company in writing of such Investor&#8217;s election to exclude all of such Investor&#8217;s Registrable Securities from such Registration Statement.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 108pt;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Each Investor agrees that, upon receipt of any notice from the Company of the happening of any event of the kind described in Section 3(g) or the first sentence of 3(f) (a &#8220;<font style="font-weight: bold;">No Sale Notice</font>&#8221;), such Investor will immediately discontinue disposition of Registrable Securities pursuant to any Registration Statement(s) covering such Registrable Securities until such Investor&#8217;s receipt of
      copies of the supplemented or amended prospectus as contemplated by Section 3(g) or the first sentence of 3(f) or receipt of notice that no supplement or amendment is required.&#160; Notwithstanding anything to the contrary, the Company shall cause its
      transfer agent to deliver unlegended shares of Common Stock to a transferee of an Investor in accordance with the terms of the Securities Purchase Agreement in connection with any sale of Registrable Securities with respect to which an Investor has
      entered into a contract for sale prior to the Investor&#8217;s receipt of a notice from the Company of the happening of any event of the kind described in Section 3(g) or the first sentence of 3(f) and for which the Investor has not yet settled.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 108pt;">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Each Investor covenants and agrees that it will comply with the prospectus delivery requirements of the 1933 Act as applicable to it or an exemption therefrom in connection with sales of
      Registrable Securities pursuant to the Registration Statement.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 72pt;">5.&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; <u>Expenses of Registration</u>.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 72pt;">All reasonable expenses, other than underwriting discounts and commissions, incurred in connection with registrations, filings or qualifications pursuant to Sections 2 and 3, including, without
      limitation, all registration, listing and qualifications fees, printers and accounting fees, and fees and disbursements of counsel for the Company shall be paid by the Company.</div>
    <div style="text-align: justify; text-indent: 72pt;"> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">13</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 72pt;">6.&#160;&#160;&#160;&#160; &#160;&#160; &#160; <u>Indemnification</u>.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 72pt;">In the event any Registrable Securities are included in a Registration Statement under this Agreement:</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 108pt;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;To the fullest extent permitted by law, the Company will, and hereby does, indemnify, hold harmless and defend each Investor, the directors, officers, partners, members, employees,
      agents, representatives of, and each Person, if any, who controls any Investor within the meaning of the 1933 Act or the 1934 Act (each, an &#8220;<font style="font-weight: bold;">Indemnified Person</font>&#8221;), against any losses, claims, damages,
      liabilities, judgments, fines, penalties, charges, costs, reasonable attorneys&#8217; fees, amounts paid in settlement or expenses, joint or several (collectively, &#8220;<font style="font-weight: bold;">Claims</font>&#8221;), incurred in investigating, preparing or
      defending any action, claim, suit, inquiry, proceeding, investigation or appeal taken from the foregoing by or before any court or governmental, administrative or other regulatory agency, body or the SEC, whether pending or threatened, whether or not
      an indemnified party is or may be a party thereto (&#8220;<font style="font-weight: bold;">Indemnified Damages</font>&#8221;), to which any of them may reasonably become subject insofar as such Claims (or actions or proceedings, whether commenced or threatened,
      in respect thereof) arise out of or are based upon:&#160; (i) any untrue statement or alleged untrue statement of a material fact in a Registration Statement or any post-effective amendment thereto or in any filing made in connection with the
      qualification of the offering under the securities or other &#8220;blue sky&#8221; laws of any jurisdiction in which Registrable Securities are offered (&#8220;<font style="font-weight: bold;">Blue Sky Filing</font>&#8221;), or the omission or alleged omission to state a
      material fact required to be stated therein or necessary to make the statements therein not misleading, (ii) any untrue statement or alleged untrue statement of a material fact contained in any preliminary prospectus required to be filed hereunder if
      used prior to the effective date of such Registration Statement, or contained in the final prospectus (as amended or supplemented, if the Company files any amendment thereof or supplement thereto with the SEC) or the omission or alleged omission to
      state therein any material fact necessary to make the statements made therein, in light of the circumstances under which the statements therein were made, not misleading, (iii) any violation or alleged violation by the Company of the 1933 Act, the
      1934 Act, any other law, including, without limitation, any state securities law, or any rule or regulation thereunder relating to the offer or sale of the Registrable Securities pursuant to a Registration Statement required to be filed hereunder or
      (iv) any violation of this Agreement (the matters in the foregoing clauses (i) through (iv) being, collectively, &#8220;<font style="font-weight: bold;">Violations</font>&#8221;).&#160; Subject to Section 6(c), the Company shall reimburse the Indemnified Persons,
      promptly as such expenses are incurred and are due and payable, for any legal fees or other reasonable expenses incurred by them in connection with investigating or defending any such Claim.&#160; Notwithstanding anything to the contrary contained herein,
      the indemnification agreement contained in this Section 6(a):&#160; (i) shall not apply to a Claim by an Indemnified Person arising out of or based upon a Violation which occurs in reliance upon and in conformity with information furnished to the Company
      by such Indemnified Person for such Indemnified Person expressly for use in connection with the preparation of the Registration Statement or any such amendment thereof or supplement thereto; (ii) shall not be available to the Investor to the extent
      the Claim is based on a failure of the Investor to deliver or to cause to be delivered the prospectus (as amended or supplemented) made available by the Company (to the extent applicable; and (iii) shall not apply to amounts paid in settlement of any
      Claim if such settlement is effected without the prior written consent of the Company, which consent shall not be unreasonably withheld or delayed.&#160; Such indemnity shall remain in full force and effect regardless of any investigation made by or on
      behalf of the Indemnified Person and shall survive the transfer of the Registrable Securities by the Investors pursuant to Section 9. If, after the Company makes any payments to an Indemnified Person pursuant to this section, such Indemnified Person
      receives an award or other judgment granting such Indemnified Person repayment of any Indemnified Damages or costs incurred with a Claim or Claims, such Indemnified Person shall repay such amounts to the Company within five (5) Business Days of the
      receipt thereof.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 108pt;">(b)&#160;&#160;&#160;&#160;&#160;&#160; &#160; In connection with any Registration Statement in which an Investor is participating, each such Investor agrees to severally and not jointly indemnify, hold harmless and defend, to the
      same extent and in the same manner as is set forth in Section 6(a), the Company, each of its directors, each of its officers who signs the Registration Statement and each Person, if any, who controls the Company within the meaning of the 1933 Act or
      the 1934 Act (each, an &#8220;<font style="font-weight: bold;">Indemnified Party</font>&#8221;), against any Claim or Indemnified Damages to which any of them may become subject, under the 1933 Act, the 1934 Act or otherwise, insofar as such Claim or Indemnified
      Damages arise out of or are based upon any Violation, in each case to the extent, and only to the extent, that such Violation occurs in reliance upon and in conformity with information furnished to the Company by such Investor expressly for use in
      connection with such Registration Statement; and, subject to Section 6(c), such Investor shall reimburse the Indemnified Party for any legal or other expenses reasonably incurred by an Indemnified Party in connection with investigating or defending
      any such Claim; provided, however, that the indemnity agreement contained in this Section 6(b) and the agreement with respect to contribution contained in Section 7 shall not apply to amounts paid in settlement of any Claim if such settlement is
      effected without the prior written consent of such Investor, which consent shall not be unreasonably withheld or delayed; provided, further, however, that the Investor shall be liable under this Section 6(b) for only that amount of a Claim or
      Indemnified Damages as does not exceed the net proceeds to such Investor as a result of the sale of Registrable Securities pursuant to such Registration Statement.&#160; Such indemnity shall remain in full force and effect regardless of any investigation
      made by or on behalf of such Indemnified Party and shall survive the transfer of the Registrable Securities by the Investors pursuant to Section 9.</div>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">14</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 108pt;">(c)&#160;&#160;&#160;&#160; &#160;&#160; Promptly after receipt by an Indemnified Person or Indemnified Party under this Section 6 of notice of the commencement of any action or proceeding (including any governmental action or
      proceeding) involving a Claim, such Indemnified Person or Indemnified Party shall, if a Claim in respect thereof is to be made against any indemnifying party under this Section 6, deliver to the indemnifying party a written notice of the commencement
      thereof, and the indemnifying party shall have the right to participate in, and, to the extent the indemnifying party so desires and has acknowledged its indemnification obligations hereunder in writing, jointly with any other indemnifying party
      similarly noticed, to assume control of the defense thereof with counsel mutually satisfactory to the indemnifying party and the Indemnified Person or the Indemnified Party, as the case may be; provided, however, that an Indemnified Person or
      Indemnified Party shall have the right to retain its own counsel with the fees and expenses of not more than one counsel for all such Indemnified Person or Indemnified Party to be paid by the indemnifying party, if, in the reasonable opinion of
      counsel retained by the Indemnified Person or Indemnified Party, as applicable, the representation by such counsel of the Indemnified Person or Indemnified Party and the indemnifying party would be inappropriate due to differing interests between
      such Indemnified Person or Indemnified Party and any other party represented by such counsel in such proceeding.&#160; In the case of an Indemnified Person, legal counsel referred to in the immediately preceding sentence shall be selected by the Investors
      holding at least a majority in interest of the Registrable Securities included in the Registration Statement to which the Claim relates.&#160; The Indemnified Party or Indemnified Person shall reasonably cooperate with the indemnifying party in connection
      with any negotiation or defense of any such action or Claim by the indemnifying party and shall furnish to the indemnifying party all information reasonably available to the Indemnified Party or Indemnified Person which relates to such action or
      Claim.&#160; The indemnifying party shall keep the Indemnified Party or Indemnified Person fully apprised at all times as to the status of the defense or any settlement negotiations with respect thereto.&#160; No indemnifying party shall be liable for any
      settlement of any action, claim or proceeding effected without its prior written consent, provided, however, that the indemnifying party shall not unreasonably withhold, delay or condition its consent.&#160; No indemnifying party shall, without the prior
      written consent of the Indemnified Party or Indemnified Person, consent to entry of any judgment or enter into any settlement or other compromise which does not include as an unconditional term thereof the giving by the claimant or plaintiff to such
      Indemnified Party or Indemnified Person of a release from all liability in respect to such Claim or litigation and such settlement shall not include any admission as to fault on the part of the Indemnified Party.&#160; Following indemnification as
      provided for hereunder, the indemnifying party shall be subrogated to all rights of the Indemnified Party or Indemnified Person with respect to all third parties, firms or corporations relating to the matter for which indemnification has been made.&#160;
      The failure to deliver written notice to the indemnifying party within a reasonable time of the commencement of any such action shall not relieve such indemnifying party of any liability to the Indemnified Person or Indemnified Party under this
      Section 6, except to the extent that the indemnifying party is prejudiced in its ability to defend such action.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 108pt;">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; The indemnification required by this Section 6 shall be made by periodic payments of the amount thereof during the course of the investigation or defense, as and when bills are received
      or Indemnified Damages are incurred.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 108pt;">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160; The indemnity agreements contained herein shall be in addition to (i) any cause of action or similar right of the Indemnified Party or Indemnified Person against the indemnifying party or
      others, and (ii) any liabilities the indemnifying party may be subject to pursuant to the law.</div>
    <div style="text-align: justify; text-indent: 108pt;"> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">15</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 72pt;">7.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; <u>Contribution</u>.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 72pt;">To the extent any indemnification by an indemnifying party is prohibited or limited by law, the indemnifying party agrees to make the maximum contribution with respect to any amounts for which it
      would otherwise be liable under Section 6 to the fullest extent permitted by law; provided, however, that:&#160; (i) no Person involved in the sale of Registrable Securities which Person is guilty of fraudulent misrepresentation (within the meaning of
      Section 11(f) of the 1933 Act) in connection with such sale shall be entitled to contribution from any Person involved in such sale of Registrable Securities who was not guilty of fraudulent misrepresentation; and (ii) contribution by any seller of
      Registrable Securities shall be limited in amount to the amount of net proceeds received by such seller from the sale of such Registrable Securities pursuant to such Registration Statement.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 72pt;">8.&#160;&#160;&#160;&#160; &#160; &#160;&#160;&#160; <u>Reports Under the 1934 Act</u>.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 72pt;">With a view to making available to the Investors the benefits of Rule 144 promulgated under the 1933 Act or any other similar rule or regulation of the SEC that may at any time permit the Investors
      to sell securities of the Company to the public without registration (&#8220;<font style="font-weight: bold;">Rule 144</font>&#8221;), the Company agrees to:</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 108pt;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;make and keep public information available, as those terms are understood and defined in Rule 144;</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 108pt;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; file with the SEC in a timely manner all reports and other documents required of the Company under the 1933 Act and the 1934 Act so long as the Company remains subject to such
      requirements and the filing of such reports and other documents is required for the applicable provisions of Rule 144; and</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 108pt;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; furnish to each Investor so long as such Investor owns Registrable Securities, promptly upon request no more than three (3) times per calendar year, a written statement by the Company,
      if true, that it has complied with the reporting requirements of the 1933 Act and the 1934 Act and that it has satisfied the current public information provisions set forth in Rule 144.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 72pt;">9.&#160;&#160;&#160; &#160;&#160;&#160;&#160;&#160; <u>Assignment of Registration Rights</u>.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 72pt;">The rights under this Agreement shall be automatically assignable by the Investors to any transferee of all or any portion of such Investor&#8217;s Registrable Securities if:&#160; (i) the Investor agrees in
      writing with the transferee or assignee to assign such rights, and a copy of such agreement is furnished to the Company within a reasonable time after such assignment; (ii) the Company is, within a reasonable time after such transfer or assignment,
      furnished with written notice of (a) the name and address of such transferee or assignee, and (b) the securities with respect to which such registration rights are being transferred or assigned; (iii) immediately following such transfer or assignment
      the further disposition of such securities by the transferee or assignee is restricted under the 1933 Act or applicable state securities laws; (iv) at or before the time the Company receives the written notice contemplated by clause (ii) of this
      sentence the transferee or assignee agrees in writing with the Company to be bound by all of the provisions contained herein; and (v) such transfer shall have been made in accordance with the applicable requirements of the Securities Purchase
      Agreement.<br>
      <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">16</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 72pt;">10.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Amendment of Registration Rights</u>.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 72pt;">Provisions of this Agreement may be amended and the observance thereof may be waived (either generally or in a particular instance and either retroactively or prospectively), only with the written
      consent of the Company and the Required Holders; provided that any such amendment or waiver that complies with the foregoing but that disproportionately, materially and adversely affects the rights and obligations of any Investor relative to the
      comparable rights and obligations of the other Investors shall require the prior written consent of such adversely affected Investor.&#160; Any amendment or waiver effected in accordance with this Section 10 shall be binding upon each Investor and the
      Company.&#160; No such amendment shall be effective to the extent that it applies to less than all of the holders of the Registrable Securities.&#160; No consideration shall be offered or paid to any Person to amend or consent to a waiver or modification of
      any provision of this Agreement unless the same consideration (other than the reimbursement of legal fees) also is offered to all of the parties to this Agreement.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 72pt;">11.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Miscellaneous</u>.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 108pt;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; A Person is deemed to be a holder of Registrable Securities whenever such Person owns or is deemed to own of record such Registrable Securities.&#160; If the Company receives conflicting
      instructions, notices or elections from two or more Persons with respect to the same Registrable Securities, the Company shall act upon the basis of instructions, notice or election received from such record owner of such Registrable Securities.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 108pt;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160; Any notices, consents, waivers or other communications required or permitted to be given under the terms of this Agreement must be in writing and will be deemed to have been delivered:&#160;
      (i) upon receipt, when delivered personally; (ii) upon receipt, when sent by facsimile (provided confirmation of transmission is mechanically or electronically generated and kept on file by the sending party); (iii) when sent, if sent by electronic
      mail; or (iv) one Business Day after deposit with a nationally recognized overnight delivery service, in each case properly addressed to the party to receive the same.&#160; The addresses, facsimile numbers and email addresses for such communications
      shall be:</div>
    <div>&#160;</div>
    <div style="text-align: justify; margin-left: 108pt;">If to the Company:</div>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);" id="z8ecb9dda315f4a9b91cd764c83bfe4e5">

        <tr>
          <td colspan="1" style="width: 55%; vertical-align: top;">&#160;</td>
          <td style="width: 45%; vertical-align: top;">
            <div style="text-align: justify; color: #000000;">Momentus Inc.</div>
          </td>
        </tr>
        <tr>
          <td colspan="1" style="width: 55%; vertical-align: top;">&#160;</td>
          <td style="width: 45%; vertical-align: top;">
            <div style="color: #000000;">3901 N. First Street</div>
          </td>
        </tr>
        <tr>
          <td colspan="1" style="width: 55%; vertical-align: top;">&#160;</td>
          <td style="width: 45%; vertical-align: top;">
            <div style="color: #000000;">San Jose, CA, 95134</div>
          </td>
        </tr>
        <tr>
          <td colspan="1" style="width: 55%; vertical-align: top;">&#160;</td>
          <td style="width: 45%; vertical-align: top;">
            <div style="color: #000000;">Attn: John Rood</div>
          </td>
        </tr>
        <tr>
          <td colspan="1" style="width: 55%; vertical-align: top;">&#160;</td>
          <td style="width: 45%; vertical-align: top;">
            <div style="color: #000000;">Email: [***]</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <div style="text-align: justify; margin-left: 108pt;">With a copy (for informational purposes only) to:</div>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);" id="z3769bde0ce2e416f8846f1b18e490f85">

        <tr>
          <td colspan="1" style="width: 55%; vertical-align: top;">&#160;</td>
          <td style="width: 45%; vertical-align: top;">
            <div>Bradley Arant Boult Cummings LLP</div>
          </td>
        </tr>
        <tr>
          <td colspan="1" style="width: 55%; vertical-align: top;">&#160;</td>
          <td style="width: 45%; vertical-align: top;">
            <div style="color: #000000;">1221 Broadway, Suite 2400</div>
          </td>
        </tr>
        <tr>
          <td colspan="1" style="width: 55%; vertical-align: top;">&#160;</td>
          <td style="width: 45%; vertical-align: top;">
            <div style="color: #000000;">Nashville, TN 37203</div>
          </td>
        </tr>
        <tr>
          <td colspan="1" style="width: 55%; vertical-align: top;">&#160;</td>
          <td style="width: 45%; vertical-align: top;">
            <div style="color: #000000;">Attn: Stephen Hinton, Esq.</div>
          </td>
        </tr>
        <tr>
          <td colspan="1" style="width: 55%; vertical-align: top;">&#160;</td>
          <td style="width: 45%; vertical-align: top;">
            <div style="color: #000000;">Email: [***]</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">17</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; margin-left: 108pt;">If to the Transfer Agent:</div>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);" id="z5fe1a5eb70e04159bf07d81fab270d4f">

        <tr>
          <td colspan="1" style="width: 55%; vertical-align: top;">&#160;</td>
          <td style="width: 45%; vertical-align: top;">
            <div style="color: #000000;">Continental Stock Transfer &amp; Trust Company</div>
          </td>
        </tr>
        <tr>
          <td colspan="1" style="width: 55%; vertical-align: top;">&#160;</td>
          <td style="width: 45%; vertical-align: top;">
            <div style="color: #000000;">1 State Street, 30th Floor</div>
          </td>
        </tr>
        <tr>
          <td colspan="1" style="width: 55%; vertical-align: top;">&#160;</td>
          <td style="width: 45%; vertical-align: top;">
            <div style="color: #000000;">New York, New York 10004</div>
          </td>
        </tr>
        <tr>
          <td colspan="1" style="width: 55%; vertical-align: top;">&#160;</td>
          <td style="width: 45%; vertical-align: top;">
            <div style="color: #000000;">Attn: Vito Cirone</div>
          </td>
        </tr>
        <tr>
          <td colspan="1" style="width: 55%; vertical-align: top;">&#160;</td>
          <td style="width: 45%; vertical-align: top;">
            <div style="color: #000000;">Email: [***]</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <div style="margin-left: 108pt;">If to Legal Counsel:</div>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);" id="z39c1dbf4d36f488e93650205634c22ae">

        <tr>
          <td style="width: 55%; vertical-align: top;">&#160;</td>
          <td style="width: 45%; vertical-align: top;">
            <div>Grushko &amp; Mittman, P.C.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 55%; vertical-align: top;">&#160;</td>
          <td style="width: 45%; vertical-align: top;">
            <div>1800 Rockaway Avenue, Suite 206</div>
          </td>
        </tr>
        <tr>
          <td style="width: 55%; vertical-align: top;">&#160;</td>
          <td style="width: 45%; vertical-align: top;">
            <div>Hewlett, NY 11557</div>
          </td>
        </tr>
        <tr>
          <td style="width: 55%; vertical-align: top;">&#160;</td>
          <td style="width: 45%; vertical-align: top;">
            <div>Attn: Eliezer Drew, Esq.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 55%; vertical-align: top;">&#160;</td>
          <td style="width: 45%; vertical-align: top;">
            <div>Email: [***]</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <div style="text-align: justify;">If to a Purchaser, to its address, facsimile number and/or email address set forth on the Schedule of Purchasers attached hereto or on the signature pages of the Securities Purchase Agreement, with copies to such
      Purchaser&#8217;s representatives as set forth on the Schedule of Purchasers, or to such other address, facsimile number and/or email address to the attention of such other Person as the recipient party has specified by written notice given to each other
      party five (5) days prior to the effectiveness of such change.&#160; Written confirmation of receipt (A) given by the recipient of such notice, consent, waiver or other communication, (B) mechanically or electronically generated by the sender&#8217;s facsimile
      machine or email containing the time, date, recipient facsimile number and an image of the first page of such transmission or (C) provided by a courier or overnight courier service shall be rebuttable evidence of personal service, receipt by
      facsimile or receipt from a nationally recognized overnight delivery service in accordance with clause (i), (ii) or (iii) above, respectively.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 108pt;">(c)&#160;&#160;&#160;&#160; &#160; &#160; Failure of any party to exercise any right or remedy under this Agreement or otherwise, or delay by a party in exercising such right or remedy, shall not operate as a waiver thereof.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 108pt;">(d)&#160;&#160;&#160; &#160; &#160; All questions concerning the construction, validity, enforcement and interpretation of this Agreement shall be governed by the internal laws of the State of New York, without giving
      effect to any choice of law or conflict of law provision or rule (whether of the State of New York or any other jurisdictions) that would cause the application of the laws of any jurisdictions other than the State of New York.&#160; Each party hereby
      irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in The City of New York, Borough of Manhattan, for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated
      hereby or discussed herein, and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of any such court, that such suit, action or proceeding is brought
      in an inconvenient forum or that the venue of such suit, action or proceeding is improper.&#160; Each party hereby irrevocably waives personal service of process and consents to process being served in any such suit, action or proceeding by mailing a copy
      thereof to such party at the address for such notices to it under this Agreement and agrees that such service shall constitute good and sufficient service of process and notice thereof.&#160; Nothing contained herein shall be deemed to limit in any way
      any right to serve process in any manner permitted by law.&#160; <font style="font-weight: bold;">EACH PARTY HEREBY IRREVOCABLY WAIVES ANY RIGHT IT MAY HAVE, AND AGREES NOT TO REQUEST, A JURY TRIAL FOR THE ADJUDICATION OF ANY DISPUTE HEREUNDER OR IN
        CONNECTION HEREWITH OR ARISING OUT OF THIS AGREEMENT OR ANY TRANSACTION CONTEMPLATED HEREBY.</font></div>
    <div style="text-align: justify; text-indent: 108pt;"><font style="font-weight: bold;"> <br>
      </font></div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">18</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 108pt;">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; If any provision of this Agreement is prohibited by law or otherwise determined to be invalid or unenforceable by a court of competent jurisdiction, the provision that would otherwise be
      prohibited, invalid or unenforceable shall be deemed amended to apply to the broadest extent that it would be valid and enforceable, and the invalidity or unenforceability of such provision shall not affect the validity of the remaining provisions of
      this Agreement so long as this Agreement as so modified continues to express, without material change, the original intentions of the parties as to the subject matter hereof and the prohibited nature, invalidity or unenforceability of the
      provision(s) in question does not substantially impair the respective expectations or reciprocal obligations of the parties or the practical realization of the benefits that would otherwise be conferred upon the parties.&#160; The parties will endeavor in
      good faith negotiations to replace the prohibited, invalid or unenforceable provision(s) with a valid provision(s), the effect of which comes as close as possible to that of the prohibited, invalid or unenforceable provision(s).</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 108pt;">(f)&#160;&#160;&#160;&#160;&#160;&#160;&#160; This Agreement, the other Transaction Documents (as defined in the Securities Purchase Agreement) and the instruments referenced herein and therein constitute the entire agreement among
      the parties hereto with respect to the subject matter hereof and thereof.&#160; There are no restrictions, promises, warranties or undertakings, other than those set forth or referred to herein and therein.&#160; This Agreement, the other Transaction Documents
      and the instruments referenced herein and therein supersede all prior agreements and understandings among the parties hereto with respect to the subject matter hereof and thereof.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 108pt;">(g)&#160;&#160;&#160;&#160;&#160;&#160;&#160; Subject to the requirements of Section 9, this Agreement shall inure to the benefit of and be binding upon the permitted successors and assigns of each of the parties hereto.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 108pt;">(h)&#160;&#160;&#160;&#160;&#160; &#160;&#160; The headings in this Agreement are for convenience of reference only and shall not limit or otherwise affect the meaning hereof.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 108pt;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; This Agreement may be executed in identical counterparts, each of which shall be deemed an original but all of which shall constitute one and the same agreement.&#160; This Agreement, once
      executed by a party, may be delivered to the other party hereto by facsimile transmission of a copy of this Agreement bearing the signature of the party so delivering this Agreement.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 108pt;">(j)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Each party shall do and perform, or cause to be done and performed, all such further acts and things, and shall execute and deliver all such other agreements, certificates, instruments
      and documents, as any other party may reasonably request in order to carry out the intent and accomplish the purposes of this Agreement and the consummation of the transactions contemplated hereby.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 108pt;">(k)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; All consents and other determinations required to be made by the Investors pursuant to this Agreement shall be made, unless otherwise specified in this Agreement, by the Required
      Holders, determined as if the outstanding Warrants then held by Investors have been exercised for Registrable Securities without regard to any limitations on exercise of the Warrants.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 108pt;">(l)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; The language used in this Agreement will be deemed to be the language chosen by the parties to express their mutual intent and no rules of strict construction will be applied against any
      party.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 108pt;">(m)&#160;&#160; &#160; &#160;&#160; This Agreement is intended for the benefit of the parties hereto and their respective permitted successors and assigns, and is not for the benefit of, nor may any provision hereof be
      enforced by, any other Person.</div>
    <div style="text-align: justify; text-indent: 108pt;"> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">19</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 108pt;">(n)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; The obligations of each Investor hereunder are several and not joint with the obligations of any other Investor, and no provision of this Agreement is intended to confer any obligations
      on any Investor vis-&#224;-vis any other Investor.&#160; Nothing contained herein, and no action taken by any Investor pursuant hereto, shall be deemed to constitute the Investors as a partnership, an association, a joint venture or any other kind of entity,
      or create a presumption that the Investors are in any way acting in concert or as a group with respect to such obligations or the transactions contemplated herein.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 108pt;">(o)&#160;&#160;&#160;&#160;&#160;&#160;&#160; Legal Counsel may resign as Legal Counsel on five (5) calendar days prior notice to the Company and the Purchasers.&#160; Legal Counsel may rely on instructions from the holders of a majority
      of the Registrable Securities.</div>
    <div>&#160;</div>
    <div style="text-align: center;">* * * * * *</div>
    <div>&#160;</div>
    <div style="text-align: center; font-weight: bold;">[Signature Page Follows]</div>
    <div style="text-align: center; font-weight: bold;"> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">20</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 72pt;">IN WITNESS WHEREOF, the parties have executed this Registration Rights Agreement as of the date first written above.</div>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z9e0b442360f5463db7a7edb03d2fde53">

        <tr>
          <td colspan="1" style="width: 49.94%; vertical-align: top;">&#160;</td>
          <td colspan="3" style="vertical-align: top;">
            <div style="font-weight: bold;">COMPANY:</div>
          </td>
        </tr>
        <tr>
          <td colspan="1" rowspan="1" style="width: 49.94%; vertical-align: top;">&#160;</td>
          <td colspan="3" rowspan="1" style="vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td colspan="1" style="width: 49.94%; vertical-align: top;">&#160;</td>
          <td colspan="3" style="vertical-align: top;">
            <div style="font-weight: bold;">MOMENTUS INC.</div>
          </td>
        </tr>
        <tr>
          <td rowspan="1" colspan="1" style="width: 49.94%; vertical-align: top;">&#160;</td>
          <td rowspan="1" colspan="3" style="vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td colspan="1" rowspan="1" style="width: 49.94%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
          <td rowspan="1" style="width: 5%; vertical-align: top; padding-bottom: 2px;">
            <div>By:</div>
          </td>
          <td rowspan="1" style="width: 40%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">/s/ John C. Rood</td>
          <td rowspan="1" style="width: 5%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
        </tr>
        <tr>
          <td colspan="1" rowspan="1" style="width: 49.94%; vertical-align: top;">&#160;</td>
          <td rowspan="1" style="width: 5%; vertical-align: top;"><br>
          </td>
          <td colspan="2" rowspan="1" style="vertical-align: top;">
            <div>Name: John C. Rood</div>
          </td>
        </tr>
        <tr>
          <td colspan="1" rowspan="1" style="width: 49.94%; vertical-align: top;">&#160;</td>
          <td rowspan="1" style="width: 5%; vertical-align: top;"><br>
          </td>
          <td colspan="2" rowspan="1" style="vertical-align: top;">
            <div>Title:&#160;&#160; Chief Executive Officer</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="text-align: center;">[SIGNATURE PAGE OF HOLDERS FOLLOWS]</div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">21</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: center;">[SIGNATURE PAGE OF PURCHASER TO MOMENTUS INC. RRA]</div>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);" id="z90b0b178c3fd444aa78f23bb1646e132">

        <tr>
          <td style="width: 15%; vertical-align: top; padding-bottom: 2px;">
            <div>Name of Purchaser: <br>
            </div>
          </td>
          <td style="width: 85%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
        </tr>

    </table>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

        <tr>
          <td style="width: 32%; vertical-align: top; padding-bottom: 2px;">
            <div><font style="font-style: italic;">Signature of Authorized Signatory of Purchaser</font>: <br>
            </div>
          </td>
          <td style="width: 68%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
        </tr>

    </table>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

        <tr>
          <td style="width: 21%; vertical-align: top; padding-bottom: 2px;">
            <div>Name of Authorized Signatory: <br>
            </div>
          </td>
          <td style="width: 79%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
        </tr>

    </table>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

        <tr>
          <td style="width: 20%; vertical-align: top; padding-bottom: 2px;">
            <div>Title of Authorized Signatory: <br>
            </div>
          </td>
          <td style="width: 80%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
        </tr>

    </table>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

        <tr>
          <td style="width: 27%; vertical-align: top; padding-bottom: 2px;">
            <div>Email Address of Authorized Signatory: <br>
            </div>
          </td>
          <td style="width: 73%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
        </tr>

    </table>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

        <tr>
          <td style="width: 29%; vertical-align: top; padding-bottom: 2px;">
            <div>Facsimile Number of Authorized Signatory: <br>
            </div>
          </td>
          <td style="width: 71%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
        </tr>

    </table>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

        <tr>
          <td style="width: 24%; vertical-align: top; padding-bottom: 2px;">
            <div>State of Incorporation of Purchaser: <br>
            </div>
          </td>
          <td style="width: 76%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
        </tr>

    </table>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

        <tr>
          <td style="width: 23%; vertical-align: top;">
            <div>Address for Notice to Purchaser:</div>
          </td>
          <td style="width: 77%; vertical-align: top;">&#160;</td>
        </tr>

    </table>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

        <tr>
          <td style="width: 20%; vertical-align: top; padding-bottom: 2px;">
            <div style="text-align: justify;">Taxpayer ID# (if applicable): <br>
            </div>
          </td>
          <td style="width: 20%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td style="width: 60%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">22</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: center; font-weight: bold;">SCHEDULE OF PURCHASERS</div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: right; font-weight: bold;">EXHIBIT A</div>
    <div>&#160;</div>
    <div style="text-align: center; font-weight: bold;">FORM OF NOTICE OF EFFECTIVENESS</div>
    <div style="text-align: center; font-weight: bold;">OF REGISTRATION STATEMENT</div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: right; font-weight: bold;"><u>EXHIBIT B</u></div>
    <div style="text-align: center; font-weight: bold;">SELLING SHAREHOLDERS</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">The shares of Common Stock being offered by the selling stockholders are those issued upon conversion of the Notes and exercise of Warrants that were issued to the selling stockholders pursuant to
      the Securities Purchase Agreement dated as of September 25, 2025 (the &#8220;<font style="font-weight: bold;">Securities Purchase Agreement</font>&#8221;), by and among the Company and the investors named therein, and upon exercise of the Warrants. We are
      registering the shares of Common Stock in order to permit the selling stockholders to offer the shares for resale from time to time. Except for the ownership of the shares of common stock and the warrants issued pursuant to the Securities Purchase
      Agreement, the selling shareholders have not had any material relationship with us within the past three years.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">&#160;The table below lists the selling stockholders and other information regarding the beneficial ownership of the shares of Common Stock by each of the selling stockholders. The second column lists the
      number of shares of Common Stock beneficially owned by each selling stockholder, based on its ownership of the Notes and the Warrants, as of _________, 2025, assuming exercise of all Warrants held by the selling stockholder on that date, without
      regard to any limitations on exercise.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">The third column lists the shares of Common Stock being offered by this prospectus by the selling stockholders and does not take in account any limitations on (i) conversion of the Notes or issuance
      of Common Stock or (ii) exercise of the Warrants.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">&#160;In accordance with the terms of a registration rights agreement with the selling stockholders (the &#8220;<font style="font-weight: bold;">Registration Rights Agreement</font>&#8221;), this prospectus generally
      covers the resale of at least the sum of (i) the number of shares of Common Stock issued upon conversion of the Notes issued pursuant to the Securities Purchase Agreement as of the trading day immediately preceding the date the registration statement
      is initially filed with the SEC, and (ii) the maximum number of shares of common stock issued and issuable upon exercise of the related Warrants as of the trading day immediately preceding the date the registration statement is initially filed with
      the SEC.<font style="font-weight: bold;">&#160;</font>The fourth column assumes the sale of all of the shares offered by the selling stockholders pursuant to this prospectus.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">Under the terms of the Notes, a selling stockholder may not convert the Notes to the extent such exercise would cause such selling stockholder, together with its affiliates, to beneficially own a
      number of shares of Common Stock which would exceed 4.99% of our then outstanding shares of Common Stock following such exercise. Under the terms of the Warrants, a selling stockholder may not exercise the Warrants to the extent such exercise would
      cause such selling stockholder, together with its affiliates, to beneficially own a number of shares of common stock which would exceed 4.99% of our then outstanding shares of common stock following such exercise, excluding for purposes of such
      determination shares of common stock issuable upon exercise of the Warrants which have not been exercised. The number of shares in the second column does not reflect these limitations. The selling stockholders may sell all, some or none of their
      shares in this offering. See &#8220;Plan of Distribution.&#8221;</div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);" id="z6d25e9f359aa48049f0165a1c5b5b6c5">

        <tr>
          <td style="width: 32.98%; vertical-align: middle;">
            <div style="font-weight: bold;"><u>Name of Selling Shareholder</u></div>
          </td>
          <td style="width: 22.81%; vertical-align: top;">
            <div style="text-align: center; font-weight: bold;"><u>Number of Shares</u></div>
            <div style="text-align: center; font-weight: bold;"><u>of Common Stock</u></div>
            <div style="text-align: center; font-weight: bold;"><u>Owned Prior to</u></div>
            <div style="text-align: center; font-weight: bold;"><u>Offering</u></div>
          </td>
          <td style="width: 23.34%; vertical-align: top;">
            <div style="text-align: center; font-weight: bold;"><u>Maximum Number</u></div>
            <div style="text-align: center; font-weight: bold;"><u>of Shares of</u></div>
            <div style="text-align: center; font-weight: bold;"><u>Common Stock to be</u></div>
            <div style="text-align: center; font-weight: bold;"><u>Sold Pursuant to</u></div>
            <div style="text-align: center; font-weight: bold;"><u>this Prospectus</u></div>
          </td>
          <td style="width: 20.87%; vertical-align: top;">
            <div style="text-align: center; font-weight: bold;"><u>Number of Shares</u></div>
            <div style="text-align: center; font-weight: bold;"><u>of Common Stock</u></div>
            <div style="text-align: center; font-weight: bold;"><u>Owned After</u></div>
            <div style="text-align: center; font-weight: bold;"><u>Offering</u></div>
          </td>
        </tr>
        <tr>
          <td style="width: 32.98%; vertical-align: top;">&#160;</td>
          <td style="width: 22.81%; vertical-align: middle;">&#160;</td>
          <td style="width: 23.34%; vertical-align: middle;">&#160;</td>
          <td style="width: 20.87%; vertical-align: middle;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 32.98%; vertical-align: top;">&#160;</td>
          <td style="width: 22.81%; vertical-align: middle;">&#160;</td>
          <td style="width: 23.34%; vertical-align: middle;">&#160;</td>
          <td style="width: 20.87%; vertical-align: middle;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 32.98%; vertical-align: top;">&#160;</td>
          <td style="width: 22.81%; vertical-align: middle;">&#160;</td>
          <td style="width: 23.34%; vertical-align: middle;">&#160;</td>
          <td style="width: 20.87%; vertical-align: middle;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 32.98%; vertical-align: top;">&#160;</td>
          <td style="width: 22.81%; vertical-align: middle;">&#160;</td>
          <td style="width: 23.34%; vertical-align: middle;">&#160;</td>
          <td style="width: 20.87%; vertical-align: middle;">&#160;</td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: center; text-indent: 36pt; font-weight: bold;">PLAN OF DISTRIBUTION</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">We are registering the shares of Common Stock that may be issued upon conversion of the Notes issued pursuant to the Securities Purchase Agreement and upon exercise of the Warrants issued pursuant to
      the terms of the Securities Purchase Agreement to permit the resale of these shares of Common Stock by the holders of such shares and Warrants from time to time after the date of this prospectus. We will not receive any of the proceeds from the sale
      by the selling stockholders of the shares of Common Stock. We will bear all fees and expenses incident to our obligation to register the shares of Common Stock.</div>
    <div style="text-align: justify; text-indent: 36pt;"> <br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;">The selling stockholders may sell all or a portion of the shares of Common Stock beneficially owned by them and offered hereby from time to time directly or through one or more underwriters,
      broker&#8209;dealers or agents. If the shares of Common Stock are sold through underwriters or broker-dealers, the selling stockholders will be responsible for underwriting discounts or commissions or agent&#8217;s commissions. The shares of Common Stock may be
      sold in one or more transactions at fixed prices, at prevailing market prices at the time of the sale, at varying prices determined at the time of sale, or at negotiated prices. These sales may be effected in transactions, which may involve crosses
      or block transactions, pursuant to one or more of the following methods:</div>
    <div><br>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z55267e2f91e34a68a3959511b5111ddc">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top;">&#8226;</td>
            <td style="width: auto; vertical-align: top;">
              <div>on any national securities exchange or quotation service on which the securities may be listed or quoted at the time of sale;</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z5386e9dd99c547cda24e8dd9a93ff77d">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top;">&#8226;</td>
            <td style="width: auto; vertical-align: top;">
              <div>in the over-the-counter market;</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div>
        <div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="zc35318d16cf043138d661c8245b1eff1">

              <tr>
                <td style="width: 36pt; vertical-align: top;"><br>
                </td>
                <td style="width: 18pt; vertical-align: top;">&#8226;</td>
                <td style="width: auto; vertical-align: top;">in transactions otherwise than on these exchanges or systems or in the over-the-counter market;</td>
              </tr>

          </table>
        </div>
      </div>
      <div>&#160;</div>
      <div>
        <div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z3ec74c1fc9f14ed6b59f56ebc2fa8677">

              <tr>
                <td style="width: 36pt; vertical-align: top;"><br>
                </td>
                <td style="width: 18pt; vertical-align: top;">&#8226;</td>
                <td style="width: auto; vertical-align: top;">through the writing of options, whether such options are listed on an options exchange or otherwise;</td>
              </tr>

          </table>
        </div>
      </div>
      <div>&#160;</div>
      <div>
        <div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="zd3474dafa35b48abad619b60c041cebb">

              <tr>
                <td style="width: 36pt; vertical-align: top;"><br>
                </td>
                <td style="width: 18pt; vertical-align: top;">&#8226;</td>
                <td style="width: auto; vertical-align: top;">ordinary brokerage transactions and transactions in which the broker-dealer solicits purchasers;</td>
              </tr>

          </table>
        </div>
      </div>
      <div>&#160;</div>
      <div>
        <div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="zb550672f3a364e718b6ad47e1f8edb8a">

              <tr>
                <td style="width: 36pt; vertical-align: top;"><br>
                </td>
                <td style="width: 18pt; vertical-align: top;">&#8226;</td>
                <td style="width: auto; vertical-align: top;">block trades in which the broker-dealer will attempt to sell the shares as agent but may position and resell a portion of the block as principal to facilitate the transaction;</td>
              </tr>

          </table>
        </div>
      </div>
      <div>&#160;</div>
      <div>
        <div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z57855ac43ecf42389209872ca9c1538c">

              <tr>
                <td style="width: 36pt; vertical-align: top;"><br>
                </td>
                <td style="width: 18pt; vertical-align: top;">&#8226;</td>
                <td style="width: auto; vertical-align: top;">purchases by a broker-dealer as principal and resale by the broker-dealer for its account;</td>
              </tr>

          </table>
        </div>
      </div>
      <div>&#160;</div>
      <div>
        <div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="za7c411d96c6746a29b9ff5f8aa80e4bf">

              <tr>
                <td style="width: 36pt; vertical-align: top;"><br>
                </td>
                <td style="width: 18pt; vertical-align: top;">&#8226;</td>
                <td style="width: auto; vertical-align: top;">an exchange distribution in accordance with the rules of the applicable exchange;</td>
              </tr>

          </table>
        </div>
      </div>
      <div>&#160;</div>
      <div>
        <div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z08889dd52bcd4622b3973563c6d6bd5c">

              <tr>
                <td style="width: 36pt; vertical-align: top;"><br>
                </td>
                <td style="width: 18pt; vertical-align: top;">&#8226;</td>
                <td style="width: auto; vertical-align: top;">privately negotiated transactions;</td>
              </tr>

          </table>
        </div>
      </div>
      <div>&#160;</div>
      <div>
        <div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="zc1100cf42ca944b0a9cb3cb49e91a4e9">

              <tr>
                <td style="width: 36pt; vertical-align: top;"><br>
                </td>
                <td style="width: 18pt; vertical-align: top;">&#8226;</td>
                <td style="width: auto; vertical-align: top;">short sales effected after the effective date of this Registration Statement;</td>
              </tr>

          </table>
        </div>
      </div>
      <div>&#160;</div>
      <div>
        <div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z4e21f05e9de84e6c8f28fc912dd398da">

              <tr>
                <td style="width: 36pt; vertical-align: top;"><br>
                </td>
                <td style="width: 18pt; vertical-align: top;">&#8226;</td>
                <td style="width: auto; vertical-align: top;">sales pursuant to Rule 144;</td>
              </tr>

          </table>
        </div>
      </div>
      <div>&#160;</div>
      <div>
        <div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="zf8d5a229c9b94555bc847b041123b9fd">

              <tr>
                <td style="width: 36pt; vertical-align: top;"><br>
                </td>
                <td style="width: 18pt; vertical-align: top;">&#8226;</td>
                <td style="width: auto; vertical-align: top;">broker-dealers may agree with the selling securityholders to sell a specified number of such shares at a stipulated price per share;</td>
              </tr>

          </table>
        </div>
      </div>
      <div>&#160;</div>
      <div>
        <div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="zf5c55c22a08a40dcabc82463e4601ca9">

              <tr>
                <td style="width: 36pt; vertical-align: top;"><br>
                </td>
                <td style="width: 18pt; vertical-align: top;">&#8226;</td>
                <td style="width: auto; vertical-align: top;">a combination of any such methods of sale; and</td>
              </tr>

          </table>
        </div>
      </div>
      <div>&#160;</div>
      <div>
        <div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="zdd1f6ba56f084c3bad5ddd6a5963db68">

              <tr>
                <td style="width: 36pt; vertical-align: top;"><br>
                </td>
                <td style="width: 18pt; vertical-align: top;">&#8226;</td>
                <td style="width: auto; vertical-align: top;">any other method permitted pursuant to applicable law.</td>
              </tr>

          </table>
        </div>
      </div>
      <div>&#160;</div>
    </div>
    <div style="text-align: justify; text-indent: 36pt;">If the selling stockholders effect such transactions by selling shares of Common Stock to or through underwriters, broker-dealers or agents, such underwriters, broker-dealers or agents may receive
      commissions in the form of discounts, concessions or commissions from the selling stockholders or commissions from purchasers of the shares of Common Stock for whom they may act as agent or to whom they may sell as principal (which discounts,
      concessions or commissions as to particular underwriters, broker-dealers or agents may be in excess of those customary in the types of transactions involved). In connection with sales of the shares of Common Stock or otherwise, the selling
      stockholders may enter into hedging transactions with broker-dealers, which may in turn engage in short sales of the shares of Common Stock in the course of hedging in positions they assume. The selling stockholders may also sell shares of Common
      Stock short and deliver shares of Common Stock covered by this prospectus to close out short positions and to return borrowed shares in connection with such short sales. The selling stockholders may also loan or pledge shares of Common Stock to
      broker-dealers that in turn may sell such shares.</div>
    <div style="text-align: justify; text-indent: 36pt;"> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt;">The selling stockholders may pledge or grant a security interest in some or all of the shares of Common Stock, Notes or Warrants owned by them and, if they default in the performance of their secured
      obligations, the pledgees or secured parties may offer and sell the shares of Common Stock from time to time pursuant to this prospectus or any amendment to this prospectus under Rule 424(b)(3) or other applicable provision of the Securities Act of
      1933, as amended, amending, if necessary, the list of selling stockholders to include the pledgee, transferee or other successors in interest as selling stockholders under this prospectus. The selling stockholders also may transfer and donate the
      shares of Common Stock in other circumstances in which case the transferees, donees, pledgees or other successors in interest will be the selling beneficial owners for purposes of this prospectus.</div>
    <div style="text-align: justify; text-indent: 36pt;"> <br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;">The selling stockholders and any broker-dealer participating in the distribution of the shares of Common Stock may be deemed to be &#8220;underwriters&#8221; within the meaning of the Securities Act, and any
      commission paid, or any discounts or concessions allowed to, any such broker-dealer may be deemed to be underwriting commissions or discounts under the Securities Act. At the time a particular offering of the shares of Common Stock is made, a
      prospectus supplement, if required, will be distributed which will set forth the aggregate amount of shares of Common Stock being offered and the terms of the offering, including the name or names of any broker-dealers or agents, any discounts,
      commissions and other terms constituting compensation from the selling stockholders and any discounts, commissions or concessions allowed or re-allowed or paid to broker-dealers.</div>
    <div style="text-align: justify; text-indent: 36pt;"> <br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;">Under the securities laws of some states, the shares of Common Stock may be sold in such states only through registered or licensed brokers or dealers. In addition, in some states the shares of
      Common Stock may not be sold unless such shares have been registered or qualified for sale in such state or an exemption from registration or qualification is available and is complied with.</div>
    <div style="text-align: justify; text-indent: 36pt;"> <br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;">There can be no assurance that any selling stockholder will sell any or all of the shares of Common Stock registered pursuant to the registration statement, of which this prospectus forms a part.</div>
    <div style="text-align: justify; text-indent: 36pt;"> <br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;">The selling stockholders and any other person participating in such distribution will be subject to applicable provisions of the Exchange Act and the rules and regulations thereunder, including,
      without limitation, Regulation M of the Exchange Act, which may limit the timing of purchases and sales of any of the shares of Common Stock by the selling stockholders and any other participating person. Regulation M may also restrict the ability of
      any person engaged in the distribution of the shares of Common Stock to engage in market-making activities with respect to the shares of Common Stock. All of the foregoing may affect the marketability of the shares of Common Stock and the ability of
      any person or entity to engage in market-making activities with respect to the shares of Common Stock.</div>
    <div style="text-align: justify; text-indent: 36pt;"> <br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;">We will pay all expenses of the registration of the shares of Common Stock pursuant to the Registration Rights Agreement, estimated to be $[___] in total, including, without limitation, SEC filing
      fees and expenses of compliance with state securities or &#8220;blue sky&#8221; laws; provided, however, that a selling stockholder will pay all underwriting discounts and selling commissions, if any. We will indemnify the selling stockholders against
      liabilities, including some liabilities under the Securities Act, in accordance with the Registration Rights Agreement, or the selling stockholders will be entitled to contribution. We may be indemnified by the selling stockholders against civil
      liabilities, including liabilities under the Securities Act, that may arise from any written information furnished to us by the selling stockholder specifically for use in this prospectus, in accordance with the Registration Rights Agreement, or we
      may be entitled to contribution.</div>
    <div style="text-align: justify; text-indent: 36pt;"> <br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;">Once sold under the registration statement, of which this prospectus forms a part, the shares of Common Stock will be freely tradable in the hands of persons other than our affiliates.</div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div>
      <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>8
<FILENAME>ny20047547x33_ex10-3.htm
<DESCRIPTION>EXHIBIT 10.3
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc.
         Document created using Broadridge PROfile 25.9.1.5330
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <!--PROfilePageNumberReset%Num%1%%%-->




  <div>
    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
    <div style="text-align: right;"><font style="font-weight: bold;"> Exhibit 10.3</font><br>
    </div>
    <div> <br>
    </div>
    <div>
      <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">SECURITY AGREEMENT</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">This SECURITY AGREEMENT, dated as of September 25, 2025 (this &#8220;<u>Agreement</u>&#8221;), is among </font>Momentus Inc., a Delaware corporation<font style="color: rgb(0, 0, 0);"> (the &#8220;<u>Company</u>&#8221;), Momentus Space LLC, a Delaware limited liability company, and each other Subsidiary of the Company which shall become a party to this Agreement by execution and delivery of the form annexed hereto as Annex
          A and the Subsidiary Guaranty annexed thereto (each such Subsidiary, a &#8220;<u>Guarantor</u>&#8221; and together with the Company, the &#8220;<u>Debtors</u>&#8221;), </font><a name="z_Hlk209433356"></a><font style="color: rgb(0, 0, 0);">Yield Point NY LLC, as
          collateral agent (the &#8220;<u>Collateral Agent</u>&#8221;) for and the holders of the Company&#8217;s Secured Convertible Notes issued at or about September 25, 2025, in the original aggregate principal amount of up to $5,630,434.78 and such other of the
          Company&#8217;s secured Convertible Notes which may be issued in the future (collectively, the &#8220;<u>Notes</u>&#8221;) (collectively, the &#8220;<u>Secured Parties</u>&#8221;).</font></div>
      <div><br>
      </div>
      <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">W I T N E S S E T H:</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0);">WHEREAS, pursuant to the Securities Purchase Agreement (as defined in the Notes), the Secured Parties have severally agreed to extend loans to the Company evidenced and to be
        evidenced by the Notes;</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0);">WHEREAS, pursuant to a certain Subsidiary Guaranty (&#8220;<u>Guaranty</u>&#8221;) to be dated as of the date of the Additional Debtor Joinder, forms of which are annexed hereto as Annex
        A, each Guarantor agrees to guarantee and act as surety for payment of such Notes, and other obligations of the Company;</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0);">WHEREAS, in order to induce the Secured Parties to extend the loans evidenced by the Notes, each Debtor has agreed to execute and deliver to the Collateral Agent this Agreement
        and to grant Collateral Agent, for the ratable benefit of the Secured Parties, a security interest in certain property of such Debtor to secure the prompt payment, performance and discharge in full of all of the Debtors&#8217; obligations under the Notes
        and Transaction Documents.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0);">NOW, THEREFORE, in consideration of the agreements herein contained and for other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged,
        the parties hereto hereby agree as follows:</div>
      <div><br>
      </div>
      <div style="text-align: justify;"><font style="color: rgb(0, 0, 0);">1.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="color: rgb(0, 0, 0);"><font style="font-weight: bold;">Certain Definitions</font>. As used in this Agreement, the following terms shall have the
          meanings set forth in this Section 1. Terms used but not otherwise defined in this Agreement that are defined in Article 8 or 9 of the UCC (such as &#8220;account,&#8221; &#8220;chattel paper,&#8221; &#8220;commercial tort claim,&#8221; &#8220;deposit account,&#8221; &#8220;document,&#8221; &#8220;equipment,&#8221;
          &#8220;fixtures,&#8221; &#8220;general intangibles,&#8221; &#8220;goods,&#8221; &#8220;instruments,&#8221; &#8220;inventory,&#8221; &#8220;investment property,&#8221; &#8220;letter-of-credit rights,&#8221; &#8220;proceeds&#8221; and &#8220;supporting obligations&#8221;) shall have the respective meanings given such terms in Article 8 or 9 of the UCC,
          as applicable.&#160; Upper case terms shall have the meanings attributed to them in the Securities Purchase Agreement.</font></div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="color: rgb(0, 0, 0);">&#8220;<u>Collateral</u>&#8221; means the collateral in which the Collateral Agent is granted a security interest by
          this Agreement and which shall include the following personal property of the Debtors, whether presently owned or existing or hereafter acquired or coming into existence, wherever situated, and all additions and accessions thereto and all
          substitutions and replacements thereof, and all proceeds, products and accounts thereof, including, without limitation, all proceeds from the disposition, sale or transfer of the Collateral and of insurance covering the same and of any tort
          claims in connection therewith, and all dividends, interest, cash, notes, securities, equity interest or other property at any time and from time to time acquired, receivable or otherwise distributed in respect of, or in exchange for, any or all
          of the Pledged Securities (as defined below):</font></div>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">1</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; margin-left: 36pt; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(i)</font>&#160;&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);">All goods, including, without limitation, (A) all machinery, equipment, computers, motor
          vehicles, trucks, tanks, boats, ships, appliances, furniture, special and general tools, fixtures, test and quality control devices and other equipment of every kind and nature and wherever situated, together with all documents of title and
          documents representing the same, all additions and accessions thereto, replacements therefor, all parts therefor, and all substitutes for any of the foregoing and all other items used and useful in connection with any Debtor&#8217;s businesses and all
          improvements thereto; and (B) all inventory;</font></div>
      <div><br>
      </div>
      <div style="text-align: justify; margin-left: 36pt; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(ii)</font>&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);">All contract rights and other general intangibles, including, without limitation,
          Intellectual Property, all partnership interests, membership interests, stock or other securities, rights under any of the Organizational Documents (as defined herein), agreements related to the Pledged Securities (as defined herein), licenses,
          distribution and other agreements, computer software (whether &#8220;off-the-shelf,&#8221; licensed from any third party or developed by any Debtor), computer software development rights, leases, franchises, customer lists, quality control procedures, grants
          and rights, goodwill, trademarks, service marks, trade styles, trade names, patents, patent applications, copyrights, and income tax refunds;</font></div>
      <div><br>
      </div>
      <div style="text-align: justify; margin-left: 36pt; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(iii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);">All accounts, together with all instruments, all documents of title representing any of
          the foregoing, all rights in any merchandising, goods, raw materials, timber cut or to be cut, oil, gas, hydrocarbons, and minerals extracted or to be extracted, equipment, motor vehicles and trucks which any of the same may represent, and all
          right, title, security and guaranties with respect to each account, including any right of stoppage in transit;</font></div>
      <div><br>
      </div>
      <div style="text-align: justify; margin-left: 36pt; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(iv)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);">All documents, letter-of-credit rights, instruments and chattel paper;</font></div>
      <div><br>
      </div>
      <div style="text-align: justify; margin-left: 36pt; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(v)</font>&#160;&#160;&#160;&#160;&#160; &#160; &#160; <font style="color: rgb(0, 0, 0);">All commercial tort claims;</font></div>
      <div><br>
      </div>
      <div style="text-align: justify; margin-left: 36pt; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(vi)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);">All deposit accounts and all cash (whether or not deposited in such deposit accounts);</font></div>
      <div><br>
      </div>
      <div style="text-align: justify; margin-left: 36pt; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(vii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);">All investment property;</font></div>
      <div><br>
      </div>
      <div style="text-align: justify; margin-left: 36pt; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(viii)</font>&#160;&#160; &#160; &#160; <font style="color: rgb(0, 0, 0);">All supporting obligations;</font></div>
      <div><br>
      </div>
      <div style="text-align: justify; margin-left: 36pt; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(ix)</font>&#160;&#160;&#160;&#160; &#160; &#160; <font style="color: rgb(0, 0, 0);">All files, records, books of account, business papers, and computer programs; and</font></div>
      <div><br>
      </div>
      <div style="text-align: justify; margin-left: 36pt; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(x)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);">the products and proceeds of all of the foregoing Collateral set forth in clauses
          (i)&#8209;(ix) above.</font></div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0);">Without limiting the generality of the foregoing, the &#8220;<u>Collateral</u>&#8221; shall include all investment property and general intangibles respecting ownership and/or other equity
        interests in Guarantor, including, without limitation, the shares of capital stock and the other equity interests, including member interests in limited liability companies listed on <u>Schedule H</u>&#160; hereto (as the same may be modified from time
        to time pursuant to the terms hereof), and any other shares of capital stock and/or other equity interests of any other direct or indirect Subsidiary of any Debtor obtained in the future, and, in each case, all certificates representing such shares
        and/or equity interests and, in each case, all rights, options, warrants, stock, other securities and/or equity interests that may hereafter be received, receivable or distributed in respect of, or exchanged for, any of the foregoing and all rights
        arising under or in connection with the Pledged Securities, including, but not limited to, all dividends, interest and cash.</div>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">2</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0);">Notwithstanding the foregoing, nothing herein shall be deemed to constitute an assignment of any asset which, in the event of an assignment, becomes void by operation of
        applicable law or the assignment of which is otherwise prohibited by applicable law (in each case to the extent that such applicable law is not overridden by Sections 9-406, 9-407 and/or 9-408 of the UCC or other similar applicable law); <u>provided</u>,
        <u>however</u>, that to the extent permitted by applicable law, this Agreement shall create a valid security interest in such asset and, to the extent permitted by applicable law, this Agreement shall create a valid security interest in the
        proceeds of such asset.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0);">Additionally, notwithstanding the foregoing, nothing herein shall be deemed to constitute a grant of security on any asset which, in the event of such grant of security
        interest is an event of default under the Senior Secured Debt (as defined in the Securities Purchase Agreement); provided, however, that to the extent permitted, this Agreement shall create a valid security interest in such asset when such security
        interest shall no longer constitute an event of default and this Agreement shall create a valid security interest in the proceeds of such asset. For the purposes of clarity, this security interest will be subordinate to any current security
        interest on the Company&#8217;s assets until such time as the first position interest is removed at such point this will become a first position interest.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="color: rgb(0, 0, 0);">&#8220;<u>Intellectual Property</u>&#8221; means the collective reference to all rights, priorities and privileges
          relating to intellectual property, whether arising under United States, multinational or foreign laws or otherwise, including, without limitation, (i) all copyrights arising under the laws of the United States, any other country or any political
          subdivision thereof, whether registered or unregistered and whether published or unpublished, all registrations and recordings thereof, and all applications in connection therewith, including, without limitation, all registrations, recordings and
          applications in the United States Copyright Office, (ii) all patents of the United States, any other country or any political subdivision thereof, all reissues and extensions thereof, and all applications for letters patent of the United States
          or any other country and all divisions, continuations and continuations-in-part thereof, (iii) all trademarks, trade names, corporate names, company names, business names, fictitious business names, trade dress, service marks, logos, domain names
          and other source or business identifiers, and all goodwill associated therewith, now existing or hereafter adopted or acquired, all registrations and recordings thereof, and all applications in connection therewith, whether in the United States
          Patent and Trademark Office or in any similar office or agency of the United States, any State thereof or any other country or any political subdivision thereof, or otherwise, and all common law rights related thereto, (iv) all trade secrets
          arising under the laws of the United States, any other country or any political subdivision thereof, (v) all rights to obtain any reissues, renewals or extensions of the foregoing, (vi) all licenses for any of the foregoing, (vii) any items
          included in the definition of Intellectual Property Rights as defined in the Securities Purchase Agreement and not set forth above, and (viii) all causes of action for infringement of the foregoing.</font></div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="color: rgb(0, 0, 0);">&#8220;<u>Majority in Interest</u>&#8221; means, at any time of determination, the holders of not less than 50.1%
          (based on then-outstanding principal amounts and accrued interest of Notes at the time of such determination) of the Notes.</font></div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(d)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="color: rgb(0, 0, 0);">&#8220;<u>Necessary Endorsement</u>&#8221; means undated stock powers endorsed in blank and other proper instruments of
          assignment duly executed and such other instruments or documents as the Collateral Agent (as that term is defined below) may reasonably request.</font></div>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">3</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(e)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="color: rgb(0, 0, 0);">&#8220;<u>Obligations</u>&#8221; means all of the liabilities and obligations (primary, secondary, direct, contingent,
          sole, joint or several) due or to become due, or that are now or may be hereafter contracted or acquired, or owing to, of any Debtor to the Secured Parties, comprising all obligations under this Agreement, the Notes, the Guaranty and obligations
          under any other Transaction Document, instrument, agreement or other document executed and/or delivered in connection herewith in each case, whether now or hereafter existing, voluntary or involuntary, direct or indirect, absolute or contingent,
          liquidated or unliquidated, whether or not jointly owed with others, and whether or not from time to time decreased or extinguished and later increased, created or incurred, and all or any portion of such obligations or liabilities that are paid,
          to the extent all or any part of such payment is avoided or recovered directly or indirectly from any of the Secured Parties as a preference, fraudulent transfer or otherwise as such obligations may be amended, supplemented, converted, extended
          or modified from time to time. Without limiting the generality of the foregoing, the term &#8220;Obligations&#8221; shall include, without limitation: (i) principal of, and interest on the Notes and the loans extended pursuant thereto; (ii) any and all other
          fees, indemnities, costs, obligations and liabilities of the Debtors from time to time under or in connection with this Agreement, the Notes and any other Transaction Documents, instruments, agreements or other documents executed and/or delivered
          in connection herewith or therewith; and (iii) all amounts (including but not limited to post&#8209;petition interest) in respect of the foregoing that would be payable but for the fact that the obligations to pay such amounts are unenforceable or not
          allowable due to the existence of a bankruptcy, reorganization or similar proceeding involving any Debtor.</font></div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(f)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="color: rgb(0, 0, 0);">&#8220;<u>Organizational Documents</u>&#8221; means with respect to any Debtor, the documents by which such Debtor was
          organized (such as a certificate of incorporation, certificate of limited partnership or articles of organization, and including, without limitation, any certificates of designation for preferred stock or other forms of preferred equity) and
          which relate to the internal governance of such Debtor (such as bylaws, a partnership agreement or an operating, limited liability or members agreement).</font></div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(g)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="color: rgb(0, 0, 0);">&#8220;<u>Pledged Securities</u>&#8221; shall have the meaning ascribed to such term in Section 4(i).</font></div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(h)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="color: rgb(0, 0, 0);">&#8220;<u>UCC</u>&#8221; means the Uniform Commercial Code of the State of Delaware and or any other applicable law of
          any state or states which has jurisdiction with respect to all, or any portion of, the Collateral or this Agreement, from time to time. It is the intent of the parties that defined terms in the UCC should be construed in their broadest sense so
          that the term &#8220;Collateral&#8221; will be construed in its broadest sense. Accordingly, if there are, from time to time, changes to defined terms in the UCC that broaden the definitions, they are incorporated herein and if existing definitions in the
          UCC are broader than the amended definitions, the existing ones shall be controlling.</font></div>
      <div><br>
      </div>
      <div style="text-align: justify;"><font style="color: rgb(0, 0, 0);">2.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="color: rgb(0, 0, 0);"><font style="font-weight: bold;">Grant of Security Interest in Collateral</font>. As an inducement for the Secured Parties to
          extend the loans as evidenced by the Notes and to secure the complete and timely payment, performance and discharge in full, as the case may be, of all of the Obligations, each Debtor hereby unconditionally and irrevocably pledges, grants and
          hypothecates to the Secured Parties a first priority security interest in and to, a lien upon and a right of set-off against all of their respective right, title and interest of whatsoever kind and nature in and to, the Collateral (a &#8220;<u>Security
            Interest</u>&#8221; and, collectively, the &#8220;<u>Security Interests</u>&#8221;), subject only to the lien of the Senior Secured Debt.</font></div>
      <div><br>
      </div>
      <div style="text-align: justify;"><font style="color: rgb(0, 0, 0);">3.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="color: rgb(0, 0, 0);"><font style="font-weight: bold;">Delivery of Certain Collateral</font>. At any time at the request of the Collateral Agent,
          each Debtor shall deliver or cause to be delivered to the Collateral Agent, any and all certificates and other instruments or documents representing any of the Collateral, in each case, together with all Necessary Endorsements.</font></div>
      <div><br>
      </div>
      <div style="text-align: justify;"><font style="color: rgb(0, 0, 0);">4.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="color: rgb(0, 0, 0);"><font style="font-weight: bold;">Representations, Warranties, Covenants and Agreements of the Debtors</font>. Except as set
          forth under the corresponding section of the disclosure schedules delivered to the Secured Parties and Collateral Agent concurrently herewith (the &#8220;<u>Disclosure Schedules</u>&#8221;), which Disclosure Schedules shall be deemed a part hereof.&#160; As of
          the date hereof, each Debtor represents and warrants to the Secured Parties as follows and, until the repayment in full of the Obligations, covenants and agrees with, the Secured Parties as follows:</font></div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="color: rgb(0, 0, 0);">Each Debtor has the requisite corporate, partnership, limited liability company or other power and
          authority to enter into this Agreement and otherwise to carry out its obligations hereunder. The execution, delivery and performance by each Debtor of this Agreement and the filings contemplated herein have been duly authorized by all necessary
          action on the part of such Debtor and no further action is required by such Debtor. This Agreement, when executed and delivered, will constitute the legal, valid and binding obligation of each Debtor, enforceable against each Debtor in accordance
          with its terms except as such enforceability may be limited by applicable bankruptcy, insolvency, reorganization and similar laws of general application relating to or affecting the rights and remedies of creditors and by general principles of
          equity.</font></div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);"> <br>
        </font></div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">4</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);">The Debtors have no place of business or offices where their respective books of account and records are
          kept (other than temporarily at the offices of its attorneys or accountants) or places where Collateral is stored or located, except as set forth on <u>Schedule A</u> attached hereto. Except as specifically set forth on <u>Schedule A</u>, each
          Debtor is the record owner of the real property where such Collateral is located, and there exist no mortgages or other liens on any such real property or on the Collateral except for Permitted Liens (as defined in the Securities Purchase
          Agreement), all of which are identified on <u>Schedule B</u> hereto. Except as disclosed on <u>Schedule A</u> and except for Collateral to be held by the Collateral Agent, none of such Collateral is in the possession of any consignee, bailee,
          warehouseman, agent or processor.</font></div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="color: rgb(0, 0, 0);">Except for Permitted Liens and except as set forth on <u>Schedule B</u> attached hereto, the Debtors are
          the sole owners of the Collateral (except for non-exclusive licenses granted by any Debtor in the ordinary course of business), free and clear of any liens, security interests, encumbrances, rights or claims, and are fully authorized to grant the
          Security Interests. Except for Permitted Liens and other items which are all as set forth on <u>Schedule B</u> attached hereto, there is not on file in any governmental or regulatory authority, agency or recording office an effective financing
          statement, security agreement, license or transfer or any notice of any of the foregoing (other than those that will be filed in favor of the Secured Parties pursuant to this Agreement) covering or affecting any of the Collateral.</font></div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(d)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);">No written claim has been received that any Collateral or any Debtor&#8217;s use of any Collateral violates the
          rights of any third party. There has been no adverse decision to any Debtor&#8217;s claim of ownership rights in or exclusive rights to use the Collateral in any jurisdiction or to any Debtor&#8217;s right to keep and maintain such Collateral in full force
          and effect, and there is no proceeding involving said rights pending or, to the best knowledge of any Debtor, threatened before any court, judicial body, administrative or regulatory agency, arbitrator or other governmental authority.</font></div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(e)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);">Each Debtor shall at all times maintain its books of account and records relating to the Collateral at its
          principal place of business and its Collateral at the locations set forth on <u>Schedule A</u>&#160; attached hereto and may not relocate such books of account and records or tangible Collateral except in the ordinary course of sales unless it
          delivers to the Secured Parties at least 15 days prior to such relocation (i) written notice of such relocation and the new location thereof (which must be within the United States) and (ii) evidence that appropriate financing statements under
          the UCC and other necessary documents have been filed and recorded and other steps have been taken to perfect the Security Interests to create in favor of the Secured Parties a valid, perfected and continuing perfected first priority lien in the
          Collateral, except as otherwise permitted hereby.</font></div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(f)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="color: rgb(0, 0, 0);">This Agreement creates in favor of the Secured Parties a valid security interest in the Collateral, subject
          only to Permitted Liens securing the payment and performance of the Obligations. Upon making the filings described in the immediately following paragraph, all security interests created hereunder in any Collateral that may be perfected by filing
          Uniform Commercial Code financing statements shall have been duly perfected. Except for the filing of the Uniform Commercial Code financing statements referred to in the immediately following paragraph, the recordation of the Intellectual
          Property Security Agreement (as defined below) with respect to copyrights and copyright applications in the United States Copyright Office referred to in paragraph (m), the execution and delivery of deposit account control agreements satisfying
          the requirements of Section 9-104(a)(2) of the UCC with respect to each deposit account of the Debtors, and the delivery of the certificates and other instruments provided in Section 3, no action is necessary to create, perfect or protect the
          security interests created&#160; hereunder.&#160; Without limiting the generality of the foregoing, except for the filing of said financing statements, the recordation of said Intellectual Property Security Agreement, and the execution and delivery of said
          deposit account control agreements, no consent of any third parties and no authorization, approval or other action by, and no notice to or filing with, any governmental authority or regulatory body is required for (i) the execution, delivery and
          performance of this Agreement, (ii) the creation or perfection of the Security Interests created hereunder in the Collateral or (iii) the enforcement of the rights of the Collateral Agent and the Secured Parties hereunder.</font></div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);"> <br>
        </font></div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">5</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(g)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);">Each Debtor hereby authorizes the Collateral Agent to file one or more financing statements under the UCC,
          with respect to the Security Interests, with the proper filing and recording agencies in any jurisdiction deemed proper by it and authorizes Collateral Agent to take any other action in Collateral Agent&#8217;s absolute discretion to effectuate,
          memorialize and protect Secured Parties&#8217; interest and rights under this Agreement.</font></div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(h)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);">Except as set forth on Schedule <u>I hereto, the</u> execution, delivery and performance of this
          Agreement by the Debtors does not (i) violate any of the provisions of any Organizational Documents of any Debtor or, to the knowledge of any Debtor, any judgment, decree, order or award of any court, governmental body or arbitrator or any
          applicable law, rule or regulation applicable to any Debtor or (ii) to the knowledge of each Debtor, conflict with, or constitute a default (or an event that with notice or lapse of time or both would become a default) under, or give to others
          any rights of termination, amendment, acceleration or cancellation (with or without notice, lapse of time or both) of, any agreement, credit facility, debt or other instrument (evidencing any Debtor&#8217;s debt or otherwise) or other understanding to
          which such Debtor is a party or by which any property or asset of any Debtor is bound or affected. If any, all required consents (including, without limitation, from stockholders or creditors of any Debtor) necessary for any Debtor to enter into
          and perform its obligations hereunder have been obtained.</font></div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(i)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);">The capital stock and other equity interests listed on <u>Schedule I</u> hereto (the &#8220;<u>Pledged
            Securities</u>&#8221;) represent all of the capital stock and other equity interests of the Guarantor, and other Subsidiaries, if any, and represent all capital stock and other equity interests owned, directly or indirectly, by the Company. All of
          the Pledged Securities, if applicable, are validly issued, fully paid and nonassessable, and the Company is the legal and beneficial owner of the Pledged Securities, free and clear of any lien, security interest or other encumbrance except for
          the security interests created by this Agreement and other Permitted Liens.</font></div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(j)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);">The ownership and other equity interests in partnerships and limited liability companies (if any) included
          in the Collateral (the &#8220;<u>Pledged Interests</u>&#8221;) by their express terms do not provide that they are securities governed by Article 8 of the UCC and are not held in a securities account or by any financial intermediary.</font></div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(k)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);">Except for Permitted Liens, each Debtor shall at all times maintain the liens and Security Interests
          provided for hereunder as valid and perfected first priority liens and security interests in the Collateral in favor of the Secured Parties until this Agreement and the Security Interest hereunder shall be terminated pursuant to Section 14
          hereof. Each Debtor hereby agrees to defend the same against the claims of any and all persons and entities. Each Debtor shall safeguard and protect all Collateral for the account of the Secured Parties.&#160; Upon request of the Collateral Agent,
          each Debtor will sign and deliver to the Collateral Agent on behalf of the Secured Parties at any time or from time to time one or more financing statements pursuant to the UCC in form reasonably satisfactory to the Collateral Agent and will pay
          the cost of filing the same in all public offices wherever filing is, or is deemed by the Collateral Agent to be, necessary or desirable to effect the rights and obligations provided for herein. Without limiting the generality of the foregoing,
          each Debtor shall pay all fees, taxes and other amounts necessary to maintain the Collateral and the Security Interest hereunder, and each Debtor shall obtain and furnish to the Collateral Agent from time to time, upon demand, such releases
          and/or subordinations of claims and liens (other than Permitted Liens) that may be required to maintain the priority of the Security Interest hereunder.</font></div>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">6</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(l)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);">Other than with respect to Permitted Liens and except as detailed in <font style="font-weight: bold;"><u>Schedule






              4(l)</u></font> hereto, no Debtor will transfer, pledge, hypothecate, encumber, license, sell or otherwise dispose of any of the Collateral (except for non-exclusive licenses granted by a Debtor in its ordinary course of business, sales of
          inventory by a Debtor in its ordinary course of business and disposition of obsolete equipment) without the prior written consent of the Collateral Agent.&#160; The foregoing notwithstanding, Debtor may replace noncash components of the Collateral
          with a cash or Cash Equivalent deposit made at an institution subject to a cash account control agreement acceptable to the Secured Parties, provided the amount of cash deposited subject to such agreement is not less than the highest amount of
          the Obligations that may be outstanding pursuant to the Transaction Documents. Cash Equivalent shall mean U.S. government Treasury bills, bank certificates of deposit, bankers&#8217; acceptances, corporate commercial paper and other money market
          instruments.</font></div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(m)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);">Each Debtor shall keep and preserve its equipment, inventory and other tangible Collateral in good
          condition, repair and order (except for any of the foregoing disposed of in the ordinary course of such Debtor&#8217;s business) and shall not operate or locate any such Collateral (or cause to be operated or located) in any area excluded from
          insurance coverage.</font></div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(n)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);">Each Debtor shall maintain with financially sound and reputable insurers, insurance with respect to the
          Collateral, including Collateral hereafter acquired, against loss or damage of the kinds and in the amounts customarily insured against by entities of established reputation having similar properties similarly situated and in such amounts as are
          customarily carried under similar circumstances by other such entities and otherwise as is prudent for entities engaged in similar businesses but in any event sufficient to cover the full replacement cost thereof. Each Debtor shall cause each
          insurance policy issued in connection herewith to provide, and the insurer issuing such policy to certify to the Collateral Agent, that (a) [reserved]; and (b) if such insurance is proposed to be cancelled or materially changed for any reason
          whatsoever, such insurer or the Company will promptly notify the Collateral Agent.</font></div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(o)</font>&#160;&#160;&#160;&#160;&#160;&#160; &#160; <font style="color: rgb(0, 0, 0);">Each Debtor shall, within ten (10) days of obtaining knowledge thereof, advise Collateral Agent promptly,
          in sufficient detail, of any material adverse change in the Collateral, and of the occurrence of any event which would have a material adverse effect on the value of the Collateral or on the Secured Parties&#8217; security interest.</font></div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(p)</font>&#160;&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);">Each Debtor shall promptly execute and deliver to the Collateral Agent such further deeds, mortgages,
          assignments, security agreements, financing statements or other instruments, documents, certificates and assurances and take such further action as the Collateral Agent may from time to time reasonably request and may in its sole discretion deem
          reasonably necessary to perfect, protect or enforce the Secured Parties&#8217; security interest in the Collateral including, without limitation, one or more deposit account control agreements, and if applicable, the execution and delivery of a
          separate security agreement with respect to each Debtor&#8217;s Intellectual Property (&#8220;<u>Intellectual Property Security Agreement</u>&#8221;) in which the Secured Parties have been granted a security interest hereunder, all substantially in customary forms
          reasonably acceptable to the Collateral Agent, which Intellectual Property Security Agreement, and other such documents and agreements other than as stated therein, shall be subject to all of the terms and conditions hereof.</font></div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(q)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);">Subject to being supervised by such Debtor&#8217;s personnel and subject to not interfering with such Debtor&#8217;s
          business and signing an NDA in the customary form, each Debtor shall permit the Collateral Agent and its representatives and agents to inspect the Collateral during normal business hours and upon reasonable prior notice, and to make copies of
          records pertaining to the Collateral as may be reasonably requested by the Collateral Agent from time to time.</font></div>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">7</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(r)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);">Each Debtor shall take commercially reasonable steps necessary to diligently pursue and seek to preserve,
          enforce and collect any rights, claims, causes of action and accounts receivable in respect of the Collateral.</font></div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(s)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);">Each Debtor shall promptly notify the Secured Parties in sufficient detail upon becoming aware of any
          attachment, garnishment, execution or other legal process levied against any Collateral and of any other information received by such Debtor that may materially affect the value of the Collateral, the Security Interest or the rights and remedies
          of the Secured Parties hereunder.</font></div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(t)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);">All information herein supplied to the Secured Parties by or on behalf of any Debtor with respect to the
          Collateral is accurate and complete in all material respects as of the date furnished and in light of the circumstances under which such statements were made.</font></div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(u)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);">Each Debtor shall at all times preserve and keep in full force and effect its existence and good standing
          and any rights and franchises material to its business.</font></div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(v)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);">No Debtor will change its name, type of organization, jurisdiction of organization, organizational
          identification number (if it has one), legal or corporate structure, or add any new fictitious name unless it provides at least 15 days prior written notice to the Collateral Agent of such change and, at the time of such written notification,
          such Debtor provides any financing statements or fixture filings necessary to perfect and continue the perfection of the Security Interests granted and evidenced by this Agreement.</font></div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(w)</font>&#160;&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);">Except in the ordinary course of business, no Debtor may consign any of its inventory or sell any of its
          inventory on bill and hold, sale or return, sale on approval, or other conditional terms of sale without the consent of the Collateral Agent which shall not be unreasonably withheld.</font></div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(x)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);">No Debtor may relocate its chief executive office to a new location without providing 30 days prior written
          notification thereof to the Secured Parties and provided that at the time of such written notification, such Debtor provides any financing statements necessary to perfect and continue the perfection of the Security Interests granted and evidenced
          by this Agreement.</font></div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(y)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);">Each Debtor was organized and remains organized solely under the laws of the state set forth next to such
          Debtor&#8217;s name in <u>Schedule D</u> attached hereto, which <u>Schedule D</u> sets forth each Debtor&#8217;s organizational identification number or, if any Debtor does not have one, states that one does not exist.</font></div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0);">(z)</div>
      <div><br>
      </div>
      <div style="text-align: justify; margin-left: 72pt;"><font style="color: rgb(0, 0, 0);">(i)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);">The actual name of each Debtor is the name set forth in <u>Schedule D</u> attached hereto;</font></div>
      <div><br>
      </div>
      <div style="text-align: justify; margin-left: 72pt;"><font style="color: rgb(0, 0, 0);">(ii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);">no Debtor has any trade names except as set forth on <u>Schedule E</u> attached hereto;</font></div>
      <div><br>
      </div>
      <div style="text-align: justify; margin-left: 72pt;"><font style="color: rgb(0, 0, 0);">(iii)</font>&#160;&#160;&#160;&#160; &#160;&#160; <font style="color: rgb(0, 0, 0);">no Debtor has used any name other than that stated in the preamble hereto or as set forth on <u>Schedule
            E</u> for the preceding five years; and</font></div>
      <div><br>
      </div>
      <div style="text-align: justify; margin-left: 72pt;"><font style="color: rgb(0, 0, 0);">(iv)</font>&#160;&#160;&#160;&#160; &#160; &#160; <font style="color: rgb(0, 0, 0);">no entity has merged into any Debtor or been acquired by any Debtor within the past five years except as
          set forth on <u>Schedule E</u>.</font></div>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">8</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(aa)</font>&#160;&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);">At any time that any Collateral consists of instruments, certificated securities or other items that require
          or permit possession by a secured party to perfect the security interest created hereby, the applicable Debtor shall deliver such Collateral to the Collateral Agent.</font></div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(bb)</font>&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);">During the continuance of an Event of Default, each Debtor, in its capacity as issuer, hereby agrees to
          comply with any and all reasonable orders and instructions of Collateral Agent regarding the Pledged Securities consistent with the terms of this Agreement without the further consent of any Debtor as contemplated by Section 8-106 (or any
          successor section) of the UCC. Further, each Debtor agrees, solely with respect to the Pledged Securities, that it shall not enter into a similar agreement (or one that would confer &#8220;control&#8221; within the meaning of Article 8 of the UCC) with any
          other person or entity.</font></div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(cc)</font>&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);">Upon the occurrence of an Event of Default, each Debtor shall cause all tangible chattel paper constituting
          Collateral to be delivered to the Collateral Agent or, if such delivery is not possible, then to cause such tangible chattel paper to contain a legend noting that it is subject to the security interest created by this Agreement. To the extent
          that any Collateral consists of electronic chattel paper, the applicable Debtor shall cause the underlying chattel paper to be &#8220;marked&#8221; within the meaning of Section 9-105 of the UCC (or successor section thereto).</font></div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(dd)</font>&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);">If there is any investment property or deposit account included as Collateral that can be perfected by
          &#8220;control&#8221; through an account control agreement, the applicable Debtor shall at the request of the Collateral Agent cause such an account control agreement, in form and substance in each case reasonably satisfactory to the Collateral Agent, to be
          entered into and delivered to the Collateral Agent for the benefit of the Secured Parties.</font></div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(ee)</font>&#160;&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);">To the extent that any Collateral consists of letter-of-credit rights, the applicable Debtor shall cause the
          issuer of each underlying letter of credit to consent to an assignment of the proceeds thereof to the Secured Parties.</font></div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(ff)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);">To the extent that any Collateral is in the possession of any third party, the applicable Debtor shall join
          with the Collateral Agent in notifying such third party of the Secured Parties&#8217; security interest in such Collateral and shall use commercially reasonable efforts to obtain an acknowledgement and agreement from such third party with respect to
          the Collateral, in form and substance reasonably satisfactory to the Collateral Agent.</font></div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(gg)</font>&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);">If any Debtor shall at any time hold or acquire a commercial tort claim, such Debtor shall promptly notify
          the Secured Parties in a writing signed by such Debtor of the particulars thereof and grant to the Secured Parties in such writing a security interest therein and in the proceeds thereof, all upon the terms of this Agreement, with such writing to
          be in form and substance satisfactory to the Collateral Agent.</font></div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(hh)</font>&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);">Each Debtor shall promptly provide written notice to the Collateral Agent of any and all accounts which arise
          out of contracts with any governmental authority and, to the extent necessary to perfect or continue the perfected status of the Security Interests in such accounts and proceeds thereof, shall execute and deliver to the Collateral Agent an
          assignment of claims for such accounts and cooperate with the Collateral Agent in taking any other steps required, in its judgment, under the Federal Assignment of Claims Act or any similar federal, state or local statute or rule to perfect or
          continue the perfected status of the Security Interests in such accounts and proceeds thereof.</font></div>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">9</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(ii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);">The Company shall cause each subsidiary of the Company to promptly become a party hereto (an &#8220;<u>Additional
            Debtor</u>&#8221;), by executing and delivering an Additional Debtor Joinder substantially in the form of <u>Annex A</u> attached hereto and comply with the provisions hereof applicable to the Debtors. Concurrent therewith, the Additional Debtor
          shall deliver replacement schedules for, or supplements to all other Disclosure Schedules to (or referred to in) this Agreement, as applicable, which replacement schedules shall supersede, or supplements shall modify, the Schedules then in
          effect. The Additional Debtor shall also deliver such opinions of counsel, authorizing resolutions, good standing certificates, incumbency certificates, organizational documents, financing statements and other information and documentation as the
          Collateral Agent may reasonably request. Upon delivery of the foregoing to the Collateral Agent, the Additional Debtor shall be and become a party to this Agreement with the same rights and obligations as the Debtors, for all purposes hereof as
          fully and to the same extent as if it were an original signatory hereto and shall be deemed to have made the representations, warranties and covenants set forth herein as of the date of execution and delivery of such Additional Debtor Joinder
          (other than representations and warranties that specifically refer to an earlier date), and all references herein to the &#8220;Debtors&#8221; shall be deemed to include each Additional Debtor.</font></div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(jj)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);">Each Debtor shall vote the Pledged Securities to comply with the covenants and agreements set forth herein
          and in the Notes.</font></div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(kk)</font>&#160;&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);">Each Debtor shall register the pledge of the applicable Pledged Securities on the books of such Debtor. Each
          Debtor shall notify each issuer of Pledged Securities to register the pledge of the applicable Pledged Securities in the name of the Collateral Agent on the books of such issuer. Further, except with respect to certificated securities delivered
          to the Collateral Agent, the applicable Debtor shall deliver to Collateral Agent an acknowledgement of pledge (which, where appropriate, shall comply with the requirements of the relevant UCC with respect to perfection by registration) signed by
          the issuer of the applicable Pledged Securities, which acknowledgement shall confirm that: (a) it has registered the pledge on its books and records; and (b) at any time directed by Collateral Agent during the continuation of an Event of Default,
          such issuer will transfer the record ownership of such Pledged Securities into the name of any designee of the Collateral Agent, will take such steps as may be necessary to effect the transfer, and will comply with all other instructions of the
          Collateral Agent regarding such Pledged Securities without the further consent of the applicable Debtor.</font></div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(ll)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);">In the event that, upon an occurrence of an Event of Default, Collateral Agent shall sell all or any of
          the Pledged Securities to another party or parties (herein called the &#8220;<u>Transferee</u>&#8221;) or shall purchase or retain all or any of the Pledged Securities, each Debtor shall, to the extent applicable: (i) deliver to Collateral Agent or the
          Transferee, as the case may be, the articles of incorporation, bylaws, minute books, stock certificate books, corporate seals, deeds, leases, indentures, agreements, evidences of indebtedness, books of account, financial records and all other
          Organizational Documents and records of the Debtors and their direct and indirect subsidiaries; (ii) use its commercially reasonable efforts to obtain resignations of the persons then serving as officers and directors of the Debtors and their
          direct and indirect subsidiaries, if so requested; and (iii) use its commercially reasonable efforts to obtain any approvals that are required by any governmental or regulatory body in order to permit the sale of the Pledged Securities to the
          Transferee or the purchase or retention of the Pledged Securities by Collateral Agent and allow the Transferee or Collateral Agent to continue the business of the Debtors and their direct and indirect subsidiaries.</font></div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(mm)</font>&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);">Without limiting the generality of the other obligations of the Debtors hereunder, each Debtor shall (i) cause
          to be registered at the United States Copyright Office all of its material copyrights, (ii) cause the security interest contemplated hereby with respect to all Intellectual Property registered at the United States Copyright Office or United
          States Patent and Trademark Office to be duly recorded at the applicable office, and (iii) give the Collateral Agent notice whenever it acquires (whether absolutely or by license) or creates any additional material Intellectual Property.</font></div>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">10</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(nn)</font>&#160;&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);">Each Debtor will from time to time, at the joint and several expense of the Debtors, promptly execute and
          deliver all such further instruments and documents, and take all such further action as may be reasonably necessary or desirable, or as the Collateral Agent may reasonably request, in order to perfect and protect any security interest granted or
          purported to be granted hereby or to enable the Collateral Agent to exercise and enforce Collateral Agent&#8217;s rights and remedies hereunder and with respect to any Collateral or to otherwise carry out the purposes of this Agreement.</font></div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(oo)</font>&#160;&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);"><u>Schedule F</u> attached hereto lists all of the patents, patent applications, trademarks, trademark
          applications, registered copyrights, and domain names owned by any of the Debtors as of the date hereof.&#160; <u>Schedule F</u> lists all material licenses in favor of any Debtor for the use of any patents, trademarks, copyrights and domain names as
          of the date hereof. All material patents and trademarks of the Debtors have been duly recorded at the United States Patent and Trademark Office and all material copyrights of the Debtors have been duly recorded at the United States Copyright
          Office.</font></div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(pp)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);">Except as set forth on <u>Schedule G</u> attached hereto, none of the account debtors or other persons or
          entities obligated on any of the Collateral is a governmental authority covered by the Federal Assignment of Claims Act or any similar federal, state or local statute or rule in respect of such Collateral.</font></div>
      <div><br>
      </div>
      <div style="text-align: justify;"><font style="color: rgb(0, 0, 0);">5.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="color: rgb(0, 0, 0);"><font style="font-weight: bold;">Effect of Pledge on Certain Rights</font>.<font style="font-weight: bold;">&#160;</font>If any of
          the Collateral subject to this Agreement consists of nonvoting equity or ownership interests (regardless of class, designation, preference or rights) that may be converted into voting equity or ownership interests upon the occurrence of certain
          events (including, without limitation, upon the transfer of all or any of the other stock or assets of the issuer), it is agreed that the pledge of such equity or ownership interests pursuant to this Agreement or the enforcement of any of
          Collateral Agent&#8217;s rights hereunder shall not be deemed to be the type of event which would trigger such conversion rights notwithstanding any provisions in the Organizational Documents or agreements to which any Debtor is subject or to which any
          Debtor is party.</font></div>
      <div><br>
      </div>
      <div style="text-align: justify;"><font style="color: rgb(0, 0, 0);">6.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; <font style="color: rgb(0, 0, 0);"><font style="font-weight: bold;">Defaults</font>. The following events shall be &#8220;<u>Events of Default</u>&#8221;:</font></div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);">The occurrence of an Event of Default (as defined in the Notes) under the Notes;</font></div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);">Any representation or warranty of any Debtor in this Agreement shall prove to have been incorrect in any
          material respect when made;</font></div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);">The failure by any Debtor to observe or perform any of its obligations hereunder for three (3) Business
          Days after delivery to such Debtor of written notice of such failure by or on behalf of a Secured Party or five (5) Business Days after Debtor otherwise becomes aware of such non-observance or non&#8209;performance; or</font></div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(d)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);">If any material provision of this Agreement shall at any time for any reason be declared to be null and
          void, or the validity or enforceability thereof shall be contested by any Debtor, or a proceeding shall be commenced by any Debtor, or by any governmental authority having jurisdiction over any Debtor, seeking to establish the invalidity or
          unenforceability thereof, or any Debtor shall deny that any Debtor has any liability or obligation purported to be created under this Agreement.</font></div>
      <div><br>
      </div>
      <div style="text-align: justify;"><font style="color: rgb(0, 0, 0);">7.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);"><font style="font-weight: bold;">Duty to Hold In Trust</font>.</font></div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);">During the continuance of an uncured Event of Default, each Debtor shall, upon receipt of any revenue,
          income, dividend, interest or other sums subject to the Security Interests, whether payable pursuant to the Notes or otherwise, or of any check, draft, note, trade acceptance or other instrument evidencing an obligation to pay any such sum, hold
          the same in trust for the Secured Parties and shall forthwith endorse and transfer any such sums or instruments, or both, to the Collateral Agent for distribution to the Secured Parties, pro-rata in proportion to their respective then-currently
          outstanding principal amount of Notes for application to the satisfaction of the Obligations (and if any Note is not outstanding, pro-rata in proportion to the initial purchases of the remaining Notes).</font></div>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">11</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);">If any Debtor shall become entitled to receive or shall receive any securities or other property
          (including, without limitation, shares of Pledged Securities or instruments representing Pledged Securities acquired after the date hereof, or any options, warrants, rights or other similar property or certificates representing a dividend, or any
          distribution in connection with any recapitalization, reclassification or increase or reduction of capital, or issued in connection with any reorganization of such Debtor or any of its direct or indirect subsidiaries) in respect of the Pledged
          Securities (whether as an addition to, in substitution of, or in exchange for, such Pledged Securities or otherwise), such Debtor agrees to (i) hold the same in trust on behalf of and for the benefit of the Secured Parties; and (ii) to deliver
          any and all certificates or instruments evidencing the same to Collateral Agent on or before the close of business on the fifth Business Day following the receipt thereof by such Debtor, in the exact form received together with the Necessary
          Endorsements, to be held by Collateral Agent subject to the terms of this Agreement as Collateral.</font></div>
      <div><br>
      </div>
      <div style="text-align: justify;"><font style="color: rgb(0, 0, 0);">8.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; <font style="color: rgb(0, 0, 0);"><font style="font-weight: bold;">Rights and Remedies Upon Default</font>.</font></div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);">After the occurrence and during the continuance of any Event of Default, the Collateral Agent shall have the
          right to exercise all of the remedies conferred hereunder and under the Notes, and the Collateral Agent shall have all the rights and remedies of a secured party under the UCC. Without limitation, the Collateral Agent, for the benefit of the
          Secured Parties, shall have the following rights and powers:</font></div>
      <div><br>
      </div>
      <div style="text-align: justify; margin-left: 36pt; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(i)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);">The Collateral Agent shall have the right to take possession of the Collateral and, for
          that purpose, enter, with the aid and assistance of any person, any premises where the Collateral, or any part thereof, is or may be placed and remove the same, so long as the same can be accomplished without breach of the peace and otherwise in
          compliance with applicable law, and each Debtor shall assemble the Collateral and make it available to the Collateral Agent at places which the Collateral Agent shall reasonably select, whether at such Debtor&#8217;s premises or elsewhere, and make
          available to the Collateral Agent, without rent, all of such Debtor&#8217;s respective premises and facilities for the purpose of the Collateral Agent taking possession of, removing or putting the Collateral in saleable or disposable form.</font></div>
      <div><br>
      </div>
      <div style="text-align: justify; margin-left: 36pt; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(ii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);">Upon notice to the Debtors by Collateral Agent, all rights of each Debtor to exercise
          the voting and other consensual rights which it would otherwise be entitled to exercise and all rights of each Debtor to receive the dividends and interest which it would otherwise be authorized to receive and retain, shall cease. Upon such
          notice, Collateral Agent shall have the right to receive, for the benefit of the Secured Parties, any interest, cash dividends or other payments on the Collateral and, at the option of Collateral Agent, to exercise in such Collateral Agent&#8217;s
          discretion all voting rights pertaining thereto. Without limiting the generality of the foregoing, Collateral Agent shall have the right (but not the obligation) to exercise all rights with respect to the Collateral as if it were the sole and
          absolute owner thereof, including, without limitation, to vote and/or to exchange, at its sole discretion, any or all of the Collateral in connection with a merger, reorganization, consolidation, recapitalization or other readjustment concerning
          or involving the Collateral or any Debtor or any of its direct or indirect subsidiaries.</font></div>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">12</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; margin-left: 36pt; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(iii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);">The Collateral Agent shall have the right to seek an Order from a court appointing a
          Trustee&#160; to operate the business of each Debtor using the Collateral and shall have the right to assign, sell, lease or otherwise dispose of and deliver all or any part of the Collateral, at public or private sale or otherwise, either with or
          without special conditions or stipulations, for cash or on credit or for future delivery, in such parcel or parcels and at such time or times and at such place or places, and upon such terms and conditions as are commercially reasonable.&#160; Upon
          each such sale, lease, assignment or other transfer or disposition of Collateral, the Collateral Agent, for the benefit of the Secured Parties, may, unless prohibited by applicable law which cannot be waived, purchase all or any part of the
          Collateral being sold, free from and discharged of all trusts, claims, right of redemption and equities of any Debtor, which are hereby waived and released.</font></div>
      <div><br>
      </div>
      <div style="text-align: justify; margin-left: 36pt; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(iv)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);">The Collateral Agent shall have the right (but not the obligation) to notify any account
          debtors and any obligors under instruments or accounts to make payments directly to the Collateral Agent, on behalf of the Secured Parties, and to enforce the Debtors&#8217; rights against such account debtors and obligors.</font></div>
      <div><br>
      </div>
      <div style="text-align: justify; margin-left: 36pt; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(v)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);">The Collateral Agent, for the benefit of the Secured Parties, may (but is not obligated
          to) direct any financial intermediary or any other person or entity holding any investment property to transfer the same to the Collateral Agent, on behalf of the Secured Parties, or its designee.</font></div>
      <div><br>
      </div>
      <div style="text-align: justify; margin-left: 36pt; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(vi)</font>&#160;&#160;&#160; &#160; &#160; <font style="color: rgb(0, 0, 0);">The Collateral Agent may (but is not obligated to) transfer any or all Intellectual
          Property registered in the name of any Debtor at the United States Patent and Trademark Office and/or Copyright Office into the name of the Collateral Agent or any purchaser of any Collateral.</font></div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);">The Collateral Agent shall comply with any applicable law in connection with a disposition of Collateral and
          such compliance will not be considered adversely to affect the commercial reasonableness of any sale of the Collateral. The Collateral Agent may sell the Collateral without giving any warranties and may specifically disclaim such warranties. If
          the Collateral Agent sells any of the Collateral on credit, the Debtors will only be credited with payments actually made by the purchaser. In addition, each Debtor waives any and all rights that it may have to a judicial hearing in advance of
          the enforcement of any of the Collateral Agent&#8217;s rights and remedies hereunder, including, without limitation, its right following an Event of Default to take immediate possession of the Collateral and to exercise its rights and remedies with
          respect thereto.</font></div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);">If any notice to Debtor of the sale or other disposition of Collateral is required by then applicable law,
          ten (10) business days prior written notice (which Debtor agree is reasonable notice within the meaning of Section 9.612(a) of the Uniform Commercial Code) shall be given to Debtor of the time and place of any sale of Collateral.&#160; The rights
          granted in this Section are in addition to any and all rights available to Collateral Agent under the Uniform Commercial Code.</font></div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(d)</font>&#160;&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);">For the purpose of enabling the Collateral Agent to further exercise rights and remedies under this Section 8
          or elsewhere provided by agreement or applicable law, each Debtor hereby grants to the Collateral Agent for the benefit of the Collateral Agent and the Secured Parties, an irrevocable, nonexclusive license (exercisable without payment of royalty
          or other compensation to such Debtor) to use, license or sublicense during the continuance of an uncured Event of Default, any Intellectual Property now owned or hereafter acquired by such Debtor, and wherever the same may be located, and
          including in such license access to all media in which any of the licensed items may be recorded or stored and to all computer software and programs used for the compilation or printout thereof.</font></div>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">13</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify;"><font style="color: rgb(0, 0, 0);">9.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="color: rgb(0, 0, 0);"><font style="font-weight: bold;">Applications of Proceeds</font>. The proceeds of any such sale, lease or other disposition of
          the Collateral hereunder or from payments made on account of any insurance policy insuring any portion of the Collateral shall be applied first, to the expenses of retaking, holding, storing, processing and preparing for sale, selling, and the
          like (including, without limitation, any taxes, fees and other costs incurred in connection therewith) of the Collateral, if any, to the reasonable attorneys&#8217; fees and expenses incurred by the Collateral Agent in enforcing the Secured Parties&#8217;
          rights hereunder and in connection with collecting, storing and disposing of the Collateral, and then to satisfaction of the Obligations pro rata among the Secured Parties (based on then-outstanding principal amounts of Notes at the time of any
          such determination), and then to the payment of any other amounts required by applicable law, after which the Secured Parties shall pay to the applicable Debtor any surplus proceeds. If, upon the sale, license or other disposition of the
          Collateral, the proceeds thereof are insufficient to pay all amounts to which the Secured Parties are legally entitled, the Debtors will be liable for the deficiency, together with interest thereon, at the rate of 12% per annum or the lesser
          amount permitted by applicable law (the &#8220;Default Rate&#8221;), and the reasonable fees of any attorneys employed by the Secured Parties to collect such deficiency. To the extent permitted by applicable law, each Debtor waives all claims, damages and
          demands against the Secured Parties arising out of the repossession, removal, retention or sale of the Collateral, unless due solely to the gross negligence or willful misconduct of the Secured Parties as determined by a final judgment (not
          subject to further appeal) of a court of competent jurisdiction.</font></div>
      <div><br>
      </div>
      <div style="text-align: justify;"><font style="color: rgb(0, 0, 0);">10.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);"><font style="font-weight: bold;">Securities Law Provision</font>. Each Debtor recognizes that Collateral Agent may be limited
          in its ability to effect a sale to the public of all or part of the Pledged Securities by reason of certain prohibitions in the Securities Act of 1933, as amended, or other federal or state securities laws (collectively, the &#8220;<u>Securities Laws</u>&#8221;),







          and may reasonably be obliged to resort to one or more sales to a restricted group of purchasers who may be required to agree to acquire the Pledged Securities for their own account, for investment and not with a view to the distribution or
          resale thereof. Each Debtor agrees that sales so made may be at prices and on terms less favorable than if the Pledged Securities were sold to the public, and that Collateral Agent has no obligation to delay the sale of any Pledged Securities for
          the period of time necessary to register the Pledged Securities for sale to the public under the Securities Laws. Each Debtor shall cooperate with Collateral Agent in its attempt to satisfy any requirements under the Securities Laws (including,
          without limitation, registration thereunder if requested by Collateral Agent) applicable to the sale of the Pledged Securities by Collateral Agent.</font></div>
      <div><br>
      </div>
      <div style="text-align: justify;"><font style="color: rgb(0, 0, 0);">11.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);"><font style="font-weight: bold;">Costs and Expenses</font>. Each Debtor agrees to pay all reasonable out-of-pocket fees, costs
          and expenses incurred in connection with any filing required hereunder, including without limitation, any financing statements pursuant to the UCC, continuation statements, partial releases and/or termination statements related thereto or any
          expenses of any searches reasonably required by the Collateral Agent. The Debtors shall also pay all other claims and charges which in the reasonable opinion of the Collateral Agent is reasonably likely to prejudice, imperil or otherwise affect
          the Collateral or the Security Interests therein. The Debtors will also, upon demand, pay to the Collateral Agent the amount of any and all reasonable expenses, including the reasonable fees and expenses of its counsel and of any experts and
          agents, which the Collateral Agent, for the benefit of the Secured Parties, may incur in connection with (i) the enforcement of this Agreement, (ii) the custody or preservation of, or the sale of, collection from, or other realization upon, any
          of the Collateral, or (iii) the exercise or enforcement of any of the rights of the Secured Parties under the Notes.&#160; Until so paid, any fees payable hereunder shall be added to the principal amount of the Notes and shall bear interest at the
          Default Rate.</font></div>
      <div><br>
      </div>
      <div style="text-align: justify;"><font style="color: rgb(0, 0, 0);">12.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);"><font style="font-weight: bold;">Responsibility for Collateral</font>. The Debtors assume all liabilities and responsibility
          in connection with all Collateral, and the Obligations shall in no way be affected or diminished by reason of the loss, destruction, damage or theft of any of the Collateral or its unavailability for any reason. Without limiting the generality of
          the foregoing, (a) except for acting in a commercially reasonable manner in all events, neither the Collateral Agent nor any Secured Party (i) has any duty (either before or after an Event of Default) to collect any amounts in respect of the
          Collateral or to preserve any rights relating to the Collateral, or (ii) has any obligation to clean-up or otherwise prepare the Collateral for sale, and (b) each Debtor shall remain obligated and liable under each contract or agreement included
          in the Collateral to be observed or performed by such Debtor thereunder. Neither the Collateral Agent nor any Secured Party shall have any obligation or liability under any such contract or agreement by reason of or arising out of this Agreement
          or the receipt by the Collateral Agent or any Secured Party of any payment relating to any of the Collateral, nor shall the Collateral Agent or any Secured Party be obligated in any manner to perform any of the obligations of any Debtor under or
          pursuant to any such contract or agreement, to make inquiry as to the nature or sufficiency of any payment received by the Collateral Agent or any Secured Party in respect of the Collateral or as to the sufficiency of any performance by any party
          under any such contract or agreement, to present or file any claim, to take any action to enforce any performance or to collect the payment of any amounts which may have been assigned to the Collateral Agent or to which the Collateral Agent or
          any Secured Party may be entitled at any time or times.</font></div>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">14</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify;"><font style="color: rgb(0, 0, 0);">13.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);"><font style="font-weight: bold;">Security Interests Absolute</font>. Subject to the terms and conditions of this Agreement and
          the other Transaction Documents, all rights of the Secured Parties and all obligations of the Debtors hereunder, shall be absolute and unconditional, irrespective of: (a) any lack of validity or enforceability of this Agreement, the Notes or any
          agreement entered into in connection with the foregoing, or any portion hereof or thereof; (b) any change in the time, manner or place of payment or performance of, or in any other term of, all or any of the Obligations, or any other amendment or
          waiver of or any consent to any departure from the Notes or any other agreement entered into in connection with the foregoing; (c) any exchange, release or non&#8209;perfection of any of the Collateral, or any release or amendment or waiver of or
          consent to departure from any other collateral for, or any guarantee, or any other security, for all or any of the Obligations; (d) any action by the Secured Parties to obtain, adjust, settle and cancel in its sole discretion any insurance claims
          or matters made or arising in connection with the Collateral; or (e) any other circumstance which might otherwise constitute any legal or equitable defense available to a Debtor, or a discharge of all or any part of the Security Interests granted
          hereby. Until the Obligations shall have been paid and performed in full, the rights of the Secured Parties shall continue even if the Obligations are barred for any reason, including, without limitation, the running of the statute of limitations
          or bankruptcy. Each Debtor expressly waives presentment, protest, notice of protest, demand, notice of nonpayment and demand for performance. In the event that at any time any transfer of any Collateral or any payment received by the Secured
          Parties hereunder shall be deemed by final order of a court of competent jurisdiction to have been a voidable preference or fraudulent conveyance under the bankruptcy or insolvency laws of the United States, or shall be deemed to be otherwise due
          to any party other than the Secured Parties, then, in any such event, each Debtor&#8217;s obligations hereunder shall survive cancellation of this Agreement, and shall not be discharged or satisfied by any prior payment thereof and/or cancellation of
          this Agreement, but shall remain a valid and binding obligation enforceable in accordance with the terms and provisions hereof. Each Debtor waives all right to require the Secured Parties to proceed against any other person or entity or to apply
          any Collateral which the Secured Parties may hold at any time, or to marshal assets, or to pursue any other remedy. Each Debtor waives any defense arising by reason of the application of the statute of limitations to any Obligations secured
          hereby.</font></div>
      <div><br>
      </div>
      <div style="text-align: justify;"><font style="color: rgb(0, 0, 0);">14.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);"><font style="font-weight: bold;">Term of Agreement</font>. This Agreement and the Security Interest shall terminate on the
          date on which all payments under the Notes have been paid in full and all other Obligations have been paid or discharged; provided, however, that all indemnities of the Debtors contained in this Agreement (including, without limitation, Annex B
          hereto) shall survive and remain operative and in full force and effect regardless of the termination of this Agreement.</font></div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">15</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify;"><font style="color: rgb(0, 0, 0);">15.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);"><font style="font-weight: bold;">Power of Attorney; Further Assurances</font>.</font></div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);">Each Debtor authorizes the Collateral Agent, and does hereby make, constitute and appoint the Collateral
          Agent and its officers, agents, successors or assigns with full power of substitution, as such Debtor&#8217;s true and lawful attorney-in-fact, with power, in the name of the Collateral Agent or such Debtor, after the occurrence and during the
          continuance of an uncured Event of Default, (i) to endorse any note, checks, drafts, money orders or other instruments of payment (including, without limitation, payments payable under or in respect of any policy of insurance) in respect of the
          Collateral that may come into possession of the Collateral Agent; (ii) to sign and endorse any financing statement pursuant to the UCC or any invoice, freight or express bill, bill of lading, storage or warehouse receipts, drafts against debtors,
          assignments, verifications and notices in connection with accounts, and other documents relating to the Collateral; (iii) to pay or discharge taxes, liens, security interests or other encumbrances at any time levied or placed on or threatened
          against the Collateral; (iv) to demand, collect, receipt for, compromise, settle and sue for monies due in respect of the Collateral; (v) to transfer any Intellectual Property or provide licenses respecting any Intellectual Property; and (vi)
          generally, at the option of the Collateral Agent, and at the reasonable expense of the Debtors, at any time, or from time to time, to execute and deliver any and all documents and instruments and to do all acts and things which the Collateral
          Agent reasonably deems necessary to protect, preserve and realize upon the Collateral and the Security Interests granted therein in order to effect the intent of this Agreement and the Notes all as fully and effectually as the Debtors might or
          could do; and each Debtor hereby ratifies all that said attorney shall lawfully do or cause to be done by virtue hereof so long as such actions are in compliance with applicable law and in accordance with the terms and conditions of this
          Agreement and the other Transaction Documents. This power of attorney is coupled with an interest and shall be irrevocable for the term of this Agreement and thereafter as long as any of the Obligations shall be outstanding. Without limiting the
          generality of the foregoing, after the occurrence and during the continuance of an uncured Event&#160; of Default, each Secured Party is specifically authorized to execute and file any applications for or instruments of transfer and assignment of any
          patents, trademarks, copyrights or other Intellectual Property with the United States Patent and Trademark Office and the United States Copyright Office.</font></div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);">On a continuing basis, each Debtor will make, execute, acknowledge, deliver, file and record, as the case
          may be, with the proper filing and recording agencies in any jurisdiction, including, without limitation, the jurisdictions indicated on <u>Schedule C</u> attached hereto, all such instruments, and take all such action as may reasonably be
          deemed necessary or advisable, or as reasonably requested by the Collateral Agent, to perfect the Security Interest granted hereunder and otherwise to carry out the intent and purposes of this Agreement, or for assuring and confirming to the
          Collateral Agent the grant or perfection of a perfected security interest in all the Collateral under the UCC.</font></div>
      <div><br>
      </div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);">Each Debtor hereby irrevocably appoints the Collateral Agent as such Debtor&#8217;s attorney&#8209;in&#8209;fact, with full
          authority in the place and instead of such Debtor and in the name of such Debtor, from time to time in the Collateral Agent&#8217;s discretion, to take any action permitted under this Agreement and to execute any instrument which the Collateral Agent
          may reasonably deem necessary or advisable to accomplish the purposes of this Agreement, including the filing, in its reasonable discretion, of one or more financing or continuation statements and amendments thereto, relative to any of the
          Collateral without the signature of such Debtor where permitted by law, which financing statements may (but need not) describe the Collateral as &#8220;all assets&#8221; or &#8220;all personal property&#8221; or words of like import, and ratifies all such actions taken
          by the Collateral Agent. This power of attorney is coupled with an interest and shall be irrevocable for the term of this Agreement and thereafter as long as any of the Obligations shall be outstanding.</font></div>
      <div><br>
      </div>
      <div style="text-align: justify;"><font style="color: rgb(0, 0, 0);">16.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold; color: rgb(0, 0, 0);">Notices</font><font style="color: rgb(0, 0, 0);">.&#160;&#160; </font>All notices, demands, requests, consents,
        approvals, and other communications required or permitted hereunder shall be in writing and, unless otherwise specified herein, shall be (a) personally served, (b) deposited in the mail, registered or certified, return receipt requested, postage
        prepaid, (c) delivered by a reputable overnight courier service with charges prepaid, or (d) transmitted by hand delivery, telegram, or facsimile, addressed as set forth below or to such other address as such party shall have specified most
        recently by written notice.&#160; Any notice or other communication required or permitted to be given hereunder shall be deemed effective (i) upon hand delivery or delivery by facsimile, with accurate confirmation generated by the transmitting facsimile
        machine, at the address or number designated below (if delivered on a Business Day during normal business hours), or the first Business Day following such delivery (if delivered other than on a Business Day during normal business hours), (ii) on
        the first Business Day following the date deposited with an overnight courier service with charges prepaid, or (iii) on the fifth Business Day following the date of mailing pursuant to subpart (b) above, or upon actual receipt of such mailing,
        whichever shall first occur.&#160; <font style="color: rgb(0, 0, 0);">The addresses for such communications shall be:</font></div>
      <div style="text-align: justify;"><font style="color: rgb(0, 0, 0);"> <br>
        </font></div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">16</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);" id="zfa07e9ea17664ee6ad92180424916ccc">

          <tr>
            <td style="width: 10.01%; vertical-align: top;" colspan="1"><br>
            </td>
            <td style="width: 25%; vertical-align: top;">
              <div style="text-align: justify;">To Debtors, to:</div>
            </td>
            <td style="width: 2%; vertical-align: top;" colspan="1">&#160;</td>
            <td style="width: 43%; vertical-align: top;">
              <div style="text-align: justify; color: rgb(0, 0, 0);">c/o Momentus Inc.</div>
            </td>
            <td colspan="1" style="width: 20%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 10.01%; vertical-align: top;" colspan="1"><br>
            </td>
            <td style="width: 25%; vertical-align: top;">&#160;</td>
            <td style="width: 2%; vertical-align: top;" colspan="1">&#160;</td>
            <td style="width: 43%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">3901 N. First Street</div>
            </td>
            <td colspan="1" style="width: 20%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 10.01%; vertical-align: top;" colspan="1"><br>
            </td>
            <td style="width: 25%; vertical-align: top;">&#160;</td>
            <td style="width: 2%; vertical-align: top;" colspan="1">&#160;</td>
            <td style="width: 43%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">San Jose, CA, 95134</div>
            </td>
            <td colspan="1" style="width: 20%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 10.01%; vertical-align: top;" colspan="1"><br>
            </td>
            <td style="width: 25%; vertical-align: top;">&#160;</td>
            <td style="width: 2%; vertical-align: top;" colspan="1">&#160;</td>
            <td style="width: 43%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">Attn: John Rood</div>
            </td>
            <td colspan="1" style="width: 20%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 10.01%; vertical-align: top;" colspan="1"><br>
            </td>
            <td style="width: 25%; vertical-align: top;">&#160;</td>
            <td style="width: 2%; vertical-align: top;" colspan="1">&#160;</td>
            <td style="width: 43%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">Email: [***]</div>
            </td>
            <td colspan="1" style="width: 20%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 10.01%; vertical-align: top;" colspan="1"><br>
            </td>
            <td style="width: 25%; vertical-align: top;">&#160;</td>
            <td style="width: 2%; vertical-align: top;" colspan="1">&#160;</td>
            <td style="width: 43%; vertical-align: top;">&#160;</td>
            <td colspan="1" style="width: 20%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 10.01%; vertical-align: top;" colspan="1"><br>
            </td>
            <td nowrap="nowrap" style="width: 25%; vertical-align: top;">
              <div style="text-align: justify;">With a copy by email only to</div>
            </td>
            <td style="width: 2%; vertical-align: top;" colspan="1">&#160;</td>
            <td style="width: 43%; vertical-align: top;">&#160;</td>
            <td colspan="1" style="width: 20%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 10.01%; vertical-align: top;" colspan="1"><br>
            </td>
            <td nowrap="nowrap" style="width: 25%; vertical-align: top;">
              <div>(which shall not constitute notice):</div>
            </td>
            <td style="width: 2%; vertical-align: top;" colspan="1">&#160;</td>
            <td style="width: 43%; vertical-align: top;">
              <div><a name="z_Hlk209363364"></a>Bradley Arant Boult Cummings LLP</div>
            </td>
            <td colspan="1" style="width: 20%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 10.01%; vertical-align: top;" colspan="1"><br>
            </td>
            <td style="width: 25%; vertical-align: top;">&#160;</td>
            <td style="width: 2%; vertical-align: top;" colspan="1">&#160;</td>
            <td style="width: 43%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">1221 Broadway, Suite 2400</div>
            </td>
            <td colspan="1" style="width: 20%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 10.01%; vertical-align: top;" colspan="1"><br>
            </td>
            <td style="width: 25%; vertical-align: top;">&#160;</td>
            <td style="width: 2%; vertical-align: top;" colspan="1">&#160;</td>
            <td style="width: 43%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">Nashville, TN 37203</div>
            </td>
            <td colspan="1" style="width: 20%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 10.01%; vertical-align: top;" colspan="1"><br>
            </td>
            <td style="width: 25%; vertical-align: top;">&#160;</td>
            <td style="width: 2%; vertical-align: top;" colspan="1">&#160;</td>
            <td style="width: 43%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">Attn: Stephen Hinton, Esq.</div>
            </td>
            <td colspan="1" style="width: 20%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 10.01%; vertical-align: top;" colspan="1"><br>
            </td>
            <td style="width: 25%; vertical-align: top;">&#160;</td>
            <td style="width: 2%; vertical-align: top;" colspan="1">&#160;</td>
            <td style="width: 43%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">Email: [***]</div>
            </td>
            <td colspan="1" style="width: 20%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 10.01%; vertical-align: top;" colspan="1"><br>
            </td>
            <td style="width: 25%; vertical-align: top;">&#160;</td>
            <td style="width: 2%; vertical-align: top;" colspan="1">&#160;</td>
            <td style="width: 43%; vertical-align: top;">&#160;</td>
            <td colspan="1" style="width: 20%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 10.01%; vertical-align: top;" colspan="1"><br>
            </td>
            <td style="width: 25%; vertical-align: top;">&#160;</td>
            <td style="width: 2%; vertical-align: top;" colspan="1">&#160;</td>
            <td style="width: 43%; vertical-align: top;">&#160;</td>
            <td colspan="1" style="width: 20%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 10.01%; vertical-align: top;" colspan="1"><br>
            </td>
            <td style="width: 25%; vertical-align: top;">
              <div style="text-align: justify;">To the Collateral Agent:</div>
            </td>
            <td style="width: 2%; vertical-align: top;" colspan="1">&#160;</td>
            <td style="width: 43%; vertical-align: top;">
              <div style="text-align: justify;">Yield Point NY LLC</div>
            </td>
            <td colspan="1" style="width: 20%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 10.01%; vertical-align: top;" colspan="1"><br>
            </td>
            <td style="width: 25%; vertical-align: top;">&#160;</td>
            <td style="width: 2%; vertical-align: top;" colspan="1">&#160;</td>
            <td style="width: 43%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">[***]</div>
            </td>
            <td colspan="1" style="width: 20%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 10.01%; vertical-align: top;" colspan="1"><br>
            </td>
            <td style="width: 25%; vertical-align: top;">&#160;</td>
            <td style="width: 2%; vertical-align: top;" colspan="1">&#160;</td>
            <td style="width: 43%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">Attn: Ari Kluger</div>
            </td>
            <td colspan="1" style="width: 20%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 10.01%; vertical-align: top;" colspan="1"><br>
            </td>
            <td style="width: 25%; vertical-align: top;">&#160;</td>
            <td style="width: 2%; vertical-align: top;" colspan="1">&#160;</td>
            <td style="width: 43%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">Email: [***]</div>
            </td>
            <td colspan="1" style="width: 20%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 10.01%; vertical-align: top;" colspan="1"><br>
            </td>
            <td style="width: 25%; vertical-align: top;">&#160;</td>
            <td style="width: 2%; vertical-align: top;" colspan="1">&#160;</td>
            <td style="width: 43%; vertical-align: top;">&#160;</td>
            <td colspan="1" style="width: 20%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 10.01%; vertical-align: top;" colspan="1"><br>
            </td>
            <td style="width: 25%; vertical-align: top;">
              <div style="text-align: justify;">With a copy by email only to</div>
            </td>
            <td style="width: 2%; vertical-align: top;" colspan="1">&#160;</td>
            <td style="width: 43%; vertical-align: top;">&#160;</td>
            <td colspan="1" style="width: 20%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 10.01%; vertical-align: top;" colspan="1"><br>
            </td>
            <td style="width: 25%; vertical-align: top;">
              <div>(which shall not constitute notice):</div>
            </td>
            <td style="width: 2%; vertical-align: top;" colspan="1">&#160;</td>
            <td style="width: 43%; vertical-align: top;">
              <div><a name="z_Hlk209363390"></a>Grushko &amp; Mittman, P.C.</div>
            </td>
            <td colspan="1" style="width: 20%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 10.01%; vertical-align: top;" colspan="1"><br>
            </td>
            <td style="width: 25%; vertical-align: top;">&#160;</td>
            <td style="width: 2%; vertical-align: top;" colspan="1">&#160;</td>
            <td style="width: 43%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">1800 Rockaway Avenue, Suite 206</div>
            </td>
            <td colspan="1" style="width: 20%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 10.01%; vertical-align: top;" colspan="1"><br>
            </td>
            <td style="width: 25%; vertical-align: top;">&#160;</td>
            <td style="width: 2%; vertical-align: top;" colspan="1">&#160;</td>
            <td style="width: 43%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">Hewlett, NY 11557</div>
            </td>
            <td colspan="1" style="width: 20%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 10.01%; vertical-align: top;" colspan="1"><br>
            </td>
            <td style="width: 25%; vertical-align: top;">&#160;</td>
            <td style="width: 2%; vertical-align: top;" colspan="1">&#160;</td>
            <td style="width: 43%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">Attn: Eliezer Drew, Esq.</div>
            </td>
            <td colspan="1" style="width: 20%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 10.01%; vertical-align: top;" colspan="1"><br>
            </td>
            <td style="width: 25%; vertical-align: top;">&#160;</td>
            <td style="width: 2%; vertical-align: top;" colspan="1">&#160;</td>
            <td style="width: 43%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">Email: [***]</div>
            </td>
            <td colspan="1" style="width: 20%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 10.01%; vertical-align: top;" colspan="1"><br>
            </td>
            <td style="width: 25%; vertical-align: top;">&#160;</td>
            <td style="width: 2%; vertical-align: top;" colspan="1">&#160;</td>
            <td style="width: 43%; vertical-align: top;">&#160;</td>
            <td colspan="1" style="width: 20%; vertical-align: top;">&#160;</td>
          </tr>

      </table>
      <div><br>
      </div>
      <div style="text-align: justify;"><font style="color: rgb(0, 0, 0);">17.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);"><font style="font-weight: bold;">Other Security</font>. To the extent that the Obligations are now or hereafter secured by
          property other than the Collateral or by the guarantee, endorsement or property of any other person, firm, corporation or other entity, then the Collateral Agent shall have the right, in its sole discretion, to pursue, relinquish, subordinate,
          modify or take any other action with respect thereto, without in any way modifying or affecting any of the Secured Parties&#8217; rights and remedies hereunder.</font></div>
      <div><br>
      </div>
      <div style="text-align: justify;"><font style="color: rgb(0, 0, 0);">18.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold; color: rgb(0, 0, 0);">Appointment of Collateral Agent</font><font style="color: rgb(0, 0, 0);">. The Secured Parties hereby
          appoint </font>Yield Point NY LLC<font style="color: rgb(0, 0, 0);"> to act as their agent (&#8220;<u>Collateral Agent</u>&#8221;) for purposes of exercising any and all rights and remedies of the Secured Parties hereunder. Such appointment shall continue
          until revoked in writing by a Majority in Interest, at which time a Majority in Interest shall appoint a new Collateral Agent. The Collateral Agent shall have the rights, responsibilities and immunities set forth in <u>Annex B</u> hereto.</font></div>
      <div><br>
      </div>
      <div style="text-align: justify;"><font style="color: rgb(0, 0, 0);">19.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="color: rgb(0, 0, 0);"><font style="font-weight: bold;">Miscellaneous</font>.</font></div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);">No course of dealing between the Debtors and the Collateral Agent, nor any failure to exercise, nor any
          delay in exercising, on the part of the Collateral Agent, any right, power or privilege hereunder or under the Notes shall operate as a waiver thereof; nor shall any single or partial exercise of any right, power or privilege hereunder or
          thereunder preclude any other or further exercise thereof or the exercise of any other right, power or privilege.</font></div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">17</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);">All of the rights and remedies of the Collateral Agent with respect to the Collateral, whether established
          hereby or by the Notes or by any other agreements, instruments or documents or by law shall be cumulative and may be exercised singly or concurrently.</font></div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);">This Agreement, together with the exhibits and schedules hereto, contain the entire understanding of the
          parties with respect to the subject matter hereof and supersede all prior agreements and understandings, oral or written, with respect to such matters, which the parties acknowledge have been merged into this Agreement and the exhibits and
          schedules hereto. No provision of this Agreement may be waived, modified, supplemented or amended except in a written instrument signed, in the case of an amendment, by the Debtors and Collateral Agent or, in the case of a waiver, by the party
          against whom enforcement of any such waived provision is sought.</font></div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(d)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);">If any term, provision, covenant or restriction of this Agreement is held by a court of competent
          jurisdiction to be invalid, illegal, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall remain in full force and effect and shall in no way be affected, impaired or invalidated, and
          the parties hereto shall use their commercially reasonable efforts to find and employ an alternative means to achieve the same or substantially the same result as that contemplated by such term, provision, covenant or restriction. It is hereby
          stipulated and declared to be the intention of the parties that they would have executed the remaining terms, provisions, covenants and restrictions without including any of such that may be hereafter declared invalid, illegal, void or
          unenforceable.</font></div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(e)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);">No waiver of any default with respect to any provision, condition or requirement of this Agreement shall
          be deemed to be a continuing waiver in the future or a waiver of any subsequent default or a waiver of any other provision, condition or requirement hereof, nor shall any delay or omission of any party to exercise any right hereunder in any
          manner impair the exercise of any such right.</font></div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(f)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; <font style="color: rgb(0, 0, 0);">This Agreement shall be binding upon and inure to the benefit of the parties and their successors and
          permitted assigns. The Debtors may not assign this Agreement or any rights or obligations hereunder without the prior written consent of a Majority in Interest (other than by merger). Any Secured Party may assign any or all of its rights under
          this Agreement to any Person to whom such Secured Party assigns or transfers any Obligations, provided such transferee agrees in writing to be bound, with respect to the transferred Obligations, by the provisions of this Agreement that apply to
          the &#8220;Secured Parties.&#8221;</font></div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(g)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);">Each party shall take such further action and execute and deliver such further documents as may be
          necessary or appropriate in order to carry out the provisions and purposes of this Agreement.</font></div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(h)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);">Except as otherwise stated herein, all questions concerning the construction, validity, enforcement and
          interpretation of this Agreement shall be governed by and construed and enforced in accordance with the internal laws of the State of New York, without regard to the principles of conflicts of law thereof. Each Debtor agrees that all proceedings
          concerning the interpretations, enforcement and defense of the transactions contemplated by this Agreement and the Notes (whether brought against a party hereto or its respective affiliates, directors, officers, shareholders, partners, members,
          employees or agents) shall be commenced exclusively in the state and federal courts sitting in the City of New York, Borough of Manhattan. Each Debtor hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts
          sitting in the City of New York, Borough of Manhattan for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein, and hereby irrevocably waives, and agrees not to assert
          in any proceeding, any claim that it is not personally subject to the jurisdiction of any such court, that such proceeding is improper. Each party hereto hereby irrevocably waives personal service of process and consents to process being served
          in any such proceeding by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under this Agreement and agrees that such service shall
          constitute good and sufficient service of process and notice thereof.&#160; Nothing contained herein shall be deemed to limit in any way any right to serve process in any manner permitted by law. <font style="font-weight: bold;">Each party hereto
            hereby irrevocably waives, to the fullest extent permitted by applicable law, any and all right to trial by jury in any legal proceeding arising out of or relating to this Agreement or the transactions contemplated hereby.</font> If any party
          shall commence a proceeding to enforce any provisions of this Agreement, then the prevailing party in such proceeding shall be reimbursed by the other party for its reasonable attorney&#8217;s fees and other costs and expenses incurred with the
          investigation, preparation and prosecution of such proceeding.</font></div>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">18</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(i)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; <font style="color: rgb(0, 0, 0);">This Agreement may be executed in any number of counterparts, each of which when so executed shall be
          deemed to be an original and, all of which taken together shall constitute one and the same Agreement. In the event that any signature is delivered by facsimile or other electronic transmission, such signature shall create a valid binding
          obligation of the party executing (or on whose behalf such signature is executed) the same with the same force and effect as if such signature were the original thereof.</font></div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(j)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; <font style="color: rgb(0, 0, 0);">All Debtors shall jointly and severally be liable for the obligations of each Debtor to the Secured
          Parties hereunder.</font></div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(k)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);">Each Debtor shall indemnify, reimburse and hold harmless the Collateral Agent and the Secured Parties and
          their respective partners, members, shareholders, officers, directors, employees and agents (and any other persons with other titles that have similar functions) (collectively, &#8220;<u>Indemnitees</u>&#8221;) from and against any and all losses, claims,
          liabilities, damages, penalties, suits, costs and expenses, of any kind or nature, (including fees relating to the cost of investigating and defending any of the foregoing) imposed on, incurred by or asserted against such Indemnitee in any way
          related to or arising from or alleged to arise from this Agreement or the Collateral, except any such losses, claims, liabilities, damages, penalties, suits, costs and expenses which result from the fraud, bad faith, gross negligence or willful
          misconduct or willful breach of this Agreement or any other Transaction Document of the Indemnitee as determined by a final, non-appealable decision of a court of competent jurisdiction. This indemnification provision is in addition to, and not
          in limitation of, any other indemnification provision in the Notes, the Securities Purchase Agreement (as such term is defined in the Notes) or any other agreement, instrument or other document executed or delivered in connection herewith or
          therewith.</font></div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(l)</font>&#160;&#160;&#160;&#160;&#160; &#160; &#160; <font style="color: rgb(0, 0, 0);">Nothing in this Agreement shall be construed to subject Collateral Agent or any Secured Party to liability
          as a partner in any Debtor or any if its direct or indirect subsidiaries that is a partnership or as a member in any Debtor or any of its direct or indirect subsidiaries that is a limited liability company, nor shall Collateral Agent or any
          Secured Party be deemed to have assumed any obligations under any partnership agreement or limited liability company agreement, as applicable, of any such Debtor or any if its direct or indirect subsidiaries or otherwise, unless and until any
          such Secured Party exercises its right to be substituted for such Debtor as a partner or member, as applicable, pursuant hereto.</font></div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(m)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);">To the extent that the grant of the security interest in the Collateral and the enforcement of the terms
          hereof require the consent, approval or action of any partner or member, as applicable, of any Debtor or any direct or indirect subsidiary of any Debtor or compliance with any provisions of any of the Organizational Documents, the Debtors hereby
          grant such consent and approval and waive any such noncompliance with the terms of said documents.</font></div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(n)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);">A default or Event of Default hereunder shall not be deemed cured for purposes of this Agreement unless
          such default or Event of Default was subject to cure and if so, timely cured.</font></div>
      <div><br>
      </div>
      <div style="text-align: center; color: rgb(0, 0, 0); font-style: italic;">[signature page to follow]</div>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">19</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-indent: 36pt; color: rgb(0, 0, 0);">IN WITNESS WHEREOF, the parties hereto have caused this Security Agreement to be duly executed on the day and year first above written.</div>
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z86908dd16e3d45fa82d226bfe7fbff06">

          <tr>
            <td colspan="2" style="vertical-align: top;">
              <div style="text-align: justify; color: rgb(0, 0, 0); font-weight: bold;">MOMENTUS INC.</div>
            </td>
            <td colspan="1" style="vertical-align: top; width: 50%;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 3%; vertical-align: top;">&#160;</td>
            <td style="width: 47%; vertical-align: top;">&#160;</td>
            <td colspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 3%; vertical-align: top;">&#160;</td>
            <td style="width: 47%; vertical-align: top;">&#160;</td>
            <td colspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 3%; vertical-align: top; padding-bottom: 2px;">
              <div style="color: rgb(0, 0, 0);">By:</div>
            </td>
            <td style="width: 47%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: justify; color: rgb(0, 0, 0);">/s/ John C. Rood</div>
            </td>
            <td colspan="1" style="width: 50%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 3%; vertical-align: top;">&#160;</td>
            <td style="width: 47%; vertical-align: top;">
              <div style="text-align: justify; color: rgb(0, 0, 0);">Name: John C. Rood</div>
            </td>
            <td colspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 3%; vertical-align: top;">&#160;</td>
            <td style="width: 47%; vertical-align: top;">
              <div style="text-align: justify; color: rgb(0, 0, 0);">Title:&#160;&#160; Chief Executive Officer</div>
            </td>
            <td colspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
          </tr>

      </table>
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);" id="z4ab16e3aa3324f22b138a95b26274ebf">

          <tr>
            <td style="vertical-align: top;" rowspan="1" colspan="3">
              <div style="text-align: justify; color: rgb(0, 0, 0); font-weight: bold;">COLLATERAL AGENT</div>
            </td>
          </tr>
          <tr>
            <td style="width: 3%; vertical-align: top;"><br>
            </td>
            <td colspan="2" style="vertical-align: top;"><br>
            </td>
          </tr>
          <tr>
            <td style="vertical-align: top;" rowspan="1" colspan="3">
              <div style="text-align: justify;">YIELD POINT NY LLC</div>
            </td>
          </tr>
          <tr>
            <td style="width: 3%; vertical-align: top;"><br>
            </td>
            <td colspan="2" style="vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 3%; vertical-align: top; padding-bottom: 2px;">
              <div style="text-align: justify; color: rgb(0, 0, 0);">By:</div>
            </td>
            <td style="width: 47%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: justify; color: rgb(0, 0, 0);">/s/ Ari Kluger</div>
            </td>
            <td style="width: 48.5%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 3%; vertical-align: top;"><br>
            </td>
            <td colspan="2" style="vertical-align: top;">
              <div style="text-align: justify; color: rgb(0, 0, 0);">Name: Ari Kluger</div>
            </td>
          </tr>
          <tr>
            <td style="width: 3%; vertical-align: top;"><br>
            </td>
            <td colspan="2" style="vertical-align: top;">
              <div style="text-align: justify; color: rgb(0, 0, 0);">Title:&#160;&#160; Manager</div>
            </td>
          </tr>

      </table>
      <div> <br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">20</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: center; font-weight: bold;">OMNIBUS SECURED PARTY SIGNATURE PAGE TO</div>
      <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">MOMENTUS INC.</div>
      <div style="text-align: center; font-weight: bold;"><u>SECURITY AGREEMENT</u></div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">The undersigned, in its capacity as a Secured Party, hereby executes and delivers the Security Agreement to which this signature page is attached and agrees to be bound by the Security Agreement on
        the date set forth on the first page of the Security Agreement.&#160; This counterpart signature page, together with all counterparts of the Security Agreement and signature pages of the other parties named therein, shall constitute one and the same
        instrument in accordance with the terms of the Security Agreement.</div>
      <div><br>
      </div>
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z1b6b9a536ae04a478f613e7f8af4860e">

          <tr>
            <td nowrap="nowrap" style="width: 8%; vertical-align: top; padding-bottom: 2px;">
              <div>Name of Secured Party:<br>
              </div>
            </td>
            <td style="width: 82%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);"><br>
            </td>
            <td style="width: 10%; vertical-align: top;"><br>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td colspan="3" style="vertical-align: top;"><br>
            </td>
          </tr>
          <tr>
            <td nowrap="nowrap" style="width: 20%; vertical-align: top; padding-bottom: 2px;">
              <div><font style="font-style: italic;">Signature of Authorized Signatory of Secured Party</font>: <br>
              </div>
            </td>
            <td style="width: 70%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);"><br>
            </td>
            <td style="width: 10%; vertical-align: top;">&#160;</td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td colspan="3" style="vertical-align: top;"><br>
            </td>
          </tr>
          <tr>
            <td nowrap="nowrap" style="width: 8%; vertical-align: top; padding-bottom: 2px;">
              <div>Name of Authorized Signatory: <br>
              </div>
            </td>
            <td style="width: 82%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);"><br>
            </td>
            <td style="width: 10%; vertical-align: top;"><br>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td colspan="3" style="vertical-align: top;"><br>
            </td>
          </tr>
          <tr>
            <td nowrap="nowrap" style="width: 8%; vertical-align: top; padding-bottom: 2px;">
              <div>Title of Authorized Signatory: <br>
              </div>
            </td>
            <td style="width: 82%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 10%; vertical-align: top;">&#160;</td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td colspan="3" style="vertical-align: top;"><br>
            </td>
          </tr>
          <tr>
            <td nowrap="nowrap" style="width: 8%; vertical-align: top; padding-bottom: 2px;">
              <div>Email Address of Authorized Signatory:</div>
            </td>
            <td style="width: 82%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 10%; vertical-align: top;">&#160;</td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td colspan="3" style="vertical-align: top;"><br>
            </td>
          </tr>
          <tr>
            <td nowrap="nowrap" style="width: 8%; vertical-align: top; padding-bottom: 2px;">
              <div>Facsimile Number of Authorized Signatory: <br>
              </div>
            </td>
            <td style="width: 82%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 10%; vertical-align: top;">&#160;</td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td colspan="3" style="vertical-align: top;"><br>
            </td>
          </tr>
          <tr>
            <td nowrap="nowrap" style="width: 8%; vertical-align: top; padding-bottom: 2px;">
              <div>State of Incorporation of Secured Party: <br>
              </div>
            </td>
            <td style="width: 82%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 25%; vertical-align: top;">&#160;</td>
          </tr>

      </table>
      <div><br>
      </div>
      <div>Address for Notice to Secured Party:</div>
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z3f0558fa75fc4e77835c5debf912f7a5">

          <tr>
            <td nowrap="nowrap" style="width: 15%; vertical-align: top;">
              <div style="text-align: justify;">Taxpayer ID# (if applicable):&#160;</div>
            </td>
            <td style="width: 20%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 65%; vertical-align: top;">&#160;</td>
          </tr>

      </table>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">21</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">ANNEX A to SECURITY AGREEMENT</div>
      <div><br>
      </div>
      <div style="text-align: center; text-indent: -39.6pt; margin-left: 39.6pt; color: rgb(0, 0, 0); font-weight: bold;">FORM OF ADDITIONAL DEBTOR JOINDER</div>
      <div><br>
      </div>
      <div style="text-align: center; color: rgb(0, 0, 0);">Security Agreement dated as of September 25, 2025 made by</div>
      <div style="text-align: center; color: rgb(0, 0, 0);">Momentus Inc.</div>
      <div style="text-align: center; color: rgb(0, 0, 0);">and its Subsidiaries party thereto from time to time, as Debtors</div>
      <div style="text-align: center; color: rgb(0, 0, 0);">to and in favor of</div>
      <div style="text-align: center; color: rgb(0, 0, 0);">the Secured Parties identified therein (the &#8220;<u>Security Agreement</u>&#8221;)</div>
      <div><br>
      </div>
      <div style="text-align: justify; color: rgb(0, 0, 0);">Reference is made to the Security Agreement as defined above; capitalized terms used herein and not otherwise defined herein shall have the meanings given to such terms in, or by reference in,
        the Security Agreement.</div>
      <div><br>
      </div>
      <div style="text-align: justify; color: rgb(0, 0, 0);">The undersigned hereby agrees that upon delivery of this Additional Debtor Joiner to the Secured Parties referred to above, the undersigned shall (a) be an Additional Debtor under the Security
        Agreement, (b) have all the rights and obligations of the Debtors under the Security Agreement as fully and to the same extent as if the undersigned was an original signatory thereto and (c) be deemed to have made the representations and warranties
        set forth therein as of the date of execution and delivery of this Additional Debtor Joinder (except to the extent such representation or warranty specifically refers to an earlier date). WITHOUT LIMITING THE GENERALITY OF THE FOREGOING, THE
        UNDERSIGNED SPECIFICALLY GRANTS TO THE SECURED PARTIES A SECURITY INTEREST IN THE COLLATERAL AS MORE FULLY SET FORTH IN THE SECURITY AGREEMENT AND ACKNOWLEDGES AND AGREES TO THE WAIVER OF JURY TRIAL PROVISIONS SET FORTH THEREIN.</div>
      <div><br>
      </div>
      <div style="text-align: justify; color: rgb(0, 0, 0);">Attached hereto are supplemental and/or replacement Schedules to the Security Agreement, as applicable.</div>
      <div><br>
      </div>
      <div>Attached hereto is an original Subsidiary Guaranty executed by the undersigned and delivered herewith.</div>
      <div><br>
      </div>
      <div style="text-align: justify; color: rgb(0, 0, 0);">An executed copy of this Additional Debtor Joinder shall be delivered to the Secured Parties, and the Secured Parties may rely on the matters set forth herein on or after the date hereof. This
        Additional Debtor Joinder shall not be modified, amended or terminated without the prior written consent of the Secured Parties.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0);">IN WITNESS WHEREOF, the undersigned has caused this Joiner to be executed in the name and on behalf of the undersigned.</div>
      <div><br>
      </div>
      <div>[________________________________]]</div>
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);" id="z1b2014ff3e344c97b1b0bcec35887e5d">

          <tr>
            <td style="width: 3%; vertical-align: top; padding-bottom: 2px;">
              <div>By: <br>
              </div>
            </td>
            <td style="width: 47%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);"><br>
            </td>
            <td colspan="1" style="width: 50%; vertical-align: top; padding-bottom: 2px;"><br>
            </td>
          </tr>
          <tr>
            <td style="width: 3%; vertical-align: top;"><br>
            </td>
            <td style="width: 47%; vertical-align: top;">
              <div>Name:</div>
            </td>
            <td colspan="1" style="width: 50%; vertical-align: top;"><br>
            </td>
          </tr>
          <tr>
            <td style="width: 3%; vertical-align: top;"><br>
            </td>
            <td style="width: 47%; vertical-align: top;">
              <div>Title:</div>
            </td>
            <td colspan="1" style="width: 50%; vertical-align: top;"><br>
            </td>
          </tr>

      </table>
      <div> <br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">22</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: center; font-weight: bold;"><u>SUBSIDIARY GUARANTY</u></div>
      <div><br>
      </div>
      <div>1.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Identification</u>.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">This Guaranty (the &#8220;<u>Guaranty</u>&#8221;), dated as of September 25, 2025 is entered into by and among Momentus Space LLC, a Delaware limited liability company (&#8220;<u>Guarantor</u>&#8221;), and the lenders
        identified on Schedule A hereto (each a &#8220;<u>Lender</u>&#8221; and collectively, &#8220;<u>Lenders</u>&#8221;).</div>
      <div><br>
      </div>
      <div style="text-align: justify;">2.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Recitals</u>.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">2.1&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Guarantor is a direct or indirect subsidiary of Momentus Inc., a Delaware corporation (&#8220;<u>Parent</u>&#8221;).&#160; The Lenders have made and/or are making loans to Parent (the &#8220;<u>Loans</u>&#8221;).&#160;
        Guarantor will obtain substantial benefit from the proceeds of the Loans.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">2.2&#160;&#160;&#160;&#160;&#160; The Loans are and will be evidenced by certain Secured Convertible Promissory Notes in the aggregate principal amount of up to $<font style="color: rgb(0, 0, 0);">5,630,434.78</font>
        (collectively, &#8220;<u>Note</u>&#8221; or the &#8220;<u>Notes</u>&#8221;) issued by Parent as &#8220;Borrower&#8221; for the benefit of Lender as the &#8220;Holder&#8221; thereof on, about or after the date of this Guaranty pursuant to those certain Securities Purchase Agreements dated at or
        about the date hereof (&#8220;<u>Securities Purchase Agreements</u>&#8221;).</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">2.3&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; In consideration of the Loans made and to be made by Lender to Parent and for other good and valuable consideration, and as security for the performance by Parent of its obligations
        under the Notes and as security for the repayment of the Loans and all other sums due from Debtor to Lender arising under the Notes (collectively, the &#8220;<u>Obligations</u>&#8221;), Guarantor, for good and valuable consideration, receipt of which is
        acknowledged, has agreed to enter into this Guaranty.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">2.4&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Lenders have appointed Yield Point NY LLC as Collateral Agent pursuant to that certain Security Agreement dated at or about the date of this Agreement (&#8220;<u>Security Agreement</u>&#8221;),
        among the Parent, Guarantor, Lender and Collateral Agent.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">2.5&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Upper case terms employed but not defined herein shall have the meanings ascribed to them in the Transaction Documents (as defined in the Securities Purchase Agreement).</div>
      <div><br>
      </div>
      <div style="text-align: justify;">3.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Guaranty</u>.<a name="z_Toc68690373"></a></div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">3.1&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Guaranty</u>.&#160; Guarantor hereby unconditionally and irrevocably guarantees, jointly and severally with any other guarantor of the Obligations, the punctual payment, performance and
        observance when due, whether at stated maturity, by acceleration or otherwise, of all of the Obligations now or hereafter existing, whether for principal, interest (including, without limitation, all interest that accrues after the commencement of
        any insolvency, bankruptcy or reorganization of Parent, whether or not constituting an allowed claim in such proceeding), fees, commissions, expense reimbursements, liquidated damages, indemnifications or otherwise arising under the Notes, Security
        Agreement, or any other Transaction Document (as defined in the Securities Purchase Agreement) (such obligations, to the extent not paid by Parent being the &#8220;<u>Guaranteed Obligations</u>&#8221; and included in the definition of Obligations), and agrees
        to pay any and all reasonable costs, fees and expenses (including reasonable counsel fees and expenses) incurred by Collateral Agent and the Lenders in enforcing any rights under the Guaranty set forth herein.&#160; Without limiting the generality of
        the foregoing, Guarantor&#8217;s liability shall extend to all amounts that constitute part of the Guaranteed Obligations and would be owed by Parent to Collateral Agent and the Lenders, but for the fact that they are unenforceable or not allowable due
        to the existence of an insolvency, bankruptcy or reorganization involving Parent.</div>
      <div style="text-align: justify; text-indent: 36pt;"><a name="z_Toc68690374"></a><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">23</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <!--PROfilePageNumberReset%Num%1%%%-->
      <div style="text-align: justify; text-indent: 36pt;">3.2&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Guaranty Absolute</u>.&#160; Guarantor guarantees that the Guaranteed Obligations will be paid strictly in accordance with the terms of the Notes, regardless of any law, regulation or
        order now or hereafter in effect in any jurisdiction affecting any of such terms or the rights of Collateral Agent or the Lenders with respect thereto.&#160; The obligations of Guarantor under this Guaranty are independent of the Guaranteed Obligations,
        and a separate action or actions may be brought and prosecuted against Guarantor to enforce such obligations, irrespective of whether any action is brought against Parent or any other guarantor or whether Parent or any other guarantor is joined in
        any such action or actions.&#160; The liability of Guarantor under this Guaranty constitutes a primary obligation, and not a contract of surety, and to the extent permitted by law, shall be irrevocable, absolute and unconditional irrespective of, and
        Guarantor hereby irrevocably waives any defenses it may now or hereafter have in any way relating to, any or all of the following:</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 72pt;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;any lack of validity of the Notes or any agreement or instrument relating thereto;</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;any change in the time, manner or place of payment of, or in any other term of, all or any of the Guaranteed Obligations, or any other amendment or waiver of or any consent to
        departure from the Notes, including, without limitation, any increase in the Guaranteed Obligations resulting from the extension of additional credit to Parent or otherwise;</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;any taking, exchange, release, subordination or non-perfection of any Collateral, or any taking, release or amendment or waiver of or consent to departure from any other guaranty, for
        all or any of the Guaranteed Obligations;</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;any change, restructuring or termination of the corporate, limited liability company or partnership structure or existence of Parent; or</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 72pt;">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;any other circumstance (including, without limitation, any statute of limitations) or any existence of or reliance on any representation by Collateral Agent or the Lenders that might
        otherwise constitute a defense available to, or a discharge of, Parent or any other guarantor or surety.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">This Guaranty shall continue to be effective or be reinstated, as the case may be, if at any time any payment of any of the Guaranteed Obligations is rescinded or must otherwise be returned by
        Collateral Agent, the Lenders or any other entity upon the insolvency, bankruptcy or reorganization of the Parent or otherwise (and whether as a result of any demand, settlement, litigation or otherwise), all as though such payment had not been
        made.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">3.3&#160;&#160;&#160;&#160;&#160;&#160; <u>Waiver</u>.&#160; Guarantor hereby waives promptness, diligence, notice of acceptance and any other notice with respect to any of the Guaranteed Obligations and this Guaranty and any
        requirement that Collateral Agent or the Lenders exhaust any right or take any action against any Borrower or any other person or entity or any Collateral.&#160; Guarantor acknowledges that it will receive direct and indirect benefits from the financing
        arrangements contemplated herein and that the waiver set forth in this Section 3.3 is knowingly made in contemplation of such benefits.&#160; Guarantor hereby waives any right to revoke this Guaranty, and acknowledges that this Guaranty is continuing in
        nature and applies to all Guaranteed Obligations, whether existing now or in the future.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">3.4&#160; &#160; &#160;&#160;&#160;&#160; <a name="z_Toc68690376"></a><u>Continuing Guaranty; Assignments</u>.&#160; This Guaranty is a continuing guaranty and shall (a) remain in full force and effect until the later of the
        indefeasible cash or other payment in full of the Guaranteed Obligations, (b) be binding upon Guarantor, its successors and assigns, and (c) inure to the benefit of and be enforceable by the Lenders and their successors, pledgees, transferees and
        assigns.&#160; Without limiting the generality of the foregoing clause (c), any Lender may pledge, assign or otherwise transfer all or any portion of its rights and obligations under this Guaranty (including, without limitation, all or any portion of
        its Notes owing to it) to any other Person, and such other Person shall thereupon become vested with all the benefits in respect thereof granted such Collateral Agent or Lender herein or otherwise.</div>
      <div>&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">24</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">3.5&#160; &#160; &#160; &#160;&#160; <u>Subrogation</u>.&#160; Guarantor will not exercise any rights that it may now or hereafter acquire against the Collateral Agent or any Lender or other guarantor (if any) that arise from
        the existence, payment, performance or enforcement of such Guarantor&#8217;s obligations under this Guaranty, including, without limitation, any right of subrogation, reimbursement, exoneration, contribution or indemnification, whether or not such claim,
        remedy or right arises in equity or under contract, statute or common law, including, without limitation, the right to take or receive from the Collateral Agent or any Lender or other guarantor (if any), directly or indirectly, in cash or other
        property or by set-off or in any other manner, payment or security solely on account of such claim, remedy or right, unless and until all of the Guaranteed Obligations and all other amounts payable under this Guaranty shall have been indefeasibly
        paid in full.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">3.6&#160; &#160;&#160;&#160;&#160;&#160; <u>Maximum Obligations</u>. Notwithstanding any provision herein contained to the contrary, Guarantor&#8217;s liability with respect to the Obligations shall be limited to an amount not to
        exceed, as of any date of determination, the amount that could be claimed by Lenders from Guarantor without rendering such claim voidable or avoidable under Section 548 of the Bankruptcy Code or under any applicable state Uniform Fraudulent
        Transfer Act, Uniform Fraudulent Conveyance Act or similar statute or common law.</div>
      <div>&#160;</div>
      <div style="text-align: justify;">4.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Miscellaneous</u>.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">4.1&#160;&#160;&#160;&#160;&#160;&#160; <u>Expenses</u>.&#160; Guarantor shall pay to the Lenders, on demand, the amount of any and all reasonable expenses, including, without limitation, reasonable attorneys&#8217; fees, reasonable
        legal expenses and reasonable brokers&#8217; fees, which the Lenders may incur in connection with exercise or enforcement of any the rights, remedies or powers of the Lenders hereunder or with respect to any or all of the Obligations.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">4.2&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Waivers, Amendment and Remedies</u>.&#160; No course of dealing by the Lenders and no failure by the Lenders to exercise, or delay by the Lender in exercising, any right, remedy or power
        hereunder shall operate as a waiver thereof, and no single or partial exercise thereof shall preclude any other or further exercise thereof or the exercise of any other right, remedy or power of the Lenders.&#160; No amendment, modification or waiver of
        any provision of this Guaranty and no consent to any departure by Guarantor therefrom, shall, in any event, be effective unless contained in a writing signed by the Guarantor and the Majority in Interest (as such term is defined in the Security
        Agreement) or Lenders against whom such amendment, modification or waiver is sought, and then such waiver or consent shall be effective only in the specific instance and for the specific purpose for which given.&#160; The rights, remedies and powers of
        the Lenders, not only hereunder, but also under any other Transaction Documents and under applicable law are cumulative, and may be exercised by the Lenders from time to time in such order as the Lenders may elect.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">4.3&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Notices</u>.&#160; &#160; All notices, demands, requests, consents, approvals, and other communications required or permitted hereunder shall be in writing and, unless otherwise specified
        herein, shall be (a) personally served, (b) deposited in the mail, registered or certified, return receipt requested, postage prepaid, (c) delivered by a reputable overnight courier service with charges prepaid, or (d) transmitted by hand delivery,
        telegram, or facsimile, addressed as set forth below or to such other address as such party shall have specified most recently by written notice.&#160; Any notice or other communication required or permitted to be given hereunder shall be deemed
        effective (i) upon hand delivery or delivery by facsimile, with accurate confirmation generated by the transmitting facsimile machine, at the address or number designated below if delivered on a Business Day during normal business hours, or the
        first Business Day following such delivery (if delivered other than on a Business Day during normal business hours), (ii) on the first Business Day following the date deposited with an overnight courier service with charges prepaid, or (iii) on the
        fifth Business Day following the date of mailing pursuant to subpart (b) above, or upon actual receipt of such mailing, whichever shall first occur.&#160; <font style="color: rgb(0, 0, 0);">The addresses for such communications shall be:</font></div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);"> <br>
        </font></div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">25</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);" id="z224d96558fb046b6aad5e04790401800">

          <tr>
            <td style="width: 10.01%; vertical-align: top;" colspan="1">&#160;</td>
            <td style="width: 25%; vertical-align: top;">
              <div style="text-align: justify;">To Guarantor, to:</div>
            </td>
            <td style="width: 2%; vertical-align: top;">&#160;</td>
            <td style="width: 43%; vertical-align: top;">
              <div style="text-align: justify; color: rgb(0, 0, 0);">c/o Momentus Inc.</div>
            </td>
            <td style="width: 20%; vertical-align: top;" colspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="width: 10.01%; vertical-align: top;" colspan="1">&#160;</td>
            <td style="width: 25%; vertical-align: top;">&#160;</td>
            <td style="width: 2%; vertical-align: top;">&#160;</td>
            <td style="width: 43%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">3901 N. First Street</div>
            </td>
            <td style="width: 20%; vertical-align: top;" colspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="width: 10.01%; vertical-align: top;" colspan="1">&#160;</td>
            <td style="width: 25%; vertical-align: top;">&#160;</td>
            <td style="width: 2%; vertical-align: top;">&#160;</td>
            <td style="width: 43%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">San Jose, CA, 95134</div>
            </td>
            <td style="width: 20%; vertical-align: top;" colspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="width: 10.01%; vertical-align: top;" colspan="1">&#160;</td>
            <td style="width: 25%; vertical-align: top;">&#160;</td>
            <td style="width: 2%; vertical-align: top;">&#160;</td>
            <td style="width: 43%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">Attn: John Rood</div>
            </td>
            <td style="width: 20%; vertical-align: top;" colspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="width: 10.01%; vertical-align: top;" colspan="1">&#160;</td>
            <td style="width: 25%; vertical-align: top;">&#160;</td>
            <td style="width: 2%; vertical-align: top;">&#160;</td>
            <td style="width: 43%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">Email: [***]</div>
            </td>
            <td style="width: 20%; vertical-align: top;" colspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="width: 10.01%; vertical-align: top;" colspan="1">&#160;</td>
            <td style="width: 25%; vertical-align: top;">&#160;</td>
            <td style="width: 2%; vertical-align: top;">&#160;</td>
            <td style="width: 43%; vertical-align: top;">&#160;</td>
            <td style="width: 20%; vertical-align: top;" colspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="width: 10.01%; vertical-align: top;" colspan="1">&#160;</td>
            <td style="width: 25%; vertical-align: top;">
              <div style="text-align: justify;">With a copy by email only to</div>
            </td>
            <td style="width: 2%; vertical-align: top;">&#160;</td>
            <td style="width: 43%; vertical-align: top;">&#160;</td>
            <td style="width: 20%; vertical-align: top;" colspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="width: 10.01%; vertical-align: top;" colspan="1">&#160;</td>
            <td style="width: 25%; vertical-align: top;">
              <div>(which shall not constitute notice):</div>
            </td>
            <td style="width: 2%; vertical-align: top;">&#160;</td>
            <td style="width: 43%; vertical-align: top;">
              <div>Bradley Arant Boult Cummings LLP</div>
            </td>
            <td style="width: 20%; vertical-align: top;" colspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="width: 10.01%; vertical-align: top;" colspan="1">&#160;</td>
            <td style="width: 25%; vertical-align: top;">&#160;</td>
            <td style="width: 2%; vertical-align: top;">&#160;</td>
            <td style="width: 43%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">1221 Broadway, Suite 2400</div>
            </td>
            <td style="width: 20%; vertical-align: top;" colspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="width: 10.01%; vertical-align: top;" colspan="1">&#160;</td>
            <td style="width: 25%; vertical-align: top;">&#160;</td>
            <td style="width: 2%; vertical-align: top;">&#160;</td>
            <td style="width: 43%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">Nashville, TN 37203</div>
            </td>
            <td style="width: 20%; vertical-align: top;" colspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="width: 10.01%; vertical-align: top;" colspan="1">&#160;</td>
            <td style="width: 25%; vertical-align: top;">&#160;</td>
            <td style="width: 2%; vertical-align: top;">&#160;</td>
            <td style="width: 43%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">Attn: Stephen Hinton, Esq.</div>
            </td>
            <td style="width: 20%; vertical-align: top;" colspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="width: 10.01%; vertical-align: top;" colspan="1">&#160;</td>
            <td style="width: 25%; vertical-align: top;">&#160;</td>
            <td style="width: 2%; vertical-align: top;">&#160;</td>
            <td style="width: 43%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">Email: [***]</div>
            </td>
            <td style="width: 20%; vertical-align: top;" colspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="width: 10.01%; vertical-align: top;" colspan="1">&#160;</td>
            <td style="width: 25%; vertical-align: top;">&#160;</td>
            <td style="width: 2%; vertical-align: top;">&#160;</td>
            <td style="width: 43%; vertical-align: top;">&#160;</td>
            <td style="width: 20%; vertical-align: top;" colspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="width: 10.01%; vertical-align: top;" colspan="1">&#160;</td>
            <td style="width: 25%; vertical-align: top;">&#160;</td>
            <td style="width: 2%; vertical-align: top;">&#160;</td>
            <td style="width: 43%; vertical-align: top;">&#160;</td>
            <td style="width: 20%; vertical-align: top;" colspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="width: 10.01%; vertical-align: top;" colspan="1">&#160;</td>
            <td style="width: 25%; vertical-align: top;">
              <div style="text-align: justify;">To the Collateral Agent:</div>
            </td>
            <td style="width: 2%; vertical-align: top;">&#160;</td>
            <td style="width: 43%; vertical-align: top;">
              <div style="text-align: justify;">Yield Point NY LLC</div>
            </td>
            <td style="width: 20%; vertical-align: top;" colspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="width: 10.01%; vertical-align: top;" colspan="1">&#160;</td>
            <td style="width: 25%; vertical-align: top;">&#160;</td>
            <td style="width: 2%; vertical-align: top;">&#160;</td>
            <td style="width: 43%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">[***]</div>
            </td>
            <td style="width: 20%; vertical-align: top;" colspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="width: 10.01%; vertical-align: top;" colspan="1">&#160;</td>
            <td style="width: 25%; vertical-align: top;">&#160;</td>
            <td style="width: 2%; vertical-align: top;">&#160;</td>
            <td style="width: 43%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">Attn: Ari Kluger</div>
            </td>
            <td style="width: 20%; vertical-align: top;" colspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="width: 10.01%; vertical-align: top;" colspan="1">&#160;</td>
            <td style="width: 25%; vertical-align: top;">&#160;</td>
            <td style="width: 2%; vertical-align: top;">&#160;</td>
            <td style="width: 43%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">Email: [***]</div>
            </td>
            <td style="width: 20%; vertical-align: top;" colspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="width: 10.01%; vertical-align: top;" colspan="1">&#160;</td>
            <td style="width: 25%; vertical-align: top;">&#160;</td>
            <td style="width: 2%; vertical-align: top;">&#160;</td>
            <td style="width: 43%; vertical-align: top;">&#160;</td>
            <td style="width: 20%; vertical-align: top;" colspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="width: 10.01%; vertical-align: top;" colspan="1">&#160;</td>
            <td style="width: 25%; vertical-align: top;">
              <div style="text-align: justify;">With a copy by email only to</div>
            </td>
            <td style="width: 2%; vertical-align: top;">&#160;</td>
            <td style="width: 43%; vertical-align: top;">&#160;</td>
            <td style="width: 20%; vertical-align: top;" colspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="width: 10.01%; vertical-align: top;" colspan="1">&#160;</td>
            <td style="width: 25%; vertical-align: top;">
              <div>(which shall not constitute notice):</div>
            </td>
            <td style="width: 2%; vertical-align: top;">&#160;</td>
            <td style="width: 43%; vertical-align: top;">
              <div>Grushko &amp; Mittman, P.C.</div>
            </td>
            <td style="width: 20%; vertical-align: top;" colspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="width: 10.01%; vertical-align: top;" colspan="1">&#160;</td>
            <td style="width: 25%; vertical-align: top;">&#160;</td>
            <td style="width: 2%; vertical-align: top;">&#160;</td>
            <td style="width: 43%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">1800 Rockaway Avenue, Suite 206</div>
            </td>
            <td style="width: 20%; vertical-align: top;" colspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="width: 10.01%; vertical-align: top;" colspan="1">&#160;</td>
            <td style="width: 25%; vertical-align: top;">&#160;</td>
            <td style="width: 2%; vertical-align: top;">&#160;</td>
            <td style="width: 43%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">Hewlett, NY 11557</div>
            </td>
            <td style="width: 20%; vertical-align: top;" colspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="width: 10.01%; vertical-align: top;" colspan="1">&#160;</td>
            <td style="width: 25%; vertical-align: top;">&#160;</td>
            <td style="width: 2%; vertical-align: top;">&#160;</td>
            <td style="width: 43%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">Attn: Eliezer Drew, Esq.</div>
            </td>
            <td style="width: 20%; vertical-align: top;" colspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="width: 10.01%; vertical-align: top;" colspan="1">&#160;</td>
            <td style="width: 25%; vertical-align: top;">&#160;</td>
            <td style="width: 2%; vertical-align: top;">&#160;</td>
            <td style="width: 43%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">Email: [***]</div>
            </td>
            <td style="width: 20%; vertical-align: top;" colspan="1">&#160;</td>
          </tr>

      </table>
      <div><br>
      </div>
      <div style="text-align: justify;">Any party may change its address by written notice in accordance with this paragraph.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">4.4&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Term; Binding Effect</u>.&#160; This Guaranty shall (a) remain in full force and effect until payment and satisfaction in full of all of the Guaranteed Obligations; (b) be binding upon
        Guarantor and its successors and permitted assigns; and (c) inure to the benefit of the Lenders and their respective successors and assigns.&#160; <a name="z_Toc520574790"></a><a name="z_Toc520574990"></a><a name="z_Toc520575156"></a><a name="z_Toc520575322"></a><a name="z_Toc524781210"></a>All the rights and benefits granted by Guarantor to the Collateral Agent and Lenders hereunder and other agreements and documents delivered in connection therewith are deemed granted to both
        the Collateral Agent and Lenders.&#160; Upon the payment in full of the Guaranteed Obligations, (i) this Guaranty shall terminate and (ii) the Lenders will, upon Guarantor&#8217;s request and at Guarantor&#8217;s expense, execute and deliver to Guarantor such
        documents as Guarantor shall reasonably request to evidence such termination, all without any representation, warranty or recourse whatsoever.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">4.5&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Captions</u>.&#160; The captions of Paragraphs, Articles and Sections in this Guaranty have been included for convenience of reference only, and shall not define or limit the provisions
        hereof and have no legal or other significance whatsoever.</div>
      <div style="text-align: justify; text-indent: 36pt;"> <br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">26</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">4.6&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Governing Law; Venue; Severability</u>.&#160; This Guaranty shall be governed by and construed in accordance with the laws of the State of New York without regard to principles of
        conflicts or choice of law.&#160; Any legal action or proceeding against Guarantor with respect to this Guaranty may be brought in the courts of the State of New York or of the United States for the Southern District of New York, and, by execution and
        delivery of this Guaranty, Guarantor hereby irrevocably accepts for itself and in respect of its property, generally and unconditionally, the jurisdiction of the aforesaid courts.&#160; Guarantor hereby irrevocably waives any objection which it may now
        or hereafter have to the laying of venue of any of the aforesaid actions or proceedings arising out of or in connection with this Guaranty brought in the aforesaid courts and hereby further irrevocably waives and agrees not to plead or claim in any
        such court that any such action or proceeding brought in any such court has been brought in an inconvenient forum.&#160; If any provision of this Guaranty, or the application thereof to any person or circumstance, is held invalid, such invalidity shall
        not affect any other provisions which can be given effect without the invalid provision or application, and to this end the provisions hereof shall be severable and the remaining, valid provisions shall remain of full force and effect.&#160; <font style="font-weight: bold;">This Guaranty shall be deemed an unconditional obligation of Guarantor for the payment of money and, without limitation to any other remedies of Lenders, may be enforced against Guarantor by summary proceeding pursuant
          to New York Civil Procedure Law and Rules Section 3213 or any similar rule or statute in the jurisdiction where enforcement is sought.&#160; For purposes of such rule or statute, any other document or agreement to which Lenders and Guarantor are
          parties or which Guarantor delivered to Lenders, which may be convenient or necessary to determine Lenders&#8217; rights hereunder or Guarantor&#8217;s obligations to Lenders are deemed a part of this Guaranty, whether or not such other document or agreement
          was delivered together herewith or was executed apart from this Guaranty.</font>&#160;<font style="color: rgb(0, 0, 0);">Each party hereto hereby irrevocably waives personal service of process and consents to process being served in any such
          proceeding by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under this Agreement and agrees that such service shall constitute
          good and sufficient service of process and notice thereof.&#160; </font>Nothing contained herein shall be deemed to limit in any way any right to serve process in any other manner permitted by law.&#160; Guarantor irrevocably appoints Parent its true and
        lawful agent for service of process upon whom all processes of law and notices may be served and given in the manner described above; and such service and notice shall be deemed valid personal service and notice upon Guarantor with the same force
        and validity as if served upon Guarantor.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">4.7&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Satisfaction of Obligations</u>.&#160; For all purposes of this Guaranty, the payment in full of the Obligations shall be conclusively deemed to have occurred when the Obligations have
        been paid pursuant to the terms of the Notes and the Securities Purchase Agreements.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">4.8&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Counterparts/Execution</u>.&#160; This Agreement may be executed in any number of counterparts and by the different signatories hereto on separate counterparts, each of which, when so
        executed, shall be deemed an original, but all such counterparts shall constitute but one and the same instrument.&#160; This Agreement may be executed by facsimile signature and delivered by electronic transmission.</div>
      <div><br>
      </div>
      <div style="text-align: center; text-indent: 36pt;">[THE BALANCE OF THIS PAGE HAS BEEN INTENTIONALLY LEFT BLANK]</div>
      <div style="text-align: center; text-indent: 36pt;"> <br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">27</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-indent: 36pt;"><font style="font-weight: bold;">IN WITNESS WHEREOF, </font>the undersigned have executed and delivered this Guaranty, as of the date first written above.</div>
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);" id="zb39e217cd9584f11b51b54f80af7580c">

          <tr>
            <td style="width: 3%; vertical-align: top;" rowspan="1" colspan="2">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">&#8220;GUARANTOR&#8221;</div>
            </td>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 3%; vertical-align: top;">&#160;</td>
            <td style="width: 47%; vertical-align: top;">&#160;</td>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 3%; vertical-align: top;" rowspan="1" colspan="2">
              <div>[REQUIRES COMPLETION]</div>
            </td>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 3%; vertical-align: top;">&#160;</td>
            <td style="width: 47%; vertical-align: top;">&#160;</td>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 3%; vertical-align: top; padding-bottom: 2px;">
              <div style="color: rgb(0, 0, 0);">By:</div>
            </td>
            <td style="width: 47%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);"> <br>
            </td>
            <td style="width: 50%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 3%; vertical-align: top;">&#160;</td>
            <td style="width: 47%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">Name:</div>
            </td>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 3%; vertical-align: top;">&#160;</td>
            <td style="width: 47%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">Title:</div>
            </td>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
          </tr>

      </table>
      <div><br>
      </div>
      <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">This Guaranty Agreement may be signed by facsimile signature and</div>
      <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"><a name="z_DV_M109"></a>delivered by confirmed facsimile transmission.</div>
      <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"> <br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">28</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: center; font-weight: bold;"><u>SCHEDULE A TO SUBSIDIARY GUARANTY</u></div>
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" align="center" style="border-collapse: collapse; width: 70%; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: left;" id="z9b1c03263b5449a9aaea4a4a6ecdfbca">

          <tr>
            <td style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>
            <td style="width: 34%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">LENDER AND ADDRESS</div>
            </td>
            <td style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>
            <td style="width: 34%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">NOTE</div>
              <div style="color: rgb(0, 0, 0); font-weight: bold;">PRINCIPAL</div>
            </td>
          </tr>
          <tr>
            <td style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>
            <td style="width: 34%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>
            <td style="width: 34%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          </tr>
          <tr>
            <td style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>
            <td style="width: 34%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>
            <td style="width: 34%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          </tr>
          <tr>
            <td style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>
            <td style="width: 34%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>
            <td style="width: 34%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          </tr>

      </table>
      <div><br>
      </div>
      <div></div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">29</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">ANNEX B to SECURITY AGREEMENT</div>
      <div><br>
      </div>
      <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">THE COLLATERAL AGENT</div>
      <div><br>
      </div>
      <div style="text-align: justify; color: rgb(0, 0, 0);">1.<font style="font-weight: bold;"> Appointment</font>.<font style="font-style: italic;">&#160;</font>The Secured Parties (all capitalized terms used herein and not otherwise defined shall have the
        respective meanings provided in the Security Agreement to which this Annex B is attached (the &#8220;<u>Agreement</u>&#8221;), by their acceptance of the benefits of the Agreement, hereby designate Yield Point NY LLC (&#8220;<u>Collateral Agent</u>&#8221;) as the
        Collateral Agent to act as specified herein and in the Agreement. Each Secured Party shall be deemed irrevocably to authorize the Collateral Agent to take such action on its behalf under the provisions of the Agreement and any other Transaction
        Document (as such term is defined in the Notes) and to exercise such powers and to perform such duties hereunder and thereunder as are specifically delegated to or required of the Collateral Agent by the terms hereof and thereof and such other
        powers as are reasonably incidental thereto. The Collateral Agent may perform any of its duties hereunder by or through its agents or employees.</div>
      <div><br>
      </div>
      <div style="text-align: justify; color: rgb(0, 0, 0);">2.<font style="font-weight: bold;"> Nature of Duties</font><font style="font-style: italic;">.</font> The Collateral Agent shall have no duties or responsibilities except those expressly set
        forth in the Agreement. Neither the Collateral Agent nor any of its partners, members, shareholders, officers, directors, employees or agents shall be liable for any action taken or omitted by it as such under the Agreement or hereunder or in
        connection herewith or therewith, be responsible for the consequence of any oversight or error of judgment or answerable for any loss, unless caused solely by its or their gross negligence or willful misconduct as determined by a final judgment
        (not subject to further appeal) of a court of competent jurisdiction. The duties of the Collateral Agent shall be mechanical and administrative in nature; the Collateral Agent shall not have by reason of the Agreement or any other Transaction
        Document a fiduciary relationship in respect of any Debtor or any Secured Party; and nothing in the Agreement or any other Transaction Document, expressed or implied, is intended to or shall be so construed as to impose upon the Collateral Agent
        any obligations in respect of the Agreement or any other Transaction Document except as expressly set forth herein and therein.</div>
      <div><br>
      </div>
      <div style="text-align: justify; color: rgb(0, 0, 0);">3.<font style="font-weight: bold;"> Lack of Reliance on the Collateral Agent</font>. Independently and without reliance upon the Collateral Agent, each Secured Party, to the extent it deems
        appropriate, has made and shall continue to make (i) its own independent investigation of the financial condition and affairs of the Company and its subsidiaries in connection with such Secured Party&#8217;s investment in the Debtors, the creation and
        continuance of the Obligations, the transactions contemplated by the Transaction Documents, and the taking or not taking of any action in connection therewith, and (ii) its own appraisal of the creditworthiness of the Company and its subsidiaries,
        and of the value of the Collateral from time to time, and the Collateral Agent shall have no duty or responsibility, either initially or on a continuing basis, to provide any Secured Party with any credit, market or other information with respect
        thereto, whether coming into its possession before any Obligations are incurred or at any time or times thereafter. The Collateral Agent shall not be responsible to the Debtors or any Secured Party for any recitals, statements, information,
        representations or warranties herein or in any document, certificate or other writing delivered in connection herewith, or for the execution, effectiveness, genuineness, validity, enforceability, perfection, collectability, priority or sufficiency
        of the Agreement or any other Transaction Document, or for the financial condition of the Debtors or the value of any of the Collateral, or be required to make any inquiry concerning either the performance or observance of any of the terms,
        provisions or conditions of the Agreement or any other Transaction Document, or the financial condition of the Debtors, or the value of any of the Collateral, or the existence or possible existence of any default or Event of Default under the
        Agreement, the Notes or any of the other Transaction Documents.</div>
      <div style="text-align: justify; color: rgb(0, 0, 0);"> <br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">30</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; color: rgb(0, 0, 0);">4.<font style="font-weight: bold;"> Certain Rights of the Collateral Agent</font>. The Collateral Agent shall have the right to take any action with respect to the Collateral, on behalf of all of
        the Secured Parties. To the extent practical, the Collateral Agent shall request instructions from the Secured Parties with respect to any material act or action (including failure to act) in connection with the Agreement or any other Transaction
        Document, and shall be entitled to act or refrain from acting in accordance with the instructions of Secured Parties holding a majority in principal amount of Notes (based on then-outstanding principal amounts of Notes at the time of any such
        determination); if such instructions are not provided despite the Collateral Agent&#8217;s request therefor, the Collateral Agent shall be entitled to refrain from such act or taking such action, and if such action is taken, shall be entitled to
        appropriate indemnification from the Secured Parties in respect of actions to be taken by the Collateral Agent; and the Collateral Agent shall not incur liability to any person or entity by reason of so refraining. Without limiting the foregoing,
        (a) no Secured Party shall have any right of action whatsoever against the Collateral Agent as a result of the Collateral Agent acting or refraining from acting hereunder in accordance with the terms of the Agreement or any other Transaction
        Document, and the Debtors shall have no right to question or challenge the authority of, or the instructions given to, the Collateral Agent pursuant to the foregoing and (b) the Collateral Agent shall not be required to take any action which the
        Collateral Agent believes (i) could reasonably be expected to expose it to personal liability or (ii) is contrary to this Agreement, the Transaction Documents or applicable law.</div>
      <div><br>
      </div>
      <div style="text-align: justify; color: rgb(0, 0, 0);">5.<font style="font-weight: bold;"> Reliance</font>. The Collateral Agent shall be entitled to rely, and shall be fully protected in relying, upon any writing, resolution, notice, statement,
        certificate, telex, teletype or telecopier message, cablegram, radiogram, order or other document or telephone message signed, sent or made by the proper person or entity, and, with respect to all legal matters pertaining to the Agreement and the
        other Transaction Documents and its duties thereunder, upon advice of counsel selected by it and upon all other matters pertaining to this Agreement and the other Transaction Documents and its duties thereunder, upon advice of other experts
        selected by it. Anything to the contrary notwithstanding, the Collateral Agent shall have no obligation whatsoever to any Secured Party to assure that the Collateral exists or is owned by the Debtors or is cared for, protected or insured or that
        the liens granted pursuant to the Agreement have been properly or sufficiently or lawfully created, perfected, or enforced or are entitled to any particular priority.</div>
      <div><br>
      </div>
      <div style="text-align: justify; color: rgb(0, 0, 0);">6.<font style="font-weight: bold;"> Indemnification</font><font style="font-style: italic;">.</font> To the extent that the Collateral Agent is not reimbursed and indemnified by the Debtors, the
        Secured Parties will jointly and severally reimburse and indemnify the Collateral Agent, in proportion to their initially purchased respective principal amounts of Notes, from and against any and all liabilities, obligations, losses, damages,
        penalties, actions, judgments, suits, costs, expenses or disbursements of any kind or nature whatsoever which may be imposed on, incurred by or asserted against the Collateral Agent in performing its duties hereunder or under the Agreement or any
        other Transaction Document, or in any way relating to or arising out of the Agreement or any other Transaction Document except for those determined by a final judgment (not subject to further appeal) of a court of competent jurisdiction to have
        resulted solely from the Collateral Agent&#8217;s own gross negligence or willful misconduct. Prior to taking any action hereunder as Collateral Agent, the Collateral Agent may require each Secured Party to deposit with it sufficient sums as it
        determines in good faith is necessary to protect the Collateral Agent for costs and expenses associated with taking such action.</div>
      <div><br>
      </div>
      <div style="text-align: justify; color: rgb(0, 0, 0);">7.<font style="font-weight: bold;"> Resignation by the Collateral Agent</font><font style="font-weight: bold; font-style: italic;">.</font></div>
      <div style="text-align: justify;"><font style="color: rgb(0, 0, 0);"> </font><br>
      </div>
      <div style="text-align: justify; color: rgb(0, 0, 0); margin-left: 36pt; text-indent: 36pt;">(a) The Collateral Agent may resign from the performance of all its functions and duties under the Agreement and the other Transaction Documents at any time
        by giving 5 days&#8217; prior written notice (as provided in the Agreement) to the Debtors and the Secured Parties. Such resignation shall take effect upon the appointment of a successor Collateral Agent pursuant to clauses (b) and (c) below.</div>
      <div><br>
      </div>
      <div style="text-align: justify; color: rgb(0, 0, 0); margin-left: 36pt; text-indent: 36pt;">(b) Upon any such notice of resignation, the Secured Parties, acting by a Majority in Interest, shall appoint a successor Collateral Agent hereunder.</div>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">31</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; color: rgb(0, 0, 0); margin-left: 36pt; text-indent: 36pt;">(c) If a successor Collateral Agent shall not have been so appointed within said 5-day period, the Collateral Agent shall then appoint a successor Collateral
        Agent who shall serve as Collateral Agent until such time, if any, as the Secured Parties appoint a successor Collateral Agent as provided above. If a successor Collateral Agent has not been appointed within such 5-day period, the Collateral Agent
        may petition any court of competent jurisdiction or may interplead the Debtors and the Secured Parties in a proceeding for the appointment of a successor Collateral Agent, and all fees, including, but not limited to, extraordinary fees associated
        with the filing of interpleader and expenses associated therewith, shall be payable by the Debtors on demand.</div>
      <div><br>
      </div>
      <div style="text-align: justify; color: rgb(0, 0, 0);">8.<font style="font-weight: bold;"> Rights with respect to Collateral</font><font style="font-style: italic;">.</font> Each Secured Party agrees with all other Secured Parties and the Collateral
        Agent (i) that it shall not, and shall not attempt to, exercise any rights with respect to its security interest in the Collateral, whether pursuant to any other agreement or otherwise (other than pursuant to this Agreement), or take or institute
        any action against the Collateral Agent or any of the other Secured Parties in respect of the Collateral or its rights hereunder (other than any such action arising from the breach of this Agreement) and (ii) that such Secured Party has no other
        rights with respect to the Collateral other than as set forth in this Agreement and the other Transaction Documents. Upon the acceptance of any appointment as Collateral Agent hereunder by a successor Collateral Agent, such successor Collateral
        Agent shall thereupon succeed to and become vested with all the rights, powers, privileges and duties of the retiring Collateral Agent and the retiring Collateral Agent shall be discharged from its duties and obligations under the Agreement.&#160; After
        any retiring Collateral Agent&#8217;s resignation or removal hereunder as Collateral Agent, the provisions of the Agreement including this Annex B shall inure to its benefit as to any actions taken or omitted to be taken by it while it was Collateral
        Agent.</div>
      <div style="text-align: justify;"><font style="color: rgb(0, 0, 0);"> </font><br>
      </div>
      <div style="text-align: justify;"><font style="color: rgb(0, 0, 0);"> </font><br>
      </div>
      <div style="text-align: center;"><font style="color: rgb(0, 0, 0);"> </font><font style="font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">32</font> </div>
      <div>
        <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.4
<SEQUENCE>9
<FILENAME>ny20047547x33_ex10-4.htm
<DESCRIPTION>EXHIBIT 10.4
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc.
         Document created using Broadridge PROfile 25.9.1.5330
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">



  <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
  <div>
    <div style="text-align: right; font-weight: bold;">Exhibit 10.4</div>
    <div>&#160;</div>
    <div style="text-align: center;">EQUITY PURCHASE AGREEMENT</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">THIS EQUITY PURCHASE AGREEMENT (this &#8220;<u>Agreement</u>&#8221;) is entered into as of September 25, 2025 (the &#8220;<u>Execution Date</u>&#8221;), by and between <u>Momentus Inc</u>, a corporation incorporated in the
      State of Delaware (the &#8220;<u>Company</u>&#8221;), and Yield Point NY LLC, a New York limited liability company (the &#8220;<u>Investor</u>&#8221;).</div>
    <div>&#160;</div>
    <div style="text-align: center;">RECITALS</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">WHEREAS, the parties desire that, upon the terms and subject to the conditions contained herein, the Company may issue and sell to the Investor, from time to time as provided herein, and the Investor
      may purchase from the Company up to Fifty Million Dollars ($50,000,000.00) of the Company&#8217;s Common Stock (as defined below);</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">NOW, THEREFORE, in consideration of the mutual covenants contained in this Agreement, and for other good and valuable consideration, the receipt and adequacy of which are hereby acknowledged, the
      Company and the Investor hereby agree as follows:</div>
    <div>&#160;</div>
    <div style="text-align: center; color: #010000;">ARTICLE I</div>
    <div style="text-align: center;">CERTAIN DEFINITIONS</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">Section 1.1</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>RECITALS</u>.&#160; The parties acknowledge and agree that the recitals set forth above are true and correct and are hereby incorporated in and
      made a part of this Agreement.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">Section 1.2</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>DEFINED TERMS</u>.&#160; As used in this Agreement, the following terms shall have the following meanings specified or indicated (such meanings
      to be equally applicable to both the singular and plural forms of the terms defined):</div>
    <div>&#160;</div>
    <div style="text-indent: 36pt;">&#8220;<u>Agreement</u>&#8221; shall have the meaning specified in the preamble hereof.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">&#8220;<u>Available Amount</u>&#8221; means, initially, the Maximum Commitment Amount, which amount shall be reduced by the Investment Amount following each successful Closing, each time the Investor purchases
      Put Shares.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">&#8220;<u>Average Daily Trading Volume</u>&#8221; shall mean the average trading volume of the Common Stock on the applicable Trading Days.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">&#8220;<u>Bankruptcy Law</u>&#8221; means Title 11, U.S. Code, or any similar federal or state law for the relief of debtors.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">&#8220;<u>Beneficial Ownership Limitation</u>&#8221; shall have the meaning specified in <u>Section 7.2(g)</u>.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">&#8220;<u>Cancellable Commitment Share Amount</u>&#8221; shall have the meaning specified in <u>Section 6.4</u>.</div>
    <div>&#160;</div>
    <div style="text-indent: 36pt;">&#8220;<u>Claim Notice</u>&#8221; shall have the meaning specified in <u>Section 9.3(a)</u>.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">&#8220;<u>Clearing Costs</u>&#8221; shall mean, in respect of any Put Notice, 6% of the applicable Purchase Price.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">&#8220;<u>Clearing Date</u>&#8221; shall be the date on which the Investor receives the Put Shares as DWAC Shares in its brokerage account.</div>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <!--PROfilePageNumberReset%Num%2%%%-->
    <div style="text-align: justify; text-indent: 36pt;">&#8220;<u>Closing</u>&#8221; shall mean one of the closings of a purchase and sale of Common Stock pursuant to <u>Section 2.3</u>.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">&#8220;<u>Closing Certificate</u>&#8221; shall mean the closing &#8220;Officer&#8217;s Certificate&#8221; of the Company in the form of <u>Exhibit B</u> hereto.</div>
    <div>&#160;</div>
    <div style="text-indent: 36pt;">&#8220;<u>Closing Date</u>&#8221; shall mean the date of any Closing hereunder.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">&#8220;<u>Commitment Cash</u>&#8221; has the meaning set forth in <u>Section 6.4</u>.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">&#8220;<u>Commitment Fee</u>&#8221; means either the Commitment Cash or the Commitment Shares.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">&#8220;<u>Commitment Period</u>&#8221; shall mean the period commencing on the Execution Date, and ending on the earlier of (i) the date on which the Investor shall have purchased Put Shares pursuant to this
      Agreement equal to the Maximum Commitment Amount, (ii) the date that is thirty-six (36) months from the Effective Date, (iii) written notice of termination by the Company to the Investor, or (iv) written notice of termination by the Investor to the
      Company pursuant to <u>Section 6.1</u> or <u>Section 6.4</u>.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">&#8220;<u>Commitment Shares</u>&#8221; means Common Stock issued by the Company to the Investor pursuant to <u>Section 6.4</u>.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">&#8220;<u>Common Stock</u>&#8221; means the common stock of the Company, having a par value per share of $0.00001, and any shares of any other class of common stock of the Company whether now or hereafter
      authorized, having the right to participate in the distribution of dividends (as and when declared) and assets (upon liquidation of the Company).</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">&#8220;<u>Common Stock Equivalents</u>&#8221; means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire at any time Common Stock, including, without limitation,
      any debt, preferred stock, right, option, warrant or other instrument that is at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.</div>
    <div>&#160;</div>
    <div style="text-indent: 36pt;">&#8220;<u>Company</u>&#8221; shall have the meaning specified in the preamble to this Agreement.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">&#8220;<u>Company Termination Notice</u>&#8221; shall have the meaning specified in <u>Section 10.6</u>.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">&#8220;<u>Condition Satisfaction Date</u>&#8221; shall have the meaning specified in the form of <u>Exhibit B</u> hereto.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">&#8220;<u>Confidential Information</u>&#8221; means any information disclosed by either party to this Agreement, or their affiliates, agents, or representatives, to the other party to this Agreement, either
      directly or indirectly, in writing, orally or by inspection of tangible objects (including, without limitation, documents, formulae, business information, trade secrets, technology, strategies, prototypes, samples, plant, and equipment), which may or
      may not be designated as &#8220;Confidential,&#8221; &#8220;Proprietary&#8221; or some similar designation.&#160; Information communicated orally shall be considered Confidential Information.&#160; Confidential Information may also include information disclosed by third parties.&#160;
      Confidential Information shall not, however, include any information which (i) was publicly known and made generally available in the public domain prior to the time of disclosure by the disclosing party; (ii) becomes publicly known and made
      generally available after disclosure by the disclosing party to the receiving party through no fault, action or inaction of the receiving party; (iii) is already in the possession of the receiving party at the time of disclosure by the disclosing
      party as shown by the receiving party&#8217;s files and records immediately prior to the time of disclosure; (iv) is obtained by the receiving party from a third party without a breach of such third-party&#8217;s obligations of confidentiality; (v) is
      independently developed by the receiving party without use of or reference to the disclosing party&#8217;s Confidential Information, as shown by documents and other competent evidence in the receiving party&#8217;s possession; or (vi) is required by law to be
      disclosed by the receiving party; provided that the receiving party gives the disclosing party prompt written notice of such requirement prior to such disclosure and assistance in obtaining an order protecting the information from public disclosure.</div>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">2</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt;">&#8220;<u>Cover Price</u>&#8221; shall have the meaning specified in <u>Section 2.3(b)</u>.</div>
    <div>&#160;</div>
    <div style="text-indent: 36pt;">&#8220;<u>Current Report</u>&#8221; shall have the meaning set forth in <u>Section 6.3</u>.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">&#8220;<u>Custodian</u>&#8221; means any receiver, trustee, assignee, liquidator, or similar official under any Bankruptcy Law.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">&#8220;<u>Damages</u>&#8221; shall mean any loss, claim, damage, liability, cost, and expense (including, without limitation, reasonable attorneys&#8217; fees and disbursements and costs and expenses of expert
      witnesses and investigation).</div>
    <div>&#160;</div>
    <div style="text-indent: 36pt;">&#8220;<u>Dispute Period</u>&#8221; shall have the meaning specified in <u>Section 9.3(a)</u>.</div>
    <div>&#160;</div>
    <div style="text-indent: 36pt;">&#8220;<u>Disqualification Event</u>&#8221; shall have the meaning specified in <u>Section 4.27</u>.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">&#8220;<u>DTC</u>&#8221; shall mean The Depository Trust Company, or any successor performing substantially the same function for the Company.</div>
    <div>&#160;</div>
    <div style="text-indent: 36pt;">&#8220;<u>DTC/FAST Program</u>&#8221; shall mean the DTC&#8217;s Fast Automated Securities Transfer Program.</div>
    <div>&#160;</div>
    <div style="text-indent: 36pt;">&#8220;<u>DWAC</u>&#8221; shall mean Deposit and Withdrawal at Custodian service, as defined by the DTC.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">&#8220;<u>DWAC Eligible</u>&#8221; shall mean that, (a) the Common Stock is eligible at DTC for full services pursuant to DTC&#8217;s operational arrangements, including, without limitation, transfer through DTC&#8217;s
      DWAC system, (b) the Company has been approved by the DTC&#8217;s underwriting department, (c) the Transfer Agent is approved as an agent in the DTC/FAST Program, (d) the Commitment Shares or Put Shares, as applicable, are otherwise eligible for delivery
      via DWAC, and (e) the Transfer Agent does not have a policy prohibiting or limiting delivery of the Put Shares or Commitment Shares, as applicable, via DWAC; provided that the Investor acknowledges and agrees that the Transfer Agent does not have
      such policy as of the date hereof.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">&#8220;<u>DWAC Shares</u>&#8221; means shares of Common Stock that are (i) issued in electronic form, (ii) freely tradable and transferable and without restriction on resale, and (iii) timely credited by the
      Company to the Investor&#8217;s or its designee&#8217;s specified DWAC account with DTC under the DTC/FAST Program, or any similar program hereafter adopted by DTC performing substantially the same function.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">&#8220;<u>Effective Date</u>&#8221; means the date the <font style="color: #000000;">Registration Statement is declared effectiv</font>e.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">&#8220;<u>Eligible Market</u>&#8221; means the Principal Market or any nationally recognized exchange upon which the Common Stock is listed.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">&#8220;<u>Excess Purchase Amount</u>&#8221; shall have the meaning specified in the form of <u>Exhibit A</u> hereto.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">&#8220;<u>Exchange Act</u>&#8221; shall mean the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</div>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">3</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-indent: 36pt;">&#8220;<u>Execution Date</u>&#8221; shall have the meaning set forth in the preamble to this Agreement.</div>
    <div>&#160;</div>
    <div style="text-indent: 36pt;">&#8220;<u>FINRA</u>&#8221; shall mean the Financial Industry Regulatory Authority, Inc.</div>
    <div>&#160;</div>
    <div style="text-indent: 36pt;">&#8220;<u>Indemnified Party</u>&#8221; shall have the meaning specified in <u>Section 9.2</u>.</div>
    <div>&#160;</div>
    <div style="text-indent: 36pt;">&#8220;<u>Indemnifying Party</u>&#8221; shall have the meaning specified in <u>Section 9.2</u>.</div>
    <div>&#160;</div>
    <div style="text-indent: 36pt;">&#8220;<u>Indemnity Notice</u>&#8221; shall have the meaning specified in <u>Section 9.3(b)</u>.</div>
    <div>&#160;</div>
    <div style="text-indent: 36pt;">&#8220;<u>Initial Commitment Share Amount</u>&#8221; shall have the meaning specified in <u>Section 6.4</u>.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">&#8220;<u>Intellectual Property</u>&#8221; shall mean all trademarks, trademark applications, trade names, service marks, service mark registrations, service names, patents, patent applications, patent rights,
      copyrights, inventions, licenses, approvals, government authorizations, trade secrets or other intellectual property rights.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">&#8220;<u>Investment Amount</u>&#8221; shall mean the dollar value equal to the amount of Put Shares referenced in the Put Notice multiplied by the Purchase Price minus the Clearing Costs.</div>
    <div>&#160;</div>
    <div style="text-indent: 36pt;">&#8220;<u>Investor</u>&#8221; shall have the meaning specified in the preamble to this Agreement.</div>
    <div>&#160;</div>
    <div style="text-indent: 36pt;">&#8220;<u>Issuer Covered Person</u>&#8221; shall have the meaning specified in <u>Section 4.27</u>.</div>
    <div>&#160;</div>
    <div style="text-indent: 36pt;">&#8220;<u>JAMS</u>&#8221; shall have the meaning specified in <u>Section 10.2</u>.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">&#8220;<u>Jewish Holiday</u>&#8221; shall mean each of the following Jewish holidays: Rosh Hashanah (both days), Yom Kippur, Succoth (first two (2) days), Shmini Atzereth, Simchas Torah, Passover (first two (2)
      days and last two (2) days) and Shavuoth (both days).</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">&#8220;<u>Lien</u>&#8221; means a lien, charge, pledge, security interest, encumbrance, right of first refusal, preemptive right or any other restriction.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">&#8220;<u>Material Adverse Effect</u>&#8221; shall mean any effect on the business, operations, properties, or financial condition of the Company and/or the Subsidiaries that is material and adverse to the
      Company and/or the Subsidiaries and/or any condition, circumstance, or situation that would prohibit or otherwise materially interfere with the ability of the Company and/or the Subsidiaries to enter into and/or perform its obligations under any
      Transaction Document and which shall be deemed to include any investigation of the Company, its directors or its officers by the SEC; provided, however, that &#8220;Material Adverse Effect&#8221; shall not include the effect of (i) general economic or political
      conditions; (ii) conditions generally affecting the industries in which the Company operates; (iii) any changes in financial or securities markets in general; (iv) acts of war (whether or not declared), armed hostilities or terrorism, or the
      escalation or worsening thereof; (v) any action required or permitted by this Agreement or any action taken (or omitted to be taken) with the written consent of or at the written request of Investor; (vi) any changes in applicable laws or accounting
      rules, including accounting principles generally accepted in the United States of America; (vii) the public announcement, pendency or completion of the transactions contemplated by this Agreement; (viii) any natural or man-made disasters or acts of
      God; (ix) any epidemics, pandemics, or disease outbreaks or any worsening thereof; or (x) any matter of which Investor is aware on the date hereof; provided further, however, that any event, occurrence, fact, condition or change referred to in
      clauses (i) through (ix) immediately above shall be taken into account in determining whether a Material Adverse Effect has occurred or could reasonably be expected to occur to the extent that such event, occurrence, fact, condition or change has a
      disproportionate effect on the Company compared to other participants in the industries in which the Company conducts its businesses (in which case, only the incremental disproportionate adverse effect may be taken into account in determining whether
      a Material Adverse Effect has occurred).</div>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">4</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt;">&#8220;<u>Maximum Commitment Amount</u>&#8221; shall mean Fifty Million Dollars ($50,000,000.00).</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">&#8220;<u>Maximum Put Amount</u>&#8221; shall mean the lesser of (i) seventy-five percent (75%) of the Average Daily Trading Volume over the five (5) Trading Days preceding the applicable Put Date, and (ii) a&#160;
      number of shares equal to the quotient (rounded up or down to the nearest whole number) obtained by dividing (x) 350,000 by (y) the last closing price on the applicable Put Date (in each case to be appropriately adjusted for any reorganization,
      recapitalization, non-cash dividend, stock split, reverse stock split or other similar transaction during the applicable period).</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">&#8220;<u>Person</u>&#8221; shall mean an individual, a corporation, a partnership, an association, a trust or other entity or organization, including a government or political subdivision or an agency or
      instrumentality thereof.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">&#8220;<u>Principal Market</u>&#8221; shall mean The Nasdaq Capital Market.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">&#8220;<u>Purchase Price</u>&#8221; shall mean $1.24.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">&#8220;<u>Purchase Quantity</u>&#8221; shall meant the Number of Put Shares purchased in the most recent Put Notice.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">&#8220;<u>Put</u>&#8221; shall mean the right of the Company to require the Investor to purchase Common Stock at the Purchase Price, subject to the terms and conditions of this Agreement.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">&#8220;<u>Put Date</u>&#8221; shall mean any Trading Day during the Commitment Period that a Put Notice is deemed delivered pursuant to <u>Section 2.2(b)</u>.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">&#8220;<u>Put Notice</u>&#8221; shall mean a written notice, substantially in the form of <u>Exhibit A</u> hereto, addressed to the Investor and setting forth the amount of Put Shares which the Company intends
      to require the Investor to purchase pursuant to the terms of this Agreement.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">&#8220;<u>Put Notice Delivery Window</u>&#8221; shall have the meaning specified in <u>Section 2.2(b)</u>.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">&#8220;<u>Put Shares</u>&#8221; shall mean all shares of Common Stock issued, or that the Company shall be entitled to issue, per any applicable Put Notice in accordance with the terms and conditions of this
      Agreement.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">&#8220;<u>Reference VWAP Price</u>&#8221; shall have the meaning specified in <u>Section 6.4</u>.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">&#8220;<u>Registration Rights Agreement</u>&#8221; means that agreement in the form attached hereto as <u>Exhibit D</u>.</div>
    <div>&#160;</div>
    <div style="text-indent: 36pt;">&#8220;<u>Registration Statement</u>&#8221; shall have the meaning specified in <u>Section 6.3</u>.</div>
    <div>&#160;</div>
    <div style="text-indent: 36pt;">&#8220;<u>Regulation D</u>&#8221; shall mean Regulation D promulgated under the Securities Act.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">&#8220;<u>Rule 144</u>&#8221; shall mean Rule 144 promulgated under the Securities Act or any similar provision then in force under the Securities Act.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">&#8220;<u>Rules</u>&#8221; shall have the meaning specified in <u>Section 10.2</u>.</div>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">5</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-indent: 36pt;">&#8220;<u>SEC</u>&#8221; shall mean the United States Securities and Exchange Commission.</div>
    <div>&#160;</div>
    <div style="text-indent: 36pt;">&#8220;<u>SEC Documents</u>&#8221; shall have the meaning specified in <u>Section 4.5</u>.</div>
    <div>&#160;</div>
    <div style="text-indent: 36pt;">&#8220;<u>Securities</u>&#8221; means, collectively, the Put Shares and the Commitment Shares.</div>
    <div>&#160;</div>
    <div style="text-indent: 36pt;">&#8220;<u>Securities Act</u>&#8221; shall mean the Securities Act of 1933, as amended.</div>
    <div>&#160;</div>
    <div style="text-indent: 36pt;">&#8220;<u>Share Delivery Deadline</u>&#8221; shall have the meaning specified in <u>Section 2.3(a)</u>.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">&#8220;<u>Short Sales</u>&#8221; shall mean all &#8220;short sales&#8221; as defined in Rule 200 of Regulation SHO under the Exchange Act, including all short positions effected through any direct or indirect share pledges
      (other than pledges in the ordinary course of business as part of prime brokerage arrangements), forward sale contracts, options, puts, calls, swaps and similar arrangements and any hedging transaction that establishes a net short position with
      respect to the Common Stock.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">&#8220;<u>Subsidiary</u>&#8221; or &#8220;<u>Subsidiaries</u>&#8221; means any Person the Company wholly-owns or controls, or in which the Company, directly or indirectly, owns a majority of the voting stock or similar
      voting interest, in each case that would be disclosable pursuant to Item 601(b)(21) of Regulation S-K promulgated under the Securities Act.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">&#8220;<u>Suspension</u>&#8221; means any suspension of trading in the Company&#8217;s securities on its principal securities exchange or trading market that continues for one full Trading Day or is imposed by the
      SEC, the Principal Market or FINRA due to the Company&#8217;s failure to comply with applicable listing or reporting requirements; provided, that any temporary halt or interruption in trading is imposed by the exchange for technical reasons, market
      volatility, or in connection with public announcements or events of general market significance shall not constitute a Suspension for purposes of this Agreement.</div>
    <div>&#160;</div>
    <div style="text-indent: 36pt;">&#8220;<u>Third-Party Claim</u>&#8221; shall have the meaning specified in <u>Section 9.3(a)</u>.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">&#8220;<u>Trading Day</u>&#8221; means any full trading day (beginning at 9:30:01 a.m., New York City time, and ending at 4:00 p.m., New York City time) on the Principal Market or, if the Common Stock is then
      listed on an Eligible Market, on such Eligible Market.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">&#8220;<u>Transaction Documents</u>&#8221; shall mean this Agreement, the Registration Rights Agreement, the Transfer Agent Instruction Letter, and all schedules and exhibits hereto and thereto.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">&#8220;<u>Transfer Agent</u>&#8221; shall mean Continental Stock Transfer and Trust Company, the current transfer agent of the Company, and any successor transfer agent of the Company.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">&#8220;<u>Transfer Agent Instruction Letter</u>&#8221; means the letter from the Company to the Transfer Agent which instructs the Transfer Agent to issue the Put Shares and the Commitment Shares pursuant to the
      Transaction Documents, in the form of <u>Exhibit C</u> attached hereto.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">&#8220;<u>Valuation Period</u>&#8221; shall mean the period of three (3) consecutive Trading Days immediately following the applicable Put Date, during which the Purchase Price of the Common Stock is set.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">&#8220;<u>Variable Rate Transaction</u>&#8221; shall have the meaning specified in <u>Section 7.2(q)</u>.</div>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">6</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt;">&#8220;<u>VWAP</u>&#8221; means, for the Common Stock as of any Trading Day, the dollar volume-weighted average price for the Common Stock on the Principal Market (or, if the Common Stock is then listed on an
      Eligible Market, on such Eligible Market) during the period beginning at 9:30:01 a.m., New York City time, or such other time publicly announced by the Principal Market (or by such Eligible Market, as applicable) as the official open (or
      commencement) of trading on the Principal Market (or on such Eligible Market, as applicable) on such Trading Day, and ending at 4:00 p.m., New York City time, or such other time publicly announced by the Principal Market (or by such Eligible Market,
      as applicable) as the official close of trading on the Principal Market (or on such Eligible Market, as applicable) on such Trading Day, as reported by Bloomberg through its &#8220;AQR&#8221; function or, if no dollar volume-weighted average price is reported
      for the Common Stock by Bloomberg through its &#8220;AQR&#8221; function for such hours, the average of the highest closing bid price and the lowest closing ask price of any of the market makers for such security on such Trading Day as reported by OTC Markets
      Group Inc.&#160; All such determinations shall be appropriately adjusted for any stock dividend, stock split, stock combination, recapitalization, or other similar transaction during such period.</div>
    <div>&#160;</div>
    <div style="text-align: center; color: #010000;">ARTICLE II</div>
    <div style="text-align: center;">PURCHASE AND SALE OF SHARES OF COMMON STOCK</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">Section 2.1</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>PUTS</u>.&#160; Subject to the terms and conditions set forth herein (including, without limitation, the provisions of <u>Article VII</u>),
      the Company shall have the right, but not the obligation, to direct the Investor to process a Put to purchase Put Shares by its delivery to the Investor of a Put Notice from time to time during the Commitment Period; provided that, notwithstanding
      any other terms of this Agreement, in each instance, (i) the Put Shares are not more than the Maximum Put Amount for any Put; (ii) the aggregate Investment Amount of all Puts shall not exceed the Maximum Commitment Amount; (iii) at least one (1)
      Trading Day has elapsed since the most recent Closing Date of a Put; (iv) all Common Stock resulting from prior submitted Put Notices for Puts has been delivered; and (v) the price of the Common Stock as listed on the Trading Market is at or above
      106% of the Purchase Price; <u>provided</u> however, the Investor&#8217;s good faith estimate of the Maximum Put Amount, shall be the Maximum Put Amount for such Put.&#160; Notwithstanding the foregoing, the Company and the Investor may agree in respect of any
      Put that the amount of Put Shares in respect of such Put may exceed the applicable Maximum Put Amount.&#160; If the Company delivers a Put Notice for a number of Put Shares in excess of the Maximum Put Amount, then the number of Put Shares to be purchased
      under such Put Notice shall be deemed without any further action of the Company to be the Maximum Put Amount, and the Investor shall remain obligated to purchase the Maximum Put Amount with respect to such Put Notice.</div>
    <div>&#160;</div>
    <div style="text-indent: 36pt;"><font style="color: #010000;">Section 2.2</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>MECHANICS</u>.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>PUT NOTICE</u>.&#160; At any time and from time to time during the Commitment Period, except as provided in this Agreement, the Company may cause a Put
      by delivering a Put Notice to the Investor via e-mail, subject to satisfaction of the conditions set forth in <u>Section 2.1</u>, <u>Section 7.2</u> and otherwise provided in this Agreement.&#160; The Company shall deliver, or cause to be delivered, the
      Put Shares as DWAC Shares to the Investor as required pursuant to <u>Section 2.3(a)</u>.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(1, 0, 0);">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>DATE OF DELIVERY OF PUT NOTICE</u>.&#160; A Put Notice shall be deemed delivered on a Trading Day if it is received by e-mail by the Investor if
      such notice is received on or after 9:30 a.m., New York City time, and prior to 2:00 p.m., New York City time, on such Trading Day (&#8220;<u>Put Notice Delivery Window</u>&#8221;) and shall be confirmed by Investor by 4:00 p.m., New York City time.&#160; However, if
      a Put Notice is not confirmed by the Investor to the Company no later than 4:00 p.m., New York City time, on the Trading Day it was received, the Put Notice will nonetheless be deemed validly delivered unless withdrawn by the Company; provided, no
      Put Notice may be delivered on a Jewish Holiday. Provided further however, the Company shall have the option to send Put Notices outside the Put Notice Delivery Window (any such Put Notice, a &#8220;<u>Post Window Put Notice</u>&#8221;) and if such Post Window
      Put Notice is confirmed by the Investor within 30 minutes after delivery of such Post Window Put Notice it will be deemed to have been delivered in the most recent Put Notice Delivery Period prior to the delivery of such Post Window Put Notice.</div>
    <div>&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">7</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-indent: 36pt;"><font style="color: #010000;">Section 2.3</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>CLOSINGS</u>.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(1, 0, 0);">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>TIMING</u>.&#160; The Clearing Date of a Put shall occur on the Trading Day following the delivery of the applicable Put Notice in accordance with
      <u>Section 2.2(b)</u>, whereby the Company shall use its best efforts to deliver, or cause to be delivered, the Put Shares as DWAC Shares to the Investor on such Trading Day by 9:30 a.m., New York City time, and shall deliver or cause to be delivered
      such Put Shares no later than 12:30 p.m., New York City time (the &#8220;<u>Share Delivery Deadline</u>&#8221;); provided that the Investor shall have validly posted a DWAC request to accept the shares into the brokerage account for a minimum period commencing
      at 8:30 a.m. to 12:30 p.m., New York City time, on such Trading Day.&#160; The Share Delivery Deadline for a Post Window Put Notice shall be 10:00 a.m. New York City time on the Trading Day following the Investor&#8217;s confirmation of a Post Window Put
      Notice; provided that the Investor shall have validly posted a DWAC receive to accept the shares into the brokerage account for a minimum period commencing one hour after acceptance of a Post Window Put Notice.&#160; The Closing of a Put shall occur one
      (1) Trading Day following the end of the Valuation Period.&#160; In addition, on or prior to any such Closing or on the date of the delivery of the applicable Put Notice, as required pursuant to <u>Sections 7.1</u> and <u>7.2</u>, each of the Company
      and the Investor shall deliver to each other all documents, instruments and writings required to be delivered or reasonably requested by either of them pursuant to this Agreement in order to implement and effect the transactions contemplated herein.&#160;
      In addition to any other rights available to the Investor, unless the Investor shall not have validly posted such a DWAC receive, if the Company fails to cause the Transfer Agent to transmit to the Investor Put Shares pursuant to a Put Notice before
      the applicable Share Delivery Deadline, the Investor may elect to deem such Put Notice rescinded.&#160; Payment of the Investment Amount related to any Put Notice shall be made by the Investor by wire transfer of immediately available funds to an account
      designated by the Company not later than one (1) Trading Day following the end of the applicable Valuation Period, as may be adjusted for any credit of a Cover Price available to the Investor in accordance with <u>Section 2.3(b)</u>.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(1, 0, 0);">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>COMPENSATION FOR FAILURE TO TIMELY DELIVER PUT SHARES</u>.&#160; In addition to any other rights available to the Investor, if the Company fails
      to cause the Transfer Agent to transmit to the Investor Put Shares pursuant to a Put Notice before the applicable Share Delivery Deadline in accordance with Section 2.3(a) or Section 2.4, and, if on or after such Share Delivery Deadline, the Investor
      purchases (in an open market transaction or otherwise) shares of Common Stock to deliver in satisfaction of a sale by the Investor of such Put Shares that the Investor anticipated receiving from the Company in respect of such Put Notice, then the
      Company shall, within two (2) Trading Days after the Investor&#8217;s request, either (i) pay cash to the Investor in an amount equal to the Investor&#8217;s total purchase price (including brokerage commissions, if any) for the Common Stock so purchased (the &#8220;<u>Cover
        Price</u>&#8221;), at which point the Company&#8217;s obligation to deliver such Put Shares shall terminate, (ii) promptly honor its obligation to deliver to the Investor such Put Shares as DWAC Shares and pay cash to the Investor in an amount equal to the
      excess (if any) of the Cover Price over the total Investment Amount paid by the Investor in connection with such Put Notice, or (iii) be deemed to have accepted notice that such Cover Price shall be credited as the Investment Amount to be paid in
      respect of one or more subsequent Put Notices, in the discretion of the Investor.&#160; The Investor shall provide the Company with written notice indicating the amounts payable to the Investor in respect of the Cover Price and evidence of the amount of
      such loss.&#160; Nothing herein shall limit the Investor&#8217;s right to pursue a decree of specific performance and/or injunctive relief with respect to the Company&#8217;s failure to timely deliver shares of Common Stock in connection with a Put Notice.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(1, 0, 0);">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160; <u>RETURN OF SURPLUS</u>.&#160; If the value of the Put Shares delivered to the Investor causes the Company to exceed the Maximum Commitment Amount,
      then the Investor shall return to the Company the surplus amount of Put Shares associated with such Put, and the Purchase Price with respect to such Put shall be reduced by any Clearing Costs related to the return of such Put Shares at the time of
      payment of the Investment Amount.</div>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">8</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(1, 0, 0);">(d)</font>&#160;&#160; &#160; &#160;&#160;&#160; <u>RESALES DURING VALUATION PERIOD</u>.&#160; The parties acknowledge and agree that, during a Valuation Period, the Investor may contract for, or
      otherwise effect, the resale of the subject purchased Put Shares to third parties so long as such resale complies with applicable securities laws.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">Section 2.4</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="color: #010000;"><u>OPTIONAL ADDITIONAL PUT SHARES</u></font>.&#160; Following the Put Date in respect of any Put, at any time during
      the Valuation Period relating to such Put, the Company and Investor may agree to increase the amount of Put Shares relating to such Put up to 1000%.&#160; Such mutual agreement may be made after the relevant Put Notice is delivered and before the
      expiration of the Valuation Period.&#160; Following any such agreement the Company agrees that it shall deliver, or cause to be delivered any such additional Put Shares as DWAC Shares to the Investor on the Trading Day following the date the Company and
      Investor shall have agreed to such increase by 9:30 a.m., New York City time but in no event later than 10:30 a.m. New York City time; provided that the Investor shall have validly posted a DWAC receive to accept the shares into the brokerage account
      for a minimum period commencing at 8:30 a.m. to 10:30 a.m., New York City time, on such Trading Day.&#160; A failure to deliver such additional Put Shares by such time shall entitle the Investor to the rights set forth in <u>Section 2.3(b)</u> in respect
      of such failure.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">Section 2.5&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; COMPLIANCE WITH PRINCIPAL MARKET RULES. Notwithstanding anything in this Agreement to the contrary, and in addition to the limitations set forth in Section 7.2(g) hereof, the
      Company shall not issue under this Agreement (including the Commitment Shares) more than 19.99% of the Company&#8217;s outstanding shares of Common Stock on the date hereof (the &#8220;<u>Exchange Cap</u>&#8221;) unless stockholder approval is obtained to issue in
      excess of the Exchange Cap; provided, however, that the foregoing limitation shall not apply if at any time the Exchange Cap is reached and at all times thereafter the average price paid for all shares of Common Stock issued under this Agreement is
      equal to or greater than a price equal to the lower of (i) the Nasdaq Official Closing Price immediately preceding the execution of this Agreement or (ii) the arithmetic average of the five (5) Nasdaq Official Closing Prices for the Common Stock
      immediately preceding the execution of this Agreement, as calculated in accordance with the rules of the Principal Market (in such circumstance, for purposes of the Principal Market, the transaction contemplated hereby would not be &#8220;below market&#8221; and
      the Exchange Cap would not apply). Notwithstanding the foregoing, the Company shall not be required or permitted to issue, and the Investor shall not be required to purchase, any shares of Common Stock under this Agreement if such issuance would
      violate the rules or regulations of the Principal Market. The Company may, in its sole discretion, determine whether to obtain stockholder approval to issue more than 19.99% of its outstanding shares of Common Stock hereunder if such issuance would
      require stockholder approval under the rules or regulations of the Principal Market. The Exchange Cap shall be reduced, on a share-for-share basis, by the number of shares of Common Stock issued or issuable that may be aggregated with the
      transactions contemplated by this Agreement under applicable rules of the Principal Market.</div>
    <div>&#160;</div>
    <div style="text-align: center; text-indent: 36pt; color: #010000;">ARTICLE III</div>
    <div style="text-align: center; text-indent: 36pt;">REPRESENTATIONS AND WARRANTIES OF INVESTOR</div>
    <div>&#160;</div>
    <div style="text-indent: 36pt;">The Investor represents and warrants to the Company that:</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">Section 3.1</font>&#160;&#160;&#160; &#160;&#160; &#160; <u>INTENT</u>.&#160; The Investor is entering into this Agreement for its own account, and the Investor has no present arrangement (whether or not
      legally binding) at any time to sell the Securities to or through any Person in violation of the Securities Act or any applicable state securities laws; <u>provided</u>, <u>however</u>, that the Investor reserves the right to dispose of the
      Securities at any time in accordance and in compliance with federal and state securities laws applicable to such disposition.</div>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">9</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">Section 3.2</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>NO LEGAL ADVICE FROM THE COMPANY</u>.&#160; The Investor acknowledges that it has had the opportunity to review this Agreement and the
      transactions contemplated by this Agreement with its own legal counsel and investment and tax advisors.&#160; Except with respect to the representations, warranties and covenants contained in this Agreement, the Investor is relying solely on such counsel
      and advisors and not on any statements or representations of the Company or any of its representatives or agents for legal, tax or investment advice with respect to this investment, the transactions contemplated by this Agreement or the securities
      laws of any jurisdiction.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">Section 3.3</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>ACCREDITED INVESTOR</u>.&#160; The Investor is an accredited investor as defined in Rule 501(a)(3) of Regulation D, and the Investor has such
      experience in business and financial matters that it is capable of evaluating the merits and risks of an investment in the Securities.&#160; The Investor acknowledges that an investment in the Securities is speculative and involves a high degree of risk.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">Section 3.4</font>&#160;&#160;&#160;&#160;&#160;&#160; <u>AUTHORITY</u>.&#160; The Investor has the requisite power and authority to enter into and perform its obligations under this Agreement and the
      other Transaction Documents and to consummate the transactions contemplated hereby and thereby.&#160; The execution and delivery of this Agreement and the other Transaction Documents and the consummation by it of the transactions contemplated hereby and
      thereby have been duly authorized by all necessary action and no further consent or authorization of the Investor is required.&#160; Each Transaction Document to which it is a party has been duly executed by the Investor, and when delivered by the
      Investor in accordance with the terms hereof, will constitute the valid and binding obligation of the Investor enforceable against it in accordance with its terms, subject to applicable bankruptcy, insolvency, or similar laws relating to, or
      affecting generally the enforcement of, creditors&#8217; rights and remedies or by other equitable principles of general application.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">Section 3.5</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>NOT AN AFFILIATE</u>.&#160; The Investor is not an officer or director or an &#8220;affiliate&#8221; (as such term is defined in Rule 405 of the Securities
      Act) of the Company.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">Section 3.6</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>ORGANIZATION AND STANDING</u>.&#160; The Investor is an entity duly formed, validly existing and in good standing under the laws of the
      jurisdiction of its formation with full right, limited liability company power and authority to enter into and to consummate the transactions contemplated by this Agreement and the other Transaction Documents.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">Section 3.7</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>ABSENCE OF CONFLICTS</u>.&#160; The execution and delivery of this Agreement and the other Transaction Documents, and the consummation of the
      transactions contemplated hereby and thereby and compliance with the requirements hereof and thereof, will not (a) violate any law, rule, regulation, order, writ, judgment, injunction, decree or award binding on the Investor, (b) violate any
      provision of any indenture, instrument or agreement to which the Investor is a party or is subject, or by which the Investor or any of its assets is bound, or conflict with or constitute a material default thereunder, (c) result in the creation or
      imposition of any lien pursuant to the terms of any such indenture, instrument or agreement, or constitute a breach of any fiduciary duty owed by the Investor to any third party, or (d) require the approval of any third party (that has not been
      obtained) pursuant to any material contract, instrument, agreement, relationship or legal obligation to which the Investor is subject or to which any of its assets, operations or management may be subject.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">Section 3.8</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>DISCLOSURE; ACCESS TO INFORMATION</u>.&#160; The Investor had an opportunity to review copies of the SEC Documents filed on behalf of the
      Company, has had access to all publicly available information with respect to the Company and has had an opportunity to discuss with Company management and ask questions relating to everything it deems relevant; <u>provided</u>, <u>however</u>,
      that the Investor makes no representation or warranty hereunder with respect to any SEC Document and is relying on the representations and warranties of the Company in <u>Article IV</u> with respect to the SEC Documents.</div>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">10</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">Section 3.9</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>MANNER OF SALE</u>.&#160; At no time was the Investor presented with or solicited by or through any leaflet, public promotional meeting,
      television advertisement or any other form of general solicitation or advertisement regarding the Securities.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">Section 3.10&#160;&#160;&#160;&#160;&#160; <u>NO MARKET MANIPULATION</u>.&#160; Neither the Investor, nor any of its Affiliates has, and to its knowledge no Person acting on either of their behalf has, (i) taken, directly or
      indirectly, any action designed to cause or to result in the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of any of the Securities, (ii) sold, bid for, purchased, or paid any compensation
      for soliciting purchases of, any of the Securities, or (iii) paid or agreed to pay to any Person any compensation for soliciting another to purchase any other securities of the Company.</div>
    <div>&#160;</div>
    <div style="text-align: center; color: #010000;">ARTICLE IV</div>
    <div style="text-align: center;">REPRESENTATIONS AND WARRANTIES OF THE COMPANY</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">The Company represents and warrants to the Investor that, except as set forth in the disclosure schedules hereto or the SEC Documents, as of the Execution Date, each date a Put Notice is submitted
      and at each Closing Date:</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">Section 4.1</font>&#160;&#160;&#160;&#160; &#160; &#160; <u>ORGANIZATION OF THE COMPANY</u>.&#160; The Company is a corporation duly incorporated, validly existing and in good standing under the laws of
      the State of Delaware, with the requisite power and authority to own and use its properties and assets and to carry on its business as currently conducted.&#160; Each of the Subsidiaries is an entity duly incorporated or otherwise organized, validly
      existing and in good standing under the laws of the jurisdiction of its incorporation or organization, with the requisite power and authority to own and use its properties and assets and to carry on its business as currently conducted.&#160; Each of the
      Company and the Subsidiaries is not in violation or default of any of the provisions of its respective certificate or articles of incorporation, bylaws or other organizational or charter documents.&#160; Each of the Company and the Subsidiaries is duly
      qualified to conduct business and is in good standing as a foreign corporation or other entity in each jurisdiction in which the nature of the business conducted or property owned by it makes such qualification necessary, except where the failure to
      be so qualified or in good standing, as the case may be, could not have or reasonably be expected to result in a Material Adverse Effect and no proceeding has been instituted in any such jurisdiction revoking, limiting or curtailing or seeking to
      revoke, limit or curtail such power and authority or qualification.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">Section 4.2</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>AUTHORITY</u>.&#160; The Company has the requisite corporate power and authority to enter into and perform its obligations under this Agreement
      and the other Transaction Documents.&#160; The execution and delivery of this Agreement and the other Transaction Documents by the Company and the consummation by it of the transactions contemplated hereby and thereby have been duly authorized by all
      necessary corporate action and no further consent or authorization of the Company or its board of directors or stockholders is required.&#160; Each of this Agreement and the other Transaction Documents has been duly executed and delivered by the Company
      and constitutes a valid and binding obligation of the Company enforceable against the Company in accordance with its terms, except as such enforceability may be limited by applicable bankruptcy, insolvency, or similar laws relating to, or affecting
      generally the enforcement of, creditors&#8217; rights and remedies or by other equitable principles of general application.</div>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">11</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">Section 4.3</font>&#160;&#160;&#160;&#160;&#160; &#160; <u></u><u>CAPITALIZATION</u>.&#160; The authorized capital stock of the Company as of the Effective Date is as set forth in the SEC Documents.&#160;
      Except as set forth in the SEC Documents or on <u>Schedule 4.3</u>, the Company has not issued any capital stock since its most recently filed periodic report under the Exchange Act, other than pursuant to the exercise of employee stock options
      under the Company&#8217;s stock option plans, the issuance of shares of Common Stock to employees pursuant to the Company&#8217;s employee stock purchase plans and pursuant to the conversion and/or exercise of Common Stock Equivalents outstanding as of the date
      of the most recently filed periodic report under the Exchange Act.&#160; No Person has any right of first refusal, preemptive right, right of participation, or any similar right to participate in the transactions contemplated by the Transaction
      Documents.&#160; Except as set forth in the SEC Documents or on <u>Schedule 4.3</u>, and except as a result of the purchase and sale of the Securities, issuances of stock under the Company&#8217;s equity incentive plans and the issuance of shares of Common
      Stock to employees pursuant to the Company&#8217;s employee stock purchase plans, as of the Effective Date there are no outstanding options, warrants, scrip rights to subscribe to, calls or commitments of any character whatsoever relating to, or
      securities, rights or obligations convertible into or exercisable or exchangeable for, or giving any Person any right to subscribe for or acquire any shares of Common Stock, or contracts, commitments, understandings or arrangements by which the
      Company or any Subsidiary is or may become bound to issue additional shares of Common Stock or Common Stock Equivalents.&#160; Except as set forth on <u>Schedule 4.3</u>, as of the Effective Date, the issuance and sale of the Securities will not obligate
      the Company to issue shares of Common Stock or other securities to any Person (other than the Investor) and will not result in a right of any holder of Company securities to adjust the exercise, conversion, exchange or reset price under any of such
      securities.&#160; Except as set forth on <u>Schedule 4.3</u>, as of the Effective Date there are no material agreements of the Company with its stockholders or, to the knowledge of the Company, between or among any of the Company&#8217;s stockholders, that (a)
      govern or restrict the voting of any equity securities of the Company, (b) provide for rights to participate in future issuances of equity securities of the Company, or (c) provide a stockholder with information or governance rights not available to
      stockholders generally.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">Section 4.4</font>&#160;&#160;&#160;&#160;&#160;&#160; <u>LISTING AND MAINTENANCE REQUIREMENTS</u>.&#160; The Common Stock is registered pursuant to Section 12(b) or 12(g) of the Exchange Act, and the
      Company has taken no action designed to, or which to its knowledge is likely to have the effect to, terminate the registration of the Common Stock under the Exchange Act, nor has the Company received any notification that the SEC is contemplating
      terminating such registration.&#160; Except as set forth on <u>Schedule 4.4(a)</u>, the Company has not, in the twelve (12) months preceding the Execution Date, received notice from the Principal Market to the effect that the Company is not in compliance
      with the listing or maintenance requirements of such Principal Market.&#160; Except as set forth on <u>Schedule 4.4(b)</u>, the Company is, and has no reason to believe that it will not in the foreseeable future continue to be, in compliance with all
      such listing and maintenance requirements.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">Section 4.5</font>&#160;&#160;&#160;&#160;&#160; &#160; <u>SEC DOCUMENTS; DISCLOSURE</u>.&#160; Except as set forth on <u>Schedule 4.5</u>, the Company has filed all reports, schedules, forms,
      statements and other documents required to be filed by the Company under the Securities Act and the Exchange Act, including pursuant to Section 13(a) or 15(d) thereof, for the one (1) year preceding the Execution Date (or such shorter period as the
      Company was required by law or regulation to file such material) (the foregoing materials, including the exhibits thereto and documents incorporated by reference therein, being collectively referred to herein as the &#8220;<u>SEC Documents</u>&#8221;) on a
      timely basis or has received a valid extension of such time of filing and has filed any such SEC Documents prior to the expiration of any such extension.&#160; As of their respective dates, the SEC Documents complied in all material respects with the
      requirements of the Securities Act and the Exchange Act, as applicable, and other federal laws, rules and regulations applicable to such SEC Documents, and none of the SEC Documents when filed contained any untrue statement of a material fact or
      omitted to state a material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading.&#160; The financial statements of the Company included in the
      SEC Documents comply as to form and substance in all material respects with applicable accounting requirements and the published rules and regulations of the SEC or other applicable rules and regulations with respect thereto.&#160; Such financial
      statements have been prepared in accordance with generally accepted accounting principles applied on a consistent basis during the periods involved (except (a) as may be otherwise indicated in such financial statements or the notes thereto or (b) in
      the case of unaudited interim statements, to the extent they may not include footnotes or may be condensed or summary statements) and fairly present in all material respects the financial position of the Company as of the dates thereof and the
      results of operations and cash flows for the periods then ended (subject, in the case of unaudited statements, to normal, immaterial, year-end audit adjustments).&#160; The Company maintains a system of internal accounting controls appropriate for its
      size.&#160; There is no transaction, arrangement, or other relationship between the Company and an unconsolidated or other off-balance-sheet-entity that is not disclosed by the Company in its financial statements or otherwise that would be reasonably
      likely to have a Material Adverse Effect.&#160; Except with respect to the material terms and conditions of the transactions contemplated by the Transaction Documents, the Company confirms that neither it nor any other Person acting on its behalf has
      provided the Investor or its agents or counsel with any information that it believes constitutes or might constitute material, non-public information.&#160; The Company understands and confirms that the Investor will rely on the foregoing representation
      in effecting transactions in securities of the Company.</div>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">12</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">Section 4.6</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>VALID ISSUANCES</u>.&#160; The Securities are duly authorized and, when issued and paid for in accordance with the applicable Transaction
      Documents, will be validly issued, fully paid, and non-assessable, free and clear of all Liens imposed by the Company, other than restrictions on transfer provided for in the Transaction Documents and under the Securities Act.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">Section 4.7</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>NO CONFLICTS</u>.&#160; The execution, delivery and performance of this Agreement and the other Transaction Documents by the Company, and the
      consummation by the Company of the transactions contemplated hereby and thereby, including, without limitation, the issuance of the Put Shares and the Commitment Shares, do not and will not: (a) result in a violation of the Company&#8217;s or any
      Subsidiary&#8217;s certificate or articles of incorporation, by-laws or other organizational or charter documents, (b) conflict with, or constitute a material default (or an event that with notice or lapse of time or both would become a material default)
      under, result in the creation of any Lien upon any of the properties or assets of the Company or any Subsidiary, or give to others any rights of termination, amendment, acceleration or cancellation of, any agreement, indenture, instrument or any
      &#8220;lock-up&#8221; or similar provision of any underwriting or similar agreement to which the Company or any Subsidiary is a party, or (c) result in a violation of any federal, state or local law, rule, regulation, order, judgment or decree (including federal
      and state securities laws and regulations) applicable to the Company or any Subsidiary or by which any property or asset of the Company or any Subsidiary is bound or affected (except for such conflicts, defaults, terminations, amendments,
      accelerations, cancellations and violations as would not, individually or in the aggregate, have a Material Adverse Effect), nor is the Company otherwise in violation of, conflict with or in default under any of the foregoing.&#160; The business of the
      Company is not being conducted in material violation of any law, ordinance, or regulation of any governmental entity.&#160; The Company is not required under federal, state or local law, rule or regulation to obtain any consent, authorization or order of,
      or make any filing or registration with, any court or governmental agency in order for it to execute, deliver or perform any of its obligations under this Agreement or the other Transaction Documents (other than any Eligible Market, SEC, FINRA or
      state securities filings or submissions that may be required to be made by the Company in connection with the issuance of the Commitment Shares, Put Shares or subsequent to any Closing or any registration statement that may be filed pursuant hereto);
      provided that, for purposes of the representation made in this sentence, the Company is assuming and relying upon the accuracy of the relevant representations and agreements of the Investor herein.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">Section 4.8</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>NO MATERIAL ADVERSE CHANGE</u>.&#160; No event has occurred that would have a Material Adverse Effect on the Company or any Subsidiary that has
      not been disclosed in subsequent SEC filings.</div>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">13</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">Section 4.9</font>&#160;&#160;&#160;&#160;&#160; &#160; <u>LITIGATION AND OTHER PROCEEDINGS</u>.&#160; Except as set forth on <u>Schedule 4.9</u>, there are no actions, suits, investigations, inquiries,
      or proceedings pending or, to the knowledge of the Company, threatened against or affecting the Company, any Subsidiary or any of their respective properties, nor has the Company received any written or oral notice of any such action, suit,
      proceeding, inquiry, or investigation, which would have a Material Adverse Effect or would require disclosure under the Securities Act or the Exchange Act.&#160; No judgment, order, writ, injunction or decree or award has been issued by or, to the
      knowledge of the Company, requested of any court, arbitrator or governmental agency which would have a Material Adverse Effect.&#160; There has not been and, to the knowledge of the Company, there is not pending or contemplated, any investigation by the
      SEC involving the Company, any Subsidiary, or any current or former director or officer of the Company or any Subsidiary.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">Section 4.10</font>&#160;&#160;&#160;&#160; <u>REGISTRATION RIGHTS</u>.&#160; Except as set forth on <u>Schedule 4.10</u>, no Person (other than the Investor) has any right to cause the
      Company to effect the registration under the Securities Act of any securities of the Company or any Subsidiary.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">Section 4.11</font>&#160;&#160;&#160;&#160;&#160;&#160; <u>INVESTOR&#8217;S STATUS</u>.&#160; The Company acknowledges and agrees that the Investor is acting solely in the capacity of arm&#8217;s-length purchaser
      with respect to the Transaction Documents and the transactions contemplated hereby and thereby.&#160; The Company further acknowledges that the Investor is not acting as a financial advisor or fiduciary of the Company (or in any similar capacity) with
      respect to the Transaction Documents and the transactions contemplated hereby and thereby and any advice given by the Investor or any of its representatives or agents in connection with the Transaction Documents and the transactions contemplated
      hereby and thereby is merely incidental to the Investor&#8217;s purchase of the Securities.&#160; The Company further represents to the Investor that the Company&#8217;s decision to enter into the Transaction Documents has been based solely on the independent
      evaluation by the Company and its representatives and advisors.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">Section 4.12</font>&#160;&#160;&#160;&#160; &#160; <u>NO GENERAL SOLICITATION; NO INTEGRATED OFFERING</u>.&#160; Neither the Company, any Subsidiary, nor any of their respective affiliates, nor any
      Person acting on their behalf, has engaged in any form of general solicitation or general advertising (within the meaning of Regulation D under the Securities Act) in connection with the offer or sale of the Securities.&#160; Neither the Company, any
      Subsidiary, nor any of their respective affiliates, nor any Person acting on their behalf has, directly or indirectly, made any offers or sales of any security or solicited any offers to buy any security, under circumstances that would require
      registration of the offer and sale of any of the Securities under the Securities Act, whether through integration with prior offerings or otherwise.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">Section 4.13</font>&#160;&#160;&#160;&#160;&#160; <u>INTELLECTUAL PROPERTY RIGHTS</u>.&#160; The Company and each Subsidiary owns or possesses adequate rights or licenses to use all material
      trademarks, trade names, service marks, service mark registrations, service names, patents, patent rights, copyrights, inventions, licenses, approvals, governmental authorizations, trade secrets and rights necessary to conduct their respective
      businesses as now conducted.&#160; None of the Company&#8217;s, nor any Subsidiary&#8217;s Intellectual Property has expired or been terminated, or, by the terms and conditions thereof, could expire or terminate within three years from the date of this Agreement if
      such expiration or termination could reasonably be expected to have a Material Adverse Effect.&#160; The Company does not have any knowledge of any infringement by the Company and/or any Subsidiary of any material Intellectual Property of others, or of
      any such development of similar or identical trade secrets or technical information by others, and there is no claim, action or proceeding being made or brought against, or to the Company&#8217;s knowledge, being threatened against, the Company and/or any
      Subsidiary regarding the infringement of any Intellectual Property, which could reasonably be expected to have a Material Adverse Effect.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">Section 4.14</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>[RESERVED]</u></div>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">14</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">Section 4.15</font>&#160;&#160;&#160;&#160;&#160;&#160; <u>TITLE</u>.&#160; Except as disclosed in the SEC Documents, the Company and each Subsidiary has good and marketable title in fee simple to all
      real property owned by it and good and marketable title in all personal property owned by it that is material to the business of the Company and each Subsidiary, in each case free and clear of all Liens and, except for Liens as do not materially
      affect the value of such property and do not materially interfere with the use made and proposed to be made of such property by the Company or any Subsidiary and Liens for the payment of federal, state or other taxes, the payment of which is neither
      delinquent nor subject to penalties.&#160; Any real property and facilities held under lease by the Company or any Subsidiary is held under valid, subsisting, and enforceable leases with which the Company is in compliance with such exceptions as are not
      material and do not interfere with the use made and proposed to be made of such property and buildings by the Company or any Subsidiary.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">Section 4.16</font>&#160;&#160;&#160;&#160; <u>INSURANCE</u>.&#160; The Company and each Subsidiary is insured by insurers of recognized financial responsibility against such losses and risks
      and in such amounts as management of the Company believes to be prudent and customary in the businesses in which the Company and each Subsidiary is engaged.&#160; Neither the Company, nor any Subsidiary has been refused any insurance coverage sought or
      applied for, and the Company has no reason to believe that it or any Subsidiary will not be able to renew its existing insurance coverage as and when such coverage expires or to obtain similar coverage from similar insurers as may be necessary to
      continue its business at a cost that would not materially and adversely affect the condition, financial or otherwise, or the earnings, business or operations of the Company, taken as a whole.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">Section 4.17</font>&#160;&#160; &#160; &#160; <u>REGULATORY PERMITS</u>.&#160; The Company and each Subsidiary possesses all material certificates, authorizations and permits issued by the
      appropriate federal, state, or foreign regulatory authorities necessary to conduct its businesses, and neither the Company, nor any Subsidiary has received any notice of proceedings relating to the revocation or modification of any such certificate,
      authorization, or permit.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">Section 4.18</font>&#160;&#160;&#160;&#160;&#160;&#160; <u>TAX STATUS</u>.&#160; The Company and each Subsidiary has made or filed all federal and state income and all other material tax returns, reports
      and declarations required by any jurisdiction to which it is subject (unless and only to the extent that the Company has set aside on its books provisions reasonably adequate for the payment of all unpaid and unreported taxes) and has paid all taxes
      and other governmental assessments and charges that are material in amount, shown or determined to be due on such returns, reports and declarations, except those being contested in good faith and has set aside on its books provision reasonably
      adequate for the payment of all taxes for periods subsequent to the periods to which such returns, reports or declarations apply.&#160; There are no unpaid taxes in any material amount claimed to be due by the taxing authority of any jurisdiction, and the
      officers of the Company know of no basis for any such claim.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">Section 4.19</font>&#160;&#160;&#160;&#160;&#160;&#160; <u>TRANSACTIONS WITH AFFILIATES</u>.&#160; Except as set forth in the SEC Documents, none of the officers or directors of the Company or any
      Subsidiary, and to the knowledge of the Company, none of the employees of the Company or any Subsidiary is presently a party to any transaction with the Company or any Subsidiary (other than for services as employees, officers and directors),
      including any contract, agreement or other arrangement providing for the furnishing of services to or by, providing for rental of real or personal property to or from, or otherwise requiring payments to or from any officer, director or such employee
      or, to the knowledge of the Company, any entity in which any officer, director, or any such employee has a substantial interest or is an officer, director, trustee or partner, in each case in excess of the lesser of (i) $120,000 or (ii) one percent
      of the average of the Company&#8217;s total assets at year-end for the last two completed fiscal years, other than for (i) payment of salary or consulting fees for services rendered, (ii) reimbursement for expenses incurred on behalf of the Company or any
      Subsidiary and (iii) other employee benefits, including stock option agreements under any stock option plan of the Company.</div>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">15</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">Section 4.20</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>APPLICATION OF TAKEOVER PROTECTIONS</u>.&#160; The Company and its board of directors have taken or will take prior to the Execution Date all
      necessary action, if any, in order to render inapplicable any control share acquisition, business combination, poison pill (including any distribution under a rights agreement) or other similar anti-takeover provision under the articles of
      incorporation or the laws of the state of its incorporation which is or could become applicable to the Investor as a result of the transactions contemplated by this Agreement, including, without limitation, the Company&#8217;s issuance of the Securities
      and the Investor&#8217;s ownership of the Securities.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">Section 4.21</font>&#160;&#160;&#160;&#160;&#160;&#160; <u>FOREIGN CORRUPT PRACTICES</u>.&#160; Neither the Company, any Subsidiary, nor, to the knowledge of the Company, any agent or other Person acting
      on behalf of the Company or any Subsidiary, has (i) directly or indirectly, used any funds for unlawful contributions, gifts, entertainment or other unlawful expenses related to foreign or domestic political activity, (ii) made any unlawful payment
      to foreign or domestic government officials or employees or to any foreign or domestic political parties or campaigns from corporate funds, (iii) failed to disclose fully any contribution made by the Company or any Subsidiary (or made by any Person
      acting on its behalf of which the Company is aware) which is in violation of law, or (iv) violated in any material respect any provision of the Foreign Corrupt Practices Act of 1977, as amended.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">Section 4.22</font>&#160;&#160;&#160;&#160;&#160;&#160; <u>SARBANES-OXLEY</u>.&#160; The Company is in compliance in all material respects with all provisions of the Sarbanes-Oxley Act of 2002, as
      amended, which are applicable to it.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">Section 4.23</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>CERTAIN FEES</u>.&#160; Except as set forth in Schedule 4.23, no brokerage or finder&#8217;s fees or commissions are or will be payable by the
      Company to any broker, financial advisor or consultant, finder, placement agent, investment banker, bank, or other Person with respect to the transactions contemplated by the Transaction Documents.&#160; The Investor shall have no obligation with respect
      to any fees or with respect to any claims made by or on behalf of any Persons for fees of a type contemplated in this <u>Section 4.23</u> that may be due in connection with the transactions contemplated by the Transaction Documents.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">Section 4.24</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>INVESTMENT COMPANY</u>.&#160; The Company is not an &#8220;investment company&#8221; within the meaning of the Investment Company Act of 1940, as amended.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">Section 4.25</font>&#160;&#160;&#160;&#160; <u>ACCOUNTANTS</u>.&#160; The Company&#8217;s accountants are set forth in the SEC Documents and, to the knowledge of the Company, such accountants are an
      independent public accounting firm registered with the Public Company Accounting Oversight Board, as required by the Securities Act.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">Section 4.26</font>&#160;&#160;&#160;&#160;&#160;&#160; <u>NO MARKET MANIPULATION</u>.&#160; Neither the Company, nor any Subsidiary has, and to its knowledge no Person acting on either of their behalf
      has, (i) taken, directly or indirectly, any action designed to cause or to result in the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of any of the Securities, (ii) sold, bid for,
      purchased, or paid any compensation for soliciting purchases of, any of the Securities, or (iii) paid or agreed to pay to any Person any compensation for soliciting another to purchase any other securities of the Company.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">Section 4.27</font>&#160;&#160;&#160;&#160;&#160;&#160; <u>NO DISQUALIFICATION EVENTS</u>.&#160; None of the Company, any Subsidiary, any of their predecessors, any affiliated issuer, any director,
      executive officer, other officer of the Company or any Subsidiary participating in the offering contemplated hereby, any beneficial owner of 20% or more of the Company&#8217;s outstanding voting equity securities, calculated on the basis of voting power,
      nor any promoter (as that term is defined in Rule 405 under the Securities Act) connected with the Company in any capacity at the time of sale (each, an &#8220;<u>Issuer Covered Person</u>&#8221;) is subject to any of the &#8220;Bad Actor&#8221; disqualifications described
      in Rule 506(d)(1) under the Securities Act (a &#8220;<u>Disqualification Event</u>&#8221;), except for a Disqualification Event covered by Rule 506(d)(2) or (d)(3) under the Securities Act.&#160; The Company has exercised reasonable care to determine whether any
      Issuer Covered Person is subject to a Disqualification Event.</div>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">16</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">Section 4.28</font>&#160;&#160;&#160;&#160;&#160;&#160; <u>MONEY LAUNDERING</u>.&#160; The Company and each Subsidiary is in compliance with, and has not previously violated, the USA PATRIOT ACT of 2001
      and all other applicable U.S. and non-U.S. anti-money laundering laws and regulations, including, but not limited to, the laws, regulations and Executive Orders and sanctions programs administered by the U.S. Office of Foreign Assets Control,
      including, but not limited, to (i) Executive Order 13224 of September 23, 2001 entitled, &#8220;Blocking Property and Prohibiting Transactions With Persons Who Commit, Threaten to Commit, or Support Terrorism&#8221; (66 Fed. Reg. 49079 (2001)) and (ii) any
      regulations contained in 31 CFR, Subtitle B, Chapter V.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">Section 4.29</font>.&#160;&#160;&#160;&#160; <u>ILLEGAL OR UNAUTHORIZED PAYMENTS; POLITICAL CONTRIBUTIONS</u>.&#160; Neither the Company, nor any Subsidiary has, nor, to the best of the
      Company&#8217;s knowledge (after reasonable inquiry of its officers and directors), any of the officers, directors, employees, agents or other representatives of the Company or any Subsidiary, has, directly or indirectly, made or authorized any payment,
      contribution or gift of money, property, or services, whether or not in contravention of applicable law, (a) as a kickback or bribe to any Person or (b) to any political organization, or the holder of or any aspirant to any elective or appointive
      public office except for personal political contributions not involving the direct or indirect use of funds of the Company.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-right: 6.1pt; margin-left: 5pt;"><font style="color: #010000;">Section 4.30</font>&#160;&#160;&#160;&#160; <u>SHELL COMPANY STATUS</u>.&#160; The Company is not currently an issuer identified in Rule 144(i)(1)(i)
      under the Securities Act, is subject to the reporting requirements of Section 13(a) or 15(d) of the Exchange Act, and, except as set forth on <u>Schedule 4.5</u>, has filed all reports and other materials required to be filed by Section 13(a) or
      15(d) of the Exchange Act, as applicable during the preceding twelve (12) months.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-right: 6.05pt; margin-left: 5pt;"><font style="color: #010000;">Section 4.31</font>&#160;&#160;&#160; <u>ABSENCE OF SCHEDULES</u>.&#160; In the event that, on the Execution Date, the Company does not deliver any
      disclosure schedule contemplated by this Agreement, the Company hereby acknowledges and agrees that (i) each such undelivered disclosure schedule shall be deemed to read as follows: &#8220;Nothing to Disclose&#8221; and (ii) the Investor has not otherwise waived
      delivery of such disclosure schedule.</div>
    <div>&#160;</div>
    <div style="text-align: center; color: #010000;">ARTICLE V</div>
    <div style="text-align: center;">COVENANTS OF INVESTOR</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">Section 5.1</font>&#160;&#160;&#160;&#160;&#160; &#160;&#160; <u>COMPLIANCE WITH LAW; TRADING IN SECURITIES</u>.&#160; The Investor&#8217;s trading activities with respect to the Common Stock will be in compliance
      with all applicable state and federal securities laws and regulations and the rules and regulations of FINRA and the Principal Market.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">Section 5.2</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>SHORT SALES AND CONFIDENTIALITY</u>.&#160; The Investor, or any affiliate of the Investor acting on its behalf or pursuant to any understanding
      with it, hereby represents that, as of the Execution Date, it is not &#8220;short&#8221; any Common Stock and will not, in any manner whatsoever, directly or indirectly, participate in or execute (i) any Short Sales during the period from the Execution Date to
      the end of the Commitment Period or (ii) any hedging transaction that would create a net short position with respect to the shares of Common Stock.&#160; For the purposes hereof, and in accordance with Regulation SHO, the sale after delivery of a Put
      Notice of such number of shares of Common Stock reasonably expected to be purchased under a Put Notice shall not be deemed a Short Sale.&#160; The Investor shall, until such time as the transactions contemplated by this Agreement are publicly disclosed by
      the Company in accordance with the terms of this Agreement, maintain the confidentiality of the existence and terms of this transaction and the information included in the Transaction Documents.</div>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">17</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: center; color: #010000;">ARTICLE VI</div>
    <div style="text-align: center;">COVENANTS OF THE COMPANY</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">Section 6.1</font>&#160;&#160;&#160; &#160;&#160; &#160; <u>LISTING OF SHARES OF COMMON STOCK</u>.&#160; The Company shall promptly, in connection with the issuance of the Commitment Shares and the Put
      Shares to the Investor hereunder, submit to the Principal Market any required application to list such shares on the Principal Market and shall use commercially reasonable efforts to maintain, so long as the Common Stock shall be so listed, the
      listing of all such Put Shares and Commitment Shares that are issued from time to time hereunder.&#160; The Company shall use its commercially reasonable efforts to continue the listing and trading of the Common Stock on the Principal Market.&#160; The Company
      shall not take any action that would reasonably be expected to result in the delisting or suspension of the Common Stock on the Principal Market.&#160; The Company shall promptly provide to the Investor copies of any notices it receives from any Person
      regarding the continued eligibility of the Common Stock for listing on the Principal Market, provided that the public filings of such notices shall constitute delivery of such notices to the Investor.&#160; The Company shall pay all fees and expenses in
      connection with satisfying its obligations under this <u>Section 6.1</u>).&#160; The Company shall take all action necessary to ensure that the Common Stock can be transferred electronically as DWAC Shares.&#160; If the Company receives a delisting notice
      from the Principal Market or if the Common Stock fails to be listed on an Eligible Market, then the Investor may terminate its obligations under this Agreement by written notice to the Company and may deem any outstanding Put Notice as withdrawn.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">Section 6.2</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>OTHER EQUITY LINES AND AT-THE-MARKET OFFERINGS</u>.&#160; For a period ending on the earlier of (i) twelve (12) months after the Effective Date
      and (ii) the date that this Agreement is terminated, the Company covenants and agrees that it will not, without the prior written consent of the Investor, enter into any other equity line of credit agreement with any other party without the
      Investor&#8217;s prior written consent, which consent may be granted or withheld in the Investor&#8217;s sole and absolute discretion.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">Section 6.3</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>FILING OF CURRENT REPORT AND REGISTRATION STATEMENT</u>.&#160; The Company agrees that it shall file a Current Report on Form 8-K, including the
      Transaction Documents as exhibits thereto, with the SEC within the time required by the Exchange Act, relating to the transactions contemplated by, and describing the material terms and conditions of, the Transaction Documents (the &#8220;<u>Current Report</u>&#8221;).&#160;
      The Company shall permit the Investor to review and comment upon the final pre-filing draft version of the Current Report at least two (2) Trading Days prior to its filing with the SEC, and the Company shall give reasonable consideration to all such
      comments.&#160; The Investor shall use its reasonable best efforts to comment upon the final pre-filing draft version of the Current Report within one (1) Trading Day from the date the Investor receives it from the Company.&#160; Pursuant to the terms of the
      Registration Rights Agreement, the Company shall also file with the SEC, on or before the thirtieth (30<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup>) day following the Execution Date, a new registration statement on Form S-1 (the &#8220;<u>Registration Statement</u>&#8221;) covering only the
      resale of the Put Shares and Commitment Shares and shall use its best efforts to have such Registration declared no later than Sixty (60) days following the Execution Date.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">Section 6.4</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="color: #010000;"><u>COMMITMENT FEE; </u></font><u>ISSUANCE OF COMMITMENT SHARES</u>.&#160; In consideration for the Investor&#8217;s
      execution and delivery of, and performance under this Agreement, on the Execution Date, the Company in its discretion shall either (i) pay to the Investor in cash $750,000 (&#8220;<u>Commitment Cash</u>&#8221;) or (ii) issue a prefunded warrant (the &#8220;<u>PFW</u>&#8221;)
      to purchase Common Stock (the &#8220;<u>Warrant Shares</u>&#8221;) in a form acceptable to the Investor in its sole discretion and having an exercise price per share of $0.00001, to purchase Shares of Common Stock (the &#8220;<u>Commitment Shares</u>&#8221;) to the Investor
      having a value of $750,000 valued as set forth in PFW.&#160; For the avoidance of doubt, all of the Commitment Shares shall be fully earned as of the Execution Date, and the issuance of the Commitment Shares is not contingent upon any other event or
      condition, including, without limitation, the effectiveness of the Registration Statement or the Company&#8217;s submission of a Put Notice to the Investor and irrespective of any termination of this Agreement.</div>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">18</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">Section 6.5</font>&#160;&#160;&#160;&#160;&#160; <u>DUE DILIGENCE; CONFIDENTIALITY; NON-PUBLIC INFORMATION</u>.&#160; The Investor shall have the right, from time to time as the Investor may
      reasonably deem appropriate, not to exceed more than two (2) times per calendar year, to perform reasonable due diligence on the Company during normal business hours, to the extent it does not unreasonably interrupt the operations of the Company or
      its management.&#160; The Company, each Subsidiary and their respective officers and employees shall provide information and reasonably cooperate with the Investor in connection with any reasonable request by the Investor related to the Investor&#8217;s due
      diligence of the Company.&#160; Notwithstanding the foregoing, the Company shall have the right to withhold any such information from the Investor that is considered confidential by the Company until the Investor enters into a customary nondisclosure
      agreement with the Company regarding such information.&#160; The Company agrees not to disclose any Confidential Information of the Investor to any third party, except for attorneys, accountants, advisors who have a need to know such Confidential
      Information and are bound by confidentiality, and shall not use any Confidential Information for any purpose other than in connection with, or in furtherance of, the transactions contemplated hereby.&#160; The Company acknowledges that the Confidential
      Information of the Investor shall remain the property of the Investor and agrees that it shall take all reasonable measures to protect the secrecy of any Confidential Information disclosed by the Investor.&#160; The Company confirms that neither it nor
      any other Person acting on its behalf shall provide the Investor or its agents with any information that constitutes or might constitute material, non-public information, unless (i) such information has been requested by the Investor or (ii) a
      simultaneous public announcement thereof is made by the Company in the manner contemplated by Regulation FD, while any Put Notice is outstanding or while the Investor holds any shares of Common Stock.&#160; In the event of a breach of the foregoing
      covenant by the Company or any Person acting on its behalf (as determined in the reasonable good faith judgment of the Investor), in addition to any other remedy provided herein or in the other Transaction Documents, the Investor shall have the right
      to make a public disclosure, in the form of a press release, public advertisement or otherwise, of such material, non-public information without the prior approval by the Company; provided that the Investor shall have first provided notice to the
      Company that it believes it has received information that constitutes material, non-public information, and the Company shall have had at least forty-eight (48) hours, or twenty-four (24) hours if during a period between a Put Date and the Share
      Delivery Deadline, to publicly disclose such purported material, non-public information prior to any such disclosure by the Investor, and the Company shall have failed to publicly disclose such purported material, non-public information within such
      time period.&#160; The Investor shall not have any liability to the Company, any Subsidiary, or any of their respective directors, officers, employees, stockholders, affiliates or agents, for any such disclosure.&#160; The Company understands and confirms that
      the Investor shall be relying on the foregoing covenants in effecting transactions in securities of the Company.&#160; Notwithstanding any requirement to disclose information to the Investor pursuant to this Section 6.5, the Company shall not be in breach
      of this Section 6.5 if it determines in good faith not to disclose such information reasonably requested by the Investor if disclosure of such information would likely result in the public disclosure of such information pursuant to this Section 6.5.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">Section 6.6</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>PURCHASE RECORDS</u>.&#160; The Company shall maintain records showing the Available Amount at any given time and the date, Investment Amount
      and Put Shares for each Put, contained in the applicable Put Notice.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">Section 6.7</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>TAXES</u>.&#160; The Company shall pay any and all transfer, stamp or similar taxes that may be payable with respect to the issuance and
      delivery of any shares of Common Stock to the Investor made under this Agreement.</div>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">19</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">Section 6.8</font>&#160;&#160;&#160;&#160;&#160;&#160; <u>USE OF PROCEEDS</u>.&#160; The Company will use the net proceeds from the offering of Put Shares hereunder for general corporate purposes in the
      manner described in the Registration Statement or the SEC Documents.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">Section 6.9</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>OTHER TRANSACTIONS</u>.&#160; The Company shall not enter into, announce, or recommend to its stockholders any agreement, plan, arrangement or
      transaction in or of which the terms thereof would restrict, materially delay, conflict with or impair the ability or right of the Company to perform its obligations under the Transaction Documents, including, without limitation, the obligation of
      the Company to deliver the Put Shares and to issue the Commitment Shares to the Investor in accordance with the terms of the Transaction Documents.&#160; Provided however, the Company may raise capital in a transaction not otherwise prohibited herein, if
      such transaction occurs on a Trading Day after the most recent Pricing Period (and not during the pendency of any Pricing Period).</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">Section 6.10&#160;&#160;&#160;&#160;&#160;&#160; </font><u>INTEGRATION</u>.&#160; In any case subject to the terms of the Registration Rights Agreement, from and after the Execution Date, neither the
      Company, nor or any of its Subsidiaries or affiliates will, and the Company shall use its reasonable best efforts to ensure that no Person acting on their behalf will, directly or indirectly, make any offers or sales of any security or solicit any
      offers to buy any security, under circumstances that would require registration of the offer and sale of any of the Securities under the Securities Act.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">Section 6.12</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>TRANSACTION DOCUMENTS</u>.&#160; On the Execution Date, the Company shall deliver to the Investor executed copies of all of the Transaction
      Documents.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">Section 6.13&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>STANDSTILL</u>.&#160; Unless waived by the Investor, notwithstanding any other provisions set forth in the Transaction Documents, the Company hereby covenants and agrees not to
      issue any shares of Common Stock or other securities (including debt securities) convertible or exercisable into shares of Common Stock or enter into agreement to sell such securities, during each period beginning (i) upon the submission of any Put
      Notice that has been accepted in accordance with the terms hereof and (ii) ending upon the close of the Trading Day of the Closing with respect to such Put Notice.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">Section 6.14&#160;&#160; &#160; &#160; <u>MOST FAVORED NATIONS</u>.&#160; For a period ending on the date that this Agreement is terminate, if any of the contractual provisions, or side letters in respect, of any equity
      line of credit agreement entered into by the Company, contain or provide terms more favorable to the investors thereunder, than the terms provided to the Investor hereunder, then the Company shall specifically notify the Investor of such additional
      or more favorable terms and such terms, at Investor&#8217;s option, shall become a part of the Transaction Documents.&#160; Failure of the Company to provide such notice of additional or more favorable terms, shall not be deemed to constitute a waiver or
      release by the Investor to deem such additional or more favorable terms to become part of the Transaction Documents.</div>
    <div>&#160;</div>
    <div style="text-align: center; color: #010000;">ARTICLE VII</div>
    <div style="text-align: center;">CONDITIONS TO DELIVERY OF PUT NOTICES AND CONDITIONS TO CLOSING</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">Section 7.1</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>CONDITIONS PRECEDENT TO THE RIGHT OF THE COMPANY TO ISSUE AND SELL PUT SHARES</u>.&#160; The right of the Company to issue and sell the Put
      Shares to the Investor is subject to the satisfaction of each of the conditions set forth below:</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(1, 0, 0);">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>ACCURACY OF INVESTOR&#8217;S REPRESENTATIONS AND WARRANTIES</u>.&#160; The representations and warranties of the Investor shall be true and correct in
      all material respects as of the Execution Date and as of the date of each Closing as though made at each such time.</div>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">20</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(1, 0, 0);">(b)</font>&#160;&#160;&#160;&#160;&#160; &#160; &#160; <u>DELIVERY OF DOCUMENTS</u>.&#160; The Investor shall have executed each of the Transaction Documents and delivered the same to the Company.</div>
    <div style="text-align: justify;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(1, 0, 0);">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>REGISTRATION STATEMENT</u>.&#160; The Company shall not have the right to issue any Put Shares if, as of the date of the Closing for such issuance
      and sale, the Registration Statement, and any amendment or supplement thereto, shall fail to be and remain effective for the resale by the Investor of the Put Shares and Commitment Shares.</div>
    <div style="text-align: justify;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(1, 0, 0);">Section 7.2&#160;&#160;&#160;&#160;&#160; &#160; </font><u>CONDITIONS PRECEDENT TO THE OBLIGATION OF INVESTOR TO PURCHASE PUT SHARES</u>.&#160; The obligation of the Investor hereunder to purchase
      Put Shares is subject to the satisfaction of each of the following conditions:</div>
    <div style="text-align: justify;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(1, 0, 0);">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>REGISTRATION STATEMENT</u>.&#160; The Registration Statement, and any amendment or supplement thereto, shall be and remain effective for the
      resale by the Investor of the Put Shares and the Commitment Shares and (i) neither the Company nor the Investor shall have received notice that the SEC has issued or intends to issue a stop order with respect to such Registration Statement or that
      the SEC otherwise has suspended or withdrawn the effectiveness of such Registration Statement, either temporarily or permanently, or intends or has threatened to do so and (ii) no other suspension of the use of, or withdrawal of the effectiveness of,
      such Registration Statement or related prospectus shall exist.&#160; The Company shall have prepared and filed with the SEC a final and complete prospectus (the preliminary form of which shall be included in the Registration Statement) and shall have
      delivered to the Investor a true and complete copy thereof.&#160; Such prospectus shall be current and available for the resale by the Investor of all of the Securities covered thereby.</div>
    <div style="text-align: justify;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(1, 0, 0);">(b)</font>&#160;&#160;&#160;&#160; &#160; &#160; <u>ACCURACY OF THE COMPANY&#8217;S REPRESENTATIONS AND WARRANTIES</u>.&#160; The representations and warranties of the Company shall be true and correct in
      all material respects as of the Execution Date for each date a Put Notice is submitted and as of the date of each Closing (except for representations and warranties under the first sentence of <u>Section 4.3</u> that are specifically made as of the
      Execution Date and shall be true and correct in all respects as of the Execution Date).</div>
    <div style="text-align: justify;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(1, 0, 0);">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>PERFORMANCE BY THE COMPANY</u>.&#160; The Company shall have performed, satisfied, and complied in all material respects with all covenants,
      agreements and conditions required by this Agreement to be performed, satisfied, or complied with by the Company.</div>
    <div style="text-align: justify;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(1, 0, 0);">(d)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>NO INJUNCTION</u>.&#160; No statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered,
      promulgated or adopted by any court or governmental authority of competent jurisdiction that prohibits or directly and materially adversely affects any of the transactions contemplated by the Transaction Documents, and no proceeding shall have been
      commenced that may have the effect of prohibiting or materially adversely affecting any of the transactions contemplated by the Transaction Documents.</div>
    <div style="text-align: justify;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(1, 0, 0);">(e)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>ADVERSE CHANGES</u>.&#160; Since the date of filing of the Company&#8217;s most recent SEC Document, no event that had or is reasonably likely to have a
      Material Adverse Effect has occurred.</div>
    <div style="text-align: justify;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(1, 0, 0);">(f)</font>&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160; <u>NO SUSPENSION OF TRADING IN OR DELISTING OF THE SHARES OF COMMON STOCK</u>.&#160; Trading of the Common Stock shall not have been Suspended by
      the SEC, the Principal Market or FINRA, and the Common Stock shall have been approved for listing or quotation on and shall not have been delisted from the Principal Market.&#160; In the event of a Suspension of trading of the Common Stock, as
      contemplated by this <u>Section 7.2(f)</u>, the Investor shall have the right to return to the Company any remaining amount of Put Shares associated with such Put, and the Purchase Price with respect to such Put shall be reduced accordingly.</div>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">21</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(1, 0, 0);">(g)</font>&#160;&#160;&#160;&#160; &#160;&#160; &#160; <u>BENEFICIAL OWNERSHIP LIMITATION</u>.&#160; As of the date of the Closing for such issuance and sale, the number of Put Shares to be purchased by
      the Investor shall not exceed the number of such shares that, when aggregated with all other shares of Common Stock then owned by the Investor beneficially or deemed beneficially owned by the Investor, would result in the Investor owning more than
      the Beneficial Ownership Limitation (as defined below), as determined in accordance with Section 16 of the Exchange Act and the regulations promulgated thereunder.&#160; For purposes of this <u>Section 7.2(g)</u>, in the event that the amount of shares
      of Common Stock outstanding, as determined in accordance with Section 16 of the Exchange Act and the regulations promulgated thereunder, is greater on a Closing Date than on the date upon which the Put Notice associated with such Closing Date is
      given, the number of shares of Common Stock outstanding on such Closing Date shall govern for purposes of determining whether the Investor, when aggregating all purchases of shares of Common Stock made pursuant to this Agreement, would own more than
      the Beneficial Ownership Limitation following such Closing Date.&#160; The &#8220;<u>Beneficial Ownership Limitation</u>&#8221; shall be the lesser of (i) 4.99% of the number of shares of Common Stock outstanding immediately after giving effect to the issuance of
      shares of Common Stock issuable pursuant to a Put Notice and (ii) 19.99% of the number of shares of Common Stock outstanding as of the date the applicable Put Notice is submitted, excluding Common Stock held by &#8220;affiliates&#8221; (as such term is defined
      in Rule 405 of the Securities Act) of the Company.&#160; The Investor, upon notice to the Company, may increase or decrease the Beneficial Ownership Limitation provisions of this <u>Section 7.1(g)</u>; provided that the Beneficial Ownership Limitation in
      no event shall exceed 9.99% of the number of shares of Common Stock outstanding immediately after giving effect to the issuance of Common Stock issuable pursuant to a Put Notice and the provisions of this <u>Section 7.1(g)</u> shall continue to
      apply.&#160; Any increase in the Beneficial Ownership Limitation will not be effective until the 61<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">st</sup> day after such notice is delivered to the Company.</div>
    <div style="text-align: justify;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(1, 0, 0);">(h)</font>&#160;&#160; &#160;&#160; &#160;&#160; <u>NO KNOWLEDGE</u>.&#160; The Company shall have no knowledge of any event more likely than not to have the effect of causing the Registration
      Statement to be suspended or otherwise ineffective (which event is more likely than not to occur within the fifteen (15) Trading Days following the Trading Day on which such Put Notice is deemed delivered).&#160; The Company shall have no knowledge of any
      untrue statement of a material fact or omission of a material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under which they were made, not misleading, in the Registration Statement, any
      effective registration statement filed pursuant to the Registration Rights Agreement or any post-effective amendment or prospectus which is a part of the foregoing, unless the Company has filed an amendment with the SEC.</div>
    <div style="text-align: justify;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(1, 0, 0);">(i)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>NO VIOLATION OF STOCKHOLDER APPROVAL REQUIREMENT; STOCKHOLDER APPROVAL</u>.&#160; The issuance of the Put Shares shall not violate the stockholder
      approval requirements of the Principal Market.&#160; The Company shall seek shareholder approval if required, by the applicable rules and regulations of the Nasdaq Stock Market including, Nasdaq Listing Rule 5635(d), to issue all shares issuable pursuant
      to this Agreement.</div>
    <div style="text-align: justify;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(1, 0, 0);">(j)</font>&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160; <u>OFFICER&#8217;S CERTIFICATE</u>.&#160; On the date of delivery of each Put Notice, the Investor shall have received the Closing Certificate executed by
      an executive officer of the Company and to the effect that all the conditions to such Closing shall have been satisfied as of the date of each such certificate.</div>
    <div style="text-align: justify;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(1, 0, 0);">(k)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>DWAC ELIGIBLE</u>.&#160; The Common Stock must be DWAC Eligible and not subject to a &#8220;DTC chill.&#8221;</div>
    <div style="text-align: justify;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(1, 0, 0);">(l)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>SEC DOCUMENTS</u>.&#160; All reports, schedules, registrations, forms, statements, information, and other documents required to have been filed by
      the Company with the SEC pursuant to the reporting requirements of the Exchange Act (other than Forms 8-K) shall have been filed with the SEC within the applicable time periods prescribed for such filings under the Exchange Act.</div>
    <div style="text-align: justify;">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">22</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(1, 0, 0);">(m)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>TRANSFER AGENT INSTRUCTION LETTER</u>.&#160; The Transfer Agent Instruction Letter shall have been executed by the Company and delivered to the
      Transfer Agent and acknowledged and agreed to in writing by the Transfer Agent, and the Company shall have no knowledge of any fact or circumstance that would prevent the Transfer Agent from complying with the terms of the Transfer Agent Instruction
      Letter.</div>
    <div style="text-align: justify;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(1, 0, 0);">(n)</font>&#160;&#160;&#160;&#160;&#160; &#160; &#160; <u>BROKER APPROVAL</u>.&#160; The Put Shares and Commitment Shares shall have been approved by the Investor&#8217;s prime broker or designated clearing
      firm for deposit to its account with the Depository Trust Company; provided that the Company&#8217;s securities, as of the date hereof, are approved by the Investor&#8217;s prime broker.</div>
    <div style="text-align: justify;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(1, 0, 0);">(o)</font>&#160;&#160;&#160;&#160; &#160; &#160;&#160; <u>NO VIOLATION</u>.&#160; No statute, regulation, order, guidance, decree, writ, ruling or injunction shall have been enacted, entered,
      promulgated, threatened, or endorsed by any federal, state, local or foreign court or governmental authority of competent jurisdiction, including, without limitation, the SEC, which prohibits the consummation of or which would materially modify or
      delay any of the transactions contemplated by the Transaction Documents.</div>
    <div style="text-align: justify;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(1, 0, 0);">(p)</font>&#160;&#160;&#160;&#160; &#160;&#160;&#160; <u>LEGAL OPINION</u>.&#160; Upon effectiveness of the Registration Statement, the Company shall cause to be delivered to the Investor a written
      opinion of counsel, in form and substance previously agreed, relating to the availability and effectiveness of the Registration Statement, as supplemented by any prospectus supplement or amendment thereto, and regarding the Company&#8217;s compliance with
      the laws of the State of Delaware and the federal securities laws of the United States in the issuance, sale and registration of the Put Shares and Commitment Shares and entrance into the transaction documents.</div>
    <div style="text-align: justify;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(1, 0, 0);">(q)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>NO VARIABLE-RATE TRANSACTIONS</u>.&#160; Without the prior written consent of the Investor, the Company shall not have entered into any Variable
      Rate Transaction until the termination of this Agreement. For purposes of this Agreement, &#8220;<u>Variable Rate Transaction</u>&#8221; means a transaction in which the Company (i) issues or sells any equity or debt securities that are convertible into,
      exchangeable or exercisable for, or include the right to receive additional shares of Common Stock or Common Stock Equivalents either (A) at a conversion price, exercise price, exchange rate or other price that is based upon and/or varies with the
      trading prices of or quotations for the Common Stock at any time after the initial issuance of such equity or debt securities or (B) with a conversion, exercise or exchange price that is subject to being reset at some future date after the initial
      issuance of such equity or debt security or upon the occurrence of specified or contingent events directly or indirectly related to the business of the Company or the market for the Common Stock (including, without limitation, any &#8220;full ratchet&#8221; or
      &#8220;weighted average&#8221; anti-dilution provisions, but not including any standard anti-dilution protection for any reorganization, recapitalization, non-cash dividend, stock split, combination, or other similar transaction), (ii) issues or sells any equity
      or debt securities, including without limitation, shares of Common Stock or Common Stock Equivalents, either (A) at a price that is subject to being reset at some future date after the initial issuance of such debt or equity security or upon the
      occurrence of specified or contingent events directly or indirectly related to the business of the Company or the market for the Common Stock (other than standard anti&#8209;dilution protection for any reorganization, recapitalization, non-cash dividend,
      stock split, combination, or other similar transaction) or (B) that are subject to or contain any put, call, redemption, buy-back, price-reset or other similar provision or mechanism (including, without limitation, a &#8220;Black&#8209;Scholes&#8221; put or call
      right, other than in connection with a &#8220;fundamental transaction&#8221;) that provides for the issuance of additional equity securities of the Company or the payment of cash by the Company, or (iii) enters into any agreement, including, but not limited to,
      an &#8220;equity line of credit&#8221; or other continuous offering or similar offering of shares of Common Stock or Common Stock Equivalents whereby the Company may sell shares of Common Stock or Common Stock Equivalents at a future determined price; provided
      however, that an &#8220;at-the-market offering&#8221; in accordance with Rule 415(a)(4) under the Securities Act of 1933, as amended, including sales made directly on or through a national securities exchange, to or through a market maker, or in any other manner
      permitted by law that qualifies as an &#8220;at-the-market offering&#8221;, shall not be considered a Variable Rate Transaction notwithstanding the foregoing definition.</div>
    <div style="text-align: justify;">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">23</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(1, 0, 0);">(r)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>NO NON-PUBLIC INFORMATION</u>.&#160; Neither the Investor nor any of its agents or counsel shall be in possession of any information that
      constitutes or might constitute material, non-public information with respect to the Company.</div>
    <div>&#160;</div>
    <div style="text-align: center; color: #010000;">ARTICLE VIII</div>
    <div style="text-align: center;">LEGENDS</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">Section 8.1</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>NO RESTRICTIVE STOCK LEGEND</u>.&#160; No restrictive stock legend shall be placed on the share certificates representing the Put Shares.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">Section 8.2</font>&#160; &#160; &#160; &#160; <u>INVESTOR&#8217;S COMPLIANCE</u>.&#160; Nothing in this <u>Article VIII</u> shall affect in any way the Investor&#8217;s obligations hereunder to comply
      with all applicable securities laws upon the sale or transfer of the Common Stock.</div>
    <div>&#160;</div>
    <div style="text-align: center; color: #010000;">ARTICLE IX</div>
    <div style="text-align: center;">NOTICES; INDEMNIFICATION</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">Section 9.1 &#160; &#160; &#160;&#160; </font><u>NOTICES</u>.&#160; All notices, demands, requests, consents, approvals, and other communications required or permitted hereunder shall be in
      writing and, except for Put Notices which shall be delivered via e-mail in accordance with <u>Section 2.2</u> and unless otherwise specified herein, shall be (a) personally served, (b) deposited in the mail, registered or certified, return receipt
      requested, postage prepaid, (c) delivered by reputable air courier service with charges prepaid, or (d) transmitted by hand delivery, or e-mail as a PDF, addressed as set forth below or to such other address as such party shall have specified most
      recently by written notice given in accordance herewith.&#160; Any notice or other communication required or permitted to be given hereunder shall be deemed effective (i) upon hand delivery or delivery by e-mail at the address designated below (if
      delivered on a business day during normal business hours where such notice is to be received), or the first business day following such delivery (if delivered other than on a business day during normal business hours where such notice is to be
      received) or (ii) on the second business day following the date of transmittal by express courier service or on the fifth business day after deposited in the mail, in each case, fully prepaid, addressed to such address, or upon actual receipt of such
      mailing, whichever shall first occur.</div>
    <div>&#160;</div>
    <div style="text-indent: 36pt;">The addresses for such communications shall be:</div>
    <div>&#160;</div>
    <div style="text-indent: 72pt;">If to the Company:</div>
    <div>&#160;</div>
    <div style="text-align: justify; margin-left: 72pt; color: #000000;">Momentus Inc.</div>
    <div style="margin-left: 72pt; color: #000000;">3901 N. First Street</div>
    <div style="margin-left: 72pt; color: #000000;">San Jose, CA 95134</div>
    <div style="margin-left: 72pt; color: #000000;">Attn: John Rood</div>
    <div style="margin-left: 72pt; color: #000000;">Email: [***]</div>
    <div><br>
    </div>
    <div style="text-indent: 72pt;">With mandatory copies (which shall not constitute notice) to:</div>
    <div>&#160;</div>
    <div style="margin-left: 72pt;">Bradley Arant Boult Cummings LLP</div>
    <div style="margin-left: 72pt;">1221 Broadway, Suite 2400</div>
    <div style="margin-left: 72pt;">Nashville, TN 37203</div>
    <div style="margin-left: 72pt;">Attention: Stephen Hinton, Esq.</div>
    <div style="margin-left: 72pt;">E-mail: [***]</div>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">24</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="margin-left: 72pt;">If to the Investor:</div>
    <div>&#160;</div>
    <div style="margin-left: 72pt;">Yield Point NY LLC</div>
    <div style="margin-left: 72pt;">[***]</div>
    <div style="margin-left: 72pt;">Attention: Ari Kluger</div>
    <div style="margin-left: 72pt;">E-mail: [***]</div>
    <div>&#160;</div>
    <div style="margin-left: 72pt;">with a mandatory copy to (which shall not constitute notice) to:</div>
    <div>&#160;</div>
    <div style="margin-left: 72pt;">Grushko &amp; Mittman, P.C.</div>
    <div style="margin-left: 72pt;">1800 Rockaway Avenue, Suite 206</div>
    <div style="margin-left: 72pt;">Hewlett, NY 11557</div>
    <div style="margin-left: 72pt;">Attn: Eliezer Drew, Esq.</div>
    <div style="margin-left: 72pt;">E-mail: [***]</div>
    <div>&#160;</div>
    <div style="text-align: justify;">Either party hereto may from time to time change its address or e-mail for notices under this <u>Section 9.1 </u>by giving at least ten (10) days&#8217; prior written notice of such changed address to the other party
      hereto.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">Section 9.2</font>&#160;&#160;&#160;&#160;&#160; <u>INDEMNIFICATION</u>.&#160; The Company (an &#8220;<u>Indemnifying Party</u>&#8221;) agrees to indemnify and hold harmless the Investor along with its
      officers, directors, employees, and authorized agents and representatives, and each Person or entity, if any, who controls such party within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act or the rules and
      regulations thereunder (an &#8220;<u>Indemnified Party</u>&#8221;) from and against any and all Damages, joint or several, and any and all actions in respect thereof to which the Indemnified Party becomes subject to, resulting from, arising out of or relating to
      (i) any misrepresentation, breach of warranty, or nonfulfillment of or failure to perform any covenant or agreement on the part of the Indemnifying Party contained in this Agreement, (ii) any untrue statement or alleged untrue statement of a material
      fact contained in the Registration Statement, any registration statement pursuant to the Registration Rights Agreement, or any post-effective amendment thereof or supplement thereto, or the omission or alleged omission therefrom of a material fact
      required to be stated therein or necessary to make the statements therein not misleading, (iii) any untrue statement or alleged untrue statement of a material fact contained in any preliminary prospectus or contained in the final prospectus (as
      amended or supplemented, if the Company files any amendment thereof or supplement thereto with the SEC) or the omission or alleged omission to state therein any material fact necessary to make the statements made therein, in the light of the
      circumstances under which the statements therein were made, not misleading, or (iv) any violation or alleged violation by the Company of the Securities Act, the Exchange Act, any state securities law, or any rule or regulation under the Securities
      Act, the Exchange Act, or any state securities law, as such Damages are incurred, except to the extent such Damages result primarily from the Indemnified Party&#8217;s failure to perform any covenant or agreement contained in this Agreement or the
      Indemnified Party&#8217;s negligence, recklessness, fraud, willful misconduct, or bad faith in performing its obligations under this Agreement; <u>provided</u>, <u>however</u>, that the foregoing indemnity agreement shall not apply to any Damages of an
      Indemnified Party to the extent, but only to the extent, arising out of or based upon any untrue statement or alleged untrue statement or omission or alleged omission made by an Indemnifying Party in reliance upon and in conformity with written
      information furnished to the Indemnifying Party by the Indemnified Party expressly for use in the Registration Statement, any post- effective amendment thereof or supplement thereto, or any preliminary prospectus or final prospectus (as amended or
      supplemented). If, after the Indemnifying Party makes any payments to an Indemnified Party pursuant to this section, such Indemnified Party receives an award or other judgment granting such Indemnified Party repayment of any Damages or costs
      incurred, upon receipt of payment for such reward, such Indemnified Party shall repay from such amounts to the Company within five (5) Business Days of the receipt thereof, the amounts disbursed by the Indemnifying Party on behalf of such Indemnified
      Party not to exceed the lessor of (i) the amount received by such Indemnified Party, or (ii) the amounts disbursed by the Indemnifying Party on behalf of such Indemnified Party.</div>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">25</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">Section 9.3&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u></u></font><u>METHOD OF ASSERTING INDEMNIFICATION CLAIMS</u>.&#160; All claims for indemnification by any Indemnified Party under <u>Section 9.2</u>
      shall be asserted and resolved as follows:</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; In the event any claim or demand in respect of which an Indemnified Party might seek indemnity under <u>Section 9.2</u> is asserted against or sought
      to be collected from such Indemnified Party by a Person other than a party hereto or an affiliate thereof (a &#8220;<u>Third-Party Claim</u>&#8221;), the Indemnified Party shall deliver a written notification, enclosing a copy of all papers served, if any, and
      specifying the nature of and basis for such Third-Party Claim and for the Indemnified Party&#8217;s claim for indemnification that is being asserted under any provision of <u>Section 9.2</u> against an Indemnifying Party, together with the amount or, if
      not then reasonably ascertainable, the estimated amount, determined in good faith, of such Third-Party Claim (a &#8220;<u>Claim Notice</u>&#8221;) with reasonable promptness to the Indemnifying Party.&#160; If the Indemnified Party fails to provide the Claim Notice
      with reasonable promptness after the Indemnified Party receives notice of such Third-Party Claim, the Indemnifying Party shall not be obligated to indemnify the Indemnified Party with respect to such Third-Party Claim to the extent that the
      Indemnifying Party&#8217;s ability to defend has been prejudiced by such failure of the Indemnified Party.&#160; The Indemnifying Party shall notify the Indemnified Party as soon as practicable within the period ending thirty (30) calendar days following
      receipt by the Indemnifying Party of either a Claim Notice or an Indemnity Notice (as defined below) (the &#8220;<u>Dispute Period</u>&#8221;) whether the Indemnifying Party disputes its liability or the amount of its liability to the Indemnified Party under <u>Section
        9.2</u> and whether the Indemnifying Party desires, at its sole cost and expense, to defend the Indemnified Party against such Third-Party Claim.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 72pt;"><font style="color: rgb(1, 0, 0);">(i)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; If the Indemnifying Party notifies the Indemnified Party within the Dispute Period that the Indemnifying Party desires to defend the Indemnified
      Party with respect to the Third-Party Claim pursuant to this <u>Section 9.3(a)</u>, then the Indemnifying Party shall have the right to defend, with counsel reasonably satisfactory to the Indemnified Party, at the sole cost and expense of the
      Indemnifying Party, such Third-Party Claim by all appropriate proceedings, which proceedings shall be vigorously and diligently prosecuted by the Indemnifying Party to a final conclusion or will be settled at the discretion of the Indemnifying Party
      (but only with the consent of the Indemnified Party in the case of any settlement that provides for any relief other than the payment of monetary damages or that provides for the payment of monetary damages as to which the Indemnified Party shall not
      be indemnified in full pursuant to <u>Section 9.2</u>).&#160; The Indemnifying Party shall have full control of such defense and proceedings, including any compromise or settlement thereof; <u>provided</u>, <u>however</u>, that the Indemnified Party
      may, at the sole cost and expense of the Indemnified Party, at any time prior to the Indemnifying Party&#8217;s delivery of the notice referred to in the first sentence of this clause (i), file any motion, answer, or other pleadings or take any other
      action that the Indemnified Party reasonably believes to be necessary or appropriate to protect its interests; and <u>provided</u>, <u>further</u>, that if requested by the Indemnifying Party, the Indemnified Party will, at the sole cost and
      expense of the Indemnifying Party, provide reasonable cooperation to the Indemnifying Party in contesting any Third-Party Claim that the Indemnifying Party elects to contest.&#160; The Indemnified Party may participate in, but not control, any defense or
      settlement of any Third-Party Claim controlled by the Indemnifying Party pursuant to this clause (i), and, except as provided in the preceding sentence, the Indemnified Party shall bear its own costs and expenses with respect to such participation.&#160;
      Notwithstanding the foregoing, the Indemnified Party may take over the control of the defense or settlement of a Third-Party Claim at any time if it irrevocably waives its right to indemnity under <u>Section 9.2</u> with respect to such Third-Party
      Claim.</div>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">26</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 72pt;"><font style="color: rgb(1, 0, 0);">(ii)</font>&#160;&#160;&#160;&#160;&#160;&#160; If the Indemnifying Party fails to notify the Indemnified Party within the Dispute Period that the Indemnifying Party desires to defend the
      Third-Party Claim pursuant to this <u>Section 9.3(a)</u>, or if the Indemnifying Party gives such notice but fails to prosecute vigorously and diligently or settle the Third-Party Claim, or if the Indemnifying Party fails to give any notice
      whatsoever within the Dispute Period, then the Indemnified Party shall have the right to defend, at the sole cost and expense of the Indemnifying Party, the Third-Party Claim by all appropriate proceedings, which proceedings shall be prosecuted by
      the Indemnified Party in a reasonable manner and in good faith or will be settled at the discretion of the Indemnified Party (with the consent of the Indemnifying Party, which consent will not be unreasonably withheld, delayed, denied, or
      conditioned).&#160; The Indemnified Party will have full control of such defense and proceedings, including any compromise or settlement thereof; <u>provided</u>, <u>however</u>, that, if requested by the Indemnified Party, the Indemnifying Party will,
      at the sole cost and expense of the Indemnifying Party, provide reasonable cooperation to the Indemnified Party and its counsel in contesting any Third-Party Claim which the Indemnified Party is contesting.&#160; Notwithstanding the foregoing provisions
      of this clause (ii), if the Indemnifying Party has notified the Indemnified Party within the Dispute Period that the Indemnifying Party disputes its liability or the amount of its liability hereunder to the Indemnified Party with respect to such
      Third-Party Claim and if such dispute is resolved in favor of the Indemnifying Party in the manner provided in clause (iii) below, the Indemnifying Party will not be required to bear the costs and expenses of the Indemnified Party&#8217;s defense pursuant
      to this clause (ii) or of the Indemnifying Party&#8217;s participation therein at the Indemnified Party&#8217;s request, and the Indemnified Party shall reimburse the Indemnifying Party in full for all reasonable costs and expenses incurred by the Indemnifying
      Party in connection with such litigation.&#160; The Indemnifying Party may participate in, but not control, any defense or settlement controlled by the Indemnified Party pursuant to this clause (ii), and the Indemnifying Party shall bear its own costs and
      expenses with respect to such participation.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 72pt;"><font style="color: rgb(1, 0, 0);">(iii)</font>&#160;&#160; &#160; &#160; If the Indemnifying Party notifies the Indemnified Party that it does not dispute its liability or the amount of its liability to the Indemnified
      Party with respect to the Third-Party Claim under <u>Section 9.2</u> or fails to notify the Indemnified Party within the Dispute Period whether the Indemnifying Party disputes its liability or the amount of its liability to the Indemnified Party
      with respect to such Third&#8209;Party Claim, the amount of Damages specified in the Claim Notice shall be conclusively deemed a liability of the Indemnifying Party under <u>Section 9.2</u> and the Indemnifying Party shall pay the amount of such Damages
      to the Indemnified Party on demand.&#160; If the Indemnifying Party has timely disputed its liability or the amount of its liability with respect to such Third-Party Claim, the Indemnifying Party and the Indemnified Party shall proceed in good faith to
      negotiate a resolution of such dispute; <u>provided</u>, <u>however</u>, that if the dispute is not resolved within thirty (30) days after the Claim Notice, the Indemnifying Party shall be entitled to institute such legal action as it deems
      appropriate.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(1, 0, 0);">(b)</font>&#160;&#160;&#160;&#160;&#160; &#160;&#160; In the event any Indemnified Party should have a claim under <u>Section 9.2</u> against the Indemnifying Party that does not involve a
      Third-Party Claim, the Indemnified Party shall deliver a written notification of a claim for indemnity under <u>Section 9.2</u> specifying the nature of and basis for such claim, together with the amount or, if not then reasonably ascertainable, the
      estimated amount, determined in good faith, of such claim (an &#8220;<u>Indemnity Notice</u>&#8221;) with reasonable promptness to the Indemnifying Party.&#160; The failure by any Indemnified Party to give the Indemnity Notice shall not impair such party&#8217;s rights
      hereunder except to the extent that the Indemnifying Party demonstrates that it has been irreparably prejudiced thereby.&#160; If the Indemnifying Party notifies the Indemnified Party that it does not dispute the claim or the amount of the claim described
      in such Indemnity Notice or fails to notify the Indemnified Party within the Dispute Period whether the Indemnifying Party disputes the claim or the amount of the claim described in such Indemnity Notice, the amount of Damages specified in the
      Indemnity Notice will be conclusively deemed a liability of the Indemnifying Party under <u>Section 9.2</u> and the Indemnifying Party shall pay the amount of such Damages to the Indemnified Party on demand.&#160; If the Indemnifying Party has timely
      disputed its liability or the amount of its liability with respect to such claim, the Indemnifying Party and the Indemnified Party shall proceed in good faith to negotiate a resolution of such dispute; <u>provided</u>, <u>however</u>, that, if the
      dispute is not resolved within thirty (30) days after the Claim Notice, the Indemnifying Party shall be entitled to institute such legal action as it deems appropriate.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(1, 0, 0);">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; The Indemnifying Party agrees to pay the Indemnified Party, promptly as such expenses are incurred and are due and payable, for any reasonable
      legal fees or other reasonable expenses incurred by them in connection with investigating or defending any such Claim.</div>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">27</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(1, 0, 0);">(d)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; The indemnity provisions contained herein shall be in addition to (i) any cause of action or similar rights of the Indemnified Party against the
      Indemnifying Party or others and (ii) any liabilities the Indemnifying Party may be subject to.</div>
    <div>&#160;</div>
    <div style="text-align: center; color: #010000;">ARTICLE X</div>
    <div style="text-align: center;">MISCELLANEOUS</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">Section 10.1</font>&#160;&#160;&#160;&#160; <u>GOVERNING LAW</u>.&#160; This Agreement shall be governed by and interpreted in accordance with the laws of the State of New York without regard
      to the principles of conflicts of law (whether of the State of New York or any other jurisdiction).</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">Section 10.2</font>&#160;&#160;&#160;&#160;&#160;&#160; <u>ARBITRATION</u>.&#160; Any disputes, claims, or controversies arising out of or relating to the Transaction Documents, or the transactions,
      contemplated thereby, or the breach, termination, enforcement, interpretation or validity thereof, including the determination of the scope or applicability of this Agreement to arbitrate, shall be referred to and resolved solely and exclusively by
      binding arbitration to be conducted before the <u>JAMS</u>, or its successor pursuant the expedited procedures set forth in the JAMS Comprehensive Arbitration Rules and Procedures (the &#8220;<u>Rules</u>&#8221;), including Rules 16.1 and 16.2 of those Rules.&#160;
      The arbitration shall be held in New York, New York, before a tribunal consisting of three (3) arbitrators each of whom will be selected in accordance with the &#8220;strike and rank&#8221; methodology set forth in Rule 15.&#160; Either party to this Agreement may,
      without waiving any remedy under this Agreement, seek from any federal or state court sitting in the Southern District of New York any interim or provisional relief that is necessary to protect the rights or property of that party, pending the
      establishment of the arbitral tribunal.&#160; The costs and expenses of such arbitration shall be paid by and be the sole responsibility of the Company, including, but not limited to, the Investor&#8217;s attorneys&#8217; fees and each arbitrator&#8217;s fees.&#160; The
      arbitrators&#8217; decision must set forth a reasoned basis for any award of damages or finding of liability.&#160; The arbitrators&#8217; decision and award will be made and delivered as soon as reasonably possibly and in any case within sixty (60) days&#8217; following
      the conclusion of the arbitration hearing and shall be final and binding on the parties and may be entered by any court having jurisdiction thereof.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">Section 10.3</font>&#160;&#160;&#160;&#160;&#160;&#160; <u>JURY TRIAL WAIVER</u>.&#160; TO THE MAXIMUM PERMITTED BY LAW, THE COMPANY AND THE INVESTOR HEREBY WAIVE A TRIAL BY JURY IN ANY ACTION,
      PROCEEDING OR COUNTERCLAIM BROUGHT BY EITHER OF THE PARTIES HERETO AGAINST THE OTHER IN RESPECT OF ANY MATTER ARISING OUT OF OR IN CONNECTION WITH THE TRANSACTION DOCUMENTS.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">Section 10.4</font>&#160;&#160;&#160;&#160;&#160;&#160; <u>ASSIGNMENT</u>.&#160; This Agreement shall be binding upon and inure to the benefit of the Company and the Investor and their respective
      successors.&#160; Neither this Agreement nor any rights of the Company hereunder may be assigned without the consent of the Investor.&#160; Investor may assign or Novate this Agreement and its right and obligations hereunder with the consent of the Company,
      which shall not be unreasonably withheld.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">Section 10.5</font>&#160;&#160;&#160;&#160;&#160;&#160; <u>NO THIRD-PARTY BENEFICIARIES</u>.&#160; This Agreement is intended for the benefit of the Company and the Investor and their respective
      successors, and is not for the benefit of, nor may any provision hereof be enforced by, any other Person, except as set forth in <u>Article IX</u>.</div>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">28</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">Section 10.6</font>&#160;&#160;&#160;&#160;&#160; <u>TERMINATION</u>.&#160; At any time after the effectiveness of the Registration Statement, the Company shall have the option to terminate this
      Agreement for any reason or for no reason by delivering written notice (a &#8220;<u>Company Termination Notice</u>&#8221;) to the Investor electing to terminate this Agreement without any liability whatsoever of any party to any other party under this Agreement
      (except as set forth below).&#160; The Company Termination Notice shall not be effective until one business day after it has been received by the Investor, provided that this Agreement cannot be terminated (i) within thirty (30) days of the delivery by
      the Company of a Put Notice to the Investor and (ii) prior to the expiration of the Registration Period (as defined in the Registration Rights Agreement).&#160; In addition, this Agreement shall automatically terminate on the earlier of (i) the end of the
      Commitment Period; (ii) the date that the Company sells and the Investor purchases the Maximum Commitment Amount; or (iii) the date that, pursuant to or within the meaning of any Bankruptcy Law, the Company commences a voluntary case or any Person
      commences a proceeding against the Company, a Custodian is appointed for the Company or for all or substantially all of its property, or the Company makes a general assignment for the benefit of its creditors.&#160; Notwithstanding the foregoing, in the
      event of termination of this Agreement, the provisions of <u>Articles III, IV, V, VI, IX</u> and <u>X</u> shall survive the termination of this Agreement for the maximum length of time allowed under applicable law.&#160; If the Company does not send the
      first Put Notice on or before December 1, 2025, the Investor may terminate this Agreement at any time.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">Section 10.7</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="color: #010000;"><u>[RESERVED]</u></font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">Section 10.8</font>&#160;&#160;&#160;&#160;&#160; <u>ENTIRE AGREEMENT</u>.&#160; The Transaction Documents, together with the exhibits and schedules thereto, contain the entire understanding of the
      Company and the Investor with respect to the matters covered herein and therein and supersede all prior agreements and understandings, oral or written, with respect to such matters, which the parties acknowledge have been merged into such documents,
      exhibits and schedules.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">Section 10.9</font>&#160;&#160;&#160;&#160;&#160; <u>FEES AND EXPENSES</u>.&#160; Except as expressly set forth in the Transaction Documents or any other writing to the contrary, each party shall
      pay the fees and expenses of its advisers, counsel, accountants, and other experts, if any, and all other expenses incurred by such party incident to the negotiation, preparation, execution, delivery, and performance of this Agreement.&#160; The Company
      shall pay all Transfer Agent fees, stamp taxes and other taxes and duties levied in connection with the delivery of any Securities to the Investor.&#160; The Company shall pay $40,000 to the Investor on the first Put Date for reimbursement of the
      Investor&#8217;s transaction fees relating to the preparation of the Transaction Documents.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">Section 10.10</font>&#160;&#160;&#160; <u>COUNTERPARTS</u>.&#160; This Agreement may be executed in multiple counterparts, each of which may be executed by less than all of the parties and
      shall be deemed to be an original instrument which shall be enforceable against the parties actually executing such counterparts and all of which together shall constitute one and the same instrument.&#160; This Agreement may be delivered to the other
      parties hereto by e-mail of a copy of this Agreement bearing the signature of the parties so delivering this Agreement.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">Section 10.11</font>&#160;&#160;&#160;&#160; <u>SEVERABILITY</u>.&#160; In the event that any provision of this Agreement becomes or is declared by a court of competent jurisdiction to be
      illegal, unenforceable, or void, this Agreement shall continue in full force and effect without said provision; provided that such severability shall be ineffective if it materially changes the economic benefit of this Agreement to any party.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">Section 10.12</font>&#160;&#160;&#160;&#160; <u>FURTHER ASSURANCES</u>.&#160; Each party shall do and perform, or cause to be done and performed, all such further acts and things, and shall
      execute and deliver all such other agreements, certificates, instruments, and documents, as the other party may reasonably request in order to carry out the intent and accomplish the purposes of this Agreement and the consummation of the transactions
      contemplated hereby.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">Section 10.13</font>&#160;&#160;&#160;&#160; <u>NO STRICT CONSTRUCTION</u>.&#160; The language used in this Agreement will be deemed to be the language chosen by the parties to express their
      mutual intent, and no rules of strict construction will be applied against any party.</div>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">29</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">Section 10.14</font>&#160;&#160;&#160;&#160;&#160; <u>EQUITABLE RELIEF</u>.&#160; Each party acknowledges that a breach by it of its obligations hereunder will cause irreparable harm to the other by
      vitiating the intent and purpose of the transactions contemplated hereby.&#160; Accordingly, each party acknowledges that the remedy at law for a breach of its obligations under this Agreement will be inadequate and agrees, in the event of a breach or
      threatened breach by the such party of the provisions of this Agreement, that the other party shall be entitled, in addition to all other available remedies at law or in equity, and in addition to the penalties assessable herein, to an injunction or
      injunctions restraining, preventing or curing any breach of this Agreement and to enforce specifically the terms and provisions hereof, without the necessity of showing economic loss and without any bond or other security being required.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">Section 10.15</font>&#160;&#160; <u>TITLES AND SUBTITLES</u>.&#160; The titles and subtitles used in this Agreement are used for the convenience of reference and are not to be
      considered in construing or interpreting this Agreement.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">Section 10.16</font>&#160;&#160;&#160;&#160; <u>AMENDMENTS; WAIVERS</u>.&#160; No provision of this Agreement may be amended or waived by the parties from and after the date that is one (1)
      Trading Day immediately preceding the initial filing of the Registration Statement with the SEC.&#160; Subject to the immediately preceding sentence, (i) no provision of this Agreement may be amended other than by a written instrument signed by both
      parties hereto and (ii) no provision of this Agreement may be waived other than in a written instrument signed by the party against whom enforcement of such waiver is sought.&#160; No failure or delay in the exercise of any power, right or privilege
      hereunder shall operate as a waiver thereof, nor shall any single or partial exercise of any such power, right or privilege preclude other or further exercise thereof or of any other right, power, or privilege</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">Section 10.17</font>&#160;&#160;&#160;&#160;&#160;<u></u><u>PUBLICITY</u>.&#160; The Company and the Investor shall reasonably consult with each other in issuing any press releases or otherwise
      making public statements with respect to the transactions contemplated hereby and no party shall issue any such press release or otherwise make any such public statement referencing the transaction, other than as required by law, without the prior
      written consent of the other parties, which consent shall not be unreasonably withheld, delayed, denied, or conditioned, except that no prior written consent shall be required if such disclosure is required by law, in which such case the disclosing
      party shall provide the other party with prior notice of such public statement.&#160; Notwithstanding the foregoing, the Company shall not publicly disclose the name of the Investor without the prior written consent of the Investor, except to the extent
      required by law or if requested by an applicable regulator.&#160; The Investor acknowledges that this Agreement and all or part of the Transaction Documents may be deemed to be &#8220;material contracts,&#8221; as that term is defined by Item 601(b)(10) of Regulation
      S-K, and that the Company may, therefore, be required to file such documents as exhibits to reports or registration statements filed under the Securities Act or the Exchange Act.&#160; The Investor further agrees that the status of such documents and
      materials as material contracts shall be determined solely by the Company, in consultation with its counsel.</div>
    <div>&#160;</div>
    <div style="text-align: center;">** Signature Page Follows **</div>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">30</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-indent: 36pt;">IN WITNESS WHEREOF, the parties have caused this Agreement to be duly executed by their respective officers thereunto duly authorized as of the Execution Date.</div>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);" id="z52ac4249625445aeaf7590e7bc8e3f17">

        <tr>
          <td colspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
          <td colspan="3" style="vertical-align: top;">
            <div>MOMENTUS, INC.</div>
          </td>
        </tr>
        <tr>
          <td colspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
          <td colspan="3" style="vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td colspan="1" style="width: 50%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
          <td style="width: 3%; vertical-align: top; padding-bottom: 2px;">
            <div>By:<br>
            </div>
          </td>
          <td style="width: 32%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">/s/ John C. Rood</td>
          <td style="width: 15%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
        </tr>
        <tr>
          <td colspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
          <td colspan="3" style="vertical-align: top;">
            <div>Name: John C. Rood</div>
          </td>
        </tr>
        <tr>
          <td colspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
          <td colspan="3" style="vertical-align: top;">
            <div>Title:&#160;&#160; Chief Executive Officer</div>
          </td>
        </tr>
        <tr>
          <td colspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
          <td colspan="3" style="vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td colspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
          <td colspan="3" style="vertical-align: top;">
            <div>YIELD POINT NY LLC</div>
          </td>
        </tr>
        <tr>
          <td colspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
          <td colspan="3" style="vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td colspan="1" style="width: 50%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
          <td style="width: 3%; vertical-align: top; padding-bottom: 2px;">
            <div>By:<br>
            </div>
          </td>
          <td style="width: 32%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">/s/ Ari Kluger</td>
          <td style="width: 15%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
        </tr>
        <tr>
          <td colspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
          <td colspan="3" style="vertical-align: top;">
            <div>Name: Ari Kluger</div>
          </td>
        </tr>
        <tr>
          <td colspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
          <td colspan="3" style="vertical-align: top;">
            <div>Title:&#160;&#160; Manager</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="text-align: center;">** Signature Page to Equity Purchase Agreement **</div>
    <div style="text-align: center;"> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: center;">EXHIBIT A</div>
    <div style="text-align: center;">FORM OF PUT NOTICE</div>
    <div>&#160;</div>
    <div>TO: [*]</div>
    <div>&#160;</div>
    <div>DATE:</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">We refer to the Equity Purchase Agreement, dated September 25, 2025 (the &#8220;<u>Agreement</u>&#8221;), entered into by and between Momentus, Inc. and you.&#160; Capitalized terms defined in the Agreement shall,
      unless otherwise defined herein, have the same meaning when used herein.</div>
    <div>&#160;</div>
    <div style="text-indent: 36pt;">We hereby:</div>
    <div>&#160;</div>
    <div style="text-indent: 36pt;">1)&#160;&#160;&#160; Notify you that the Maximum Put Amount as of the delivery of this Put Notice is _________</div>
    <div>&#160;</div>
    <div style="text-indent: 36pt;">2)&#160;&#160;&#160; Give you notice that:</div>
    <div>&#160;</div>
    <div style="text-indent: 54pt;">(a)&#160;&#160; [__] we require you to purchase Put Shares in an amount equal to ____________________, which is not in excess of the Maximum Put Amount;</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 54pt;">(b)&#160; [__] we request that you purchase an amount of Put Shares equal to ___________________ (the &#8220;<u>Excess Purchase Amount</u>&#8221;) which is in excess of the Maximum Put Amount but less than or equal
      to 10x the Maximum Put Amount.&#160; If we have requested that you purchase in excess of the Maximum Put Amount, prior to the opening of trading on the Trading Day immediately following the delivery of this Put Notice, please confirm if you will purchase
      the Maximum Put Amount, the Excess Purchase Amount, or some amount of Put Shares between the Maximum Put Amount and the Excess Purchase Amount and, if so, what amount; or</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 54pt;">(c)&#160; [__] this is a request by the Company in accordance with <u>Section 2.4</u> of the Agreement to increase the amount of Put Shares subject to the Put Notice dated, ____________________________,
      2025, for _________________ Put Shares, by _________________ additional Put Shares.&#160; In the event of any such increase, following the date of the Valuation Period relating to this Put Notice, the Company will reflect the amount of Put Shares as so
      increased in the space provided below and resubmit this Put Notice to you for your records.</div>
    <div>&#160;</div>
    <div style="text-indent: 36pt;">3)&#160;&#160;&#160; Certify that, as of the date hereof, the conditions set forth in <u>Section 7.2</u> of the Agreement are satisfied.</div>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);" id="z4283ba9a00c148f4b6100904ef04d386">

        <tr>
          <td colspan="1" style="width: 30%; vertical-align: top;">&#160;</td>
          <td colspan="3" style="vertical-align: top;">
            <div>Momentus, Inc.</div>
          </td>
        </tr>
        <tr>
          <td colspan="1" style="width: 30%; vertical-align: top;">&#160;</td>
          <td colspan="3" style="vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td colspan="1" style="width: 30%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
          <td style="width: 3%; vertical-align: top; padding-bottom: 2px;">
            <div>By:</div>
          </td>
          <td style="width: 27%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td style="width: 40%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
        </tr>
        <tr>
          <td colspan="1" style="width: 30%; vertical-align: top;">&#160;</td>
          <td colspan="3" style="vertical-align: top;">
            <div>Name:</div>
          </td>
        </tr>
        <tr>
          <td colspan="1" style="width: 30%; vertical-align: top;">&#160;</td>
          <td colspan="3" style="vertical-align: top;">
            <div>Title:</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: center;">EXHIBIT B</div>
    <div style="text-align: center;">FORM OF OFFICER&#8217;S CERTIFICATE</div>
    <div style="text-align: center;">OF</div>
    <div style="text-align: center;">MOMENTUS, INC.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">Pursuant to <u>Section 7.2(j)</u> of that certain Equity Purchase Agreement, dated September 25, 2025 (the &#8220;<u>Agreement</u>&#8221;), by and between Momentus, Inc. (the &#8220;<u>Company</u>&#8221;) and Yield Point
      NY LLC (the &#8220;<u>Investor</u>&#8221;), the undersigned, in his capacity as Chief Financial Officer of the Company, and not in his individual capacity, hereby certifies, as of the date hereof (such date, the &#8220;<u>Condition Satisfaction Date</u>&#8221;), the
      following:</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">1.&#160;&#160; The representations and warranties of the Company contained in the Agreement are true and correct in all material respects as of the Condition Satisfaction Date as though made on the Condition
      Satisfaction Date (except for representations and warranties specifically made as of a particular date) with respect to all periods, and as to all events and circumstances occurring or existing to and including the Condition Satisfaction Date, except
      for any conditions which have temporarily caused any representations or warranties of the Company set forth in the Agreement to be incorrect and which have been corrected with no continuing impairment to the Company or the Investor; and</div>
    <div>&#160;</div>
    <div style="text-indent: 36pt;">2.&#160;&#160;&#160; All of the conditions precedent to the obligation of the Investor to purchase Put Shares set forth in the Agreement, including but not limited to Section 7.2 of the Agreement, have been satisfied as of the
      Condition Satisfaction Date.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">Capitalized terms used herein shall have the meanings set forth in the Agreement unless otherwise defined herein.</div>
    <div>&#160;</div>
    <div style="text-indent: 36pt;">IN WITNESS WHEREOF, the undersigned has hereunto affixed his hand as of ________, 2025.</div>
    <div>&#160;</div>
    <div style="margin-left: 36pt;">
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);" id="z6c477a24881449a1b183bc295c0b7ad5">

          <tr>
            <td style="width: 3%; vertical-align: top; padding-bottom: 2px;">
              <div>By:</div>
            </td>
            <td style="width: 40%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 57%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="3" style="vertical-align: top;">
              <div>Name:</div>
            </td>
          </tr>
          <tr>
            <td rowspan="1" colspan="3" style="vertical-align: top;">
              <div>Title:</div>
            </td>
          </tr>

      </table>
    </div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: center;">EXHIBIT C</div>
    <div style="text-align: center;">FORM OF TRANSFER AGENT INSTRUCTION LETTER</div>
    <div style="text-align: center;"> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: center;">EXHIBIT D</div>
    <div style="text-align: center;">FORM OF REGISTRATION RIGHTS AGREEMENT</div>
    <div style="text-align: center;"> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: center;"><u>DISCLOSURE SCHEDULES</u></div>
    <div style="text-align: center;"><u> <br>
      </u></div>
    <div style="text-align: center;"><u> <br>
      </u></div>
    <div style="text-align: center;">
      <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; margin-left: auto; margin-right: auto; border: none;"><u> </u></div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.5
<SEQUENCE>10
<FILENAME>ny20047547x33_ex10-5.htm
<DESCRIPTION>EXHIBIT 10.5
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc.
         Document created using Broadridge PROfile 25.9.1.5330
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">




  <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
  <div>
    <div style="text-align: right; font-weight: bold;">Exhibit 10.5</div>
    <div>&#160;</div>
    <div style="text-align: center;">REGISTRATION RIGHTS AGREEMENT</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">REGISTRATION RIGHTS AGREEMENT (this &#8220;<u>Agreement</u>&#8221;), dated as of September 25, 2025 (the &#8220;<u>Execution Date</u>&#8221;), is entered into by and between Momentus<font style="color: rgb(0, 0, 0);">, Inc.</font>,
      a corporation incorporated in the State of Delaware (the &#8220;<u>Company</u>&#8221;), and Yield Point NY LLC, a New York limited liability company (together with its permitted assigns, the &#8220;<u>Investor</u>&#8221;).&#160; Capitalized terms used herein and not otherwise
      defined herein shall have the respective meanings set forth in that certain Equity Purchase Agreement by and between the parties hereto, dated as of the Execution Date (as amended, restated, supplemented, or otherwise modified from time to time, the
      &#8220;<u>Purchase Agreement</u>&#8221;).</div>
    <div>&#160;</div>
    <div style="text-align: center;">WHEREAS:</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">The Company has agreed, upon the terms and subject to the conditions of the Purchase Agreement, to sell to the Investor up to Fifty Million Dollars ($50,000,000.00) of Put Shares and, to induce the
      Investor to enter into the Purchase Agreement, the Company has agreed to provide certain registration rights under the Securities Act of 1933, as amended, and the rules and regulations thereunder, or any similar successor statute (collectively, the &#8220;<u>Securities
        Act</u>&#8221;), and applicable state securities laws.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">NOW, THEREFORE, in consideration of the promises and the mutual covenants contained herein and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the
      Company and the Investor hereby agree as follows:</div>
    <div>&#160;</div>
    <div><font style="color: rgb(1, 0, 0);">1.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160; <u>DEFINITIONS</u>.</div>
    <div>&#160;</div>
    <div style="margin-left: 36pt;">As used in this Agreement, the following terms shall have the following meanings:</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 72pt;"><font style="color: rgb(1, 0, 0);">a.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160; &#8220;<u>Investor</u>&#8221; means the Investor, any transferee or assignee thereof to whom the Investor assigns its rights under this Agreement in
      accordance with <u>Section 9</u> and who agrees to become bound by the provisions of this Agreement, and any transferee or assignee thereof to whom a transferee or assignee assigns its rights under this Agreement in accordance with <u>Section 9</u>
      and who agrees to become bound by the provisions of this Agreement.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 72pt;"><font style="color: rgb(1, 0, 0);">b.</font>&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#8220;<u>Person</u>&#8221; means any individual or entity, including, but not limited to, any corporation, limited liability company, association,
      partnership, organization, business, individual, governmental or political subdivision thereof, or governmental agency.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 72pt;"><font style="color: rgb(1, 0, 0);">c.</font>&#160;&#160; &#160;&#160; &#160; &#160; &#8220;<u>Register</u>,&#8221; &#8220;<u>Registered</u>,&#8221; and &#8220;<u>Registration</u>&#8221; refer to a registration effected by preparing and filing one or more
      registration statements of the Company in compliance with the Securities Act and/or pursuant to Rule 415 under the Securities Act or any successor rule providing for the offering of securities on a continuous basis (&#8220;<u>Rule 415</u>&#8221;), and the
      declaration or ordering of effectiveness of such registration statement(s) by the United States Securities and Exchange Commission (the &#8220;<u>SEC</u>&#8221;).</div>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <!--PROfilePageNumberReset%Num%2%%%-->
    <div style="text-align: justify; text-indent: 72pt;"><font style="color: rgb(1, 0, 0);">d.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8220;<u>Registrable Securities</u>&#8221; means all of the (i) Commitment Shares, (ii) Put Shares which have been, or which may, from time to time be
      issued, including without limitation all of the shares of Common Stock which have been issued or will be issued to the Investor under the Purchase Agreement (without regard to any limitation or restriction on purchases) and (iii) any and all shares
      of capital stock issued or issuable with respect to the Put Shares, Commitment Shares, and the Purchase Agreement as a result of any stock split, combination, stock dividend, recapitalization, exchange, or similar event or otherwise, without regard
      to any limitation on purchases under the Purchase Agreement.</div>
    <div style="text-align: justify;">&#160;</div>
    <div style="text-align: justify; text-indent: 72pt;"><font style="color: rgb(1, 0, 0);">e.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#8220;<u>Registration Statement</u>&#8221; means one or more registration statements of the Company on Form S-1 covering the resale of the Registrable
      Securities including the Initial Registration Statement and any New Registration Statement or Other Registration Statement (each as defined herein).</div>
    <div style="text-align: justify;">&#160;</div>
    <div style="text-align: justify;"><font style="color: rgb(1, 0, 0);">2.</font>&#160;&#160;&#160; &#160; &#160;&#160;&#160;&#160; <u>REGISTRATION</u>.</div>
    <div style="text-align: justify;">&#160;</div>
    <div style="text-align: justify; text-indent: 72pt;"><font style="color: rgb(1, 0, 0);">a.</font>&#160;&#160;&#160; &#160; &#160;&#160; <u>Mandatory Registration</u>.&#160; The Company shall, by the date that is thirty (30) calendar days following the Execution Date, file with the SEC
      an initial Registration Statement on Form S-1 covering the maximum number of Registrable Securities as shall be permitted to be included thereon in accordance with applicable SEC rules, regulations, and interpretations so as to permit the resale of
      such Registrable Securities by the Investor, including, but not limited to, under Rule 415 at then-prevailing market prices (and not fixed prices) (the &#8220;<u>Initial Registration Statement</u>&#8221;).&#160; The Initial Registration Statement shall register only
      Registrable Securities.&#160; The Company shall use its commercial best efforts to have the Initial Registration Statement and any amendment thereto declared effective by the SEC at the earliest possible date, but in no event later than sixty (60) days
      following the Execution Date.</div>
    <div style="text-align: justify;">&#160;</div>
    <div style="text-align: justify; text-indent: 72pt;"><font style="color: rgb(1, 0, 0);">b.</font>&#160;&#160;&#160;&#160;&#160; &#160;&#160; &#160; <u>Rule 424 Prospectus</u>.&#160; In addition to the Initial Registration Statement, the Company shall, as required by applicable securities
      regulations, from time to time file with the SEC, pursuant to Rule 424 promulgated under the Securities Act, such prospectuses and prospectus supplements, if any, to be used in connection with sales of the Registrable Securities under each
      Registration Statement.&#160; The Investor and its counsel shall have a reasonable opportunity to review and comment upon such prospectuses prior to its filing with the SEC, and the Company shall give due consideration to all such comments.&#160; The Investor
      shall use its reasonable best efforts to comment upon any prospectus within two (2) business days from the date the Investor receives the final pre-filing version of such prospectus.</div>
    <div style="text-align: justify;">&#160;</div>
    <div style="text-align: justify; text-indent: 72pt;"><font style="color: rgb(1, 0, 0);">c.</font>&#160;&#160; &#160; &#160;&#160; &#160;&#160; <u>Sufficient Number of Shares Registered</u>.&#160; In the event the number of shares available under the Initial Registration Statement is
      insufficient to cover all of the Registrable Securities, the Company shall amend the Initial Registration Statement or file a new Registration Statement (a &#8220;<u>New Registration Statement</u>&#8221;) so as to cover all of such Registrable Securities
      (subject to the limitations set forth in <u>Section 2(e)</u>) as soon as practicable, but in any event not later than thirty (30) business days after the necessity therefor arises, subject to any limits that may be imposed by the SEC pursuant to
      Rule 415.&#160; The Company shall use its commercial best efforts to cause such amendment and/or New Registration Statement to become effective as soon as practicable following the filing thereof.&#160; In the event that any of the Registrable Securities are
      not included in the Initial Registration Statement, or have not been included in any New Registration Statement, and the Company files any other registration statement under the Securities Act (other than on Form S-4, Form S-8, or with respect to
      other employee related plans or rights offerings), then the Company shall use its commercial best efforts to also include in such other registration statement such Registrable Securities that have not been previously Registered (such other
      registration statement that Registers Registrable Securities, an &#8220;<u>Other Registration Statement</u>&#8221;).</div>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">2</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 72pt;"><font style="color: rgb(1, 0, 0);">d.</font>&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; <u>Effectiveness</u>.&#160; The Investor and its counsel shall have a reasonable opportunity to review and comment upon any Registration Statement
      and any amendment or supplement to such Registration Statement and any related prospectus prior to its filing with the SEC, and the Company shall give due consideration to all reasonable comments.&#160; The Investor shall furnish all information
      reasonably requested by the Company for inclusion therein.&#160; The Company shall use its commercial best efforts to keep all Registration Statements effective, including, but not limited to, pursuant to Rule 415 and available for the resale by the
      Investor of all of the Registrable Securities covered thereby at all times until the earlier of:</div>
    <div style="text-align: justify;">&#160;</div>
    <div style="text-align: justify; text-indent: 108pt;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; the date as of which the Investor may sell all of the Registrable Securities without any restrictions (including any restrictions under Rule 144(c) or Rule 144(i)); and</div>
    <div style="text-align: justify;">&#160;</div>
    <div style="text-align: justify; text-indent: 108pt;">(ii)&#160;&#160;&#160; &#160; &#160; the date on which the Investor shall have sold all the Registrable Securities covered thereby and no Put Shares remain issuable under the Purchase Agreement (the &#8220;<u>Registration Period</u>&#8221;).</div>
    <div style="text-align: justify;">&#160;</div>
    <div style="text-align: justify;">In the event that any Registration Statement filed hereunder is no longer effective and Rule 144 is available for sales of the Registrable Securities, the Company shall provide an opinion upon request of the Investor
      that the Investor may sell any such Registrable Securities held by the Investor pursuant to Rule 144 with all costs related to such opinion to be borne by the Company.&#160; Each Registration Statement (including any amendments or supplements thereto and
      prospectuses contained therein) shall not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein, or necessary to make the statements therein, in light of the circumstances in which they were
      made, not misleading.</div>
    <div style="text-align: justify;">&#160;</div>
    <div style="text-align: justify; text-indent: 72pt;"><font style="color: rgb(1, 0, 0);">e.</font>&#160;&#160;&#160;&#160; &#160;&#160;&#160; <u>Offering</u>.&#160; If the staff of the SEC (the &#8220;<u>Staff</u>&#8221;) or the SEC seeks to characterize any offering pursuant to a Registration Statement
      filed pursuant to this Agreement as constituting an offering of securities that does not permit such Registration Statement to become or remain effective and be used for resales by the Investor under Rule 415 at then-prevailing market prices (and not
      fixed prices) by comment letter or otherwise or, if after the filing of the Initial Registration Statement with the SEC pursuant to <u>Section 2(a)</u>, the Company is otherwise required by the Staff or the SEC to reduce the number of Registrable
      Securities included in such initial Registration Statement, then the Company shall reduce the number of Registrable Securities to be included in such Initial Registration Statement (with the prior consent, which shall not be unreasonably withheld,
      delayed, or denied of the Investor and its legal counsel as to the specific Registrable Securities to be removed therefrom) until such time as the Staff and the SEC shall so permit such Registration Statement to become effective and be used as
      aforesaid.&#160; In the event of any reduction in Registrable Securities pursuant to this paragraph, the Company shall file one or more New Registration Statements in accordance with <u>Section 2(c)</u> until such time as all Registrable Securities have
      been included in Registration Statements that have been declared effective and the prospectuses contained therein are available for use by the Investor.&#160; Notwithstanding any provision herein or in the Purchase Agreement to the contrary, the Company&#8217;s
      obligations to register Registrable Securities (and any related conditions to the Investor&#8217;s obligations) shall be qualified as necessary to comport with any requirement of the SEC or the Staff as addressed in this <u>Section 2(e)</u>.</div>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">3</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 72pt;"><font style="color: rgb(1, 0, 0);">f.</font>&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; <u>Liquidated Damages</u>.&#160; <font style="color: rgb(0, 0, 0);">If: (i) the Initial Registration Statement is not filed in accordance with
        Section 2(a) above (if the Company files the Initial Registration Statement without affording the Investor the opportunity to review (and, with respect to disclosure on the Investor, to comment) on the same as required by Section 3(b) herein, the
        Company shall be deemed to have not satisfied this clause (i)), or (ii) the Company fails to file with the SEC a request for acceleration of a Registration Statement in accordance with Rule 461 promulgated by the SEC pursuant to the Securities Act,
        within five (5) Trading Days of the date that the Company is notified (orally or in writing, whichever is earlier) by the SEC that such Registration Statement will not be &#8220;reviewed&#8221; or will not be subject to further review, or (iii) a Registration
        Statement registering for resale all of the Registrable Securities is not declared effective by the SEC in accordance with Section 2(a) above, or (iv) after the effective date of a Registration Statement, such Registration Statement ceases for any
        reason to remain continuously effective as to all Registrable Securities included in such Registration Statement, or the Investor is otherwise not permitted to utilize the prospectus therein to resell such Registrable Securities, for more than
        thirty (30) consecutive calendar days or more than an aggregate of forty five (45) calendar days (which need not be consecutive calendar days) during any 12-month period (any such failure or breach being referred to as an &#8220;<u>Event</u>&#8221;, and for
        purposes of clauses (i) and (iii), the date on which such Event occurs, and for purpose of clause (ii) the date on which such five (5) Trading Day period is exceeded, and for purpose of clause (iv) the date on which such thirty (30) or forty five
        (45) calendar day period, as applicable, is exceeded being referred to as &#8220;<u>Event Date</u>&#8221;), then, in addition to any other rights the Investor&#160; may have hereunder or under applicable law, on each such Event Date and on each monthly anniversary
        of each such Event Date (if the applicable Event shall not have been cured by such date) until the applicable Event is cured or, if earlier, the Company shall pay to the Investor an amount in cash, as partial liquidated damages and not as a
        penalty, equal to the product of 0.0025 multiplied by the Maximum Commitment Amount; <u>provided</u>, <u>however</u>, that the Company shall not be required to make any payments with respect to Registrable Securities which may be freely tradable
        pursuant to Rule 144 or any other exemption from registration under the Securities Act. The parties agree that the maximum aggregate liquidated damages payable to the Investor under this Agreement shall be 10% of the Maximum Commitment Amount. If
        the Company fails to pay any partial liquidated damages pursuant to this Section in full within seven days after the date payable, the Company will pay interest thereon at a rate of 12% per annum (or such lesser maximum amount that is permitted to
        be paid by applicable law) to the Investor, accruing daily from the date such partial liquidated damages are due until such amounts, plus all such interest thereon, are paid in full. The partial liquidated damages pursuant to the terms hereof shall
        apply on a daily pro rata basis for any portion of a month prior to the cure of an Event.</font></div>
    <div style="text-align: justify;">&#160;</div>
    <div style="text-align: justify;"><font style="color: rgb(1, 0, 0);">3.</font>&#160;&#160;&#160;&#160;&#160; &#160; &#160;&#160; <u>RELATED OBLIGATIONS</u>.</div>
    <div style="text-align: justify;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">With respect to a Registration Statement and whenever any Registrable Securities are to be Registered pursuant to <u>Section 2</u>, including on any Other Registration Statement, the Company shall
      use its commercial best efforts to effect the registration of the Registrable Securities in accordance with the intended method of disposition thereof and, pursuant thereto, the Company shall have the following obligations:</div>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">4</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 72pt;"><font style="color: rgb(1, 0, 0);">a.</font>&#160;&#160;&#160;&#160; &#160; &#160;&#160;&#160; The Company shall prepare and file with the SEC such amendments (including post-effective amendments on Form S-1) and supplements to any
      Registration Statement and any Other Registration Statement and the prospectus used in connection with such Registration Statement and Other Registration Statement, which prospectus is to be filed pursuant to Rule 424 promulgated under the Securities
      Act, as may be necessary to keep the Registration Statement effective at all times during the Registration Period, and, during such period, comply with the provisions of the Securities Act with respect to the disposition of all Registrable Securities
      of the Company covered by the Registration Statement or applicable Other Registration Statement until such time as all of such Registrable Securities shall have been disposed of in accordance with the intended methods of disposition by the seller or
      sellers thereof as set forth in such registration statement.</div>
    <div style="text-align: justify;">&#160;</div>
    <div style="text-align: justify; text-indent: 72pt;"><font style="color: rgb(1, 0, 0);">b.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Company shall permit the Investor to review and comment upon each Registration Statement or any Other Registration Statement and all
      amendments and supplements thereto at least two (2) business days prior to their filing with the SEC, and not file any document in a form to which Investor reasonably objects; <u>provided</u>, <u>however</u>, that any delay in the Investor or its
      counsel review of the Registration Statement beyond the two (2) business day period shall extend the deadlines set forth in Section 2(a) of this Agreement by such delay period.&#160; The Investor shall use its reasonable best efforts to comment upon the
      Registration Statement or any Other Registration Statement and any amendments or supplements thereto within two (2) business days from the date the Investor receives the final version thereof.&#160; The Company shall furnish to the Investor, without
      charge, and within one (1) business day, any comments and/or any other correspondence from the SEC or the Staff to the Company or its representatives relating to the Registration Statement or any Other Registration Statement.&#160; The Company shall
      respond to the SEC or the Staff, as applicable, regarding the resolution of any such comments and/or correspondence as promptly as practicable and in any event within two weeks upon receipt thereof.</div>
    <div style="text-align: justify;">&#160;</div>
    <div style="text-align: justify; text-indent: 72pt;"><font style="color: rgb(1, 0, 0);">c.</font>&#160;&#160;&#160;&#160; &#160; &#160;&#160;&#160; Upon request of the Investor, the Company shall furnish to the Investor, (i) promptly after the same is prepared and filed with the SEC, at
      least one copy of such Registration Statement and any amendment(s) thereto, including financial statements and schedules, all documents incorporated therein by reference and all exhibits, (ii) upon the effectiveness of any Registration Statement, a
      copy of the prospectus included in such Registration Statement and all amendments and supplements thereto (or such other number of copies as the Investor may reasonably request), and (iii) such other documents, including copies of any preliminary or
      final prospectus, as the Investor may reasonably request from time to time in order to facilitate the disposition of the Registrable Securities owned by the Investor.&#160; For the avoidance of doubt, any filing available to the Investor via the SEC&#8217;s
      live EDGAR system shall be deemed &#8220;furnished to the Investor&#8221; hereunder.</div>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">5</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 72pt;"><font style="color: rgb(1, 0, 0);">d.</font>&#160; &#160; &#160;&#160;&#160;&#160; The Company shall use commercial best efforts to (i) register and qualify the Registrable Securities covered by a Registration Statement under
      such other securities or &#8220;blue sky&#8221; laws of New York, Delaware, and such other jurisdictions in the United States as the Investor reasonably requests, (ii) prepare and file in those jurisdictions, such amendments (including post&#8209;effective amendments)
      and supplements to such registrations and qualifications as may be necessary to maintain the effectiveness thereof during the Registration Period, (iii) take such other actions as may be necessary to maintain such registrations and qualifications in
      effect at all times during the Registration Period, and (iv) take all other actions reasonably necessary or advisable to qualify the Registrable Securities for sale in such jurisdictions; <u>provided</u>, <u>however</u>, that the Company shall not
      be required in connection therewith or as a condition thereto to (x) qualify to do business in any jurisdiction where it would not otherwise be required to qualify but for this <u>Section 3(d)</u>, (y) subject itself to general taxation in any such
      jurisdiction, or (z) file a general consent to service of process in any such jurisdiction.&#160; The Company shall promptly notify the Investor who holds Registrable Securities of the receipt by the Company of any notification with respect to the
      suspension of the registration or qualification of any of the Registrable Securities for sale under the securities or &#8220;blue sky&#8221; laws of any jurisdiction in the United States or its receipt of actual notice of the initiation or threatening of any
      proceeding for such purpose.</div>
    <div style="text-align: justify;">&#160;</div>
    <div style="text-align: justify; text-indent: 72pt;"><font style="color: rgb(1, 0, 0);">e.</font>&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160; As promptly as practicable after becoming aware of such event or facts, the Company shall notify the Investor in writing of the happening of any
      event or existence of such facts as a result of which the prospectus included in any Registration Statement, as then in effect, includes an untrue statement of a material fact or omits to state a material fact required to be stated therein or
      necessary to make the statements therein, in light of the circumstances under which they were made, not misleading, and promptly prepare a supplement or amendment to such Registration Statement to correct such untrue statement or omission, and
      deliver a copy of such supplement or amendment to the Investor (or such other number of copies as the Investor may reasonably request).&#160; The Company shall also promptly notify the Investor in writing (i) when a prospectus or any prospectus supplement
      or post-effective amendment has been filed, and when a Registration Statement or any post-effective amendment thereto has become effective (notification of such effectiveness shall be delivered to the Investor by e-mail or facsimile on the same day
      of such effectiveness and by overnight mail), (ii) of any request by the SEC for amendments or supplements to any Registration Statement or related prospectus or related information, and (iii) of the Company&#8217;s reasonable determination that a
      post-effective amendment to a Registration Statement would be appropriate.</div>
    <div style="text-align: justify;">&#160;</div>
    <div style="text-align: justify; text-indent: 72pt;"><font style="color: rgb(1, 0, 0);">f.</font>&#160;&#160;&#160;&#160;&#160; &#160; &#160;&#160; The Company shall use its commercial best efforts to prevent the issuance of any stop order or other suspension of effectiveness of any
      registration statement, or the suspension of the qualification of any Registrable Securities for sale in any jurisdiction and, if such an order or suspension is issued, to obtain the withdrawal of such order or suspension at the earliest possible
      moment and to notify the Investor of the issuance of such order and the resolution thereof or its receipt of actual notice of the initiation or threat of any proceeding for such purpose. In addition, if the Company shall receive any comment letter
      from the SEC relating to any Registration Statement under which Registrable Securities are Registered, the Company shall notify the Investor of the issuance of such order and use its commercial best efforts to address such comments in a manner
      satisfactory to the SEC.</div>
    <div style="text-align: justify;">&#160;</div>
    <div style="text-align: justify; text-indent: 72pt;"><font style="color: rgb(1, 0, 0);">g.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160; The Company shall (i) cause all the Registrable Securities to be listed on each securities exchange on which securities of the same class or
      series issued by the Company are then listed, if any, if the listing of such Registrable Securities is then permitted under the rules of such exchange or (ii) secure designation and quotation of all the Registrable Securities on the Principal
      Market.&#160; The Company shall pay all fees and expenses in connection with satisfying its obligation under this Section.</div>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">6</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 71.5pt;"><font style="color: rgb(1, 0, 0);">h.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; The Company shall cooperate with the Investor to facilitate the timely preparation and delivery of DWAC Shares representing the Registrable
      Securities to be offered pursuant to any Registration Statement.</div>
    <div style="text-align: justify;">&#160;</div>
    <div style="text-align: justify; text-indent: 72pt;"><font style="color: rgb(1, 0, 0);">i.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160; The Company shall at all times maintain the services of its Transfer Agent and registrar with respect to its Common Stock.</div>
    <div style="text-align: justify;">&#160;</div>
    <div style="text-align: justify; text-indent: 72pt;"><font style="color: rgb(1, 0, 0);">j.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; If reasonably requested by the Investor, the Company shall (i) immediately incorporate in a prospectus supplement or post-effective amendment such
      information relating solely to the Investor as the Investor believes should be included therein relating to the sale and distribution of Registrable Securities, including, without limitation, information with respect to the number of Registrable
      Securities being sold, the purchase price being paid therefor and any other terms of the offering of the Registrable Securities; (ii) make all required filings of such prospectus supplement or post- effective amendment as soon as practicable upon
      notification of the matters to be incorporated in such prospectus supplement or post-effective amendment; and (iii) supplement or make amendments to any Registration Statement.</div>
    <div style="text-align: justify;">&#160;</div>
    <div style="text-align: justify; text-indent: 72pt;"><font style="color: rgb(1, 0, 0);">k.</font>&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160; The Company shall use its commercial best efforts to cause the Registrable Securities covered by any Registration Statement to be registered with
      or approved by such other governmental agencies or authorities as may be necessary to consummate the disposition of such Registrable Securities.</div>
    <div style="text-align: justify;">&#160;</div>
    <div style="text-align: justify; text-indent: 72pt;"><font style="color: rgb(1, 0, 0);">l.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Within one (1) business day after any Registration Statement which includes Registrable Securities is declared effective by the SEC, or any
      prospectus supplement or post-effective amendment including Registrable Securities is filed with the SEC, the Company shall deliver, and shall cause legal counsel for the Company to deliver, to the Transfer Agent for such Registrable Securities (with
      copies to the Investor) confirmation that such Registration Statement has been declared effective by the SEC in the form attached hereto as <u>Exhibit A</u>.&#160; Thereafter, if requested by the Investor at any time, the Company shall require its
      counsel to deliver to the Investor a written confirmation whether or not (i) the effectiveness of such Registration Statement has lapsed at any time for any reason (including, without limitation, the issuance of a stop order), (ii) any comment letter
      has been issued by the SEC, and (iii) whether or not the Registration Statement is current and available to the Investor for sale of all of the Registrable Securities.</div>
    <div style="text-align: justify;">&#160;</div>
    <div style="text-align: justify; text-indent: 72pt;"><font style="color: rgb(1, 0, 0);">m.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; The Company shall take all other reasonable actions necessary to expedite and facilitate disposition by the Investor of Registrable Securities
      pursuant to any Registration Statement.</div>
    <div style="text-align: justify;">&#160;</div>
    <div style="text-align: justify;"><font style="color: rgb(1, 0, 0);">4.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160; <u>OBLIGATIONS OF THE INVESTOR</u>.</div>
    <div style="text-align: justify;">&#160;</div>
    <div style="text-align: justify; text-indent: 72pt;"><font style="color: rgb(1, 0, 0);">a.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Company shall notify the Investor in writing of the information the Company reasonably requires from the Investor in connection with any
      Registration Statement hereunder.&#160; The Investor shall furnish to the Company such information regarding itself, the Registrable Securities held by it, and the intended method of disposition of the Registrable Securities held by it as shall be
      reasonably required to effect the registration of such Registrable Securities and shall execute such documents in connection with such registration as the Company may reasonably request.&#160; Notwithstanding the foregoing, the Registration Statement
      shall contain the &#8220;Selling Stockholder&#8221; and &#8220;Plan of Distribution&#8221; sections, each in substantially the form provided to the Company by the Investor.</div>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">7</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 72pt;"><font style="color: rgb(1, 0, 0);">b.</font>&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; The Investor agrees to cooperate with the Company as reasonably requested by the Company in connection with the preparation and filing of any
      Registration Statement hereunder.</div>
    <div style="text-align: justify;">&#160;</div>
    <div style="text-align: justify; text-indent: 72pt;"><font style="color: rgb(1, 0, 0);">c.</font>&#160;&#160;&#160;&#160;&#160; &#160;&#160; &#160; The Investor agrees that, upon receipt of any notice from the Company of the happening of any event or existence of facts of the kind described
      in <u>Section 3(f)</u> or the first sentence of <u>Section 3(e)</u>, the Investor will immediately discontinue disposition of Registrable Securities pursuant to any Registration Statement(s) covering such Registrable Securities until withdrawal of
      a stop order contemplated by <u>Section 3(f)</u> or the Investor&#8217;s receipt of the copies of the supplemented or amended prospectus contemplated by <u>Section 3(e)</u>.&#160; Notwithstanding anything to the contrary, the Company shall cause its Transfer
      Agent to issue DWAC Shares promptly in accordance with the terms of the Purchase Agreement in connection with any sale of Registrable Securities with respect to which an Investor has entered into a contract for sale prior to the Investor&#8217;s receipt of
      a notice from the Company of the happening of any event of the kind described in <u>Section 3(f)</u> or the first sentence of <u>Section 3(e)</u> and for which the Investor has not yet settled.</div>
    <div style="text-align: justify;">&#160;</div>
    <div style="text-align: justify;"><font style="color: rgb(1, 0, 0);">5.</font>&#160;&#160;&#160;&#160; &#160; &#160;&#160;&#160; <u>EXPENSES OF REGISTRATION</u>.</div>
    <div style="text-align: justify;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">All reasonable Registration expenses, other than sales or brokerage commissions, incurred in connection with registrations, filings, or qualifications pursuant to <u>Sections 2</u> and <u>3</u>,
      including, without limitation, all Company registration, listing and qualifications fees, printers and accounting fees, and fees and disbursements of counsel for the Company (but not counsel for the Investor) shall be paid by the Company.</div>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">8</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div><font style="color: rgb(1, 0, 0);">6.</font>&#160;&#160;&#160;&#160; &#160;&#160; &#160;&#160;&#160; <u>INDEMNIFICATION</u>.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 72pt;"><font style="color: rgb(1, 0, 0);">a.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160; To the fullest extent permitted by law, the Company will, and hereby does, indemnify, hold harmless and defend the Investor, each Person, if
      any, who controls or is under common control with the Investor, the members, the directors, officers, partners, employees, agents, representatives of the Investor, and each Person, if any, who is an &#8220;affiliate&#8221; of the Investor within the meaning of
      the Securities Act or the Exchange Act (each, an &#8220;<u>Indemnified Person</u>&#8221;), against any losses, claims, damages, liabilities, judgments, fines, penalties, charges, costs, attorneys&#8217; fees, amounts paid in settlement, or expenses, joint or several,
      (collectively, &#8220;<u>Claims</u>&#8221;) incurred in investigating, preparing, or defending any action, claim, suit, inquiry, proceeding, investigation, or appeal taken from the foregoing by or before any court or governmental, administrative, or other
      regulatory agency, body, or the SEC, whether pending or threatened, whether or not an Indemnified Person is or may be a party thereto (&#8220;<u>Indemnified Damages</u>&#8221;), to which any of them may become subject insofar as such Claims (or actions or
      proceedings, whether commenced or threatened, in respect thereof) arise out of or are based upon: (i) any untrue statement or alleged untrue statement of a material fact in a Registration Statement, any Other Registration Statement for which the
      Registrable Securities are registered, or any post-effective amendment thereto, or the omission or alleged omission to state a material fact required to be stated therein or necessary to make the statements therein not misleading, (ii) any untrue
      statement or alleged untrue statement of a material fact contained in the final prospectus (as amended or supplemented, if the Company files any amendment thereof or supplement thereto with the SEC) or the omission or alleged omission to state
      therein any material fact necessary to make the statements made therein, in light of the circumstances under which the statements therein were made, not misleading, (iii) any violation or alleged violation by the Company of the Securities Act, the
      Exchange Act, any other law, including, without limitation, any state securities law, or any rule or regulation thereunder relating to the offer or sale of the Registrable Securities pursuant to a Registration Statement or any Other Registration
      Statement, or (iv) any material violation by the Company of this Agreement (the matters in the foregoing clauses (i) through (iv) being, collectively, &#8220;<u>Violations</u>&#8221;).&#160; The Company shall reimburse each Indemnified Person promptly as such
      expenses are incurred and are due and payable, for any reasonable legal fees or other reasonable expenses incurred by them in connection with investigating or defending any such Claim.&#160; Notwithstanding anything to the contrary contained herein, the
      indemnification agreement contained in this <u>Section 6(a)</u>: (i) shall not apply to a Claim by an Indemnified Person arising out of or based upon a Violation which occurs in reliance upon and in conformity with information about the Investor
      furnished in writing to the Company by such Indemnified Person expressly for use in connection with the preparation of a Registration Statement, any Other Registration Statement or any such amendment thereof or supplement thereto, if such prospectus
      was timely made available by the Company pursuant to <u>Section 3(c)</u> or <u>Section 3(e)</u>; (ii) with respect to any superseded prospectus, shall not inure to the benefit of any such person from whom the person asserting any such Claim
      purchased the Registrable Securities that are the subject thereof (or to the benefit of any person controlling such person) if the untrue statement or omission of material fact contained in the superseded prospectus was corrected in the revised
      prospectus, as then amended or supplemented, if such revised prospectus was timely made available by the Company pursuant to <u>Section 3(c)</u> or <u>Section 3(e)</u>, and the Indemnified Person was promptly advised in writing not to use the
      incorrect prospectus prior to the use giving rise to a violation and such Indemnified Person, notwithstanding such advice, used it; (iii) shall not be available to the extent such Claim is based on a failure of the Investor to deliver or to cause to
      be delivered the prospectus made available by the Company, if such prospectus was timely made available by the Company pursuant to <u>Section 3(c)</u> or <u>Section 3(e)</u>; and (iv) shall not apply to amounts paid in settlement of any Claim if
      such settlement is effected without the prior written consent of the Company, which consent shall not be unreasonably withheld, delayed, denied, or conditioned.&#160; Such indemnity shall remain in full force and effect regardless of any investigation
      made by or on behalf of the Indemnified Person and shall survive the transfer of the Registrable Securities by the Investor pursuant to <u>Section 9</u>. If, after the Company makes any payments to an Indemnified Person pursuant to this section,
      such Indemnified Person receives an award or other judgment granting such Indemnified Person repayment of any Damages or costs incurred, upon receipt of payment for such reward, such Indemnified Person shall repay from such amounts to the Company the
      amounts disbursed by the Company on behalf of such Indemnified Person up to the amounts disbursed by the Company on behalf of such Indemnified Party.</div>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">9</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 72pt;"><font style="color: rgb(1, 0, 0);">b.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);">Each Investor agrees (severally and not jointly) to indemnify and hold harmless, to the fullest extent
        permitted by law, the Company, its directors and officers and each Person who controls the Company (within the meaning of the Securities Act or the Exchange Act), and each other Investor, each of such other Investor&#8217;s respective direct or indirect
        partners, members or shareholders and each of such partner&#8217;s, member&#8217;s or shareholder&#8217;s partners members or shareholders and, with respect to all of the foregoing Persons, each of their respective Affiliates, employees, directors, officers,
        trustees or agents and each Person who controls (within the meaning of the Securities Act or the Exchange Act) such Persons and each of their respective Representatives from and against any Losses resulting from (i) any untrue statement or alleged
        untrue statement of a material fact contained in any Registration Statement under which such Investor&#8217;s Registrable Securities were Registered under the Securities Act (including any final, preliminary or summary prospectus contained therein or any
        amendment or supplement thereto or any documents incorporated by reference therein, which shall include any information that has been deemed to be a part of any prospectus under Rule 159 under the Securities Act), or (ii) any omission or alleged
        omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading, in each case to the extent, but only to the extent, that such untrue statement or omission is contained in any
        information furnished in writing by such Investor to the Company specifically for inclusion in such&#160; Registration Statement (including, without limitation, any written information provided for inclusion in the Registration Statement) and was known
        to be untrue by the Investor at the time it was furnished.</font></div>
    <div style="text-align: justify;">&#160;</div>
    <div style="text-align: justify; text-indent: 72pt;"><font style="color: rgb(1, 0, 0);">c.</font>&#160;&#160;&#160;&#160;&#160; &#160;&#160; Promptly after receipt by an Indemnified Person under this <u>Section 6</u> of notice of the commencement of any action or proceeding (including
      any governmental action or proceeding) involving a Claim, such Indemnified Person shall, if a Claim in respect thereof is to be made against the Company under this <u>Section 6</u>, deliver to the Company a written notice of the commencement
      thereof, and the Company shall have the right to participate in, and, to the extent the Company so desires, to assume control of the defense thereof with counsel mutually satisfactory to the Company and to the Indemnified Person; <u>provided</u>, <u>however</u>,
      that an Indemnified Person shall have the right to retain its own counsel with the fees and expenses to be paid by the Company, if, in the reasonable opinion of counsel retained by the Company, the representation by such counsel of the Indemnified
      Person and the Company would be inappropriate due to actual or potential differing interests between such Indemnified Person and any other party represented by such counsel in such proceeding. The Indemnified Person shall cooperate fully with the
      Company in connection with any negotiation or defense of any such action or Claim by the Company and shall furnish to the Company all information reasonably available to the Indemnified Person which relates to such action or Claim. The indemnifying
      party shall keep the Indemnified Person fully apprised at all times as to the status of the defense or any settlement negotiations with respect thereto. The Company shall not be liable for any settlement of any action, Claim or proceeding effectuated
      without its written consent; <u>provided</u>, <u>however</u>, that the Company shall not unreasonably withhold, delay or condition its consent. The Company shall not, without the consent of the Indemnified Person, consent to entry of any judgment
      or enter into any settlement or other compromise which does not include as an unconditional term thereof the giving by the claimant or plaintiff to such Indemnified Person of a release from all liability in respect to such Claim or litigation.
      Following indemnification as provided for hereunder, the Company shall be subrogated to all rights of the Indemnified Person with respect to all third parties, firms or corporations relating to the matter for which indemnification has been made. The
      failure to deliver written notice to the Company within a reasonable time of the commencement of any such action shall not relieve the Company of any liability to the Indemnified Person under this <u>Section 6</u>, except to the extent that the
      Company is prejudiced in its ability to defend such action.</div>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">10</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 72pt;">d.&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; The indemnification required by this <u>Section 6</u> shall be made by periodic payments of the amount thereof during the course of the investigation or defense, as and when bills are
      received or Indemnified Damages are incurred.</div>
    <div style="text-align: justify;">&#160;</div>
    <div style="text-align: justify; text-indent: 72pt;">e.&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160; The indemnity agreements contained herein shall be in addition to (i) any cause of action or similar right of the Indemnified Person against the indemnifying party or others, and (ii)
      any liabilities the indemnifying party may be subject to pursuant to the law.</div>
    <div>&#160;</div>
    <div><font style="color: rgb(1, 0, 0);">7.</font>&#160;&#160;&#160;&#160; &#160; &#160;&#160;&#160; <u>CONTRIBUTION</u>.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">To the extent any indemnification by the Company is prohibited or limited by law, the Company agrees to make the maximum contribution with respect to any amounts for which it would otherwise be
      liable under <u>Section 6</u> to the fullest extent permitted by law; <u>provided</u>, <u>however</u>, that: (i) no seller of Registrable Securities guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act)
      shall be entitled to contribution from any seller of Registrable Securities who was not guilty of fraudulent misrepresentation and (ii) contribution by any seller of Registrable Securities shall be limited in amount to the net amount of proceeds
      received by such seller from the sale of such Registrable Securities.</div>
    <div>&#160;</div>
    <div><font style="color: rgb(1, 0, 0);">8.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; <u>REPORTS AND DISCLOSURE UNDER THE SECURITIES ACTS</u>.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">Notwithstanding any other provision contained herein to the contrary, during such times that the Registration Statement is not available for resales of Registrable Securities held by the Investor,
      with a view to making available to the Investor the benefits of Rule 144 promulgated under the Securities Act or any other similar rule or regulation of the SEC that may at any time permit the Investor to sell securities of the Company to the public
      without registration (&#8220;<u>Rule 144</u>&#8221;), the Company agrees, at the Company&#8217;s sole expense, to:</div>
    <div style="text-align: justify;">&#160;</div>
    <div style="text-align: justify; text-indent: 72pt;"><font style="color: rgb(1, 0, 0);">a.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; make and keep &#8220;current public information&#8221; available, as such term is understood and defined in Rule 144;</div>
    <div style="text-align: justify;">&#160;</div>
    <div style="text-align: justify; text-indent: 72pt;"><font style="color: rgb(1, 0, 0);">b.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160; file with the SEC in a timely manner all reports and other documents required of the Company under the Securities Act and the Exchange Act;</div>
    <div style="text-align: justify;">&#160;</div>
    <div style="text-align: justify; text-indent: 72pt;"><font style="color: rgb(1, 0, 0);">c.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; furnish to the Investor so long as the Investor owns Registrable Securities, promptly upon request, (i) a written statement by the Company that
      it has complied with the reporting and or disclosure provisions of Rule 144, the Securities Act and the Exchange Act, (ii) a copy of the most recent annual or quarterly report of the Company and such other reports and documents so filed by the
      Company, and (iii) such other information as may be reasonably requested to permit the Investor to sell such securities pursuant to Rule 144 without registration; and</div>
    <div style="text-align: justify;">&#160;</div>
    <div style="text-align: justify; text-indent: 72pt;"><font style="color: rgb(1, 0, 0);">d.</font>&#160;&#160;&#160;&#160;&#160; &#160; &#160;&#160; take such additional action as is reasonably requested by the Investor to enable the Investor to sell the Registrable Securities pursuant to
      Rule 144, including, without limitation, delivering all such legal opinions, consents, certificates, resolutions, and instructions to the Company&#8217;s Transfer Agent as may be requested from time to time by the Investor at the Company&#8217;s expense and
      otherwise fully cooperate with Investor and Investor&#8217;s broker to effect such sale of securities pursuant to Rule 144.</div>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">11</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt;">The Company agrees that damages may be an inadequate remedy for any breach of the terms and provisions of this <u>Section 8</u> and that Investor shall, whether or not it is pursuing any remedies at
      law, be entitled to equitable relief in the form of a preliminary or permanent injunctions, without having to post any bond or other security, upon any breach or threatened breach of any such terms or provisions.</div>
    <div>&#160;</div>
    <div><font style="color: rgb(1, 0, 0);">9.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160; <u>ASSIGNMENT OF REGISTRATION RIGHTS</u>.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">The Company shall not assign this Agreement or any rights or obligations hereunder without the prior written consent of the Investor, or any Investor as assignee pursuant to this <u>Section 9</u>.&#160;
      The Investor, or any Investor, may not assign its rights under this Agreement without the written consent of the Company other than to an affiliate of such Investor.</div>
    <div>&#160;</div>
    <div><font style="color: rgb(1, 0, 0);">10.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>AMENDMENT OF REGISTRATION RIGHTS</u>.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">No provision of this Agreement may be (i) amended other than by a written instrument signed by both parties hereto or (ii) waived other than in a written instrument signed by the party against whom
      enforcement of such waiver is sought.&#160; Failure of any party to exercise any right or remedy under this Agreement or otherwise, or delay by a party in exercising such right or remedy, shall not operate as a waiver thereof.</div>
    <div>&#160;</div>
    <div style="text-align: justify;">11.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>REPRESENTATIONS AND WARRANTIES</u>.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 72pt;">a.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Due Authorization</u>.&#160; The Company has the requisite power and authority to enter into this Agreement and to perform and consummate the transactions contemplated hereby and the
      execution and delivery by the Company of this Agreement and the performance and consummation of the transactions contemplated hereby (i) are within the power and authority of the Company and (ii) have been duly authorized by all necessary action of
      the Company.&#160; This Agreement has been duly and validly executed and delivered by the Company.&#160; Assuming the due authorization, execution, and delivery by the Investors of this Agreement, this Agreement constitutes a valid and binding obligation of
      the Company enforceable against it in accordance with its terms, except as such enforceability may be limited by applicable bankruptcy, insolvency, reorganization, or other similar laws relating to enforcement of creditors&#8217; rights generally, and
      general equitable principles relating to the availability of remedies and the public policy underlying such laws, and except as rights to indemnity or contribution, including but not limited to, indemnification provisions set forth in <u>Section 6</u>
      of this Agreement, may be limited by federal or state securities law or the public policy underlying such laws.&#160; The Company&#8217;s Board of Directors, at a duly called meeting or by a written consent, has unanimously adopted and approved this Agreement
      and the transactions contemplated hereby, and no other corporate actions on the part of the Company are necessary in connection with the authorization, execution and delivery of this Agreement by the Company and the performance by the Company of the
      transactions contemplated hereby.</div>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">12</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 72pt;">b.&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; <u>No Conflicts</u>.&#160; Except as set forth on the Disclosure Schedules to the Equity Purchase Agreement, the execution, delivery and performance of this Agreement by the Company and the
      performance by the Company, or the consummation, of the transactions contemplated by this Agreement and the compliance by the Company with the terms of this Agreement do not and will not conflict with or do not result and will not result in any
      breach or violation of any of the terms or provisions of, or do not constitute or will not constitute a default under, do not cause or will not cause (or do not permit or will not permit) the maturation or acceleration of any liability or obligation
      or the termination of any right under, or do not result in the creation or imposition of any lien, charge or encumbrance upon, any property or assets of the Company pursuant to the terms of (i) the charter or bylaws or other applicable organizational
      documents of the Company; (ii) any indenture, mortgage, deed of trust, voting trust agreement, stockholders&#8217; agreement, note agreement or other material agreement or instrument to which the Company is a party or by which it is bound or to which its
      respective property is subject; or (iii) any law, statute, judgment, decree, order, rule or regulation applicable to the Company of any government, arbitrator, court, regulatory body or administrative agency or other governmental agency or body,
      domestic or foreign, having jurisdiction over the Company or its activities or properties.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 72pt;">c.&#160;&#160;&#160;&#160;&#160;&#160; <u>Consents and Approvals</u>.&#160; No consent, approval, authorization, order, registration, notice, filing, license, recording, or qualification of or with any court, government, or
      governmental agency or body, domestic or foreign, having jurisdiction (other than under the Securities Act) over the Company or any of its Subsidiaries or any of their properties, is required for the execution and delivery by the Company of this
      Agreement, the performance by the Company of its obligations hereunder and the consummation of the transactions contemplated hereby.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 72pt;">d.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Acknowledgment Regarding Investors&#8217; Acquisition of Common Stock</u>.&#160; The Company acknowledges and agrees that each Investor is acting solely in the capacity of an arm&#8217;s length
      purchaser with respect to this Agreement and the transactions contemplated hereby.&#160; The Company further acknowledges that no Investor is acting as a financial advisor or fiduciary of the Company (or in any similar capacity) with respect to this
      Agreement and the transactions contemplated hereby and any advice given by any Investor or any of its respective representatives or agents in connection with this Agreement and the transactions contemplated hereby is merely incidental to such
      Investor&#8217;s acquisition of Common Stock.&#160; The Company further represents to each of the Investors that the Company&#8217;s decision to enter into this Agreement has been based solely on the independent evaluation of the transactions contemplated hereby by
      the Company and its representatives.</div>
    <div>&#160;</div>
    <div><font style="color: rgb(1, 0, 0);">11.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>MISCELLANEOUS</u>.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 72pt;"><font style="color: rgb(1, 0, 0);">a.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160; A Person is deemed to be a holder of Registrable Securities whenever such Person owns or is deemed to own of record such Registrable
      Securities.&#160; If the Company receives conflicting instructions, notices, or elections from two or more Persons with respect to the same Registrable Securities, the Company shall act upon the basis of instructions, notice, or election received from the
      registered owner of such Registrable Securities.</div>
    <div style="text-align: justify;">&#160;</div>
    <div style="text-align: justify; text-indent: 72pt;"><font style="color: rgb(1, 0, 0);">b.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160; Any notices, consents, waivers, or other communications required or permitted to be given under the terms of this Agreement must be in writing
      and will be deemed to have been delivered: (i) upon receipt, when delivered personally; (ii) upon receipt, when sent by e-mail (provided confirmation of transmission is mechanically or electronically generated and kept on file by the sending party);
      or (iii) one (1) business day after deposit with a nationally recognized overnight delivery service, in each case properly addressed to the party to receive the same.&#160; The addresses for such communications shall be:</div>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">13</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-indent: 72pt;">If to the Company:</div>
    <div>&#160;</div>
    <div style="text-align: justify; margin-left: 72pt; color: #000000;">Momentus Inc.</div>
    <div style="margin-left: 72pt; color: #000000;">3901 N. First Street</div>
    <div style="margin-left: 72pt; color: #000000;">San Jose, CA, 95134</div>
    <div style="margin-left: 72pt; color: #000000;">Attn: John Rood</div>
    <div style="margin-left: 72pt; color: #000000;">Email: [***]</div>
    <div>&#160;</div>
    <div style="margin-left: 72pt;">With mandatory copies (which shall not constitute notice) to:</div>
    <div>&#160;</div>
    <div style="margin-left: 72pt;">Bradley Arant Boult Cummings LLP</div>
    <div style="margin-left: 72pt; color: #000000;">1221 Broadway, Suite 2400</div>
    <div style="margin-left: 72pt; color: #000000;">Nashville, TN 37203</div>
    <div style="margin-left: 72pt; color: #000000;">Attn: Stephen Hinton, Esq.</div>
    <div style="margin-left: 72pt; color: #000000;">Email: [***]</div>
    <div>&#160;</div>
    <div style="margin-left: 72pt;">If to the Investor:</div>
    <div>&#160;</div>
    <div style="margin-left: 72pt; color: #000000;">Yield Point NY LLC</div>
    <div style="margin-left: 72pt; color: #000000;">[***]</div>
    <div style="margin-left: 72pt; color: #000000;">Attn: Ari Kluger</div>
    <div style="margin-left: 72pt; color: #000000;">Email: [***]</div>
    <div>&#160;</div>
    <div style="margin-left: 72pt;">with a mandatory copy to (which shall not constitute notice) to:</div>
    <div>&#160;</div>
    <div style="margin-left: 72pt;">Grushko &amp; Mittman, P.C.</div>
    <div style="margin-left: 72pt;">1800 Rockaway Avenue, Suite 206</div>
    <div style="margin-left: 72pt;">Hewlett, NY 11557</div>
    <div style="margin-left: 72pt;">Attn: Eliezer Drew, Esq.</div>
    <div style="margin-left: 72pt;">E-mail: [***]</div>
    <div>&#160;</div>
    <div style="text-align: justify;">and/or email address and/or to the attention of such other person as the recipient party has specified by written notice given to each other party three (3) business days prior to the effectiveness of such change.&#160;
      Written confirmation of receipt (A) given by the recipient of such notice, consent, waiver or other communication, (B) mechanically or electronically generated by the sender&#8217;s email account containing the time, date, recipient email address, as
      applicable, and an image of the first page of such transmission, or (C) provided by a nationally recognized overnight delivery service, shall be rebuttable evidence of personal service, receipt by email or receipt from a nationally recognized
      overnight delivery service in accordance with clause (i), (ii), or (iii) above, respectively.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 72pt;"><font style="color: rgb(1, 0, 0);">c.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; All questions concerning the construction, validity, enforcement, and interpretation of this Agreement shall be governed by the internal laws
      of the State of New York, without giving effect to any choice of law or conflict of law provision or rule (whether of the State of New York or any other jurisdictions) that would cause the application of the laws of any jurisdictions other than the
      State of New York.</div>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">14</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 72pt;"><font style="color: rgb(1, 0, 0);">d.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Any disputes, claims, or controversies hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein shall
      be referred to and resolved solely and exclusively by binding arbitration to be conducted before the JAMS, or its successor pursuant the expedited procedures set forth in the JAMS Comprehensive Arbitration Rules and Procedures (the &#8220;<u>Rules</u>&#8221;),
      including Rules 16.1 and 16.2 of those Rules.&#160; The arbitration shall be held in New York, New York, before a tribunal consisting of three (3) arbitrators each of whom will be selected in accordance with the &#8220;strike and rank&#8221; methodology set forth in
      Rule 15. Either party to this Agreement may, without waiving any remedy under this Agreement, seek from any federal or state court sitting in the Southern District of New York any interim or provisional relief that is necessary to protect the rights
      or property of that party, pending the establishment of the arbitral tribunal.&#160; The costs and expenses of such arbitration shall be paid by and be the sole responsibility of the Company, including but not limited to the Investor&#8217;s attorneys&#8217; fees and
      each arbitrator&#8217;s fees.&#160; The arbitrators&#8217; decision must set forth a reasoned basis for any award of damages or finding of liability.&#160; The arbitrators&#8217; decision and award will be made and delivered as soon as reasonably possible and in any case within
      sixty (60) days&#8217; following the conclusion of the arbitration hearing and shall be final and binding on the parties and may be entered by any court having jurisdiction thereof.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 72pt;"><font style="color: rgb(1, 0, 0);">e.</font>&#160;&#160;&#160;&#160;&#160; &#160; &#160;&#160; If any provision of this Agreement shall be invalid or unenforceable in any jurisdiction, such invalidity or unenforceability shall not affect
      the validity or enforceability of the remainder of this Agreement in that jurisdiction or the validity or enforceability of any provision of this Agreement in any other jurisdiction.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 72pt;"><font style="color: rgb(1, 0, 0);">f.</font>&#160;&#160;&#160; &#160;&#160; &#160;&#160;&#160;&#160; TO THE MAXIMUM PERMITTED BY LAW, EACH PARTY HEREBY IRREVOCABLY WAIVES ANY RIGHT IT MAY HAVE, AND AGREES NOT TO REQUEST, A JURY TRIAL FOR THE
      ADJUDICATION OF ANY DISPUTE HEREUNDER OR IN CONNECTION HEREWITH OR ARISING OUT OF THIS AGREEMENT OR ANY TRANSACTION CONTEMPLATED HEREBY.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 67pt; margin-left: 5pt;"><font style="color: rgb(1, 0, 0);">g.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; This Agreement and the Purchase Agreement constitute the entire agreement among the parties hereto with respect to the subject
      matter hereof and thereof.&#160; There are no restrictions, promises, warranties or undertakings, other than those set forth or referred to herein and therein.&#160; This Agreement and the Purchase Agreement supersede all prior agreements and understandings
      among the parties hereto with respect to the subject matter hereof and thereof.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 72pt;"><font style="color: rgb(1, 0, 0);">h.</font>&#160;&#160;&#160;&#160;&#160; &#160; &#160;&#160; Subject to the requirements of <u>Section 9</u>, this Agreement shall inure to the benefit of and be binding upon the successors and permitted
      assigns of each of the parties hereto.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 72pt;"><font style="color: rgb(1, 0, 0);">i.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; The headings in this Agreement are for convenience of reference only and shall not limit or otherwise affect the meaning hereof.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 72pt;"><font style="color: rgb(1, 0, 0);">j.</font>&#160;&#160;&#160;&#160;&#160; &#160; &#160;&#160; This Agreement may be executed in identical counterparts, each of which shall be deemed an original but all of which shall constitute one and
      the same agreement.&#160; This Agreement, once executed by a party, may be delivered to the other party hereto by facsimile transmission or by e-mail in a &#8220;.pdf&#8221; format data file of a copy of this Agreement bearing the signature of the party so delivering
      this Agreement.</div>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">15</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 72pt;"><font style="color: rgb(1, 0, 0);">k.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Each party shall do and perform, or cause to be done and performed, all such further acts and things, and shall execute and deliver all such
      other agreements, certificates, instruments, and documents, as the other party may reasonably request in order to carry out the intent and accomplish the purposes of this Agreement and the consummation of the transactions contemplated hereby.</div>
    <div style="text-align: justify;">&#160;</div>
    <div style="text-align: justify; text-indent: 72pt;"><font style="color: rgb(1, 0, 0);">l.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; The language used in this Agreement will be deemed to be the language chosen by the parties to express their mutual intent and no rules of
      strict construction will be applied against any party.</div>
    <div style="text-align: justify;">&#160;</div>
    <div style="text-align: justify; text-indent: 72pt;"><font style="color: rgb(1, 0, 0);">m.</font>&#160;&#160; &#160; &#160;&#160;&#160;&#160; This Agreement is intended for the benefit of the parties hereto and their respective successors and permitted assigns, and is not for the
      benefit of, nor may any provision hereof be enforced by, any other Person.</div>
    <div style="text-align: justify;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">IN WITNESS WHEREOF, the parties have caused this Agreement to be duly executed as of the Execution Date.</div>
    <div>&#160;</div>
    <div>Momentus, Inc.</div>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);" id="za13e87c842924f838949b82c1389f683">

        <tr>
          <td style="width: 3%; vertical-align: top; padding-bottom: 2px;">
            <div>By:&#160; <br>
            </div>
          </td>
          <td style="width: 24.97%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">/s/ John C. Rood</td>
          <td style="width: 72%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
        </tr>
        <tr>
          <td colspan="3" style="vertical-align: top;">
            <div>Name: John C. Rood</div>
          </td>
        </tr>
        <tr>
          <td colspan="3" style="vertical-align: top;">
            <div>Title:&#160;&#160; Chief Executive Officer</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);" id="zfed6cb52db5a41d3a3109186884e1bf5">

        <tr>
          <td colspan="3" style="vertical-align: top;">
            <div>Yield Point NY LLC</div>
          </td>
        </tr>
        <tr>
          <td colspan="3" style="vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 3%; vertical-align: top; padding-bottom: 2px;">
            <div>By:&#160; <br>
            </div>
          </td>
          <td style="width: 24.97%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">/s/ Ari Kluger</td>
          <td style="width: 72%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
        </tr>
        <tr>
          <td colspan="3" style="vertical-align: top;">
            <div>Name: Ari Kluger</div>
          </td>
        </tr>
        <tr>
          <td colspan="3" style="vertical-align: top;">
            <div>Title: Manager</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">16</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: center;"><u>EXHIBIT A</u></div>
    <div>&#160;</div>
    <div style="text-align: center;"><u>TO REGISTRATION RIGHTS AGREEMENT</u></div>
    <div>&#160;</div>
    <div style="text-align: center;">FORM OF NOTICE OF EFFECTIVENESS OF REGISTRATION STATEMENT</div>
    <div>&#160;</div>
    <div>[<u>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</u>] [<u>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </u>], 2025</div>
    <div>&#160;</div>
    <div>[*]TA address</div>
    <div>&#160;</div>
    <div>Re: <u>EFFECTIVENESS OF REGISTRATION STATEMENT</u></div>
    <div>&#160;</div>
    <div>Ladies and Gentlemen:</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">We are counsel to Momentus<font style="color: rgb(0, 0, 0);">, Inc.</font>, a corporation incorporated in the State of Delaware (the &#8220;<u>Company</u>&#8221;), and have represented the Company in connection
      with that certain Equity Purchase Agreement, dated as of September 25, 2025 (the &#8220;<u>Purchase Agreement</u>&#8221;), entered into by and between the Company and Yield Point NY LLC (the &#8220;<u>Investor</u>&#8221;) pursuant to which the Company has agreed to issue to
      the Investor shares of common stock of the Company, $0.00001 par value (the &#8220;<u>Common Stock</u>&#8221;), in an amount up to Fifty Million Dollars ($50,000,000.00) (the &#8220;<u>Put Shares</u>&#8221;), in accordance with the terms of the Purchase Agreement. In
      connection with the transactions contemplated by the Purchase Agreement, the Company has registered with the U.S. Securities and Exchange Commission (the &#8220;<u>SEC</u>&#8221;) the following shares of Common Stock:</div>
    <div>&#160;</div>
    <div style="text-align: justify;"><font style="color: rgb(1, 0, 0);">(1)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>&#160;&#160;</u><u>&#160;&#160;&#160;&#160;&#160; &#160; &#160;</u><font style="color: rgb(1, 0, 0);"><u> </u></font>Put Shares to be issued to the Investor upon purchase from the Company by the Investor
      from time to time in accordance with the Purchase Agreement; and</div>
    <div>&#160;</div>
    <div style="text-align: justify;">(2)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; &#160;&#160;</u><u> </u>Commitment Shares which were issued to the Investor pursuant to the Purchase Agreement.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">Pursuant to the Purchase Agreement, the Company also has entered into a Registration Rights Agreement, of even date with the Purchase Agreement with the Investor (the &#8220;<u>Registration Rights
        Agreement</u>&#8221;) pursuant to which the Company agreed, among other things, to register the Put Shares and the Commitment Shares under the Securities Act of 1933, as amended (the &#8220;<u>Securities Act</u>&#8221;).&#160; In connection with the Company&#8217;s obligations
      under the Equity Purchase Agreement and the Registration Rights Agreement, on [<u> &#160; &#160; &#160; &#160; &#160; &#160;&#160; </u>] [&#160; &#160;&#160;&#160;&#160; ], 2025, the Company filed a Registration Statement (File No. 333-[<u> &#160; &#160; &#160; &#160;&#160; ]</u>) (the &#8220;<u>Registration Statement</u>&#8221;) with the SEC
      relating to the resale of the Put Shares and the Commitment Shares.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">In connection with the foregoing, we advise you that a member of the SEC&#8217;s staff has advised us by telephone that the SEC has entered an order declaring the Registration Statement effective under the
      Securities Act at <u>[&#160; ] </u>[A.M./P.M.] on <u>[&#160; ]</u>, 2025 and we have no knowledge, after telephonic inquiry of a member of the SEC&#8217;s staff, that any stop order suspending its effectiveness has been issued or that any proceedings for that
      purpose are pending before, or threatened by, the SEC and the Put Shares are available for resale under the Securities Act pursuant to the Registration Statement and may be issued without any restrictive legend.</div>
    <div>&#160;</div>
    <div>Very truly yours, [Company Counsel]</div>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);" id="z9a8c05b98b134b0ebddd7bec2f201757">

        <tr>
          <td style="width: 3%; vertical-align: top; padding-bottom: 2px;">
            <div>By:</div>
          </td>
          <td style="width: 15%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td colspan="1" style="width: 82%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
        </tr>

    </table>
    <div><br>
    </div>
    <div>cc:&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;[*]</div>
    <div>&#160;</div>
    <div> <br>
    </div>
    <div>
      <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"> </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>11
<FILENAME>mnts-20250925.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 25.9.1.5330 Broadridge-->
<xs:schema targetNamespace="http://momentus.space/20250925" elementFormDefault="qualified" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:mnts="http://momentus.space/20250925" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2024-01-31" xmlns:us-types="http://fasb.org/us-types/2025" xmlns:srt-types="http://fasb.org/srt-types/2025">
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xlink:type="simple" xlink:href="mnts-20250925_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="mnts-20250925_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="mnts-20250925_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:roleType roleURI="http://momentus.space/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
        <link:definition>000100 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:import namespace="http://fasb.org/us-gaap/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/dei/2025" schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/country/2025" schemaLocation="https://xbrl.sec.gov/country/2025/country-2025.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/currency/2025" schemaLocation="https://xbrl.sec.gov/currency/2025/currency-2025.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/exch/2025" schemaLocation="https://xbrl.sec.gov/exch/2025/exch-2025.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/naics/2025" schemaLocation="https://xbrl.sec.gov/naics/2025/naics-2025.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/sic/2025" schemaLocation="https://xbrl.sec.gov/sic/2025/sic-2025.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/stpr/2025" schemaLocation="https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd" />
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xs:import namespace="http://www.xbrl.org/2004/ref" schemaLocation="http://www.xbrl.org/2004/ref-2004-08-10.xsd" />
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xs:import namespace="http://fasb.org/us-types/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" />
  <xs:import namespace="http://fasb.org/srt/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd" />
  <xs:import namespace="http://fasb.org/srt-types/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd" />
  <xs:import namespace="http://www.xbrl.org/dtr/type/2024-01-31" schemaLocation="https://www.xbrl.org/dtr/type/2024-01-31/types.xsd" />
  <xs:element name="WarrantsMember" id="mnts_WarrantsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>12
<FILENAME>mnts-20250925_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 25.9.1.5330 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:t1="http://xbrl.org/2005/xbrldt">
  <link:roleRef roleURI="http://momentus.space/role/DocumentAndEntityInformation" xlink:type="simple" xlink:href="mnts-20250925.xsd#DocumentAndEntityInformation" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" />
  <link:definitionLink xlink:type="extended" xlink:role="http://momentus.space/role/DocumentAndEntityInformation">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityListingsLineItems" xlink:label="EntityListingsLineItems" xlink:title="EntityListingsLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="DocumentType" xlink:title="definition: EntityListingsLineItems to DocumentType" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="AmendmentFlag" xlink:title="definition: EntityListingsLineItems to AmendmentFlag" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="DocumentPeriodEndDate" xlink:title="definition: EntityListingsLineItems to DocumentPeriodEndDate" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="DocumentFiscalYearFocus" xlink:title="definition: EntityListingsLineItems to DocumentFiscalYearFocus" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="DocumentFiscalPeriodFocus" xlink:title="definition: EntityListingsLineItems to DocumentFiscalPeriodFocus" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityFileNumber" xlink:title="definition: EntityListingsLineItems to EntityFileNumber" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityRegistrantName" xlink:title="definition: EntityListingsLineItems to EntityRegistrantName" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityCentralIndexKey" xlink:title="definition: EntityListingsLineItems to EntityCentralIndexKey" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityIncorporationStateCountryCode" xlink:title="definition: EntityListingsLineItems to EntityIncorporationStateCountryCode" order="9.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityTaxIdentificationNumber" xlink:title="definition: EntityListingsLineItems to EntityTaxIdentificationNumber" order="10.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressAddressLine1" xlink:title="definition: EntityListingsLineItems to EntityAddressAddressLine1" order="11.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressAddressLine2" xlink:title="definition: EntityListingsLineItems to EntityAddressAddressLine2" order="12.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressAddressLine3" xlink:title="definition: EntityListingsLineItems to EntityAddressAddressLine3" order="13.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressCityOrTown" xlink:title="definition: EntityListingsLineItems to EntityAddressCityOrTown" order="14.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressStateOrProvince" xlink:title="definition: EntityListingsLineItems to EntityAddressStateOrProvince" order="15.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressCountry" xlink:title="definition: EntityListingsLineItems to EntityAddressCountry" order="16.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressPostalZipCode" xlink:title="definition: EntityListingsLineItems to EntityAddressPostalZipCode" order="17.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="CityAreaCode" xlink:title="definition: EntityListingsLineItems to CityAreaCode" order="18.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="LocalPhoneNumber" xlink:title="definition: EntityListingsLineItems to LocalPhoneNumber" order="19.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="Security12bTitle" xlink:title="definition: EntityListingsLineItems to Security12bTitle" order="20.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="TradingSymbol" xlink:title="definition: EntityListingsLineItems to TradingSymbol" order="21.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="NoTradingSymbolFlag" xlink:title="definition: EntityListingsLineItems to NoTradingSymbolFlag" order="22.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="SecurityExchangeName" xlink:title="definition: EntityListingsLineItems to SecurityExchangeName" order="23.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityEmergingGrowthCompany" xlink:title="definition: EntityListingsLineItems to EntityEmergingGrowthCompany" order="24.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="WrittenCommunications" xlink:title="definition: EntityListingsLineItems to WrittenCommunications" order="25.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="SolicitingMaterial" xlink:title="definition: EntityListingsLineItems to SolicitingMaterial" order="26.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="PreCommencementTenderOffer" xlink:title="definition: EntityListingsLineItems to PreCommencementTenderOffer" order="27.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="PreCommencementIssuerTenderOffer" xlink:title="definition: EntityListingsLineItems to PreCommencementIssuerTenderOffer" order="28.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityListingsTable" xlink:label="EntityListingsTable" xlink:title="EntityListingsTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="EntityListingsLineItems" xlink:to="EntityListingsTable" xlink:title="definition: EntityListingsLineItems to EntityListingsTable" order="29.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="StatementClassOfStockAxis" xlink:title="StatementClassOfStockAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="EntityListingsTable" xlink:to="StatementClassOfStockAxis" xlink:title="definition: EntityListingsTable to StatementClassOfStockAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="ClassOfStockDomain" xlink:title="ClassOfStockDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="StatementClassOfStockAxis" xlink:to="ClassOfStockDomain" xlink:title="definition: StatementClassOfStockAxis to ClassOfStockDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="ClassOfStockDomain_2" xlink:title="ClassOfStockDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="StatementClassOfStockAxis" xlink:to="ClassOfStockDomain_2" xlink:title="definition: StatementClassOfStockAxis to ClassOfStockDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember" xlink:label="CommonStockMember" xlink:title="CommonStockMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockDomain" xlink:to="CommonStockMember" xlink:title="definition: ClassOfStockDomain to CommonStockMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="mnts-20250925.xsd#mnts_WarrantsMember" xlink:label="WarrantsMember" xlink:title="WarrantsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockDomain" xlink:to="WarrantsMember" xlink:title="definition: ClassOfStockDomain to WarrantsMember" order="2.0" />
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>13
<FILENAME>mnts-20250925_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 25.9.1.5330 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember" xlink:label="CommonStockMember" xlink:title="CommonStockMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CommonStockMember" xml:lang="en-US" id="us-gaap_CommonStockMember">Common Stock [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockMember" xlink:to="us-gaap_CommonStockMember" xlink:title="label: CommonStockMember to us-gaap_CommonStockMember" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="ClassOfStockDomain" xlink:title="ClassOfStockDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ClassOfStockDomain" xml:lang="en-US" id="us-gaap_ClassOfStockDomain">Class of Stock [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfStockDomain" xlink:to="us-gaap_ClassOfStockDomain" xlink:title="label: ClassOfStockDomain to us-gaap_ClassOfStockDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="StatementClassOfStockAxis" xlink:title="StatementClassOfStockAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StatementClassOfStockAxis" xml:lang="en-US" id="us-gaap_StatementClassOfStockAxis">Class of Stock [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis" xlink:title="label: StatementClassOfStockAxis to us-gaap_StatementClassOfStockAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:label xlink:type="resource" xlink:label="dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CoverAbstract" xml:lang="en-US" id="dei_CoverAbstract">Cover [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CoverAbstract" xlink:to="dei_CoverAbstract" xlink:title="label: CoverAbstract to dei_CoverAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentType" xml:lang="en-US" id="dei_DocumentType">Document Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentType" xlink:to="dei_DocumentType" xlink:title="label: DocumentType to dei_DocumentType" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:label xlink:type="resource" xlink:label="dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_WrittenCommunications" xml:lang="en-US" id="dei_WrittenCommunications">Written Communications</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WrittenCommunications" xlink:to="dei_WrittenCommunications" xlink:title="label: WrittenCommunications to dei_WrittenCommunications" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:label xlink:type="resource" xlink:label="dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_SolicitingMaterial" xml:lang="en-US" id="dei_SolicitingMaterial">Soliciting Material</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SolicitingMaterial" xlink:to="dei_SolicitingMaterial" xlink:title="label: SolicitingMaterial to dei_SolicitingMaterial" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:label xlink:type="resource" xlink:label="dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_PreCommencementTenderOffer" xml:lang="en-US" id="dei_PreCommencementTenderOffer">Pre-commencement Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer" xlink:title="label: PreCommencementTenderOffer to dei_PreCommencementTenderOffer" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:label xlink:type="resource" xlink:label="dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_PreCommencementIssuerTenderOffer" xml:lang="en-US" id="dei_PreCommencementIssuerTenderOffer">Pre-commencement Issuer Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer" xlink:title="label: PreCommencementIssuerTenderOffer to dei_PreCommencementIssuerTenderOffer" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:label xlink:type="resource" xlink:label="dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_AmendmentFlag" xml:lang="en-US" id="dei_AmendmentFlag">Amendment Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmendmentFlag" xlink:to="dei_AmendmentFlag" xlink:title="label: AmendmentFlag to dei_AmendmentFlag" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalYearFocus" xml:lang="en-US" id="dei_DocumentFiscalYearFocus">Document Fiscal Year Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus" xlink:title="label: DocumentFiscalYearFocus to dei_DocumentFiscalYearFocus" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalPeriodFocus" xml:lang="en-US" id="dei_DocumentFiscalPeriodFocus">Document Fiscal Period Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus" xlink:title="label: DocumentFiscalPeriodFocus to dei_DocumentFiscalPeriodFocus" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentPeriodEndDate" xml:lang="en-US" id="dei_DocumentPeriodEndDate">Document Period End Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate" xlink:title="label: DocumentPeriodEndDate to dei_DocumentPeriodEndDate" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:label xlink:type="resource" xlink:label="dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityRegistrantName" xml:lang="en-US" id="dei_EntityRegistrantName">Entity Registrant Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityRegistrantName" xlink:to="dei_EntityRegistrantName" xlink:title="label: EntityRegistrantName to dei_EntityRegistrantName" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:label xlink:type="resource" xlink:label="dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityCentralIndexKey" xml:lang="en-US" id="dei_EntityCentralIndexKey">Entity Central Index Key</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey" xlink:title="label: EntityCentralIndexKey to dei_EntityCentralIndexKey" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:label xlink:type="resource" xlink:label="dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityFileNumber" xml:lang="en-US" id="dei_EntityFileNumber">Entity File Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityFileNumber" xlink:to="dei_EntityFileNumber" xlink:title="label: EntityFileNumber to dei_EntityFileNumber" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:label xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityTaxIdentificationNumber" xml:lang="en-US" id="dei_EntityTaxIdentificationNumber">Entity Tax Identification Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber" xlink:title="label: EntityTaxIdentificationNumber to dei_EntityTaxIdentificationNumber" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:label xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityIncorporationStateCountryCode" xml:lang="en-US" id="dei_EntityIncorporationStateCountryCode">Entity Incorporation, State or Country Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode" xlink:title="label: EntityIncorporationStateCountryCode to dei_EntityIncorporationStateCountryCode" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:label xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityEmergingGrowthCompany" xml:lang="en-US" id="dei_EntityEmergingGrowthCompany">Entity Emerging Growth Company</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany" xlink:title="label: EntityEmergingGrowthCompany to dei_EntityEmergingGrowthCompany" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine1" xml:lang="en-US" id="dei_EntityAddressAddressLine1">Entity Address, Address Line One</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1" xlink:title="label: EntityAddressAddressLine1 to dei_EntityAddressAddressLine1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine2" xml:lang="en-US" id="dei_EntityAddressAddressLine2">Entity Address, Address Line Two</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2" xlink:title="label: EntityAddressAddressLine2 to dei_EntityAddressAddressLine2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine3" xml:lang="en-US" id="dei_EntityAddressAddressLine3">Entity Address, Address Line Three</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3" xlink:title="label: EntityAddressAddressLine3 to dei_EntityAddressAddressLine3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressCityOrTown" xml:lang="en-US" id="dei_EntityAddressCityOrTown">Entity Address, City or Town</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown" xlink:title="label: EntityAddressCityOrTown to dei_EntityAddressCityOrTown" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressStateOrProvince" xml:lang="en-US" id="dei_EntityAddressStateOrProvince">Entity Address, State or Province</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince" xlink:title="label: EntityAddressStateOrProvince to dei_EntityAddressStateOrProvince" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressCountry" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressCountry" xml:lang="en-US" id="dei_EntityAddressCountry">Entity Address, Country</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressCountry" xlink:to="dei_EntityAddressCountry" xlink:title="label: EntityAddressCountry to dei_EntityAddressCountry" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressPostalZipCode" xml:lang="en-US" id="dei_EntityAddressPostalZipCode">Entity Address, Postal Zip Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode" xlink:title="label: EntityAddressPostalZipCode to dei_EntityAddressPostalZipCode" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:label xlink:type="resource" xlink:label="dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CityAreaCode" xml:lang="en-US" id="dei_CityAreaCode">City Area Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CityAreaCode" xlink:to="dei_CityAreaCode" xlink:title="label: CityAreaCode to dei_CityAreaCode" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:label xlink:type="resource" xlink:label="dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_LocalPhoneNumber" xml:lang="en-US" id="dei_LocalPhoneNumber">Local Phone Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber" xlink:title="label: LocalPhoneNumber to dei_LocalPhoneNumber" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityListingsTable" xlink:label="EntityListingsTable" xlink:title="EntityListingsTable" />
    <link:label xlink:type="resource" xlink:label="dei_EntityListingsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityListingsTable" xml:lang="en-US" id="dei_EntityListingsTable">Entity Listings [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityListingsTable" xlink:to="dei_EntityListingsTable" xlink:title="label: EntityListingsTable to dei_EntityListingsTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityListingsLineItems" xlink:label="EntityListingsLineItems" xlink:title="EntityListingsLineItems" />
    <link:label xlink:type="resource" xlink:label="dei_EntityListingsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityListingsLineItems" xml:lang="en-US" id="dei_EntityListingsLineItems">Entity Listings [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityListingsLineItems" xlink:to="dei_EntityListingsLineItems" xlink:title="label: EntityListingsLineItems to dei_EntityListingsLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:label xlink:type="resource" xlink:label="dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_Security12bTitle" xml:lang="en-US" id="dei_Security12bTitle">Title of 12(b) Security</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Security12bTitle" xlink:to="dei_Security12bTitle" xlink:title="label: Security12bTitle to dei_Security12bTitle" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:label xlink:type="resource" xlink:label="dei_NoTradingSymbolFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_NoTradingSymbolFlag" xml:lang="en-US" id="dei_NoTradingSymbolFlag">No Trading Symbol Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag" xlink:title="label: NoTradingSymbolFlag to dei_NoTradingSymbolFlag" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:label xlink:type="resource" xlink:label="dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_TradingSymbol" xml:lang="en-US" id="dei_TradingSymbol">Trading Symbol</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TradingSymbol" xlink:to="dei_TradingSymbol" xlink:title="label: TradingSymbol to dei_TradingSymbol" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:label xlink:type="resource" xlink:label="dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_SecurityExchangeName" xml:lang="en-US" id="dei_SecurityExchangeName">Security Exchange Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SecurityExchangeName" xlink:to="dei_SecurityExchangeName" xlink:title="label: SecurityExchangeName to dei_SecurityExchangeName" />
    <link:loc xlink:type="locator" xlink:href="mnts-20250925.xsd#mnts_WarrantsMember" xlink:label="WarrantsMember" xlink:title="WarrantsMember" />
    <link:label xlink:type="resource" xlink:label="mnts_WarrantsMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="mnts_WarrantsMember_lbl1" xml:lang="en-US" id="mnts_WarrantsMember_lbl1">Warrants [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WarrantsMember" xlink:to="mnts_WarrantsMember_lbl1" xlink:title="label: WarrantsMember to mnts_WarrantsMember_lbl1" />
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>14
<FILENAME>mnts-20250925_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 25.9.1.5330 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:roleRef roleURI="http://momentus.space/role/DocumentAndEntityInformation" xlink:type="simple" xlink:href="mnts-20250925.xsd#DocumentAndEntityInformation" />
  <link:presentationLink xlink:type="extended" xlink:role="http://momentus.space/role/DocumentAndEntityInformation">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityListingsTable" xlink:label="EntityListingsTable" xlink:title="EntityListingsTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="StatementClassOfStockAxis" xlink:title="StatementClassOfStockAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="ClassOfStockDomain" xlink:title="ClassOfStockDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember" xlink:label="CommonStockMember" xlink:title="CommonStockMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfStockDomain" xlink:to="CommonStockMember" xlink:title="presentation: ClassOfStockDomain to CommonStockMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="mnts-20250925.xsd#mnts_WarrantsMember" xlink:label="WarrantsMember" xlink:title="WarrantsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfStockDomain" xlink:to="WarrantsMember" xlink:title="presentation: ClassOfStockDomain to WarrantsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementClassOfStockAxis" xlink:to="ClassOfStockDomain" xlink:title="presentation: StatementClassOfStockAxis to ClassOfStockDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsTable" xlink:to="StatementClassOfStockAxis" xlink:title="presentation: EntityListingsTable to StatementClassOfStockAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityListingsLineItems" xlink:label="EntityListingsLineItems" xlink:title="EntityListingsLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="DocumentType" xlink:title="presentation: EntityListingsLineItems to DocumentType" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="AmendmentFlag" xlink:title="presentation: EntityListingsLineItems to AmendmentFlag" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="DocumentPeriodEndDate" xlink:title="presentation: EntityListingsLineItems to DocumentPeriodEndDate" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="DocumentFiscalYearFocus" xlink:title="presentation: EntityListingsLineItems to DocumentFiscalYearFocus" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="DocumentFiscalPeriodFocus" xlink:title="presentation: EntityListingsLineItems to DocumentFiscalPeriodFocus" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityFileNumber" xlink:title="presentation: EntityListingsLineItems to EntityFileNumber" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityRegistrantName" xlink:title="presentation: EntityListingsLineItems to EntityRegistrantName" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityCentralIndexKey" xlink:title="presentation: EntityListingsLineItems to EntityCentralIndexKey" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityIncorporationStateCountryCode" xlink:title="presentation: EntityListingsLineItems to EntityIncorporationStateCountryCode" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityTaxIdentificationNumber" xlink:title="presentation: EntityListingsLineItems to EntityTaxIdentificationNumber" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressAddressLine1" xlink:title="presentation: EntityListingsLineItems to EntityAddressAddressLine1" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressAddressLine2" xlink:title="presentation: EntityListingsLineItems to EntityAddressAddressLine2" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressAddressLine3" xlink:title="presentation: EntityListingsLineItems to EntityAddressAddressLine3" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressCityOrTown" xlink:title="presentation: EntityListingsLineItems to EntityAddressCityOrTown" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressStateOrProvince" xlink:title="presentation: EntityListingsLineItems to EntityAddressStateOrProvince" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressCountry" xlink:title="presentation: EntityListingsLineItems to EntityAddressCountry" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressPostalZipCode" xlink:title="presentation: EntityListingsLineItems to EntityAddressPostalZipCode" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="CityAreaCode" xlink:title="presentation: EntityListingsLineItems to CityAreaCode" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="LocalPhoneNumber" xlink:title="presentation: EntityListingsLineItems to LocalPhoneNumber" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="Security12bTitle" xlink:title="presentation: EntityListingsLineItems to Security12bTitle" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="TradingSymbol" xlink:title="presentation: EntityListingsLineItems to TradingSymbol" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="NoTradingSymbolFlag" xlink:title="presentation: EntityListingsLineItems to NoTradingSymbolFlag" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="SecurityExchangeName" xlink:title="presentation: EntityListingsLineItems to SecurityExchangeName" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityEmergingGrowthCompany" xlink:title="presentation: EntityListingsLineItems to EntityEmergingGrowthCompany" order="23.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="WrittenCommunications" xlink:title="presentation: EntityListingsLineItems to WrittenCommunications" order="24.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="SolicitingMaterial" xlink:title="presentation: EntityListingsLineItems to SolicitingMaterial" order="25.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="PreCommencementTenderOffer" xlink:title="presentation: EntityListingsLineItems to PreCommencementTenderOffer" order="26.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="PreCommencementIssuerTenderOffer" xlink:title="presentation: EntityListingsLineItems to PreCommencementIssuerTenderOffer" order="27.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsTable" xlink:to="EntityListingsLineItems" xlink:title="presentation: EntityListingsTable to EntityListingsLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityListingsTable" xlink:title="presentation: CoverAbstract to EntityListingsTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Sep. 25, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityListingsLineItems', window );"><strong>Entity Listings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Sep. 25,  2025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-39128<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Momentus Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001781162<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">84-1905538<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">3901 N. FIRST STREET<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">SAN JOSE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">95134<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">650<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">564-7820<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityListingsLineItems', window );"><strong>Entity Listings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Class A common stock<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MNTS<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=mnts_WarrantsMember', window );">Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityListingsLineItems', window );"><strong>Entity Listings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Warrants<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MNTSW<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityListingsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityListingsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=mnts_WarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=mnts_WarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>3</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>2</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="ny20047547x33_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000100 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://momentus.space/role/DocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>mnts-20250925.xsd</File>
    <File>mnts-20250925_def.xml</File>
    <File>mnts-20250925_lab.xml</File>
    <File>mnts-20250925_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="ny20047547x33_8k.htm">ny20047547x33_8k.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="25">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>23
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "ny20047547x33_8k.htm": {
   "nsprefix": "mnts",
   "nsuri": "http://momentus.space/20250925",
   "dts": {
    "schema": {
     "local": [
      "mnts-20250925.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2004/ref-2004-08-10.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd",
      "https://xbrl.sec.gov/country/2025/country-2025.xsd",
      "https://xbrl.sec.gov/currency/2025/currency-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/exch/2025/exch-2025.xsd",
      "https://xbrl.sec.gov/naics/2025/naics-2025.xsd",
      "https://xbrl.sec.gov/sic/2025/sic-2025.xsd",
      "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "mnts-20250925_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "mnts-20250925_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "mnts-20250925_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "ny20047547x33_8k.htm"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 1,
   "axisCustom": 0,
   "memberStandard": 1,
   "memberCustom": 1,
   "hidden": {
    "total": 9,
    "http://xbrl.sec.gov/dei/2025": 9
   },
   "contextCount": 3,
   "entityCount": 1,
   "segmentCount": 2,
   "elementCount": 35,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2025": 25
   },
   "report": {
    "R1": {
     "role": "http://momentus.space/role/DocumentAndEntityInformation",
     "longName": "000100 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c20250925to20250925",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ny20047547x33_8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c20250925to20250925",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ny20047547x33_8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://momentus.space/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://momentus.space/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://momentus.space/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockMember",
     "presentation": [
      "http://momentus.space/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://momentus.space/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://momentus.space/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://momentus.space/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://momentus.space/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://momentus.space/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://momentus.space/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://momentus.space/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://momentus.space/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://momentus.space/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://momentus.space/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://momentus.space/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://momentus.space/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://momentus.space/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://momentus.space/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://momentus.space/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityListingsLineItems",
     "presentation": [
      "http://momentus.space/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listings [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityListingsTable",
     "presentation": [
      "http://momentus.space/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listings [Table]",
        "documentation": "Container for exchange listing information for an entity"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://momentus.space/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://momentus.space/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://momentus.space/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://momentus.space/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://momentus.space/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://momentus.space/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://momentus.space/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://momentus.space/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://momentus.space/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://momentus.space/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://momentus.space/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "mnts_WarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://momentus.space/20250925",
     "localname": "WarrantsMember",
     "presentation": [
      "http://momentus.space/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://momentus.space/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>24
<FILENAME>0001140361-25-036535-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001140361-25-036535-xbrl.zip
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M)';=)7\3>-F65^(-SLOV@,ZV::%PY=0UD[?H HEVCB 4;%L &]_F?AKFO/7
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MT9N3;_U"G5@WOO&O&]M%^ _^]5SO_@=02P,$%     @ QH@]6[I=:E\Z)P
MD?8  !0   !N>3(P,#0W-30W>#,S7SAK+FAT;>T]V7;;R)7O_14U2B<MGT-2
MV+A MC5'+<N)$EO62.J3S+SD%(""B#0(,  HB?GZN;<6[""IG>YF/[1%H%"X
M=>ON2^'#?]_/0G++DC2(HX\_Z0/M)\(B-_:"Z.;C3\=7)V=G/_WWT0\?IAD,
M@Z%1>GCO)&'P<6^:9?/#@X.[N[L!7AG$R<V!H6GF01"E&8U<MB?'AT'TZXKA
M>-NA:3[\OC'^SN2C==NV#_C=?&@:M V$:?6#?WS]<N5.V8SVZ_#@Z[WBP3(T
MHP-Q4PT-TM@R]/&JQ8H1ZH$TR?+!/DT=/A NPF!CF,]ZWS6ACMB#%;)__'SY
MI1B>M8\OAAYD"8U2/TYF-(-]Q+=I?<WHZT9IDG[*W,I$\'MP$]^NG$<?]K5)
MW]35/(NT?T/IO+E(>:.R4(_5T*S>"#<J ]UX$67)LGVPO%E]8)$D0*9=3\B[
M56"RI)\MYRQM1R;</L#;^(S5U_3RFK.DDP+L [BK!D8T<--VD/BM"CQIX+8/
MA1O5@=D\Z1@)=RI#V;T[;1^*=ZH89'X'\IA?';CT.@8NO<K 6905BY_%,Q9E
MBW20SJG+D3K4['QL-WNCG-D[^H&0#U-&/?P#_LR"+&1''P[$O^+:?_7[Y$O@
MLBAE'LGB0_)S$E,O";P;1CX'$3!\0$-R%8<+I.2T1\XB=\ ?Y?]]BMT%0DC<
MA-$,IEBD(/'*DUQ<?O.#D!%C.+ '^F!HFEKQ^$D\7R;!S30C /:0] DNL/QT
MOR_AG+&,$EQMG_U[$=Q^W#N)HPQ>W+\&8MLCKOCU<2]C]]D!7_T!B-L#L?H?
M/CBQMR1IM@S9QST?QO9].@O"Y2'YZ3J8L92<LSMR&<]H]%./\"L]DK(D\-\3
M/CH-_L,.B:[-L_<$W]"G87 3'9*0^7#%C<,X.21_T/A_[XE#W5]O$F WKZ]N
M^?R_][ E'[S@E@1 "Y^N+CX'*"W^$G@>B_84>%Z0SD,*H$5QQ.")#\'](2Z#
M)>)//IK_"0/. ?M)X)*(SO!1%AP>PW9XN"6?0WJSQ]_TF;K9/SUS/-(UP_-,
MW;0,>^)8KJ6-)_K8<?W1T+$D#N^S2Z1H5U%:%A<T)P3:QST0@H=^<,\\P&((
M&N>(__/AH )2-X2*9B[@>NR=1MXGH)P2I+8WF1@:TYCKCJV13VUM[-'1Q/;9
MT*+^> -(C_"OOF;WC>'&4)U&P!;+$X KH>%9Y+'[O[%E":H)R+.1;IC.R#$L
M9IGVV&?>R)R,)LS4#<O? "H@#ATPKH^,!T(%/!<G\SCAVN0J W2="&%^$GME
MS%'J6-[(<2:V2ZVA/[%MZKOVV'+LX=BFFK$!C)].'PC;L><E+$WE/U]  ^HE
MB$:6/=+&INM[EF;IWM#Q+-O6)T!_IC?4'',#B$Q;T\GY@'P^N[RZ)E?7EZ>G
MUX^#\03^_)9<QW=1>5^MH3MTJ4NISZSQV+6'NCWR)N;(MD<C:[P)SJZ.S\E?
MOUT]$G-\/[\E%TE\&W#S*@?-8JX%B)LPP)UE3@!$0[.TB3UVAR-G1(<;@'9R
MO#%05PST/8!U"BJ.1C?L'.Z4\:1K0V9XP)+>Q +902W=]]VQ,QD9-INPR5I@
M_LD7BHQ_$M(T_>9?9;'[Z_%]D/[S[S0!@RE+O[*9PY*]H_/CJT_'__-<D-LF
MA6UEVL@W76NLTPEL\- $_M!T0S?&]E,@/XEG,V1)^+T&^(.J[$Z8S]"X8NG1
M![3%#U-N90,(A-OFA],$H4%CH*_@&-RGWIZ\C3;6Q[TTF,U#!JJ.3U^>D_],
MXT7"?W%?XU NDV.FE5KD.,;)4_T*//SM!RPA'$;6:OR>G/VM*N#J#Q^I2]79
MYUP)J%_@8209JH.*!*_?R\'T.H:J.^JW>LE!!0\;HN4!=/NR^)-H8#<(B_CI
MP<ONYV'@!IF @7A@O$3<"=V3KL1A)_Q[1TA>A]55?#AHG3A'7O[^W]YVMC#S
M=[>C:DAC+=_QOAY4A=E!R2 ^ &M:VM32?$8?O#]EZ%0<DB *,O!?WDM7*%&#
MG#B!QZ6)3<2OOA-G63P#,W]^3](X##SBA&#)Y_>S>'Y(K/I-]2IP#NX+5T#:
M^RM<@8H? ?Y7QI+W9$:3FR#JHUMQ2.@BB_-+B7@+OX:N#2R'+YT[1Z7EM\VZ
MQN$1_DZ+NV.AN\,OW,E%.G'H 3)_.3^[/OT$MMCQ]>F5W(.W@>3J].27R[/K
ML],K<GS^B9S^X^0OQ^=_/B4GW[Y^/;NZ.OMV_AK@&5W@_9VF4_"'LSCJD4^#
MDP'XMT/+KH-T],%)#N16O@*TDRYH/W^[_$K6NFW"X2XL?,<TG#&X00XX'_[$
ML<WAQ'3!?'8ML*3]]7;AWM&D_[>FN?0:*%KGZK<A">CM\O3\FER>7GR[O'YC
M8"X62;H W4VRF( 5C.XAT4WR[9+HPWWO'8E]<CUE1!K( ;Q0V<CDV,WPMFZ;
MUE8@&W1M.J>1>@%&6?O!?5^8S(>;!0:.KM@\$UK3&/9X,.G# <[Z1BM"[89(
MOF3@O&=DWY._&07]QM*,L%N,G27\-O/>;:M@6./(7K*;(,60=U;SO'R=6H;F
M,<L;@[MHZ,[8G7CF2!M/AN;0TC=Q8+_* "B/.S:DQ+8(A?W3>U@O1PSN;Y(C
MA-"4I'/FHL'G@3E"@BPEP(&PW<G&VYU1)V0 ?AAB%!@S2GO:'O\]IYZG?C]/
M=/,N\+(I_M#^F!L^8+F$=)["&/771E%0\; $^9!HP@K#__( ,)HQ67)4!(2)
M7+&GEB/A,4<#>PP0W;(D"UP:JE>#359,*_Y;M_UU.%^ '-9*LK6!NJ-/+*1W
M-&$-^94O\R"W_]2%S-L D\9HH(U:,"FLW_?(DDAFX&T86XC8U8+H<Q RN(>>
M6R&$] DU-6]B,,9 "&GZQ!X[U&:>,0;F\3<*BFJ8Q[)U8](M@)ZZ+=\9@:_>
MAVMZ?R;=7)?'K!N; EZQ9^M#;61;(VL"FL$V7&_([(GN.)IGCC>Q&JV^;FO#
MH?GT7?F!7TB.?D-R"702CQ*0."%Q-@6+Z%]@ J9>((Q$4%(-G+P^B$$YK\$A
M36YH%/R'_W[WW!*.[\FVB#?8'PS1!"E&=@@*+B*8Y-'+WF92/!M<#JX&Y'0V
M#^,ET&)5.I#S>+!NV<_/HDKA'?WI#_I(>[\AEG5SH)E;.MNC5KH5LN\M;+"U
MJ<DB\Q@DX*M=90ECV>;VV':N>FVZ\^@*)OAKG"K+LT?6SKDV3WET BOWXR0*
MJ,+?(X7<]\A^,T!5R+X_*T[FIR_B-*/A_P7S6K&!YWECRY@8[F3,K(G';(=Y
MU'%'+F6^Z;N;!/Z ^##ZM+/>6E2FQ#Y::A<)&$K!G(;D])ZYBRRX9>2;#]J3
MI8^V%KY'1MJ&;0$^(,@(#[17^#\_P!4,Y119FRV*8'4* ZR:.4X8K;&_Y@Y]
MYD]<TP.WVAC9$YL9P^'(-'W-G-#A: /V'PVU.O._Z\X_?(F!%"ZF<=1T\4%=
M3S1G[(W9T+/8R'5,1H<3.O(TUYOXQB:B:#BR^N.)T0#H-</%11SU3W\ GWC\
M/B49"]D<UTPBON@> 5$0+C#H1RAL"BS,8T\,&XOPW5.!/YDR]U<"GB:A\WD2
MSY, O4\GOB<."^,[$OC\YN<XF9%)_V_$#T)<1)#"BC(6>;S\E*3!;!%F-&+Q
M(@V7) 7_(/67_$GY0.P U%0YL7BC%&U=P#P)H=%2WI/<Y\<A@(!/S['*"EVN
ME.RGC)$_LX@E(%C/(IAA(7SCXX$Q$$"_.WP]_)%=\+=+'PP'AOTT== .9!5;
M5^PF9N27,W*UG(%0!&RE-$K[W>FJ+D'U]R3(@*+1O5]$TL5-RQE3S7+9A.F&
MYXRMD6$YCF98AC.FQGAL@@1[6"4N&N2'3AR'#@4BSX#A4-O:8\MZ_W+12ML:
MC/67WY*'<Y'$/<Q;1CZ9E_*DEPO@)\L82F&15?.CF!;=U\?DY/,E,4QM  -?
M+C3QG1'V5<P+AX"AOX)L!P$?EG7PR!G:;.1Y/C70^:,F<TW'T<>::SG,W$ '
M[ZBZ:T<*Q).9Q'R3I'6+]G6C1-655'].TY8V$"-W9"W)^B)A**NQ<);7MZ Q
MDH!_53$QJ::-] ECFJ.[ED_UB6;;$\V=6(PZ\&N#5/:.O+MV!C:@[Y9V8*WT
MUBVO;^P[[S8C=@^M:<U^CT_LB+Z=Z,_2=,&2=M*WK='$'#+?\7SPKKR)HXUL
M9V33B:YY-F4;>'H[TG\^TC=9W]IW-R-]DTG2QR?>)&+Q/+Y1R3X3SAY+P%TL
MXR95Q6_&_LT[Y1@"/G8.W#8X<.9H8$ZZPX/J9:+L68) #%5I72W [KZMZK>;
M(]XX:'B-_;:B[L^=$A=K]A^=VS8'PQ75.[]Y3":4A[Z$]MM_?/@;I..J*JA-
M\2BK\G][B#Z7E8R<8IE2,"!@[Z8!7"FD\$OF9EIEALRF_=8I?6VSHVXX7*Z4
M#377&E+F:)IK.!:UAK9M.2/-9>/)V*<3DSYSHR,?0XZYR1)C@ACNO9P)UR7Y
M?N_T($6BD(CEYN&A.;:\H3VACFU-#-,V77U$W;$Q@G_\X?I^]8<1P]?SZZN7
MV_PN<?W S?_-BNOUK1/K>J"/L$_DG*8>_3?A&TN^TN17EI$O7TX>6X.\$_ZO
M*/Q=0]=T71^YFN=:KF6"ESX>^1.7^8:IVY[SG/WYZO=.VF^+M-=\4_,=ZNN.
M-K%TPYN8&F7^Q!@/7:8[QI/..*CO/HKZO^]D_=;*^K4G=;R"K.^('KU^].5%
M7WH6>1BI8\19$I?7/\P D> C,5YQ7RM."%("&P<\A@W=-^0FB>^R*5K/<RQ8
MH"GQF!]$HDU,)"FUH0IEU3*4HG'3)/M85S5^+S*5:G3 .\SFV&$F=R-.9/#0
M</I&RY1M3:'%W!A)-!P51&^\8[ 5Y2>G'6A=4^.H'OLS?^I$/%3N8+3 6F:V
M9VCFT+)MPS$<"L@PQ\9D,AG9+QC[W@:DGODK*!9+D5K)/VB4Y4R!N%G(7#P@
M+HIYP':1,CX*8);%/WAD8L"#N.(<"$0<?U>XQ)??!?!JW-$(%A GDK(3=AO@
MR75^?E0==?E!A_@(GE?IT<1+1=F/5XL9%PW3^S2/&9=985 M?6ZOH]LL-5/:
MYW+]\ROLX3,N@92U0L="\ML;'K;1.$^CK)T;)W&\S6$;79OEAHPF/&8XS1\5
M<'/<RBOYL2)\/T3X]^/>SY<7GR_H#?LY8?17+*_,K8KR&^8PHN_@D#[U,T0B
M#>_H,NV8IV29-/#?E^:5P%P3<K$5_&XEBZ!0;I0QKFR9%HS+6W6T;4KO\H3$
M!Y'M1DQ1J7>M+P1INTG/&R=O!(:?,8]3QW-;7J<M-5-*SK1YV]WUVS#OPT3%
M<^#\#!P.H@\T7>*>M%F=59^A.\/[)BLXQ4,8L8 U)I2HHBCR">VX@)?I']\D
MC'M5.7DU?*!&B*3%=-Z<>T2A_2;_?Y3%_ I=*1=)<(M&Q06(?)$3YP4)0.I/
MM(G^M4BSP%\^OT?V+2+-@T=ZI')T!=E'ZP*-:$-[+^U,_DM__XYPA<0-?TY(
M:6&9@[T"]@C82E014F6B"W4[I[-\3FXO_6_ 0D^2U$4,TY/S_^VAFU>9Y2RZ
M96D6)^K97L5,$AD?''ZB7!5\F2C7!D%8F4IM50[&?O .5O37112 -<==#GCR
M)(ZX=X^R]3R&O9[26U[1'L'<,/D-[O\\[WJA,[3HT$+[4>^-3*UGF8!>,*H7
M^"J2W;$06&T&^S(%%POU) <WP)H6@F>N] 0V8M#K8">&XHY$BQ>DKII^\L<>
MVO,Y;'P_TBE-&._#:4MX*+OQ1!G%<YJ06QK"FW_4!DA?.MJS8A;TJ10!X S<
M^<Y113-"Y>MY4S @P&5BU0-='Q73] !1'IK9:$M+>'$_IBQ"7 'P_X&?\:W$
M@\_7G ;W"D7PB.HA@-<49?("H]E2X@Q?LA_ _MW) !#N>$Z0BSG^U'O62.O9
M(ZN,IM+B^*+ A;AGB0N&>F5-EE;&3 L]$A5Y4B@:\-.,%!DFS&4@8SW1<' ?
M8&EDN$0:&6I:#V,VX$B#=9)R^]\%DDV)G\0SCA1%J$_U7E](J,@+^+Y#$F3P
M,K=:!]/D_.U<B @V-:'E?C,-(JSHF0/AP"59\H1D)RDN$ 15D3T1)W22TX@0
M3TA"V7*.\4+N-W)ODKIB1AFQD%2.)Z<.X'F"!AP.Z/$)5X'H FY@M:#J7>"J
MB/."X!Q2$N6\80?8'Z3F%,E^ Y X,#V,_=RA)(5_.</F[2H*1)@B?_,AEZDX
M(PP/8QPE'D-)BNB< <PD7F3<_859>F5 )1*D")?.. -FP,A/(C21U$,1.?WW
M L4!'NK,&1MD=\"'%=JH>!IW!P4K?B,"(P+E78OSIAP\_RA=.&G@!33!_0VB
MVS@4TA_D)MA/*'@35  EA/7D&1: V @!DX*"9OPM,QZ]E$("7B(XNRZ*WA<"
MK1!Y394V!2L$=3 ^@G_#6V>,92H$ :@=:2 @ESEEJD.]>,59CA< K:DX[P+8
MY%04<_,;I;>DDH1 @?D!_W $Z+1;5(Y\JU'$@5I1+\H1':!P=66CJ&X/[#_B
M'TH8%T2 1-($6)D&3=J'>3&2DGC\+5Q]RMXN@)[O44CO.$:31<@$UX+B7H0T
M)_ 54>9<$8K[N7S_SF28[$5C:667@8B"R&.S*)"=:[FL0B0AC<<+Y-.0?S !
M!0;R 8]V@2)'Y@U!9W'64&HZF\:IVBS8V$7(Z9$K,VY@P5MG05J5I,AT&#H
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M.%/"F[X)N($F#3U)YKD)4I^+WT 4+>9Q)-=?HHP.7(*)E_3X(V2D<P-+&41
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M1''$:N=G@,,;YY<2\4I^K1+J4'_)?S\<.+&WQ'^GV2P\^G]02P,$%     @
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M[SN\GKD)?*/_HK[X%2&;P#0_=+_&%_FK?5IDI1M-P,* %8!1'%77>=O5GG(
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MD!9$$:F#L'I/ALH6,0-PM%FH2]DM1O]B :^*K-CZ)R8F#M\)C[T?=5\1,^>
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MZT-T+=F(+4YQ*R[# &WF56:S'AV-U)&V [^?N^>#XO3F/O?58N=^CSGY]HC
M')9_[_76=-NA<XSOK+NIDUNPF! >#FJ@<7MY-_:6B5BV5S4%%%E#3 0+:(]O
MUGI K#*[$>>KJ7BO1X]#-XF@+!FVF<P+\<^7-:7#RA>M'B1+/&*1DFP4 1:Z
MV?;P^^-;KHN7"Z4<9J^D0A.KW6!>]3R3Y-(&OC'4!7GK>4ZQ""X6!GY%\T$Y
M*)B)Q=@GRJ62N+&Z/'$>.%XW,[Y#IOVP^\\@5U47?%Z"_-=%T7B1)7K>OK#G
M_RD:C:K'!1?#1[\"F53*0O!?4=I:/R&A\47[)CM8>35;Y4%+C=O+W>.N7^*:
MH[E)51X:GY^N6>;N2'*&E^WX+!,:7$GI(;E'8?W@F< -*P6C9 MA"P[#2'\+
MS3'%'["[2B;8?2<V16FN>B_8-BD:V,*HO>$MP&+ JFNWS R#SF#.OY\7;9F3
MGWH(J,M<,>+ ;'3D\@P%WMZK5Q@O&!(W.]2> ZBKX03W-A].A1D)]\\*TF/<
M/5&W-KI7EUS*U=M89@LU2P/34_%$U3/C9/=Y)HV\T#PLDICM'S\SI^?LGX],
M@J(GAXLA&\!(^GGZBDM@@K<1[E@[3F5(*1SB8LWQ(]&#\3.LE(M%;TC\3&$A
M15BRL,8!7R-L<9IL.7GVPVATZM$?*K-5<'D.."UH0>Y,.S@OAB^.2JEJ 2U-
MD\*UK+(EEX>)M@'O=K.!FUU..,W!K*X[;EW?-C@4%AFSK&C0<\XYI,,SUWG;
M>U&W@^D7S'F$L,^"692\;$K)(:VF]E(E66KN6K=C8PDB[,//6IC,LKYI31-J
M+\CR=2CO<F9ZDI.<AN%M-ZMN+DEY9M=P2C?]BYP0^@CX4-"4SS[TS7SH+S_[
MT!^N\S^,AU1G!1V0&M%^AW$EQB' YC^\YHW_OF"LL^#%WN:@Y]6+GF'PYXS*
MBO_G%__X[Q_+3_N[W^Q]\_KK+W=QX-EPZOX0A#/@+A9I@I[(5J,-5TD_>Y\*
M:U=/]W%"V@V:7 BMH^QR/T@-+$"X7PPS,^'Y4D,%4S&4;^HFB24U_@+V((MU
MA/X1).9^<!@W?L;%"!XQ&DNH%$%-J19R"Z\"N-M(L?/19,[C0B1M#<;-%]DM
MJA.&4'#28(0"^UNU>>O>(K,,!P@6I&%H",M4G3]I[EBZV1<8JA1.&/8Y;;V1
M?:W[&Z)>QFH6P.0H>>**>&I>='MH,P]O/5HVO0\,G("  Q'@@<9BA/.>E1VG
M>^ MG'=7-67.."5E'1C2$8;'6K=D1N1>G'I49T2F6!":<"I#<OD"E$/?7CD/
MG(6)H<^N[S*RON@IHNJ$#4->2F]27BA-WD/V*CX>.&#[@6\!6)@[DBZ%-4&Q
MOE,G=!X*\:$A16"7\&B&"\HE+?G@ZQVP>CEL=KKU(O:"73L>;8IG1$QKV<"D
MZR*I%38USM%$[X-9;FF?@Y@C)09!D+B65.>E0W2OL<647ZKGFU'(4[VCA\0M
M3D\/!=0W/5<G%:9*&)J3>YN2#9AZ-MDJ6>F1:E&0H&A9&2Y:+2VUJ*3G[<.!
M*31 C8\-=FU Y]'TS7DCMHBOJZE9Y4T5@CJ-9"G3=/8SDE,M^<<]?));J:@C
M2T.50I"2LKQP388H8' .Z>32I--9IC_M!66941?+,;RLO%6=@D<85D+DE\-%
ME WU"W6*%BW6A:=UAOY\3\4(7:+O86(O>_""P[BJ$+*U_+QM(9ODBL8CD0G8
MN 6IA:8&+OIM:F'_,P=EIGUE4J\)'87!#I/79^3&@",_FL:*/4&9D9-31[+_
M+,#7F+;VX2!^53?*_^^?"Y5"('*, <@*,ITUXZ*C-+X /HW-3N=%)2A'1)]>
M$LVN\W+6S:W"AFZ%D%*Z16\=M-3#,B+KP_8:>>X.HF'N'M;$5K>$(MVT,0A<
M7MU$B",$Q<NY%D83LQ45=%!?-!'V$&WS]],XS&?Z;C1,P=:O[5RODO[//I",
M8F6(F6-G-_GGQ!\FWM*1H=) -PDY8-&>*^;>3B?CO7'7A,@X WQ'1WD4CDF@
M==L<6H$,1(<K<CFA/3M==@:BYZ;A:+C[HLP;R9>:Y/K5<3)UOCMU,+T;DH^3
M?X:C-)MZS]N#$*05N.F,A)R%6T9N\;D&N,86V1],X/4T_8KH7:#S+ R W&5+
M3<DEVII)(!<Z2Q=0!?"&D'WA@<>=4SD:NNF'TN-@)N,D<SH*#V:T[L@]![WR
MUJ=[A>3>9V,8U5DNKEA]"1W7< K&K-,OEL0R+MK1!J%=)!F98]V[JE\T2$5Y
M'7QE?4(8.]57S_2&0G:3[ \["U4X.IT3&*IU)N_;#8P2GN:YP=IFL+DHJH9W
M D%;<@')8-A'?F7?T)B%03XW;12:2<*?*6"3FBZ*PZS@>A+[R--)57(6KI,*
MM27CK+F4<@4J!RT@H;-^5Z_5,>:C7ULMC>]V-RX7C((OW+PA @%9B*S$6+/E
M]#5D$C>N\P$Q- 2?(>>LC?-8.PRMBI9>706J?<IB^<;;7F/FK[7.ZU[VF/T&
MDQ@M2H&&3F+* (52SR#CA#QG4-5L4,,<(Y>_9JAR$ *[5A3ZJJL7&-K)N\+_
M,N#C-Z^G3W4#+%DE:PU)O:2.(?DOLNO:LO&!+MY,>2>Y3<(^('+EN*'6N@!4
M?]FL,6OC8/U%Y)T<.07.6'<S[I2 %6+)BV;##]LA6KK>7L==2\E$&(!U 26,
M97S<.=\92%>2, 0QB,4R[CQ."#5Y%*"Q?^I0%#NX,(Y 5!]"Y6!*OEC K6WE
M!G0!?NP*G6AK*</\,=Y!*,-:IL08>0U*% 75.#$#7Y%=7F)QU(Z2*H=D-WDU
MUGLIG];D*Q_J"S^PD_<PZH$XUM,*R73E%:"O"_0V$^>?32!G)8A7QY-@6UX&
MC''#^,Z4OI$O58+QBW2C5/34>JW=96WZMID&M\WFQU4 >>D_;0$?SDPVBC\-
MA$D(W-RXT=M)\I_3\V4T<]Q!L'QXYC/2Q"6!NR=A@Z(HO 0V=WN &4%GY!:=
M+QJU_6P3;[?@:(M2+0(6"^T:8L=&#<':9;R$/0ZX_I#IW2X)6B4^2T)HW'+?
M)&U36&MZ!F/O]2A@ER1*ELRT-RT81^>CF^3I^ LUA$DR]E7:$W+?R"U+ 6Z2
MWVD@XDFFLI3OL_MDO^(ASJOKHJG-RV&MNER<.'B<%H8;XBK/2KQ*""<[R[%W
M\"R151)/77>KO@NN!NX%:?-RHZ4JV=K2[J/DV5R6^\'^Y\NU_A<.9+_Z',A^
M^.4]OTM-18*M6H\)<TKWLE)7,14O:DH 1>W*%N(CII@V2)AO36KYG B%V1,B
M%QTQ]8&FCP)E,./=:)#.PZ-#U[:RB%\"SO#=KHA%<$5#SGB(PL5JH@\#E9,5
M.LM9NUJ+E(D1 DX9]B-Q-VBXE'G$+Q*K5M+AJ-;9S&I9?9RHXS/ ="CK5N^3
MN2$-Z<2BN^?UU-&MR4UD1\0]?%H]MKJ7TTBRMB^*CA'H(XI#K3H4M&.TG41:
M/)$,<VH^NAT9T$Z-HCV)J4H%W&#T"D9R\_5((62XFFF^4D>&#"]A K_!=CT6
M9VQR07D?JMF@-=;J6F6P\S):?$$$=Q:.U:]LLRH'W)X7C(X&]/4<N@;51_YJ
MA0M+ERC*7'&GZZQ<YC99Q(S.)\[J-T"D_ B[=KZF99N;^/N4VJ%@E.(X"-\1
MHSGK+7]FJC?Q:$PT>)%9IT"@15G-4'0F_(70SRC1*'GO&N9)?=1,YB'6D\ 8
MQ!L0]$!TZ=9*!*0 J1BG4]4>,G>1PQ[2N3@C<I3H?<48QXD!F%SE(.;8>, X
M9Y0<KC]K&#[ 'YKMR0T01IVK."M6>\W$2:_0##DX\'Y.V>!+/6O_:252?<?+
MV3!(P,XE7R62$)S*I-]9(J5L55SG*N]GB3E:)"LPL$GA>/J'ID!!2QR!2RAO
M]+^#9W!SXAW!CZD0*H&>$,YF?BQE-TEVH''-OY_4BUON&&(>)HR&<IDKA9X#
MN_%D))&B$DX/J!4M"IXL*CX0I<2YMXY 3J8^5972!UKQ[6Q@@ PK!\;--. E
MLNK!*BZ5Z%X2;APO-.J'"!Z@/GB6%.Z0K9L&9;\K),!@.;J.V*[G3J_J*KV#
M\DM0$S-T>0QTX22#,708^LY$:47K*5G\0_)LF%_R#_7/#-3QIDZV]K<ES$F<
M(SZ44@-W5B]OH#**5]CDR*2:]8_43NX+B>P-5,=-/(^K=X[LKSL6T]"KK<"F
M*G#:0YT^$&R:)68']5U:>D_9M'\75[$UPE=N+D.K27,XP[R%G)D?2<NU+(TN
MA5H#8._F+[Z[,SB(X:T+'9%XIZVV<LAX$WK\UH:O5* W-EQD)H2V)<%4/+(Q
MC9Y108=5[]XX_D 3PG4F5.G$UO#!SN&S9<-A$7$T,:H"KQNDQ@[B3?02JTNZ
MXDE%_+8A;=<[P$J^3TG$VU.::F7\T<,!SQ(%6-S+>CJJ8 E"S_\Z+P)K8;AV
M7/>%_MG0$8.%JR^IOI&2%7A)(_198ET&C$6;O*Q;HS@T1?M)2MQ(=A!7ZK6L
M9HMF.17_H4IY@UFIYY)"I\TA F</*):Q$>7597:93W?N(D<Y!HG;@:T0%5LN
M.I>C3Q<5VXY-7N4W7*S4G5!9 PIA-M )&C#I*+G,A/V&KT+-(],H)D2C5-G'
MZ?XSG]J%<KE9H?N%8J)^!2?##IM!.Y?,R$Y!5N3;-:I9^]EINJ'3]/5GI^G#
M9=TO=['+;)C3>(HTS<]/:$I8>#R?ND,#^_ !2 YZ(WB EG,,;$60=: .MNO7
M7?\Z7=D"4#S:J+70$4$=HQ-& 6@0":$(C&( GJ IS4""EIB8C"0_;-=2-QWD
MQS'SL:WC51QA,S@2+YHH 4;',2.$% 1U"5,99\NF*MHKH=.P_6%6G3$'H=1O
M&T'=SMC_43<1'QO_%N5D^&NZ3.JFH=JBV,@<EN:612K&B0WVT7S!+3EMEJU8
MHE5@1TZK7B;*5B19PP-?"<#-1SBOT!T1NF.KO#E*Y-Z+'#&6]S:ZT\AYTV6<
M=V%*8XI5AL'B?EM= \<USU.=0Y-:G%E#F[#*F\#YB'_\.A''Y1]>[Z8@.Q)_
MRQ$?K8*2.(=8FY7B+""2_Y*A4;G0K]J=T6"^:R.5TK?ASV(^QKPL!F!2XD28
MR(58U?PJ*V<;P !=Z1*I;F(F<@S7_*SH/-X)+W%&90^QXRQFAC27XZW=-,'_
MMTTT\9'LFZ"7QB9\4EVSN:-?["!O2#UY%PC5 4*5,+6@D=0",&O&3?V)-)L4
M]4N8-Y?H1K)H8F&\+)V7F%P"0Z*$FYF!\J&_5EA4);LO#N*(@1F-+.6>I$K-
MI6+N?(9E3V8(..!^IKA84IL'H<Y=*OAHMLNRBAK#_SJA*"9:B W#?CZ,JPX5
M?%72@RLZD_&"A&JNGM)@/I&5'#2E=1/%KY&!+VDW8Z:YUD=+CY%/[4RPMUG2
MW2YR?UB18M>P+UC5%ET6%WN ._N>T_6DAZC=K,A>WV*SN\8>>3A1GM'&Z'P6
M3X+4!T%AU1SK'RSF6(()/J%X34?\=I.\6 B1XJV5DC[2//4L&W'$]=MW.T?<
MF6K#3QQ(;'_O.^TYFN=9I>BU^\-E]/LLV?OFU2X1B%&9#5=35D\$[VP35O;,
M&HK8"@UW6\=L-JXZ4JWOO0J^>%!_A]SOC\(CP(P.YRDWGTI8OZ@GKU[NOMY_
M]<WN-YRP'GSYZIO]UZ^^^EJRV;>Z!R281?C=UZ31?_GR]7W3Z*N0351),D.>
M.*$B#JNU8/0_NUCFP ('+$4&]C5$OA;3)52XM?/D\].*H>5#;*GSK($K*V]?
MG/Q:YO &=!LVJ%Z/'/?. >K]=7FWD/P0=+ERI:H<':!+#XT22'E][)V[_=W=
M?8EE-"I_9X@FDMZ^KA=18B$P+N;+\E+?.BKIJ'-U0S?M#/>AM:AU3<9NC]1Z
MK7+M6LQ!=6/JG*2]!3U_SBG8LM**96DB*PT"$6V$0A"BAF!0^8"SUKB\<+!2
M=4+?T31\4ULR0HH$@CMC<]$J@*8V(JK_IBJACVE*M9^$>2/"=Z+_LL%81A9
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M'WI[@SV#(JC#XCC6M\GY',%FZS/K%IPE 78BJS$+Q%+!;F#799.S+3#HG=.
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M62)M&H10<E-P5VZ];%?)>9!>"3!0P,*[CN+";8F\E@R_6F1BK]JNZB3DDT)
MP8$I&T8:RLCT7Q$:))9NA"[$07OM)7NJQBG ,6K%@+P'(PA;A(:]V@T7+#9Z
MI:2*G8"C!VO#0%39+/>$GFT-B+RBZ^^C88/$])A7\E&=K;-#AE@= ";5/9,,
M3@ M2^AV,S0TD/A45'M!L2#G>VDU%J[BQH8\]G6F=1OT(6AEIN8$6 \7_70U
M"[2/Q ,[//( \Y""R1T:Z]%,$ QW*;OS*PJ?>$Y^QP//D*P+WA)L*\8'ECKH
M!%5EY8(5TM?@ $Y+.H-YZ-V=62AI+77/( <3)\S5%(F\EA2K),D1[*D(W' O
MP6YN4LJOBVQ?&('K8UIORHK&1K/&7A133K$\2+JXM:0A>:>R@V*-)8\P@4!9
M<&"C,@MS@YP6J4%[C9B[2UR_]!(K"C[?V49E8 H8EN5XA&DII'G=<LL:+CJ@
M"Q)"*O<<$:;3:GF39LF_RHE#N>>V'5#BI$+_FS)EB*&\4KGS&M0H$RFS,'!K
M,JU82,B&O 56'#R..Z3HFWO[L&3>L8;9 ?%B0='KR.2<LH50PRPA:A(96.2B
M'9D00\#GLG]HI5_^O?IBV91+QZ!&KJ^#W#(,>G4/8EJ5HC1/@UOJ.H'4X5P9
MP$=?DJM",>B;, DR6&F,IEEQ;$2F7GBYC*1'?5>6@J; #L62BA$9Y:,=5+#-
ME"L\A'DH4RH\;*_.IZ+(YZ]HKORK4"%!AS.=SQZJSDZ(IBN;I\8*):P$TR</
M*? E):#7+)MSV9]DR,D(:<FBJ]0+CS3MCM;?>L9[IDL-!"DI>-P^'4?!+W;B
M;L9N$41L;[A!#B"L =98,CQN2V;\&(EOF./V3XG'.F1J/ "IU)LWR[EQ')+H
M#*\M>IZ)E])=J&+!.1YKN\X$N5P9JY8@9&&_;5^7J4.P0$!5YTR:SRZ.6Z@"
MS&UYD7"MO*\8.\#%+:0M #'L?1Y_JSS^<)_'?X[@76NWZ/>%5HO9G4O#?DCR
MI0OWL"OP;56'Z(MC+]7)6\M",STG2'9V/3EH-@+X?X?ZZ6,_(FX,S:(]EN'R
M<2-^(8]2;;13W&6EB)\$OUT$SL=\MVMZ9V0C,.MRCV;QPEP!/VD+['9URX&B
MAN7>U)<>8_1B:/J.C7 +&<?K=SIM&.O,43DZ)%QIKJZ@W)?)X Y\T",P#V@Q
M:J&A]2TE 5L EM.? 0S#4DK*(,U<A,C&;CPHEU5H0@R5#._X(07>OA10 #G@
M:+HR;U4-4XF$%,=05)1F@.1O(>Z(-DQMN5#U0-F 9*!"OH1*B[&8K7+1DRQL
M$[JS0PMN98V!.NXO+HGF_! YE(X"^O86NB+1-Q$6L+8C$6O,"6KMGKDR6L]'
M1),@3U.$BM%OSBT_#/MZ!/ !]F6!FW7T$N!"B/>"-T2A"QVD;6VW\+6:0W1$
M]"V[9*CI'_8G2UDB.K\5*2S]GXA0NR*N\ [JQ)H,Z 38.WB]Q%K-]?P!@6'4
M1.2D7+S,?P'.L_@*MPSV7151!DBA:(=.*7,Q@-!X (-&ZFRC/LW('A,VARM/
M2O7A$$ PQ6IQ*CZ@T53B?7%A%6IC&2'C?(#^^Z\/567_+L=I@#&*$_TW;X9<
MP^+FN'%6QOUV-%(3HYQL-H2.&\'@V>(I;[5--<4#C\;E8O41<[50&[H5$E<)
M*Y*GR>UF<?0"%H!G1DX9(3/@7RL:!R B\(\T$R?(+5'BJ*CQ2A&)Z9+"Y!F3
M(_)H\3*NL= #M.6(=E?8]3(9D</>2SST4^UGT2K8[)%9 4+ 0;9,!/X'?*5"
M_\;ER3&LNP30L4#5H&-ML4&K>_R;VEV31_!5754<4X$CPEV[WV$LC;>3Z+_U
MNC&\2Y%_TF'<%5M:%E#LD(D^7Z<W^*-NW[DC(YQ+3 ,6FAG;PER3Q%6'S(ZW
M!;&$O=T]GH:J^U->#A1W<Z\TD4!L10/EM%0+"(@#VP-4,%A](CFP*VR-B='/
M'FPCAEK8Y,^"?ZX$M;5<,+M.%??YTM;O-SAZ:%M62HW,"GXOKZ3*EQ,:VMUA
M -5A5JM4CY.?4\5_@"M:N0EN =9:H'6K@($X&]P1?SE:XV"XX$XI+FCWED,8
M_N9:AZ%N#?!6X7&P.BTM1W$*4[_?M\#$"*@7F/MQ\!A% %N,]"3HT-PN9A@'
M8YH:R)B4:0AD-@W*@. 9K (=G4TU,O7DP:2B""6)+Y":I6>?IH@@%\+=Y]CK
MS$)2WK*8%E]1@9X1/S:LQ2)M7" ? M5XU8*#NN"I5 2V/!*FPCFR"4%7&6;[
M3L:NA/(#-%.:\KTD<Y"'85 84F!@/KW,*$+*(0O%'$N#0Z*%(],*#D;Q*3'1
M*I<H08J?*Q3F8HZ$0#9-G!6>="C0.]<\S* 'KD%_+;GF!8Q5"0/KIK\U'JS5
M+6U'-6<16:54%-!9B20BRE:(R4/8?PT!0^,X7O"+U<0J9?(Z%DKSH3H,V$S4
M"4ZX2RR3MP,FSBW^CGMP7L*/K9.F FBL 7>M@'3=!<G5P;;6B8+U'VH8RD L
M**I;VN'*GA$OPEX%#5FJ0UM@\27#.5)T?8ZA' ?JN &:PE!(%)$?W]1#/]+M
M5N@DVP>@MPM C_8!Z.<(0&_%V1'(4C=K&E@@LP\6NC/?#&_)C:083Q*ZRM8<
MY,$U0JG%Y5R=0R*I[1GQ2Q?,\[W"$5'6C$IITULK$Z&HXAAKEV=D&JS,6QNN
MFO9?__M^]GDT:C5;W7Z7*F>+-9S+])IQ8<J-VG;%9:%7=14E=[#A?0<RM0B\
M!Q<B:46&W7*JON+5V@8RP)I ],J1R/2>V$4MK1T&<^TG@G/+?.&DI0A%:FU9
MJ#M=$+6:J6LEK[*$N88?%^$GV@%K1I(H5)&BR0X[XJO%,DTI$5B$B-E0XZ?M
M/$&;"<5+'6ZBB7H@YB:\'BTV.7%#D?A$%E$SE^?F5ZC=W^:M+UUPO@-G""J.
M3"2MT-.EZ#R4&@/6@UZ-6J8?@XQC6W5</()CW!1R8+^3XN/F\<H\OL$[BG"H
M=PG0=I$M-M5G/KI!@$&6IW^LLB2/DP(_L(EZR<P"G4"P)$WU.K='T:\2,'#Q
M&((GH]=55@WAG.2K7"D,R@ _(G+(]-;%Q*X#=6^&9%L> $8*H1XL6.$]5@&A
M+\'8X%I#F?&B;/O#M=BT54VH6%<3<8,H=>=I3XYK@\8Q&,!Z/PF$Z87%;ROL
M9>J -D ;;Y/<7]*3.XMP7UGW8ZK[?%!36^Q5%0UC#+N40.OA8=5OE87-^+%3
MB*5"OPGBO(D"1^Y)-ECS+@/CP(T%<,5"6SQ8C4,E98 GIGU]V*='C<.\'E2/
MRQJZ7FTN]7#5,Q 0I3ZWE^UX66^&:_GH[1#OW$S +#/LJ)+K=!4WNYKVUA03
M=B(_-P'/0B3I:H)ET@+UXF;LLM2RC9M@EU$DB7&OH -Q]H"OX)"]]EC=[UWD
MA^2X8?HZT1.';YGPE9*4/<4X4=G9K8M)4I[$UM)B"7,A7#:5JQ RZ\JV;UC+
ML(:[4Z+N(6,CM[JMM-;8EA:;2&55++&!Z-X)C=6"++O*3!&4%JM8FI.+U,DE
MP(BC@+LV];:Y?S?8V/*Z-W!PF<7!;&UL%[-J<I0CY0T3P>3:TDE*YQ?BI*(>
M<7/(M,!"+@*F50>A%#"MB7?:<M:7"'QN$>Y\Y\<E_4P5Z0,P&1ZA#@I(EIX6
MVE R8##VBDI)Z4DF7-99M>Y81#/3JYBE\R22=#A8MX]?>*NP#!A S:XRK=;]
M'FQ:3:T8]7"2'#IQT>'UNV6ER;6!-V+R8 (]HJ5TRBNQ:3A"^JM&) =2!8M&
MQGMY.?;QG*WB.9WF/I[S'-9Q+0+T9E.GMFS09&E*10KZY!!1C2&8@*Y)ZM,V
MF9C*@NOE^FIK3Y?Y%1_%S  \U998$%V!MGENL??Z3FU.^N)7.:+.10U.H:_K
M]8/O%-SR(K_V69C'X3]MT!NIOWK]3N\@/@P..-O$GVF-CD:C/P?'X<(EFDP+
MBP%*D8D.&V"PC0IDL4W3V2R]MY=]83./B@%VJ(E$ ]_0=%1]2Q "55*/2 S%
M(F.L=R76EP L;PH@:V9U+52L"%Q5;V1E'\9F42N'=#C35,9BW'(V1Y5Q3UD%
MUFX6B[]JP!*P&L++?R?S!#,(9)%4(VP:T![*?<D7][=]<;F(3'9Z!P<N$17.
M\E3T9X7S.:36:KYX"!^C[Y93?[E2GT5ADOB>T !&YCSBXHV''#' L>NJMN^/
MC$A@WWHP/!5D'9MH;LR .@=:"Z>9J0IB:%K&\>#62Y,-%-\61S:G]%(R/V3=
MD>/IMYE(5UHEXD\;*:HKZ5=-H1\/$!NK;<%3]5&W F6+VHH6IV<D5U3K"I)%
M+G&3M2QUS9&FA@_*_9!]"8*QR3(OG'LC@;[]A0N*(V?+-0<D7@X90PP.W"'4
M ?IW(6-:FM'EUD<KE!K:=GWWI3=Z&FF":0+\L!D.S>$.7.0E-F>;:0"C6WB7
M9C:P;LO^*K2$J3)T%KJ,P/G1 W-*ZK1R2=7'J9*ZOH9%:BEJ#]84;4;HU=EC
M;O+&<!=3;E,F@I$Y59_MRC=6\GT:S>2F7W?QV(M++[&(U3DB3]:$#^42D)<.
M4VX MH4 )8)!O?UK\,-,:[++SP_!.U+KM>%PZ]6QE\.T&/2<2B!'26HM[FGF
M%K8@-?K;+BY#0(?Z@"T>.!4^;3CW'ZH,9 OF/U<@FL6NK2KY=E$,%[\HRY:(
M$MA6]%((W-(AL32'6/C @#[3E+"Y1;B[L!3X"01O*M>\8=+?J-'*$AUY'1ND
M#3;GS$ZR%<=-^5Q!NR3* Q.724"-8,TH1WT*!='%VCL#L^#M1/T&O+!X;T @
M+>$V.U:W$Z* O-3+G[\N1OCR__[W!3?)_,\K8V&7_WN^M'R!^O^=X#G :'Z(
MN2^+5B9:HRC[E>+M6*XDY,R05T!8/J@3Y<'1EQD/Q*$R&#V0-.*Z<LE><6J+
MJ;1PWR03/!HX;H=7AP#>C Q/#.=S(TH?0$6 0:156\+UG@+%V3(:!E0#SX0P
MU70Y:15N8]'6JD<'0VZX4()UP[=7\V29&UT*)=-WZ>S.BW*%P=_UNU#%7, V
M"6?%W 2N/K%RVJ)*$5&@R!R5%(KVM?IMIN9_,]8U=H9 #W'JBA;AVU!1P#F/
MHDOI%6'PL!>KI1D=5NP[9<PJ6+RD )'.;T-T<K.Q<1%! 8>ZE'^G\KJ,?X R
M?7W9E1>S=MU+"PJE?K,98>[,$.:S1@!Q+(6EK_![L'H>K'VT2X#VE?:,\/XR
MYLH5%K!8,RQ"R93Q5;"R&TX%A@T0OXO0'JP+$C*"0HFUPFX4USHT*DKKBP>
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MHU9_..QUF%GD9:VUK=M;?PK1@31!U(\9=%,M'[X]U2L&76*U/6J,3F<]2*K
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MPF:RY1*RE[>-W)2^OMI_0]C.9VMUBRK#@HD[=8B^DBY-$8QQ*UQ;GXA35D<
M_/(=[CO.$L)[7%5UHT*\8F6[@M9F;+'O9.GWKCHBHJD?OY!7L?X<;#]A2'E
M&ZXZE!T=XX.Y2FUB$:]944"*1;_>0KL63 I8.\!CM(R"U!C",*HF>0I!!D76
MJH \75LX*W'.*79*1S^^3>;:&\ZH/JC<*%S0@[2F7EN'&1L6WD10:S=GNFL&
MPQ&M.-;ZND$_U2#>"CU<KMF%-4,CA!T&\@#1;9?<"5[MGN-BJ/?ZV#-U\RV1
MK['04) )J&!#']?-8J+!N#!\8:&-BZ%WWU5QKJTHY;0UY+&T,+4*H2I124<O
MH]JE.G3#SU5_-F (#%5=FK)' T>0_PVQ%M5?*B@Y;2W,2#AF#Z7OXDMN4W9A
MQ0J]<-BJMI,13(D/B=Y5#,IJCP93$S58SY70X4N7_L*D!\8C[ --KL/"P1EV
M0&J<WN3\(KF.0-8HE;V63XS?L6_AT9D+'HL+V=&H'ZVK1C?#=07,^-UY%;%K
M& FW7V00,5J)J;H'+[HO..-V63FX1>.5\NT'O07H20KT/D)&QSSOR\=%M^ZT
MO 1;%5CN 3]I3C^\3R$I #^I951(M<-:SD**WF@7$@P37!QG]1$I@C'E7)"0
MHJV+Q)5(N)"?5&0FN^C5O9J\7/ #([*)V >!J&B!C2D(\%#-%>-JC'A,!K$?
M#3QS9=)X7$D_9E,L"M9<KS9U]M)-:T:SY2!>&DR^MJT!=OI8=,=RFJPZ,2KR
MM4AD]BUMGM_>[%VT9 )P5!12 %!5O@#DF-6<.6#@(\R&5IOX;-BJA6(Q-:,F
M9H &3XVO#G?;Y%<,"0 'M</;27*]<M2B!DTQ)Y8QTRB*@:U,N[BNW<:3. N+
MQ*'%77J'V:BS"#(6T_=(IN+9K$&C%7/GG&J+Q/RI$!O96['[BY5J5?74FF"V
MLZ%EB54,4H5_GJ(900R4V =*(33B*PORQ2S!:!+^2TLH1*%B^PMM8DV8F4$J
M[$JFM/6UE80&-+\NPD^:^9J:2V_:N.^8=1(,M 8$\PL2_^A3N*&_(2C'? I4
M*/JP_CP^_?O)17#^+O@_GRY^":XN3L<?/$U\%HS/?@G&QU>GYV=:=7\ZO6H$
MYQ?!QXOSXY.3MZ=G/YJ/Z.^?7KX]Q0\&/UR<?_KQ_57PPR_XMX_CBRO]TX_C
MT[/+*_S-^=5[_5K\?2/0/^./IR>7P<GX^+W<D/\\._]9O^4#/.BM?M?5R1F\
M8?SA WSQ'+_[X\7)^.I$/_GDO^#/P<>3BY].KZY.WN+[/W[\<'H\_N'#2?!A
M_+.^=$XN3N#7/UR>?_AT=0*/^71V?'[V]M0]]_3BXN3OY_ E>NW)?WV\.+F\
MU/_"];H,WIWK#^@)X'K!6V#UZOD2=][=C5L7_/LDDW&V36]^3.BQ/J#Y=00E
M!^N"DAO#C]5AR^V#DH6P(\8:RYM0%[1\9(QR0UCR_WGS1A]<Z#QS"W6A/?+E
MG_7/?^X,__SG/[]Y\V2]M*'47@!.GMB:AK&]'3P?A,T<X.^$;D2RA!MT.WU;
M_"U6V!*)A];%ANRU^/NZZPQF05W6)0^SH3]JBH$%"%.&A==^)6^CBO=54)9,
MM:V06>+J35@@IN;C@6]//;@#J*(T4:5X9=-,V-R=3J=0,B/,%)BP?ZOR0#!K
MRJ2 $K(E5L!//JE>!JC4ECG1V*[RL[)_\0'74]>STS)U<&D["S^B;T0(7(?[
MY,Q6>G"X3\X\^4+61L[/IU=GV@@(?@8+XOP=]]#[78P4#H3061P8J$93!&ZB
M/C[6&T3O5[,'U[Q'(6O?"1)E%0;N MT-F_Q% Y30NAVB<CA)[[9W!;FV3,UF
M.1 BSZ__XYOF-_CO!7@0_&_:+_PQB?_CFW]%[6XK&O7[O>&DU1WVXZ&*6\U.
MKS]MCKIQU!E\XXGU--3*Y^&[X-^ND)W[3-T'%^EM./\W#SZ=#ER5F$",+5SD
M^C/F)]XMWL*9FBY+4B-EU9/:9>9),?PF-L,MX;ZG"SAA*2S._#^^:7]3^*HO
M5I6\@^<_:=OTTZ6V88^/BD>1I'09UP^(EZ/7^7,%*#T,[GO?(JQ\HOZ%_YE'
MK$&6WM,:M/SUV.+UNTU(OLF*[.,F-$_OLW !N@G^^TUA"*UVS1 "EGRK]4$I
M^>.JDH+O?] B_FW^+6' 'Q\A#/RC=[S3JQL='PHQ.(A=)W&074\.FHT _M_A
M=NNXT\YLL2Q/VZY'R=^Z\\B7-ZB'[X(1*O2S\%9]5Q4?\!?O^\(F5EZDKTO8
MGT6#52U&4+&,5Y B_8[-]>.;1$T#AC*Y0X(] #E["66WW1(Y P!O-_\6E IK
M)R/UF^__^^+DI_'IV5N*G'P<_WCB1R:"#R?OKH(?/HS/_G/')U^>_G@VOOIT
M<;(A=@7OO#0!JG?G%YL^_NGB^/WX\N0"0A<?/IS_?/0_.P4K[/@V,&YL&Y7X
M UOCH[TUOMM9L[(;N,.!1^[J/#!&5:/"JMI\UDZ./UV<8M31O",8_WAQ<@+/
M_)\*NWF]QJCU$2C=3?A'7X>#L&:BCW,31G$[[DP&8:_5&G553PT'DVX\:G?B
M,!I&T^[P-W03"O?]+K["!K.RN9/]5&U*GB%,C2CP^RXH&]K%33*_V^**'=4.
M<DOK\JDW\<[R]#4*RM8FV8NZ.;6.Q [R6'$Y%H)U+E:GQ7;L]-*EP>GTQ)DO
MPV>6ZN%3?::]5'\U4OV<6K9*7/<*=R^:OZ%HHH.]E\V];+Y"V3Q!/.HQXT?O
M970OHZ]/1M]9T%J*P-2*Z5XB]Q+Y1232\EJ<SJ,T6P@H-^?D_[Y4YA:Q,W.)
M0&GHF84]% NR<S1./O&M .:6E*VRV1 HUA%"'''/<TN+X,@0#A\Q"A'?_6+'
MM!B,E<>6XW&J'2G5FK3B;B_LMIO]2;<['4U&G6&[.6EUHXDOND4!JY#-[8Y.
M]2FY7$V@YHCZ!\=8J/5=E617R38&-;85X^+C>(\^7?ZIZFQ5GJZJ,0QZM5.K
M>6-5 <::EY9TETRQ%,Y:602+29GB2U^)8!;F7%[VLM0]4>X0=]3!#E")X'>5
MF_YDT:M2Z#4"MJ.(!0>9FLZ0$U=B[!-N)&#-FL+'X9\/JP6Z*%V%Z[@@8>6+
MJ*0'2V+X%>C%9U=X]3MF:B:K1>T%!&W+]PSKC\J63WV:HOK:KM(O>4>.3R^"
MG\<7%^.SJQ<1FS\]_:Y[<1F1XH'AA],S=NH:@'WD<'T:%OS'(F<QFJMI,$<L
MP9U%<'V>VL].7P;'YV=7IV>?3BHRR6L?%&P8Q!^W=J+;W-=.[%Q,7^[Y.OFO
M]Z<_G%X%[[ +XQD/0>4+Q\?'%R=O3Z$;Z_3L[R>75^<7P=\^Z?^>GI^=:;5V
M\O17:#V@#]O9"?6>_7QZ]9Y?!84<T)^&E1YZ /I3?S^YN#J%9K"S\ZMG>+57
MU=MXAM4*WIY\&&M-?Z('>_'Q_&(,<WKZ<S]^NKC\I"\/*)I96_<2O!W#5EV>
M?+PZ^>F'DXN@W6L$[6:[M_N%?75.?LYW6_6(_Y1"Q<LJA[#(FDH>KP81B_/+
M]=[__9<U.O>+/  CX]\%E<^I[5&!LPD-DA>?4) O:X[GTUM(!VU4^1\_G.#6
MGUW^K/=Y_.&#/9>71Z8%7U^J6:I])*)LS>\5$G<R@N-9.E>&_,M1@FFW2F#<
M\=\!5@-A 2U(S,<9P 6B_X5-_LN'A0H>4NBKQ?<01+*D83X*QLLEMC [:)K\
M1JDEPLDZD!N)_@M@IC.UK'CR_"%(ENKV99IT>85_D2\U-LEGH,DFQJ49HH-.
MJ?<,7%#B10:<5#W;]T2MT?"/AH>A*0 Z #<3V_\98X?*R_[&BS<',BZ/_Y/K
MPY(EHD?EWDY+W%1]J2)GW#)7,T&U:P$OTNF4(7+RD#*5N8NP%>!E< D@R,;T
M6M!#'MPEZ<QK<B?V4PZ+EBDR10!O3!UNK5&G@S (V $/N+.(DUUZL!B88<5&
M@,'ECE#CW[>.ME%I+.C>/ZS4$YX/ 9I",QL!81%!H!YR5:BQ=CBOSC.B(.,D
MGO2;X6C0CUK=;KO;'@[54/7ZHZC75J->/WR, [6MCUT3>,.J_\J$9'5\?6O?
M>?0"/OK>F[8C?-8 C-=K84I_)-R9J+5\_MW?LAVG')1[P558VQ92?_=A;N^;
M[P]8J=F[5N@Q4/'F#@IZAUN?L3^6[).^G$[;_2CN]EO]]J@;AM-A%+6[O; 3
M=]J#?FLX?;J^K(RT5RS+UEO_EE.9DR1;WA!7T)0!6;2!  @Q6&ZN[[H5\#D\
M:,\6^4JRZW">_,LR#R0R$UJ9B2_OI!"')QR>RO5YK'[>Z34O?EM\S9/VE.07
MN2[]8-+:=$;%<<%?M'>P"BOLQ N5,PT6IYXWGR>7O$*(=?O-TA$J_=N?WFO2
M@EK_#7K-*!Y,PU:W.6D-1U/5;L;=UG38:W54YYFTX!>5Q-V.XK-;",\U_1<:
MRW["6[ZD7J%MI[5>QS%_=D-_3=KL^2R=*S53BYMTKH(Y9B,J2[2J5GW][[=U
M,+Z$P;!6O+Y:V=GLVCRY'.?+">YEBCPJEP96]HQE<2];OXELU;G0+^_6[RXZ
M5^&OB_!!&Y*GC'3&]#2_"Q':#H5XGU>OR:NW]GGUKR5(-!G$K6:_WXH[O6:W
MU1I,FLUAM]/I#P:#:-2-'A54?VY5TWF:(VS!KHTW6WN*I;9X[>IK>P]A38AN
M1TNE;K*_@254(5./\,@V((Z]P$Z\Z!W_BA9EIV#9ZXP??4G-9W74LN@7KE%3
MKTD=[;3?&_(IW9WU/1MLVI&9QP%VD2[3K<J$ZO[7!4__%__O*<^R>TN/^M]=
M4O&]K98B\/_S<X'G:JGF(3.S$@=T@YFYS!^0?H9_9HHKL.DS!<Q<-@T'7$80
M/Y;IN#B!<@U+;@D%)P "M*FSZ0]YQDL!^4>=[?6O_XU-C\UK\R6OWRUVZJG7
MXY?QS/^PB_9X*^+K\<!Z<:1ZTU:KTYF,NL-A=ZC"4;?=ZX6]7J?;>UR:?A_@
M_JTC2*]$Q!XA.U7NXQ.MS]](3^U#X7LI_,JD\'<=5?]]2>-+A]1>O[#^T0*K
MCUV_WY?UOE_7U[6NOV\?Z14X/X^*S7X-FFXGR=D@.!AY_>D%(J^_5>AU77/>
M-]_WGY22Y 8'PXU&S82FSR[-@MLTAYXVR.0'$S,%('".HM6"#$(B*2?D=6K"
MDV%9IO!UP,GX!N*$)>JUF_0^F &!N/Z+X'FVM+'(^,J<5+8JV(V%GN@$B+^7
M%;\!7'1WU")'D DX$*T(PFME2:U7"Y4Q+[LA0L^C=*&" W5T?13$  27,6E?
M V:MMP'X9L/Y9Z1Z/CK$-D%#D4SO^SV :SV#I?JZ4M'-H[4=(U\N7;S+LOSV
M@]VOFOV_K>^L KK+'[D<J[TOQY+_&CRMG(@O;^SR#NYO%';3P"UZD!PB8[M>
M3X@E B,*$*MB\_ATFLS$K\+@5AGT6+CNWB7S<([QQU-SNUVHZ]6," [&_$ D
M7:>>?>[7?W=Z=C$VW?H-/0(SA'F0WL_I^<37"M8#$9M[W?3X #.8 ]$9Y'_+
M+)WXLNEJC8.4N&?UA3V'4_)9+0^QU4B/1@\';8M;+1!ZTOD*MAO8UO779JE^
M#2,GR&%\MY5Y]OHN:\KF],-VOSN()BKL3;O1M#EI]7JM]B >1'&S'7?4,]SI
M3X;,JGKJ,^!>/D/D:XVO;UWE=2TNKW=F_2\.ZKF+/#U5=&HG\8O*GRP03]O[
M>NR&],D;^MM;.5O$=-:BS)3!A[[Y_B \?,H%>8J^(</4:#W_H"Q CKYPX)*$
M"ZO5^BM?$%@PU @6=*U:GY;1@ACVQX %@7\XR1(UG3TX]QE13T) +)VH67J_
M!NOD-98@<9OJH!5U)OUNJQV-NN&P%8XFK>9H.NAVIG%[T.ON?<&7&\AO[]7L
M5^VK7K5=U/7ZN.)PO%W!IP-$ ]UZ:GOX\^#\[,,O!4PTUIT^.)2%00/(L$AE
M\X2"@5DPM<Z(_@NAV" 8UMR@A(51I!5[ D9\,K_3CTDS ]MV .Y-0@[!K0KQ
MH5KK7ZST0'O-%OY,C@T\]>VA&2G#PUFHG"#)W:+>IH U!EX)Q-XE8($*,?!I
M?A'<KI"0,B'TL[F9^3T$,_$%9M;VGM'S,M/2%U49?6Z>FM]!0:U>+H5W$+[(
MWDD/[%O9IT]7L]E#P[P$%D'OTOU-XH^6(I;\$-A0E:]9#_,/_32W-%C'.WL@
MKQ( VO3(T<M;I*M<WZJP8/P&P'*;*$'7"4P$\)(H72UFQ%&@QYC.*JMW:_VP
MX5%K9Q?Z;:K7'65MKI;!?9HM;_ZBO<^,RY+M+VE:^$&:$(:+X2>]>NJ?J^0N
MG*GY\C!0OT9*S^A/K8:^7^'__W]_T-S7WE7<NXH;7[IW%?^HKN+CDIW#H_;N
M*EZ?&)M:]&"&$)WK5OWE+]"/ HJ;\HE_:I/F#NPU0)_3-^<UQ5BWNPP*3^WP
M4^&W8"QPP'5YGWI95D 2HSZ8.,5Q9]IR2N=Z/1_< JM?34=-AL_"1"7@_?%(
M9^I.P?3H5EUEF7ERQ6VT?L6?X-)[.8G]/;;FJ:]#V^_OL4>_='^/[>^QDC?2
M>4KL<IPI#EYJ9:^BU3*Y4XR%EQ7 IZL\C*\G6;57R>OFME?)CWWI7B7_$55R
MD4EI9W7W6!U7D4@).U&_VVRI=G?2ZH["]K#?;_:ZK4Y[VH^'JA/9,IFWEQ_?
M?4CRY16,<(-"- .LI(M=MTW20L^@L*6&.=64_1:*BN1VKC?Z__(X,2I3ZZX;
M7KA:IH\<WSOMK"U6V2+-]9Y".#:=-D2@+[\)B<T"R".@_#0%IVJVBA42B9@*
M5KUQ:IDW@EFB_;T8\6QG_/-/IV>?+C$6.TO"23+#*I6CW]H>^4U/0C?N1YUI
MIQ6V)ET5CR;#_J33G_8ZW<F@'[:[O]>3\%4>!0Q*J.S6Y!THI&!R#TF.-">S
MY!:S+OITF%1,#,_5O[K.TCP/_&]A%3C0JL!S]2-B-4WF'/B?*FV*V&!,L Q_
MM6-J!)/5,LA"#+KP*<RUH&;+,)DCR0V&5OB;E-6 HK-8Q:N(DD+E92'JG!7F
M0K88N\F#O$,T=\HQY9"=P#?EX2S,$OU-+CN',<,"TH/PKP^V)-Q\O1'<)O-5
M3A0M>DNPN7*^Q*C.'+9BH3((^<P Y62.X9L8T%"\AQ"&RGRN(LSS8$A*A90\
MHW 0O!NJ&?A--*NJ]4#(%)<[RK5^BQ2O-SQN-8<'XW+"(QJP@V$P#9,,,FLY
M%_97BLNT+&$;%E3-IO#EYNBOI@.@42N)UVH.HD-D0_DR6Y%$0KI/_W>IA2I3
M=VJ^TN^&Z)IVH>(@7F5FB2((T\5A1NC]N"=5RU.Y179?UFP#[I<9P8M< $$U
M:M4&!, _<@5R9U^!7!&J^&'GJ+J?]C]V)!=: 7X,LZ4^F/E-LM#_NLJT;M7_
M_<!7Q@<VBAXX?H%T7?.8E<_)?(GV$KT&2@AVR0&OO^ZNBGELR,N7*PBT\1>%
M$-7W\]Y3K6CR@*L*]%T&%0U+3&MS.,95-$!6^SK-8&8'QS<J^HSD9Y*'; ;=
M2X=;3VT[BPUMK78\&?::JM?N1IUNL]T-A^U)*PX[W?9D,AEUAC6VUK.8>T'9
M<BD1"+JSXIV:"F>]Q-!+U'-ES[Q*AY:^37R&U<8B]N-M\0PTM:J-L4T)$+'#
M6)VOC^_\,]A%QA320G7)ETCG(#P\:!\:N4(N."KNR,,[O=ET7K!J/70%^:ZP
M/M%W8;)<F7*9NC?T#@_&WDM,"P&TKB%I&W#CR7P96&OZ)_U";=5$(8CB\J'2
MK2\M9^%2<]JHX-$\QQ'HA(,P&K:B[G0T[?;"UDA%<3,>1--1?]+NML+]$?CM
MCP"=@2S]K#(V]V*ES;&,.1*Q7E?KWGP%5I>^88SDMGH5;(DGOVH=/;]6@C:Q
M*VD37Y^(QFK2FFKYG$",J--I#UNCN-6>QE&OWVM/IFHOHJ] 1$%&YVP68(MP
M&-\E^689;3<[1DA/W9?']&7![=G%$H.:A\&W+9<G]7B]/C$>#*)A)XJZW4@-
MNI-6.!FT)KU1?Q3VHE&SU:H+[.S%^ N*\5V]%,\>L"J6RD34K]KAIII1B <8
ML81/H%?+&<?;),?^>&JB%R)_,#O$7KO;PRV%__6)<Z<;]Z:3Z2#L:]LYCCJ3
M:-@+NTW5&42]5JNY-QQ^>W$VTIROLA"@.2(F8*ZV<]L'K8XT<5^?R/7BT; ;
M=[H*;-4PZ@_#=K,=M=KM:;LYB'N=O<C]]B)7L@.,T(FKF]1A0>L9=G"A]*19
MZA&>2V49+2WO.?)]6[23&.KZTH4WB#K)UQY>=UBIBU_C.5"3X4!;$E&_W=>6
M1',X&3:'G; _G(Y&7=4,>_MS\ K. 3IME[<0S+)X1A7B/DLB")+'!L']T]'E
M4?%KX_@VF>MMI*!AP9KH-%L'$5D3L97@^O?:X]4;OFZOK],<]51G-.STM8/:
M59%6^:U)OQ>IENIW>IW!7LA?@Y"CE%^L(">Y3LIK(FO#[MC5Y\VQJ@I[G-Z%
MV2W&[>C);X4F?Y4*N=<;3(?3YJC?#D?=5CP=MCHC[=Q%72VTT6BPCR/_]K*:
M_ J2NIA!C6@.6YOD-UK20F(>F4.2G)0PQP\:&,]=I%"1$F'7WP1"NSEE;3C$
M'%ZK>?1 W.604@4)#3%=XP(1^-<UCS+]?!,UUR<$E3-\7.3(J0\2$Z0X_ANH
M$,",+176>+T3Q=D'P9]ZIKWN%1Z<R: ][,1:H0_TP5'=,&S'D\FTV^RTIL-V
M=V_1__8'YU<TZ(TX6C%%2:QN&[Y*EGK_6T:SGYBO7B@@IT$M?DI5*!:VW5HE
M@VZMT6^?(TS^AF@2%CY'K"(")DQR C'"<XU#MCF91O6E1!+=.6BW#BM/DS<C
M/9*&:1#61S:AC!"FJQIK\T^-LE?>*,0WRT$H5CLU>X$U0VM5@] $]"A90!+K
MK<$R('Z87,_R*I@%QL>Z6B)<:WV-J]D#+#F5YG Y$P)<V00R+;,M:7E^S;3G
M^:PMZ^CNRSH>>U^%X6C8Z[=:[6@RZ?8ZP\FHU^EWVRILJVX4#Z;[^^JWOZ_0
M)5EDR1T87^NB034W0-!N8D"HW=XV./^Z'>E6IQ-I!Z4]#'NMKE*3(6 43?K-
M00Q$1=$^[_0:9);"IFEVK:VH?S%)'P-E>;+9PVC/04>(IM;#<WWA7U#MI':D
M8^V\A'J=;9D9_/,GO<5A=+/25L$2\4;R1&]IF+D3LH3:,S8,%JXJ#7]C2IAG
MMA[-GB&H< 8(:P%- A2&4 1JJEG1&XK^N4HR#P7%_!]^1>);3L$ :G F;0MK
MYO6=.36*HD$G5OVXU]%G+IY,^]%@TNH-II'J#J=[O^95G#F\*<CPA4+S4N\H
MBC[739LC8<Y=DN<K]R\AOA-%;A *,1ZT=!;;B,$CWA96#T&;U#2&UR?]0RWV
M@T$G5,-AV VC2=@>-EO:;)I";5FWL[]Q7H/T0W*8J 9 LM!3@\:"7$)UN5:O
MA@/X*. \H232]Q$A<O#7?#W2!Z$^Y0+VZ?5)L!;?..K&PRD8]H-1/!SU!]U6
M<SCHQ2J<3O?)AU<@P34"'&AOLQ*ZI@:X9BN(F2*ZS>,D?PN,&SA_#M4&PCEA
MV6"R*#>*P6VXIGE*"#>NJVD+D)O7=_:&K4X<QZ.HW^KUNOKJ&+6G_>:H,QE,
M>YW6=#+:G[U7</;0=&*/86L[?7=GH=XWP)-B&DZP3=($,#'6RS'C/%W<: DA
MZ$33#$='EKU_X6,QW&7_8 (=!5AVO<C2V]7L&KY=/H:NC(7CP"D>6$S4?)ZG
M]S,57Q/N))S2+$%ZI&0ND#H1%]GX7[?A<@F!!0KDD@Y!0Q.[!^#XZ)516I6L
M&)L2H^Y9PDSP69)_SHT6T^-&'GEM7LI(*T0P7M^![_=[<6<R[ W;_6:W%ZI)
M/!GTIA-]^/N]5CB(]P?^-1SXI.*ZO=&N#7>_7*<IO%M+(I7)*F+$RE 6IPKK
M8 &;%D9B^%'Q7M5'4 _!_1LR!$"B"JBXW&PK&\^@6QD_C/>ZZ]VAEFF_[/:&
M3C@^'G*]>?!/;0[H><(0?1-!:Z/R :_J=X.<[NH%\A5//43=N!V'O79S&$63
M;JL[F4Q4,QQTVJ,^U,NH_:WY.@Y1U2F"BR,1B,;V[B +C[-] AY Q*SASN*4
M9=3#,L;#K<LK@X/6(#A^=Q&T!\VC3L2)0'I*ZQ#88!X3ZI 96?KB?;K2OY[
M55@^8^5*T;JP?$?2Q1':@;$AM+$Q6^&1U\I&GVBR C@?Z_KXHL.#%E;*>;\:
M.!ZZ5UE<-!QTH\% 7XS-N-WM#/31;K5;JM=2S6Z[U>PV]R?[MS_95%W$YY<6
MF\-Z?&R+0HVV)B>:6JW#@Q\/W[2J#VYE*Y0^N71P>T>%AQQZ-1/O:"CG.!16
M%K9R BFMR&"G-PN"QUH+G@./!4N^)JC_*-,>C%DV[YT5*_5$R=CWG/]G,L#Q
M(=Y.KK7$RPNPA6D>O&:K' K,)V$TC;0BZ,;-P:@]&?6B27O8CX8CU=U;Y:]
M[51HG6BFQ7Q9;2P@9UU)(S0HR>#+.IT!+=[Y% XGTOH XT^003R+JKAR<52=
M).>$*B0.*#Z+'D]"2>_8U_Q\P9J?WK[FY]'U$^U8=::#4:LYZ70GK7@83:)6
MU)R.HM%@VA_M/:O7H A-VYEUZ"F*IOV1?$T HA!_*(8?2F&-BGA$90Q"P"V
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MD% X!3M)5TL_!H^%?4&LU*V^"0 _,LPH,A\NH$XN2[#T'6"$4$O#A_6_D+;
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MH*_^594E'T_@O[[YSI P?:+U&+OTZ;D!W[31YH,O^Q$)9B^XU(YKWSO(HJR
M!1F>A /8WX$:*R>I-\C?HCE\_MD(U_B,.-6+*)G> )?NV0BW"7VA"AF7]Y9B
M$]$VQB=N\K2YPDW>_K,)(SR3W\&2#'/=73.4H4_X&V^9#W %T_5TPSO?N"'5
M!KCJZT6#.R"."K*:JNR?B[QB]C5"M]9XNDA9[T:)LO12^NJ)D\I:/-%=!SD
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ML5':-+CT]!Z1?32?CWU\)?D ^OZX?("0 /QLR0"+%4-M=]CZE7,!AO48ERE
MX9_%C*R>)<S>)@RIF)1SG+BWPOP3W[;\IR4 U.V[5V#?5#$]7N;!(U+-]6->
M70YK]%Q2%[\1IR505E%/,JR0PM_4-<P_RTS$%/?CYJJ<>6_R0S7%S5I%?9KU
M$1G RUQ_52L#9Y2-RUD&,X;7S)&0D5.[:F-OI$"QI4D_.>;BNW56TO/@G9>U
MXGK,ZE=;UB-2W\TRGK4FR;T'B6BA'-KY +!(4@46R30V$6^XB-,\&8'>#CKY
MF+D__A&KY@L8["J?XX^_E3E\&!6"184^0 T<$=,YPCI1/8)SR@OS1U)_+I-"
MU Q=,YI$ERA)"B.7*'4FPZ_:WUQ2!:+0S).[?DUW_=Z3NW[]>\G(&!Z^SMXA
MW]1/]S*DEZ&A\.V6$UMZR5N!N^!U5R$UCN3QLX_(RVX?6O\R&3,&F<8L<-WW
ML[0] G*@]4;Q,'+,,%4VX>R:Q*G"2D-DQS^K.O,*F1LJSOCM"?M)-/A&7X(3
M8BB88N!1-BUO-KE:? 86GH\;8'5T_$(X?]/83AR;D*R;BK.$:$(3%ZT@SR F
M/:$V%Y[=1FU\L3:N^ZC.K']]%F?6&HZ:Y?9.**3VV2VCI+]R^FYJQAK&Z H^
MT8$MZF1&?Z;@XVB=NNDUMDT,R1_AYPZHDVS8%?^-_#E-!$*NAAT"F?1;64DB
M<--;T_.8-8[+BAS7WX554^NS7/*I'R63]?,15;I:D=KJ&RE\/;AIYH]H_<P6
MTTN&;^PZ=#H),PCO(G$N% D8<RI!)E2<5FWY&D6Q,+,S+Q;E@IQ[:39-;E%,
M87K?P^\C:6*^<B;@&AO9:F5B:^XO"+->EO9+0;83L::ZS>]-TA1Y<O(:3<_N
M=CP$<*$K3UJG/BGJKEPP,_M0;#2DYMK:JWZYN\W=\2ZJ).7 V^U*8X8GU"W*
MT%&Z%G 7^B$D6S6<&5=6L8GQMO\H86SQ-)B_-;*(&3\S,=5VZKLQ9]'*-]VK
MZI(9M[RSO"+RT+LG9/SAQ5&R+JW01; YQBQGI[;<+ZQ0J?BK;60M^(H<:<9O
MVKQD'6-0V[)G5>"K<E'5UAF@P^#Z*WHO*'NBGG-H>P*,SNY[NC!>:E"V403@
MX"0\^8$090VC5*Y)A .KQB3%?-+[Y[24&H@T0R\8QC+0.Y5>D[JOE&W\SUA*
M8YI\EJGE#6RZD)W:(-H:V$.R3IIH_\7V-OS_:+XUVXI=/BA^8=,E H3S 1Z"
MJ07XO!CAN^MCK!F.M_!TUL>!>KH;4!%,S6@U/X/P2)JRNHTZDY6'WP.-SYOI
MK89GPONA"J1\2"Z^QFQ]9F0 DKY3ERB_L3(@&3=2"3):D!NT*"6%"8-P4L76
MS7]J0X3$%#+RLAI64?WAAS=E-8O.G^UYH25=8^J* 9:$EF2/SCIY6/83.?J1
MD^LDG]*[R'[HEO@1L] .+NK,#+,3R6MF#SC4,<&_)AAXB99^@;2G0D(D<V#)
MP/WQGM,8%:C\H+6.L(@?E+)Y8^ 66>_W38BX#17J.[M=92C<7=F?B^7'(O2B
MW B"GLJ;81PK.-]6$-":+'Y(JZ=R"A:33,W,5]+M;1U3VH[WKI9\D_,3T]M
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M B'[!#Q2:MS1?\X"%AN.H%,2#E>U*!5XG+9R5S@]!5$%I)Y:/ZS8)A8"&F9
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M[[A/TG:YM-W=?I*VZ[,<0:X[>QO]>G;Q]O3\//H5P_SOWL2^2IM<*^\22;@
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M1/CU9R(@_QO?=KQ47Q>!$2F-]P[V=H[2G</Q9'M_;V?O*#T\W!D?[>X?C'9
MS.RTM[NS^1V2&B"K%3&N>HZG;^B[T5QXK"&Z:PE;U56"6EYQ@Z,ZL^R0=);Z
M%MC;K):>RL,D&IACBR3;)] F35_X=G[ZGT2X>]GX^?YX9S(^GNSL9^GAZ.!X
M<G"8C<:[D^3H\/GS)\*U8QG-G9*-1<_&7(RY51HY"81AQ^>B!U=.-E,C:_,'
M+>WM%7BBWO6H-]W;?[Z?)I-D[V"T?Y2,DO1PYWATN#W>WM\99Z/1$_7:L4I,
MYP9;2@Q-!#'W#3;,>=:_R+7"Z5FG5 \ZQC2GN46.?Z+<]2AW='"P??A\=[*7
M[!WN9\]WCD:'2;K_/-N9'&7IZ"AYHEP[EC6TTVR0*LDQ@GTB9W-I$ \_*Y<,
M=HJXI$9Q"_:NSLLZ)QL+:1^>($]4VP7%7T^HDT(QSN=@L\'8$R"C:=Z8/%EU
M<9XNPGH7X>#YT<%!,MX'162RO[MW=+R[?7ST?'><'(]WP$ ;/UT$.Y;AMC7W
M5?2IWZ-0(>AD:MN^^0^COY#25+F\XHEFUZ/9Y/EX?V<G/3X<'S[?/TQVCT?'
MD\G!Y"A)CK:S_='DB6;M6$GA--U49<B:XIYV 8SM+X<_.. +.\@3J:Y'JMM'
M1T?':7JP.QJG^X>[NZ.]X^=[!X=[XT.P]=*#)_:JV&N57W,UC H?:)7XB?;6
M=(KMP/,HU4&8[^^/MD&DC_;&H_WC['@GV<^.GVC/CE5?@=8IT2D;EG)!;/X5
M1JB]<+97N7=NRK.>R'0],MW/=G<FVP?9<9H=[6>'XZ/)[M%D?+RSFZ9[QT?I
MDRFFR)0(5$<Y/X"\CG;V]Y^(;CVBFQRE!\GN[O$8=,?]@X.#T?AH__EH&]3*
MW3W0)M,GHG/VOY<9P3UR,;4H4 /-8=%;A4$A1KUK6*T*S'0Z48,/-?E\,759
M YBTQ \\4?>:U'TP/C@8[^XFVT?)_G8**CS&P@[WLOW#[1W0!IZHVQE(F($S
M,O65THV62%-R1&ST'JWZ)SI<+SZ0[DP.1\G!X63[:'^\-TK2@S1-#Y.#8^S<
M=WCT1(?*4#=]>YGN5$-S+>^523Y-;K:^&#W>.RGQK!^81M1MOH5>3&1TZX,#
M!5)W2YU4Z"42ME+\7.Y@S%]:[6'IQDOYJF:/=(*?A,<1R@<G9Q,!8VZ:[-(
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MM1,"ORM!7ALX/T!CPF4#\7#?'Q[WA!1GW<WG"6S6O&E[RXR7[C]Z!H($J]?
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MLQ>X8_BK8A7/0KI).%([UWC"+9=E,44-M<<;+OEU"6^:3-%LC,F\?RY(3U.
M%/,!"5\MU*+<:()>J07_J3&-G6SW\RBIF(-I/6B<U98FSSBH,)U\$$3-#- 0
M9$K@X1,Q!29KN]0]A8(": ,2X%"6JUG>TWD@""V9J=:6,*=^"O=@GW\)CX3[
M@HM0GZ%^ JG+/Q8MBW5#AU(VAX&!JH#-W_ 5H&/P>QAQS5>C24;W;-#C2$"U
MK-",9GL4AYF)Y=R*.3O-VY;^U "&7&C?O 4;OH,[^=\U^;+,IG*0TR_KN7^&
M[M44_P569><>ACK._(#G#-X@I9 '^O$4)Y(3WMXKF8.9Q7Y T9+.I$O:K$0'
M/^G0&)H[%]TN-5GB<W@6&.UDE$UKF!HZD.#"-EOD>@EZ7JBJ@V ':NU6[)E*
MCB%Z 1RQ?V?876@0XTNK_*2H N"2BBWCUFUIL))A":VD.:O'B0F>5CB<0H;'
MKX]_H::@3T4.4K:"3LE&TAOQ:0@"H?H%7D T7X(S#]?!)_E'T"S5,<7"4GH>
MNC[AXLN$OF'+R2HFZPA/<A#XW:>?JIA X68-6AW=B0ME=_528_KR"7S=U0OY
M\"M<HK;]RU??OWWS X;POX>-\N$0_L]7W_GW."=^,;@)YP'X+D/KB/,,CW%(
M@;54H=U?:C("?^ ^&WD"V'C1.0M'O(3K[TSPO>Z0#G@*BW26K=N1E[<O/I:<
MD#OSC%(V(KF+&8FS8M:=X-3>_5H3!W?D,SC9-'EQ[X+)"[NN7_7%XV+'5)#S
M8)?DLB=7<9&3*]GBCH>@"-AV.D^U[1SNDMI8@+L,&PA#Q-ZFH] X[%H\'A8U
M:"2[G*?Y"=HE\!588],/^-^LPO],ZJQ#-7-2+-&U1:L$U1W\>[YJP&@'6Q"^
M!0U0B%)40["KZQ*O4GL1YK/E\^WOJTQ"]577U*#DP.N'.YK@AALTZHF<PNL?
MBHH=MRJCL"8?E(,#*0QVDPI5)Y9T#B8S\;?VW?T5< #Q>6GU>+K5"9=&3B_6
M?WC<@"L8?";JW1V!>2LA;)M'R(]K'(=>S%-3=+DZ*O@%_ .<_]Y!PN\.]V)S
MP(61)YAMA7'+7/=4<K& 8^+4CA^S?'CASO<L5LX@?W8MIN)5[L$M-^&VVX]$
M%:-T[$8848WY/>=L4SOI+^&@H'@[[(GDC3HS3FC@WKCSW)&.6Y?R$?U/VZZ>
M?O 'OK4*9,@<]3$2]KHY!H?A'YE&/-TNL"<PAU-V4QMB:?(R\\[%>6>XNT/)
MN($V>']G3&@^C<?OG^;55M+6\XZR?CMJW8KQ7L_G=^#O.^U)7LZ=BU<J3H&,
M'#)[3HIF)JD]F"K0.V!?+#G8Z+?+;NR1<BWI)'$E$SA]6E*$: ""&8__GH(P
MU^"@P]-I7?JZC@S/&2M$<A*"'!@9P7)WU/AG15FB1H:S%3;'!S+W&E26B?Q)
M7['XNK\P3X=&,JP1S1__0QU*P65,%4@A06606$Q\=ME'6-XYR$K[!>SQ"YVT
M%]OPZE7$3A0;LA@[8H*3A#==Z/49#<\WD6U:5'0YQGC B(;M01?(\=]D9S"#
M()APV.+0"DI-3E=DZG-^ _X .[P L3G.X)*3]0PD+FLFM.JXTHN"%%:+P7=4
M:>SR\8_=1X'=0,:"LQ X6DY&@B9#O$XAOP>SD>[]T]A10^^:\E2EWD4F\X$3
M(ZA%:,+5O4!7%), &M+R.I:>SZ @C*B#88^&+84\T'TKNILOR:>7#79L*\Y.
M0E%KQ2-C5JQI)8(PY(V?PRVG, G_L_7Q'PFZWGP->7H)!7E!N0H#S<ZNI!B%
M/Z?KAB+J<C7'#2@NVO_][A<PI]=XZD0"VU_"A$1GY'([+1YUO_&34'P\3R@N
M-QT((&TI%%<W,_+&ZP]D9;AC4'TZ5M-RQCO[%:0(K$Q05?CQ39_$<^?PTS>9
M9-9]]-@%@L/LN?>^3<@W2"#"$0"^=V"][Q2[Z'O<??(,Y0$19*?YYTJJC&$R
MK/>I00UQ68MN&&SH [[B.9$P-9'%%5<0##+>L4N5X18_4P<7+O[&>:\<Q_93
MZ_Q<G'B'ICDW&D8&Z0EX;[2ZTVP)WY3B*2M8T#[0^M/>NF1_.QS#&.P4K59T
M_-"FKA($S$U/P-L#?^ GGC^24\5T9FUH,X,!OJAGQ;S(36#>8 HD0M_'E7$R
MD),?NV)NHT7.@8#Q]^_/MWE%R5KPM[.BH?@^SH'\.P33>M<9=+:@+@(,(@V*
MT!MDPF,*DWT>A,3 ^X)7FO>";V0=\. #? H.>C#<D;NK85LOQ>D%3YY<;@F7
MI(-@R>@3*,^/:^039A/!B9P.<R6;,R2:'IF9_,A8S(]?P<Q 0PZA!',XW=(/
M_,5C,L%N48B#RC&&+T?237R>@#5W>0S0GS#]<N\V_7)-B+"Z0R%O.XR-R'EF
M3B\0ZA/\6%!@"NH'/R-?<,02X5X<<@?)3F":82"::<"M")_ ,4^!#0?USD_=
M!>87J50+M,EI75 ,$0\^Q:69/>N0'$F9G24")@R?[&!E/LT*YR@5PDAX,KS)
MCM5V>A 0FE(P28PT"G\$MR=<TVG>-,4,YAIO+!BH-GERY_[=ARG]YY'J0?SC
ML44P^0 S:(XR:WJ/V'V&AQZF$4"-S/#(,\%>^.:D/L-\#7W!XPR'#O,'"BGZ
MRFD?*<%KRW5D289X/EB$*/!24%>XKG12?(YG!B T:V3ZP?Q1H$J/<D: ?W65
M&TH@M/B:.BEU=?ZVHCD9_'1H_U$I4N5_-\OGV:KL#*#U75X5(*,*R46K)(:L
MWXB# B%6"4X3D=C-TGHULGEVHFBQ#3/ =Z[JI*S!A&AZZFPP,VSF7EZ&QT0W
M^4'4&!BCR[H5"Q,40M&M93:&M\1L!LI.N\(CJ*AP  0- O-YU30TN/$W9X#,
MH#2&QH/9K:XH!6M',!:VK>=% S]58$\@2$V^ $U(Y3[TLR75)M'09:!2"C9R
MCVO?OMLYS9//CI.+IBS'(7."BFSR.4P; J5PR8UUOFQ@QSKK&_\\+<K\.'2M
M*>5(ZJFF!7#/=_A/AW@+3>1?*SI!WW49H:46L"E0\#CE"3*,J@X6 K5]&\"<
MSL=:%)P4]YFTWJ.IJH%N*^=G.!3O8%$DIV&4%'RXK,&CA$.H#Y9#X[QU.#%T
M)O2505NCTRGHO55E_A:8!*/ 5A-P3D_T*O>G>$OTHR:S<+PI[=/C"!C/9A/'
M86Q;(/&"QZ;VF3V41O^)@RDUQ>&O$;.?XQK)(DDR]-)+$9]_'C]5W?&,T<%@
M8"&C,X9@#T[$M)J?C0TM0,PUD7%:G&"KF5WTH%=F'8-/0,?<P0RX'R E4NDN
M-M$<Y)*UL-=\P!5E\J<+0LK?,/L=:LM5._B*[SL##3K,9I?U<0W_F=4+K J@
M'_2SXV)]UG!JDZOM;H]^*\827 PT$]04*7,X)>IIP:@%+YY5?3:&AIW52\F,
M>D#D=>T2W9\QH;;O_T82^5REPRLEHBZA %P2M<QK]P66TT[7&V2?_JVCCPO:
M=ALB5* N%U0O%C6I6$UR.P2)8J<P!>I%$,T ^#Q<_*O5K?'Q[\@H9)APV'!
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MI'CP-4E9SK/3NO$!SM"]#LE,K*.RZQG5 W,[&A&[6?KDTGCS;:R85W5RUJ#
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M0<+"$D6TDJTD]4Z(/L*_"^)*BRQ)8[_@_N&( 7WG?H5K0!A!VV1K=V#[((;
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M%M:^_6C3/*-==7&T-9^P)!:-:%BQO>2/UO1Q>L9=ZC!(0OBXK=-G3<Z.B]%
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MK,F6Z#/B?P?O=97.PM^8F!+A$!@F0[R_]%KJZB_"<[@5CD\1CN^D%9"O8S/
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M9B"_?)S"Q%18NT8+CAFCU_:"Z72(=9PH+:BU6'N"_*,3(B2".P>TC8MZ!N)
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M@,.VZ9;CZYYL?=UO$EYI=[N=_PO.( 7EIG/^^?KR]DO0_OFZT_G0Z=X^:I+
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M$T\P)@L:.%T>.M0H_)*71EG^<X&0\[5J/&S*,L]8&P(Q5F3Q;2EG2S"+10L
M"3I>%F7L3BM\4:E?1"<P?BXJL\/A=6@+R#,2\O/)>7TWCU#WP"7E8EG%G9[O
MQPI3KVH@.K(Y@(0OZE_? 6^D&OKRV?,?'VFS'8T..U8D OF.0&J4"2P<A-/
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MDRDCN*WMP/JN1\GW>(EM!DQJ4L"4,11!@H9PK%$3Z=V,##;.3!\M:QJ5RA+
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M78)X)'0CHI-)+8+))%XX-JC@(B._-3E(:7YZ<UBRDXC:)&E( CV*L@P>/1'
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M,R]#)\IMOJRM%>HB5O6Z(_SDFO/928<:%8(Q+WRAX<BV6@6F(=$_>(6HX<I
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M[S>=9:WFM*-4 8*3**XN/,0(,K!:*2*<%3:<-*0Z>MB/:M3I@U89[*%PIQ
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MDISX&</H!:?+O':C".7JSJL181X.FM1QU/)@G&3!6NGMS 4..'004*U:#YB
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M$3L[T *%R8@N8W,AYFGM39-T6<-#A-#XBL2.8V@C<80@!#C5FC=6@@HP%0?
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M8VN]FBY\Z0/3@&[' WK<?]\_P9(@3\GG^=.=^3QE]0S[YZ/AX' T^-1GW%G
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M?V-$/L2N_B/!)/BS'%9^</('[./#;>YN7? ;;KI>D02_I<O+N'BLK=;V/ D
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M8UEWN/3/[VW<$NO6".Q8T0PX7M '*$;^[I?OOX\&-A4"@97H'36JB[[__CG
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MA;9M/"8[Z,+8].K ^Q#&7^V;-]!QQQ&2S0D\H#0C9CB>?>+YR94^C\^A'''
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M?O_Z^(?#X:HLGS9P)'5<?FXQP$'+BNMHF)QL%!W+[4(IQ5.L('=#(0)FX#X
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MR ?P#K@0PU-]FN9Z0JEAI"$4&:<_V62/.4,UY+LN>(?GNC1XZ21G)TDQ3Z/
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MI=MQ !,MFHM+?AUA$E'0]\OAO]L)!/Q_.(\!SM&2+$S6J'I$D,[>UAA2E_"
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MNB#!ITE[;4$XL-<YI:E95^4<*>7*!'GWS821CI0^HF" -D\.+)H5%K[T7M#
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MB,2/F[IP'Y7\$OZ,SP,Z=W,#.Z+68?_Z[FNLL$Q_7-;+#/[X+U!+ P04
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MKY=G%KTZ/AI$KP_W#^#7)S_+Y-\##>5[Q<NO3H[_\^ $=W[[Q0_[!X,WL!%
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MT_.L D&)1[*J8*Y5>$A^ 78(CX#=Q60\+H'9X6VPIFR$CAE-IB*G7^&X2;V
MTSA/SGEF^+&]Y ;G<#+P2-.TJHMD.L53AC_/QM%\45:+!*8NC\%L9U4$W),N
M@(XELXL[B=5BMI$0.08A]3:;3D$P1*?9Q^@7& W)<':1E?42_E,L*I12KXM%
M&7Y)G^&7SYY_O[.]'>T#BR=EI9<>13U/=^D;EH'7W>#LF:>#S7F+9,U@1JAX
MZCTB0N*92I-RFL% 8_@!;'%$9Q>/% KJ,OW'(L-UP:_G0-:LKLD[%PU3^(ZH
MGZ"4*RZS,7RA:(Z+%P;+\*)-*]B\#&1^OH0-*30E<,;,1(8?DG/8\'.<T"(?
M%?EE6M9R)<"W>50LZJJ&OU#*NGU-2"/$K55+R*-D!!)^G.0@?2U7TH0K="/2
ME(M)J\3XTEK3+5_&BLJ:1'# 8#>!JN<EG"$D,[PXSY ]TA'SCME (B<<YIHD
MLA$HWP3MU)FH%L/?X;HRTF8"1[NX0E8$69>A&H&WO66PEU\_=4#,G.+]#8=W
M!T7,UK__V\[3[1^BMO_('_#(?CK)<J(7W=V@! '+T>%<@$*&-P8?S9BX3DCK
MB_@Q#@$<FTZK] I_C3^UG W:7-*/1LD\JV'9__0O'AX M O6,Z[@0K3#X4@P
MD+IF\)6S-,EAEV'_TQIH4H(HR?*.:XI$56_8#QB$7QJ,Z[XV;VAEF3^O^N+%
M &[*8^Y&&TR!C#G>#7O .G#ML.ZNM<KVG?,WSG#L;F]\?7UQLV7^P=LRFH)L
M_MN#5R?O7K\#+>I5F28?!O#_'EC]?PIW/:H0]86=;EW,S6SD$_BZ+F;RX0/_
M]5VOL:] ]>WA$#]ZF$QJ#.DDTZMD604#>?$F?B_%FZ)MC#E=9>/Z B>P_9T)
M#3V4ST!TF/#4HVN&I_3J6T),3>=9^/?_>?A0(HBX[J,%JE\G*3#5=_#O[QY]
M]]UW$B&\,T?E59)_*!?S>K2,#B[A-?J,X*&H4!MC;4#+H11_6[TD\6FMAJ*D
M'Y\NAG#FLJ1<XD,HGV$/9B#S1C"-!*0MB$'X*0E5O>-P(8[2E#0V4A!IL*&=
M7PS:9%&>PSG]IUCB20GJR+DH_<D8J4:2%5T%Z;#&!T!MG9B_BQ+,PG%651(?
MQEL#_@TK@<7#A*89*+)C&ILTWPSHE\#'R14Y(F ROX.N4X&)0C^!P>&W*+*+
M#4@0&UE?DH)@".)=.,EY C.J-R$H?DRJN:&F(EY]D=01&]>X7##D,%R.BBW(
MM*?;H,4O81_PZ-EI, E[HXTV$X9&8HNI9HE8XR-FN\SC=#*1?&8K9-_Y"V_Q
M<U*(4$=:L39X-_GDTC%,=[S1=*O%9)*6S,?P$C1@#9?@1R/@F@*>H#U')I]F
M'Y#3T;0UHX(ZA\9$C=D%\Z2D9]EU4X#%4R]#DL-57YZS103/+3WJCY)IFH^3
MDK;!(P#M""U<31.6F6ZTS%GR@8[7>9K#=3<52YQ6.I&5#>&K24:S'P$%,SX1
MO<EF1QCN2QQ_EJ;$]4(".Q!;3DETF8&@@2/!AY/V$]D,U+5,3JTZJ!X'H/E0
M+D9HC+KQ\>!6.*W>^2;3C*/ADG=Z1+LW2;(I^@QP0B,@9OIQCKX&=!B*KZ'B
M98">D))[(!9.!!(6Q*_)",1"6HWPG)">J>4AF* %S18HS!N +"7N0B?F\.4H
M,R:^_@KC: *DP*BCVAR!\!U?AP;RA6\[.@&4)71\!>>DNLCFT1L0]/4G*8A/
M;J(@?EN$7RP?'GX"?4?]WF4[B>^RG7S+1-R[0'4'!0.8-7593*,SD+$5RY:&
MXA:+Z(&[*4>IR-H<*6/H+:M$S4D_IN4H(UE$&\$1%/&CX0Z@?P?DGZ:1!%OJ
MXCRE5UBG&3W,SM1B!$^6)#3Y9L,/R8$H%XK<O_ ?5"*3G 4MWQ(=CY!L)\E]
MF8T7**%!/4O/X1] =/1"N<@+:OAS0X]>@A=)-2JS(2DLT<EBFD8[C\</=T$K
MZ^WTR>&]F)YS4B IG_CN@X\C)OE@5/=QIB*A+[THR$@VHW=UD0K%X>7G%S(U
MU(J<V"FLV*$[E1P/P%;%Z(/VE]$U1N/*/68]$#0-6$'Z<80!(OAC=_L[LW>7
M1<UGR&R:/R9JH/8*G:7E.;G<X6HL2KH BRFJOZFYRG%S:#WO8,9X<\NMRW]J
M"JP=R[Z5@CF\N><9:7M,4KR@2?6I'4<S'Q%M+L@IZ2TGRD!UA;N_QHC0O$1G
M9,L82&_8AZKB8Z!HY?S'0K4Y:Q833\N@&2Q&2&L\*\)E'&KR?$5ZVIX>7:6H
M-^%0^!/61*=3=JU;K1+CFM.IT7G$?XHZ2ZYWP)[*/YXF]"V>3]+-F Z>1% O
M=F?7IPJHZPE&!##*R1ZPFJ*\-<@\I,>8%3]Z$#]"7G.N>U3(C8^YQ# F"C/E
MY#>GUGKV4"<N4/7#1<)['L*%,S%KF5%DI#)_OBJ2<HQ_[&<E<".ILQ<9D$UT
M>E8)03:@! *Q_GM1!@2@@5"E<]()QT ]>).W25"C)1,HZJ$ 6:X8O4I+MINJ
MS5Z$="6I>D5#YL4,7JD]IVW4@,$](GC'7^AQ'>(&A,E#6=\G<8.V#WX!E]2(
M;'9\MSN?$[HVK$<5IL^[YLX#6BQHL='5 ,_*KI*Q-D0?4"R1*23@Q!BM/&_V
M<?@:R6B:+-#O#%>6'YYBB4\\/@0B??.JRK2@U'I*/6KZE(0+<6>RT6*:2&@1
M%0$RP1,ZY&!$X7T\DK&&&,?%\3#,B/IC*;K0;(;A5[Y#\X9HII&%P4!?HIU^
MFY0?8%M1+["O0<Z:%@4RY'GT9NO=%LJG)R]W=J/YUFPKZN%*_UZ4'Z(]9'64
M4'UA4KA6LXGS[>0B<GFN,B.:1LRQ29Q)<U'M4]0G(T\3$G]@PH[8'6)'#I>B
M"7##58WZ$HCAM?ET%KE(RYEB\)^<'?]8%/0OV-UP'7AUP4"TU,K:P=Z8"0GK
M-'?K,%+Q;"]ZM9A.T?' TB3&S_[??_%_7O'=H#,^YEG^ 3@DA6M4&,]S-"Z&
M,.<+WG,<_!W^_'@.KY;9XO52)Q3I(='+<^ OJ^AGU"VYN(2D<V)]A=H_2>K2
M.3D728,0YUQ!5_QDD=.U6+%O#-<KD6H@3Y\UGUE!IP"3T+IXOT'#JK#4XUT<
M&][4!*#GJ\;AP4'MKA*11G"=PR6.<7OR1219B9("27293!<F0ZOU*)+.C>$L
M0T96W5,@\YAN?[A.$M!H246">X$U\_.B&.-[0-P*Y24@C0Q4I@FH0<D0E0R@
MZ+R&?Z;:_\J$FZ1BP:0?YU@K5 5^%KX$V  =2H*(NE?N'2VW(/^MC;F!S9\8
MR\PJJ\ UGOU_OR6WN25AHL\U?3')?3#T$X*A'!3TWM.9<GR]M1/I6M_VP*.H
MR1/+BW+F:A#Q!_:S!S\]ZJ@7^-8CO'?J'#>TZ^L=Y.%7<I#OS'Z<DE[5XHG5
MZ<OBUFI7P="S2DK-8@Z?:4]M9\JBI]D81ZS+;_T3)B[>\@8=7$JX=S^=)(MI
M?=,#\[SKYON&:/D:;,FRRZK_R_;6HT>Q3GY4L=Y)8>R6:CX%$RB6O\B?!2:!
M_6 $QJHXI*K8CP_;1+U$;"<37C7V%[MLOOE-@ILO0:(GG1&BZZ6_C;YYOC\T
MKN=WR9+8^5-4Z$>]G6^>H&_!/D_JHEP:J2S5FDVIPB&8F0D4XI_G!-]!#N!>
MQA]MGN_/ L=+O!)/0ZA9><XW_$?7I"DM*2-)U!OTHW$*RT6?22^;R!\HJO*B
MQD%UR02(2(8B0>=(>$_UO<!?-%Y0E*3WJL\>"V"HR6(ZC=F= 9*OI#S]))J2
MZSM<3!S-8,P,9&_#08A+^_6WP;L;K??CYU[O<MUZ+\ 4@#]P!>SSRH G=AZY
ML%8K;WBI5RUL8M*S*2['.3ST*]+F*OR/]2[A3TWR("P29"]5*.$",O1F5G.\
M#O7HW_KI)PJ?2-G8S<5HQ[UT;\!<=S.RD4DKV=QK=SWOT#?$W"U!W/9;C2-3
MDN9'Y;UD_N4C/QD'\YC/DW(\E80/C)RY9 +YP,@L7V'6C^%X.;F#.(4$DRUG
M%.%D?_@L6:(WW.;V@#*-BODH99\L3>6;WUJZ"#@BT;3S(Y62P;^\)YHE6EB!
M+23C=#.,;&).+LXB&\'1H4P$5U!G6++0]&\4]3:+K.ZOAT_?OB95VZ692Q5L
M+<IFW2BAP]%$IT'E"I'X5)Y8&+0LC%B5[8]Q,#1SQQCKG!7C;)))SOUB/I_2
M:^'O25G,.)\(N03_VU+PBR%9<IE]ZV=5;>)@M'ZC!ZS7,AJ9W@Z3J58NIJ(@
MPV6TF(K?1F=;UK8@_)NG/=HHF"IUFM8U\R\F_F7%N,,H-K^OW._G]'M;Y\ Q
M]43=^R8M8S]98H9P'IXR<P+Q=3O/?B!XDAD66 3Y''1LC&DC\C<,_V.:*F=W
M:L.2JK&F&2B:2TX?&!;%!TPI+!$I$WY!"RE37 !>!_#.]\@>TR7^DUWLS&QP
MRN&R&$[!MI4K0FI0J)(D(W\[)N$"3]Y?!+? G^2>W3=[]VE!Y%$?S?0O?^3O
M@\ K@L"/[X/ S$!WYBPR/H(]D38S_8 RLF^]P/TNW[XWF(T#H7BT#H3"QZ)P
MD!0V$( ZS<]2:_G.0GG0L'\>2CY[=#-*)OTV\K1\9@CGP"Q/TLF3YR^V=YZ]
M>/I"P"P=5?6N6$HS)X/*7B[$)6]]M#47)N0Y%@.5HEV05$!-B#(G>\^_Z^,?
MGK\7'IA] ]LT]+:I^?^CEH_0XI,8U\\EXM$Y%=3LS!DE]9OZ%B=GDFB"&E=O
MMQ^],@AVH&<B:A GKL(X!O )?5:@+*8UZI;B62>/N:OCT'3\DSG-;[IAHS4;
MUKY??JCG,D.5MPHW3/WH! ](U:&9R89RB8T)NN#O1AP3$8U>%_RPB>W;$;IL
M#Q^#_<VFUJ>)02$=U&EQ5:KZ0:[S",-%;G%&'*B,WB4ET9C1Q?SP@,YBF!*]
M#^R,RZQ88$VXPQ&C4C8_,Z?I-7 T^],EVMR40<?79E#]_Q&:AXVV6G*:1-14
MK8+?D_5V<T?)%$M&5'W ,*DR=H2#:K#]< SB90D:GG5")*,:[P=K!/M\NJRB
M=)K,P58V$S"3 J5M3$P$?)'+7DN&56-69(RBNXG\^)CZHF2:=7'HDEP5I<['
M"@"/'")20U>XFC?\T03]7U."8[1/?P-,EU[G&N,+K,Q@%ZMJH?A*OC[XB(4#
MY(BTH68G"1G7*Z:H[]QC U_Q$,Y2KFWZC!45=G(A'D3>$FFW-V?3A;)B^-BQ
M&DV'?D)O:-EJ-N,H56H$])LC.>9,#M[':[W:' OX Y^SH72XPA'4Y-RX?[A>
MN>3"Y43#I/DX'YDM=+(5J:8Q"RPS,PH?5J(,:51"\(+1\B)_Z-;"Y7H6K[",
M='"&XE=361W6T*!B8L^2N7K\TK'2EB79+6+8D 4=.@U3V7C85"[0.Y$F;EH-
MG"/^ZJO!B[CIJ9YL=JJ5[?46]':)#;PS4,DBJYOG_%VK>&T>8Y;(]JQO).V]
M8C+1-<06X<VUWM-B,J&"-P8@( A;C()@B2B^:II<@8)"BK M.WV?9_B;TSH1
M6./!##3G48*_]\JL+Y-L2J^>P-W"A?;%HD9A]A!>&\,+QXN1J40;X6T$)M$T
MR6;F0+_''&.%$R03<+2:&#;V,1-]W=\_VE6=)F,"(V*$)#$EPE =OS5-+:$X
M'BVBDY*?Z=3.:197)8+*YB:CJ!9UJR'1FW+<[1V&MT6DS 66ML!B-LYPRCSM
MSY!2I%JEB+/B\'Y=E^[YM8_G8(95C%+\V*;8[3':&%7KXP[O//? R+H*X,GJ
M()?S8_F]4I%Z:8*U?+8.-O& *<15UC8S&MNA40<W,QQSXN'T'Z@YPOFL+X!#
MX!)*9W/F4?X&V'GG^Z<_5HNYV1%D(0QAFUVAS:B+^0_1-$,0 O%9[GA[4LW@
M(*4ED+V^^/%[&.TG=Q@S@AT+NUH$X"L,>84>$B?K-"&83*!U*I#,%J)X".GF
M>.&3K13T*RA1<B;5Q9_H:-R"'_'Q%I-L0P>B.RR<_%9:0^C,H8, NQO@F6Y_
MXM<;N_I4GV0;_16D<(9H@'3^4X=\(?#"'H9S*GO 5RQ!0\BA=S I;9G&M@7%
MV+[*]:SP3$\] 8IH8IYL6M6NZERNWXH\(? O@X]2);-T"][$V!]P)3+B( LN
MY0"9& 3W,F WDS_&"%"\T$_D,]JWKXVIAJU,Y<4#+E.I<#DQ(>MVEK(@ZA*K
M5F4R([@SV-MF!RO]P:Q7S$^"08U'$VL3S&G)\S,<(,C]A@G0J4+HB 3:.,U\
M4/R.(5TD/IJD8X:?A(\IFJ_1J$#=;22#_ FY[CYFO")F_.0^9LP,]"7C!VN5
M#SG8<!DT4O&W4-=DY##T78H8<D"RYN;P8(\GK?8AR0;43,_%@C+?Z-U$>51C
M40A+&$8Z _DCZ%0)9N[I>YFZ0*F6,^($]M;!34I21MLS88@F^*IXAJ@N1'3:
MI#).*]NQA#RO>/_;2A#3?@!K45@)YW(7?Z)@XY= 04Z&RZ5>IHT"N8491AW]
MW%.M$PJWL$9@S%_?W?;5.))N01U_<BUUO"V"=AL*]\[6[K>L<C?ES:_%%)1C
M= T'A/;V85!S:0-A_ZWT"+A@8GL0)0@D&_W+A^TD7<RO+-,5]J/I@A'';0!&
MS&N2)KF*1[';*.,\1));TU0@J1#@+.9@8A?F$HN]8FXU<ZOVQ_BEHTC>ELO<
M"SK-*,2 J84U5HZQP ^O 8P-\-X6A8N-?DFKE)BO&[Q"<219G"$$?A*U%10)
M,A-H">30,^"*25TGHPNA*GK;*_(DY7GZ,1H@B[#G D@1;5RPU(\C#&P FXNY
M1.+<XY9-BO]"=XIN3:7VW36=LDAS@B]%$/9N/RS#I$:D]WQ@.*^I8!=6#VS/
MX00AYH*?4-<A6G5FDGZ[MR%X5E/#SE(5@@(;FA*@QH!T(Z,I,#;\H'M\ 2\5
M;=P3-%[SF$V<M+IF='ZQK-"G-ETZ4UCMEN8^">KCJ)@\7+;;Z%YKJX90J JW
MN5MJK6K>87J=R7.></6ML=.OUX4L-]]8WR*YRIUQY4CH'5+DOR ?QP#8H88#
M*C!V%)+^0JN/0:_J=S+V)&1I^/&6 A1.K$C I10DEP155"K4FMPC?1$0!A9A
MF+VTH2!1O),%X43P\4Y-A@@AG&;5?,$0_-B1 5W^^4C 5PQ1_%2 !B<.4X/M
M/.5XY]@BVB4U!Q1YAX:5R5.!BS&;X&T!AG4![+^V2]^9%O=&79;@"('F,<Z=
MK0FT2C:8*GEQ-4W'YR;VC"8Y8?K6!!_-8'GF2E'M[&0<WZ*"FPH&2.8@:EV7
M%Q]_)HD(IC  HV&*+G)N]$>9/HZ!5O.\>"(<%#$1DW](O@.KW$\PVF>3;%KM
MR[OK9OX\OJ>N]"\&9M&97VH7&4+2&D(=&2CFGFN)A5Y:3<Y7!M:=H[_L;.WL
M/.T&;NU"C0D[1\*4&OUW.^&POIZ># ]WGC<LBA?;M^(C6)/O_#9%OV VJIKJ
MUNV827>(Y!YY^=3>BH&:;9!H'AQD+G,BFX=N?@K5[WGB.(P(&G^SKO)NCF@
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MO+WVO>PV;]MF_M4H*T>+6<4N=+$9J$#<E7\165CBJ-GKOGJ^9&RM$4D]\+Y
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MXI' &:;T*)<*&B2D*UZ71#=*@VP7HH*ST02=\;,_ F^6SN;L@,'PTMG8D*(
MHOA=969-H"9G]HKYJ1(HNC%\C$'OXT"W!)$&)K^S<@@CYD@F7#!(#E^\V>=1
M8[BV:)_X)R:K7]<7#7]HTWK!TBNN.!_QXTCU^EF3^!OU*%%WPC7FZ;2XLN#4
MZ.LW:'QF-*RE.2]\SW-'V"*(%P<3#8-X88DQ&AQNN28!D5RMZ69OM-;S2O]1
M>XQ ,L-5%C_&GCD?#=4#L+\7QE8'<F\^*1X>339_>KVLOTI'227=E+S,FX/
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M?'@$G]#V%NE@2!O+/8NQ#KA,T*;71:6V/')D.HMV\%4+L']C"79;E$*CEY7
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M =9DF%T>HK<4':S9A!(/R[)P/:,GJ33F2C_.$1O-WE >)S1?/"S*/ S^W]F
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M8&5C "LY3X.XNT"AXR!DJ).!<O,M_;E<5!<?BNC?DQD(I[=P,8+&%D?OMO:
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M[VNR3CA7G[TE@WRI\K-TNK1*42.'A:"3B?:XTJN-C,'H=RGU3RB%C\7:\[O
M$>STE2T?< ?/O=!H8^:-]H?^G$1HM\Z,8Z(&W$!+-W^IE'!7@0+%O@WN>0[Z
M#K)HSJ 4I*(CE+O?#(_!J0WB9C$:)94*K"))?&L8Z0$*5TD'S:P?!0)VFD]9
M,>(+2#1UN<R=BWJ#N7+F'$U6-]IHG;[[VDQ^0_:8 1/[F4%_0J_X9S^<D_69
M8;K !D@NY>K6K;GBW&65*9R/(XS<GG/[1E4^/V4]*1HF4X.:$QY;P7<-')RD
MWTM$)YP#O58IH'(ZWG'B*YH?60F7 I8]8WPH,V5_.2X/9D.98_+:8!@;G^'!
MQ)A2PU7KF>P^RG)7HRPO[J,LS$%?0A*=;Y"C"C+H?06VHA4^]NQB204N7ERB
MN2K=<R"I'&@0/=)^CX@!3B>]S(HIP4:11\&S8IM>8RJWPPG%X<]+\15VO$7B
M[*:BBCQ*0RQ!N#):M]3YAU7\>LAU%?WV8C3M%JNH9SV+M>WJDG%1"CS"^6#C
M FR3OOW.:0I)[;M+I"1<W?88<T^3L8D;,:P0^2&P W154&88>];PLDX^<,7?
M,,W3"2-])^-+F"CGP CP>(V90#1AHV<1R4U'9]Y;_(,-%"[U@-O@(AORF'#7
M8,9G@$$+=B-Y%[@#"-T@'OZTEY[0: EB>,M+/FCQ-V2Y:I@-FS"B@);$]75A
MO8KQ4U1MQ-$W9W1)43J'0LQ^&AN86VTVKM  [R#8_8Z-%\>/RQ]AMT^(6"";
M5H6[YIR%XO@9J_D:IKK*F*=BKO&H@/+FFG:/7J!(*3&E?)HL)1TE':>R!.6.
MX,TS!5I O]9J70X6TIO19R?FL2I+],9,R0?)C@[?37J!ACOFT)B92C_+-#<;
M_ V$_2XVC(D?_&.1<1+[8(PS0.M;@^481$^L8\)VH(PB@PZH;)1^'WY*0M:&
MBW_C!H&-S\-&KUX=(L']H4M9'-"FKZ JU%9=/=Z5E"A[8,I4Y>_WR)A3DA^G
M_#+R!-LN!>>+,K6NH/; F.N_(!1:4N"&D,=ZS*CLP1HO2*I3IQ\"3YE,*NE3
M8R#M)A@;AV41OB%&QF0B! ;<+$_691$./L6OT48GT;M%.;I &#9%&UMK98C_
M#?!ZUK\^*@'5T<#+O51M5EM^NTC)TA G]-+O%*>\G6T%"@LVBA%[2&?M^RG[
M<2.QVKS&99X0#"]O>8[SA">,!UH/=6\S-V?S^Z8I#XX5?DE)S%4&> +O^\0&
MZOTH$/HZ;2\>=+'BI9YC^>>X:*+!-IRA+(HZW#MA8 GO;@=V8Q4?&]&0D-6=
MMFD_^WY_Z'=OM,[)A1,VMO<;W!%!!9I-PYU(2N>"U1NW<ZB-\9Y%LV+,]Q/N
M$ [,_VS='E;0/$@IBV<+OS< MA+S]=R,&W7IU;!.LA/W8J$YF^D&;*(4(U?P
M=$K%8Z R>"B"T@7^TMIINM38ADLJ\RQZO3QXF4DR(CT@]8JDXNC=_NM8U4EY
M 5 [F+V.K"JAZK-2&"Z6\+A]0H*G!$P)8JD%L]4+XWEUTS:;JDH81W;$4DST
MFX2*\8/W49T$%>43I(F B]<K!-:75DIN[N;Z:]O_;O9:=GF!P@DZY4VFTK/,
M&KVC'/W75'W6OX79W+M"[XXK]-'VO2N4.6A#Q4=@ ];D/=Q@7P^/$''GZ.#T
M-/KMEX.3@^/7MP.^'/NP%:-D83 K+$SGD*$VPE[R&(P! Q:+'SD%U* M_Q-U
M%$[/5 WJ'WV.=IQL_TS 6IW7*?)X'#W:?K1[5Q"/_1^R_T._N/L]30X)65@?
MC =1-O[;@W]N[X[&3\;C9\/TV:,GSW>>#B>/ANEP\OS9:.?9X\D3$#5\@/[V
M8/M!A!G_<RPES,_MW]4\&<G?P1'U_\+%E#^%G^&G8[,^F=X3G%V#9H9R];AC
M$&!(F$O^MP<[#W#A_._':\_5@Y_>'B.6T_O3Z/!HSW+!YF^'#YN_[5ZKGF;;
MNJ6^Z_KK7/'@-:?8G%8DNVZO+!2>-]@C?^3'G0._6K[<>)2=9T[*JU&BJD U
M,K!(OJ^^YP+HO2VJ@=[X+;=#A9:-\.4"G?<V$4"'=;B[_>A%\GSRZ/F+\9,7
MVT^2W4>/MI^/)Y-GCT?C%X\?/_A,DN+/(@(:[/7)8SS!,8[@NMJ<'W?IO>NY
M[),/Y0,M"M;+C29QO.=O@5#>>&>(?WE-JGD#[%T@?MP!!U8NT^B8U8,_@I:W
MP'B?E;:?.%Z3UI_ONEM'ZN93W08@HFQ9414(=@6IL?_K_[X%P<5P&J( OVP:
M(]<DVOVF=J[D_OS\D:3>5-?YK#MRS=NFL0/7?+Y)\>MINZN5K(TM]4<[3^?=
M$NC> 75''% []PZHC=BZ;=\^U><T.#HZ^*]H<,UW?P[O5W0[SJY;==U_ZIJ.
MCL\.$>CZ-:)?_WIP<GIX?'3=B-5=C9W=%"46(^(4#F6'H\U!PZA3)2WLT76H
MDO(<!@[GZ]09FMCDN\0L">L9C![MDG/P*?H+ RBWQ%7BC@ILL<;QJ5Y0'.=*
MO/>PKVR^U*7=A,I<J*2C$3<6Y92<H$1<-QWU!]%1608:L 6.7DMJ@S[A'*R$
M^&>"O(0_2:FQ81:4I#XEI?'M"I:0Y/V0.Y=*:@0@6F67!.10&\6I5WKG*+\.
M$9XP'$B11\RTJY./6)4L/;G\6G"I-Z54?AO#Q,7; BQNP<TUPR/NZ4J]Q;.<
M2))4&HO#0JYZM2$^?$-MAJ:.0),TY6EC/1 AJMK,06E/- DZ5N5+84@.J:8,
MNF5+M/UEFP9&UXZ9?VV'_!57L=H";Y6U(E73*O,NY"N'G4Z;?R7I9QIMQ627
M5@JL1<Z(=P3&!>,#:,K@%J9CE4A8*81:%C4&QOI)F&);N9+'5IP0BW_]N#?N
MFQD=&(B>P:C^YCDC%/^F#+^@1MZ8@FPR!+ 0&<7&HG)\)%"_G%?IK@65#E^Y
MI$8"5LF:G>4LQ,6$*OXT;6@P.-QIE63C#KGZ)]G"Z[]%'<E1,ATM&"VJ:OAB
MM(M[.]UY-GGVZ/GV4XQ'I>,7V^EH,IGL#I\\?CY,A\.;N[C;E')LCI/,*_B-
M^9=P99O'R2CB-_:'!P9$JQ^@87D_V7KQXKL6B.!BOCI8U!SJZ>[6]D[G4"UF
M^%HVI.:6<-*XM[T2P2^C_UWQOW9?7,LJ6BSY.T:USJ'N_M3;-_RG=U9+'MBL
M>!75%X4Y';^,_G*_LW=SZAT[.Q X5-/B+MQ1HVPV=O9^5^_"U#MV-:PX:3N7
M]QMX%Z;>L8'LYVPK/A*;0YO<X<5ZO[-W8>HWT9UL,NQJ7>E^M^_<U&^RVY1"
MLOE&W^_U'9GZ3?9Z(%B"Z-/;5PXK3ZCO*9>D9HRO:-MO0KOKG)![FMW3[*L4
M+]CX\)C@S.YWZ2Y,O6.7]G\;[($Q;9'%JPTN^/L-O0M3[]C05V7Q@?JGO/Q:
M]ZS;,T2N/EAYR,(W7[SR[S<SKG#0/S*(\0>]+/AKLZ27#?*>>*K/[4PWR(-:
MOZ1'CSH6$9#/)3K=-'.I+1_&ZYR+:%;VHY)?PI]QJ 57E:=M64\1#?NW!SRL
MGP3E_JW^]6EL8/;]7__EQ^^'Q7A)_[BH9U/XQ_\'4$L#!!0    ( ,:(/5M?
M2/H:04X  *.@ 0 7    ;GDR,# T-S4T-W@S,U]E>#0M,BYH=&WM?7MSW,B1
MY_\;L=\!)]N[[(L6AT^)U,PH@J(H#]<2I2.I&3LV' YT TW"0@-M $U.^]-?
MOJHJJP TFQ1'DFE.W*TILANHRLK*=_[RA\MFFK_\S_^(HA\NTSBAG^#G)FOR
M].4/W_'_RB__S].GT=MLG!9UFD1-^2)Z595Q4F7)11J]R8JX&&=Q'IV5^;S)
MRJ(>1L?%>)V_2_^]+L?S:5HTT;A*XP:>,:^SXD(_Y</I^TF6I]'6[OK^^N;Z
M[O;VAOK^83E;5-G%91-M[N_O1D^CK8VM7?WUIT]Y)]_)5GX8E<DBJIM%GO[X
M9%(6S=-)/,WRQ8OHH(*E?A_1[^KLG^F+:'_6?!\UZ:_-TSC/+HH749Y.X#?C
M,B^K%]'O-NB_[Y]$HPOZU8]/?C>A_Y[P*_%)G6_Z[_-LFM;127H=G9;3N/AO
M[ZV;&_#:)R]AR?C+ETABH<&'^"(]F4]':76:UFGS!_CY#YM_^,,?S!Z3[,J<
MRV5EWGR9(GE>1#NS7UM+CT;Q^--%5<Z+Y&GX)[UO.-\FK;Z/IG%UD15/D0PO
MHGC>E/97%;^$?S<JJR2%9Q5ED0)YBK*^C!-8BOSP)*+'_OB$'_O$K!F6;Q:M
M7TZ/!H*TZ7DM6QN5>2(DO!6)CWZ]S$99$^VL;QEB?]Z9_3"J7AKFE"?"_ZIC
MP1^_Q#OL!WIH^O=YW623A3S_<^EX<G1\_M/1:73^T_%9='9T^/'T^/POT<E[
M_,V1^<7QT5ET?'+^/OKEI^/#GX+/PL]'?SXZ/3P^.WCU]BCZZ> L>G5T=!*=
M'OWQ^.S\Z/3H=?0+O"-\WL'):_C>X4\')W\\B@[?OWMW?'9V_/XD>G_J1$3P
M%?VI-_" OT1GYP?G1[ T>-G;XX.3PZ/HXP?XZ\$)+NG=AW/\Z)O3]^]D,:<'
M])N/)Z^/6OL[.#S'IV[N;V\/(]C#P;LC^-CK: T_]U^_V]O:VOC>_SC]<O/[
MP1#W O_G\/#]Z>OCDS^^_<LP>G> 1#P'2L!#WQ 1@*1G[]_2IH\^G$<?/IZ>
M?3PX.8^ K+A>^-3A^?'/1]Y2'2EHI["D\R6K/PT?>O#SP?%;.A6?'$/\+%#M
M((+WG)S!E_$ON-ZSCZ_^!]8!WQ_2*SRZG1[]OX_'I[2*,Z15QQKP5/'!1 LZ
M$#K[@P\?WAX?TDKXR-37WA[\<K8>\!0^!IZNMJ\8\0RVB$^BHQ;6.^+UZ&?@
M$0#Y/[P]>OW'(UK5X?N3DR/>*Z\J>O7^Y"!Z<_SZ"#Y]^D=9^$>@G_Q=\?"K
MT_=_.CI]^OKHX"V0'^CWGN[-V_<']FEOCD]@R\<';^%E9^?'YQ_I5><_'9SC
M)3F@I\.CCL]I.3\?G9W#8X#57A_!-WF)IQ]A8[L;FVOQP&U^V8FK5= ?<:5P
M+S["-74?7M="QI<LMY<8__6[S6<;W_<_L4OYW(NHPNL/] 2J'?X).1UD!YS[
M+P>GP,/G[?7<I[#N%M=?:-],\'?O\=Y]1$%\^$7.4V^^B4=@QF7)CT_^.4GW
MGN^-X_'.WOYX9S=YOO=L8[2U/][;VDRW=O9CL!#NN)*6@7.=)<TE_G'C#VBH
MD6'RXY.-)T#=/)_%20+6IOUW/8O'\F^U\"C2/^-&JI?^;_!WB5FRO'$77_CR
ME[BJ8F"@L\NX2NL7'3:A=[!/7FX.=YYM#/>?[1B#Y+LF6?%M71;;DY?'1=:@
M"7[T:UJ-LSJ-7H.9O<)"SM)9DZ*I"8;WD*SJ_A7!KZH>@L&?\-B5Q?)UA(@U
M>.B769$ ?5Y$S[>09V[_9E(22T5)M-9<ID;E_S WC/##=_.71N7#&56PI@S>
MUES&S1#>4T57<3Y/HRH=I]E5F@RCOV1IGD0?R@Q."VR5MV\/(_A4UM117->P
MLSI\T4]P?&FEW_.?_^&.(ZLCV#@Z</#L^:PL(OPV<,H4'E@ 5\U'?T_'#7AR
M](<\FV9-3)Y;!)]-#0_A1_'OX[)(,O[S95JEX.]-X%D1^":XF>9R&,4-?'@1
M-4!4? *LG3^"WTZ $^E[Y23<12?7>L3#)? #9U4&_Q=6O/MB8R.:K4_7HS4\
MOK^4U:?H,&OX[8.(-^MH,0$*1VN[@VB1QK"LHH!_5W5<+2)8#RZG<Q'A2L^!
M=K!O)$)[D:-Y ]Y/@T\#]Q8W/L2% I7K<96-4CIRW,EL7HTO8WC%I"JGT;L2
M7>)Y3<XRT#!ZG>;Q-4@0('@U*RM^6["0PW(Z U+K]^,1X_NL4(EJDD/16ERK
MHW8DB1.\)^2/XXK!+:05=W&RB#1ONT W6,44UG;6E.-/ZWQ!HW/XOMT@G-8X
MQ4^";\C+";\6T6OAK<"LYF7PP3R/@&#I/^9P(L*>]F ^X$.!4'64I).L2),H
M@X?![I!.6VNCP5<S7KKESO:SN\D=(+_9U2927BA\M_\+#WN-U.(+K!X7'<8S
MN/8YO#D1V3#'\ XR*G)SB>Q\C70WU.;++Z=T&<.]PN.9IG$!ZK1V\@"/!66=
MXSB4@3$?UKR"E0 )/AA6.;BHTI28,6#U]B=\KD\HDM368, AP&47M#BY+E:4
M&0:M8+EP<G%3@B"@>]N4#X][MNZ#>\SUHV=]21*-<Y#8:*DTES8 U90S8P/*
M;^#/33DU#XW&.6C,'Y^\.OWP!N-HKT @?SJ _Z--/7I)\$$.N-$G;[32;W<<
M9()UONU)IV56E-7412CQ _9W8#A:\RPPNQ7=9O""IR/<^%-21B^B.+^.%W4/
M=7PC6(44F< 44HPV,*RHK6PQLI_*[T"<F CDUBTCD/J8.Z*(P5:_AAT8#^[I
M"J$.5":B$<3ZSUI(<4RT!CMQ!CH8.3")1@M?94[C!2K,*9!JB'+W^K($]PN-
MQR*:Q57CV6;NH-&4HIV'UEJW->3,L%$*(IX%?V@3X=J2-$?[:F%TMY&_L+,X
M2N;Y JW+\1QW,HG'-1B>.9H[LP4^^\/K-_PS&"U@D<IVTZ?3.,NC-?B _!@W
M33R^1(4P,"0[*1LQ..S",[9Z8;E3-/O@O8G;/TO\4..TGZ(UCCFN7S(X 7XX
M<&Z> >70M,T&47,-C]P:1.=5C!XG4&7!!O=:AG^%+Q1T\?'SWF?&0*8JHYP(
M?NJL@2_%%2JW!HQX4HX?4C" $[+I.JV?9( K8!4]@%WG>7EMGD<F.+S36?:U
ML@;Q0.LX2]@$9,]"E+P<)_TAO@ U?(%/\@TRLF[Q V)UUK-TC/Y.8DX@GLWR
M;$QA@8YC@A.^SI"C@)WK"=*FBL9Q?0ED1<)O/O\>R'.9@L&85/%U@6P81Q^!
M2U'W@]<";QS%!9J3>5K7[*_ U^D?=K^SJARGR1Q>HU>G8H:6C&,PYU,@'?I0
MM]O)^HW.MO"/B/"3$A[[Z6D)EQQN4=Y%&VL/5V 0 Y'@B$ 3R*_Q6DW3!'[$
ME5_,8Y0':4H7A6RWJ%G,Z'GN;_ G,.WB*OLG75N\/HH1X(%=!^1>;VX ?.H:
M+D&-;(H\!M_$*W%A+$2Y_. WPJE6BP[&0@-3/1B_,;M<U$#</,?[7U5IVST(
M9,H<7-Q</QIDII6=8,?":T0Z^,Y,%%^!%*%3M.Z/ID+B?0<?.DI3YQ83-TSF
M>2[R-AM?(L>E';M<;1\3XO@"0U,L3*^-@*GP.+<#>2)[XCMM%D"2KH^-LMI<
M9*:T>OEZ] &4! A\1P"S3WF36C?0;IXWN!!4+D+HFF4[^*NT=EE= UR6*VEW
M\PF$;D4ZF:#?"M^%VPBR3T19.6\LV_4^7M86O  6'1?H&P#C>!ZF.GQWP6]Z
MN+L-Y^[8#?.8H^4]@=(JR/VI4O#L$Q LETXVW_P>^U0CQNLYG+BE_SHMP'^C
MD=ND>BD @&<#N^V^XXX PGKHM:]M#J)7F*='20J<AU^@B-6LL8LHZ%%]8D'4
M;WI1PK^&]&SDH9F$GMQ:UNJ!Q[".6X/8S\XJL1]U79K4?;?7NAGR'7)$$)O*
MK4*'MYRIQ-&NB5@TBOG;CNO0=T;QUS6N2>O7X/A5C$Z1&BD%&G,U.O3;<EU_
M=?NGCUG=TUH;QJG8R*,/HO@"9IR5* M4/ ET[E66H,2Y!/K-X@69,4*B7F-B
M3537)5Q5T;HH7%G(M!3[ &6;":,B88A42U9K6/5&71U<:CHV"L6FP"_PHG@\
M3F<-2NU03(+%/?Y4E-=YBH4I]&4\;XG^PE?!Z:H=LQ"9:HZ]RH/ ;H>OQ+/+
M86#'6<>@2^0&_!-$]OK$C/;]G%26,^67.0DJ]^ "Z%DP^\M5$=,K%C.)16S=
M4(!&F!',?1,&7N]T8K]VO.6NWN'HWKQ#N@':,40F5#8LWH\9:\I;QE-O9/??
M;Z[O;,BQ#!U/*"'4%30._:?V3JSO]##.>ORY9WUH))@759/C/K"JY8B,'[QF
MI'S3.,DS5,F^\X>?/$TOLKJ17,$IQPNLV@'Q.,%+&VBK0-Q+;H:BH"A/BU*,
M+\R<5/KY=*.)!?C79)8-(_'_0)*1;I_79/G'M,Q&7 )Z;A.(&/P6^IYYVB/$
M*-IA!#$)LJ(=_HCSNJ2D@3'0^P,AI!Z($J.%TO=I7(@9*[S<4C3"Q\[B;]GZ
MN #)N>%U$:4$C^PU\+PDQS_FH-])08Z$<AA-R4"#HO#_W[6#IZ\&T=J?!W_%
MWZ\=#-!H <J^^+;NU=.MYRHTRP6$^_MWNVNPR>A'3/8XH_P%1UF 7#__<O"A
M;>XMHFP*+G$&7 I>Y S/( EC(#=')#(V;AU_=+M4:!]CT-)%M%#7.Z,1]&<]
M%W?/Q1?B@;EO%,A(X@7;1^9^>+L![L5PTF>_13_3LX?+68JY&]R:<#Y<['D>
M5QB.P:\H*5'"F\PU" 31Z1PH^6QC8VTT6'NV1[;\*3V'EG/R[@QEPW2>7W#M
MKR@JD $I_ 1WH'9IH3R^KLF I:NJ%C[D()I(LW*F31\C']*,C,>UQ?TRR5).
MP#/Z)[_O59:(%2N/\/2S+ 3H7XRS&>S:+.E=7'U*&^3T*D6;CN_^J[PL47!<
M1&_7/X"=[[2L_8N?*;>1 2/I'65L(*WEJJQT$Y9ZC%GM6#.9DY_>S4H^![7X
M$MG:"U28*(C$5.G;*L4.[%",\SE]7R)!WB>=GS;.2S:9[[*NP<TW#)<B\5U'
M%LU[MQ(]+4>_6_JTB;?DPY\C0.Y,1VU%^E>YJX+L*U;@]:@RSK]ZJFQS8^^.
MNNP5ZK)V,4.'[UB+I2WY=A*6W^.9?7VB/29DVPG9K<>$[,W5H+++UV<?WKP%
MM^$<?_F$:T1'>SN[V_'S9&]O)]G9W9GLI\G.SF1W8[P%/\3[6W>O$?5K0C^K
M$-2LX0I+^<9Q;I@0F/][_ZO\A;!ND]Q-9U\OK_5L-\5$J[WW9@D'@NC/@Y!3
MS3&NOBKNC^I:E"$Z-0C=986!#-YO>Q-$R1^7A\[)HKXNYWF";EE6@X)#-J1*
M2!M/";,;F!X88WR>@GH4K'95DZT/BW*V3[M&YWFTT+XD.I%M"K@$2P1>M8UU
M=@0WUU<^J<^JS/WV5"]'9T0L51>CM8UAA/]O<!=Q?]Q./E7,$^R[T#%V4)_#
MIA@Y0+>D/Z3;Q3=B1SFJ;(-!M;9OJQ54&=S!6)(#8?B?@@I-_"DU5N08_A"/
M,>8"-!O70<0$DY1H7JD@B GT7X(/@'^:<05!3Z2%OBUDD:AN [N6 &[9^R1W
M*7344E(=*K/&.0\JDRUY7QA*GI4U%2;:7#&_"AZJ4_(=T<-OE6OO$G6QCIWQ
M'Y5CQP)E*"7$"W(-AL:1'&.2JJ$R'%,:A&G@JK9Y%I<_ !T\KXUL)"\$.Q70
MT,\ZG-6,7"W%P7E&)BFL B-5S!5QX,+RND:PBUFO%VS"?N2DPM7YQSRMN<Y9
M_E"DR(^-<LQQRZW<GCC-7@*\:P?MA??ZV6LCRK;JC>F<V(*KMO=?;&]$<6_J
MC9.46_W)N<$07B1A9"3]^_/#__<*EX<__+D=!]*DO2KS^11U#9H%N!70P6 U
MWD!NDG#D4JY XV Y7J&0=5UA"^->OI%*^ [*T]G+MCI>A0& ">^EMGSB/3WF
MRK/"'2#\"<7-AZSX%+V?P5^$+W"G<43U93&6%%W$A=2\4+G;15J,*5DX3B7X
M4U*WQ61>C*4/0A7&\-M(\-'B!GP:T[)N*,X+<L@QO9>@:>V@+NW:*6Z^E@Q(
M@6"M"AD#F.RLAY(QRRHT?G _W#!"9D5W]H<"<EH44/XT26<IB2<\O"H&O8!M
M&SF(5E9^%V6)A7BHLT1Z?+ %TJI8$%\[C?]>5LC%&,Q'WRMU4D;I,SH>7:2!
MQ\H93^ <FS=%<\RO1)$]HY+ KZ2_SA!M@-0<WW ;9I_%F15VIHSEWT-!8%#I
MF]$-<K^]FM*;=$,2P[:_A!C[<JI"M:"K@-R_DZIP%# ZXYM4%=FCJGA4%0]<
M5=RZ,->(RJ"4?ZC+J27-C05HTL:JZOH;:1(;RAUOEQ XRGBU"F>]M03PY3$5
MSC:ZI,"K'!C>LG3 ^L)!^!V6>D&(1)6K7KIKUE"K%[,6BD&IVV&HA3R;56E7
M18/E78RA3>-&2J)=]?%5UA&M\-(X+?]Y:"1FHPN* KJUGD =)Q33,)$TV/:5
M:D.QV2R=47R5%NDD(SRH]]<%"(?+;.8H\-:V&LO>_2A:_QHL69(TCQ>413;5
MWW59%BAA^!@J^M\:RR.*CG+ V@0W9LCR=9VAI/&3CB"28$56W/?L26T%KT:K
M\)7R[.KHQ\S33OF&=^X;$$R/"9YV@F?[,<'SY7M8DUO4V47>/\!+>I>"65)(
MB/2K=:_^=DH^^_Q^<*F(;F=./F**I*LV405U11:/T6?LTKRN<<$5BC94H4<]
M7K:SSUT"4;7<_W5PD;H>&5'?H&[&()ZSQDA7C+C/73EY4.8BV!E)R@7;]O>C
M.*<@O?DV!>MQ9Z]3"D1C,_AY!8=EM]I<PA6ZN*3'R8?PZ=@"B.UH,38C1H?P
MC1), ] W"S!DIKI8Y_4O!X=>G8YSA>@%QO>,.=6 E4&%:IPW"0IY,)F[4N1T
M,'#V%KSZQI)-4GB-I2!EQ90Z"E-H)>[S%A86>BBO!EV?0Q\$..XB,V6?\E3_
M^T;SLN/J116FV+Y9/2TG3^E[&JY$&PQ4A;:YLX/5:?5\2H&-EIT49$W$-'*&
M&2S*-**Y9E9.YS&.RYC,8V.SND)<.5#+:^Q[F<^93Q5Q6)L5,NO0^+..!/UY
MSK)=C:JP7SSJ^(:67*\X22HDC^MT] ]%5MW=MFE-7U/ 2-8E=<2RO]??$NO
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M^R.F2RN;-)<=PI2VT4&A$>@W;BP=CZMY.G#$Z7G&LDY"=NF[?';\K'72/=M
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MP^/Y$#H">JXTLWR("SBL)US2'"QY&KLSK@192A:P0M:BS78#]%'<J@WW:-Y
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M@'3 \AV98<%J#50<.$Q-=QC=%)&J8*V#'UEQ#,!7+Z+Y1H!8J1PBJ)%KE3\
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MWYH.J8H1-$X@J'<#[9URDXW?&JU3FA&7&36\%WC68-!+NPL/XS=(;??RPS^
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M-)AL#-'B]%VDH<\=BY_@@;5VPG"M<L8KYMEXKA2&O$ZD]W8^]ZZ2"  H-A<
MQO/2[,'8L^'HR9)P5"BN>?) G5PB HFF&I%F!O#1K@Y7BBA7G+5)POBS5^0C
MF(X_Y;:)OO+T"CW,Z 97V)* HV_F"MW));\[SI@-HI 7QD28B07FLV3;VNBM
MF&T!)RKN-;S ,5BH!LE&#W%$'G6Y<A&IQ@81R/MET)W<.812,'$V,$@'EP^0
M#_>\I8$!19(DM; $MY$"V.*!K2A(PC/DE1;:VY\8A 1W R$.!>0D>2Q8LDA
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M8!*,9PQ$8E:?XDLND7,F$T[2#'.>=>5>K(L+ QG:Q_&"(B?# SO4M;PXUF;
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MVWJV[B%_;N_2GE=V:-F&K_([N':\E@W'^%N\K#R*$&SMO9HWIS^T-U7'64W
M%V3%KF%'UQ.1*5Z6H<5LE1K<WT8>]W>6\O@T\EC?7;Q2JA*T6:]]I5[:?4%R
M\/@,)E?:+\3AGVJE[2Q,#ASW*KX_\I:[_L'> \[]K9S.MYG>1P&J#^[A77I
M#\79E 4Y0)O__-SZT.JQ#T^=BE>5/W\/3=GHHI&&SD'V\;QS=B,%R@*O;V[L
M6LKLQTBH!HQBX:[V$GE AXQE?+WQ,$& J NKJ/?R4KH3O9Z>$D:+"59FT84:
MK#?@*0O_)!'UFC+[6=N])NKV;MR<E/B('+FM[^1!2%HY N%@OS5.+YNLTSQN
MMGYKGM2JYX0FP#HE:DZ Y>H,9,KU<<A,.ECRY"D&]<0\?5!GPQ;?VGSS9F]_
M<ZO/=^K[.P=[.WO]^E;?/]BO[_??! ^--JH0PT(SQV[ALJH^8T01_5O!0&=
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M^^(70EZ:N7:;P+G)E$;-<8GAWL #:ZVPSQDOQ'*9-W;R%6LUMM6!W)H%'7R
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MK^L!OEUBZ"?,Q3Y4GL$3S2PY=JXPC?NARIK&=X3%YVO])C9D; ;%*0'$*5O
M5%4+==U!I&J1?C%U=9+:A:Z&[T$:8IT:@[I>8S&(X'(W!4)PIBCCQ$H[RX%>
M7-L2G[9W.=<3Q/45A3F1@7XM"@#&(1(-7P69?)97A0>0"H2=?&V1I /I-M"*
MOB-5/$\[2*[&U72H/"="M%76*VBO(S%QF<#H5?(2;VY(]H$^%V_SAI *!+:]
MB\+> FEX4.F67'!I'MG4J^0#X1%U A[&3N HM2TWC\=3OILVI[[,=!'/E>*,
M#0%'NY>W.%7.*A(R.B<L,UVN#<"_-A-+W:PPD2I!^=4I9VD[R3&AN9(&$=X
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M_*G*\")9P(+?BU'N@#E?:K;_W=G-L$G"GS/5,%L!*X%:4^H;C(Q/$W?09=)
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M7RTPAF#<P/Z]??=V[^#XP]$@V3_8O1\* CXC;?:55ZHW]N'#7]Q5;UCV"J8
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M;']V?KIBP-_2F.*']*K;@SO8"G 'O_V*S;/IA]-V4L /_PM02P$"% ,4
M" #&B#U;V)5)PJT#  #0$   $0              @ $     ;6YT<RTR,#(U
M,#DR-2YX<V102P$"% ,4    " #&B#U;)6@"JMT&  !>1   %0
M    @ '< P  ;6YT<RTR,#(U,#DR-5]D968N>&UL4$L! A0#%     @ QH@]
M6[!ZK6+^"0  ?68  !4              ( ![ H  &UN=',M,C R-3 Y,C5?
M;&%B+GAM;%!+ 0(4 Q0    ( ,:(/5LI(N-TYP8  .E,   5
M  "  1T5  !M;G1S+3(P,C4P.3(U7W!R92YX;6Q02P$"% ,4    " #&B#U;
MNEUJ7SHG  "1]@  %               @ $W'   ;GDR,# T-S4T-W@S,U\X
M:RYH=&U02P$"% ,4    " #&B#U;R-N-/8?D  #;[00 &
M@ &C0P  ;GDR,# T-S4T-W@S,U]E>#$P+3$N:'1M4$L! A0#%     @ QH@]
M6^C^4 NG:P  W%\" !@              ( !8"@! &YY,C P-#<U-#=X,S-?
M97@Q,"TR+FAT;5!+ 0(4 Q0    ( ,:(/5LP=!VM;I4  !9* P 8
M      "  3V4 0!N>3(P,#0W-30W>#,S7V5X,3 M,RYH=&U02P$"% ,4
M" #&B#U;;W$K#5:6  !.W0( &               @ 'A*0( ;GDR,# T-S4T
M-W@S,U]E>#$P+30N:'1M4$L! A0#%     @ QH@]6V*L>&P<2   M%@! !@
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M>3(P,#0W-30W>#,S7V5X-"TS+FAT;5!+ 0(4 Q0    ( ,:(/5L$X1?-E$@
M "2S 0 7              "  9#F P!N>3(P,#0W-30W>#,S7V5X-"TT+FAT
7;5!+!08     #@ . +P#  !9+P0    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>ny20047547x33_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:mnts="http://momentus.space/20250925"
  xmlns:us-gaap="http://fasb.org/us-gaap/2025"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="mnts-20250925.xsd" xlink:type="simple"/>
    <context id="c20250925to20250925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001781162</identifier>
        </entity>
        <period>
            <startDate>2025-09-25</startDate>
            <endDate>2025-09-25</endDate>
        </period>
    </context>
    <context id="c20250925to20250925_StatementClassOfStockAxis_WarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001781162</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mnts:WarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-09-25</startDate>
            <endDate>2025-09-25</endDate>
        </period>
    </context>
    <context id="c20250925to20250925_StatementClassOfStockAxis_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001781162</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-09-25</startDate>
            <endDate>2025-09-25</endDate>
        </period>
    </context>
    <dei:AmendmentFlag
      contextRef="c20250925to20250925"
      id="Fact_d376102dd3134298b4c407817bcf65b4">false</dei:AmendmentFlag>
    <dei:DocumentPeriodEndDate
      contextRef="c20250925to20250925"
      id="Fact_9d8820e0ecc746fa907da689fe54af74">2025-09-25</dei:DocumentPeriodEndDate>
    <dei:EntityCentralIndexKey
      contextRef="c20250925to20250925"
      id="Fact_80246123b6b24e4397fed63868e3124f">0001781162</dei:EntityCentralIndexKey>
    <dei:EntityIncorporationStateCountryCode
      contextRef="c20250925to20250925"
      id="Fact_aab4d6bb89ca45f899afc974b9579a02">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityAddressAddressLine1
      contextRef="c20250925to20250925"
      id="Fact_6496073cfd4041d5bd499182983d50b3">3901 N. FIRST STREET</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="c20250925to20250925"
      id="Fact_845c5cacaafe477c95196d8369966472">SAN JOSE</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="c20250925to20250925"
      id="Fact_4ec4fd48e404438caa2040897c56b6a5">CA</dei:EntityAddressStateOrProvince>
    <dei:SecurityExchangeName
      contextRef="c20250925to20250925_StatementClassOfStockAxis_WarrantsMember"
      id="Fact_8105e2dc74d844c4a41ffc7b8629e8e8">NASDAQ</dei:SecurityExchangeName>
    <dei:SecurityExchangeName
      contextRef="c20250925to20250925_StatementClassOfStockAxis_CommonStockMember"
      id="Fact_93a7c9e06f3c471a81965345f0121279">NASDAQ</dei:SecurityExchangeName>
    <dei:DocumentType
      contextRef="c20250925to20250925"
      id="Fact_6b32b7868bab4f8b93583c369c4519f8">8-K</dei:DocumentType>
    <dei:EntityRegistrantName
      contextRef="c20250925to20250925"
      id="Fact_f1a420de4d7a4121b7c8d36078535415">Momentus Inc.</dei:EntityRegistrantName>
    <dei:EntityFileNumber
      contextRef="c20250925to20250925"
      id="Fact_18a30d82eeea4101897ba9ed27addf02">001-39128</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="c20250925to20250925"
      id="Fact_017d915069464821b92cd5e981bb0d37">84-1905538</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressPostalZipCode
      contextRef="c20250925to20250925"
      id="Fact_ddd74282c87e48de9bedabc6caef3fc8">95134</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="c20250925to20250925"
      id="Fact_0c5fef8c3dea426989e255633f038a56">650</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="c20250925to20250925"
      id="Fact_50b80b7d7e5d4e6cb3ea58a6d0cd8f28">564-7820</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="c20250925to20250925"
      id="Fact_604ce8e12db74624bb0242b7a2773e5d">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="c20250925to20250925"
      id="Fact_56b59e6ddfa24089a3ec3bb170c4be38">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="c20250925to20250925"
      id="Fact_a00618ee0b1c4fa1809980c84eaba185">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="c20250925to20250925"
      id="Fact_946835efbdfd4ed8b069b69a810d9ae6">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="c20250925to20250925_StatementClassOfStockAxis_CommonStockMember"
      id="Fact_9c45aeb00c2b4a45994b60ce787fa83a">Class A common stock</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="c20250925to20250925_StatementClassOfStockAxis_CommonStockMember"
      id="Fact_45374d598ab9482393c16ac72616af5f">MNTS</dei:TradingSymbol>
    <dei:Security12bTitle
      contextRef="c20250925to20250925_StatementClassOfStockAxis_WarrantsMember"
      id="Fact_c2101116c0dc4c43b0676f8cef2319db">Warrants</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="c20250925to20250925_StatementClassOfStockAxis_WarrantsMember"
      id="Fact_0f30fbaf1b08412d830aef8275ce1b29">MNTSW</dei:TradingSymbol>
    <dei:EntityEmergingGrowthCompany
      contextRef="c20250925to20250925"
      id="Fact_f416ae9d20354992b2ba12b372888696">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
